var graphJson = {"directed": false, "multigraph": false, "graph": {"node_default": {}, "edge_default": {}}, "nodes": [{"entity_type": "DISEASE", "description": "A condition characterized by a cluster of metabolic abnormalities including high blood pressure, insulin resistance, and dyslipidemia.<SEP>The composition of the gut microbiota can be associated with metabolic syndrome, a cluster of conditions that increase the risk of heart disease, stroke, and type 2 diabetes.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20<SEP>chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "METABOLIC SYNDROME"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Represents the total cholesterol in serum which includes LDL and HDL cholesterol and other lipoproteins.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "id": "SERUM TOTAL CHOLESTEROL"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Low-density lipoprotein (LDL) concentrations represent a type of blood lipid that can contribute to cardiovascular disease when present in high amounts.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "id": "LDL CONCENTRATIONS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Concentration of triglycerides in serum, representing stored fat in the body which can affect health if elevated.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "id": "SERUM TRIGLYCERIDE CONCENTRATIONS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "High-density lipoprotein (HDL) concentrations represent a type of blood lipid that helps remove cholesterol from arteries and is typically considered beneficial.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "id": "HDL CONCENTRATIONS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A set of measurements related to the levels of various types of fats in the bloodstream, including cholesterol and triglycerides.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "id": "LIPID PROFILES"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "High-sensitivity C-reactive protein concentrations are a marker for inflammation which can be elevated in obesity.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "id": "HS-CRP CONCENTRATIONS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Measure of the force exerted by circulating blood against the walls of blood vessels, with high levels associated with cardiovascular diseases.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 27}]", "id": "BLOOD PRESSURE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Estimated glomerular filtration rate is a measure used to check kidney function.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "id": "EGFR"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Liver enzymes, their higher concentrations in serum indicate liver damage or dysfunction.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "id": "SERUM ALANINE AMINOTRANSFERASE (ALT) AND ASPARTATE AMINOTRANSFERASE (AST)"}, {"entity_type": "DIETARY PATTERN", "description": "Total amount of energy consumed through food intake over a day.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 27}]", "id": "DAILY ENERGY INTAKE"}, {"entity_type": "NUTRIENT", "description": "Amount of protein contained in the diet which is essential for body functions and structure.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 27}]", "id": "PROTEIN INTAKE"}, {"entity_type": "NUTRIENT", "description": "Intake of carbohydrates is a dietary factor investigated for interaction with genetic variants impacting Type 2 Diabetes risk.<SEP>Total amount of carbohydrates consumed through food intake over a day.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20<SEP>chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "id": "CARBOHYDRATE INTAKE"}, {"entity_type": "NUTRIENT", "description": "Fats including saturated, monounsaturated, polyunsaturated fatty acids, and cholesterol found in dietary patterns.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "id": "FAT INTAKE"}, {"entity_type": "DIETARY PATTERN", "description": "A score indicating the degree of inflammation-promoting diet based on food intake data.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "id": "DIET INFLAMMATORY INDEX (DII)"}, {"entity_type": "DIETARY PATTERN", "description": "A dietary pattern characterized by the consumption of fried foods, which interacts with PRS to influence BMI and obesity risk.<SEP>The amount of fried foods consumed which can be a factor in obesity risk.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20<SEP>chunk-3ad8ef794841d749e48b3223741e91d3", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 27}]", "id": "FRIED-FOOD INTAKE"}, {"entity_type": "NUTRIENT", "description": "Intake of sugar-containing foods like desserts, drinks etc., which contribute to the overall dietary pattern.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "id": "SUGAR-CONTAINING FOODS INTAKE"}, {"entity_type": "DIETARY PATTERN", "description": "The proportion of these diets consumed in relation to obesity risk.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "id": "KOREAN BALANCED DIET AND WESTERN-STYLE DIET INTAKE"}, {"entity_type": "DIETARY PATTERN", "description": "Intake patterns related to plant-based and rice-based diet, linked with body composition and health status.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "id": "PLANT-BASED DIET AND RICE-BASED DIET INTAKE"}, {"entity_type": "FOOD/BEVERAGE", "description": "Drinking alcohol in moderate to high amounts increasing the risk of type 2 diabetes, especially among those at genetic predisposition.<SEP>The amount of alcohol consumed which may be a risk factor for obesity.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20<SEP>chunk-f7bf38c7a21b86ad85fa360a21bfb447", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 28}]", "id": "ALCOHOL INTAKE"}, {"entity_type": "LIFESTYLE FACTOR", "description": "Individuals who are current smokers, indicating smoking as a lifestyle characteristic.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "id": "CURRENT SMOKERS"}, {"entity_type": "LIFESTYLE FACTOR", "description": "Engagement in regular physical activity which can influence body composition and health outcomes.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "id": "REGULAR EXERCISE"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant in SEC16 Homolog B involved in obesity risk by modulating transcription factors related to energy intake or expenditure.", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "id": "SEC16B (RS543874)"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant in DnaJ heat shock protein family member C27, contributing to obesity risk through modulation of transcription factors and influencing energy regulation.", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 27}]", "id": "DNAJC27 (RS713586)"}, {"entity_type": "GENOMIC VARIANT", "description": "A genetic variation in CDK5 regulatory subunit-associated protein 1-like 1 associated with the risk of obesity by modulating transcriptional processes.", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "id": "CDKAL1 (RS9356744)"}, {"entity_type": "GENE", "description": "Transcription factor AP-2 Beta, a gene involved in energy intake regulation and associated with obesity risk through genetic variation.", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "id": "TFAP2B (RS2206277)"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant in Brain-Derived Neurotrophic Factor involved in obesity risk by influencing the transcriptional regulatory network related to metabolic processes.", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "id": "BDNF (RS6265)"}, {"entity_type": "GENOMIC VARIANT", "description": "A genetic variation in myosin light chain-2, contributing to obesity risk through effects on energy expenditure and regulation of muscle function.", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "id": "MYL2 (RS3782889)"}, {"entity_type": "GENE", "description": "Olfactomedin-4 gene, involved in the regulation of energy intake or expenditure and associated with obesity through genetic variation.", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "id": "OLFM4 (RS9568856)"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant in FTO influencing obesity risk by modulating transcription factors related to energy regulation.", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "id": "FTO (RS1421085)"}, {"entity_type": "GENE", "description": "Melanocortin 4 receptor gene, a hub gene affecting the risk of obesity through genetic variation and modulation of metabolic processes.", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "id": "MC4R (RS6567160)"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant in G protein-coupled receptor for gastric inhibitory polypeptide, impacting obesity risk via regulation of energy balance.", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "id": "GIPR (RS1444988703)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A measure of body fat based on height and weight that is used to assess the risk for disease. In this study, BMI was significantly higher in asthmatic patients compared to healthy controls.<SEP>A measure of body fat based on height and weight, influencing various physiological processes including bile acid metabolism.<SEP>A measure of body fat based on height and weight, used to assess obesity-related health risks.<SEP>A measure used to assess whether an individual is underweight, normal weight, overweight, or obese.<SEP>Body Mass Index is a physiological process used to quantify and assess the impact of genetic variations on body weight status and obesity risk.<SEP>BMI is a physiological process that reflects the relationship between an individual\'s height and body mass. It serves as a measure for obesity risk.<SEP>An indicator of body fat based on height and weight; used in this study to adjust for potential confounding factors related to metabolic health.<SEP>BMI is a measure used to assess body fat based on height and weight. It influences metabolic health and dietary adherence.<SEP>BMI was observed to be lower in carriers of any minor alleles compared to those without, adjusting for age and other factors.<SEP>A physiological process indicating the weight status of an individual, influencing snoring severity and prevalence.<SEP>Cases had slightly higher BMI compared to controls, indicating a possible link between obesity and colorectal cancer risk.<SEP>Body Mass Index is a measure used to assess obesity or underweight based on an individual\'s height and weight, relevant in this context for its potential impact on T2D risk.<SEP>A measure used to determine whether a person is at a healthy weight for their height.<SEP>BMI is a measure of body fat based on height and weight, which differs significantly according to the rs671 polymorphism in men.<SEP>BMI is a measure of body fat based on an individual\'s height and weight, influencing various physiological processes including bile acid metabolism.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5<SEP>chunk-8b9890cf10c4a751a1d0ec7e9843002d<SEP>chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6<SEP>chunk-1f20dbdcc9de443dada1a2045dc7832b<SEP>chunk-d311ac0182b37003c75c0005b4337fa6<SEP>chunk-a34b927ed42ff0917960122b4d203f83<SEP>chunk-c6fdc5ed25c4e17b8c421a952bb05450<SEP>chunk-eec0b4c60ebeb28599428b3552de2d1b<SEP>chunk-f9a60d3cf951d77afa115859755dac43<SEP>chunk-2926e6216bf945b12ea4daa6345cad1f<SEP>chunk-6f7ce1c71bd46f223756da44b0d0bb2c<SEP>chunk-3135befd0c3140ad097d96ace6de86a1<SEP>chunk-44a871da300abc9be525b468f502f5cb<SEP>chunk-9e14f9bdee02839e4a6b12cff2020a5a", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 30}]", "id": "BMI (BODY MASS INDEX)"}, {"entity_type": "METABOLIC PATHWAY", "description": "Polygenic Risk Scores representing the cumulative effect of multiple genetic variants on metabolic pathways influencing obesity risk.", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "id": "PRS SCORE"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant near Transmembrane protein 18 influencing obesity risk by modulating transcriptional processes related to metabolic regulation.", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "id": "TMEM18 (RS6543156)"}, {"entity_type": "GENOMIC VARIANT", "description": "Polygenic risk score for obesity risk.", "source_id": "chunk-3ad8ef794841d749e48b3223741e91d3", "id": "PRS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The age of initial menstruation in women, which interacts with PRS to influence BMI and obesity risk.", "source_id": "chunk-3ad8ef794841d749e48b3223741e91d3", "id": "EARLY MENARCHE AGE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The later age of initial menstruation in women, which has a lower impact of PRS on BMI compared to early menarche age.", "source_id": "chunk-3ad8ef794841d749e48b3223741e91d3", "id": "LATE MENARCHE AGE"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Body Mass Index (BMI) is a measure of body fat based on an individual\'s weight in relation to their height. It was one of several T2D related quantitative traits assessed in the study for association with genomic variants.<SEP>Body Mass Index (BMI) is a measure that shows positive correlation with the prevalence of snoring in both males and females.<SEP>Body Mass Index (BMI) is a measure used to assess obesity and is related to metabolic pathways and physiological processes such as insulin resistance in conditions like T2D and IFG/IGT.<SEP>Body Mass Index (BMI) was tested for its influence but did not show a significant interaction with genetic risk factors (P = 0.47).<SEP>Body Mass Index is a measure used to assess obesity risk and was higher in participants with early menarche age and high PRS.<SEP>Body mass index (BMI) is a cardiovascular risk factor that increases hyperuricaemia risk and serum uric acid levels in T allele carriers of the ABCG2 rs2231142 variant.", "source_id": "chunk-3ad8ef794841d749e48b3223741e91d3<SEP>chunk-9977706363cc368b3be503d07ed3ef62<SEP>chunk-6a7c69534e11aa2fc4bd948484aa81c4<SEP>chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00<SEP>chunk-bb507a90a1f5d5ddd01a93200ff2d45e<SEP>chunk-44a871da300abc9be525b468f502f5cb", "clusters": "[{level: 0, cluster: 7}]", "id": "BMI"}, {"entity_type": "DIETARY PATTERN", "description": "A dietary pattern characterized by the consumption of plant-based foods, which interacts with PRS to influence obesity risk.", "source_id": "chunk-3ad8ef794841d749e48b3223741e91d3", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 27}]", "id": "PLANT-BASED DIET INTAKE"}, {"entity_type": "DIETARY PATTERN", "description": "Consumption of a high amount of plant-based diet that can protect against obesity in individuals with a high PRS.", "source_id": "chunk-3ad8ef794841d749e48b3223741e91d3", "id": "HIGH PLANT-BASED DIET"}, {"entity_type": "DISEASE", "description": "Increased obesity risk can be influenced by genetic variants and educational background.<SEP>Increased obesity risk is influenced by the presence of certain genetic variants like the FTO SNP and educational level.<SEP>The risk of developing obesity, influenced by interactions between genetic factors (PRS) and dietary patterns such as plant-based diets and fried-food intake.", "source_id": "chunk-3ad8ef794841d749e48b3223741e91d3<SEP>chunk-63d0b5be485a69f44e2799ccc9510487", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 27}]", "id": "OBESITY RISK"}, {"entity_type": "NUTRIENT", "description": "The intake of various nutrients that can interact with PRS to influence obesity risk.", "source_id": "chunk-3ad8ef794841d749e48b3223741e91d3", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 27}]", "id": "NUTRIENT INTAKE"}, {"entity_type": "DIETARY PATTERN", "description": "Different dietary patterns such as plant-based and fried-food diets, which interact differently with PRS in terms of BMI and obesity risk.", "source_id": "chunk-3ad8ef794841d749e48b3223741e91d3", "clusters": "[{level: 0, cluster: 7}]", "id": "DIETARY PATTERNS"}, {"source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "description": "Women have higher serum total cholesterol and LDL levels than men in this study.)", "entity_type": "UNKNOWN", "id": "GENDER DIFFERENCES"}, {"source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "description": "Estimated glomerular filtration rate is lower in the obese group than nonobese participants, indicating potential kidney function issues associated with obesity.)", "entity_type": "UNKNOWN", "id": "OBESITY STATUS"}, {"source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "description": "Higher liver enzymes (ALT and AST) are observed in obese groups compared to nonobese individuals across genders, highlighting the impact of obesity on liver health.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 27}]", "id": "SERUM ALT AND AST CONCENTRATIONS"}, {"source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "description": "Intake of fats like saturated fatty acids shows sex-specific associations, being higher among men and contrasting patterns among women.)", "entity_type": "UNKNOWN", "id": "SEX DIFFERENCES"}, {"source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "description": "Men have a higher DII score compared to women, indicating a more inflammatory diet for males.)", "entity_type": "UNKNOWN", "id": "DII"}, {"source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "description": "The CDKAL1 genomic variant affects energy regulation by modulating transcriptional mechanisms involved in metabolic pathways.", "entity_type": "UNKNOWN", "id": "ENERGY REGULATION"}, {"source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "description": "Genetic variation in TFAP2B impacts the function of Transcription factor AP-2 Beta, influencing energy intake and obesity risk.", "entity_type": "UNKNOWN", "id": "TRANSCRIPTION FACTOR AP-2 BETA"}, {"source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "description": "A BDNF genetic variant influences metabolic processes through modulation of transcriptional regulatory networks related to energy balance.", "entity_type": "UNKNOWN", "id": "METABOLIC PROCESSES"}, {"source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "description": "Genetic variation in MYL2 impacts muscle function and contributes to obesity risk through effects on energy expenditure.", "entity_type": "UNKNOWN", "id": "MUSCLE FUNCTION"}, {"source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "description": "A FTO genetic variant modulates transcription factors related to energy regulation, affecting the risk of obesity.", "entity_type": "UNKNOWN", "id": "TRANSCRIPTION FACTORS"}, {"source_id": "chunk-0d155c005072e55d94179ce7952bf5a9<SEP>chunk-eec0b4c60ebeb28599428b3552de2d1b", "description": "Campylobacter\'s metabolic pathways are affected by genomic variants linked to antibiotic resistance.<SEP>The MC4R gene affects metabolic pathways and is a hub gene influencing obesity risk through genetic variation.", "entity_type": "METABOLIC PATHWAY", "id": "METABOLIC PATHWAY"}, {"source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "description": "Genetic variation in GIPR impacts energy balance by modulating the effects of gastric inhibitory polypeptide.", "entity_type": "UNKNOWN", "id": "ENERGY BALANCE"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant in the FTO gene that affects body weight and composition.", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "id": "FTO RS1558902"}, {"entity_type": "DIETARY PATTERN", "description": "A dietary pattern characterized by a high intake of protein, which interacts with the FTO rs1558902 genotype to influence weight loss and body composition changes.<SEP>A dietary pattern characterized by higher protein intake compared to standard or low-protein diets.", "source_id": "chunk-a321a6d63755366a1fc3eafbd9fbce83<SEP>chunk-2926e6216bf945b12ea4daa6345cad1f", "id": "HIGH-PROTEIN DIET"}, {"entity_type": "DIETARY PATTERN", "description": "A dietary pattern characterized by a low intake of protein, showing no significant interaction effects on weight loss and body composition when paired with the FTO rs1558902 genotype.<SEP>A dietary pattern characterized by lower protein intake compared to standard or high-protein diets.<SEP>A dietary pattern prescribed to patients with HI/HA syndrome due to a GLUD1 genetic defect, consisting of 1.5 g/kg/day of natural protein intake.", "source_id": "chunk-a321a6d63755366a1fc3eafbd9fbce83<SEP>chunk-2b81371954b99facae9a0056e70aa7bd<SEP>chunk-2926e6216bf945b12ea4daa6345cad1f", "id": "LOW-PROTEIN DIET"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process of losing weight, which is influenced by both genetic factors (such as the FTO gene) and dietary patterns.<SEP>Weight loss refers to the physiological process of reducing body mass, which can be influenced by genetic factors such as SNP rs4771122.", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f<SEP>chunk-b3d775642c43fa3524a531a3f6ec1e41", "id": "WEIGHT LOSS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Changes in body composition, including fat mass and muscle mass, that are influenced by genetic variants such as the FTO rs1558902 genotype.", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "id": "BODY COMPOSITION CHANGES"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Alterations in how fat is distributed within the body, which can be affected by both genetics (like the FTO variant) and diet.", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "id": "FAT DISTRIBUTION CHANGES"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The reduction in total body fat, which is influenced by both genetic factors (e.g., FTO rs1558902) and dietary patterns.<SEP>The reduction of total fat mass in the body, influenced by genetic factors such as the presence or absence of the risk allele in the FTO rs1558902 genotype.", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "id": "TOTAL FAT LOSS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Alterations in lean muscle mass due to interactions between the FTO rs1558902 genotype and protein intake.<SEP>Changes in lean muscle mass, which are affected by interactions between the FTO rs1558902 genotype and dietary protein intake.", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "id": "LEAN MASS CHANGES"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant of the FTO gene that influences body weight changes based on dietary protein intake.", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "id": "FTO RS1558902 GENOTYPE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A measurement of the waist that helps determine the amount of abdominal fat and assess health risks.<SEP>Waist circumference is a measurement that helps in assessing abdominal obesity, impacting cardiovascular risk factors.", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f<SEP>chunk-c6fdc5ed25c4e17b8c421a952bb05450", "id": "WC (WAIST CIRCUMFERENCE)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The part of body weight that is not fat, which can be influenced by genetic variants like FTO rs1558902 in response to dietary changes.", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "id": "FAT-FREE MASS (FFM)"}, {"entity_type": "METABOLIC PATHWAY", "description": "A type of fat tissue located within the abdominal cavity and around organs, which can be affected by genetic factors like FTO rs1558902 and dietary protein intake.", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "id": "VISCERAL ADIPOSE TISSUE (VAT)"}, {"entity_type": "METABOLIC PATHWAY", "description": "Fat tissue under the skin that is influenced by diet and genetics, such as the FTO rs1558902 variant.", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "id": "SUBCUTANEOUS ADIPOSE TISSUE (SAT)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The reduction of fat accumulation in the trunk area, impacted by genetic factors like FTO rs1558902 genotype and dietary protein intake.", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "id": "TRUNK FAT LOSS"}, {"entity_type": "GENOMIC VARIANT", "description": "The AA genotype is a specific variant associated with differential responses to dietary interventions, particularly high-protein diets.<SEP>The AA genotype of rs1695 polymorphism was found in controls with a frequency of 50.00% but not significantly associated with breast cancer risk.", "source_id": "chunk-a321a6d63755366a1fc3eafbd9fbce83<SEP>chunk-ab5011584b0230efbf80a98b2a693a0e", "id": "AA GENOTYPE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Fat distribution refers to the amount and location of fat in the body, which can change in response to diet and genotype.", "source_id": "chunk-a321a6d63755366a1fc3eafbd9fbce83", "id": "FAT DISTRIBUTION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "TAT (thoracic adipose tissue) and SAT (subcutaneous abdominal adipose tissue) loss are physiological processes indicating a reduction in specific types of fat deposits.", "source_id": "chunk-a321a6d63755366a1fc3eafbd9fbce83", "id": "TAT AND SAT LOSS"}, {"entity_type": "DIETARY PATTERN", "description": "A dietary pattern characterized by lower fat intake compared to standard or high-fat diets.", "source_id": "chunk-a321a6d63755366a1fc3eafbd9fbce83", "id": "LOW-FAT DIET"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Total fat refers to the overall amount of body fat, which can change in response to diet and genotype.", "source_id": "chunk-a321a6d63755366a1fc3eafbd9fbce83", "id": "TOTAL FAT"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "FM% represents the percentage of total body mass that is fat mass, influenced by dietary patterns and genetic factors.", "source_id": "chunk-a321a6d63755366a1fc3eafbd9fbce83", "id": "FM% (FAT MASS PERCENTAGE)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The distribution of fat in the trunk area, which can change in response to dietary interventions based on genotype.", "source_id": "chunk-a321a6d63755366a1fc3eafbd9fbce83", "id": "TRUNK FAT DISTRIBUTION"}, {"source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "description": "The genetic variant affects the change in waist circumference, particularly in response to dietary protein intake.", "entity_type": "UNKNOWN", "id": "WAIST CIRCUMFERENCE CHANGES"}, {"source_id": "chunk-a321a6d63755366a1fc3eafbd9fbce83", "description": "Participants with the AA genotype showed differential responses to low-fat diet interventions, specifically affecting their fat mass percentage compared to other genotypes.)", "entity_type": "UNKNOWN", "id": "FM%"}, {"entity_type": "GENOMIC VARIANT", "description": "The FTO rs9939609 polymorphism is associated with anthropometric variables such as weight, BMI and waist circumference.", "source_id": "chunk-3135befd0c3140ad097d96ace6de86a1", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 36}]", "id": "FTO RS9939609 POLYMORPHISM"}, {"entity_type": "DISEASE", "description": "A disease characterized by excessive accumulation of fat tissue; studied due to its association with genetic variants and dietary patterns.<SEP>Obesity is a condition characterized by excessive accumulation of body fat, associated with various health risks including cardiovascular disease and diabetes.", "source_id": "chunk-7ca64f92964b051cfb1c43f967f243a5<SEP>chunk-3135befd0c3140ad097d96ace6de86a1", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 37}]", "id": "OBESITY"}, {"entity_type": "LIFESTYLE FACTOR", "description": "Educational level is a lifestyle factor that can influence the prevalence of obesity and the relationship between genetic factors like FTO polymorphism and obesity risk.", "source_id": "chunk-3135befd0c3140ad097d96ace6de86a1", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 27}]", "id": "EDUCATION LEVEL"}, {"entity_type": "GENE", "description": "A gene where the effect on CRP diminishes considerably after adjustment for multiple factors, suggesting mediation by physiological processes such as BMI.<SEP>FTO gene contains a SNP (rs1558902) located in the first intron, which showed significant association with CRP after multiple testing correction.<SEP>The FTO gene contains a polymorphism (rs9939609) that is associated with anthropometric variables such as weight, BMI, and waist circumference.<SEP>FTO is a gene previously linked to multiple health traits including smoking, alcohol consumption, and musculoskeletal conditions.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba<SEP>chunk-372184452f1f9156514992455057f843<SEP>chunk-3135befd0c3140ad097d96ace6de86a1<SEP>chunk-13862d7ab74f5d4fa3f2261984d15d64", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 36}]", "id": "FTO GENE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Anthropometric variables include measurements like weight, BMI, and waist circumference which are physiological processes used to assess body composition.", "source_id": "chunk-3135befd0c3140ad097d96ace6de86a1", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 36}]", "id": "ANTHROPOMETRIC VARIABLES"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Age as a physiological process and risk factor is considered in studies on HIV disease progression.<SEP>Age is a physiological factor affecting disease risk and genetic studies.<SEP>Age is an environmental factor that influences the relationship between FTO SNP and anthropometric variables. Different age groups may exhibit varying effects of genetic polymorphisms on these variables.<SEP>Age was tested for interaction with genetic variants but no significant evidence was found (P = 0.20).<SEP>Age is an environmental factor that shows a positive correlation with snoring prevalence.<SEP>The age of an individual influences the composition of their gut microbiota, with changes observed over different life stages.<SEP>Age is an important demographic factor influencing physiological and psychological development including behavioral traits like social disinhibition.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62<SEP>chunk-6a7c69534e11aa2fc4bd948484aa81c4<SEP>chunk-d4e04dd6cd6ea28f04fd72d964574ec1<SEP>chunk-2c395e2fed68f9267c06e9fcee853aae<SEP>chunk-055177812e320344d131432b292111b0<SEP>chunk-3135befd0c3140ad097d96ace6de86a1<SEP>chunk-2c91cdebb36ef064eb01a7021a961302", "clusters": "[{level: 0, cluster: 2}, {level: 1, cluster: 25}]", "id": "AGE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Sex is a lifestyle factor that can influence the relationship between FTO SNP and anthropometric measurements, as seen in statistical adjustments for sex differences.<SEP>Sex was considered as an environmental factor without showing a significant interaction effect on the analysis results (P = 0.59).<SEP>Sex is a physiological process that can influence genetic associations.<SEP>Sex, particularly being male, significantly influences the risk of snoring due to inherent physiological differences between sexes.<SEP>Sex, as a physiological characteristic, is analyzed for its impact on HIV disease progression.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62<SEP>chunk-6a7c69534e11aa2fc4bd948484aa81c4<SEP>chunk-3135befd0c3140ad097d96ace6de86a1<SEP>chunk-055177812e320344d131432b292111b0<SEP>chunk-2c91cdebb36ef064eb01a7021a961302", "clusters": "[{level: 0, cluster: 2}, {level: 1, cluster: 24}]", "id": "SEX"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "An indicator of smoking behavior, which can affect physiological processes including blood cortisol level.<SEP>Smoking status is an environmental factor used to adjust models assessing the impact of FTO SNP on BMI and obesity risk.<SEP>Smoking status refers to an individual\'s smoking behavior, categorized as smoker or non-smoker.", "source_id": "chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6<SEP>chunk-3135befd0c3140ad097d96ace6de86a1<SEP>chunk-9e14f9bdee02839e4a6b12cff2020a5a", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 35}]", "id": "SMOKING STATUS"}, {"entity_type": "DISEASE", "description": "A metabolic disorder characterized by high blood glucose levels due to defects in insulin production or function.<SEP>Diabetes is a disease condition that can influence anthropometric measurements such as BMI, and it\u2019s considered in statistical adjustments for its potential confounding effect.", "source_id": "chunk-3135befd0c3140ad097d96ace6de86a1<SEP>chunk-9e14f9bdee02839e4a6b12cff2020a5a", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 36}]", "id": "DIABETES"}, {"entity_type": "LIFESTYLE FACTOR", "description": "Engagement in physical activity showing interaction with genetic variants to influence the protective effect against type 2 diabetes incidence.<SEP>PA, or physical activity level, can influence the statistical significance of FTO SNP\'s effect on obesity risk.<SEP>Physical activity levels are lifestyle factors that may modify the relationship between FTO SNP and obesity risk. Different levels of PA can affect metabolic processes and body composition.<SEP>Physical activity is a lifestyle factor studied in relation to gene-environment interactions and its impact on health outcomes such as diabetes risk.", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862<SEP>chunk-3135befd0c3140ad097d96ace6de86a1<SEP>chunk-63d0b5be485a69f44e2799ccc9510487<SEP>chunk-f7bf38c7a21b86ad85fa360a21bfb447", "clusters": "[{level: 0, cluster: 15}]", "id": "PHYSICAL ACTIVITY (PA)"}, {"entity_type": "LIFESTYLE FACTOR", "description": "Having primary studies education level is a specific category within educational attainment, which influences the interaction with the FTO SNP in terms of BMI and obesity risk.", "source_id": "chunk-3135befd0c3140ad097d96ace6de86a1", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 36}]", "id": "PRIMARY STUDIES EDUCATION LEVEL"}, {"entity_type": "LIFESTYLE FACTOR", "description": "Secondary studies education level is another category under educational attainment that interacts with genetic polymorphisms like the FTO rs9939609 to affect BMI and obesity risk.", "source_id": "chunk-3135befd0c3140ad097d96ace6de86a1", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 36}]", "id": "SECONDARY STUDIES EDUCATION LEVEL"}, {"entity_type": "LIFESTYLE FACTOR", "description": "Having a university-level education is associated with lower obesity risk compared to individuals without higher education, affecting interactions between lifestyle factors and genetic susceptibility to obesity.", "source_id": "chunk-3135befd0c3140ad097d96ace6de86a1", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 36}]", "id": "UNIVERSITY-LEVEL EDUCATION"}, {"entity_type": "GENOMIC VARIANT", "description": "The FTO SNP is a genomic variant associated with obesity risk, particularly in individuals without university studies.<SEP>The FTO SNP is a genomic variant associated with obesity risk.", "source_id": "chunk-63d0b5be485a69f44e2799ccc9510487", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 29}]", "id": "FTO SNP"}, {"entity_type": "LIFESTYLE FACTOR", "description": "Having university studies is associated with lower significance in the FTO SNP\'s impact on obesity risk.", "source_id": "chunk-63d0b5be485a69f44e2799ccc9510487", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 29}]", "id": "UNIVERSITY STUDIES"}, {"entity_type": "DIETARY PATTERN", "description": "The GP refers to genetic factors that influence dietary patterns and nutrition-related health outcomes.", "source_id": "chunk-63d0b5be485a69f44e2799ccc9510487", "id": "GENETIC POLYMORPHISM (GP)"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "HCR data includes records related to healthcare access, which can affect disease risk assessment.", "source_id": "chunk-63d0b5be485a69f44e2799ccc9510487", "clusters": "[{level: 0, cluster: 15}]", "id": "HEALTH CARE RECORDS (HCR)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The OHP is a physiological process that assesses obesity risk through various health markers and genetic factors.", "source_id": "chunk-63d0b5be485a69f44e2799ccc9510487", "id": "OBESITY RISK ASSESSMENT (OHP)"}, {"source_id": "chunk-63d0b5be485a69f44e2799ccc9510487", "description": "There is a significant interaction between educational level and the FTO SNP in determining obesity risk.", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 29}]", "id": "EDUCATION"}, {"entity_type": "GENE", "description": "The TCF7L2 gene is associated with Type 2 Diabetes and End Stage Renal Disease (T2D-ESRD).<SEP>The TCF7L2 gene is associated with risk variants such as rs7903146.<SEP>The TCF7L2 gene is frequently investigated for its interaction with dietary factors in the context of type 2 diabetes risk.<SEP>The TCF7L2 gene is involved in Wnt signaling and has genetic variants like rs7903146 that are associated with type 2 diabetes risk.", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862<SEP>chunk-f9a60d3cf951d77afa115859755dac43<SEP>chunk-6a7c69534e11aa2fc4bd948484aa81c4<SEP>chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "clusters": "[{level: 0, cluster: 2}, {level: 1, cluster: 24}]", "id": "TCF7L2 GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "Investigations have focused on genetic variants interacting with dietary patterns and specific nutrients, particularly fiber and whole grains.", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "id": "GENETIC VARIANT (G \u00d7 D)"}, {"entity_type": "NUTRIENT", "description": "Fiber intake is a key dietary factor studied for its interaction with genetic variants in relation to type 2 diabetes risk.<SEP>Intake of dietary fiber shows interactions with certain genetic variants such as rs7903146 in the TCF7L2 gene, impacting Type 2 Diabetes incidence.", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862<SEP>chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "clusters": "[{level: 0, cluster: 8}]", "id": "FIBER INTAKE"}, {"entity_type": "FOOD", "description": "High intake of whole grains potentially reducing type 2 diabetes incidence through interaction with genetic variants.<SEP>Whole grain consumption has been examined for interactions with specific genetic variants associated with the development of type 2 diabetes.", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862<SEP>chunk-f7bf38c7a21b86ad85fa360a21bfb447", "id": "WHOLE GRAINS"}, {"entity_type": "DIETARY PATTERN", "description": "Various dietary patterns, including adherence to specific diets like the Mediterranean diet or low-fat diets, have been examined for their interaction with genetic variants.", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "clusters": "[{level: 0, cluster: 15}]", "id": "DIETARY PATTERN"}, {"entity_type": "DISEASE", "description": "A metabolic disorder characterized by high blood sugar levels due to insulin resistance or lack of insulin production.<SEP>The risk of developing type 2 diabetes is influenced by gene-diet and gene-environment interactions as well as lifestyle factors like physical activity and dietary patterns.<SEP>A metabolic disorder characterized by high blood sugar levels over a prolonged period due to insulin resistance or insufficient insulin production.<SEP>T2D is characterized by insulin resistance or insufficient insulin production, often preceded by IFG or IGT. It\'s associated with significant increases in KB levels.", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862<SEP>chunk-f9a60d3cf951d77afa115859755dac43<SEP>chunk-180ca3d6d27d84b30ebf5d20f135de18<SEP>chunk-f2e122f964bade37f487049bd69a3f9f", "id": "TYPE 2 DIABETES (T2D)"}, {"entity_type": "NUTRIENT", "description": "Glycemic load, a measure related to carbohydrate intake, has been studied for its interaction with genetic variants in the context of type 2 diabetes risk.", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "id": "GLYCEMIC LOAD (GL)"}, {"entity_type": "NUTRIENT", "description": "Vitamin A intake is among dietary factors considered in gene-diet interactions affecting the risk of developing type 2 diabetes.", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "id": "VITAMIN A INTAKE"}, {"entity_type": "NUTRIENT", "description": "Intake of magnesium showing no significant interaction with genetic variants for type 2 diabetes risk.<SEP>Intake of magnesium, a key nutrient, has been investigated for its interaction with genetic variants related to type 2 diabetes risk.", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862<SEP>chunk-f7bf38c7a21b86ad85fa360a21bfb447", "id": "MAGNESIUM INTAKE"}, {"entity_type": "DIETARY PATTERN", "description": "The Nurses\' Health Study is a cohort study that investigates various health outcomes, including diet-related interactions with genetic factors.", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "id": "NURSES\' HEALTH STUDY (NHS)"}, {"entity_type": "DIETARY PATTERN", "description": "The Health Professionals Follow-Up Study examines dietary patterns and their interaction with genetic variants in relation to disease risk.", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "id": "HEALTH PROFESSIONALS FOLLOW-UP STUDY (HPFS)"}, {"entity_type": "COHORT STUDY", "description": "A cohort study focusing on diet, lifestyle factors, and genetic interactions related to cancer and other diseases.", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "id": "MALM\u00d6 DIET AND CANCER STUDY (MDCS)"}, {"entity_type": "COHORT STUDY", "description": "A large-scale European cohort study examining the interaction of environmental, dietary, and genetic factors with disease outcomes.", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "id": "EUROPEAN PROSPECTIVE INVESTIGATION INTO CANCER (EPIC)\u2010INTERACT "}, {"entity_type": "COHORT STUDY", "description": "A genome-wide association study focusing on genetic variants associated with diabetes in a Chinese population.", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "id": "SHANGHAI DIABETES GWAS STUDY "}, {"entity_type": "COHORT STUDY", "description": "An observational cohort study investigating the interaction of environmental and lifestyle factors, including diet, with disease risk.", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "id": "EPIC\u2010POTSDAM "}, {"entity_type": "COHORT STUDY", "description": "A cohort study focused on understanding insulin resistance syndrome and its genetic and environmental determinants.", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "id": "EPIDEMIOLOGICAL STUDY ON THE INSULIN RESISTANCE SYNDROME (DESIR)"}, {"entity_type": "COHORT STUDY", "description": "A population-based study in Korea investigating the interaction of genetic factors, diet, and lifestyle with health outcomes.", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "id": "KOREAN GENOME AND EPIDEMIOLOGY STUDY (KOGES)"}, {"entity_type": "RCT", "description": "Randomized controlled trial aimed at preventing type 2 diabetes through lifestyle interventions such as diet and physical activity.", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "id": "FINISH DIABETES PREVENTION STUDY (DPS)"}, {"entity_type": "RCT", "description": "A major randomized clinical trial evaluating the effectiveness of lifestyle interventions in reducing risk factors for type 2 diabetes.", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "id": "AMERICAN DIABETES PREVENTION PROJECT (DPP)"}, {"entity_type": "RCT", "description": "An RCT focusing on dietary patterns, specifically the Mediterranean diet, and its effects on cardiovascular health and type 2 diabetes risk.", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "id": "PREVENCI\u00d3N CON DIETA MEDITERR\u00c1NEA (PREDIMED)"}, {"entity_type": "RCT", "description": "A randomized controlled trial conducted among Italian participants to assess lifestyle interventions for metabolic abnormalities and their impact on diabetes risk.", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "id": "STUDY IN ITALIANS FROM ASTI "}, {"entity_type": "GENOMIC VARIANT", "description": "Rs7903146 is a variant of the TCF7L2 gene known to be strongly associated with Type 2 Diabetes (T2D) risk and modifies incretin effects on insulin secretion.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "id": "RS7903146 VARIANT"}, {"entity_type": "GENOMIC VARIANT", "description": "Rs4506565 is another variant of the TCF7L2 gene that has shown interaction with fiber and whole grain intake in relation to T2D incidence.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "id": "RS4506565 VARIANT"}, {"entity_type": "GENOMIC VARIANT", "description": "Rs12255372 is a genetic variant within the TCF7L2 gene which shows interaction effects with fiber and glycemic load intake, impacting T2D risk.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "id": "RS12255372 VARIANT"}, {"entity_type": "GENE", "description": "The NOTCH2 gene harbors the rs10923931 variant that showed interactions with dietary fiber in relation to T2D incidence, though replication was not observed.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "clusters": "[{level: 0, cluster: 8}]", "id": "NOTCH2 GENE (RS10923931)"}, {"entity_type": "GENE", "description": "The ZBED3 gene has a variant rs4457053 involved in Wnt signaling and showed interaction with dietary fiber on T2D risk, lacking replication evidence.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "clusters": "[{level: 0, cluster: 8}]", "id": "ZBED3 GENE (RS4457053)"}, {"entity_type": "GENE", "description": "The IRS1 gene harbors the rs2943641 variant known to enhance insulin sensitivity but lacks validation in other studies regarding interaction with carbohydrate intake on T2D risk.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "id": "IRS1 GENE (RS2943641)"}, {"entity_type": "GENE", "description": "The GIPR gene has the rs10423928 variant known to decrease insulin secretion and showed no consistent interactions with total fat or carbohydrate intake on T2D risk.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "id": "GIPR GENE (RS10423928)"}, {"entity_type": "GENE", "description": "The PPAR\u03b3 gene has the rs1801282 variant involved in fatty acid storage, showing a trend towards interaction with fat intake and Type 2 Diabetes risk but lacking consistent evidence.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "id": "PPAR\u0393 GENE (RS1801282)"}, {"entity_type": "GENE", "description": "The HFE gene has the rs1799945 variant that shows modification of heme iron association on T2D incidence, particularly among women with high dietary heme iron intake.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "id": "HFE GENE (RS1799945)"}, {"entity_type": "GENE", "description": "The FFAR4 gene harbors the rs116454156 variant involved in G\u03b1q signaling, showing a trend for interaction with fat intake and Type 2 Diabetes risk among specific genotype carriers.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "id": "FFAR4 GENE (RS116454156)"}, {"entity_type": "GENE", "description": "The ADH1C gene has variants *1/*2 that modify the association of alcohol consumption on T2D incidence, particularly in US women carrying allele *2.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "id": "ADH1C GENE (*1/*2)"}, {"entity_type": "NUTRIENT", "description": "Dietary fat intake, including total fat and saturated fatty acids, is under investigation for its modifying effects on T2D risk in relation to specific genetic variants.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "id": "FAT INTAKE (TOTAL AND SATURATED)"}, {"entity_type": "DIETARY PATTERN", "description": "Consumption of whole grains is a dietary pattern that interacts with specific genetic variations like those in the TCF7L2 gene to affect T2D risk.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "clusters": "[{level: 0, cluster: 8}]", "id": "WHOLE GRAIN CONSUMPTION"}, {"entity_type": "DISEASE", "description": "Type 2 diabetes is a metabolic disorder whose incidence can be modified by interactions between genetic variants and dietary factors such as fiber or whole grain consumption.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "id": "T2D (TYPE 2 DIABETES)"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant associated with haemochromatosis, linked to increased risk of type 2 diabetes among women.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "id": "HFE VARIANTS RS1799945 (H63D)"}, {"entity_type": "GENOMIC VARIANT", "description": "Another genomic variant associated with haemochromatosis, also linked to increased risk of type 2 diabetes among women.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "id": "HFE VARIANTS RS1800562 (C282Y)"}, {"entity_type": "GENOMIC VARIANT", "description": "A genetic variant in the SLC40A1 gene showing interaction with heme iron intake in men and borderline significance with TMPRSS6 variant in total sample.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "id": "SLC40A1 RS744653 VARIANT"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant associated with increased risk of type 2 diabetes when interacting with dietary factors, particularly for the total sample in EPIC-InterAct study.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "id": "TMPRSS6 VARIANT RS855791"}, {"entity_type": "GENE", "description": "Variants in SLC30A8 gene showing interaction with zinc intake but without a clear trend of association with type 2 diabetes incidence.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "id": "SLC30A8 VARIANTS (ZINC TRANSPORTER)"}, {"entity_type": "NUTRIENT", "description": "Intake of vitamin A displaying nonsignificant interactions with genetic factors influencing type 2 diabetes incidence.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "id": "VITAMIN A"}, {"entity_type": "FOOD", "description": "High intake of red meat increasing the risk of developing type 2 diabetes among men with a high T2D-GRS, but not among those with low GRS.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "clusters": "[{level: 0, cluster: 15}]", "id": "RED MEAT"}, {"entity_type": "FOOD", "description": "Similar to red meat, processed meat intake also increases T2D risk among men with high genetic risk score (T2D-GRS).", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "id": "PROCESSED MEAT"}, {"entity_type": "FOOD", "description": "Interaction of olive oil consumption with GIPR variant rs10423928 in EPIC-InterAct, showing a marginally significant association.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "id": "OLIVE OIL"}, {"entity_type": "FOOD", "description": "Intake of dairy products potentially modifying T2D incidence through interaction with lactase persistence LCT gene variant rs4988235.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "id": "DAIRY PRODUCTS"}, {"entity_type": "FOOD", "description": "Interaction between coffee consumption and genetic variants (e.g., TCF7L2, IGF2BP2) influencing type 2 diabetes risk.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "id": "COFFEE INTAKE"}, {"entity_type": "GENETIC RISK SCORE", "description": "A genetic risk score indicating the combined effect of multiple genetic variants associated with type 2 diabetes risk.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "clusters": "[{level: 0, cluster: 15}]", "id": "T2D-GRS"}, {"entity_type": "DIETARY PATTERN", "description": "A dietary pattern characterized by high intake of olive oil, nuts, fruits, vegetables, legumes, fish, and moderate wine consumption.<SEP>Consumption of a Mediterranean diet pattern showing interaction with genetic factors like CLOCK variant rs4580704 to lower T2D incidence.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447<SEP>chunk-e1b4f4dac52e806f19c580640a50c729", "id": "MEDITERRANEAN DIET"}, {"entity_type": "DIETARY PATTERN", "description": "A dietary pattern reflecting Western diet associated with higher type 2 diabetes risk among individuals with high T2D-GRS.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "id": "WESTERN DIETARY PATTERN"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Increase or reduction of leisure-time physical activity interacting with specific genetic variants to modify T2D risk.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "id": "LTPA (LEISURE-TIME PHYSICAL ACTIVITY)"}, {"entity_type": "PHYSIOLOGICAL PROCESS/DISEASE", "description": "The incidence of type 2 diabetes influenced by interactions between dietary and genetic factors, as well as lifestyle choices like physical activity.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "id": "T2D INCIDENCE"}, {"entity_type": "GENOMIC VARIANT", "description": "Another genomic variant linked to higher susceptibility for developing type 2 diabetes.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "clusters": "[{level: 0, cluster: 15}]", "id": "IGF2BP2 VARIANT RS11075984"}, {"entity_type": "GENOMIC VARIANT", "description": "A genetic variant in the CLOCK gene, interacting with Mediterranean diet consumption to reduce T2D risk.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "id": "CLOCK VARIANT RS4580704"}, {"entity_type": "FOOD", "description": "Consumption of fruits and vegetables showing interactions with genetic factors to influence T2D risk reduction.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "id": "FRUITS AND VEGETABLES"}, {"entity_type": "GENOMIC VARIANT", "description": "The SLC2A2 gene has multiple variants including rs5393, rs5394, rs5400, and rs5404.", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "id": "SLC2A2 VARIANTS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "LTPA stands for Long-Term Physical Activity and is a physiological process of interest in genetic studies.", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "id": "LTPA"}, {"entity_type": "GENOMIC VARIANT", "description": "The TCF7L2 rs12255372 risk allele (TT genotype) modifies the risk to develop Type 2 Diabetes (T2D).", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "id": "TCF7L2 RS12255372 RISK TT-GENOTYPE"}, {"entity_type": "GENOMIC VARIANT", "description": "The TCF7L2 rs7903146 risk allele (T) modifies the risk to develop Type 2 Diabetes (T2D).", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "id": "TCF7L2 RS7903146 RISK T-ALLELE"}, {"entity_type": "GENOMIC VARIANT", "description": "ENPP1 rs1044498 is a genetic variant associated with increased diabetes risk.", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "id": "ENPP1 RS1044498 DIABETOGENIC VARIANT"}, {"entity_type": "GENOMIC VARIANT", "description": "The MC4R rs17066829 variant has been investigated for interaction with weight loss interventions in Type 2 Diabetes (T2D) incidence.", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "id": "MC4R RS17066829 GENETIC VARIANT"}, {"entity_type": "GENOMIC VARIANT", "description": "The PPAR\u03b3 rs1152003 CC genotype is associated with reduced T2D risk following weight loss intervention.", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "id": "PPAR\u0393 RS1152003 CC-GENOTYPE"}, {"entity_type": "GENOMIC VARIANT", "description": "TNF\u03b1 rs1800629 GG genotype shows lower incidence of Type 2 Diabetes (T2D) in response to weight loss interventions.", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "id": "TNF\u0391 RS1800629 GG-GENOTYPE"}, {"entity_type": "GENOMIC VARIANT", "description": "The ADRA2B Glu9 allele is associated with a reduced risk of developing T2D following intervention.", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "id": "ADRA2B GLU9-ALLELE"}, {"entity_type": "GENOMIC VARIANT", "description": "LIPC rs2070895 A allele shows lower incidence of Type 2 Diabetes (T2D) in response to weight loss interventions.", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "id": "LIPC RS2070895 A-ALLELE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The interaction between genetic factors (G) and lifestyle/behavioral factors (L), such as physical activity or diet, influences disease risk.", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "id": "G \u00d7 L INTERACTION"}, {"entity_type": "DIETARY PATTERN", "description": "A dietary pattern aimed at reducing weight to lower the risk of developing Type 2 Diabetes (T2D).", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "id": "WEIGHT LOSS INTERVENTION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process of developing Type 2 Diabetes for the first time.", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "id": "INCIDENT T2D"}, {"source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "description": "The rs7903146 variant in the TCF7L2 gene shows interaction with dietary fiber intake, modifying its association with Type 2 Diabetes risk.", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 8}]", "id": "TCF7L2 GENE (RS7903146)"}, {"source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "description": "The rs1799945 variant in the HFE gene modifies the association of heme iron with T2D incidence, particularly among women.", "entity_type": "UNKNOWN", "id": "HEME IRON INTAKE"}, {"source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e<SEP>chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "description": "High levels of alcohol consumption during pregnancy can lead to fetal growth restriction and developmental issues in children.<SEP>The *1/*2 variants in the ADH1C gene modify the association between alcohol consumption and T2D risk, specifically in US women carrying allele *2.", "entity_type": "ENVIRONMENTAL FACTOR", "id": "ALCOHOL CONSUMPTION"}, {"source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "description": "The rs12255372 variant in the TCF7L2 gene interacts with glycemic load intake, affecting T2D risk.", "entity_type": "UNKNOWN", "id": "GLYCEMIC LOAD INTAKE"}, {"source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "description": "The rs12255372 variant in the TCF7L2 gene interacts with glycemic load intake, affecting T2D risk.", "entity_type": "UNKNOWN", "id": "TCF7L2 GENE (RS12255372)"}, {"source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "description": "The rs545389 variant in GLUT2 shows interaction with carbohydrate intake on T2D risk.", "entity_type": "UNKNOWN", "id": "GLUT2 GENE (RS545389)"}, {"source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "description": "The rs13266634 variant in SLC30A8 shows interaction with saturated fat intake on T2D risk.", "entity_type": "UNKNOWN", "id": "FAT INTAKE (SATURATED)"}, {"source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "description": "The rs13266634 variant in SLC30A8 shows interaction with saturated fat intake on T2D risk.", "entity_type": "UNKNOWN", "id": "SLC30A8 GENE (RS13266634)"}, {"source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "description": "The rs2237892 variant in KCNQ1 interacts with total fat intake, affecting insulin resistance and T2D risk.", "entity_type": "UNKNOWN", "id": "FAT INTAKE (TOTAL)"}, {"source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "description": "The rs2237892 variant in KCNQ1 interacts with total fat intake, affecting insulin resistance and T2D risk.", "entity_type": "UNKNOWN", "id": "KCNQ1 GENE (RS2237892)"}, {"source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "description": "Intake of zinc interacts with SLC30A8 variants but without clear trend for type 2 diabetes association.", "entity_type": "UNKNOWN", "id": "ZINC INTAKE"}, {"source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "description": "Change in LTPA modifies the risk of type 2 diabetes incidence based on specific genetic variants.", "entity_type": "UNKNOWN", "id": "TYPE 2 DIABETES RISK"}, {"source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "description": "Consumption of fruits and vegetables showing a significant interaction with genetic factors to lower the incidence rate of type 2 diabetes.", "entity_type": "UNKNOWN", "id": "TYPE 2 DIABETES INCIDENCE"}, {"source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "description": "Moderate to high alcohol intake increasing T2D risk among individuals with high genetic predisposition.", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 28}]", "id": "GENETIC RISK SCORE (T2D-GRES)"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific variant in the TCF7L2 gene, rs7903146, is associated with an increased risk of Type 2 Diabetes and End Stage Renal Disease.<SEP>A specific variant of the TCF7L2 gene, rs7903146, is linked to disease risk and influences association results in analyses.", "source_id": "chunk-f9a60d3cf951d77afa115859755dac43<SEP>chunk-6a7c69534e11aa2fc4bd948484aa81c4", "id": "RS7903146 GENOMIC VARIANT"}, {"entity_type": "GENE", "description": "The WFS1 gene has a genomic variant (rs10010131) that is associated with the risk of developing T2D-ESRD, but this association was not as strong in European-derived populations.", "source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "clusters": "[{level: 0, cluster: 16}, {level: 1, cluster: 47}]", "id": "WFS1 GENE"}, {"entity_type": "GENE", "description": "The CDKAL1 gene harbors a variant (rs10946398) that is associated with an increased risk of developing T2D-ESRD, similar to findings in European samples.", "source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "clusters": "[{level: 0, cluster: 16}, {level: 1, cluster: 45}]", "id": "CDKAL1 GENE"}, {"entity_type": "GENE", "description": "A variant in the JAZF1 gene (rs864745) has been found to be associated with a higher risk for Type 2 Diabetes and End Stage Renal Disease, consistent with previous findings in European populations.", "source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "clusters": "[{level: 0, cluster: 16}, {level: 1, cluster: 46}]", "id": "JAZF1 GENE"}, {"entity_type": "GENE", "description": "The ADAMTS9 gene includes a variant (rs4607103) which is inversely associated with T2D-ESRD risk compared to the direction observed in European samples.", "source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "clusters": "[{level: 0, cluster: 16}, {level: 1, cluster: 44}]", "id": "ADAMTS9 GENE"}, {"entity_type": "DISEASE", "description": "A condition characterized by the progression of type 2 diabetes mellitus into a stage where kidney function is severely impaired.", "source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "clusters": "[{level: 0, cluster: 16}, {level: 1, cluster: 45}]", "id": "TYPE 2 DIABETES AND END STAGE RENAL DISEASE (T2D-ESRD)"}, {"entity_type": "PHYSIOLOGICAL PROCESS, METABOLIC PATHWAY", "description": "A measure that evaluates the cumulative effect of genetic risk variants on the likelihood of developing a disease such as T2D-ESRD.", "source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "id": "CUMULATIVE RISK SCORE"}, {"entity_type": "DISEASE", "description": "The final stage of chronic kidney disease where dialysis or transplantation is required for survival.", "source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "id": "END STAGE RENAL DISEASE (ESRD)"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "The proportion of genetic ancestry from Africa that individuals carry, which was found to be similar across case and control groups in the study.", "source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "clusters": "[{level: 0, cluster: 16}, {level: 1, cluster: 45}]", "id": "AFRICAN ANCESTRY PROPORTION"}, {"entity_type": "TRANSCRIPT", "description": "The transcript of TCF7L2 gene is influenced by genomic variants such as rs7903146 associated with Type 2 Diabetes and End Stage Renal Disease.", "source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "id": "TCF7L2 TRANSCRIPT"}, {"entity_type": "TRANSCRIPT", "description": "The transcript of WFS1 gene, harboring the rs10010131 variant, is linked to an increased risk for T2D-ESRD.", "source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "id": "WFS1 TRANSCRIPT"}, {"entity_type": "TRANSCRIPT", "description": "The transcript of CDKAL1 gene includes a variant (rs10946398) that increases the likelihood of developing T2D-ESRD, consistent with previous findings in European populations.", "source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "id": "CDKAL1 TRANSCRIPT"}, {"entity_type": "TRANSCRIPT", "description": "A genomic variant (rs864745) found within the JAZF1 transcript is associated with an increased risk for Type 2 Diabetes and End Stage Renal Disease, similar to results observed in European samples.", "source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "id": "JAZF1 TRANSCRIPT"}, {"entity_type": "TRANSCRIPT", "description": "The ADAMTS9 transcript includes a variant (rs4607103) that is inversely associated with T2D-ESRD risk compared to the direction observed in European populations.", "source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "id": "ADAMTS9 TRANSCRIPT"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "The degree of African ancestry is an environmental factor considered in the analysis, showing no significant interaction effect (P = 0.74).", "source_id": "chunk-6a7c69534e11aa2fc4bd948484aa81c4", "clusters": "[{level: 0, cluster: 2}, {level: 1, cluster: 24}]", "id": "AFRICAN ANCESTRY DEGREE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The count of risk alleles is considered as a physiological process in genetic analyses.", "source_id": "chunk-6a7c69534e11aa2fc4bd948484aa81c4", "id": "RISK ALLELE COUNT"}, {"entity_type": "METABOLIC PATHWAY", "description": "Analysis results from the association of TCF7L2 risk variant rs7903146 are detailed in Supplementary Table 3 and Figures 2A and B.", "source_id": "chunk-6a7c69534e11aa2fc4bd948484aa81c4", "id": "TCF7L2 RISK VARIANT RS7903146 ASSOCIATION ANALYSIS RESULTS (SUPPLEMENTARY TABLE 3 AND FIG. 2A, B)"}, {"entity_type": "MOLECULAR INTERACTION", "description": "The unweighted odds ratio (OR) is a measure used to assess the interaction between risk alleles and disease susceptibility.", "source_id": "chunk-6a7c69534e11aa2fc4bd948484aa81c4", "id": "UNWEIGHTED OR (ODDS RATIO)"}, {"entity_type": "MOLECULAR INTERACTION", "description": "The weighted odds ratio (OR) measures the interaction considering the genetic background, providing adjusted results for TCF7L2 variant analysis.", "source_id": "chunk-6a7c69534e11aa2fc4bd948484aa81c4", "id": "WEIGHTED OR (ODDS RATIO)"}, {"source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "description": "A specific variant (rs10010131) in the WFS1 gene is associated with an increased risk of developing T2D-ESRD, although this association was weaker compared to European populations.", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 16}, {level: 1, cluster: 47}]", "id": "RS10010131 GENOMIC VARIANT"}, {"source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "description": "The rs10946398 variant in the CDKAL1 gene is associated with an increased risk of developing T2D-ESRD, consistent with previous findings in European samples.", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 16}, {level: 1, cluster: 45}]", "id": "RS10946398 GENOMIC VARIANT"}, {"source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "description": "The rs864745 variant in the JAZF1 gene is associated with an increased risk of developing T2D-ESRD, similar to results observed in European populations.", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 16}, {level: 1, cluster: 46}]", "id": "RS864745 GENOMIC VARIANT"}, {"source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "description": "A variant (rs4607103) in the ADAMTS9 gene is associated with T2D-ESRD risk, but this association differs directionally from that found in European populations.", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 16}, {level: 1, cluster: 44}]", "id": "RS4607103 GENOMIC VARIANT"}, {"source_id": "chunk-6a7c69534e11aa2fc4bd948484aa81c4", "description": "The count of risk alleles is associated with the TCF7L2 risk variant rs7903146 in association analyses.", "entity_type": "UNKNOWN", "id": "TCF7L2 RISK VARIANT RS7903146 ASSOCIATION ANALYSIS RESULTS"}, {"entity_type": "DISEASE", "description": "Type 2 Diabetes (T2D) is a chronic condition characterized by high blood sugar levels over a prolonged period.<SEP>Type 2 diabetes (T2D), a chronic metabolic disorder characterized by high blood sugar levels, was the primary disease of interest in this study.<SEP>Type 2 Diabetes is a disease for which methylation levels in HIST1H4D and DVL1 genes are predictive of increased incidence.", "source_id": "chunk-44a871da300abc9be525b468f502f5cb<SEP>chunk-bb507a90a1f5d5ddd01a93200ff2d45e<SEP>chunk-8276370dea9f12d2b305c355f74c7f6e", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 42}]", "id": "T2D"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Impaired Fasting Glucose and Impaired Glucose Tolerance (IFG/IGT) are intermediate states between normal glucose tolerance and type 2 diabetes.", "source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 41}]", "id": "IFG/IGT"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "FPG measures glucose level in the blood after an overnight fast and is used to assess pre-diabetic conditions like IFG as well as diabetes.<SEP>FPG measures the concentration of glucose in the blood after an overnight fast, used to diagnose pre-diabetes or diabetes.<SEP>Fasting plasma glucose (FPG) is a physiological process indicating the level of blood sugar before eating, which interacts with genetic factors like LEPR rs1011527 to affect BMI at baseline.", "source_id": "chunk-1fde08e52a188ac6a549e7c11d59a092<SEP>chunk-bb507a90a1f5d5ddd01a93200ff2d45e<SEP>chunk-f2e122f964bade37f487049bd69a3f9f", "id": "FASTING PLASMA GLUCOSE (FPG)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "2hPG is a measure taken two hours after consuming a glucose drink as part of an oral glucose tolerance test for diagnosing diabetes or pre-diabetes.", "source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "id": "TWO-HOUR PLASMA GLUCOSE (2HPG)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Normal Glucose Tolerance (NGT) is a state where an individual\u2019s blood sugar levels remain within a normal range.", "source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 41}]", "id": "NGT"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Refers to individuals with ancestry from East Asia, showing significant ethnic differences in the prevalence of IFG/IGT and T2D.", "source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 42}]", "id": "EAST ASIAN"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Individuals with African ancestry have specific patterns of IFG/IGT and T2D distribution compared to other ethnic groups.", "source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 41}]", "id": "AFRICAN"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Individuals with European heritage exhibit certain rates of IFG/IGT and T2D in comparison to other ethnicities.", "source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 41}]", "id": "EUROPEAN"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Refers to individuals from Native North America, displaying distinct distribution patterns of IFG/IGT and T2D compared to others.", "source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 42}]", "id": "NATIVE NORTH AMERICAN"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Individuals with Latino American background show specific rates of IFG/IGT and T2D relative to other groups.", "source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 41}]", "id": "LATINO AMERICAN"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Refers to individuals from South Asia, showing particular prevalence patterns for IFG/IGT and T2D compared to others.", "source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 42}]", "id": "SOUTH ASIAN"}, {"entity_type": "POPULATION GROUP", "description": "A group of participants in the study characterized by higher percentages across all glycemic statuses.", "source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "id": "FEMALES"}, {"entity_type": "POPULATION GROUP", "description": "Another participant group with a higher likelihood of being IFG/IGT or T2D compared to NGT counterparts.", "source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "id": "MALES"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "PG levels are a physiological process that is associated with baseline body mass index (BMI) and changes in BMI.", "source_id": "chunk-1fde08e52a188ac6a549e7c11d59a092", "id": "PG LEVELS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Baseline body mass index (BMI) is a physiological measurement used to assess obesity risk, showing significant associations with PG levels and genetic variants linked to obesity.", "source_id": "chunk-1fde08e52a188ac6a549e7c11d59a092", "id": "BMI BASELINE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Changes in body mass index (BMI) over time represent a physiological process that reflects the impact of genetic factors on weight management.", "source_id": "chunk-1fde08e52a188ac6a549e7c11d59a092", "id": "BMI CHANGE"}, {"entity_type": "GENOMIC VARIANT", "description": "Single nucleotide polymorphisms (SNPs) are genomic variants associated with predispositions to obesity, showing significant associations with baseline BMI and genotype risk score (GRS).<SEP>Single nucleotide polymorphisms (SNPs) common to both studies were tested for association with \'age at first tooth\' and \'number of teeth at one year\'.<SEP>Single nucleotide polymorphisms tested in the study did not show any statistically significant associations after multiple testing adjustments.", "source_id": "chunk-0d49552280a277a8a26456d06f8f26a8<SEP>chunk-50e07db177a6a08799261934e8e71ac4<SEP>chunk-1fde08e52a188ac6a549e7c11d59a092", "id": "SNPS"}, {"entity_type": "GENOMIC VARIANT", "description": "rs9939609 in the FTO gene is a single nucleotide polymorphism associated with an increased risk of obesity at baseline.", "source_id": "chunk-1fde08e52a188ac6a549e7c11d59a092", "id": "FTO RS9939609"}, {"entity_type": "GENOMIC VARIANT", "description": "rs2984618 in TAL1 is a genomic variant that has been significantly linked to an elevated BMI at baseline.", "source_id": "chunk-1fde08e52a188ac6a549e7c11d59a092", "id": "TAL1 RS2984618"}, {"entity_type": "GENOMIC VARIANT", "description": "rs7903146 in the TCF7L2 gene represents a genetic variant contributing to increased body mass index (BMI) at baseline.", "source_id": "chunk-1fde08e52a188ac6a549e7c11d59a092", "id": "TCF7L2 RS7903146"}, {"entity_type": "GENOMIC VARIANT", "description": "The Genetic Risk Score (GRS) is derived from genotyping results of six polymorphisms and predicts neurotoxicity-related cognitive impairment in patients.<SEP>The genotype risk score (GRS) is a physiological measurement derived from multiple obesity-associated SNPs that correlates with an elevated BMI at baseline.", "source_id": "chunk-ea6355aaf22d7cdd3331602638122ed7<SEP>chunk-1fde08e52a188ac6a549e7c11d59a092", "id": "GRS"}, {"entity_type": "GENOMIC VARIANT", "description": "rs1011527 in the LEPR gene shows significant interaction effects on baseline BMI when combined with fasting plasma glucose (FPG) levels, but no main effect alone.", "source_id": "chunk-1fde08e52a188ac6a549e7c11d59a092", "id": "LEPR RS1011527"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Changes in body mass index (BMI) over time reflect alterations in physiological processes related to weight management and obesity risk factors.", "source_id": "chunk-1fde08e52a188ac6a549e7c11d59a092", "id": "BMI LEVEL CHANGE"}, {"entity_type": "DISEASE, PHYSIOLOGICAL PROCESS", "description": "Traits related to glycemic status are indicators of metabolic health and can influence the main effects and interactions with genetic variants on body mass index (BMI).", "source_id": "chunk-1fde08e52a188ac6a549e7c11d59a092", "id": "GLYCEMIC STATUS TRAITS"}, {"source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "description": "Both fasting plasma glucose (FPG) and two-hour plasma glucose (2hPG) are measures of blood sugar regulation, where high values in both correlate positively with baseline BMI but negatively predict changes in BMI over time.", "entity_type": "UNKNOWN", "id": "2HPG"}, {"source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "description": "Both fasting plasma glucose (FPG) and two-hour plasma glucose (2hPG) are measures of blood sugar regulation, where high values in both correlate positively with baseline BMI but negatively predict changes in BMI over time.", "entity_type": "UNKNOWN", "id": "FPG"}, {"source_id": "chunk-1fde08e52a188ac6a549e7c11d59a092", "description": "The interaction between fasting plasma glucose (FPG) levels and the LEPR gene variant, rs1011527, is significant for predicting changes in body mass index (BMI).)", "entity_type": "UNKNOWN", "id": "FPG LEVELS"}, {"entity_type": "GENOMIC VARIANT", "description": "Polymorphism in the MTHFR gene associated with increased risk of neurocognitive impairment.", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "id": "MTHFR 1298A>C"}, {"entity_type": "GENOMIC VARIANT", "description": "Polymorphism in the MS gene related to performance on attention and processing speed tests.", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "id": "MS 2756A>G"}, {"entity_type": "GENOMIC VARIANT", "description": "Polymorphism in the MTHFR gene not significantly associated with neurocognitive impairment or test performance.", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "id": "MTHFR 677C>T"}, {"entity_type": "GENOMIC VARIANT", "description": "Polymorphism in SHMT gene not related to general neurocognitive impairment on the DIVERGT battery.", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "id": "SHMT 1520C>T"}, {"entity_type": "GENOMIC VARIANT", "description": "Polymorphism in MTRR gene associated with lower PEGNDH and CFL scores compared to other genotypes.", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "id": "MTRR 66A>G"}, {"entity_type": "GENOMIC VARIANT", "description": "Polymorphism related to performance on TMTA and TMTB tests, particularly the 2R/3R genotype.", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "id": "TSER POLYMORPHISMS"}, {"entity_type": "PHYSIOLOGICAL PROCESS/METABOLIC PATHWAY", "description": "Assessment of fine motor skills in neurocognitive testing.", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "id": "PEGDH"}, {"entity_type": "PHYSIOLOGICAL PROCESS/METABOLIC PATHWAY", "description": "Measures the effect of nerve damage on fine motor skills.", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "id": "PEGNDH"}, {"entity_type": "PHYSIOLOGICAL PROCESS/METABOLIC PATHWAY", "description": "Assesses working memory in neurocognitive testing.", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "id": "DIG (DIGIT SPAN TEST)"}, {"entity_type": "PHYSIOLOGICAL PROCESS/METABOLIC PATHWAY", "description": "Tests executive function and cognitive flexibility.", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "id": "CFL (COLOR FIGURE MEMORY TEST)"}, {"entity_type": "PHYSIOLOGICAL PROCESS/METABOLIC PATHWAY", "description": "Measures focused attention and processing speed in neurocognitive assessment.", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "id": "TMTA (TRAIL MAKING TEST A)"}, {"entity_type": "PHYSIOLOGICAL PROCESS/METABOLIC PATHWAY", "description": "Evaluates shifting attention and cognitive flexibility.", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "id": "TMTB (TRAIL MAKING TEST B)"}, {"entity_type": "ASSESSMENT METHOD", "description": "A comprehensive battery used to assess neurocognitive impairment in patients with ALL.<SEP>Comprehensive battery for assessing neurocognitive function, particularly memory and attention in cancer survivors.<SEP>The DIVERGT battery is a cognitive test used to assess various aspects of cognition but did not show an association with GRS or MTX-related neurotoxicity.", "source_id": "chunk-ea6355aaf22d7cdd3331602638122ed7<SEP>chunk-4b6e8f78911cafc70959cfdfed786c29", "id": "DIVERGT BATTERY"}, {"entity_type": "PHYSIOLOGICAL PROCESS/METABOLIC PATHWAY", "description": "Neurological damage caused by early administration of methotrexate (MTX).", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "id": "EARLY MTX-RELATED NEUROTOXICITY"}, {"entity_type": "METRIC/SCORE", "description": "Summation score indicating genetic risk for neurocognitive impairment based on polymorphisms.", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "id": "GENETIC RISK SCORE (GRS)"}, {"entity_type": "DISEASE", "description": "A type of cancer that affects blood-forming cells in bone marrow.", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "id": "ALL (ACUTE LYMPHOBLASTIC LEUKEMIA)"}, {"entity_type": "THERAPY/MEDICAL PROTOCOL", "description": "Treatment protocols for childhood cancers used primarily by the Pediatric Oncology Group (POG).", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "id": "PEDIATRIC ONCOLOGY GROUP PROTOCOLS"}, {"entity_type": "DRUG/CHEMOTHERAPY AGENT", "description": "A chemotherapy drug commonly used in the treatment of ALL.", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "id": "MTX (METHOTREXATE)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Early MTX-related neurotoxicity does not predict impairment on specific cognitive tests but correlates with lower performance on TMTA and TMTB based on GRS value.", "source_id": "chunk-ea6355aaf22d7cdd3331602638122ed7", "id": "MTX-RELATED NEUROTOXICITY"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "These are cognitive assessments used to evaluate neurotoxicity-related impairment in patients treated with MTX.", "source_id": "chunk-ea6355aaf22d7cdd3331602638122ed7", "id": "TMTA, PEGDH, PEGNDH, DIG, CFL"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Intrathecal methotrexate exposure is an environmental factor that influences the association between GRS and TMTB performance but does not significantly impact other cognitive tests.", "source_id": "chunk-ea6355aaf22d7cdd3331602638122ed7", "id": "INTRATHECAL MTX EXPOSURE"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Cumulative intravenous methotrexate exposure is an environmental factor considered in the analysis of the relationship between GRS and neurotoxicity-related impairment.", "source_id": "chunk-ea6355aaf22d7cdd3331602638122ed7", "id": "CUMULATIVE IV MTX EXPOSURE"}, {"entity_type": "GENOMIC VARIANT", "description": "A polymorphism is a genetic variation that contributes to the calculation of Genetic Risk Score (GRS).", "source_id": "chunk-ea6355aaf22d7cdd3331602638122ed7", "id": "POLYMORPHISM"}, {"entity_type": "POPULATION GROUP", "description": "Survivors are patients who have undergone treatment and survived, with their cognitive performance assessed based on GRS.", "source_id": "chunk-ea6355aaf22d7cdd3331602638122ed7", "id": "SURVIVORS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Cognitive impairment refers to a decline in cognitive functions such as memory and attention due to MTX-related neurotoxicity.", "source_id": "chunk-ea6355aaf22d7cdd3331602638122ed7", "id": "COGNITIVE IMPAIRMENT"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A specific cognitive test used to assess executive function and processing speed, with significant association observed between lower scores and higher GRS values.", "source_id": "chunk-ea6355aaf22d7cdd3331602638122ed7", "id": "TMTB (TRAIL MAKING TEST PART B)"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Age at diagnosis is an environmental factor that affects the association between GRS and neurotoxicity-related impairment.", "source_id": "chunk-ea6355aaf22d7cdd3331602638122ed7", "id": "DIAGNOSIS AGE"}, {"source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "description": "Survivors with MTRR 66AA genotype perform worse on CFL test compared to those with the MTRR 66AG/GG genotypes.", "entity_type": "UNKNOWN", "id": "CFL"}, {"source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "description": "Individuals with TSER 2R/3R and 3R/3R genotypes score lower on TMTB than those with the 2R/2R genotype.", "entity_type": "UNKNOWN", "id": "TMTB"}, {"source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "description": "Higher genetic risk scores correlate with worse performance on certain cognitive tests and a higher likelihood of neurocognitive impairment.", "entity_type": "UNKNOWN", "id": "NEUROCOGNITIVE IMPAIRMENT"}, {"source_id": "chunk-ea6355aaf22d7cdd3331602638122ed7<SEP>chunk-0d155c005072e55d94179ce7952bf5a9<SEP>chunk-e1b4f4dac52e806f19c580640a50c729", "description": "A genomic variant associated with quinolone resistance affects Campylobacter jejuni\'s response to fluoroquinolones.<SEP>A genomic variant in the FADS1/2 gene cluster influences colon arachidonic acid (AA) concentrations after a dietary intervention.<SEP>A polymorphism contributes to the calculation of GRS, which in turn predicts neurotoxicity-related cognitive impairment.", "entity_type": "GENOMIC VARIANT", "id": "GENOMIC VARIANT"}, {"entity_type": "GENOMIC VARIANT", "description": "The SLC30A8 rs13266634 variant is associated with higher fasting proinsulin levels and a risk allele.", "source_id": "chunk-8f23bd741f82dc8ca1e2600d790b690f", "id": "SLC30A8 RS13266634"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Fasting proinsulin levels are influenced by the presence of the SLC30A8 risk allele and can be decreased by lifestyle or pharmacological interventions.", "source_id": "chunk-8f23bd741f82dc8ca1e2600d790b690f", "id": "FASTING PROINSULIN LEVELS"}, {"entity_type": "DIETARY PATTERN", "description": "The DPP cohort is a group subjected to dietary and physical activity intervention studies.", "source_id": "chunk-8f23bd741f82dc8ca1e2600d790b690f", "id": "DPP COHORT"}, {"entity_type": "THERAPY", "description": "A lifestyle intervention that includes diet and exercise can significantly reduce fasting proinsulin levels compared to placebo or pharmacological interventions.", "source_id": "chunk-8f23bd741f82dc8ca1e2600d790b690f", "id": "LIFESTYLE INTERVENTION"}, {"entity_type": "DRUG", "description": "Metformin is a drug used in the DPP study for lowering fasting proinsulin levels, but it was less effective than lifestyle intervention.", "source_id": "chunk-8f23bd741f82dc8ca1e2600d790b690f", "id": "METFORMIN"}, {"entity_type": "DRUG", "description": "Troglitazone is another drug studied alongside metformin and lifestyle interventions for reducing proinsulin levels.", "source_id": "chunk-8f23bd741f82dc8ca1e2600d790b690f", "id": "TROGLITAZONE"}, {"entity_type": "MOLECULAR INTERACTION", "description": "The interaction between genotype (SLC30A8 risk allele) and treatment (lifestyle or pharmacological intervention) did not significantly modify the effectiveness of the treatments.", "source_id": "chunk-8f23bd741f82dc8ca1e2600d790b690f", "id": "GENOTYPE \u00d7 TREATMENT INTERACTION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Fasting insulin levels are adjusted for when analyzing the relationship between SLC30A8 risk alleles and proinsulin levels.", "source_id": "chunk-8f23bd741f82dc8ca1e2600d790b690f", "id": "FASTING INSULIN"}, {"entity_type": "DEMOGRAPHIC FACTOR", "description": "These demographic factors were controlled in the analysis of proinsulin levels after intervention.", "source_id": "chunk-8f23bd741f82dc8ca1e2600d790b690f", "id": "AGE, SEX, ETHNICITY"}, {"entity_type": "THERAPY", "description": "The placebo group served as a control for comparing the effects of lifestyle and drug interventions on proinsulin levels.", "source_id": "chunk-8f23bd741f82dc8ca1e2600d790b690f", "id": "PLACEBO GROUP"}, {"source_id": "chunk-8f23bd741f82dc8ca1e2600d790b690f", "description": "Adjusting for fasting insulin helps isolate the effect of SLC30A8 risk alleles on proinsulin levels.", "entity_type": "UNKNOWN", "id": "PROINSULIN LEVELS"}, {"entity_type": "GENE", "description": "PNPLA3 is a gene that regulates the expression in liver tissues and its mRNA level correlates with lipogenic conditions.<SEP>The PNPLA3 gene is involved in lipid metabolism and does not respond to insulin or glucagon stimulation in HepG2 cells.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f<SEP>chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "id": "PNPLA3"}, {"entity_type": "GENE", "description": "SREBP1c is a key transcriptional factor involved in lipid metabolism regulation.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "id": "SREBP1C (STEROL REGULATORY ELEMENT BINDING PROTEIN 1C)"}, {"entity_type": "PROTEIN", "description": "ACC-1 catalyzes the formation of malonyl-CoA, an essential step in fatty acid synthesis.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "id": "ACC-1 (ACETYL-COA CARBOXYLASE 1)"}, {"entity_type": "DIETARY PATTERN", "description": "A dietary pattern characterized by high carbohydrate intake.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "id": "HIGH CARBOHYDRATE DIET"}, {"entity_type": "NUTRIENT", "description": "An emulsion containing lipids, used to provide fat as an energy source.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "id": "LIPID EMULSION (LE)"}, {"entity_type": "DIETARY PATTERN", "description": "A dietary pattern characterized by high fat intake.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "id": "HIGH FAT DIET (HF)"}, {"entity_type": "LIFESTYLE FACTOR", "description": "Voluntary exercise as a lifestyle factor that influences health and gene expression.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "id": "PHYSICAL ACTIVITY (EXERCISE)"}, {"entity_type": "DISEASE", "description": "A disease condition where excessive lipid accumulation occurs in liver tissue.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "id": "FATTY LIVER"}, {"entity_type": "CELL LINE", "description": "A cell line derived from human hepatocellular carcinoma, used for studying liver biology and diseases.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "id": "HEPG2 CELLS"}, {"entity_type": "GENE", "description": "ChREBP is a transcription factor that responds to glucose levels and regulates gene expression.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "id": "CHREBP (CARBOHYDRATE RESPONSE ELEMENT BINDING PROTEIN)"}, {"entity_type": "NUTRIENT", "description": "A non-metabolizable analog of glucose used in experiments to inhibit glycolysis.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "id": "2-DEOXY-D-GLUCOSE (2DG)"}, {"entity_type": "METABOLIC PATHWAY", "description": "A metabolic pathway involving triglyceride synthesis and accumulation in liver tissues.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "id": "TG (TRIGLYCERIDES)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A physiological process where cells are exposed to conditions of glucose depletion followed by refeeding, used for studying gene expression regulation.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "id": "DEPLETION-REFEEDING CONDITIONS"}, {"entity_type": "NUTRIENT", "description": "An analog of glucose that does not undergo metabolism, used in experiments to inhibit glycolysis and study its effects on gene expression.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "id": "NON-METABOLIZABLE GLUCOSE ANALOG (2DG)"}, {"entity_type": "PROTEIN", "description": "Fatty Acid Synthase (FAS) protein, a known target of insulin action, was shown to be upregulated by insulin treatment in contrast to PNPLA3\'s lack of response.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "id": "FAS"}, {"entity_type": "GENE", "description": "Acetyl-CoA Carboxylase 1 (ACC-1), similar to FAS and PNPLA3, showed a similar expression pattern under high glucose conditions.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "id": "ACC-1"}, {"entity_type": "NUTRIENT", "description": "Citrate, a Krebs cycle intermediate downstream of glucose metabolism, increased the levels of PNPLA3 in HepG2 cells.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "id": "CITRATE"}, {"entity_type": "NUTRIENT", "description": "Isocitrate did not affect PNPLA3 levels, indicating specificity of citrate\'s effect on PNPLA3.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "id": "ISOCITRATE"}, {"entity_type": "PROTEIN", "description": "HepG2 cells express the insulin receptor protein but do not upregulate PNPLA3 mRNA in response to insulin treatment.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "id": "INSULIN RECEPTOR PROTEIN"}, {"entity_type": "NUTRIENT", "description": "Treatment with glucagon did not affect PNPLA3 mRNA expression, unlike its effect on pyruvate carboxylase (PC).", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "id": "GLUCAGON"}, {"entity_type": "NUTRIENT", "description": "LA treatment suppressed PNPLA3 gene expression in HepG2 cells under both high and low glucose conditions.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "id": "LINOLEIC ACID (LA)"}, {"entity_type": "NUTRIENT", "description": "OA treatment also led to suppression of PNPLA3 mRNA levels similarly to LA, showing a similar effect on PNPLA3 regulation.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "id": "OLEIC ACID (OA)"}, {"entity_type": "NUTRIENT", "description": "ALA had no effect on the expression of PNPLA3 under both high and low glucose conditions.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "id": "\u0391-LINOLENIC ACID (ALA)"}, {"entity_type": "NUTRIENT", "description": "Treatment with EPA suppressed PNPLA3 gene expression in HepG2 cells, similar to OA and LA effects.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "id": "EICOSAPENTAENOIC ACID (EPA)"}, {"entity_type": "NUTRIENT", "description": "Like EPA, DHA treatment also reduced PNPLA3 mRNA levels under both high and low glucose conditions.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "id": "DOCOSAHEXAENOIC ACID (DHA)"}, {"entity_type": "GENE", "description": "The expression of SREBP1c gene was significantly suppressed by a combination of OA, LA, and ALA in HepG2 cells.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "id": "SREBP1C GENE"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Incubation with high glucose resulted in an increase of lipid accumulation but did not affect PNPLA3 mRNA levels as expected from insulin or glucagon treatment response.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "id": "HIGH GLUCOSE CONDITION"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "In contrast to the effects under high glucose, low glucose conditions were used for comparative studies and showed no specific effect on PNPLA3 expression patterns in HepG2 cells except for unsaturated fatty acid treatments.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "id": "LOW GLUCOSE CONDITION"}, {"entity_type": "THERAPY", "description": "Used as a non-targeting control to compare effects of PNPLA3-specific siRNA transfection in HepG2 cells, showing no effect on lipid accumulation but an increase in FAS mRNA levels.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "id": "SCRAMBLED SIRNA"}, {"entity_type": "NUTRIENT", "description": "Treatment with 2-deoxy-D-glucose altered PNPLA3 expression, indicating its role in glucose metabolism.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "id": "2-DEOXY-D-GLUCOSE"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Induced PNPLA3 gene expression in mouse liver but was reversed by Intralipid\u00ae treatment in HepG2 cells.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "id": "HIGH GLUCOSE DIET (HC-DIET)"}, {"entity_type": "NUTRIENT", "description": "Suppressed PNPLA3 gene expression and affected SREBP1c and FAS expression in HepG2 cells.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "id": "INTRALIPID\u00ae"}, {"entity_type": "THERAPY", "description": "Did not affect the level of PNPLA3 expression in contrast to PNPLA3 knockdown, showing specificity.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "id": "KNOCKDOWN OF FAS (FASN)"}, {"entity_type": "ASSAY METHOD", "description": "Used to measure lipid accumulation and showed no difference between cells with knocked down PNPLA3 and controls under glucose conditions.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "id": "OIL RED O STAINING"}, {"source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "description": "FAS protein is upregulated by insulin treatment, contrasting with no change observed for the PNPLA3 gene expression under similar conditions.", "entity_type": "UNKNOWN", "id": "FAS PROTEIN"}, {"source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "description": "FAS protein is upregulated by insulin treatment, contrasting with no change observed for the PNPLA3 gene expression under similar conditions.", "entity_type": "UNKNOWN", "id": "INSULIN TREATMENT"}, {"source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "description": "Under high glucose condition, although lipid accumulation increased, there was no significant effect on PNPLA3 mRNA levels as opposed to expected upregulation of FAS or ACC-1.", "entity_type": "UNKNOWN", "id": "PNPLA3 GENE"}, {"source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "description": "Induced PNPLA3 gene expression which was reversed by Intralipid\u00ae treatment, demonstrating dietary effects on hepatic lipid metabolism.", "entity_type": "UNKNOWN", "id": "MOUSE LIVER"}, {"source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "description": "When combined with OA and LA but not ALA, significantly suppressed PNPLA3 mRNA levels in HepG2 cells under both glucose conditions, indicating a complex interaction.", "entity_type": "UNKNOWN", "id": "FATTY ACIDS (OA, LA, ALA)"}, {"source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "description": "No difference was observed in lipid accumulation between knocked down PNPLA3 cells and controls, indicating that knockdown did not affect lipid storage capacity.", "entity_type": "UNKNOWN", "id": "HEPG2 CELLS WITH KNOCKED DOWN PNPLA3"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "PNS refers to psychological stress that leads to an increase in FoxO1 expression within the hippocampus of animals exposed to such stress.<SEP>Prenatal stress exposure is an environmental factor that causes transcriptomic changes in the hippocampus of adult male rats.", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf<SEP>chunk-704d1bc6fcda99ac888bd36c954fdb98", "id": "PNS"}, {"entity_type": "TRANSCRIPTOME", "description": "The hippocampus transcriptome analysis revealed significant modulation of 916 genes after PNS in comparison to control animals.", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "id": "HIPPOCAMPUS TRANSCRIPTOME"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A biological process involved in neurodevelopment that was altered by PNS exposure according to pathway analysis.", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "id": "AXONAL GUIDANCE SIGNALING PATHWAY"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A physiological process involved in neurodevelopment and altered by PNS exposure according to pathway analysis.", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "id": "PROTEIN KINASE A SIGNALING PATHWAY"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A biological process involved in neurodevelopment that was altered by PNS exposure according to pathway analysis.", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "id": "GLUTAMATE RECEPTOR SIGNALING PATHWAY"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A signaling pathway involved in neurodevelopment and altered by PNS exposure according to pathway analysis.", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "id": "WNT/\u0392-CATENIN SIGNALING PATHWAY"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A biological process involving CREB signaling in neurons that was affected by PNS exposure.", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "id": "CREB SIGNALING IN NEURONS PATHWAY"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A physiological process involved in synaptic plasticity and altered due to PNS exposure according to pathway analysis.", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "id": "SYNAPTIC LONG TERM DEPRESSION PATHWAY"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "An inflammatory signaling pathway that was identified as being altered by PNS exposure according to pathway analysis.", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "id": "IL-8 SIGNALING PATHWAY"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A biological process involved in inflammation and affected by PNS exposure according to pathway analysis.", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "id": "STAT3 PATHWAY"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A signaling pathway implicated in neuronal development and altered due to PNS exposure.", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "id": "CDK5 SIGNALING PATHWAY"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "An inflammatory signaling pathway affected by PNS exposure according to pathway analysis.", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "id": "IL-1 SIGNALING PATHWAY"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A biological process involved in inflammation and altered due to PNS exposure according to pathway analysis.<SEP>The biological mechanism by which IL-6 mediates its effects on cell function and inflammation.", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c<SEP>chunk-37088dc7c337929125b7fb31c9bf64cf", "id": "IL-6 SIGNALING PATHWAY"}, {"entity_type": "METABOLIC PATHWAY", "description": "Bone morphogenetic protein (BMP) signaling is a metabolic pathway that was affected by PNS exposure, as identified through pathway analysis.", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "id": "BMP SIGNALING PATHWAY"}, {"entity_type": "METABOLIC PATHWAY", "description": "Transforming Growth Factor beta (TGF-\u03b2) signaling pathway plays a significant role in cellular processes such as development, differentiation, and immune responses.<SEP>Transforming growth factor-beta (TGF-\u03b2) signaling is a metabolic pathway altered due to PNS exposure according to pathway analysis.", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf<SEP>chunk-01cd90d27130aab1a096ad616e05f182", "id": "TGF-\u0392 SIGNALING PATHWAY"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Changes in miRNA levels and their interactions with mRNA transcripts identified from the transcriptomics analysis post-PNS exposure.", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "id": "MIRNOME CHANGES"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Exposure to early life trauma is an environmental factor linked to differential gene expression and pathway modulation observed in blood mRNA analyses of adult humans.", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "id": "EARLY LIFE TRAUMA EXPOSURE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "An endothelial nitric oxide synthase signaling pathway involved in inflammation that was affected by exposure to early life trauma according to pathway analysis.", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "id": "ENOS SIGNALING PATHWAY"}, {"entity_type": "GENE LIST", "description": "A list of 916 genes that were differentially regulated in the hippocampus of male adult rats exposed to PNS compared to controls.", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "id": "916 DIFFERENTIALLY REGULATED GENES LIST"}, {"entity_type": "PATHWAY LIST", "description": "List of pathways involved in neurodevelopment (Wnt/Ca+ pathway, cAMP signaling, CREB signaling) and inflammation (eNOS signaling, chemokine signaling, B cell activation), identified through transcriptomics analysis.", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "id": "42 PATHWAYS INVOLVED IN NEURODEVELOPMENT AND INFLAMMATION"}, {"entity_type": "GENE LIST", "description": "A panel of 528 significant genes involved in neurodevelopment and inflammation pathways that were both modulated by PNS exposure and targeted by miRNAs also modulated due to PNS, as identified from combined mRNA-miRNA analysis.", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "id": "528 SIGNIFICANT GENES PANEL"}, {"entity_type": "TRANSCRIPTOME ANALYSIS", "description": "Analysis revealing 250 genes differentially modulated in individuals exposed to early life trauma compared to those without exposure.", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "id": "BLOOD TRANSCRIPTOMICS OF EARLY LIFE TRAUMA"}, {"entity_type": "DATA INTEGRATION", "description": "Combination of data from PNS-exposed rats and humans with a history of early-life trauma, identifying 22 common genes that were modulated in the same or opposite direction in both groups.", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "id": "INTEGRATED DATA SET FROM ANIMAL AND HUMAN STUDIES"}, {"entity_type": "VALIDATION METHOD", "description": "Method used to validate gene expression levels of the 22 common genes identified from integrated data sets, confirming the microarray results.", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "id": "REAL-TIME PCR VALIDATION"}, {"entity_type": "GENE", "description": "Isochorismatase domain containing 1 (ISOC1) is a gene that shows modulated expression in both animals and humans under certain conditions.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "ISOC1"}, {"entity_type": "GENE", "description": "Low density lipoprotein receptor adapter protein 1 (LDLRAP1) is a gene whose expression changes are observed in both animal models and human studies.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "LDLRAP1"}, {"entity_type": "GENE", "description": "Leucine-rich repeat neuronal protein 3 (LRRN3) shows differential regulation between rats and humans under specific conditions.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "LRRN3"}, {"entity_type": "GENE", "description": "Myosin ID (MYO1D) is a gene that exhibits similar modulation patterns in both animals and humans.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "MYO1D"}, {"entity_type": "GENE", "description": "Phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 beta (PIK3C2B) shows differential expression regulation across species under stress conditions.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "PIK3C2B"}, {"entity_type": "GENE", "description": "Phosphatidic acid phosphatase type 2A (PPAP2A) is a gene that displays similar modulation patterns in both animals and humans.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "PPAP2A"}, {"entity_type": "GENE", "description": "Sterile alpha motif domain containing 12 (SAMD12) is a gene that displays changes in expression levels across different conditions and species.<SEP>Sterile alpha motif domain containing 12 (SAMD12) shows regulation changes under specific environmental conditions in animals and humans.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "SAMD12"}, {"entity_type": "GENE", "description": "Serine incorporator 5 (SERINC5) exhibits differential regulation patterns between species under stress-related studies.<SEP>Serine incorporator 5 (SERINC5) is a gene that exhibits differential expression patterns between species in stress-related studies.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "SERINC5"}, {"entity_type": "GENE", "description": "Transforming growth factor, beta 1 (TGF-\u03b21) plays a role as a signaling molecule and modulates cellular processes under various conditions.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "TGF-\u03921"}, {"entity_type": "GENE", "description": "Alpha-2-macroglobulin (A2M) is a gene involved in immune response and protein homeostasis, showing interaction with other genes in depression studies.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "A2M"}, {"entity_type": "GENE", "description": "ARID5B plays a role in cellular processes under conditions of stress or trauma exposure.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "ARID5B"}, {"entity_type": "GENE", "description": "Adaptor related protein complex 1 delta subunit (ARRDC4) is involved in intracellular transport and shows interaction with other genes in depression research.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "ARRDC4"}, {"entity_type": "GENE", "description": "Ephrin type-A receptor 4 (EPHA4) plays a role in neuronal development and signaling, interacting with other genes studied for GxE interactions.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "EPHA4"}, {"entity_type": "GENE", "description": "F-box protein 32 (FBXO32), also known as Atrogin-1, is involved in muscle atrophy under conditions of stress or trauma exposure.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "FBXO32"}, {"entity_type": "GENE", "description": "Forkhead box O1 (FoxO1) mediates the negative effect of stress on neurogenesis and plays a significant role in GxE interactions for depression.<SEP>FoxO1 is a gene activated in hippocampal progenitor stem cells following cortisol exposure and mediates the negative effect of stress on neurogenesis.", "source_id": "chunk-704d1bc6fcda99ac888bd36c954fdb98<SEP>chunk-01cd90d27130aab1a096ad616e05f182", "id": "FOXO1"}, {"entity_type": "GENE", "description": "Heat shock transcription factor 2 (HSF2) is involved in cellular responses to environmental stresses or trauma exposure.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "HSF2"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific single nucleotide polymorphism located within the FoxO1 gene that shows a significant interaction with emotional stress during childhood, predicting depressive symptoms in adulthood.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "SNP RS17592371"}, {"entity_type": "GENE", "description": "B-Cell CLL/Lymphoma 2 (BCL2) is a gene involved in apoptosis regulation and exhibits differential expression patterns between rats and humans.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "BCL2"}, {"entity_type": "GENE", "description": "B-Cell CLL/Lymphoma 9 (BCL9) is a gene that shows down-regulation in rats and up-regulation in humans under certain conditions.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "BCL9"}, {"entity_type": "GENE", "description": "Lymphoid Enhancer-Binding Factor 1 (LEF1) is a gene displaying differential expression patterns between species in the context of stress-related studies.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "LEF1"}, {"entity_type": "GENE", "description": "Lin-54 DREAM MuvB Core Complex Subunit (LIN54) shows up-regulation in humans and down-regulation in rats under specific conditions.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "LIN54"}, {"entity_type": "PATHWAY", "description": "This pathway is involved in mediating the effects of stress hormones on gene expression and cellular processes.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "GLUCOCORTICOID RECEPTOR SIGNALING PATHWAY"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Cortisol is an environmental factor, specifically a human stress hormone that affects FoxO1 expression and neuronal proliferation when applied to hippocampal progenitor cell lines in vitro.", "source_id": "chunk-704d1bc6fcda99ac888bd36c954fdb98", "id": "CORTISOL"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The hippocampus is a region of the brain where FoxO1 upregulation occurs following exposure to PNS (Psychological stress) or childhood trauma, and it plays a role in neurogenesis under stress conditions.", "source_id": "chunk-704d1bc6fcda99ac888bd36c954fdb98", "id": "HIPPOCAMPUS"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Childhood trauma is an environmental factor linked to increased levels of FoxO1 expression in blood samples from individuals who have experienced it.", "source_id": "chunk-704d1bc6fcda99ac888bd36c954fdb98", "id": "CHILDHOOD TRAUMA"}, {"entity_type": "MOLECULAR INTERACTION", "description": "AS1842856 is a cell-permeable inhibitor used to study the functional relevance of FoxO1 by counteracting its effects on neuronal proliferation when cortisol is present.", "source_id": "chunk-704d1bc6fcda99ac888bd36c954fdb98", "id": "AS1842856"}, {"entity_type": "GENE", "description": "SGK-1 is a gene that mediates some of the glucocorticoid\'s effect on brain function, including reducing neurogenesis, and its mRNA levels are upregulated following cortisol treatment.", "source_id": "chunk-704d1bc6fcda99ac888bd36c954fdb98", "id": "SGK-1 (SERUM GLUCOCORTICOID KINASE 1)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Neuronal proliferation is a physiological process affected by FoxO1 activation under stress conditions in vitro when treated with cortisol.", "source_id": "chunk-704d1bc6fcda99ac888bd36c954fdb98", "id": "NEURONAL PROLIFERATION"}, {"entity_type": "PROTEIN", "description": "The FoxO1 protein is activated following cortisol exposure in hippocampal progenitor stem cells.", "source_id": "chunk-704d1bc6fcda99ac888bd36c954fdb98", "id": "FOXO1 PROTEIN"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "These are the stem cells found in the hippocampus that can differentiate into neurons and glial cells, affected by FoxO1 activation under stress conditions.", "source_id": "chunk-704d1bc6fcda99ac888bd36c954fdb98", "id": "HIPPOCAMPAL PROGENITOR STEM CELLS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process of generating new neurons from neural stem cells or progenitor cells, which is negatively impacted by FoxO1 under stress conditions.", "source_id": "chunk-704d1bc6fcda99ac888bd36c954fdb98", "id": "NEUROGENESIS"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Under baseline conditions, without any environmental stressors like cortisol, FoxO1 does not exhibit significant effects on neuronal proliferation.", "source_id": "chunk-704d1bc6fcda99ac888bd36c954fdb98", "id": "BASELINE CONDITIONS"}, {"source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "description": "Panel of significant genes from the PNS model\'s combined mRNA-miRNA analysis that were also modulated in individuals exposed to early-life trauma.)", "entity_type": "UNKNOWN", "id": "PRENATAL STRESS MODEL"}, {"source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "description": "FoxO1 activation occurs in hippocampal progenitor stem cells following cortisol exposure, indicating its role as a mediator between stress and neurogenesis.", "entity_type": "UNKNOWN", "id": "CORTISOL EXPOSURE"}, {"source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "description": "Transforming growth factor beta 1 (TGF-\u03b21) is involved in GxE interaction studies, showing significant associations with emotional stress and depressive symptoms in adulthood.", "entity_type": "UNKNOWN", "id": "GXE INTERACTION STUDIES"}, {"source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "description": "Single nucleotide polymorphisms within the FoxO1 gene interact significantly with childhood trauma to predict higher levels of depressive symptoms in adulthood.", "entity_type": "UNKNOWN", "id": "FOXO1 SNPS"}, {"source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "description": "The TGF-\u03b21 signaling pathway is involved in cytokine signaling, indicating interconnected pathways that play a role in cellular communication and stress responses.", "entity_type": "UNKNOWN", "id": "CYTOKINES SIGNALING PATHWAY"}, {"source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "description": "The TGF-\u03b21 signaling pathway is involved in cytokine signaling, indicating interconnected pathways that play a role in cellular communication and stress responses.", "entity_type": "UNKNOWN", "id": "TGF-\u03921 SIGNALING PATHWAY"}, {"entity_type": "GENOMIC VARIANT", "description": "SNP rs4771122 is a genomic variant that has been associated with long-term weight loss after bariatric surgery.", "source_id": "chunk-b3d775642c43fa3524a531a3f6ec1e41", "clusters": "[{level: 0, cluster: 7}]", "id": "RS4771122"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Bariatric surgery is a procedure that leads to significant weight loss and metabolic changes, often associated with long-term health outcomes.", "source_id": "chunk-b3d775642c43fa3524a531a3f6ec1e41", "id": "BARIATRIC SURGERY"}, {"source_id": "chunk-b3d775642c43fa3524a531a3f6ec1e41", "description": "The minor (G) allele of SNP rs4771122 is associated with larger percentage weight lost after bariatric surgery, adjusted for several variables including pre-surgical BMI.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 7}]", "id": "LONG-TERM WEIGHT LOSS AFTER BARIATRIC SURGERY"}, {"source_id": "chunk-b3d775642c43fa3524a531a3f6ec1e41", "description": "Additional copies of the minor (G) allele in SNP rs4771122 were significantly associated with increased pre-surgical weight, indicating a relationship between genotypic variation and baseline characteristics.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 7}]", "id": "PRE-SURGICAL WEIGHT"}, {"entity_type": "GENOMIC VARIANT", "description": "Variants in the GCK gene have been identified through Sanger sequencing or MODY gene panel.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "id": "GCK VARIANT"}, {"entity_type": "INDIVIDUAL", "description": "A proband is a person with suspected or confirmed GCK-MODY who tests positive for a GCK variant.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "id": "PROBAND"}, {"entity_type": "GENE", "description": "No variants were found in the GCK gene in this study.<SEP>The GCK gene is associated with glucose metabolism and has variants linked to GCK-MODY (Maturity-Onset Diabetes of the Young).", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf<SEP>chunk-658df2fc2f9361a65ff1d22464744763", "id": "GCK GENE"}, {"entity_type": "MEDICAL PROCEDURE", "description": "A method used for sequencing DNA fragments by selectively amplifying specific regions.<SEP>A technique used for sequencing DNA, particularly for identifying genetic variations in genes such as GCK.<SEP>Sanger sequencing is used for verification and validation of genotypes identified by HRMA, ensuring accuracy in genotype assignment.", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5<SEP>chunk-825b9a3dd613f4c55dbf49fa3998d0d5<SEP>chunk-658df2fc2f9361a65ff1d22464744763", "id": "SANGER SEQUENCING"}, {"entity_type": "TECHNIQUE", "description": "A gene panel used to detect variants in multiple MODY-related genes including the GCK gene.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "id": "MODY GENE PANEL"}, {"entity_type": "INSTITUTION", "description": "The University of Chicago has conducted research and clinical testing for GCK-MODY through Sanger sequencing or MODY gene panels.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "id": "UNIVERSITY OF CHICAGO"}, {"entity_type": "BASIS", "description": "A basis for identifying novel GCK variants through genetic analysis and interpretation.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "id": "RESEARCH BASIS"}, {"entity_type": "BASIS", "description": "The use of clinical data to identify, classify, and understand the implications of GCK gene variants.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "id": "CLINICAL BASIS"}, {"entity_type": "GUIDELINES", "description": "American College of Medical Genetics and Genomics (ACMG) guidelines for variant interpretation.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "id": "ACMG GUIDELINES"}, {"entity_type": "GENOMIC VARIANT", "description": "Variants classified as pathogenic according to ACMG guidelines, indicating a strong association with disease.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "id": "PATHOGENIC VARIANTS"}, {"entity_type": "GENOMIC VARIANT", "description": "Variants likely to be pathogenic based on interpretation of clinical and genetic data.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "id": "LIKELY PATHOGENIC VARIANTS"}, {"entity_type": "GENOMIC VARIANT", "description": "Genetic variants that do not meet criteria for pathogenicity but cannot be ruled out as benign.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "id": "VARIANT OF UNCERTAIN SIGNIFICANCE (VUS)"}, {"entity_type": "GENOMIC VARIANT", "description": "A genetic mutation that occurs in a germ cell and is present for the first time in one family member.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "id": "DE NOVO MUTATION"}, {"entity_type": "TOOL", "description": "Computational tools used to predict the impact of genetic variants on protein function.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "id": "IN-SILICO TOOLS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A condition where fasting blood glucose levels remain stable but elevated in individuals with GCK gene mutations.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "id": "STABLE FASTING HYPERGLYCEMIA"}, {"entity_type": "DISEASE", "description": "A form of maturity-onset diabetes of the young (MODY) caused by mutations in the GCK gene.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "id": "GCK-MODY"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Elevated blood glucose levels before meals, often observed in individuals with genetic predispositions like GCK-MODY.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "id": "FASTING HYPERGLYCEMIA"}, {"entity_type": "PHYSIOLOGICAL MEASUREMENT", "description": "A measure of average blood sugar control over the past 2-3 months, used to assess diabetes management.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "id": "HBA1C LEVEL"}, {"entity_type": "GENOMIC VARIANT", "description": "A type of mutation that introduces a premature stop codon in the sequence and can lead to loss-of-function protein.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "id": "NONSENSE VARIANT"}, {"entity_type": "GENOMIC VARIANT", "description": "A variant that results in a single amino acid change, which may or may not affect protein function.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "id": "MISSENSE VARIANT"}, {"entity_type": "GENOMIC VARIANT", "description": "A mutation located within the intron-exon boundaries affecting mRNA splicing and protein synthesis.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "id": "SPLICE SITE VARIANT"}, {"entity_type": "GENOMIC VARIANT", "description": "Alterations in the DNA sequence that do not disrupt the reading frame of the genetic code, potentially altering protein structure but retaining function.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "id": "IN-FRAME DELETION/DUPLICATION"}, {"entity_type": "GENOMIC VARIANT", "description": "A mutation involving the insertion or deletion of nucleotides leading to changes in amino acid sequence and potential protein dysfunction.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "id": "INSERTION/DELETION (INDEL)"}, {"entity_type": "PROCESS", "description": "The process of determining whether a genetic variant is pathogenic, likely pathogenic, VUS, or benign based on clinical and genetic data.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "id": "PATHOGENICITY CLASSIFICATION"}, {"source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "description": "Clinical information for a subset of probands with GCK variants was available and analyzed.", "entity_type": "UNKNOWN", "id": "CLINICAL INFORMATION"}, {"source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "description": "Variants not meeting criteria for pathogenicity or benign but classified as VUS based on limited evidence.", "entity_type": "UNKNOWN", "id": "VUS"}, {"source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "description": "Nonsense variants can lead to truncated proteins, impacting their function and contributing to disease.", "entity_type": "UNKNOWN", "id": "PROTEIN FUNCTION"}, {"source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "description": "Missense variants result in single amino acid changes that may alter protein structure or function.", "entity_type": "UNKNOWN", "id": "AMINO ACID CHANGE"}, {"source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "description": "Splice site variants can affect mRNA splicing and subsequently impact the efficiency of protein synthesis.", "entity_type": "UNKNOWN", "id": "PROTEIN SYNTHESIS"}, {"source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "description": "These genomic changes maintain the reading frame but may alter amino acid sequence, potentially affecting protein function.", "entity_type": "UNKNOWN", "id": "READING FRAME"}, {"source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "description": "Indels can introduce frameshift mutations or simply alter amino acid sequences without disrupting the coding frame.", "entity_type": "UNKNOWN", "id": "AMINO ACID SEQUENCE"}, {"entity_type": "DIETARY PATTERN", "description": "The Mediterranean diet is a dietary pattern associated with improved metabolic health, characterized by high intake of fruits, vegetables, whole grains, and olive oil.", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "clusters": "[{level: 0, cluster: 10}, {level: 1, cluster: 39}]", "id": "MEDITERRANEAN DIET (MD)"}, {"entity_type": "METABOLIC PATHWAY", "description": "Triglyceride levels are part of the lipid profile that can be influenced by dietary patterns such as adherence to the Mediterranean diet.", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "clusters": "[{level: 0, cluster: 10}, {level: 1, cluster: 40}]", "id": "TAG (TRIGLYCERIDES)"}, {"entity_type": "METABOLIC PATHWAY", "description": "HDL cholesterol is a component of the lipid profile and its concentration is positively associated with adherence to the Mediterranean diet.", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "clusters": "[{level: 0, cluster: 10}, {level: 1, cluster: 39}]", "id": "HDL-C (HIGH-DENSITY LIPOPROTEIN CHOLESTEROL)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The apoB:apoA-1 ratio is a physiological process related to cardiovascular risk assessment, influenced by dietary patterns such as the Mediterranean diet.", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "clusters": "[{level: 0, cluster: 10}, {level: 1, cluster: 39}]", "id": "APOB:APOA-1 RATIO"}, {"entity_type": "METABOLIC PATHWAY", "description": "HbA1c reflects average blood glucose levels over several months and its concentration is inversely associated with adherence to the Mediterranean diet.", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "clusters": "[{level: 0, cluster: 10}, {level: 1, cluster: 39}]", "id": "HBA1C (GLYCATED HEMOGLOBIN)"}, {"entity_type": "GENOMIC VARIANT", "description": "A genetic variant located on the glucokinase regulatory protein (GCKR) gene that influences triglyceride levels among other metabolic markers.", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "clusters": "[{level: 0, cluster: 10}, {level: 1, cluster: 40}]", "id": "GENETIC VARIANT (RS780094 SNP IN GCKR GENE)"}, {"entity_type": "LIFESTYLE FACTOR", "description": "Physical activity level is a lifestyle factor influencing adherence to dietary patterns such as the Mediterranean diet and associated metabolic outcomes.", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "clusters": "[{level: 0, cluster: 10}, {level: 1, cluster: 39}]", "id": "PHYSICAL ACTIVITY LEVEL"}, {"entity_type": "METABOLIC PATHWAY", "description": "LDL cholesterol is another component of the lipid profile influenced by dietary patterns and genetic variants like GCKR rs780094 SNP.", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "clusters": "[{level: 0, cluster: 10}, {level: 1, cluster: 40}]", "id": "LDL-C (LOW-DENSITY LIPOPROTEIN CHOLESTEROL)"}, {"entity_type": "METABOLIC PATHWAY", "description": "Total cholesterol includes both LDL and HDL cholesterol, reflecting overall cardiovascular risk factors.", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "clusters": "[{level: 0, cluster: 10}, {level: 1, cluster: 39}]", "id": "TC (TOTAL CHOLESTEROL)"}, {"entity_type": "DISEASE", "description": "Hypertriacylglycerolaemia refers to high levels of triglycerides in the blood, a condition influenced by dietary patterns and genetic predispositions.", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "clusters": "[{level: 0, cluster: 10}, {level: 1, cluster: 40}]", "id": "HYPERTRIACYLGLYCEROLAEMIA"}, {"entity_type": "MOLECULAR INTERACTION", "description": "A gene-diet interaction involves the combined effect of genetic variation and dietary intake on a biological trait or disease risk.", "source_id": "chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 35}]", "id": "GENE-DIET INTERACTION"}, {"entity_type": "GENOMIC VARIANT", "description": "Genotype refers to an individual\'s genetic makeup, which can influence traits such as TAG levels (triglyceride levels).", "source_id": "chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6", "id": "GENOTYPE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "TAG levels refer to the concentration of triglycerides in blood, a physiological process influenced by both genetics and diet.", "source_id": "chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6", "id": "TAG LEVELS"}, {"entity_type": "NUTRIENT", "description": "A specific dietary factor or nutrient that interacts with a genetic variant to influence TAG levels.", "source_id": "chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6", "id": "DIETARY FACTOR Y"}, {"source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "description": "Individuals adhering more closely to the MD tend to have smaller waist circumferences.", "entity_type": "UNKNOWN", "id": "MEDITERRADIAN DIET (MD)"}, {"source_id": "chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6", "description": "Smoking status may modify the effect of Gene X on health outcomes through gene-diet interactions.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 35}]", "id": "GENE X"}, {"entity_type": "GENE", "description": "The ABCC8 gene is involved in the regulation of insulin secretion through its role in potassium channel function.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "id": "ABCC8 GENE"}, {"entity_type": "GENE", "description": "KCNJ11 encodes a component of the ATP-sensitive potassium (KATP) channels but no mutations were identified in this study.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "id": "KCNJ11 GENE"}, {"entity_type": "GENE", "description": "The GLUD1 gene is associated with hyperinsulinism and hypoglycemia, contributing to CHI pathology.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "id": "GLUD1 GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "This specific mutation in ABCC8 is a deletion/insertion mutation found in five unrelated patients, representing a common variant.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "id": "ABCC8 MUTATION C.3224-3226DELACC INS CAGCCAGGAACTG (P.THR1042GLNFSX75)"}, {"entity_type": "GENOMIC VARIANT", "description": "A heterozygous mutation found in three different patients with hypoglycaemia and hyperinsulinism.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "id": "GLUD1 MUTATION P.ARG322 HIS"}, {"entity_type": "THERAPY", "description": "Treatment for CHI patients, effective in some but not all cases.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "id": "DIAZOXIDE THERAPY"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A condition marked by abnormally low blood glucose levels often linked to hyperinsulinism.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "id": "HYPOGLYCEMIA (HI)"}, {"entity_type": "DISEASE CONDITION", "description": "Patients with unusually high birth weight, indicating a potential genetic or environmental factor influencing growth.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "id": "MACROSOMIC PATIENTS"}, {"entity_type": "MOLECULAR INTERACTION", "description": "An imaging technique used to detect focal lesions in the pancreas of CHI patients.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "id": "18F-DOPA PET/CT SCAN"}, {"entity_type": "DISEASE CONDITION", "description": "Pancreatic disease affecting multiple areas of the organ, often linked with diazoxide-unresponsive cases.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "id": "DIFFUSE PANCREATIC DISEASE"}, {"entity_type": "GENOMIC VARIANT", "description": "A set of novel mutations identified in the study that contribute to CHI pathology.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "id": "NOVEL MUTATIONS P.PHE5SERFSX72, P.GLN273ARGFSX85, P.LEU724DEL, P.ASP1447GLY AND IVS 25-1G>T IN ABCC8 GENE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Brain damage caused by prolonged periods of hypoglycemia, leading to developmental delays.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "id": "HYPOGLYCEMIC BRAIN INJURY"}, {"entity_type": "DISEASE", "description": "A condition characterized by excessive insulin secretion leading to hypoglycemia.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "id": "CHI (CONGENITAL HYPERINSULINISM)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The initial phase after birth when infants may exhibit symptoms of CHI.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "id": "NEONATAL PERIOD"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The period from one month to twelve months post-birth, during which CHI symptoms can manifest.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "id": "INFANCY PERIOD (1-12 MONTHS)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The phase after the first year of life when CHI symptoms may continue or become apparent.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "id": "CHILDHOOD (>12 MONTHS)"}, {"entity_type": "THERAPY", "description": "A dietary management approach used to maintain blood glucose levels in CHI patients.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "id": "FREQUENT FEEDING THERAPY (SOLIDS AND COW\'S MILK)"}, {"entity_type": "THERAPY", "description": "An intervention that helps stabilize blood sugar levels, especially at night or during prolonged periods without food.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "id": "UNCOOKED CORNSTARCH THERAPY (1.6 G/KG)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Abnormal growth of pancreatic cells, often seen in CHI patients with genetic mutations.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "id": "PANCREATIC \u0392-CELL NUCLEI ENLARGEMENT"}, {"entity_type": "GENE", "description": "The GLUD1 gene is associated with hypoglycaemia, hyperinsulinism (HI), and mild hyperammonaemia (HA) in patients.", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "id": "GLUD1"}, {"entity_type": "GENOMIC VARIANT", "description": "A heterozygous mutation at position p.Arg322His of the GLUD1 gene identified in three patients, specifically 54, 55 and 56, who are sisters inherited from their father as an autosomal dominant trait.", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "id": "P.ARG322HIS MUTATION"}, {"entity_type": "GENOMIC VARIANT", "description": "A heterozygous mutation at position p.Ser498Leu of the GLUD1 gene identified in a single patient (patient 52).", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "id": "P.SER498LEU MUTATION"}, {"entity_type": "GENOMIC VARIANT", "description": "A heterozygous mutation at position p.Asn463Asp of the GLUD1 gene found in another single patient (patient 53).", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "id": "P.ASN463ASP MUTATION"}, {"entity_type": "DISEASE", "description": "A condition characterized by abnormally low blood sugar levels and is associated with mutations in the GLUD1 gene.", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "id": "HYPOGLYCAEMIA"}, {"entity_type": "DISEASE", "description": "Abnormally high levels of insulin production leading to hypoglycaemia, often linked to genetic defects like those in the GLUD1 gene.", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "id": "HYPERINSULINISM (HI)"}, {"entity_type": "DISEASE", "description": "A condition characterized by mild elevations in blood ammonia concentration due to metabolic issues associated with mutations in the GLUD1 gene.", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "id": "MILD HYPERAMMONAEMIA (HA)"}, {"entity_type": "DRUG", "description": "A drug used for managing hyperinsulinism, particularly when caused by genetic defects like those found in the GLUD1 gene.", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "id": "DIAZOXIDE"}, {"entity_type": "DRUG", "description": "Used as a second-line treatment for patients who do not respond well to diazoxide therapy.", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "id": "OCTREOTIDE"}, {"entity_type": "THERAPY", "description": "Surgical procedure involving removal of part or all of the pancreas in cases where medical treatments are ineffective, used as a last resort for managing persistent hypoglycaemia.", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "id": "PANCREATECTOMY"}, {"entity_type": "TRANSCRIPT", "description": "The transcript of the GLUD1 gene is associated with hypoglycaemia in patients due to mutations.", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "id": "GLUD1 TRANSCRIPT"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Abnormal active endocrine cells found in the pancreas contribute to hyperinsulinism and hypoglycemia conditions.", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "id": "ENDOCRINE CELLS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Elevated serum ammonia levels are observed in patients with mutations in the GLUD1 gene, indicating a metabolic disturbance.", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "id": "SERUM AMMONIA CONCENTRATION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Gastrointestinal disturbances and hypertrichosis were reported as side effects of diazoxide treatment for managing hypoglycaemia.", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "id": "DIAZOXIDE THERAPY SIDE EFFECTS"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Some patients did not respond to octreotide, indicating a lack of effectiveness compared to diazoxide in certain cases.", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "id": "OCTREOTIDE TREATMENT FAILURE"}, {"entity_type": "DISEASE", "description": "A severe side effect observed in one patient treated with diazoxide leading to discontinuation of the therapy.", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "id": "THROMBOCYTOPENIC PURPURA"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Development of diabetes mellitus after surgical intervention for managing hypoglycaemia due to GLUD1 gene mutations.", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "id": "DIABETES MELLITUS POST-SURGERY"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Some patients experienced malabsorption symptoms post-surgery, impacting their overall health and management of hypoglycemia.", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "id": "MALABSORPTION SYMPTOMS"}, {"source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "description": "Patients with high birth weight are more likely to have mutations affecting the ABCC8 gene.", "entity_type": "UNKNOWN", "id": "ABCC8 GENE MUTATIONS"}, {"source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "description": "Symptoms of CHI can begin to appear during the neonatal period, characterized by episodes of hypoglycemia.", "entity_type": "UNKNOWN", "id": "NEONATAL PERIOD SYMPTOMS"}, {"source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "description": "This therapy is used to manage hypoglycemic episodes by maintaining consistent blood glucose levels through regular feeding.", "entity_type": "UNKNOWN", "id": "HYPOGLYCEMIA MANAGEMENT"}, {"source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "description": "Used in combination with frequent feedings, this therapy helps maintain stable blood sugar levels over extended periods, preventing hypoglycemic episodes at night or during fasting.", "entity_type": "UNKNOWN", "id": "LONG-TERM BLOOD GLUCOSE CONTROL"}, {"source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "description": "The enlargement of pancreatic cells\' nuclei is often a result of specific genetic mutations found in CHI patients, particularly those with compound heterozygous ABCC8 mutations.", "entity_type": "UNKNOWN", "id": "GENETIC MUTATIONS"}, {"entity_type": "NUTRIENT", "description": "A ketone body produced during fat metabolism when acetyl-CoA is converted to acetoacetyl-CoA, then AcAc, which can be further metabolized or utilized as an energy source.<SEP>Acetoacetate is a ketone body that increases in concentration with hyperglycemia and type 2 diabetes.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336<SEP>chunk-f2e122f964bade37f487049bd69a3f9f", "id": "ACETOACETATE (ACAC)"}, {"entity_type": "NUTRIENT", "description": "Another ketone body produced during fatty acid metabolism; it\'s often used as a measure of metabolic state and ketosis.<SEP>Beta-hydroxybutyrate is another ketone body that rises significantly in individuals diagnosed with newly developed type 2 diabetes compared to healthy subjects, correlating with both fasting and 2-hour post-glucose levels.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336<SEP>chunk-f2e122f964bade37f487049bd69a3f9f", "id": "BETA-HYDROXYBUTYRATE (BHB)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "2hPG measures blood glucose levels two hours after consuming a meal rich in carbohydrates, used for diagnosing impaired glucose tolerance (IGT) and type 2 diabetes.", "source_id": "chunk-f2e122f964bade37f487049bd69a3f9f", "id": "2-HOUR POST-PRANDIAL GLUCOSE (2HPG)"}, {"entity_type": "DISEASE", "description": "IFG is a pre-diabetic state characterized by elevated fasting blood sugar levels but not high enough to be classified as diabetes, leading to higher AcAc and BHB compared to the reference group.", "source_id": "chunk-f2e122f964bade37f487049bd69a3f9f", "id": "IMPAIRED FASTING GLYCAEMIA (IFG)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "An intermediate state between normal glucose tolerance and impaired glucose tolerance, characterized by reduced ability to handle ingested glucose, potentially progressing towards type 2 diabetes.<SEP>IGT is a pre-diabetic condition where blood sugar rises above normal but not high enough to be classified as diabetes, often leading to the development of T2D over time.", "source_id": "chunk-44a871da300abc9be525b468f502f5cb<SEP>chunk-f2e122f964bade37f487049bd69a3f9f", "id": "IMPAIRED GLUCOSE TOLERANCE (IGT)"}, {"entity_type": "METABOLIC PATHWAY", "description": "KBs are produced by the liver from fatty acids during periods of fasting or carbohydrate restriction; their levels correlate with glucose metabolism and hyperglycemia risk.", "source_id": "chunk-f2e122f964bade37f487049bd69a3f9f", "id": "KETONE BODIES (KBS)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "IS measures how effectively cells respond to insulin, inversely correlated with AcAc and BHB in high-IS individuals compared to low-IS subjects.", "source_id": "chunk-f2e122f964bade37f487049bd69a3f9f", "id": "INSULIN SENSITIVITY (IS)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "ISec refers to the production of insulin by pancreatic beta-cells; it\'s inversely associated with KB levels when adjusted for IS, weakening or abolishing associations between KBs and hyperglycemia.", "source_id": "chunk-f2e122f964bade37f487049bd69a3f9f", "id": "INSULIN SECRETION (ISEC)"}, {"entity_type": "GENOMIC VARIANT", "description": "These single nucleotide polymorphisms are associated with an increased risk of developing type 2 diabetes and hyperglycemia, influencing the levels of AcAc and BHB.", "source_id": "chunk-f2e122f964bade37f487049bd69a3f9f", "id": "RISK SNPS FOR TYPE 2 DIABETES OR HYPERGLYCEMIA"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A test that measures how quickly a person\'s blood glucose returns to normal after drinking a sugary beverage. It helps diagnose IFG, IGT, and diabetes.", "source_id": "chunk-f2e122f964bade37f487049bd69a3f9f", "id": "GLUCOSE TOLERANCE TEST (GTT)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Condition where cells fail to respond properly to insulin, resulting in higher levels of AcAc and BHB and increased risk for T2D development.<SEP>The reduced ability of tissues to respond to insulin; observed both in the liver and in adipose tissue under HFD conditions, particularly severe in SENP1-aP2KO mice.", "source_id": "chunk-174831b97ed170039b374ba254d4f506<SEP>chunk-f2e122f964bade37f487049bd69a3f9f", "id": "INSULIN RESISTANCE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Measures glucose levels over time during GTT; an elevated AUC is associated with a higher risk of developing diabetes.", "source_id": "chunk-f2e122f964bade37f487049bd69a3f9f", "id": "GLUCOSE AREA UNDER THE CURVE (AUC)"}, {"entity_type": "DISEASE CONDITION", "description": "A condition characterized by high blood glucose levels, observed earlier and more severely in SENP1-aP2KO mice under HFD conditions compared to controls.<SEP>A condition characterized by high blood sugar levels, often preceding the diagnosis of pre-diabetes or type 2 diabetes.<SEP>The presence of abnormally high blood glucose levels, often associated with diabetes or other metabolic disorders.", "source_id": "chunk-174831b97ed170039b374ba254d4f506<SEP>chunk-bc2193bd869a06007022e1aa75877336<SEP>chunk-f2e122f964bade37f487049bd69a3f9f", "id": "HYPERGLYCEMIA"}, {"entity_type": "GENE", "description": "GCKR is a gene involved in glucose metabolism and regulation.<SEP>One of the 12 genes near which cardiometabolic SNPs are located, involved in glucose metabolism.<SEP>The GCKR gene is one of twelve genes identified where cardiometabolic SNPs are located.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336<SEP>chunk-ad609cb10e900d42a6901eea1591d8ba", "id": "GCKR GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific variant of the GCKR gene, known as rs780094, is associated with elevated levels of BHB and AcAc.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "id": "RS780094 GENOMIC VARIANT"}, {"entity_type": "GENE", "description": "FADS1 is a gene involved in fatty acid metabolism.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "id": "FADS1 GENE"}, {"entity_type": "GENE", "description": "ANK1 is a gene linked to cell adhesion and cytoskeletal dynamics, but here it\'s associated with levels of AcAc or BHB.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "id": "ANK1 GENE"}, {"entity_type": "GENE", "description": "The GIP receptor (GIPR) gene has been identified in studies as being related to glucose metabolism.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "id": "GIPR GENE"}, {"entity_type": "GENE", "description": "HMGA2 is a gene that encodes high mobility group A2, which plays a role in chromatin structure and transcription regulation.<SEP>The HMGA2 gene is associated with height and influences dental development traits.", "source_id": "chunk-c63d60b991cd7442f690dcc364af47dd<SEP>chunk-bc2193bd869a06007022e1aa75877336", "id": "HMGA2 GENE"}, {"entity_type": "GENE", "description": "The SLC2A2 gene codes for the GLUT2 transporter involved in glucose transport across membranes.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "id": "SLC2A2 GENE (GLUT2)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Fatty acid oxidation is a metabolic process that breaks down fatty acids to generate energy.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "id": "FFA OXIDATION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The production of ketone bodies from acetyl-CoA in the liver during fasting or low carbohydrate intake.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "id": "KETOGENESIS"}, {"entity_type": "GENE", "description": "CPT1A is a gene encoding an enzyme involved in fatty acid transport into mitochondria for oxidation.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "id": "CPT1A GENE (CARNITINE PALMITOYLTRANSFERASE 1A)"}, {"entity_type": "GENE", "description": "HMGCS1 encodes an enzyme that catalyzes a rate-limiting step in ketogenesis.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "id": "HMGCS1 GENE (3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE 1, SOLUBLE)"}, {"entity_type": "GENE", "description": "HMGCS2 is involved in ketone body synthesis within mitochondria.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "id": "HMGCS2 GENE (3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE 2, MITOCHONDRIAL)"}, {"entity_type": "GENE", "description": "ACAT1 is a gene encoding an enzyme that catalyzes the final step of ketolysis, converting acetoacetyl-CoA to two molecules of acetyl-CoA.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "id": "ACAT1 GENE (ACETYL-COA ACETYLTRANSFERASE 1)"}, {"entity_type": "GENE", "description": "BDH1 encodes an enzyme involved in beta-hydroxybutyrate metabolism.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "id": "BDH1 GENE (BHB DEHYDROGENASE, TYPE 1)"}, {"entity_type": "GENE", "description": "OXCT1 is a gene encoding an enzyme that catalyzes reactions important for ketolysis and fatty acid oxidation.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "id": "OXCT1 GENE (3-OXOACID COA TRANSFERASE 1)"}, {"entity_type": "GENE", "description": "ACSS2 encodes an enzyme involved in the activation of short chain fatty acids to acyl-CoAs, which can then enter metabolic pathways.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "id": "ACSS2 GENE (ACYL-COA SYNTHETASE SHORT-CHAIN FAMILY MEMBER 2)"}, {"entity_type": "PROTEIN", "description": "The protein product of CPT1A gene involved in the transport of long-chain fatty acids into mitochondria for oxidation.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "id": "CARNITINE PALMITOYLTRANSFERASE 1A PROTEIN (CPT1A)"}, {"entity_type": "PROTEIN", "description": "An enzyme that catalyzes the final step of ketolysis, converting acetoacetyl-CoA to two molecules of acetyl-CoA.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "id": "ACETYL-COA ACETYLTRANSFERASE 1 PROTEIN (ACAT1)"}, {"entity_type": "PROTEIN", "description": "This protein is involved in beta-hydroxybutyrate metabolism as part of the ketolysis process.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "id": "BHB DEHYDROGENASE TYPE 1 PROTEIN (BDH1)"}, {"entity_type": "PROTEIN", "description": "An enzyme that catalyzes important reactions for ketolysis and fatty acid oxidation.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "id": "3-OXOACID COA TRANSFERASE 1 PROTEIN (OXCT1)"}, {"entity_type": "METABOLIC PATHWAY", "description": "Measure of the area under the curve for glucose levels over time, reflecting glucose metabolism in response to an oral glucose challenge.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "id": "GLUCOSE AUC PARAMETER"}, {"entity_type": "METABOLIC PATHWAY", "description": "A measure used to quantify insulin sensitivity based on plasma glucose and insulin concentrations during a hyperglycemic clamp test.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "id": "MATSUDA ISI PARAMETER"}, {"entity_type": "METABOLIC PATHWAY", "description": "Measure reflecting the ability of beta cells to secrete insulin in response to an increase in blood glucose levels.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "id": "INSULIN SECRETION PARAMETER"}, {"entity_type": "NUTRIENT", "description": "Lipids that serve as a major energy source and are broken down through fatty acid oxidation pathways.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "id": "FATTY ACIDS (FFAS)"}, {"entity_type": "DISEASE", "description": "A chronic disease characterized by high blood sugar levels over a prolonged period.<SEP>A condition characterized by high blood sugar levels due to insulin resistance or insufficient insulin production.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336<SEP>chunk-1f20dbdcc9de443dada1a2045dc7832b", "id": "TYPE 2 DIABETES"}, {"source_id": "chunk-bc2193bd869a06007022e1aa75877336", "description": "The C allele of the GCKR gene variant rs780094 shows a significant increase in BHB levels, suggesting its role in regulating ketone body metabolism.", "entity_type": "UNKNOWN", "id": "BHB LEVELS"}, {"source_id": "chunk-bc2193bd869a06007022e1aa75877336", "description": "Variants in FADS1 have been associated with the level of AcAc, indicating their involvement in fatty acid and lipid metabolism.", "entity_type": "UNKNOWN", "id": "ACAC LEVELS"}, {"source_id": "chunk-bc2193bd869a06007022e1aa75877336", "description": "Expression of ACAT1 is positively correlated with insulin sensitivity, indicating its role in maintaining metabolic health.", "entity_type": "UNKNOWN", "id": "INSULIN SENSITIVITY PARAMETER (MATSUDA ISI)"}, {"entity_type": "GENOMIC VARIANT", "description": "283 cardiometabolic SNPs were associated with serum CRP levels, out of which 19 had p-values smaller than the multiple testing correction threshold.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "id": "CRP GWAS SNPS"}, {"entity_type": "GENE", "description": "The APOC1 gene harbors a SNP (rs4420638) that increases serum CRP levels but decreases cholesterol and triglycerides levels.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "id": "APOC1 GENE"}, {"entity_type": "GENE", "description": "The HNF1A gene contains a SNP (rs1183910) associated with increased CRP but decreased cholesterol and LDL-cholesterol levels.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "id": "HNF1A GENE"}, {"entity_type": "GENE", "description": "The IL6R gene locus showed lower linkage disequilibrium (r\u00b2 = 0.52) between CRP GWAS and CAD GWAS compared to other loci.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "id": "IL6R GENE"}, {"entity_type": "GENE", "description": "A gene among the 12 where cardiometabolic SNPs are located, involved in metabolic processes.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "id": "PPP1R3B GENE"}, {"entity_type": "GENE", "description": "One of the twelve genes with associated SNPs near it that affect cardiometabolic traits and CRP levels.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "id": "HNF4A GENE"}, {"entity_type": "GENE", "description": "A gene associated with pleiotropic effects mediated through BMI, indicating potential mediation in the relationship between genetic loci and metabolic phenotypes.<SEP>Near TMEM18 on chromosome 2 is a SNP (rs2867125), not identified in CRP GWAS but associated with it here, having a p-value of 5.0\u00d710-6.", "source_id": "chunk-372184452f1f9156514992455057f843<SEP>chunk-ad609cb10e900d42a6901eea1591d8ba", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 36}]", "id": "TMEM18 GENE"}, {"entity_type": "GENE", "description": "A SNP near PLTP gene on chromosome 20 shows association with CRP (p-value = 6.7\u00d710^-6) and is linked to metabolic phenotypes.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "id": "PLTP GENE"}, {"entity_type": "GENE", "description": "The MC4R locus has an associated SNP upstream, which showed a significant p-value of 3.8\u00d710-5 for CRP association.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "id": "MC4R GENE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Levels of LDL cholesterol and total cholesterol are influenced by genetic variants like those in the APOC1 locus, which affect both these processes and CRP levels.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "id": "LDL-CHOLESTEROL AND TOTAL CHOLESTEROL LEVELS"}, {"entity_type": "METABOLIC PATHWAY", "description": "GWAS studies investigating cardiometabolic phenotypes revealed significant associations with SNPs that also influence CRP levels.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "id": "CARDIOMETABOLIC PHENOTYPES GWAS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "C-reactive protein (CRP) levels are influenced by genetic variants and are linked to metabolic diseases such as diabetes and cardiovascular disease.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "id": "CRP LEVELS"}, {"entity_type": "DISEASE", "description": "Cardiovascular Disease Genome-Wide Association Study (GWAS), where the lead SNP from CRP GWAS showed lower linkage disequilibrium with it compared to other loci.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "id": "CAD GWAS"}, {"entity_type": "GENE", "description": "A novel gene identified in the analysis with associations close to or within it, which was not previously reported in GWAS for specific phenotypes.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "id": "IL1F10 GENE"}, {"entity_type": "GENE", "description": "One of twelve genes where cardiometabolic SNPs are located and affect CRP levels and other metabolic traits.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "id": "PABPC GENE"}, {"entity_type": "GENE", "description": "A gene among the 12 with associated SNPs near it, influencing both cardiometabolic phenotypes and CRP levels.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "id": "BCL7B GENE"}, {"entity_type": "DISEASE", "description": "The body mass index (BMI) and systolic blood pressure (SBP) GWAS did not show significant deviations in QQ-plots compared to the null hypothesis for CRP SNPs.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "id": "BMI AND SBP GWAS"}, {"entity_type": "METABOLIC PATHWAY", "description": "GWAS studies focusing on cardiometabolic traits reveal genetic variants influencing these pathways, including those also affecting CRP levels.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "id": "CARDIOMETABOLIC TRAITS GWAS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Levels of total cholesterol and triglycerides are influenced by SNPs such as rs4420638 in the APOC1 locus.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "id": "TOTAL CHOLESTEROL AND TRIGLYCERIDES LEVELS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Genetic variants influencing CRP levels also impact fasting glucose and insulin levels, reflecting pleiotropy.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "id": "FASTING GLUCOSE AND INSULIN LEVELS"}, {"entity_type": "GENE", "description": "A gene associated with CRP levels and cardiometabolic phenotypes.<SEP>GCKR codes for a gene whose missense variant p.Pro446Leu impacts de novo triglyceride and cholesterol synthesis and plasma glucose concentrations.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083<SEP>chunk-372184452f1f9156514992455057f843", "id": "GCKR"}, {"entity_type": "GENE", "description": "An interleukin 1 family gene, not identified in previous analysis for association between SNPs and CRP.", "source_id": "chunk-372184452f1f9156514992455057f843", "id": "IL1F10"}, {"entity_type": "GENE", "description": "A gene associated with cardiometabolic phenotypes and CRP levels.", "source_id": "chunk-372184452f1f9156514992455057f843", "id": "PPP1R3B"}, {"entity_type": "GENE", "description": "A hepatocyte nuclear factor 4 alpha, involved in regulating the expression of genes in liver cells.", "source_id": "chunk-372184452f1f9156514992455057f843", "id": "HNF4A"}, {"entity_type": "GENE", "description": "A gene associated with cardiometabolic phenotypes where effect size diminished after adjustment for CRP.", "source_id": "chunk-372184452f1f9156514992455057f843", "id": "BCL7B"}, {"entity_type": "GENE", "description": "A hepatocyte nuclear factor 1 alpha, involved in the pleiotropic effects observed on CRP levels and cardiometabolic phenotypes.", "source_id": "chunk-372184452f1f9156514992455057f843", "id": "HNF1A"}, {"entity_type": "GENE", "description": "A gene associated with cardiometabolic phenotypes where effect size diminished after adjustment for CRP.", "source_id": "chunk-372184452f1f9156514992455057f843", "id": "PABPC4 GENE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Levels of cholesterol in blood can mediate pleiotropic effects observed from genetic loci.", "source_id": "chunk-372184452f1f9156514992455057f843", "id": "CHOLESTEROL LEVELS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "An indicator of average blood glucose control over a period of 2 to 3 months.", "source_id": "chunk-372184452f1f9156514992455057f843", "id": "HBA1C"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Levels of triglyceride in the bloodstream, which can mediate pleiotropic effects observed from genetic loci.", "source_id": "chunk-372184452f1f9156514992455057f843", "id": "TRIGLYCERIDES"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "High-density lipoprotein cholesterol levels that can mediate certain genetic associations with metabolic phenotypes.", "source_id": "chunk-372184452f1f9156514992455057f843", "id": "HDL-CHOLESTEROL"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Adjusting for body mass index in statistical analyses to account for its influence on cardiometabolic outcomes.", "source_id": "chunk-372184452f1f9156514992455057f843", "id": "BMI ADJUSTMENT"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Adjusting for C-reactive protein levels in analyses to account for inflammation\'s role in metabolic phenotypes.", "source_id": "chunk-372184452f1f9156514992455057f843", "id": "CRP ADJUSTMENT"}, {"entity_type": "DISEASE OR CONDITION", "description": "A condition related to heart health and metabolism, influenced by genetic factors and environmental mediators.", "source_id": "chunk-372184452f1f9156514992455057f843", "id": "CARDIOMETABOLIC PHENOTYPE"}, {"source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "description": "The association of 18 CRP SNPs with cardiometabolic traits is significant across multiple phenotypes, suggesting shared genetic underpinnings.", "entity_type": "UNKNOWN", "id": "CRP SNPS"}, {"source_id": "chunk-372184452f1f9156514992455057f843", "description": "The IL1F10 gene was not identified in a previous GWAS for association between SNPs and CRP, but has been found to be significant with cholesterol levels.)", "entity_type": "UNKNOWN", "id": "GWAS STUDY"}, {"source_id": "chunk-372184452f1f9156514992455057f843", "description": "Effects on CRP levels from BCL7B decrease significantly when adjusted for CRP, indicating potential mediation through lipids.)", "entity_type": "UNKNOWN", "id": "CRP PROTEIN"}, {"source_id": "chunk-372184452f1f9156514992455057f843", "description": "The HNF1A gene\'s variant rs1183910 is linked to increased serum CRP and lower risk of CAD.)", "entity_type": "UNKNOWN", "id": "CAD DISEASE"}, {"source_id": "chunk-372184452f1f9156514992455057f843", "description": "SNP rs4420638 near APOC1 increases CRP levels but reduces the risk of type 2 diabetes.)", "entity_type": "UNKNOWN", "id": "T2D DISEASE"}, {"source_id": "chunk-372184452f1f9156514992455057f843", "description": "The FXR/RXR pathway is enriched in the analysis of GCKR and other pleiotropic genes involved in metabolic pathways.)", "entity_type": "UNKNOWN", "id": "FXR/RXR PATHWAY"}, {"source_id": "chunk-372184452f1f9156514992455057f843", "description": "The effects observed from TMEM18 are mainly mediated by BMI, suggesting its role in metabolic phenotypes through body mass index.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 36}]", "id": "BMI PHYSIOLOGICAL PROCESS"}, {"source_id": "chunk-372184452f1f9156514992455057f843", "description": "Lipids, particularly cholesterol levels, mediate pleiotropic effects observed from genetic loci on cardiometabolic phenotypes.)", "entity_type": "UNKNOWN", "id": "GENETIC LOCI MEDIATION"}, {"source_id": "chunk-372184452f1f9156514992455057f843", "description": "Adjustment for HbA1c leads to significant reduction in the association between APOC1 and type 2 diabetes, indicating mediation through glycemic control.)", "entity_type": "UNKNOWN", "id": "APOC1 GENE AND T2D DISEASE RELATIONSHIP"}, {"source_id": "chunk-372184452f1f9156514992455057f843", "description": "Adjustment for HbA1c leads to significant reduction in the association between APOC1 and type 2 diabetes, indicating mediation through glycemic control.)", "entity_type": "UNKNOWN", "id": "HBA1C PHYSIOLOGICAL PROCESS"}, {"source_id": "chunk-372184452f1f9156514992455057f843", "description": "Adjustment for triglyceride levels leads to significant reduction in the association between PABPC4 gene and metabolic phenotypes, indicating mediation through this physiological process.)", "entity_type": "UNKNOWN", "id": "PABPC4 GENE AND METABOLIC PHENOTYPE RELATIONSHIP"}, {"source_id": "chunk-372184452f1f9156514992455057f843", "description": "Adjustment for triglyceride levels leads to significant reduction in the association between PABPC4 gene and metabolic phenotypes, indicating mediation through this physiological process.)", "entity_type": "UNKNOWN", "id": "TRIGLYCERIDES PHYSIOLOGICAL PROCESS"}, {"source_id": "chunk-372184452f1f9156514992455057f843", "description": "Adjustment for HDL-cholesterol levels leads to significant reduction in the association between BCL7B gene and metabolic phenotypes, indicating mediation through this physiological process.)", "entity_type": "UNKNOWN", "id": "BCL7B GENE AND METABOLIC PHENOTYPE RELATIONSHIP"}, {"source_id": "chunk-372184452f1f9156514992455057f843", "description": "Adjustment for HDL-cholesterol levels leads to significant reduction in the association between BCL7B gene and metabolic phenotypes, indicating mediation through this physiological process.)", "entity_type": "UNKNOWN", "id": "HDL-CHOLESTEROL PHYSIOLOGICAL PROCESS"}, {"source_id": "chunk-372184452f1f9156514992455057f843", "description": "Adjusting for BMI significantly affects the pleiotropic effects observed from genetic loci on cardiometabolic phenotypes.)", "entity_type": "UNKNOWN", "id": "BMI ADJUSTMENT PHYSIOLOGICAL PROCESS"}, {"source_id": "chunk-372184452f1f9156514992455057f843", "description": "Adjusting for BMI significantly affects the pleiotropic effects observed from genetic loci on cardiometabolic phenotypes.)", "entity_type": "UNKNOWN", "id": "PLEIOTROPIC EFFECTS OF GENETIC LOCI"}, {"entity_type": "GENOMIC VARIANT", "description": "A SNP located in miR-34b/c region, associated with decreased risk of IA.", "source_id": "chunk-055177812e320344d131432b292111b0", "clusters": "[{level: 0, cluster: 13}]", "id": "MIR-34B/C RS4938723"}, {"entity_type": "GENOMIC VARIANT", "description": "An Arginine to Proline substitution variant in the TP53 gene, not associated with IA risk.", "source_id": "chunk-055177812e320344d131432b292111b0", "clusters": "[{level: 0, cluster: 14}]", "id": "TP53 ARG72PRO"}, {"entity_type": "DISEASE", "description": "A condition characterized by a bulge or balloon-like dilation of an artery within the skull, which is studied for its association with genotypic variations.", "source_id": "chunk-055177812e320344d131432b292111b0", "clusters": "[{level: 0, cluster: 13}]", "id": "IA (INTRACRANIAL ANEURYSM)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The number of aneurysms refers to the count of IA in patients, which can be a measure of severity or recurrence.", "source_id": "chunk-055177812e320344d131432b292111b0", "clusters": "[{level: 0, cluster: 17}]", "id": "NUMBER OF ANEURYSMS"}, {"source_id": "chunk-055177812e320344d131432b292111b0", "description": "The combined genotype of miR-34b/c rs4938723 CC and TP53 Arg72Pro CG/CC/GG is associated with a decreased risk of IA compared to the combined genotypes CT/TT\u2009+\u2009CG/CC/GG.", "entity_type": "UNKNOWN", "id": "MIR-34B/C RS4938723 CC"}, {"source_id": "chunk-055177812e320344d131432b292111b0", "description": "The combined genotype of miR-34b/c rs4938723 CC and TP53 Arg72Pro CG/CC/GG is associated with a decreased risk of IA compared to the combined genotypes CT/TT\u2009+\u2009CG/CC/GG.", "entity_type": "UNKNOWN", "id": "TP53 ARG72PRO CG/CC/GG"}, {"entity_type": "GENE", "description": "The INADL gene is associated with weight, BMI, FFM, FM, trunk FM, and hip circumference.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "INADL GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "A nonsynonymous SNP (rs1056513; G1178S (NP_005790.2)) in INADL on chromosome 1 attained near genome-wide significance for weight and BMI.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "RS1056513 (G1178S) SNP IN INADL"}, {"entity_type": "GENOMIC VARIANT", "description": "An intronic variant in COL4A1 on chromosome 13 was associated with weight z-score change.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "COL4A1 GENE VARIANT"}, {"entity_type": "GENOMIC VARIANT", "description": "A variant in the 5\u2032UTR region of TSEN34 on chromosome 19 is linked to linear growth (height change).", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "TSEN34 GENE VARIANT"}, {"entity_type": "GENOMIC VARIANT", "description": "An intronic variant in MTNR1B on chromosome 11 was strongly associated with fasting glucose.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "MTNR1B GENE INTRONIC VARIANT"}, {"entity_type": "GENOMIC VARIANT", "description": "Intronic and 3\u2032UTR variants in the APOA5-ZNF259 region on chromosome 11 were associated with triglycerides.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "APOA5-ZNF259 REGION VARIANTS"}, {"entity_type": "GENOMIC VARIANT", "description": "An intronic variant in PCSK2 on chromosome 20 was linked to total antioxidants levels.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "PCSK2 GENE INTRONIC VARIANT"}, {"entity_type": "GENOMIC VARIANT", "description": "Variants in the flanking 3\u2032UTR regions of RNASE1 on chromosome 14 were associated with 24-h urinary nitrogen excretion.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "RNASE1 FLANKING 3\u2032UTR REGION VARIANTS"}, {"entity_type": "GENOMIC VARIANT", "description": "Variants in the flanking 3\u2032UTR regions of ASS1P11 on chromosome 7 were linked to creatinine excretion.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "ASS1P11 FLANKING 3\u2032UTR REGION VARIANTS"}, {"entity_type": "GENOMIC VARIANT", "description": "An intronic SNP in GCH1 on chromosome 14 was associated with the 24-h urinary dopamine: creatinine ratio.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "GCH1 GENE INTRONIC SNP"}, {"entity_type": "GENOMIC VARIANT", "description": "A nonsynonymous SNP (rs3733402; S143T (NP_000883.2)) in KLKB1 on chromosome 4 was identified for serum free IGF-1.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "KLKB1 GENE NONSYNONYMOUS SNP (RS3733402; S143T)"}, {"entity_type": "GENOMIC VARIANT", "description": "An intronic SNP in MPRIP on chromosome 17 was linked to serum IGFBP-3 levels.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "MPRIP GENE INTRONIC SNP"}, {"entity_type": "GENOMIC VARIANT", "description": "A block of twenty-three SNPs in the flanking 5\u2032UTR region of XPA/FOXE1 on chromosome 9 were highly associated with serum TSH.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "XPA/FOXE1 FLANKING 5\u2032UTR REGION SNPS BLOCK "}, {"entity_type": "GENOMIC VARIANT", "description": "A nonsynonymous SNP (rs12075; G42D) in DARC on chromosome 1 was identified for MCP-1.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "DARC GENE NONSYNONYMOUS SNP (RS12075; G42D)"}, {"entity_type": "GENOMIC VARIANT", "description": "Coding variants in GREB1 on chromosome 2 were associated with MCP-1 levels.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "GREB1 GENE CODING VARIANT "}, {"entity_type": "GENOMIC VARIANT", "description": "Coding variants in DFNB31 on chromosome 9 were identified for MCP-1.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "DFNB31 GENE CODING VARIANT "}, {"entity_type": "GENOMIC VARIANT", "description": "Variants in the 3\u2032UTR region of CCR3 were highly associated with MCP-1 levels.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "CCR3 FLANKING 3\u2032UTR REGION VARIANTS "}, {"entity_type": "GENOMIC VARIANT", "description": "An intronic SNP in RASGEF1A was strongly associated with MCP-1 levels.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "RASGEF1A GENE INTRONIC SNP "}, {"entity_type": "GENOMIC VARIANT", "description": "A variant in the intronic region of ABO gene is strongly linked to IL-6 levels.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "ABO GENE INTRONIC VARIANT "}, {"entity_type": "GENOMIC VARIANT", "description": "An intronic variant in TMEM229B on chromosome 14 was associated with energy intake at dinner.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "TMEM229B GENE VARIANTS "}, {"entity_type": "GENOMIC VARIANT", "description": "An intronic variant in ARHGAP11A on chromosome 15 is linked to sleep duration.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "ARHGAP11A GENE INTRONIC SNP "}, {"entity_type": "GENOMIC VARIANT", "description": "An SNP in the intronic region of C21orf34 was detected for respiratory quotient (RQ) during sleep.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "C21ORF34 GENE INTRONIC SNP "}, {"entity_type": "ENDOMETABOLIC TRAIT", "description": "An intronic variant in MTNR1B on chromosome 11 was strongly associated with fasting glucose levels.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "FASTING GLUCOSE LEVELS "}, {"entity_type": "ENDOMETABOLIC TRAIT", "description": "Intronic and 3\u2032UTR variants in the APOA5-ZNF259 region on chromosome 11 were linked to triglyceride levels.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "TRIGLYCERIDES LEVEL "}, {"entity_type": "ENDOMETABOLIC TRAIT", "description": "An intronic variant in PCSK2 on chromosome 20 was associated with total antioxidants levels.<SEP>Genetic variations influence total antioxidants in the body, possibly impacting oxidative stress and health.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "TOTAL ANTIOXIDANTS LEVELS "}, {"entity_type": "ENDOMETABOLIC TRAIT", "description": "Variants in the flanking 3\u2032UTR regions of RNASE1 were linked to urinary nitrogen excretion.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "URINARY NITROGEN EXCRETION "}, {"entity_type": "ENDOMETABOLIC TRAIT", "description": "Flanking 3\u2032UTR variants in ASS1P11 were associated with creatinine excretion levels.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "CREATININE EXCRETION "}, {"entity_type": "ENDOMETABOLIC TRAIT", "description": "An intronic SNP in GCH1 was linked to urinary dopamine: creatinine ratio.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "24-HOUR URINARY DOPAMINE: CREATININE RATIO "}, {"entity_type": "ENDOMETABOLIC TRAIT", "description": "A nonsynonymous SNP (rs3733402; S143T) in KLKB1 on chromosome 4 was associated with serum free IGF-1 levels.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "SERUM FREE IGF-1 LEVELS "}, {"entity_type": "ENDOMETABOLIC TRAIT", "description": "An intronic SNP in MPRIP on chromosome 17 was linked to serum IGFBP-3 levels.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "SERUM IGFBP-3 LEVELS "}, {"entity_type": "ENDOMETABOLIC TRAIT", "description": "A block of SNPs in the flanking 5\u2032UTR region of XPA/FOXE1 were highly associated with serum TSH.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "SERUM TSH LEVELS "}, {"entity_type": "SUBSTRATE UTILIZATION TRAITS", "description": "A variant in the intronic region of ABO was strongly associated with IL-6 levels.<SEP>Genetic variations affecting IL-6 levels also impact metabolic health.<SEP>Genetic variations affecting IL-6 levels highlight the influence on systemic inflammation.<SEP>Genetic variations affecting IL-6 levels impact dietary behaviors and energy expenditure during physical activities.<SEP>Genetic variations affecting IL-6 levels impact dietary behaviors and energy expenditure.<SEP>Genetic variations affecting IL-6 levels impact physical activity patterns.<SEP>Genetic variations affecting IL-6 levels impact substrate utilization during physical activities.<SEP>Genetic variations affecting IL-6 levels impact substrate utilization.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "IL-6 LEVELS "}, {"entity_type": "INFLAMMATION MARKERS", "description": "A variant in ARHGAP11A on chromosome 15 is linked to sleep duration.<SEP>Variants associated with sleep duration can impact inflammatory markers.<SEP>Variants associated with sleep duration can impact inflammatory responses.<SEP>Variants associated with sleep duration can impact overall energy expenditure.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "SLEEP DURATION "}, {"entity_type": "DIET AND PHYSICAL ACTIVITY TRAIT", "description": "An SNP in C21orf34 was detected for respiratory quotient during sleep.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "RESPIRATORY QUOTIENT (RQ) DURING SLEEP "}, {"entity_type": "PHYSICAL ACTIVITY TRAIT", "description": "A variant in the 5\u2032UTR region of RPL was identified for accelerometer-measured light activity.<SEP>Variants affecting light activity can also impact inflammatory markers.<SEP>Variants affecting light activity highlight the genetic basis of physical activity patterns.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "LIGHT ACTIVITY "}, {"entity_type": "DIET AND PHYSICAL ACTIVITY TRAIT", "description": "Variants associated with substrate utilization impacting diet metabolism.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "SUBSTRATE UTILIZATION "}, {"entity_type": "ENDOMETABOLIC TRAITS", "description": "Highly significant genetic associations highlight the importance of MCP-1 in metabolic regulation and inflammation.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "MCP-1 (CCL2) LEVELS "}, {"entity_type": "INFLAMMATION MARKERS", "description": "An intronic variant in TMEM229B affects inflammatory markers through dinner energy intake.<SEP>An intronic variant in TMEM229B affects metabolic outcomes through dinner energy intake.<SEP>An intronic variant in TMEM229B affects physical activity patterns through dinner energy intake.<SEP>An intronic variant in TMEM229B affects substrate utilization through dinner energy intake.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "AD LIBITUM ENERGY INTAKE AT DINNER "}, {"entity_type": "SUBSTRATE UTILIZATION TRAITS", "description": "Genetic factors influencing BMI are also linked to metabolic traits such as total antioxidants levels.<SEP>Genetic factors influencing BMI are also linked to physical activity patterns.<SEP>Genetic factors influencing BMI traits are linked to inflammatory responses during physical activities.<SEP>Genetic factors influencing BMI traits are linked to inflammatory responses.<SEP>Genetic factors influencing BMI traits are linked to metabolic outcomes such as total antioxidants levels.<SEP>Genetic factors influencing BMI traits are linked to substrate utilization patterns.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "BMI TRAITS "}, {"entity_type": "GENE", "description": "An intronic variant in ARHGAP11A, located on chromosome 15, was associated with sleep duration.", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "id": "ARHGAP11A"}, {"entity_type": "GENE", "description": "A SNP in the intronic region of C21orf34 was detected for respiratory quotient (RQ) during sleep.", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "id": "C21ORF34"}, {"entity_type": "GENE", "description": "A variant identified in the 5\u2032UTR region of RPL7P3 on chromosome 9 was associated with accelerometer-measured light activity.", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "id": "RPL7P3"}, {"entity_type": "GENE", "description": "A variant in the 3\u2032UTR region of CTCFL on chromosome 20 was linked to sedentary-light activity.", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "id": "CTCFL"}, {"entity_type": "GENE", "description": "Highly significant variants for total energy expenditure were identified for MATK on chromosome 19, after adjusting for body weight.", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "id": "MATK"}, {"entity_type": "GENE", "description": "Variants for sleeping energy expenditure were found in CHRNA3 on chromosome 15, after controlling for body weight.", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "id": "CHRNA3"}, {"entity_type": "GENOMIC VARIANT", "description": "An intronic variant in the gene ARHGAP11A on chromosome 15 is associated with sleep duration.", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "id": "INTRONIC VARIANT OF ARHGAP11A"}, {"entity_type": "GENOMIC VARIANT", "description": "A SNP in the intronic region of C21orf34 was detected for respiratory quotient (RQ) during sleep.", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "id": "SNP IN C21ORF34 INTRONIC REGION"}, {"entity_type": "GENOMIC VARIANT", "description": "A variant identified in the 5\u2032UTR region of RPL7P3 on chromosome 9 is associated with accelerometer-measured light activity.", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "id": "VARIANT IN 5\u2032UTR OF RPL7P3"}, {"entity_type": "GENOMIC VARIANT", "description": "A variant was found in the 3\u2032UTR region of CTCFL on chromosome 20 and linked to sedentary-light activity.", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "id": "VARIANT IN 3\u2032UTR OF CTCFL"}, {"entity_type": "GENOMIC VARIANT", "description": "Highly significant variants for total energy expenditure were identified for MATK, a gene located on chromosome 19 after adjusting for body weight.", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "id": "TOTAL ENERGY EXPENDITURE VARIANTS FOR MATK"}, {"entity_type": "GENOMIC VARIANT", "description": "Variants for sleeping energy expenditure were found in CHRNA3, a gene located on chromosome 15 after controlling for body weight.", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "id": "SLEEPING ENERGY EXPENDITURE VARIANTS FOR CHRNA3"}, {"source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "description": "A SNP in C21orf34\'s intronic region was detected for respiratory quotient during sleep.", "entity_type": "UNKNOWN", "id": "RESPIRATORY QUOTIENT (RQ)"}, {"source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "description": "A variant in RPL7P3\u2019s 5\u2032UTR region is associated with accelerometer-measured light activity.", "entity_type": "UNKNOWN", "id": "LIGHT ACTIVITY"}, {"source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "description": "Variants in CTCFL\'s 3\u2032UTR region were linked to sedentary-light activity.", "entity_type": "UNKNOWN", "id": "SEDENTARY-LIGHT ACTIVITY"}, {"source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "description": "Significant variants for MATK on chromosome 19 are associated with total energy expenditure after adjusting for body weight.", "entity_type": "UNKNOWN", "id": "TOTAL ENERGY EXPENDITURE"}, {"source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "description": "Variants in CHRNA3 on chromosome 15 are linked to sleeping energy expenditure, after controlling for body weight.", "entity_type": "UNKNOWN", "id": "SLEEPING ENERGY EXPENDITURE"}, {"source_id": "chunk-46227b557f62c59155b1b9cef71d0d17<SEP>chunk-9977706363cc368b3be503d07ed3ef62", "description": "An intronic variant in the gene ARHGAP11A on chromosome 15 is associated with sleep duration.<SEP>The amount of sleep duration correlates with the prevalence of snoring (Supplementary Table 1).", "entity_type": "LIFESTYLE FACTOR", "id": "SLEEP DURATION"}, {"source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "description": "After adjusting for body weight, variants in MATK are associated with total energy expenditure, indicating a complex genetic and environmental interaction affecting metabolic rate.", "entity_type": "UNKNOWN", "id": "BODY WEIGHT"}, {"entity_type": "GENE", "description": "APOBR is a gene that codes for apolipoprotein B receptor (BDL), which plays a role in lipid metabolism.", "source_id": "chunk-7ca64f92964b051cfb1c43f967f243a5", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 37}]", "id": "APOBR"}, {"entity_type": "GENOMIC VARIANT", "description": "These are genomic variants identified in the coding region of APOBR that include both synonymous and non-synonymous mutations.", "source_id": "chunk-7ca64f92964b051cfb1c43f967f243a5", "id": "RS74949322, RS151233, RS149271, RS3833080, RS368546180, RS180743, RS180744, RS151174, RS40831, RS61738759, RS200751685, RS40833, AND RS142786317"}, {"entity_type": "PROTEIN", "description": "These are protein variants resulting from the genomic variants in APOBR that affect amino acid sequence.", "source_id": "chunk-7ca64f92964b051cfb1c43f967f243a5", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 37}]", "id": "RS3833080: P.GLY369_ASP370DEL9, RS180743: P.PRO428ALA, AND RS368546180: P.THR321_GLY329DEL9"}, {"entity_type": "NUTRIENT", "description": "A nutrient essential for energy storage and transport, relevant to lipid metabolism affected by APOBR gene function.", "source_id": "chunk-7ca64f92964b051cfb1c43f967f243a5", "id": "FATTY ACIDS (LIPIDS)"}, {"entity_type": "DIETARY PATTERN", "description": "A dietary pattern associated with obesity in children and adolescents studied in the research.", "source_id": "chunk-7ca64f92964b051cfb1c43f967f243a5", "id": "EXTREMELY OBESE CHILDREN AND ADOLESCENTS DIETARY PATTERN"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The physiological process of lipid metabolism regulation influenced by APOBR gene variants.", "source_id": "chunk-7ca64f92964b051cfb1c43f967f243a5", "id": "LIPID METABOLISM REGULATION"}, {"entity_type": "GENE", "description": "SULT1A1 is a gene involved in metabolic processes including sulfate conjugation, which may impact the body\'s handling of certain hormones and xenobiotics.", "source_id": "chunk-7ca64f92964b051cfb1c43f967f243a5", "id": "SULT1A1 (SULFOTRANSFERASE 1A1)"}, {"entity_type": "TOOL", "description": "Bioinformatics tools used for predicting the effects of genetic mutations on protein function.", "source_id": "chunk-7ca64f92964b051cfb1c43f967f243a5", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 37}]", "id": "MUTATION TASTER, SIFT, POLYPHEN2, PANTHER, SNAP, PMUT, PROVEAN"}, {"entity_type": "METHOD", "description": "A method for studying genetic associations in families, particularly useful for identifying genetic factors contributing to complex traits like obesity.", "source_id": "chunk-7ca64f92964b051cfb1c43f967f243a5", "id": "FAMILY-BASED ASSOCIATION STUDIES (FBAT)"}, {"entity_type": "METHOD", "description": "An approach used to identify genetic variations that are more common in people with a specific disease compared to those without the disease.", "source_id": "chunk-7ca64f92964b051cfb1c43f967f243a5", "id": "CASE-CONTROL ASSOCIATION ANALYSIS"}, {"entity_type": "GENOMIC VARIANT", "description": "This genomic variant affects splicing enhancer and silencer binding sites as well as transcription factor binding sites.", "source_id": "chunk-607feda7df4db8151b99560074c91eea", "id": "RS142786317: C.*118_*119DELCA"}, {"entity_type": "GENE", "description": "The SULT1A1 gene is part of the SULT1 family genes that are involved in obesity studies, but no significant variants were confirmed independently for this gene.", "source_id": "chunk-607feda7df4db8151b99560074c91eea", "id": "SULT1A1 GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "This variant was not explained by other members of the SULT1A family and could not be replicated with independent genotyping methods.", "source_id": "chunk-607feda7df4db8151b99560074c91eea", "id": "MET1VAL VARIANT"}, {"entity_type": "TRANSCRIPT", "description": "The synonymous variant in SULT1A1 predicted to change splicing enhancer and silencer, or directly affect splice sites and transcription factor binding sites.", "source_id": "chunk-607feda7df4db8151b99560074c91eea", "id": "P.PRO200 = (RS3176926)"}, {"entity_type": "GENE", "description": "This gene was studied for non-synonymous SNPs with potential functional effects on protein activity.", "source_id": "chunk-607feda7df4db8151b99560074c91eea", "id": "SULT1A2 GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "Several non-synonymous SNPs in SULT1A2 predicted to have functional changes, particularly affecting binding sites and splicing regulators.", "source_id": "chunk-607feda7df4db8151b99560074c91eea", "id": "RS4149403: P.ILE7THR, RS10797300: P.PRO19LEU, ETC."}, {"entity_type": "TRANSCRIPT", "description": "Synonymous SNPs in SULT1A2 predicted to alter transcription factor binding or splicing regulator sites.<SEP>These synonymous SNPs were predicted to alter transcription factor binding or splicing regulator sites.", "source_id": "chunk-607feda7df4db8151b99560074c91eea", "id": "RS1690407: P.SER8 =, RS139896537: P.ALA164 ="}, {"entity_type": "GENE", "description": "This gene had a previously unknown variant in the 3\u2019 untranslated region and intronic variants affecting transcription factor binding sites.", "source_id": "chunk-607feda7df4db8151b99560074c91eea", "id": "TUFM GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "A non-coding variant found in the 3\' UTR of TUFM predicted to impact splicing regulator or transcription factor binding sites.", "source_id": "chunk-607feda7df4db8151b99560074c91eea", "id": "C.3536C>G VARIANT IN TUFM"}, {"entity_type": "GENOMIC VARIANT", "description": "Seven non-synonymous variants initially detected in SULT1A1 in 95 extremely obese children and adolescents, but could not be confirmed with an independent method.", "source_id": "chunk-607feda7df4db8151b99560074c91eea", "id": "NON-SYNONYMOUS VARIANTS (SULT1A1)"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "High sequence similarity between SULT1A gene family led to unspecific amplification artifacts during mutation screening.", "source_id": "chunk-607feda7df4db8151b99560074c91eea", "id": "UNSPECIFIC AMPLIFICATION ARTIFACTS"}, {"entity_type": "GENE", "description": "Amplified alongside SULT1A1 due to high sequence similarity, leading to confusion in variant attribution.", "source_id": "chunk-607feda7df4db8151b99560074c91eea", "id": "SULT1A2 GENE FAMILY MEMBERS"}, {"entity_type": "GENOMIC VARIANT", "description": "Predicted to change splicing enhancer and silencers, or directly affect splice sites and transcription factor binding sites (particularly AML-1).", "source_id": "chunk-607feda7df4db8151b99560074c91eea", "id": "RS3176926: P.PRO200="}, {"entity_type": "MOLECULAR INTERACTION", "description": "Software used for in silico prediction of functional effects of genetic variants.", "source_id": "chunk-607feda7df4db8151b99560074c91eea", "id": "POLYPHEN2 SOFTWARE"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Used to predict the impact of non-synonymous SNPs on protein function and stability.", "source_id": "chunk-607feda7df4db8151b99560074c91eea", "id": "PANTHER SOFTWARE"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Predicts the effect of genetic variations on molecular properties, including splicing regulation.", "source_id": "chunk-607feda7df4db8151b99560074c91eea", "id": "SNAP (SEQUENCE NAME ANNOTATION PREDICTION)"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Analyzes protein sequences to predict the impact of amino acid substitutions on biological function.", "source_id": "chunk-607feda7df4db8151b99560074c91eea", "id": "SIFT (SORTING INTOLERANT FROM TOLERANT)"}, {"entity_type": "GENOMIC VARIANT", "description": "Five non-coding variants identified with potential impacts on regulatory regions, affecting splicing and transcription factors binding.", "source_id": "chunk-607feda7df4db8151b99560074c91eea", "id": "NON-CODING VARIANTS (SULT1A2)"}, {"entity_type": "GENOMIC VARIANT", "description": "Intronic variants in TUFM predicted to alter splicing regulator or transcription factor binding sites.", "source_id": "chunk-607feda7df4db8151b99560074c91eea", "id": "RS7187776: C.-55T>C, RS4788099: C.500\u221219T/C, ETC."}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant in TUFM located at position c.922+29, changing from C to G, disrupting transcription factor binding sites.<SEP>Non-coding intronic variant affecting regulatory regions of the TUFM gene.", "source_id": "chunk-fde6653b9d9013ed054505cfe4cd1455<SEP>chunk-607feda7df4db8151b99560074c91eea", "id": "RS61737565: C.922+29C>G"}, {"entity_type": "GENE", "description": "TUFM is a gene with five variants that are predicted to alter splicing regulator or transcription factor binding sites.", "source_id": "chunk-fde6653b9d9013ed054505cfe4cd1455", "id": "TUFM"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant that disrupts a transcription factor binding site for SRY, HFH 2, and HMG-IY factors.", "source_id": "chunk-fde6653b9d9013ed054505cfe4cd1455", "id": "RS8061877"}, {"entity_type": "GENOMIC VARIANT", "description": "An unknown variant in TUFM located at position g.28854194 changing from C to G, altering splice enhancer binding sites and splicing silencer sites.", "source_id": "chunk-fde6653b9d9013ed054505cfe4cd1455", "id": "G.28854194C/G"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Splice enhancer binding sites are regulatory sequences that influence the efficiency of alternative splicing in RNA processing.", "source_id": "chunk-fde6653b9d9013ed054505cfe4cd1455", "id": "SPLICE ENHANCER BINDING SITES"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Splicing silencer sites are regions within pre-mRNA molecules that inhibit the activity of spliceosomes during mRNA splicing.", "source_id": "chunk-fde6653b9d9013ed054505cfe4cd1455", "id": "SPLICING SILENCER SITES"}, {"entity_type": "PROTEIN", "description": "Transcription factors SRY, HFH 2, and HMG-IY are proteins involved in DNA binding and regulation of gene expression.", "source_id": "chunk-fde6653b9d9013ed054505cfe4cd1455", "id": "SRY, HFH 2, HMG-IY TRANSCRIPTION FACTORS"}, {"entity_type": "TRANSCRIPT", "description": "The non-coding 3\' UTR region of the TUFM transcript, where the variant g.28854194C/G is located, affects RNA processing and stability.", "source_id": "chunk-fde6653b9d9013ed054505cfe4cd1455", "id": "3\u2019 UTR OF TUFM"}, {"source_id": "chunk-7ca64f92964b051cfb1c43f967f243a5", "description": "These studies confirm associations between genetic variants and obesity in families.", "entity_type": "UNKNOWN", "id": "RS3833080 AND RS180743"}, {"source_id": "chunk-7ca64f92964b051cfb1c43f967f243a5", "description": "This analysis showed nominal associations between these genetic variants and obesity.", "entity_type": "UNKNOWN", "id": "RS180743: P.PRO428ALA AND RS3833080: P.GLY369_ASP370DEL9"}, {"source_id": "chunk-607feda7df4db8151b99560074c91eea", "description": "The variant in TUFM predicted to alter splicing regulator or transcription factor binding sites, indicating a role in regulatory function.", "entity_type": "UNKNOWN", "id": "C.3536C>G VARIANT"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant in the ALOX15 gene is associated with ovarian cancer risk.", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "id": "ALOX15 SNP"}, {"entity_type": "GENOMIC VARIANT", "description": "This SNP in arachidonate 5-lipoxygenase (ALOX5) is associated with decreased risk of ovarian cancer, showing an odds ratio of 0.77 at p=0.004.", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "id": "ALOX5 SNP RS1864414"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant in nitric oxide synthase 3 (NOS3) is associated with decreased ovarian cancer risk, showing an odds ratio of 0.79 at p=0.003.", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "id": "NOS3 SNP RS743507"}, {"entity_type": "GENOMIC VARIANT", "description": "A SNP in interleukin 18 (IL18) gene is associated with ovarian cancer risk.", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "id": "IL18 SNP"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant in the CRP gene, which codes for C-reactive protein, is associated with ovarian cancer risk.", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "id": "CRP SNP"}, {"entity_type": "GENOMIC VARIANT", "description": "A SNP in chemokine (C-C motif) ligand 2 (CCL2) is associated with ovarian cancer risk.", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "id": "CCL2 SNP"}, {"entity_type": "GENOMIC VARIANT", "description": "This missense variant in the interleukin 1, alpha gene (IL1A) shows a strong association with decreased ovarian cancer risk.", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "id": "IL1A SNP RS17561"}, {"entity_type": "GENOMIC VARIANT", "description": "A SNP near the 3\' end of the IL1A gene showing similar results to rs17561 in terms of ovarian cancer risk reduction.", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "id": "IL1A SNP RS4848300"}, {"entity_type": "GENOMIC VARIANT", "description": "This variant is correlated with ALOX5 rs1864414 and also associated with decreased ovarian cancer risk, but its effect appears less significant.", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "id": "ALOX5 SNP RS745986"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant in interleukin 1 beta (IL1B) shows an association with increased ovarian cancer risk.<SEP>A genomic variant in interleukin 1 beta (IL1B) shows an association with ovarian cancer risk.", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "id": "IL1B SNP RS7596684"}, {"entity_type": "GENOMIC VARIANT", "description": "This SNP in prostaglandin-endoperoxide synthase 1 (PTGS1) is associated with ovarian cancer risk.", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "id": "PTGS1 SNP RS2282169"}, {"entity_type": "DISEASE", "description": "A disease characterized by the growth of malignant tumors in the ovaries, influenced by genetic factors including variants in inflammation-related genes.<SEP>Ovarian cancer is a type of disease that affects women and is often associated with genetic predisposition and environmental factors.", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b<SEP>chunk-dc5e8cc04a1b16b1e00f3a4120e004c4", "id": "OVARIAN CANCER"}, {"entity_type": "GENOMIC VARIANT", "description": "Additional SNPs in IL1A, specifically rs3783516 (OR 1.10) and rs2856838 (r2=0.993), show associations with increased ovarian cancer risk.", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "id": "IL1A SNPS RS3783516 AND RS2856838"}, {"entity_type": "GENE", "description": "Interleukin 1 beta gene (IL1B) is associated with ovarian cancer risk through genetic variants.", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "id": "IL1B "}, {"entity_type": "GENE", "description": "Prostaglandin-endoperoxide synthase 1 (PTGS1) gene shows associations with ovarian cancer risk through genetic variations.", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "id": "PTGS1 "}, {"entity_type": "GENE", "description": "Interleukin 1 alpha gene (IL1A), particularly through its SNPs, is linked to a reduced risk of developing ovarian cancer.", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "id": "IL1A "}, {"entity_type": "GENE", "description": "Nitric oxide synthase 3 gene (NOS3) has genetic variants associated with decreased ovarian cancer risk.", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "id": "NOS3 "}, {"entity_type": "GENE", "description": "Interleukin 1 beta is a pro-inflammatory cytokine involved in immune response and inflammation.", "source_id": "chunk-b6ea16f7f7eb8bc6f36f2be03fe62403", "id": "IL1B (INTERLEUKIN 1, BETA)"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific variant of the IL1B gene associated with ovarian cancer risk.<SEP>A specific variant of the IL1B gene suggested to be associated with ovarian cancer risk.", "source_id": "chunk-b6ea16f7f7eb8bc6f36f2be03fe62403", "id": "RS7596684"}, {"entity_type": "GENE", "description": "An enzyme involved in prostaglandin biosynthesis.<SEP>Prostaglandin-endoperoxide synthase 1, also known as cyclooxygenase-1, is involved in the biosynthesis of prostaglandins.", "source_id": "chunk-b6ea16f7f7eb8bc6f36f2be03fe62403", "id": "PTGS1 (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE 1)"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific variant of the PTGS1 gene associated with ovarian cancer risk.<SEP>A specific variant of the PTGS1 gene suggested to be associated with ovarian cancer risk.", "source_id": "chunk-b6ea16f7f7eb8bc6f36f2be03fe62403", "id": "RS2282169"}, {"entity_type": "GENE", "description": "An enzyme involved in lipid metabolism and inflammation.", "source_id": "chunk-b6ea16f7f7eb8bc6f36f2be03fe62403", "id": "ALOX15"}, {"entity_type": "GENE", "description": "A chemokine that plays a role in immune cell recruitment and inflammation.", "source_id": "chunk-b6ea16f7f7eb8bc6f36f2be03fe62403", "id": "CCL2 (CHEMOKINE LIGAND 2)"}, {"entity_type": "PROTEIN", "description": "An acute-phase protein involved in the body\'s inflammatory response.", "source_id": "chunk-b6ea16f7f7eb8bc6f36f2be03fe62403", "id": "CRP (C-REACTIVE PROTEIN)"}, {"entity_type": "GENE", "description": "A cytokine that plays a role in immune responses and inflammation.", "source_id": "chunk-b6ea16f7f7eb8bc6f36f2be03fe62403", "id": "IL18 (INTERLEUKIN 18)"}, {"entity_type": "GENE", "description": "An inflammatory cytokine involved in immune response and acute-phase reactions.", "source_id": "chunk-b6ea16f7f7eb8bc6f36f2be03fe62403", "id": "IL6 (INTERLEUKIN 6)"}, {"source_id": "chunk-1c470c93632f3704d6f3566de7a1dd0c<SEP>chunk-089bcdf055eb2f007db49dbe2409429b", "description": "Risk factor for developing ovarian cancer, as influenced by genetic variants such as FokI.<SEP>This SNP in nitric oxide synthase 3 is associated with a decreased risk of ovarian cancer, showing an odds ratio of 0.79 at p=0.003.", "entity_type": "DISEASE", "id": "OVARIAN CANCER RISK"}, {"source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "description": "A genetic variant in the CRP gene, which codes for C-reactive protein, shows an association with ovarian cancer risk.", "entity_type": "UNKNOWN", "id": "CRP SNP "}, {"source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "description": "This variant in IL1B is associated with increased ovarian cancer risk, showing a significant result (p=0.02).", "entity_type": "UNKNOWN", "id": "IL1B SNP RS7596684 "}, {"source_id": "chunk-b6ea16f7f7eb8bc6f36f2be03fe62403<SEP>chunk-a8f2b3b97a70df26efb35263714bf43c", "description": "The ALOX15 gene plays a role in inflammation and lipid metabolism, influencing the body\'s inflammatory response.<SEP>The process in which the body\'s immune system responds to harmful stimuli such as pathogens, damaged cells, or irritants.", "entity_type": "PHYSIOLOGICAL PROCESS", "id": "INFLAMMATION"}, {"source_id": "chunk-b6ea16f7f7eb8bc6f36f2be03fe62403", "description": "CCL2 is involved in immune cell recruitment during inflammation and infection responses.", "entity_type": "UNKNOWN", "id": "IMMUNE RESPONSE"}, {"entity_type": "GENE", "description": "MTHFD2 is a gene involved in folate metabolism, and SNPs within this gene were analyzed for association with childhood ALL.", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "id": "MTHFD2 GENE"}, {"entity_type": "GENE", "description": "BHMT2 is a gene involved in the remethylation of homocysteine to methionine, part of the folate metabolic pathway; SNPs within BHMT2 were also analyzed for their association with childhood ALL.", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "id": "BHMT2 GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "A SNP in the NOS3 gene was identified as having a Bayes Factor of 7.38, suggesting an increased risk of developing childhood ALL for each copy of the minor allele.", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "id": "NOS3 GENE (RS3918186)"}, {"entity_type": "GENOMIC VARIANT", "description": "A SNP in SLC19A1 gene was found to have a Bayes Factor, though less convincing than NOS3 rs3918186, suggesting an increased risk of developing childhood ALL.", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "id": "SLC19A1 GENE (RS1051266)"}, {"entity_type": "DISEASE", "description": "Childhood ALL is the disease under study in this research, with SNPs associated with it being investigated for potential genetic risk factors.", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "id": "CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)"}, {"entity_type": "GENE GROUP", "description": "This group includes genes involved in folate metabolism that were analyzed for their SNPs potentially linked to childhood ALL, such as MTHFD2, BHMT2, NOS3, and SLC19A1.", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "id": "FOLATE METABOLIC GENES"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The Bayesian analysis model was used to evaluate the association between genetic variants (SNPs) and the risk of childhood ALL.", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "id": "BAYESIAN ANALYSIS MODEL"}, {"entity_type": "GENOMIC VARIANT GROUP", "description": "This group includes tagging SNPs of 16 folate metabolic genes analyzed for associations with childhood ALL.", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "id": "FOLATE METABOLIC GENES SNPS"}, {"entity_type": "GENOMIC VARIANT", "description": "A SNP in the NOS3 gene with a Bayes Factor of 7.38, indicating an increased risk of developing childhood ALL per copy of the minor allele.", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "id": "NOS3 RS3918186"}, {"entity_type": "GENOMIC VARIANT", "description": "A SNP in SLC19A1 gene with a Bayes Factor less than NOS3, but still indicating an increased risk of developing childhood ALL per copy of the minor allele.", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "id": "SLC19A1 RS1051266"}, {"entity_type": "DISEASE CONDITION", "description": "Risk factors include genetic variations such as SNPs in genes like MTHFD2 and BHMT2 which may increase susceptibility to childhood ALL.", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "id": "CHILDHOOD ALL RISK FACTORS"}, {"source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "description": "The SNP rs3918186 in NOS3 gene, involved in the nitric oxide synthesis pathway, was found to significantly increase the risk of childhood ALL.", "entity_type": "UNKNOWN", "id": "FOLATE METABOLIC PATHWAY"}, {"entity_type": "GENOMIC VARIANT", "description": "The FADS1/2 haplotype is defined by four SNPs chosen for genotyping with minor allele frequencies ranging from 25.0% to 32.9%.", "source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 30}]", "id": "FADS1/2 HAPLOTYPE"}, {"entity_type": "DIETARY PATTERN", "description": "This dietary pattern was assigned to half of the participants in a study on diet and genotype effects.", "source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 34}]", "id": "HEALTHY EATING DIET GROUP"}, {"entity_type": "DIETARY PATTERN", "description": "Participants in this group followed a Mediterranean diet characterized by increased intake of long chain n-3 PUFA, MUFA, and decreased SFA and n-6 PUFA.", "source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 34}]", "id": "MEDITERRANEAN DIET GROUP"}, {"entity_type": "NUTRIENT", "description": "An omega-6 polyunsaturated fatty acid whose baseline concentration in serum was significantly predicted by the number of minor alleles in FADS1/2 haplotype SNPs.", "source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 30}]", "id": "AA (ARACHIDONIC ACID)"}, {"entity_type": "NUTRIENT", "description": "A long-chain n-3 PUFA nutrient which did not show significant differences between diet groups or associations with genotype at baseline.", "source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 30}]", "id": "EPA (EICOSAPENTAENOIC ACID)"}, {"entity_type": "NUTRIENT", "description": "The sum of EPA and DHA, whose concentrations were significantly predicted by dietary intake rather than the number of minor alleles in FADS1/2 haplotype SNPs.", "source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 34}]", "id": "LONG CHAIN N-3 FATTY ACIDS"}, {"entity_type": "NUTRIENT", "description": "The ratio between polyunsaturated fat intake and saturated fat intake is a measure used to assess dietary healthfulness.<SEP>The ratio increased in the Healthy Eating group but not significantly so in the Mediterranean diet group over 6 months.", "source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d<SEP>chunk-e1b4f4dac52e806f19c580640a50c729", "id": "POLYUNSATURATED FAT:SATURATED FAT RATIO"}, {"entity_type": "GENE", "description": "The FADS1/2 gene cluster is involved in fatty acid metabolism and has been shown to interact with dietary interventions.", "source_id": "chunk-e1b4f4dac52e806f19c580640a50c729", "id": "FADS1/2 GENE CLUSTER"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The concentration of arachidonic acid (AA) in the colon is influenced by both genotype and diet interventions.", "source_id": "chunk-e1b4f4dac52e806f19c580640a50c729", "id": "COLON AA CONCENTRATIONS"}, {"entity_type": "DIETARY PATTERN", "description": "A dietary pattern emphasizing the inclusion of a wide variety of foods that are nutrient-dense and low in added sugars and unhealthy fats.", "source_id": "chunk-e1b4f4dac52e806f19c580640a50c729", "id": "HEALTHY EATING DIET"}, {"entity_type": "NUTRIENT", "description": "Linoleic acid (LA), represented as 18:2 n-6, is an essential fatty acid that plays a role in the formation of arachidonic acid (AA).", "source_id": "chunk-e1b4f4dac52e806f19c580640a50c729", "id": "18:2 N-6"}, {"entity_type": "NUTRIENT", "description": "Monounsaturated fatty acids (MUFA) are important for maintaining cardiovascular health.", "source_id": "chunk-e1b4f4dac52e806f19c580640a50c729", "id": "MUFA"}, {"entity_type": "NUTRIENT", "description": "Omega-3 polyunsaturated fatty acids (PUFAs) play a role in reducing inflammation and improving heart health.", "source_id": "chunk-e1b4f4dac52e806f19c580640a50c729", "id": "N-3 PUFA"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The increase of long chain omega-3 PUFAs in the colon can impact inflammatory processes and cardiovascular health.", "source_id": "chunk-e1b4f4dac52e806f19c580640a50c729", "id": "LONG CHAIN N-3 PUFA"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The concentration of arachidonic acid (AA) in the colon is a measure affected by genotype and diet interventions.", "source_id": "chunk-e1b4f4dac52e806f19c580640a50c729", "id": "AA CONCENTRATION IN COLON"}, {"entity_type": "NUTRIENT", "description": "Eicosapentaenoic acid (EPA), an omega-3 fatty acid, is involved in reducing inflammation and cardiovascular risk.", "source_id": "chunk-e1b4f4dac52e806f19c580640a50c729", "id": "EPA"}, {"source_id": "chunk-e1b4f4dac52e806f19c580640a50c729", "description": "Decreased 18:2 n-6 levels are associated with increased MUFA and n-3 PUFAs in the Mediterranean diet intervention.", "entity_type": "UNKNOWN", "id": "MUFA AND N-3 PUFA"}, {"source_id": "chunk-e1b4f4dac52e806f19c580640a50c729", "description": "Statistical analysis reveals significant interactions between genotype (FADS1/2 gene cluster) and diet interventions affecting fatty acid concentrations in the colon.", "entity_type": "UNKNOWN", "id": "GENOTYPE BY DIET INTERACTION"}, {"source_id": "chunk-e1b4f4dac52e806f19c580640a50c729", "description": "Statistical analysis reveals significant interactions between genotype (FADS1/2 gene cluster) and diet interventions affecting fatty acid concentrations in the colon.", "entity_type": "UNKNOWN", "id": "LINEAR MIXED MODEL RESULTS"}, {"entity_type": "DISEASE", "description": "Snoring is a condition characterized by loud, harsh or hoarse breathing during sleep, prevalent in about 37% of individuals according to the UK Biobank data.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "clusters": "[{level: 0, cluster: 9}]", "id": "SNORING"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "SES, as measured by Townsend deprivation index and average household income, is an environmental factor that increases snoring risk in males only.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "id": "SOCIOECONOMIC STATUS (SES)"}, {"entity_type": "LIFESTYLE FACTOR", "description": "Frequency of smoking correlates positively with the prevalence of snoring in females and to a lesser extent in males.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "clusters": "[{level: 0, cluster: 9}]", "id": "SMOKING FREQUENCY"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Frequency of alcohol consumption correlates positively with snoring in males and to a lesser extent in females.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "clusters": "[{level: 0, cluster: 9}]", "id": "ALCOHOL CONSUMPTION FREQUENCY"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Whole-body fat mass is correlated with snoring, indicating its role as an influential physiological process.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "clusters": "[{level: 0, cluster: 9}]", "id": "WHOLE-BODY FAT MASS"}, {"entity_type": "GENE", "description": "Genomic risk loci are specific locations in the genome associated with increased susceptibility to develop a condition like habitual snoring.<SEP>Specific genomic regions identified through GWAS that contain genetic variants associated with snoring.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "clusters": "[{level: 0, cluster: 9}]", "id": "GENOMIC RISK LOCI "}, {"entity_type": "DISEASE", "description": "Self-reported sleep apnoea is a disease that shows high genetic correlation with habitual snoring.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "clusters": "[{level: 0, cluster: 9}]", "id": "SELF-REPORTED SLEEP APNOEA "}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Genetic correlation refers to the degree of similarity in genetic risk factors between two traits or diseases, such as habitual snoring and other health conditions.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "id": "GENETIC CORRELATION "}, {"entity_type": "DISEASE", "description": "A range of diseases and physiological traits such as BMI, coronary artery disease, mood swings, heart disease, lung cancer etc. show significant genetic correlations with habitual snoring.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "id": "BMI, WHOLE-BODY FAT MASS, SODIUM IN URINE, MOOD SWINGS, CORONARY ARTERY DISEASE, ALCOHOL INTAKE FREQUENCY, PULSE RATE, CURRENT TOBACCO SMOKING, HEART DISEASE, LUNG CANCER "}, {"entity_type": "NUTRIENT", "description": "These measures are phenotypically associated with the condition of habitual snoring (see above and Supplementary Table 1).", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "id": "PULSE RATE, WHOLE-BODY FAT MASS, AND BMI "}, {"entity_type": "DISEASE", "description": "These traits show negative genetic correlation with snoring.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "id": "SCHIZOPHRENIA, FVC, FEV1, FLUID INTELLIGENCE SCORE, EDUCATIONAL ATTAINMENT, AGE AT MENARCHE, MEAN ACCUMBENS VOLUME "}, {"entity_type": "GENOMIC VARIANT", "description": "A genome-wide association study (GWAS) was conducted to uncover genetic associations with snoring.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "id": "GWAS STUDY "}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The Odds Ratio is a statistical measure indicating the strength of association or non-independence between an exposure and a health outcome.<SEP>The odds ratio is used as a measure of effect size, indicating the increased likelihood of an event occurring due to an exposure or risk factor.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62<SEP>chunk-a7d0bfa8b16262a1f313b7e3060969c6", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 19}]", "id": "ODDS RATIO (OR)"}, {"entity_type": "NUTRIENT", "description": "The proportion of phenotypic variance in a trait due to additive genetic effects, indicating the heritable component of snoring.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "id": "SNP HERITABILITY (H2SNP)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A statistical measure representing the degree of similarity between two traits or diseases at the genetic level.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "clusters": "[{level: 0, cluster: 9}]", "id": "GENETIC CORRELATION (RG)"}, {"entity_type": "LIFESTYLE FACTOR", "description": "Measures related to blood oxygen levels during sleep, including average SpO2, minimum SpO2 and percent of sleep with oxyhemoglobin saturation under 90% (Perc90).", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "id": "OXYHEMOGLOBIN SATURATION "}, {"entity_type": "DISEASE", "description": "A measure reflecting lung function, genetically correlated negatively with snoring.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "id": "FORCED EXPIRATORY VOLUME IN 1 SECOND (FEV1)"}, {"entity_type": "DISEASE", "description": "A condition showing a negative genetic correlation with habitual snoring.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "id": "ANOREXIA NERVOSA "}, {"entity_type": "GENE", "description": "DLEU7 is a gene located on chromosome 13 that has been identified as one of the nearest genes to top signals in genome-wide significant variants for snoring.", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "id": "DLEU7 GENE"}, {"entity_type": "GENE", "description": "MSRB3 is a gene located on chromosome 12, also among the closest genes to the top signals for snoring predisposition.", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "id": "MSRB3 GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "SNPs are genomic variants that have been mapped in relation to their impact on snoring predisposition.", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 38}]", "id": "SNP (GENOMIC VARIANT)"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Expression quantitative trait loci mapping is used to identify genetic variations impacting gene expression levels, particularly for snoring-related genes.", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 38}]", "id": "EQTL MAPPING"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "BMI is an environmental factor that was adjusted for in studies of snoring genetics and its associations with other traits.", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "id": "BMI (ENVIRONMENTAL FACTOR)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Snoring is a physiological process influenced by genetic factors, as well as environmental and lifestyle factors such as BMI.", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "id": "SNORING (PHYSIOLOGICAL PROCESS)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Pulse rate is another physiological measure that shows genetic correlation with snoring.", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "id": "PULSE RATE (PHYSIOLOGICAL PROCESS)"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Gene expression data from blood vessel and tibial artery tissues are associated with snoring after adjusting for BMI.", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "id": "BLOOD VESSEL TISSUE EXPRESSION"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific set of genome-wide significant SNPs were mapped to genes significantly associated with the predisposition to snore.", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 38}]", "id": "GENOME-WIDE SIGNIFICANT SNP (GENOMIC VARIANT)"}, {"entity_type": "DISEASE", "description": "Snoring-related genetic associations converge in cardiometabolic pathways and are linked to diseases such as coronary heart disease and heart attack.", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 38}]", "id": "CARDIOMETABOLIC TRAITS AND DISEASES (DISEASE)"}, {"entity_type": "DISEASE", "description": "Genetic predispositions for snoring also overlap with cognitive/neurological disorders, indicating shared genetic factors between snoring and these conditions.", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "id": "COGNITIVE/NEUROLOGICAL DISEASE (DISEASE)"}, {"entity_type": "DISEASE", "description": "Snoring is genetically related to respiratory traits such as sleep apnea, which can affect breathing during sleep.", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "id": "RESPIRATORY TRAITS/DISEASES (DISEASE)"}, {"entity_type": "DISEASE", "description": "Genetic predispositions for snoring are also associated with certain psychiatric disorders like schizophrenia and narcolepsy.", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "id": "PSYCHIATRIC DISORDERS (DISEASE)"}, {"entity_type": "GENOMIC VARIANT", "description": "A genome-wide significant SNP identified for snoring in males.", "source_id": "chunk-a34b927ed42ff0917960122b4d203f83", "id": "RS199797821"}, {"entity_type": "GENOMIC VARIANT", "description": "A genome-wide significant SNP identified for snoring in females.", "source_id": "chunk-a34b927ed42ff0917960122b4d203f83", "id": "RS200391180"}, {"entity_type": "DISEASE RISK PREDICTION MODEL", "description": "Derived from GWAS summary statistics to predict recent snoring in an independent sample.", "source_id": "chunk-a34b927ed42ff0917960122b4d203f83", "id": "PGS (POLYGENIC SCORE)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A physiological process characterized by loud, harsh breathing during sleep.", "source_id": "chunk-a34b927ed42ff0917960122b4d203f83", "id": "RECENT SNORING"}, {"entity_type": "DISEASE", "description": "A condition characterized by repeated episodes of breathing cessation and choking or struggling for breath during sleep.", "source_id": "chunk-a34b927ed42ff0917960122b4d203f83", "id": "PROBABLE OSA (OBSTRUCTIVE SLEEP APNEA)"}, {"entity_type": "METABOLIC PATHWAY", "description": "Genome-wide association studies stratified by sex to identify genetic variants associated with snoring.", "source_id": "chunk-a34b927ed42ff0917960122b4d203f83", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 30}]", "id": "SEX STRATIFIED GWAS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A method to find genetic associations with snoring across the entire genome.<SEP>A research method used to find genetic variations associated with a particular disease or trait.<SEP>A study method used to identify genetic variants associated with diseases across the entire genome.<SEP>A study design used to identify genetic variations associated with a particular trait or disease within the human genome.<SEP>A study aiming to associate genetic variations with diseases or traits across the entire genome.", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28<SEP>chunk-1f20dbdcc9de443dada1a2045dc7832b<SEP>chunk-a34b927ed42ff0917960122b4d203f83<SEP>chunk-7efd4f037425eeac77e329347b16beb2<SEP>chunk-2e31819d63b80079cb6422efd6e684e0", "id": "GWAS (GENOME-WIDE ASSOCIATION STUDY)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Measures the proportion of phenotypic variance in a trait due to additive effects of all SNP genotypes, as found in GWAS analyses.", "source_id": "chunk-a34b927ed42ff0917960122b4d203f83", "id": "H2SNP (SNP HERITABILITY)"}, {"entity_type": "PROTEIN", "description": "Genetic variants with the strongest association signals identified from GWAS studies.", "source_id": "chunk-a34b927ed42ff0917960122b4d203f83", "id": "TOP HITS"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "An independent target sample used for deriving and validating PGS for recent snoring.", "source_id": "chunk-a34b927ed42ff0917960122b4d203f83", "id": "AGDS (AUSTRALIAN GENETICS OF DEPRESSION STUDY)"}, {"source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "description": "Lower SES is associated with higher risk of habitual snoring, especially among males.", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 9}]", "id": "SES"}, {"source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "description": "Traits like BMI and heart disease are genetically correlated to habitual snoring, suggesting common underlying genetic risk factors.", "entity_type": "UNKNOWN", "id": "BMI AND HEART DISEASE "}, {"source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "description": "The GWAS study uncovered 127 independent genome-wide significant associations across 41 genomic risk loci for snoring.", "entity_type": "UNKNOWN", "id": "SNORING "}, {"source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "description": "Forced expiratory volume in 1 second (FEV1) and forced vital capacity (FVC) show negative genetic correlations with snoring, highlighting their importance in lung function.", "entity_type": "UNKNOWN", "id": "FEV1 AND FVC "}, {"source_id": "chunk-a34b927ed42ff0917960122b4d203f83", "description": "Severe cases of recent snoring may indicate probable obstructive sleep apnea, characterized by breathing cessation and choking during sleep.", "entity_type": "UNKNOWN", "id": "PROBABLE OSA"}, {"entity_type": "GENE", "description": "VDBP is a gene associated with vitamin D binding protein that plays a role in the regulation of vitamin D levels.", "source_id": "chunk-617cab4d8c10048a1335bf565693bf97", "id": "VDBP"}, {"entity_type": "GENOMIC VARIANT", "description": "VDBP single nucleotide polymorphisms are variations in the DNA sequence at specific sites within the VDBP gene, which can affect vitamin D binding and regulation.", "source_id": "chunk-617cab4d8c10048a1335bf565693bf97", "id": "SINGLE NUCLEOTIDE POLYMORPHISMS (SNPS)"}, {"entity_type": "NUTRIENT", "description": "Total 25-hydroxyvitamin D (total 25(OH)D) is a metabolite of vitamin D that serves as the main circulating form in blood, reflecting overall vitamin D status.", "source_id": "chunk-617cab4d8c10048a1335bf565693bf97", "id": "TOTAL 25(OH)D"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "These physiological processes and environmental factors are covariates used to adjust for potential confounders in the analysis of vitamin D status between mothers and neonates.", "source_id": "chunk-617cab4d8c10048a1335bf565693bf97", "id": "MATERNAL HEIGHT, PRE-PREGNANCY BMI, TERMINAL BMI, UVB, WEEKS OF GESTATION"}, {"entity_type": "DISEASE OR PHYSIOLOGICAL CONDITION", "description": "Different states of maternal and neonatal vitamin D equilibrium refer to varying levels of vitamin D sufficiency, deficiency, and toxicity in both mother and newborn.", "source_id": "chunk-617cab4d8c10048a1335bf565693bf97", "id": "VITAMIN D EQUILIBRIUM STATE"}, {"entity_type": "GENOMIC VARIANT", "description": "Maternal variations in the VDBP gene can influence maternal vitamin D status during pregnancy.", "source_id": "chunk-617cab4d8c10048a1335bf565693bf97", "id": "MATERNAL VDBP POLYMORPHISMS "}, {"entity_type": "GENOMIC VARIANT", "description": "Variations in neonates\' VDBP gene may affect their vitamin D binding and levels at birth.", "source_id": "chunk-617cab4d8c10048a1335bf565693bf97", "id": "NEONATAL VDBP POLYMORPHISMS "}, {"entity_type": "DISEASE OR PHYSIOLOGICAL CONDITION", "description": "Vitamin D status refers to the overall level of vitamin D in an individual, which can be categorized as sufficient, deficient, or toxic.", "source_id": "chunk-617cab4d8c10048a1335bf565693bf97", "id": "VITAMIN D STATUS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Cut-off levels used for categorizing maternal vitamin D sufficiency or deficiency during pregnancy.", "source_id": "chunk-617cab4d8c10048a1335bf565693bf97", "id": "MATERNAL VITAMIN D CUT-OFFS "}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Threshold values used to classify neonatal vitamin D status at birth.", "source_id": "chunk-617cab4d8c10048a1335bf565693bf97", "id": "NEONATAL VITAMIN D CUT-OFFS "}, {"entity_type": "DISEASE", "description": "Polycystic ovary syndrome (PCOS) is a condition characterized by hormonal imbalances, insulin resistance, and other clinical features.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "id": "PCOS"}, {"entity_type": "GENE", "description": "The VEGFA gene encodes the vascular endothelial growth factor A, which plays a role in angiogenesis and blood vessel formation.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "id": "VEGFA GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "A single nucleotide polymorphism (SNP) located at position -583 of the VEGFA gene, with a higher minor allele frequency in women with PCOS compared to controls.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "id": "RS3025020 (-583T>C)"}, {"entity_type": "GENOMIC VARIANT", "description": "A single nucleotide polymorphism (SNP) located at position -634 of the VEGFA gene, showing different genotype distributions between PCOS cases and controls.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "id": "RS2010963 (-634C>G)"}, {"entity_type": "PROTEIN", "description": "The protein product of the VEGFA gene, involved in angiogenesis and vascular permeability.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "id": "VEGF PROTEIN"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "An index used to estimate insulin resistance based on fasting plasma glucose and serum insulin levels.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "id": "INSULIN RESISTANCE INDEX (HOMA-IR)"}, {"entity_type": "MOLECULAR INTERACTION", "description": "The concentration of vascular endothelial growth factor A in the blood, which is correlated with certain genotypes of PCOS patients.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "id": "SERUM VEGF LEVELS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A measure of testosterone that is not bound to sex hormone-binding globulin (SHBG), which can be elevated in women with polycystic ovary syndrome.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "id": "FREE TESTOSTERONE"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Testosterone available for cellular functions, often measured as a ratio or index involving SHBG and total testosterone levels.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "id": "BIOACTIVE TESTOSTERONE"}, {"entity_type": "PROTEIN", "description": "A protein that binds sex hormones like testosterone and estradiol in the blood, affecting their bioavailability.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "id": "SHBG (SEX HORMONE-BINDING GLOBULIN)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The total amount of testosterone circulating in the bloodstream.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "id": "TOTAL TESTOSTERONE"}, {"entity_type": "PROTEIN", "description": "A hormone produced by the anterior pituitary gland that plays a role in ovulation and steroidogenesis.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "id": "LH (LUTEINIZING HORMONE)"}, {"entity_type": "PROTEIN", "description": "A hormone produced by the anterior pituitary gland that stimulates ovarian follicular growth and maturation.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "id": "FSH (FOLLICLE-STIMULATING HORMONE)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "An index used to estimate free testosterone levels in women, often correlated with clinical features of PCOS.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "id": "FREE ANDROGEN INDEX (FAI)"}, {"entity_type": "PROTEIN", "description": "A hormone produced by the anterior pituitary gland that stimulates the thyroid gland to produce T3 and T4 hormones.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "id": "TSH (THYROID-STIMULATING HORMONE)"}, {"entity_type": "GENOMIC VARIANT", "description": "Val carrier genotype is a genetic variant associated with differential response bias in behavioral studies.", "source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647", "id": "VAL CARRIER GENOTYPE"}, {"entity_type": "GENOMIC VARIANT", "description": "Iso homozygote genotype is another genetic variant often compared to the val carrier genotype for studying genetic influences on behavior.", "source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647", "id": "ISO HOMOZYGOTE GENOTYPE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Response bias refers to a behavioral process where participants alter their responses based on reinforcement contingencies.<SEP>The tendency to respond more to frequently rewarded stimuli as measured in experimental tasks under conditions of stress or no-stress.", "source_id": "chunk-5e709975097a773fb3d31e265d76a71b<SEP>chunk-4b4f7d54511e2d8bbf5af6073d25b647", "id": "RESPONSE BIAS"}, {"entity_type": "BEHAVIORAL PATTERN", "description": "The selection of shock intensity is a behavioral pattern that can be influenced by genetic factors such as genotype.", "source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647", "id": "SHOCK INTENSITY SELECTION BEHAVIOR"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "STAI scores represent the level of state anxiety reported by participants, which can vary based on condition and time.", "source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647", "id": "STAI SCORES"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "PANAS negative affect (NA) scores measure emotional distress or negative emotions experienced during a task.", "source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647", "id": "PANAS NA SCORES"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Skin conductance (SC) responses are non-specific physiological measures of arousal that increase in stressful situations.", "source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647", "id": "NON-SPECIFIC SC RESPONSES"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A time main effect on STAI scores shows an increase in reported anxiety over the duration of the experiment.", "source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647", "id": "TIME MAIN EFFECT ON STAI SCORES"}, {"entity_type": "BEHAVIORAL PATTERN", "description": "An interaction between condition and time indicates that the difference in anxiety levels is greater at later times within the stress condition compared to no-stress conditions.", "source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647", "id": "CONDITION \u00d7 TIME INTERACTION ON STAI SCORES"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Pre-stress assessment differences refer to the minor changes or lack thereof before a stressor is introduced, which may be indicative of baseline states.", "source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647", "id": "PRE-STRESS ASSESSMENT DIFFERENCES"}, {"entity_type": "BEHAVIORAL PATTERN", "description": "No significant main effect on positive affect suggests no change in reported happiness or pleasure across conditions and time.", "source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647", "id": "MAIN EFFECT ON PANAS POSITIVE AFFECT (PA)"}, {"entity_type": "GENETIC VARIANT", "description": "Individuals carrying the val variant of a gene, typically the COMT gene, show altered response bias in stress conditions compared to iso homozygotes.", "source_id": "chunk-5e709975097a773fb3d31e265d76a71b", "id": "VAL CARRIER"}, {"entity_type": "GENETIC VARIANT", "description": "Individuals with two copies of the isoleucine allele (iso) show less alteration in response bias under stress conditions compared to val carriers.", "source_id": "chunk-5e709975097a773fb3d31e265d76a71b", "id": "ISO HOMOZYGOTE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A condition that involves different levels of stress manipulation affecting physiological and psychological responses, particularly in the context of reward processing.", "source_id": "chunk-5e709975097a773fb3d31e265d76a71b", "id": "CONDITION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The ability to distinguish between different reward contingencies, which was shown to vary across blocks but not due to genotype differences.", "source_id": "chunk-5e709975097a773fb3d31e265d76a71b", "id": "DISCRIMINABILITY"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "A measure of the intensity or degree of stress applied during experimental tasks, affecting participant responses and physiological measures like skin conductance.", "source_id": "chunk-5e709975097a773fb3d31e265d76a71b", "id": "SHOCK INTENSITY"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Electrodermal activity used as an index of sympathetic nervous system arousal in response to stress conditions.", "source_id": "chunk-5e709975097a773fb3d31e265d76a71b", "id": "SKIN CONDUCTANCE RESPONSES"}, {"entity_type": "GENOMIC VARIANT", "description": "Specific single nucleotide polymorphisms within the CRHR1 gene that are associated with alterations in reward learning and responses to stress.", "source_id": "chunk-5e709975097a773fb3d31e265d76a71b", "id": "CRHR1 SNPS"}, {"entity_type": "GENE", "description": "The gene encoding catechol-O-methyltransferase (COMT), where a valine (val) to methionine (met) substitution at position 158 affects enzyme activity and influences stress response.", "source_id": "chunk-5e709975097a773fb3d31e265d76a71b", "id": "COMT GENE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A condition where individuals under stress show altered reward learning, particularly associated with genetic variations like the COMT gene val158met polymorphism.", "source_id": "chunk-5e709975097a773fb3d31e265d76a71b", "id": "STRESS-INDUCED REWARD LEARNING DEFICITS"}, {"entity_type": "GENE", "description": "The CRHR1 gene encodes the corticotropin-releasing hormone receptor 1, which plays a role in stress response pathways and is linked to variations affecting reward learning.", "source_id": "chunk-5e709975097a773fb3d31e265d76a71b", "id": "CRHR1 GENE"}, {"entity_type": "GENE", "description": "rs17563 is a SNP located in the BMP4 gene, which reached genome-wide significance.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "id": "BMP4 RS17563"}, {"entity_type": "GENE", "description": "rs10740993 is a SNP located in or near the CACNB2 gene, reaching genome-wide significance.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "id": "CACNB2 RS10740993"}, {"entity_type": "GENE", "description": "rs4937076 is a SNP located in or near the CDON gene, reaching genome-wide significance.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "id": "CDON RS4937076"}, {"entity_type": "GENOMIC VARIANT", "description": "rs1799922 is associated with \'age at first tooth\' and located within CALU or OPN1SW genes.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "id": "CALU/OPN1SW RS1799922"}, {"entity_type": "GENE", "description": "rs997154 is a SNP located in the AJUBA gene region, reaching genome-wide significance.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "id": "AJUBA/C14ORF93 RS997154"}, {"entity_type": "GENOMIC VARIANT", "description": "rs7924176 is associated with \'age at first tooth\' and \'number of teeth\'.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "id": "ADK RS7924176"}, {"entity_type": "GENE", "description": "rs412000 is a SNP located in or near the TEX14/RAD51C gene region, reaching genome-wide significance.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "id": "TEX14/RAD51C RS412000"}, {"entity_type": "GENE", "description": "rs9316505 is a SNP located within the DLEU7 gene, reaching genome-wide significance.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "id": "DLEU7 RS9316505"}, {"entity_type": "GENOMIC VARIANT", "description": "rs17101923 is associated with \'number of teeth\' in the HMGA2 region, reaching genome-wide significance.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "id": "HMGA2 RS17101923"}, {"entity_type": "GENE", "description": "Two SNPs (rs17105278 for \'age at first tooth\' and rs9788982 for \'number of teeth\') in the KCNJ2 gene are mentioned as having secondary signals.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "id": "KCNJ2 RS17105278 AND RS9788982"}, {"entity_type": "GENE", "description": "rs1458991 is associated with \'age at first tooth\' and located near MSRB3, showing evidence of a secondary signal.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "id": "MSRB3 RS1458991"}, {"entity_type": "GENE", "description": "Two SNPs in the IGF2BP1 gene (rs10932688 for \'age at first tooth\' and rs9894411 for \'number of teeth\') are significant, with secondary signals.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "id": "IGF2BP1 RS10932688 AND RS9894411"}, {"entity_type": "GENE", "description": "Two SNPs near the EDA gene (rs2520397 for \'age at first tooth\' and rs2804391 for \'number of teeth\') are significant, with secondary signals.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "id": "EDA RS2520397 AND RS2804391"}, {"entity_type": "GENE", "description": "Two SNPs in the RAD51L1 gene (rs17105278 for \'age at first tooth\' and rs1956529 for \'number of teeth\') show suggestive evidence, with secondary signals.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "id": "RAD51L1 RS17105278 AND RS1956529"}, {"entity_type": "GENOMIC VARIANT", "description": "SNPs in the TMEM9 region are reported as having a suggestive level of association.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "id": "TMEM9 REGION SNP(S)"}, {"entity_type": "GENE", "description": "rs9870336 is a SNP located near the NID2 gene, reaching genome-wide significance.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "id": "NID2 RS9870336"}, {"entity_type": "GENE", "description": "KCNJ160 is a gene identified as having associated genomic variants with \'age at first tooth\'.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "id": "KCNJ160"}, {"entity_type": "GENOMIC VARIANT", "description": "rs2804391 and rs2520397 are genomic variants located in the FAM155E-EDA region, associated with \'number of teeth\'.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "id": "FAM155E\u2013EDA"}, {"entity_type": "GENE", "description": "The BMP4 gene is linked to both \'age at first tooth\' and \'number of teeth\', suggesting a role in craniofacial development.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "id": "BMP4"}, {"entity_type": "GENE", "description": "HMGA2 is associated with early tooth eruption, number of teeth, and specific craniofacial measures such as face width.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "id": "HMGA2"}, {"entity_type": "GENE", "description": "The IGF2BP1 gene has genomic variants (rs8069452) linked to \'age at first tooth\'.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "id": "IGF2BP1"}, {"entity_type": "GENE", "description": "Genomic variant rs7924176 in ADK is associated with the width of the nose and measures related to tooth eruption timing.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "id": "ADK"}, {"entity_type": "GENE", "description": "The AJUBA gene\'s genomic variant (rs997154) affects mid-brow height and prominence.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "id": "AJUBA"}, {"entity_type": "GENE", "description": "Genomic variants in MSRB3 are linked to \'number of teeth\' at genome-wide significance levels.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "id": "MSRB3"}, {"entity_type": "GENOMIC VARIANT", "description": "SNPs associated with height, such as rs1351394 (HMGA2) and rs12534093 (IGF2BP3), also show associations with tooth eruption age and number of teeth.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "id": "HEIGHT-ASSOCIATED SNPS"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant in the FAM155E-EDA region associated with \'age at first tooth\'.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "id": "RS2520397"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant (rs1951867) located near BMP4, linked to \'number of teeth\'.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "id": "RS1951867"}, {"entity_type": "GENOMIC VARIANT", "description": "This variant is found in HMGA2 and associated with both tooth eruption timing and craniofacial measures.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "id": "RS1472259"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant (rs8069452) located near IGF2BP1, linked to \'age at first tooth\'.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "id": "RS8069452"}, {"entity_type": "GENOMIC VARIANT", "description": "This variant is in KCNJ2 and associated with \'number of teeth\'.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "id": "RS9788982"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant (rs2804391) located near FAM155E-EDA, linked to \'number of teeth\'.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "id": "RS2804391"}, {"entity_type": "GENOMIC VARIANT", "description": "Located in ADK and associated with measures indexing the width of the nose.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "id": "RS7924176"}, {"entity_type": "GENOMIC VARIANT", "description": "Found near AJUBA, this variant is linked to an increase in height and prominence of the mid-brow.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "id": "RS997154"}, {"entity_type": "BIOLOGICAL PROCESS", "description": "Refers to the developmental process involving the skull and face structures, related to dental development.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "id": "CRANIOFACIAL DEVELOPMENT"}, {"entity_type": "BIOLOGICAL PROCESS", "description": "The process by which teeth emerge through the gums into the mouth; associated with genetic factors like HMGA2 and ADK variants.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "id": "TOOTH ERUPTION"}, {"entity_type": "ANATOMICAL STRUCTURE", "description": "Teeth that are not deciduous, developing after primary teeth and influenced by genes such as BMP4 and MSRB3.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "id": "PERMANENT TEETH"}, {"entity_type": "GENE", "description": "The BMP4 gene, involved in bone and tooth formation, shows association with height and dental development traits.", "source_id": "chunk-c63d60b991cd7442f690dcc364af47dd", "id": "BMP4 GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "Significant SNPs identified for \'Age at first tooth\' and \'Number of teeth\', showing associations with height but weakened after removing HMGA2 and BMP4 variants.", "source_id": "chunk-c63d60b991cd7442f690dcc364af47dd", "id": "GENOME-WIDE SIGNIFICANT SNPS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A PMETA score is a meta-analysis measure indicating the evidence of association between genetic markers and traits; in this context, it measures the association between SNP scores and height.", "source_id": "chunk-c63d60b991cd7442f690dcc364af47dd", "id": "PMETA SCORE"}, {"entity_type": "METABOLIC PATHWAY", "description": "Pathways identified through GWAS analysis for \'age at first tooth\' that show over-representation of genes with significant associations.", "source_id": "chunk-c63d60b991cd7442f690dcc364af47dd", "id": "AGE AT FIRST TOOTH GWAS PATHWAYS"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Analysis using ALLIGATOR software to identify pathways enriched in SNPs associated with dental development traits, particularly \'Age at First Tooth\'.", "source_id": "chunk-c63d60b991cd7442f690dcc364af47dd", "id": "ALLIGATOR SOFTWARE ANALYSIS"}, {"entity_type": "DISEASE", "description": "Genome-wide association study focusing on the age when an individual gets their first tooth.", "source_id": "chunk-c63d60b991cd7442f690dcc364af47dd", "id": "AGE AT FIRST TOOTH GWAS"}, {"entity_type": "DISEASE", "description": "Genome-wide association study examining genetic factors influencing the number of teeth in individuals.", "source_id": "chunk-c63d60b991cd7442f690dcc364af47dd", "id": "NUMBER OF TEETH GWAS"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Software used to conduct pathway analysis on GWAS data, identifying significant pathways associated with traits like \'Age at First Tooth\'.", "source_id": "chunk-c63d60b991cd7442f690dcc364af47dd", "id": "ALLIGATOR SOFTWARE"}, {"entity_type": "GENOMIC VARIANT", "description": "Small variations at individual positions within a DNA sequence that can influence disease susceptibility or treatment response.<SEP>Specific genetic variations at single nucleotide positions that are investigated for their association with dental development and height.", "source_id": "chunk-c63d60b991cd7442f690dcc364af47dd<SEP>chunk-2b5346dfc62015294aa57aeab3960cd1", "id": "SNPS (SINGLE NUCLEOTIDE POLYMORPHISMS)"}, {"source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "description": "rs10740993 is significantly associated with the age of eruption of primary teeth.)", "entity_type": "UNKNOWN", "id": "AGE AT FIRST TOOTH"}, {"source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "description": "rs4937076 is linked to \'number of teeth\' and may influence tooth development or number.)", "entity_type": "UNKNOWN", "id": "NUMBER OF TEETH"}, {"source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "description": "This SNP affects both the number of teeth and the timing of their emergence, suggesting a role in overall dentition development.)", "entity_type": "UNKNOWN", "id": "NUMBER OF TEETH AND AGE AT FIRST TOOTH"}, {"source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "description": "These SNPs near KCNJ2 are significant for both timing and number, indicating a complex role in dentition.)", "entity_type": "UNKNOWN", "id": "AGE AT FIRST TOOTH AND NUMBER OF TEETH"}, {"source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "description": "Genomic variants in FAM155E-EDA are linked to \'number of teeth\', reflecting its role in craniofacial traits related to tooth count.", "entity_type": "UNKNOWN", "id": "FAM155E-EDA"}, {"source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "description": "The ADK gene\'s variant affects the width of the nose, indicating a genetic influence on craniofacial morphology related to tooth eruption timing.", "entity_type": "UNKNOWN", "id": "FACE WIDTH"}, {"source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "description": "Genomic variants in AJUBA are linked to increased mid-brow height and prominence, suggesting a role in craniofacial development.", "entity_type": "UNKNOWN", "id": "MID-BROW HEIGHT"}, {"source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "description": "The MSRB3 gene\'s variant is associated with \'number of primary teeth\', highlighting its involvement in early dental development.", "entity_type": "UNKNOWN", "id": "NUMBER OF PRIMARY TEETH"}, {"source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "description": "Genomic variant rs1472259 in HMGA2 shows associations with both early tooth eruption and permanent teeth count, suggesting a broad genetic influence on dental health.", "entity_type": "UNKNOWN", "id": "AGE AT FIRST TOOTH AND NUMBER OF PERMANENT TEETH"}, {"source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "description": "Genomic variant rs7924176 in ADK affects both face width and measures related to tooth eruption timing, indicating its role in craniofacial morphology.", "entity_type": "UNKNOWN", "id": "FACE WIDTH AND TOOTH ERUPTION TIMING"}, {"source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "description": "Genomic variant rs997154 near AJUBA influences mid-brow height and prominence, highlighting its role in craniofacial development.", "entity_type": "UNKNOWN", "id": "MID-BROW HEIGHT AND CRANIOFACIAL DEVELOPMENT"}, {"source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "description": "The HMGA2 gene\'s variants show strong associations with both height and tooth eruption timing, suggesting overlapping genetic influences between these traits.", "entity_type": "UNKNOWN", "id": "HEIGHT-ASSOCIATED SNPS IN DENTAL PHENOTYPES"}, {"source_id": "chunk-c63d60b991cd7442f690dcc364af47dd", "description": "The HMGA2 gene is significantly associated with height and impacts dental development through this association.)", "entity_type": "UNKNOWN", "id": "HEIGHT"}, {"source_id": "chunk-c63d60b991cd7442f690dcc364af47dd", "description": "The BMP4 gene plays a role in bone and tooth formation, influencing the \'Number of Teeth\' trait.)", "entity_type": "UNKNOWN", "id": "BONE AND TOOTH FORMATION"}, {"entity_type": "GENE", "description": "Interleukin-10 receptor alpha subunit (IL-10R\u03b1) is a protein component of the IL-10 receptor that plays a crucial role in immune regulation.<SEP>The IL-10 receptor alpha gene plays a role in signaling pathways associated with immune responses and inflammation regulation.", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad<SEP>chunk-bcd248f7a9b2453bfc563b9439fbdd51", "id": "IL-10R\u0391"}, {"entity_type": "DISEASE", "description": "A model of colitis induced by transferring T cells from donor mice into immunocompromised recipient mice to study the development of inflammatory bowel disease.", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "id": "T CELL TRANSFER-COLITIS MODEL"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process of inflammation in the colon, which is a key aspect of evaluating the impact of IL-10 signaling on colitis severity.", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "id": "COLONIC INFLAMMATION"}, {"entity_type": "MOLECULAR INTERACTION", "description": "A molecular interaction involving the binding and activation of the IL-10 receptor, leading to downstream anti-inflammatory effects.", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "id": "IL-10 SIGNALING"}, {"entity_type": "CELL TYPE", "description": "A type of immune cell involved in phagocytosis and regulation of inflammatory responses; plays a crucial role in the context of colitis development.", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "id": "MACROPHAGE (M\u03a6)"}, {"entity_type": "DISEASE", "description": "A toxin-induced model of acute colitis, distinct from T cell transfer-mediated colitis, used to assess macrophage response to IL-10.<SEP>An acute colitis model induced by administration of dextran sodium sulfate (DSS), a toxin that causes inflammation and ulceration in the colon.", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "id": "DSS COLITIS MODEL"}, {"entity_type": "GENOMIC VARIANT", "description": "A genetic driver line that expresses Cre recombinase specifically in a subset of immune cells (including LPM\u03d5s), used for conditional deletion of IL-10R\u03b1 gene.", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "id": "CX3CR1-CRE DRIVER LINE"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant where IL-10R\u03b1 is selectively deleted in T cells.", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "id": "IL-10R\u0391TDEL"}, {"entity_type": "CELL TYPE (TRANSCRIPT)", "description": "Na\u00efve T cells, specifically CD4+ T cells with high levels of CD45RB and low levels of CD25 used in the transfer model to induce colitis.", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "id": "NAIVE CD4+CD25\u2212CD45RBHI T CELLS"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant where IL-10R\u03b1 is selectively deleted in dendritic cells (DCs).", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "id": "IL-10R\u0391DCDEL"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant where IL-10R\u03b1 is selectively deleted in macrophages.<SEP>The IL-10R\u03b1Mdel gene is associated with the development of differential colitis severity when expressed in Rag1\u2212/\u2212 mice.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6<SEP>chunk-bcd248f7a9b2453bfc563b9439fbdd51", "id": "IL-10R\u0391MDEL"}, {"entity_type": "GENOMIC VARIANT", "description": "A genetic driver line expressing Cre recombinase driven by CX3CR1, leading to conditional deletion of IL-10R\u03b1 primarily in LPM\u03d5s (lymphoid tissue-resident macrophages).", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "id": "CX3CR1-DRIVEN CRE"}, {"entity_type": "PROTEIN", "description": "IL-10 is a gene encoding for Interleukin 10, a protein with anti-inflammatory properties that modulates immune system activity.<SEP>Interleukin 10 acts as an anti-inflammatory cytokine, inhibiting the production of pro-IL-1\u03b2 and maturing IL-1\u03b2 from macrophages.<SEP>Interleukin 10, an anti-inflammatory cytokine that plays a role in immune regulation and tolerance maintenance.<SEP>Interleukin-10 (IL-10) is a cytokine involved in reducing inflammation by inhibiting the production of pro-inflammatory molecules and promoting anti-inflammatory effects.<SEP>Interleukin-10 (IL-10) is a cytokine that plays a role in immune regulation, inhibiting pro-inflammatory responses.<SEP>Interleukin-10 is a cytokine that plays a role in anti-inflammatory processes by inhibiting pro-inflammatory cytokines and enhancing the production of anti-inflammatory mediators.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6<SEP>chunk-bcd248f7a9b2453bfc563b9439fbdd51<SEP>chunk-f2c864ef2d87119a8129e011b1c42e3c<SEP>chunk-35d8a4ea86cb92d18ee1c857a318d2d8<SEP>chunk-b971aa450a9b220806bdc000eb5efaad<SEP>chunk-380a8a6e0d08cd28068a146ae5e00ce4", "id": "IL-10"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant where IL-10R\u03b1 is germline deleted in mice also lacking Rag1, used to assess the impact of global IL-10R\u03b1 deletion on colitis.", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "id": "IL-10R\u0391\u2212/\u2212RAG1\u2212/\u2212"}, {"entity_type": "CELL TYPE", "description": "A subset of macrophages found in lymphoid tissues that play a role in immune regulation and inflammation.", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "id": "LPM\u03a6S (LYMPHOID TISSUE RESIDENT MACROPHAGES)"}, {"entity_type": "GENE", "description": "A genomic variant that modifies the Rag1 gene and impacts colitis susceptibility.<SEP>The IL-10R\u03b1MdelRag1\u2212/\u2212 is a genetic variant associated with heightened inflammatory responses in mice.<SEP>**Note: This should likely be a Genomic Variant or Disease entity based on context rather than Dietary Pattern. Let\'s correct to Genomic Variant.**", "source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8<SEP>chunk-380a8a6e0d08cd28068a146ae5e00ce4", "id": "IL-10R\u0391MDELRAG1\u2212/\u2212"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Lamina propria macrophages are a type of immune cells that play a role in the immune response within the gut, particularly in colitis models.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "id": "LPM\u03a6S (LAMINA PROPRIA MACROPHAGES)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Foxp3+ iTreg refers to induced regulatory T cells expressing Foxp3, which are involved in modulating immune responses and preventing excessive inflammation.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "id": "FOXP3+ ITREG"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Regulatory T cells are a subset of T lymphocytes that play critical roles in suppressing immune responses to prevent autoimmunity.<SEP>STAT5B plays a role in the maintenance of regulatory T cells, which are crucial for immune self-tolerance and prevention of autoimmunity. A deficiency can result in reduced function and number of these cells over time.", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a<SEP>chunk-380a8a6e0d08cd28068a146ae5e00ce4", "id": "TREGS (REGULATORY T CELLS)"}, {"entity_type": "DISEASE", "description": "A disease characterized by chronic inflammation in the colon.<SEP>An inflammatory bowel disease characterized by chronic inflammation of the colon and rectum.<SEP>Colitis refers to inflammation of the colon, often characterized by symptoms such as abdominal pain, diarrhea, and bloody stools, and can be caused by various factors including immune dysregulation.<SEP>An inflammatory condition of the colon characterized by abdominal pain, diarrhea, and intestinal inflammation.<SEP>Colitis is an inflammatory condition of the colon that can be influenced by genetic factors such as CARD9 deficiency.", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c<SEP>chunk-4d5e7ab61a7357d5106f4a8a355f40d0<SEP>chunk-35d8a4ea86cb92d18ee1c857a318d2d8<SEP>chunk-e025ebd5580ff5f1a76bedbcaed2a0b6<SEP>chunk-380a8a6e0d08cd28068a146ae5e00ce4", "id": "COLITIS"}, {"entity_type": "PROTEIN", "description": "Neutrophils are a type of granulocyte that plays an important role in the innate immune system, particularly in phagocytosing pathogens and dead cells.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "id": "NEUTROPHILS"}, {"entity_type": "PROTEIN", "description": "CD11b is a cell surface protein that functions as an integrin involved in leukocyte adhesion and migration, often used to identify specific immune cells such as neutrophils and macrophages.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "id": "CD11B"}, {"entity_type": "PROTEIN", "description": "CD64 is a cell surface protein that acts as the high-affinity receptor for human IgG, primarily expressed on activated monocytes and macrophages.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "id": "CD64"}, {"entity_type": "PROTEIN", "description": "CD103 is a cell surface protein that acts as an adhesion molecule, often expressed on epithelial tissue-resident T cells.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "id": "CD103"}, {"entity_type": "PROTEIN", "description": "Ly6G is a mouse-specific cell surface protein that serves as an important marker for identifying neutrophils and other granulocytes.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "id": "LY6G"}, {"entity_type": "PROTEIN", "description": "SiglecF is a cell surface receptor expressed on eosinophils, playing a role in modulating their activity and interactions with other cells.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "id": "SIGLECF"}, {"entity_type": "PROTEIN", "description": "CD80 is a cell surface protein that acts as an activating ligand for the T cell receptor co-stimulatory molecule CD28, enhancing T cell proliferation and cytokine production.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "id": "CD80"}, {"entity_type": "PROTEIN", "description": "CD86 is a cell surface protein that acts as an activating ligand for the T cell receptor co-stimulatory molecule CD28, enhancing T cell proliferation and cytokine production.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "id": "CD86"}, {"entity_type": "GENE", "description": "Interleukin-10 Receptor Beta (IL-10R\u03b2) is a subunit of the IL-10 receptor complex, essential for signaling downstream effects mediated by IL-10.<SEP>The IL-10R\u03b2 gene encodes for Interleukin 10 receptor subunit beta, which together with IL-10R\u03b1 forms the IL-10 receptor complex essential for signaling and immune regulation.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6<SEP>chunk-380a8a6e0d08cd28068a146ae5e00ce4", "id": "IL-10R\u0392"}, {"entity_type": "GENE", "description": "Recombination Activating Gene 2 (RAG2) is crucial for the generation of a diverse T and B cell receptor repertoire; its absence results in severe immunodeficiency.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "id": "RAG2\u2212/\u2212"}, {"entity_type": "CELL TYPE", "description": "A type of white blood cell (leukocyte) crucial for immune responses and can be classified into different subsets such as CD4+ T helper cells and CD8+ cytotoxic T cells.<SEP>T cells are a type of white blood cell that plays a central role in adaptive immunity.<SEP>T cells are immune cells that play a role in regulating immune responses, including the production of cytokines like IL-10 which can influence disease progression.<SEP>A type of white blood cell crucial for adaptive immunity; includes CD4+ T helper cells and CD8+ cytotoxic T lymphocytes.", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45<SEP>chunk-56c37d6045382dda8cc6037b2680282a<SEP>chunk-0380fd029b3eda680c87c1b8bcbe7f4c<SEP>chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "id": "T CELLS"}, {"entity_type": "ANIMAL MODEL (DISEASE)", "description": "Mice deficient in Rag1 gene, which is essential for the development of functional immune cells.<SEP>Rag1\u2212/\u2212 mice are knockout mice lacking Rag genes essential for T and B cell development, often used in studies of autoimmune diseases like colitis.", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c<SEP>chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "id": "RAG1\u2212/\u2212 MICE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process by which immune cells accumulate within the colon, contributing to inflammation and disease severity.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "id": "COLONIC INFILTRATION"}, {"entity_type": "CELL TYPE (PROTEIN)", "description": "T helper 17 cells, a subset of T cells involved in autoimmune inflammation and responses to certain pathogens.<SEP>Th17 cells are a subset of CD4+ T helper cells that produce IL-17, playing critical roles in autoimmunity and inflammatory diseases.<SEP>Th17 cells are involved in the pathologic response contributing to colonic inflammation.", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c<SEP>chunk-35d8a4ea86cb92d18ee1c857a318d2d8<SEP>chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "id": "TH17 CELLS"}, {"entity_type": "PROTEIN", "description": "Interleukin 6 gene encoding the pro-inflammatory cytokine IL-6 which is involved in immune responses and inflammation.<SEP>Interleukin 6 is a cytokine that plays a critical role in mediating inflammatory responses.<SEP>Interleukin 6, a cytokine involved in systemic inflammation and acute-phase reactions.<SEP>Interleukin-6 (IL-6) is an inflammatory cytokine involved in the regulation of immune responses and hematopoiesis.", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c<SEP>chunk-b971aa450a9b220806bdc000eb5efaad<SEP>chunk-35d8a4ea86cb92d18ee1c857a318d2d8<SEP>chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "id": "IL-6"}, {"entity_type": "GENE", "description": "The TNF-\u03b1 gene encodes a pro-inflammatory cytokine contributing to cell death, inflammation, and cellular changes during disease progression.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "id": "TNF-\u0391 (TUMOR NECROSIS FACTOR ALPHA)"}, {"entity_type": "GENE", "description": "A cytokine involved in immune response activation and inflammatory responses.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "id": "IL-1\u0392 (INTERLEUKIN 1 BETA)"}, {"entity_type": "GENE", "description": "A chemokine that recruits monocytes, memory T cells, and dendritic cells to sites of inflammation.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "id": "MCP-1 (MONOCYTE CHEMOATTRACTANT PROTEIN-1)"}, {"entity_type": "PROTEIN", "description": "Interleukin-17 (IL-17) is another cytokine involved in immune responses but was observed to have no production differences when compared with IL-22 in intraepithelial \u03b3\u03b4 T cells.<SEP>The gene encoding interleukin 17 which is a pro-inflammatory cytokine involved in immune responses.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6<SEP>chunk-29025895ac187b8e88dec5cea9478842", "id": "IL-17"}, {"entity_type": "GENE", "description": "The gene for Interferon Gamma, which plays an important role in the regulation of immune responses and inflammation.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "id": "IFN-\u0393 (INTERFERON GAMMA)"}, {"entity_type": "ANIMAL MODEL (CELL TYPE)", "description": "Reporter T cells used to track ROR\u03b3t expression in Th17 cells within colonic tissues.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "id": "ROR\u0393T-GFP REPORTER T CELLS"}, {"entity_type": "CELL TYPE (PROTEIN)", "description": "T helper 17 cells that produce IL-17, important for inflammatory responses.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "id": "CD4+IL-17A+ T CELLS"}, {"entity_type": "CELL TYPE (PROTEIN)", "description": "Macrophage population within the peritoneum of mice, characterized by high expression of Ly6C and low CD11c, associated with inflammatory responses.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "id": "LPM\u03a6S (LY6C+ PERITONEAL MACROPHAGES)"}, {"entity_type": "GENE", "description": "Interleukin 23 subunit alpha gene encoding IL-23p19 which is a pro-inflammatory cytokine involved in immune response regulation.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "id": "IL-23P19"}, {"entity_type": "PROTEIN (ENZYME)", "description": "An enzyme that breaks down the amino acid arginine, often used as an indicator of alternative macrophage activation during inflammation.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "id": "ARGINASE"}, {"entity_type": "GENE", "description": "A gene involved in nitric oxide synthesis which is upregulated under inflammatory conditions and promotes the production of reactive nitrogen species.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "id": "INOS (INDUCIBLE NITRIC OXIDE SYNTHASE)"}, {"entity_type": "PROTEIN (RECEPTOR)", "description": "Marker expressed on macrophages indicating their anti-inflammatory phenotype and scavenger function.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "id": "CD163"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A protein complex that plays a key role in regulating inflammation by activating genes involved in immune responses and cellular stress.<SEP>NF-\u03baB is a transcription factor complex involved in regulating immune responses, inflammation, and cell survival. Its activation can lead to increased expression of proinflammatory cytokines.", "source_id": "chunk-8382a49b61215482f9fc75e3a86cb987<SEP>chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "id": "NF-\u039aB"}, {"entity_type": "GENE", "description": "The STAT3 gene encodes for Signal Transducer and Activator of Transcription 3, which is crucial for the regulation of inflammatory responses through cytokine signaling.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "id": "STAT3"}, {"entity_type": "CELL TYPE (PROTEIN)", "description": "A subset of CD4+ T cells that express Foxp3 and play a critical role in immune tolerance and suppression of excessive inflammation.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "id": "FOXP3+ TREGS (REGULATORY T CELLS)"}, {"entity_type": "PROTEIN", "description": "Interleukin 27 is a cytokine with anti-inflammatory properties, known to regulate the differentiation of Th1 and Th17 cells.<SEP>Interleukin-27, a cytokine produced by innate immune cells, forms a heterodimer with EBI3 to interact with its receptor IL27RA and activate the STAT1/STAT3 pathway in T cells.", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45<SEP>chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "id": "IL-27"}, {"entity_type": "PROTEIN (ENZYME)", "description": "An enzyme that catalyzes the first step in tryptophan catabolism, which can lead to immunosuppressive effects during inflammation.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "id": "IDO (INDOLEAMINE 2,3-DIOXYGENASE)"}, {"entity_type": "ANIMAL MODEL (DISEASE)", "description": "Genetically modified mice lacking functional IL-10 receptor alpha protein, used as a model for studying inflammatory bowel disease and immune responses.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "id": "IL-10R\u0391MDEL MICE"}, {"entity_type": "CELL TYPE (PROTEIN)", "description": "CD4+ T helper cells that produce IFN-gamma and are involved in cell-mediated immunity and inflammation.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "id": "TH1 CELLS"}, {"entity_type": "PROTEIN", "description": "Interleukin 22 is a cytokine with pro-inflammatory properties, particularly important for epithelial protection and immune regulation.<SEP>Interleukin-22 (IL-22) is a cytokine involved in regulating mucosal immunity, particularly in the gastrointestinal tract.<SEP>Interleukin-22 (IL-22) protein is required for the production of AHR ligands and is involved in normalizing AHR ligand production in Card9 knockout mice.<SEP>Interleukin-22 plays a protective role in the gut and mediates recovery from inflammation via its target genes Reg3g and Reg3b.<SEP>Interleukin 22, a pro-inflammatory cytokine produced by T helper cells that plays a role in epithelial tissue repair and defense against pathogens.<SEP>Interleukin-22 is a cytokine that plays a role in immune responses.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6<SEP>chunk-29025895ac187b8e88dec5cea9478842<SEP>chunk-c791a4e35844d642ba0c69774072f7cd<SEP>chunk-56c37d6045382dda8cc6037b2680282a<SEP>chunk-0380fd029b3eda680c87c1b8bcbe7f4c<SEP>chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "id": "IL-22"}, {"entity_type": "PROTEIN (RECEPTOR)", "description": "A chemokine receptor expressed on Th17 cells and involved in their migration to sites of inflammation.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "id": "CCR6"}, {"entity_type": "GENE/PROTEIN FAMILY", "description": "A family of small proteins that play a role in cell signaling, particularly important for immune responses and regulation of inflammation.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "id": "CYTOKINES"}, {"entity_type": "MECHANISM", "description": "Mechanisms by which the immune system regulates its response to prevent excessive damage to healthy tissues.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "id": "IMMUNE CHECKPOINTS"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant affecting the IL-6 receptor alpha subunit gene, leading to impaired signaling for Th17 cell development.", "source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "id": "IL-6R\u0391\u2212/\u2212"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant affecting the Rag1 gene, impacting immune system development and function.", "source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "id": "RAG1\u2212/\u2212"}, {"entity_type": "PROTEIN", "description": "Interleukin 1 beta is a pro-inflammatory cytokine generated from an inactive cytosolic precursor (pro-IL-1\u03b2) by caspase-1 cleavage and plays a role in colonic inflammation.<SEP>Interleukin 1 beta, a pro-inflammatory cytokine that plays a role in innate immunity.", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c<SEP>chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "id": "IL-1\u0392"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Regulatory T cells expressing FoxP3 transcription factor, playing critical roles in immune regulation and tolerance maintenance.", "source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "id": "FOXP3+ CD4+ T CELLS"}, {"entity_type": "MOLECULAR INTERACTION", "description": "The process by which T cells proliferate and differentiate into effector or memory T cells.", "source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "id": "T CELL EXPANSION"}, {"entity_type": "PROTEIN", "description": "Retinoid-related orphan receptor gamma t (ROR\u03b3t), a transcription factor specifically expressed by Th17 cells.", "source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "id": "ROR\u0393T"}, {"entity_type": "CELL TYPE", "description": "A type of white blood cell involved in the immune system, particularly in phagocytosis and antigen presentation.", "source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "id": "M\u03a6 (MACROPHAGES)"}, {"entity_type": "PROTEIN", "description": "Transfers of IL-6R\u03b1\u2212/\u2212 T cells showed no detectable alteration in disease severity.<SEP>**Note: This should be corrected as it refers to a cell type with genomic variant condition rather than protein. Let\'s correct to Genomic Variant.**", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c<SEP>chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "id": "IL-6R\u0391\u2212/\u2212 T CELLS"}, {"entity_type": "CELL TYPE", "description": "Wild-type naive T cells, which are immature T lymphocytes that have not been exposed to antigen.", "source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "id": "WT NAIVE T CELLS"}, {"entity_type": "GENOMIC VARIANT", "description": "Transfers of IL-1R\u2212/\u2212 T cells led to diminished clinical and histologic measures of colitis compared with control WT T cell transfers.", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c", "id": "IL-1R\u2212/\u2212 T CELLS"}, {"entity_type": "DISEASE MODEL", "description": "Mice with a genomic variant involving the IL-10 receptor alpha subunit in a Rag1 knockout background, affecting immune responses.<SEP>This model represents mice lacking a specific gene (IL-10R\u03b1) and having Rag1 deficiency, used to study immune responses in colitis conditions.", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c<SEP>chunk-b971aa450a9b220806bdc000eb5efaad", "id": "IL-10R\u0391MDELRAG1\u2212/\u2212 MICE"}, {"entity_type": "PROTEIN", "description": "Colon-resident macrophages that are key in producing IL-1\u03b2, contributing to colonic inflammation.", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c", "id": "LPM\u03a6S (LY6G\u2212/LOSIGLECF\u2212 M\u03a6)"}, {"entity_type": "PROTEIN", "description": "An enzyme that cleaves pro-IL-1\u03b2 into its active form and is activated by inflammasome stimulation.<SEP>An enzyme that processes pro-IL-1\u03b2 to its active form, IL-1\u03b2, crucial for inflammatory response regulation.", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c<SEP>chunk-b971aa450a9b220806bdc000eb5efaad", "id": "CASPASE-1"}, {"entity_type": "MOLECULAR INTERACTION", "description": "A molecular complex involved in the activation of caspase-1 and subsequent processing of pro-inflammatory cytokines like IL-1\u03b2.", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c", "id": "INFLAMMASOME"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process through which pro-IL-1\u03b2 is produced, primarily by LPM\u03d5s under conditions of colonic inflammation.", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c", "id": "PRO-IL-1\u0392 PRODUCTION"}, {"entity_type": "GENOMIC VARIANT", "description": "Mice lacking IL-1 receptor genes show diminished clinical measures of colitis.", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c", "id": "IL-1R\u2212/\u2212 MICE"}, {"entity_type": "PROTEIN", "description": "Wild-type (normal) T cells used as a control in comparison with genetically altered T cells.", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c", "id": "WT T CELLS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process through which Th17 cells contribute to the pathogenesis of autoinflammatory diseases like colitis.", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c", "id": "TH17 RESPONSE MEDIATION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A biological pathway involving IL-10 that regulates immune responses, particularly inhibiting inflammation.", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c", "id": "IL-10 SIGNALING PATHWAY"}, {"entity_type": "PROTEIN", "description": "CD11b+ macrophages resident in the colon which produce IL-1\u03b2 and contribute to colitis development.", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c", "id": "LPM\u03a6 (LY6G\u2212/LOSIGLECF\u2212 M\u03a6)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A measure of protein expression levels used in flow cytometry analysis.", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c", "id": "MFI (MEAN FLUORESCENCE INTENSITY)"}, {"entity_type": "TRANSCRIPT", "description": "The precursor form of interleukin-1 beta (IL-1\u03b2), which requires processing by caspase-1 to become active.", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "id": "PRO-IL-\u0392"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Cultures derived from Rag1 knockout mice, lacking mature T and B cells due to the absence of RAG1 gene function.", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "id": "RAG1\u2212/\u2212 CULTURES"}, {"entity_type": "PROTEIN", "description": "Macrophages (M\u03d5s) derived from Rag1 knockout mice with a mutated IL-10 receptor alpha subunit, showing altered cytokine signaling.", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "id": "IL-10R\u0391MDELRAG1\u2212/\u2212-DERIVED M\u03a6S"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Levels of mature interleukin-1 beta (IL-1\u03b2), a pro-inflammatory cytokine involved in immune responses and inflammation.", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "id": "IL-1\u0392 LEVELS"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Stimulation of macrophages with lipopolysaccharide (LPS) and adenosine triphosphate (ATP), inducing pro-inflammatory responses.", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "id": "LPS AND ATP STIMULATION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The development of Th17 cells, a subset of T helper cells that play a role in immune defense against extracellular pathogens.", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "id": "TH17 CELL MATURATION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Leucocyte Populated Migratory Phagocytes, cells that play a role in tissue repair and inflammation.", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "id": "LPM\u03a6S"}, {"entity_type": "PROTEIN", "description": "Transforming growth factor beta (TGF\u03b2), a cytokine involved in cell differentiation and regulation of immune responses.", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "id": "TGF\u0392"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Transfer of IL-6 receptor knockout T cells, used to study the role of IL-6 signaling in immune processes.", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "id": "IL-6R\u2212/\u2212 T CELL TRANSFER"}, {"entity_type": "MOLECULAR INTERACTION", "description": "An antibody that targets and blocks the function of IL-10 receptors, inhibiting their signaling pathway.", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "id": "ANTI-IL-10R ANTIBODY"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process by which pro-interleukin-1 beta is converted into mature interleukin-1 beta through caspase-1 activation.", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "id": "IL-1\u0392 MATURATION"}, {"entity_type": "MOLECULAR INTERACTION", "description": "The enzymatic activity of caspase-1 that leads to the processing and activation of pro-inflammatory cytokines like IL-1\u03b2.", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "id": "CASPASE-1 CLEAVAGE"}, {"entity_type": "MOLECULAR INTERACTION", "description": "An antibody that blocks the interaction between IL-6 and its receptor, reducing the signaling pathway mediated by IL-6.", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "id": "IL-6R\u0391 BLOCKING ANTIBODY"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The development of Th17 cells in living organisms, which is influenced by cytokine environments such as those affected by IL-10R mutations.", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "id": "TH17 CELL MATURATION IN VIVO"}, {"source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "description": "This genetic driver line is used specifically in LPM\u03d5s to assess the role of IL-10R\u03b1 deletion on colitis development and inflammation regulation.", "entity_type": "UNKNOWN", "id": "CX3CR1-DRIVEN CRE DRIVER LINE"}, {"source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4<SEP>chunk-29025895ac187b8e88dec5cea9478842", "description": "CD64 expression on macrophages indicates their activation status and potential role in inflammation or immune response regulation.<SEP>Immune cells that play a role in the stimulation of IL-22-producing cells via interactions with dendritic cells and cytokine production.", "entity_type": "CELL TYPE", "id": "MACROPHAGES"}, {"source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "description": "Expression of CD103 marks epithelial tissue-resident T cells, which play a role in immune surveillance and regulation within the gut.", "entity_type": "UNKNOWN", "id": "EPITHELIAL T CELLS"}, {"source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "description": "Expression of SiglecF on eosinophils modulates their functional capabilities, impacting immune responses and inflammation.", "entity_type": "UNKNOWN", "id": "EOSINOPHILS"}, {"source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "description": "Incorporation of BrdU into DNA is used to measure and quantify cell proliferation, particularly in immune cells like macrophages.", "entity_type": "UNKNOWN", "id": "BRDU (BROMODEOXYURIDINE)"}, {"source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "description": "Incorporation of BrdU into DNA is used to measure and quantify cell proliferation, particularly in immune cells like macrophages.", "entity_type": "UNKNOWN", "id": "CELL PROLIFERATION"}, {"source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "description": "The absence of recombination activating gene 2 results in a significant impairment of adaptive immune responses, leading to severe immunodeficiency.", "entity_type": "UNKNOWN", "id": "IMMUNODEFICIENCY"}, {"source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "description": "The production of IL-10 by T cells does not affect disease severity, suggesting that other cell types or mechanisms are more critical for controlling inflammatory processes.", "entity_type": "UNKNOWN", "id": "IL-10 PRODUCTION"}, {"source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "description": "MCP-1 facilitates the recruitment of monocytes and other immune cells to sites of inflammation, contributing to the amplification of inflammatory responses.", "entity_type": "UNKNOWN", "id": "IMMUNE RECRUITMENT"}, {"source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "description": "Increased IL-17 levels are indicative of heightened Th17 cell activity, which is critical for exacerbating inflammatory processes and disease progression.", "entity_type": "UNKNOWN", "id": "INFLAMMATORY RESPONSE"}, {"source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "description": "IFN-\u03b3 plays a regulatory role in immune responses but its levels are not increased during Th17-dependent colitis, suggesting other cytokines are more influential.", "entity_type": "UNKNOWN", "id": "IMMUNE REGULATION"}, {"source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "description": "The absence of IL-10R\u03b1 in these mice leads to severe colitis, highlighting the importance of IL-10 signaling in controlling inflammation.", "entity_type": "UNKNOWN", "id": "COLITIS SEVERITY"}, {"source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "description": "Tregs play a critical role in suppressing excessive immune responses and limiting tissue damage during inflammatory conditions like colitis.", "entity_type": "UNKNOWN", "id": "INFLAMMATION REGULATION"}, {"source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "description": "NF-\u03baB activation is crucial for the transcription of pro-inflammatory genes, contributing to inflammation and disease progression.", "entity_type": "UNKNOWN", "id": "IMMUNE RESPONSE REGULATION"}, {"source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "description": "IL-27 can inhibit Th17 cell differentiation and promote alternative T cell lineages, thus modulating inflammatory processes.", "entity_type": "UNKNOWN", "id": "TH17 DIFFERENTIATION"}, {"source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "description": "IDO activity leads to tryptophan depletion in the microenvironment, inducing immunosuppressive effects and limiting inflammation.", "entity_type": "UNKNOWN", "id": "IMMUNOSUPPRESSION"}, {"source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c", "description": "Increased IL-1\u03b2 levels and Th17 cell activity are associated with the pathogenesis of colonic inflammation.)", "entity_type": "UNKNOWN", "id": "COLITIS PATHOGENESIS"}, {"entity_type": "PROTEIN", "description": "Bacteroides is a genus of bacteria that constitutes the most abundant genus in gut microbiota across multiple cohorts.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "BACTEROIDES"}, {"entity_type": "PROTEIN", "description": "Faecalibacterium is a genus of bacteria present in significant abundance, contributing to the core microbiota identified in the study.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "FAECALIBACTERIUM"}, {"entity_type": "PROTEIN", "description": "Blautia is a genus of bacteria that was found in several cohorts as part of the gut microbial community.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "BLAUTIA"}, {"entity_type": "PROTEIN", "description": "Alistipes is a genus of bacteria identified within gut microbiota, though present at lower levels compared to others like Bacteroides and Faecalibacterium.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "ALISTIPES"}, {"entity_type": "GENE", "description": "The genus Ruminiclostridium was found in European cohorts as part of the core microbiota, producing short-chain fatty acids which are crucial for gut health.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "RUMINOCLOSTRIDIUM"}, {"entity_type": "PROTEIN", "description": "Fusicatenibacter is a bacterial genus identified within the core microbiota of certain homogeneous clusters (e.g., European cohorts), known to contribute beneficial metabolic processes in the gut.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "FUSICATENIBACTER"}, {"entity_type": "PROTEIN", "description": "The genus Butyricicoccus was part of the core microbiota found in specific clusters, contributing to the diversity and function of the gut microbial ecosystem.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "BUTYRICICOCCUS"}, {"entity_type": "GENE", "description": "Eubacterium is a bacterial genus identified within the core microbiota of certain homogeneous groups, such as European cohorts, playing roles in producing beneficial compounds like short-chain fatty acids.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "EUBACTERIUM"}, {"entity_type": "TRANSCRIPT", "description": "The 16S rRNA gene is targeted for sequencing to profile microbial composition across different variable regions (V4, V3-V4, and V1-V2), providing insights into the diversity and structure of gut microbiota.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "16S RRNA GENE"}, {"entity_type": "TECHNIQUE", "description": "The DNA extraction method significantly influences heterogeneity in microbiome studies, contributing to 29% of variance in microbial composition across cohorts.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "DNA EXTRACTION METHOD"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Microbiome heterogeneity refers to the variation observed among different populations or samples within a study, which is influenced by factors such as ethnicity and DNA extraction methods.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "HETEROGENEITY"}, {"entity_type": "GENE", "description": "The genetic background of individuals influences their microbiome composition, contributing significantly to inter-individual differences in gut microbial communities.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "GENETIC FACTORS"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Environmental factors such as dietary habits and geographic location contribute to the variation observed in microbiome composition across different cohorts.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "ENVIRONMENTAL FACTORS"}, {"entity_type": "DISEASE", "description": "These metrics measure diversity within microbial communities. The study did not find evidence of heritability for these metrics but noted significant differences across cohorts regarding richness and Shannon diversity.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "ALPHA DIVERSITY METRICS (SHANNON, SIMPSON, INVERSE SIMPSON)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process involves estimating the proportion of variation in gut microbiome composition due to genetic factors using twin studies and SNP-based heritability estimates.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "HERITABILITY ESTIMATION (H2)"}, {"entity_type": "DISEASE", "description": "Out of 159 bacterial taxa, nineteen showed evidence for heritability in the TwinsUK cohort, with some concordance found in replication through NTR MZ twins.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "19 BACTERIAL TAXA"}, {"entity_type": "PROTEIN", "description": "Veillonella is a bacterial genus found in the human gut, known for its role in carbohydrate fermentation and short-chain fatty acid production.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "VEILLONELLA"}, {"entity_type": "GENE", "description": "Roseburia is a bacterial genus that contributes to butyrate production within the gut microbiota, important for colon health.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "ROSEBURIA"}, {"entity_type": "PROTEIN", "description": "Coprococcus is a bacterial genus present in the human gut microbiota and involved in metabolizing complex carbohydrates.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "COPROCOCCUS"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Consumption of dietary fiber can influence the composition of gut microbiota, promoting diversity and abundance of beneficial bacteria.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "DIETARY FIBER"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Exposure to antibiotics can alter gut microbiota composition by reducing microbial diversity and affecting core taxa presence.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "ANTIBIOTICS"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Gender can influence gut microbiota composition, with differences often observed between males and females.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "GENDER"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The stability of the gut microbiome refers to its ability to maintain a consistent community structure despite external perturbations.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "MICROBIOME STABILITY"}, {"entity_type": "DISEASE", "description": "A healthy gut microbiota is crucial for maintaining overall health, influencing metabolic processes and immune responses.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "GUT HEALTH"}, {"entity_type": "GENOMIC VARIANT", "description": "A bacterial taxon identified through LD score regression showing significant correlation with genetic variations.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "id": "RUMINICLOSTRIDIUM 9"}, {"entity_type": "GENOMIC VARIANT", "description": "Another bacterial taxon identified through LD score regression as significantly correlated with genetic factors.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "id": "PEPTOSTREPTOCOCCAEAE"}, {"entity_type": "GENE", "description": "A gene involved in mbBTL associations with gut microbiota abundance.<SEP>The LCT gene, associated with the abundance of Bifidobacterium and showing age and ethnic heterogeneity.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46<SEP>chunk-af413a33fae8d27bdb15cd18447dfad4", "id": "LCT GENE"}, {"entity_type": "GENE", "description": "A functionally relevant variant suggested by earlier studies in relation to gut microbiota variation.<SEP>FUT2 gene encodes alpha-1,2-fucosyltransferase responsible for the secretion of fucosylated mucus glycans in the gastrointestinal mucosa.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46<SEP>chunk-af413a33fae8d27bdb15cd18447dfad4", "id": "FUT2 GENE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The abundance of Bifidobacterium influenced by genetic and dietary factors, especially milk products intake.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "id": "BIFIDOBACTERIUM ABUNDANCE"}, {"entity_type": "DIETARY PATTERN", "description": "A dietary pattern that positively correlates with the abundance of Bifidobacterium in individuals carrying specific genotypes.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "id": "MILK PRODUCTS INTAKE"}, {"entity_type": "GENOMIC VARIANT", "description": "A SNP associated with high levels of Bifidobacterium abundance, particularly significant among adults with a CC genotype.<SEP>A genomic variant associated with higher abundance of Bifidobacterium in adults but not younger individuals.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46<SEP>chunk-af413a33fae8d27bdb15cd18447dfad4", "id": "RS182549"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific variant associated with higher Bifidobacterium abundance in adults but not in younger individuals.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "id": "NC_000002.11:G.136616754CC (RS182549)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The interaction between age and ethnicity modulates the effect of genetic variants on gut microbiota composition.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "id": "AGE AND ETHNICITY INTERACTION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A measure of diversity in microbiota abundance levels.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "id": "SIMPSON DIVERSITY INDEX"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Another measure assessing microbial diversity, complementing Simpson\'s index.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "id": "INVERSE SIMPSON DIVERSITY INDEX"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "An additional metric to assess the diversity of bacterial taxa in gut microbiota.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "id": "SHANNON DIVERSITY INDEX"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Analysis identifying genetic variants associated with microbial abundance levels.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "id": "MBQTL MAPPING ANALYSIS"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Method used to identify loci affecting the presence/absence of bacterial taxa in gut microbiota.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "id": "MBBTL MAPPING"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Analysis showing correlation between SNP-based heritability and twin-based heritability for bacterial taxa.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "id": "TWIN-BASED HERITABILITY CORRELATION"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific genetic locus strongly associated with the abundance of Bifidobacterium in multiple cohorts.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "id": "LCT LOCUS"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant located at rs4988235 associated with lactase persistence and milk drinking patterns.<SEP>Functional variant within the LCT gene, highly correlated with rs182549.", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5<SEP>chunk-af413a33fae8d27bdb15cd18447dfad4", "id": "RS4988235"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "A cohort of children aged 4-6 years used to investigate genetic and environmental impacts on gut microbiota.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "id": "COPSAC2010 COHORT"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Multi-ethnic cohort comprising individuals across different age ranges for investigating gene-diet interactions.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "id": "GEM COHORT"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Factor affecting the genetic association with microbial taxa abundance, highlighting ethnic heterogeneity in mbQTL effects.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "id": "MULTI-ETHNICITY "}, {"entity_type": "MOLECULAR INTERACTION", "description": "The FUT2-FUT1 locus is associated with the abundance of Ruminococcus torques and Ruminococcus gnavus genera groups, indicating a molecular interaction between genetic variation and gut microbiota.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "id": "FUT2-FUT1 LOCUS"}, {"entity_type": "METABOLIC PATHWAY", "description": "A genus from the Lachnospiraceae family that is involved in the degradation of complex carbohydrates, indicating its role in metabolism.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "id": "RUMINOCOCCUS TORQUES GROUP"}, {"entity_type": "GENOMIC VARIANT", "description": "A functional variant in FUT2 that introduces a stop-codon affecting ABO antigen expression on intestinal mucosa.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "id": "FUT2 SNP (RS601338)"}, {"entity_type": "METABOLIC PATHWAY", "description": "Another genus involved in the breakdown of complex carbohydrates, similar to R. torques.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "id": "RUMINOCOCCUS GNAVUS GROUP"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Mucin glycans secreted by FUT2 affect the abundance and composition of gut microbiota.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "id": "MUCUS GLYCANS"}, {"entity_type": "DIETARY PATTERN", "description": "A dietary pattern that correlates with the Ruminococcus torques group, influenced by genetic variation in FUT2.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "id": "FRUIT INTAKE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The abundance of Allisonella is linked to genetic variants affecting riboflavin and mucin biosynthesis pathways.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "id": "ALLISONELLA ABUNDANCE"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Genetic locus involved in host-microbiome crosstalk through enzymes and glycosyltransferase activities related to riboflavin metabolism and mucin biosynthesis.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "id": "9Q21 LOCUS (PCSK5, RFK, GCNT1)"}, {"entity_type": "METABOLIC PATHWAY", "description": "A metabolic pathway involving vitamin B12 absorption, regulation by the CUBN gene, and its role in host-microbial interactions.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "id": "COBALAMIN ABSORPTION AND METABOLISM PATHWAY"}, {"entity_type": "METABOLIC PATHWAY", "description": "Heritable family of bacteria affected by genetic variants related to cobalamin metabolism and host immune defense.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "id": "PEPTOSTREPTOCOCCACEAE FAMILY"}, {"entity_type": "METABOLIC PATHWAY", "description": "A taxon negatively associated with stool levels of gut inflammation markers such as chromogranin A and calprotectin.<SEP>The Peptococcaceae family is a taxon negatively associated with stool levels of chromogranin A and calprotectin, indicating an inverse relationship with gut inflammation.", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964<SEP>chunk-fed46d4ab6d22b3530c4c06a4b7def46", "id": "PEPTOCOCCACEAE FAMILY"}, {"entity_type": "DISEASE", "description": "Anemia resulting from insufficient vitamin B12 absorption, linked to genetic variants in the CUBN gene.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "id": "B12-DEFICIENT ANEMIA"}, {"entity_type": "METABOLIC PATHWAY", "description": "Specialized bacteria involved in degrading complex carbohydrates.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "id": "RUMINOCOCCUS SP."}, {"entity_type": "MOLECULAR INTERACTION", "description": "Genetic locus involving genes related to riboflavin metabolism and glycosylation processes.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "id": "9Q21 LOCUS (PCSK5, RFK)"}, {"entity_type": "GENE", "description": "The CUBN gene encodes a receptor for cobalamin complexes involved in vitamin B12 absorption and is linked to heritable microbiota abundance changes.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "id": "CUBN GENE"}, {"entity_type": "METABOLIC PATHWAY", "description": "Pathway involving riboflavin phosphorylation regulated by RFK enzyme, impacting host-microbiome interactions.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "id": "RIBOFLAVIN METABOLISM PATHWAY"}, {"entity_type": "METABOLIC PATHWAY", "description": "Glycosylation pathway regulated by GCNT1 glycosyltransferase affecting intestinal microbiota composition.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "id": "MUCIN BIOSYNTHESIS PATHWAY"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A vitamin crucial for host-microbial interactions, involved in metabolic pathways and immune defense regulation.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "id": "COBALAMIN (VITAMIN B12)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Complexes of cobalamin with gastric intrinsic factor required for B12 absorption, regulated by CUBN gene expression.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "id": "GASTRIC INTRINSIC FACTOR COMPLEXES"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Expression sites of the CUBN receptor in the body involved in vitamin B12 and albumin metabolism.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "id": "KIDNEY AND INTESTINAL EPITHELIUM EXPRESSION"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant (rs7574352) is associated with stool levels of gut inflammation markers and ulcerative colitis.", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "id": "RS7574352"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Chromogranin A levels are markers of gut inflammation that decrease in association with the Peptococcaceae family (taxon).", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "id": "CHROMOGRANIN A LEVELS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Calprotectin levels, another marker of gut inflammation, also show a negative association with the presence of the Peptococcaceae family.", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "id": "CALPROTECTIN LEVELS"}, {"entity_type": "DISEASE", "description": "An inflammatory bowel disease that affects only the colon and rectum, causing long-lasting inflammation and ulcers in the innermost lining of the large intestine.<SEP>Ulcerative colitis is an inflammatory bowel disease (IBD) for which certain gut microbial taxa may have protective effects.<SEP>Ulcerative colitis is associated negatively with the presence of the Peptococcaceae family in stool samples.", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd<SEP>chunk-159d4c797dae6eb825c74067af703228<SEP>chunk-938d8bf2e56584de9dd556be5eb70964", "id": "ULCERATIVE COLITIS"}, {"entity_type": "GENE", "description": "IRF1, located near a block of SNPs associated with gut inflammation and ulcerative colitis, is involved in insulin resistance and susceptibility to type 2 diabetes.", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "id": "INTERFERON REGULATORY FACTOR 1 (IRF1)"}, {"entity_type": "GENOMIC VARIANT OR GENE (IMPLIED BY ASSOCIATION STUDY)", "description": "The class Actinobacteria has been associated with a protective effect against ulcerative colitis.", "source_id": "chunk-159d4c797dae6eb825c74067af703228", "id": "ACTINOBACTERIA CLASS"}, {"entity_type": "GENOMIC VARIANT OR GENE (IMPLIED BY ASSOCIATION STUDY)", "description": "The genus Bifidobacterium, part of the class Actinobacteria, is linked to a reduced risk of developing ulcerative colitis.", "source_id": "chunk-159d4c797dae6eb825c74067af703228", "id": "BIFIDOBACTERIUM GENUS"}, {"entity_type": "GENOMIC VARIANT OR GENE (IMPLIED BY ASSOCIATION STUDY)", "description": "The family Oxalobacteraceae has been linked to a reduced risk of rheumatoid arthritis, another autoimmune disease.", "source_id": "chunk-159d4c797dae6eb825c74067af703228", "id": "OXALOBACTERACEAE FAMILY"}, {"entity_type": "DISEASE", "description": "Rheumatoid arthritis is an autoimmune condition for which certain gut microbial taxa may have protective effects.", "source_id": "chunk-159d4c797dae6eb825c74067af703228", "id": "RHEUMATOID ARTHRITIS"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific location in a genome where variation occurs, often used to study genetic associations with traits or diseases.<SEP>A variation in a single nucleotide that occurs at a specific position in the genome.<SEP>SNPs are genetic variants that were used to perform MR analysis for identifying causal links between gut microbial taxa and phenotypes.", "source_id": "chunk-7efd4f037425eeac77e329347b16beb2<SEP>chunk-159d4c797dae6eb825c74067af703228<SEP>chunk-1f20dbdcc9de443dada1a2045dc7832b", "id": "SNP (SINGLE NUCLEOTIDE POLYMORPHISM)"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Gut microbial taxa refer to the diverse communities of microorganisms in the gastrointestinal tract, which can be associated with various health outcomes.", "source_id": "chunk-159d4c797dae6eb825c74067af703228", "id": "GUT MICROBIAL TAXA"}, {"entity_type": "DIETARY PATTERN", "description": "Dietary preferences are patterns of food intake that were not found to have a causal relationship with gut microbial composition based on MR analysis.", "source_id": "chunk-159d4c797dae6eb825c74067af703228", "id": "DIETARY PREFERENCES"}, {"entity_type": "DISEASE (CATEGORY)", "description": "Autoimmune diseases include conditions like rheumatoid arthritis and ulcerative colitis, where the immune system attacks healthy tissue in the body.", "source_id": "chunk-159d4c797dae6eb825c74067af703228", "id": "AUTOIMMUNE DISEASES"}, {"entity_type": "DISEASE (CATEGORY)", "description": "Cardiovascular diseases encompass a range of conditions affecting the heart and blood vessels, some of which may be influenced by gut microbial composition.", "source_id": "chunk-159d4c797dae6eb825c74067af703228", "id": "CARDIOVASCULAR DISEASES"}, {"entity_type": "DISEASE (CATEGORY)", "description": "Metabolic diseases involve disorders in metabolic processes; these could potentially be linked to alterations in gut microbiome.", "source_id": "chunk-159d4c797dae6eb825c74067af703228", "id": "METABOLIC DISEASES"}, {"entity_type": "DISEASE (CATEGORY)", "description": "Psychiatric disorders include mental health conditions that might be influenced by the composition of the gut microbiota.", "source_id": "chunk-159d4c797dae6eb825c74067af703228", "id": "PSYCHIATRIC DISORDERS"}, {"entity_type": "GENOMIC VARIANT OR GENE", "description": "Host genetics refers to the genetic makeup of an individual, which can influence their microbiome and, consequently, various phenotypes including diseases and dietary patterns.", "source_id": "chunk-159d4c797dae6eb825c74067af703228", "id": "HOST GENETICS"}, {"source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "description": "The abundance and distribution of Bacteroides within the gut microbiota can influence protein metabolism processes.)", "entity_type": "UNKNOWN", "id": "PROTEIN METABOLISM"}, {"source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "description": "The presence of Blautia reflects broader patterns of heterogeneity observed in microbiome studies across different cohorts and populations.)", "entity_type": "UNKNOWN", "id": "MICROBIOME HETEROGENEITY"}, {"source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "description": "The presence of Fusicatenibacter within core microbiota supports the production of short-chain fatty acids, beneficial for gut health and metabolism.)", "entity_type": "UNKNOWN", "id": "SHORT-CHAIN FATTY ACIDS PRODUCTION"}, {"source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "description": "Butyricicoccus is part of the core taxa found in homogeneous clusters, indicating its role in maintaining stable microbial communities under various conditions.)", "entity_type": "UNKNOWN", "id": "MICROBIOME CORE TAXA"}, {"source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "description": "Sequencing the 16S rRNA gene helps in profiling microbial diversity, identifying core microbiota across different populations and cohorts.)", "entity_type": "UNKNOWN", "id": "16S RRNA GENE SEQUENCING"}, {"source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "description": "Sequencing the 16S rRNA gene helps in profiling microbial diversity, identifying core microbiota across different populations and cohorts.)", "entity_type": "UNKNOWN", "id": "MICROBIOME PROFILING"}, {"source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "description": "The DNA extraction method significantly contributes to heterogeneity in microbiome studies by affecting microbial composition variance across studies.)", "entity_type": "UNKNOWN", "id": "HETEROGENEITY IN MICROBIOME STUDIES"}, {"source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "description": "Prevotella\'s abundance is often linked to high-fiber diets due to its ability to ferment complex carbohydrates.)", "entity_type": "UNKNOWN", "id": "DIETARY FIBER METABOLISM"}, {"source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "description": "Prevotella\'s abundance is often linked to high-fiber diets due to its ability to ferment complex carbohydrates.)", "entity_type": "UNKNOWN", "id": "PREVOTELLA"}, {"source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "description": "Veillonella plays a key role in carbohydrate fermentation, producing short-chain fatty acids that support gut health.)", "entity_type": "UNKNOWN", "id": "CARBOHYDRATE FERMENTATION"}, {"source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "description": "Roseburia is particularly noted for its ability to produce butyrate, which supports colonic epithelial cell integrity and function.)", "entity_type": "UNKNOWN", "id": "BUTYRATE PRODUCTION"}, {"source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "description": "The presence of Coprococcus within the gut microbiota indicates a more diverse microbial community capable of metabolizing complex carbohydrates.)", "entity_type": "UNKNOWN", "id": "MICROBIOME DIVERSITY"}, {"source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "description": "Consumption of dietary fiber influences the diversity and abundance of bacteria in the gut, promoting health benefits.)", "entity_type": "UNKNOWN", "id": "GUT MICROBIOTA COMPOSITION"}, {"source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "description": "Antibiotic use can reduce microbial diversity within the gut microbiome, affecting core taxa presence and stability.)", "entity_type": "UNKNOWN", "id": "MICROBIAL DIVERSITY REDUCTION"}, {"source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "description": "The composition of the gut microbiota changes with age, impacting its role in health and disease.", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 2}, {level: 1, cluster: 25}]", "id": "GUT MICROBIOTA DYNAMICS"}, {"source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "description": "Gender differences influence microbial abundance within the gut microbiome, reflecting sex-specific factors.", "entity_type": "UNKNOWN", "id": "MICROBIAL ABUNDANCE VARIATIONS"}, {"source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "description": "Stability of the gut microbiome is influenced by various environmental factors including diet and antibiotic exposure.", "entity_type": "UNKNOWN", "id": "ENVIRONMENTAL INFLUENCES"}, {"source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "description": "Maintaining a healthy gut microbial composition supports overall health, affecting metabolic processes and immune responses.", "entity_type": "UNKNOWN", "id": "MICROBIAL COMPOSITION IMPACT"}, {"source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "description": "An imbalance in the gut microbiota is associated with an increased risk of developing metabolic syndrome, indicating a link between microbiome composition and systemic diseases.", "entity_type": "UNKNOWN", "id": "MICROBIOTA DYSBIOSIS"}, {"source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "description": "Genetic variation in rs601338 affects the secretion of mucus glycans, impacting gut microbiota composition.", "entity_type": "UNKNOWN", "id": "MUCUS GLYCANS PRODUCTION"}, {"source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "description": "These bacteria are specialized in breaking down complex carbohydrates, supporting their role in metabolic pathways within the gut.", "entity_type": "UNKNOWN", "id": "COMPLEX CARBOHYDRATES DEGRADATION"}, {"source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "description": "The genetic locus involved in regulating riboflavin metabolism and mucin biosynthesis contributes to host-microbiota interactions within the intestine.", "entity_type": "UNKNOWN", "id": "HOST-MICROBIOME CROSSTALK"}, {"source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "description": "Genetic variation affecting cobalamin absorption via CUBN gene is linked to albuminuria, indicating a role in metabolic regulation.", "entity_type": "UNKNOWN", "id": "ALBUMINURIA REGULATION"}, {"source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "description": "Genetic variation affecting cobalamin absorption via CUBN gene is linked to albuminuria, indicating a role in metabolic regulation.", "entity_type": "UNKNOWN", "id": "COBALAMIN ABSORPTION PATHWAY"}, {"source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "description": "The glycosylation pathway regulated by GCNT1 impacts the composition of intestinal microbiota through mucin production.", "entity_type": "UNKNOWN", "id": "INTESTINAL MICROBIOTA COMPOSITION"}, {"source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "description": "Genetic variation near IRF1 influences susceptibility to T2DM, indicating potential pathways linking gene function with metabolic diseases.", "entity_type": "UNKNOWN", "id": "IRF1 GENE"}, {"source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "description": "Genetic variation near IRF1 influences susceptibility to T2DM, indicating potential pathways linking gene function with metabolic diseases.", "entity_type": "UNKNOWN", "id": "TYPE 2 DIABETES MELLITUS (T2DM)"}, {"source_id": "chunk-159d4c797dae6eb825c74067af703228", "description": "There is a complex relationship between cardiovascular health, host genetics, and the composition of the gut microbiome.)", "entity_type": "UNKNOWN", "id": "HOST GENETICS AND GUT MICROBIAL TAXA"}, {"source_id": "chunk-159d4c797dae6eb825c74067af703228", "description": "There is emerging evidence suggesting a link between gut microbiota, genetic predisposition, and the development of psychiatric disorders.)", "entity_type": "UNKNOWN", "id": "GUT MICROBIAL TAXA AND HOST GENETICS"}, {"entity_type": "GENOMIC VARIANT", "description": "The rs4988235 T/T genotype is a genetic variant associated with lactase persistence and higher milk intake.", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "id": "RS4988235 T/T GENOTYPE"}, {"entity_type": "GENE", "description": "LP refers to the gene responsible for lactase persistence, which affects the ability to digest milk sugar lactose into adulthood.", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "id": "LP (LACTASE PERSISTENCE)"}, {"entity_type": "DIETARY PATTERN", "description": "Milk intake varies between countries and is a dietary pattern that can be influenced by genetic factors such as LP genotype.", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "id": "MILK INTAKE"}, {"entity_type": "METABOLIC PATHWAY", "description": "C15:0 is a fatty acid involved in metabolic pathways related to diet and health outcomes, specifically associated with higher plasma levels due to LP genotypes.", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "id": "C15:0"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "HDL cholesterol is a physiological process indicator of cardiovascular health that was shown to be modestly lower in individuals carrying the LP allele.", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "id": "HDL CHOLESTEROL"}, {"entity_type": "NUTRIENT", "description": "Intake of dairy products is influenced by genetic factors, such as the rs4988235 T/T genotype, and can affect health outcomes.", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "id": "DAIRY PRODUCTS INTAKE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Certain dietary patterns and genotypes influence diabetes risk factors like HDL cholesterol and other biomarkers.", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "id": "DIABETES RISK FACTORS"}, {"entity_type": "DISEASE BIOMARKER", "description": "HbA1c levels are a biomarker for assessing long-term blood sugar control, which was not significantly affected by the LP genotype in this study.", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "id": "BASELINE HBA1C LEVELS"}, {"entity_type": "DISEASE", "description": "The risk of developing diabetes did not differ based on lactase persistence genotypes as indicated by this study\'s results.", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "id": "DIABETES RISK"}, {"entity_type": "NUTRIENT", "description": "Energy intake refers to the total amount of energy derived from food consumption, which was not found to be affected by LP genotypes in this study.", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "id": "ENERGY INTAKE"}, {"entity_type": "DIETARY PATTERN", "description": "Intake of poultry is a dietary pattern that showed a slight decrease associated with the LP genotype in this study.", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "id": "POULTRY CONSUMPTION"}, {"entity_type": "NUTRIENT", "description": "Consumption of non-alcoholic beverages was found to be lower among individuals carrying the rs4988235 T allele compared to those without.", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "id": "NON-ALCOHOLIC BEVERAGES INTAKE"}, {"source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "description": "Intake of dairy products is associated with higher plasma C15:0 levels, reflecting metabolic pathways influenced by dietary habits.", "entity_type": "UNKNOWN", "id": "C15:0 LEVELS"}, {"entity_type": "NUTRIENT", "description": "Choline is a nutrient essential for various physiological processes, including methylation reactions and phospholipid biosynthesis.<SEP>Choline is a nutrient that plays an important role in fetal development and cognitive function.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e<SEP>chunk-d594d57f0043cce2b3d29c80323b1a11", "id": "CHOLINE"}, {"entity_type": "DISEASE", "description": "Fetal Alcohol Spectrum Disorders (FASD) are a range of conditions that can occur in a child whose mother drank alcohol during pregnancy, affecting physical growth and mental abilities.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "FETAL ALCOHOL SPECTRUM DISORDER (FASD)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Eyeblink conditioning is a measure used to assess learning and memory functions in infants.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "EYEBLINK CONDITIONING"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Visual recognition memory function refers to the ability of an infant to recognize previously seen objects, which can be assessed using tests like FTII.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "VISUAL RECOGNITION MEMORY FUNCTION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Fetal alcohol growth restriction is a condition where fetal development is impaired due to maternal alcohol consumption during pregnancy.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "FETAL ALCOHOL GROWTH RESTRICTION (FAGR)"}, {"entity_type": "MEASURE", "description": "A novelty preference score is used in the Fagan Test of Infant Intelligence (FTII) to assess visual recognition memory function in infants.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "NOVELTY PREFERENCE SCORE"}, {"entity_type": "LIFESTYLE FACTOR", "description": "The social class of participants did not differ between the treatment and placebo groups.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "SOCIAL CLASS"}, {"entity_type": "BACKGROUND INFORMATION", "description": "Educational background was similar for mothers in both the choline treatment and placebo arms.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "MATERNAL EDUCATION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Assessment of verbal intellectual competence did not differ significantly between groups.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "VERBAL INTELLECTUAL COMPETENCE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Nonverbal intellectual competence was also similar for both treatment and placebo groups.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "NONVERBAL INTELLECTUAL COMPETENCE"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Levels of perceived stress were comparable in the choline treatment group compared to the placebo group.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "PERCEIVED STRESS"}, {"entity_type": "DISEASE", "description": "Rates of depression did not differ between mothers receiving choline supplementation and those on placebo.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "DEPRESSION"}, {"entity_type": "BACKGROUND INFORMATION", "description": "Both groups had similar nutritional statuses at baseline, though many were poorly nourished based on dietary caloric intake.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "NUTRITIONAL STATUS"}, {"entity_type": "DIETARY PATTERN", "description": "Only a minority of participants met the AI for dietary choline intake during pregnancy.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "DIETARY CHOLINE INTAKE"}, {"entity_type": "LIFESTYLE FACTOR", "description": "Women in both groups consumed alcohol heavily before and during early stages of pregnancy but reduced frequency later on.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "HEAVY ALCOHOL CONSUMPTION"}, {"entity_type": "LIFESTYLE FACTOR", "description": "A lifestyle factor where the frequency or level of smoking may affect disease risk, including RCC.<SEP>Both treatment arms had similar smoking habits, with an average of a quarter pack per day.", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5<SEP>chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "SMOKING"}, {"entity_type": "LIFESTYLE FACTOR", "description": "Use of illicit drugs other than marijuana was rare among the participants; methamphetamine use occurred in a few cases.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "ILLICIT DRUG USE"}, {"entity_type": "SUBSTANCE", "description": "A small number of women used methamphetamine during pregnancy, affecting some infants\u2019 development.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "METHAMPHETAMINE"}, {"entity_type": "MEASURE", "description": "The majority of pregnancies were full-term and there was no difference in GA between the groups.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "GESTATIONAL AGE (GA)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Low birth weight (<2500 g) was common, but incidence did not differ significantly between treatment arms.<SEP>The body weight at birth of a newborn influenced by both maternal and fetal nutrient levels, such as B12 and folate.<SEP>The body weight of a newborn, influenced by maternal and fetal nutrient levels such as B12 and folate.", "source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0<SEP>chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "BIRTH WEIGHT"}, {"entity_type": "DISEASE PROGRESSION", "description": "Infants in the choline arm showed catch-up growth in weight and head circumference compared to placebo group.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "CATCH-UP GROWTH"}, {"entity_type": "MEASURE", "description": "The FTII test was used to assess visual recognition memory function at 12 months.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "FAGAN TEST OF INFANT INTELLIGENCE (FTII)"}, {"entity_type": "DISEASE", "description": "Some infants had partial fetal alcohol syndrome, indicating chromosomal abnormalities related to prenatal alcohol exposure.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "CHROMOSOME ABNORMALITIES (PFAS)"}, {"entity_type": "DISEASE", "description": "Diagnosis related to Fetal Alcohol Spectrum Disorders, including FAS and PFAS.", "source_id": "chunk-d594d57f0043cce2b3d29c80323b1a11", "id": "FASD DIAGNOSIS"}, {"entity_type": "DIETARY PATTERN", "description": "The dietary pattern of choline intake by pregnant mothers affects fetal development and outcomes.", "source_id": "chunk-d594d57f0043cce2b3d29c80323b1a11", "id": "MATERNAL DIETARY CHOLINE STATUS"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant in the PEMT gene that influences endogenous choline synthesis.", "source_id": "chunk-d594d57f0043cce2b3d29c80323b1a11", "id": "PEMT ENZYME VARIANT (RS12325817)"}, {"entity_type": "DISEASE", "description": "A condition within Fetal Alcohol Spectrum Disorders characterized by specific facial abnormalities, growth deficiencies, and central nervous system impairments.", "source_id": "chunk-d594d57f0043cce2b3d29c80323b1a11", "id": "FAS (FETAL ALCOHOL SYNDROME)"}, {"entity_type": "DISEASE", "description": "A less severe form of FAS that includes some but not all criteria for FAS, such as partial facial abnormalities or neurobehavioral deficits.", "source_id": "chunk-d594d57f0043cce2b3d29c80323b1a11", "id": "PFAS (PARTIAL FETAL ALCOHOL SYNDROME)"}, {"entity_type": "DIETARY PATTERN", "description": "The group of infants whose mothers did not receive choline supplementation during pregnancy; instead, they received a placebo.", "source_id": "chunk-d594d57f0043cce2b3d29c80323b1a11", "id": "PLACEBO ARM"}, {"entity_type": "DIETARY PATTERN", "description": "Infants born to mothers who received choline supplementation during pregnancy.", "source_id": "chunk-d594d57f0043cce2b3d29c80323b1a11", "id": "CHOLINE-TREATED GROUP"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process by which the body synthesizes choline internally through enzymes like PEMT, independent of dietary intake.", "source_id": "chunk-d594d57f0043cce2b3d29c80323b1a11", "id": "ENDOGENOUS CHOLINE SYNTHESIS"}, {"source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "description": "High levels of alcohol consumption during pregnancy are linked to the development of FASD in children.", "entity_type": "UNKNOWN", "id": "MATERNAL ALCOHOL CONSUMPTION"}, {"source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "description": "Maternal smoking can contribute to developmental delays and other adverse outcomes in children exposed to prenatal nicotine.", "entity_type": "UNKNOWN", "id": "FETAL DEVELOPMENT"}, {"source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "description": "Use of illicit drugs during pregnancy may lead to poor developmental outcomes, including lower cognitive abilities in infants.", "entity_type": "UNKNOWN", "id": "DEVELOPMENTAL OUTCOMES"}, {"source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "description": "Infants receiving choline supplementation showed improved growth patterns compared to those without supplementation.", "entity_type": "UNKNOWN", "id": "CHOLINE SUPPLEMENTATION"}, {"entity_type": "GENOMIC VARIANT", "description": "The GRK5 (CA)n polymorphism is a genomic variant where the number of CA repeat sequences varies within the population.", "source_id": "chunk-66f614368ca7f1bd578d9eb259083dd9", "id": "GRK5 (CA)N POLYMORPHISM"}, {"entity_type": "DISEASE", "description": "IFG, or Impaired Fasting Glucose, indicates an abnormal increase in blood glucose levels during fasting and is linked to prediabetes conditions.", "source_id": "chunk-66f614368ca7f1bd578d9eb259083dd9", "id": "IFG (IMPAIRED FASTING GLUCOSE)"}, {"entity_type": "DISEASE", "description": "IGT, or Impaired Glucose Tolerance, represents a condition where blood glucose levels are higher than normal but not high enough for a diabetes diagnosis.", "source_id": "chunk-66f614368ca7f1bd578d9eb259083dd9", "id": "IGT (IMPAIRED GLUCOSE TOLERANCE)"}, {"entity_type": "DISEASE", "description": "T2DM is a chronic disease characterized by high blood sugar levels due to insulin resistance or insufficient insulin production.", "source_id": "chunk-66f614368ca7f1bd578d9eb259083dd9", "id": "T2DM (TYPE 2 DIABETES MELLITUS)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "These clinical parameters indicate metabolic and physiological processes affected in individuals with abnormal glucose metabolism.", "source_id": "chunk-66f614368ca7f1bd578d9eb259083dd9", "id": "WAIST CIRCUMFERENCE, BMI, SBP, DBP, FPG, AND 2 H PG"}, {"entity_type": "GENOMIC VARIANT", "description": "CA repeat sequences are short tandem repeats found within the human genome that can influence gene expression through splicing enhancers or repressors.", "source_id": "chunk-66f614368ca7f1bd578d9eb259083dd9", "id": "CA REPEAT SEQUENCES"}, {"entity_type": "GENE", "description": "The GRK5 gene plays a role in physiological processes, particularly related to glucose metabolism.", "source_id": "chunk-66f614368ca7f1bd578d9eb259083dd9", "id": "GRK5"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Polymorphism Information Content (PIC) values are used to assess genetic diversity within populations by measuring allele frequencies.", "source_id": "chunk-66f614368ca7f1bd578d9eb259083dd9", "id": "PIC VALUES"}, {"entity_type": "MOLECULAR INTERACTION", "description": "A statistical method analyzing the association between genotypes and disease risk.", "source_id": "chunk-66f614368ca7f1bd578d9eb259083dd9", "id": "LOGISTIC REGRESSION ANALYSIS"}, {"entity_type": "DISEASE", "description": "Type 2 Diabetes Mellitus, characterized by insulin resistance and relative lack of insulin due to inadequate pancreatic beta cell function; T2DM phenotypes are also exacerbated by HFD in SENP1-aP2KO mice.<SEP>Type 2 diabetes mellitus (T2DM) is a disease characterized by high blood sugar levels over a prolonged period.", "source_id": "chunk-174831b97ed170039b374ba254d4f506<SEP>chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9", "id": "T2DM"}, {"entity_type": "GENOMIC VARIANT", "description": "The (CA)16 allele is a specific genomic variant that serves as a reference in genetic studies of T2DM and abnormal blood glucose conditions.", "source_id": "chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9", "id": "(CA)16 ALLELE"}, {"entity_type": "DISEASE", "description": "Impaired Fasting Glucose (IFG), a condition characterized by higher than normal fasting blood sugar levels but not high enough to be classified as diabetes, is associated with an increased risk of developing Type 2 Diabetes Mellitus.", "source_id": "chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9", "clusters": "[{level: 0, cluster: 3}]", "id": "IFG"}, {"entity_type": "DISEASE", "description": "Impaired Glucose Tolerance (IGT) is a prediabetic state characterized by higher than normal blood sugar levels after consuming glucose, which can progress to Type 2 Diabetes Mellitus if not addressed.", "source_id": "chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9", "clusters": "[{level: 0, cluster: 3}]", "id": "IGT"}, {"entity_type": "GENOMIC VARIANT", "description": "These alleles represent multiple genomic variants that are studied in relation to T2DM risk and blood glucose regulation.", "source_id": "chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9", "clusters": "[{level: 0, cluster: 3}]", "id": "MULTIPLE ALLELES INCLUDING (CA)15, (CA)17, (CA)18, AND (CA)19"}, {"entity_type": "DIETARY PATTERN", "description": "The NFG group is used as a control group in studies comparing different dietary patterns or genetic factors related to blood glucose levels.", "source_id": "chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9", "clusters": "[{level: 0, cluster: 3}]", "id": "NFG GROUP"}, {"source_id": "chunk-66f614368ca7f1bd578d9eb259083dd9", "description": "The presence of GRK5 (CA)16 allele polymorphisms is significantly associated with increased risk for prediabetes and type 2 diabetes mellitus.", "entity_type": "UNKNOWN", "id": "IFG, IGT, T2DM"}, {"source_id": "chunk-66f614368ca7f1bd578d9eb259083dd9", "description": "Abnormal glucose metabolism as seen in IFG, IGT, and T2DM leads to an increase in clinical parameters such as waist circumference, BMI, SBP, DBP, FPG, and 2 h PG.", "entity_type": "UNKNOWN", "id": "CLINICAL PARAMETERS"}, {"source_id": "chunk-66f614368ca7f1bd578d9eb259083dd9", "description": "The genetic variation within the GRK5 gene is assessed using PIC values to determine polymorphism.", "entity_type": "UNKNOWN", "id": "GRK5 GENE"}, {"source_id": "chunk-66f614368ca7f1bd578d9eb259083dd9", "description": "The PIC values indicate significant differences in the frequency distribution of specific alleles like (CA)16 and (CA)17 across different groups.", "entity_type": "UNKNOWN", "id": "(CA)16, (CA)17 ALLELES)"}, {"source_id": "chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9", "description": "There are no significant associations between the (CA)16 allele and abnormal blood glucose conditions, indicating that this allele does not significantly influence these conditions.", "entity_type": "UNKNOWN", "id": "ABNORMAL BLOOD GLUCOSE"}, {"entity_type": "GENE", "description": "The GPX4 gene has a SNP (rs8178974) that was statistically significantly associated with colorectal cancer risk.", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "id": "GPX4 GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific genomic variant (rs8178974) in the GPX4 gene is linked to an increased risk of colorectal cancer.", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "id": "SNP IN GPX4 GENE (RS8178974)"}, {"entity_type": "NUTRIENT", "description": "Selenium supplements were not associated with a different risk of colorectal cancer compared to controls.", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 32}]", "id": "SELENIUM SUPPLEMENTS"}, {"entity_type": "DISEASE", "description": "Colorectal cancer is the disease under study, particularly its association with selenium and genetic factors.", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 32}]", "id": "COLORECTAL CANCER"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Serum selenium concentration was studied for its potential role in colorectal cancer risk.", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 32}]", "id": "SERUM SELENIUM CONCENTRATION"}, {"entity_type": "NUTRIENT", "description": "Intakes of calcium were lower in cases (colorectal cancer patients) than controls.", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "id": "CALCIUM INTAKE"}, {"entity_type": "NUTRIENT", "description": "Intakes of dietary fiber were also lower among colorectal cancer cases compared to healthy controls.", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "id": "DIETARY FIBER INTAKE"}, {"entity_type": "DISEASE", "description": "The study indicates that serum selenium may be marginally significantly associated with the risk of colon cancer, a type of colorectal cancer.", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 32}]", "id": "COLON CANCER"}, {"entity_type": "GENOMIC VARIANT", "description": "Genetic variants within selenoenzyme genes did not modify the association between serum selenium and colorectal cancer risk.", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 32}]", "id": "GENOMIC VARIANTS IN SELENOENZYMES"}, {"entity_type": "DRUG", "description": "Use of NSAIDs was similar between cases with colorectal cancer and controls, indicating no significant impact on disease risk from this medication use.", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 32}]", "id": "NSAIDS (NONSTEROIDAL ANTI-INFLAMMATORY DRUGS)"}, {"entity_type": "THERAPY", "description": "Cases used postmenopausal hormone less frequently than controls, suggesting a potential influence on colorectal cancer incidence.", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 32}]", "id": "POSTMENOPAUSAL HORMONE USE"}, {"entity_type": "LIFESTYLE FACTOR", "description": "Cases were less physically active than controls, suggesting reduced activity levels may be associated with increased disease risk.<SEP>The amount of physical activity individuals engage in is a lifestyle factor that influences overall health and hormone levels.", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6<SEP>chunk-9e14f9bdee02839e4a6b12cff2020a5a", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 32}]", "id": "PHYSICAL ACTIVITY"}, {"entity_type": "GENE", "description": "CARD9 is a gene that contributes to the susceptibility of mice to colitis by altering IL-22 signaling pathway via impaired tryptophan metabolism.<SEP>CARD9 is a gene that plays a role in mediating recovery from DSS-induced colitis.", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd<SEP>chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "id": "CARD9"}, {"entity_type": "TRANSCRIPT", "description": "Reg3g (encoding REGIII-\u03b3) and Reg3b (encoding REGIII-\u03b2) are transcripts induced by IL-22, contributing to antimicrobial defense in the gut during colitis.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "id": "REG3G AND REG3B"}, {"entity_type": "GENE", "description": "Interleukin 1beta gene is upregulated in Card9\u2212/\u2212 mice compared to wild-type mice under DSS-induced colitis conditions.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "id": "IL1B"}, {"entity_type": "TRANSCRIPT", "description": "Colonic expression of these transcripts is reduced on day 12 in Card9\u2212/\u2212 mice relative to wild-type mice during recovery from DSS-induced colitis.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "id": "REG3G, REG3B, AND IL22"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Interleukin 17A, a pro-inflammatory cytokine produced by T helper cells (Th17), contributing to inflammation and tissue damage.<SEP>This cytokine has a protective role alongside IL-22 during colitis.", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c<SEP>chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "id": "IL-17A"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A model for studying inflammatory bowel disease induced by dextran sodium sulfate (DSS) that is influenced by factors such as IL-22 signaling.<SEP>An experimental model of colonic inflammation induced by dextran sulfate sodium, used to study the mechanisms of inflammatory bowel disease.<SEP>Colonic inflammation induced by dextran sodium sulfate (DSS), a model for studying inflammatory bowel disease.", "source_id": "chunk-29025895ac187b8e88dec5cea9478842<SEP>chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "id": "DSS-INDUCED COLITIS"}, {"entity_type": "METABOLIC PATHWAY", "description": "Pathways activated in response to DSS-induced colitis are enriched for immune processes in Card9\u2212/\u2212 mice compared to wild-type controls.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "id": "IMMUNE-RELATED PATHWAYS"}, {"entity_type": "CELL TYPE", "description": "Cells lining the gut that express antimicrobial proteins such as REGIII-\u03b3 and REGIII-\u03b2 when stimulated by IL-22.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "id": "INTESTINAL EPITHELIAL CELLS"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "The collective microbial community in the gastrointestinal tract, which includes bacteria, fungi, and other microorganisms.<SEP>The gut microbiota influences the susceptibility of mice to colitis by altering IL-22 signaling pathway via impaired tryptophan metabolism.", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd<SEP>chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "id": "GUT MICROBIOTA"}, {"entity_type": "CHEMICAL COMPOUND", "description": "A chemical compound used experimentally to induce colitis in mice.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "id": "DSS (DEXTRAN SULFATE SODIUM)"}, {"entity_type": "CELL TYPE", "description": "Genetically normal mice used as controls in experiments.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "id": "WT MICE (WILD-TYPE MICE)"}, {"entity_type": "ANIMAL MODEL", "description": "Mice lacking the CARD9 gene, making them more susceptible to colitis and having impaired recovery.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "id": "CARD9\u2212/\u2212 MICE"}, {"entity_type": "PROTEIN", "description": "A protein present in all phases of the active cell cycle but absent in resting cells. It serves as an indicator for cellular proliferation status.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "id": "KI67 (PROLIFERATION MARKER)"}, {"entity_type": "PROTEIN", "description": "A marker used to identify apoptosis, or programmed cell death, in tissues.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "id": "CLEAVED CASPASE 3"}, {"entity_type": "CELL TYPE", "description": "Immune cells that produce interleukin-22 and contribute to the regulation of epithelial barrier functions and antimicrobial defense during inflammation.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "id": "IL-22+ CELLS (INTERLEUKIN-22 POSITIVE CELLS)"}, {"entity_type": "CELL TYPE", "description": "A subset of IL-22+ cells characterized by the absence of CD3, CD4, and NKp46 markers. These are innate lymphoid cells (ILCs).", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "id": "CD3\u2212CD4\u2212NKP46\u2212 SUBSET"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "The microbial composition in feces or colonic samples reflects changes due to genetic modifications like CARD9 deficiency.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "id": "MICROBIAL COMPOSITION (FUNGAL AND BACTERIAL)"}, {"entity_type": "GENE", "description": "The CARD9 gene plays a role in shaping bacterial and fungal gut microbiota, specifically controlling fungal expansion during colitis.<SEP>The Card9 gene plays a critical role in immune responses and contributes to susceptibility to DSS-induced colitis.", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6<SEP>chunk-29025895ac187b8e88dec5cea9478842", "id": "CARD9 GENE"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Germ-free mice are used to isolate the effect of gut microbiota in disease models, particularly when investigating the role of specific genes like Card9.", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "id": "GERM-FREE (GF) MICE"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "DSS is an environmental factor used to induce colitis in experimental mouse models.", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "id": "DEXTRAN SODIUM SULFATE (DSS)"}, {"entity_type": "GENE", "description": "The IL-22 gene encodes a cytokine that plays a critical role in intestinal homeostasis and innate antimicrobial resistance, as observed in the context of CARD9 deficiency.", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "id": "IL-22 GENE"}, {"entity_type": "PROTEIN", "description": "CXCL1 and CXCL5 are chemokine proteins that play roles in inflammation. In Card9\u2212/\u2212 mice, their expression is altered during colitis, suggesting involvement in the disease process.", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "id": "CYTOKINES (CXCL1, CXCL5)"}, {"entity_type": "GENE", "description": "The FOS gene encodes a transcription factor involved in cellular responses to growth factors and cytokines, with reduced expression observed in Card9\u2212/\u2212 mice.", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "id": "TRANSCRIPTION FACTOR (FOS)"}, {"entity_type": "GENE", "description": "REG3G and REG3B encode proteins that are part of the innate immune system\'s response against fungi. Their decreased expression in Card9\u2212/\u2212\u2192GF mice suggests a compromised fungal resistance mechanism.", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "id": "REG3G AND REG3B GENES"}, {"entity_type": "PROTEIN", "description": "IL-17 is a cytokine produced by various immune cells and involved in inflammation. The study did not find changes in IL-17 expression or production, indicating that the defect seen in Card9\u2212/\u2212\u2192GF mice might be specific to other pathways.", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "id": "INTERLEUKIN-17 (IL-17)"}, {"entity_type": "CELL TYPE", "description": "ILCs are immune cells known for their role in producing cytokines like IL-22 and IL-17. Their function was altered in Card9\u2212/\u2212\u2192GF mice, particularly in the production of IL-22.", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "id": "INNATE LYMPHOID CELLS (ILCS)"}, {"entity_type": "CELL TYPE", "description": "TH22 cells are a subset of T helper cells that produce IL-22 and play an important role in mucosal immune responses. Their function was decreased in Card9\u2212/\u2212\u2192GF mice.", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "id": "TH22 CELLS"}, {"entity_type": "MOLECULAR INTERACTION", "description": "The IL-23 pathway is crucial for the induction of IL-17 and IL-22 production by specific T cells and innate lymphoid cells. This pathway appears to be intact in Card9\u2212/\u2212\u2192GF mice, as dendritic cells and macrophages involved in this process did not show differences.", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "id": "IL-23 SIGNALING PATHWAY"}, {"entity_type": "MICROBIAL SPECIES", "description": "Adlercreutzia is a genus of bacteria that was observed to decrease in Card9\u2212/\u2212 mouse microbiota, indicating its potential role in maintaining gut homeostasis.", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "id": "ADLERCREUTZIA (GENUS)"}, {"entity_type": "MICROBIAL PHYLUM", "description": "Actinobacteria is a phylum of bacteria. Its reduction in the Card9\u2212/\u2212 mouse microbiota suggests it plays an important role in gut health and may be influenced by CARD9 deficiency.", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "id": "ACTINOBACTERIA (PHYLUM)"}, {"entity_type": "MICROBIAL SPECIES", "description": "Lactobacillus reuteri is a species of bacteria that was found to decrease in the Card9\u2212/\u2212 mouse microbiota, possibly indicating its importance in gut health under CARD9 influence.", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "id": "LACTOBACILLUS REUTERI (SPECIES)"}, {"entity_type": "PROTEIN", "description": "IL-1\u03b2 is a pro-inflammatory cytokine that works with TNF-\u03b1 and others to initiate inflammatory responses in the body.", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "id": "INTERLEUKIN-1\u0392 (IL-1\u0392)"}, {"entity_type": "GENE", "description": "A gene associated with inflammatory bowel disease, but not linked to reduced AHR activation by fecal samples in the study.<SEP>The NOD2 gene encodes a protein involved in innate immune recognition of bacterial products, similar to CARD9\'s role in fungal sensing.", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd<SEP>chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "id": "NOD2 GENE"}, {"entity_type": "MICROBIAL SPECIES", "description": "Bifidobacterium longum is a species of bacteria commonly found in the gut microbiota that influences host health and immune responses.", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "id": "BIFIDOBACTERIUM LONGUM (SPECIES)"}, {"entity_type": "PROTEIN", "description": "FGF15 is involved in regulating intestinal inflammation and metabolism, with its expression affected by genetic factors like CARD9 deficiency.", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "id": "FIBROBLAST GROWTH FACTOR 15 (FGF15)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The metabolism of tryptophan by gut microbiota influences the activation of Aryl Hydrocarbon Receptor (AHR).<SEP>The process by which tryptophan is metabolized into indole derivatives or kynurenine via different pathways involving gut bacteria and host cells.", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd<SEP>chunk-29025895ac187b8e88dec5cea9478842", "id": "TRYPTOPHAN METABOLISM"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Activation of the Aryl Hydrocarbon Receptor (AHR) through ligand binding, which promotes local IL-22 production.", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "id": "AHR ACTIVATION"}, {"entity_type": "PROTEIN", "description": "An enzyme that converts tryptophan into kynurenine as part of the immune response and regulation of T cell activation.<SEP>IDO1 is a protein involved in the catabolism of tryptophan to produce Kynurenine (Kyn) which plays a role in immune regulation and AHR activation.", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd<SEP>chunk-29025895ac187b8e88dec5cea9478842", "id": "INDOLEAMINE 2,3-DIOXYGENASE 1 (IDO1)"}, {"entity_type": "METABOLIC PATHWAY PRODUCT", "description": "A metabolite derived from tryptophan metabolism by gut bacteria, which activates AHR and promotes local IL-22 production.", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "id": "INDOLE-3-ACETIC ACID (IAA)"}, {"entity_type": "METABOLIC PATHWAY PRODUCT", "description": "A metabolite of tryptophan that can influence immune responses through AHR activation.<SEP>A product of tryptophan metabolism via the enzyme IDO1, involved in immune regulation.<SEP>Kyn is a metabolite of tryptophan involved in immune regulation through AHR activation.", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd<SEP>chunk-29025895ac187b8e88dec5cea9478842", "id": "KYNURENINE (KYN)"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Specific strains of Lactobacillus that were isolated from WT mice due to their ability to activate AHR and contribute to the regulation of colitis susceptibility.", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "id": "LACTOBACILLUS STRAINS"}, {"entity_type": "PROTEIN INTERACTION", "description": "T cells that reside within the epithelial layer and can produce cytokines like IL-22 or IL-17.", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "id": "INTRAEPITHELIAL \u0393\u0394 T CELLS"}, {"entity_type": "CELL TYPE", "description": "Immune cells located in the intestine involved in antigen presentation and activation of T cells via cytokine production, such as IL-23.", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "id": "INTESTINAL DENDRITIC CELLS"}, {"entity_type": "MOLECULAR INTERACTION", "description": "The process by which intestinal dendritic cells produce interleukin-23 to stimulate IL-22-producing cells.", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "id": "IL-23 PRODUCTION"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "The community of microorganisms living within the gut, which affects immune responses and colonic health.", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "id": "MICROBIOTA"}, {"entity_type": "GENOMIC VARIANT", "description": "Mice deficient in the Ido1 gene, which results in altered tryptophan metabolism and subsequent effects on AHR activation and IL-22 production.", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "id": "IDO1\u2212/\u2212 MICE"}, {"entity_type": "MICROBIOTA STRAINS", "description": "Specific bacterial strains identified for their ability to activate the Aryl Hydrocarbon Receptor (AHR) and are decreased in abundance in Card9\u2212/\u2212 mice microbiota.", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "id": "L. REUTERI AND ALLOBACULUM SP."}, {"entity_type": "GENOMIC VARIANT", "description": "Mice deficient in IL-22, which show alterations in their gut microbiota affecting AHR activity and IAA levels.", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "id": "IL22\u2212/\u2212 MICE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The Aryl Hydrocarbon Receptor is activated by ligands produced through tryptophan metabolism, playing an important role in the gut microbiota\'s interaction with host immune cells.", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "id": "ARYL HYDROCARBON RECEPTOR (AHR)"}, {"entity_type": "DISEASE", "description": "A type of inflammatory bowel disease characterized by chronic inflammation of the gastrointestinal tract.", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "id": "CROHN\u2019S DISEASE"}, {"entity_type": "GENOMIC VARIANT", "description": "A genetic variant within CARD9 that is associated with increased risk for inflammatory bowel disease (IBD).", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "id": "IBD-ASSOCIATED SINGLE-NUCLEOTIDE POLYMORPHISM (RS10781499)"}, {"entity_type": "NUTRIENT", "description": "An essential amino acid involved in the production of neurotransmitters and important for immune regulation via its metabolism to Kynurenine.", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "id": "TRYPTOPHAN"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The enzymatic activity of IDO1 leading to the production of Kyn from tryptophan, which is reduced in subjects with IBD.", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "id": "IDO1 ACTIVITY"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Production of AHR ligands is influenced by the gut microbiota and is crucial for normalizing AHR ligand production in Card9\u2212/\u2212 mice.", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "id": "AHR LIGAND PRODUCTION"}, {"entity_type": "DISEASE", "description": "A chronic inflammatory condition affecting the gastrointestinal tract, including Crohn\u2019s disease and ulcerative colitis.", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "id": "INFLAMMATORY BOWEL DISEASE (IBD)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Analysis of fecal samples to assess the ability of gut microbiota to activate Aryl Hydrocarbon Receptor (AHR).", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "id": "FECAL SAMPLES ANALYSIS"}, {"entity_type": "FIGURE REFERENCE", "description": "Figures showing the effects of exogenous IL-22 on AHR ligand production in Card9\u2212/\u2212 mice and its relation to gut microbiota.", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "id": "SUPPLEMENTARY FIG. 13C\u2013H AND SUPPLEMENTARY FIG. 14"}, {"entity_type": "GENE", "description": "Another gene associated with IBD, showing no correlation with decreased AHR activation through microbiota-derived metabolites.", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "id": "AUTOPHAGY-RELATED 16-LIKE 1 (ATG16L1) GENE"}, {"entity_type": "GENE", "description": "A gene related to IBD that did not show an association with reduced AHR activation in the study.", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "id": "LEUCINE-RICH REPEAT KINASE 2 (LRRK2) GENE"}, {"source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "description": "Decreased proliferation (Ki-67) and increased apoptosis (cleaved caspase 3) indicate impaired intestinal healing in Card9\u2212/\u2212 mice.", "entity_type": "UNKNOWN", "id": "DSS-INDUCED COLITIS RECOVERY"}, {"source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "description": "Decreased proliferation (Ki-67) and increased apoptosis (cleaved caspase 3) indicate impaired intestinal healing in Card9\u2212/\u2212 mice.", "entity_type": "UNKNOWN", "id": "KI67 AND CLEAVED CASPASE 3"}, {"source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "description": "The CD3\u2212CD4\u2212NKp46\u2212 subset is a subpopulation of IL-22+ cells that plays a crucial role in the immune response to colitis.", "entity_type": "UNKNOWN", "id": "IL-22+ CELLS"}, {"source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "description": "The unaltered levels of IL-17 production indicate that the defect seen in Card9\u2212/\u2212\u2192GF mice might be specific to pathways other than those regulated by IL-17.", "entity_type": "UNKNOWN", "id": "CARD9 GENE "}, {"source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "description": "ILC function is compromised in the production of IL-22, indicating a critical role for these cells in maintaining gut homeostasis through this cytokine.", "entity_type": "UNKNOWN", "id": "IL-22 GENE "}, {"source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "description": "TH22 cell dysfunction leads to decreased production of REG3G and REG3B, highlighting the importance of IL-22 for maintaining anti-fungal defense mechanisms in the gut.", "entity_type": "UNKNOWN", "id": "REG3G AND REG3B GENES "}, {"source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "description": "While the IL-23 pathway is intact in Card9\u2212/\u2212\u2192GF mice, the inability of ILCs to produce sufficient IL-22 indicates a specific defect downstream of this pathway.", "entity_type": "UNKNOWN", "id": "IL-23 SIGNALING PATHWAY "}, {"source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "description": "Together, IL-1\u03b2 and TNF-\u03b1 form a cytokine network critical for initiating inflammation in the body. Their roles are intertwined with those of CARD9 during colitis.", "entity_type": "UNKNOWN", "id": "TNF-\u0391 GENE "}, {"source_id": "chunk-29025895ac187b8e88dec5cea9478842", "description": "The production of Kyn through IDO1 activity modulates IL-22 levels, impacting the susceptibility to DSS-induced colitis in Card9\u2212/\u2212 mice.)", "entity_type": "UNKNOWN", "id": "IL-22 PRODUCTION"}, {"source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "description": "IDO1 is responsible for converting tryptophan into Kynurenine, a process that is impaired in subjects with IBD.)", "entity_type": "UNKNOWN", "id": "IDO1 PROTEIN"}, {"source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "description": "IDO1 is responsible for converting tryptophan into Kynurenine, a process that is impaired in subjects with IBD.)", "entity_type": "UNKNOWN", "id": "KYNURENINE PRODUCTION"}, {"source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "description": "A specific genetic variant within CARD9 affects the ability of gut microbiota to produce AHR ligands, influencing disease susceptibility in IBD patients.)", "entity_type": "UNKNOWN", "id": "CARD9 GENE EXPRESSION"}, {"source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "description": "A specific genetic variant within CARD9 affects the ability of gut microbiota to produce AHR ligands, influencing disease susceptibility in IBD patients.)", "entity_type": "UNKNOWN", "id": "IBD-ASSOCIATED SNP (RS10781499)"}, {"source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "description": "Impaired tryptophan metabolism by the gut microbiota leads to defective AHR activation and increased susceptibility to IBD.)", "entity_type": "UNKNOWN", "id": "GUT MICROBIOTA FUNCTION"}, {"source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "description": "Fecal samples from patients with IBD show reduced ability to activate Aryl Hydrocarbon Receptor (AHR), indicating impaired tryptophan metabolism and microbiota function.)", "entity_type": "UNKNOWN", "id": "AHR ACTIVATION "}, {"source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "description": "Fecal samples from patients with IBD show reduced ability to activate Aryl Hydrocarbon Receptor (AHR), indicating impaired tryptophan metabolism and microbiota function.)", "entity_type": "UNKNOWN", "id": "IBD-DERIVED FECAL SAMPLES"}, {"source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "description": "An SNP within CARD9 associated with increased susceptibility to IBD, affecting AHR activation by gut microbiota-derived metabolites.)", "entity_type": "UNKNOWN", "id": "CARD9 GENE VARIANT (RS10781499)"}, {"source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "description": "An SNP within CARD9 associated with increased susceptibility to IBD, affecting AHR activation by gut microbiota-derived metabolites.)", "entity_type": "UNKNOWN", "id": "IBD SUSCEPTIBILITY "}, {"source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "description": "The enzymatic activity of IDO1 is crucial for converting tryptophan into Kynurenine, a process that is impaired in subjects with IBD.)", "entity_type": "UNKNOWN", "id": "IDO1 ENZYMATIC ACTIVITY"}, {"source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "description": "The enzymatic activity of IDO1 is crucial for converting tryptophan into Kynurenine, a process that is impaired in subjects with IBD.)", "entity_type": "UNKNOWN", "id": "TRYPTOPHAN METABOLISM "}, {"source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "description": "Activation of Aryl Hydrocarbon Receptor (AHR) regulates immune responses through metabolites produced by tryptophan metabolism.)", "entity_type": "UNKNOWN", "id": "IMMUNE RESPONSE REGULATION "}, {"entity_type": "GENE", "description": "\u03b22M, also known as Beta-2-Microglobulin, is a gene that encodes the beta-2-microglobulin protein.", "source_id": "chunk-c29d575e156569afaa1ca3d6418a71b9", "id": "\u03922M GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "The rs3184504 polymorphism is associated with plasma \u03b22M levels and SH2B3 expression.", "source_id": "chunk-c29d575e156569afaa1ca3d6418a71b9", "id": "RS3184504 POLYMORPHISM"}, {"entity_type": "TRANSCRIPT", "description": "Expression of the SH2B3 gene, which may be influenced by genomic variants like rs3184504.", "source_id": "chunk-c29d575e156569afaa1ca3d6418a71b9", "id": "SH2B3 EXPRESSION"}, {"entity_type": "DISEASE", "description": "A disease characterized by persistently elevated blood pressure.<SEP>A disease characterized by persistently high blood pressure levels that can lead to cardiovascular complications.", "source_id": "chunk-c29d575e156569afaa1ca3d6418a71b9<SEP>chunk-9e14f9bdee02839e4a6b12cff2020a5a", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 35}]", "id": "HYPERTENSION"}, {"entity_type": "PROTEIN", "description": "The SH2B3 protein, whose expression is associated with \u03b22M levels and hypertension risk.", "source_id": "chunk-c29d575e156569afaa1ca3d6418a71b9", "id": "SH2B3 PROTEIN"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A model that uses angiotensin II to induce hypertension in mice for research purposes.", "source_id": "chunk-c29d575e156569afaa1ca3d6418a71b9", "id": "ANGIOTENSIN II-INDUCED HYPERTENSION MODEL"}, {"entity_type": "METABOLIC PATHWAY", "description": "The pathway through which \u03b22M levels are regulated and influence disease risk, such as hypertension.", "source_id": "chunk-c29d575e156569afaa1ca3d6418a71b9", "id": "CIRCULATING BETA-2-MICROGLOBULIN LEVELS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Dysfunctions in the kidney and blood vessels that occur during hypertension or other cardiovascular conditions.", "source_id": "chunk-c29d575e156569afaa1ca3d6418a71b9", "id": "RENAL/VASCULAR DYSFUNCTION"}, {"entity_type": "ANIMAL MODEL", "description": "A model involving mice with a deficiency of SH2B3 protein used to study the effects on \u03b22M expression and hypertensive responses.", "source_id": "chunk-c29d575e156569afaa1ca3d6418a71b9", "id": "SH2B3\u2212/\u2212 MOUSE MODEL"}, {"entity_type": "PROTEIN", "description": "The \u03b22M protein is encoded by the \u03b22M gene and has been linked to hypertension risk.", "source_id": "chunk-c29d575e156569afaa1ca3d6418a71b9", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 35}]", "id": "\u03922M PROTEIN"}, {"entity_type": "GENE", "description": "SH2B3, also known as SH2-containing B adaptor-like protein 3, plays a role in regulating \u03b22M expression and hypertension risk through its expression level.", "source_id": "chunk-c29d575e156569afaa1ca3d6418a71b9", "id": "SH2B3 GENE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A condition where albumin is present in the urine, often indicating kidney dysfunction associated with hypertension.", "source_id": "chunk-c29d575e156569afaa1ca3d6418a71b9", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 35}]", "id": "ALBUMINURIA"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "A measure of kidney function that can indicate early-stage chronic kidney disease and influence risk factors for hypertension.", "source_id": "chunk-c29d575e156569afaa1ca3d6418a71b9", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 35}]", "id": "LOW EGFR (ESTIMATED GLOMERULAR FILTRATION RATE)"}, {"entity_type": "THERAPY", "description": "Medication used to lower cholesterol levels, which is often considered in the context of cardiovascular health along with \u03b22M levels.", "source_id": "chunk-c29d575e156569afaa1ca3d6418a71b9", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 35}]", "id": "STATIN USE"}, {"entity_type": "NUTRIENT/MOLECULAR INTERACTION", "description": "A hormone that plays a role in regulating blood pressure and can be used as an inducer of hypertension in experimental models.", "source_id": "chunk-c29d575e156569afaa1ca3d6418a71b9", "id": "ANGIOTENSIN II"}, {"entity_type": "GENE", "description": "MTHFD1 is a gene associated with increased risk of neural tube defects in infants who carry specific variants and have low dietary folate intake.<SEP>Methylenetetrahydrofolate dehydrogenase 1 gene (MTHFD1) encodes an enzyme with three activities: 5,10-methylene-THF dehydrogenase, cyclohydrolase, and synthetase. It is crucial for methionine, thymidylate, and purine synthesis.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223<SEP>chunk-9a35876dc1aaf7342f023cab4f5b9914", "id": "MTHFD1"}, {"entity_type": "GENOMIC VARIANT", "description": "rs2236224 is a genomic variant within the MTHFD1 gene that shows an association with increased risk of neural tube defects in infants when there is low maternal folate intake.", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "id": "SNP RS2236224"}, {"entity_type": "GENOMIC VARIANT", "description": "rs2236225 is a genomic variant within the MTHFD1 gene that shows an association with increased risk of neural tube defects in infants when there is low maternal folate intake.", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "id": "SNP RS2236225"}, {"entity_type": "GENOMIC VARIANT", "description": "rs11627387 is a genomic variant within the MTHFD1 gene that appears to be associated with an increased risk of neural tube defects in infants when there is low maternal folate intake.", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "id": "SNP RS11627387"}, {"entity_type": "GENE", "description": "MTHFR is a gene whose variants have shown reduced risk of neural tube defects when mothers are heterozygous and have high dietary folate intake.<SEP>The MTHFR gene codes for the methylenetetrahydrofolate reductase enzyme, which plays a critical role in homocysteine metabolism and methylation pathways.<SEP>The Methylene-Tetrahydrofolate Reductase gene, which plays a role in folate metabolism and has variants associated with LV (Leiomyoma of the uterus).", "source_id": "chunk-d0476488384aadcae4630e94d982d2e0<SEP>chunk-b025a32e74a29cbbd5a0ce3d051f3fdb<SEP>chunk-9a35876dc1aaf7342f023cab4f5b9914", "id": "MTHFR"}, {"entity_type": "GENOMIC VARIANT", "description": "rs1476413 is a genomic variant within the MTHFR gene associated with reduced risk of neural tube defects when mothers are heterozygous and have high dietary folate intake.", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "id": "SNP RS1476413"}, {"entity_type": "GENOMIC VARIANT", "description": "rs1801131 is a genomic variant within the MTHFR gene associated with reduced risk of neural tube defects when mothers are heterozygous and have high dietary folate intake.", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "id": "SNP RS1801131"}, {"entity_type": "GENOMIC VARIANT", "description": "rs1801133 is a genomic variant within the MTHFR gene associated with reduced risk of neural tube defects when mothers are heterozygous and have high dietary folate intake.", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "id": "SNP RS1801133"}, {"entity_type": "GENE", "description": "SHMT1 is a gene whose variants appear to be associated with reduced risk of neural tube defects in mothers but increased risk in infants, depending on maternal folate intake levels.<SEP>Serine Hydroxymethyltransferase 1 gene (SHMT1) is involved in the conversion of serine to glycine and transferring methyl groups to tetrahydrofolate, contributing to pyrimidine synthesis during cellular proliferation.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223<SEP>chunk-9a35876dc1aaf7342f023cab4f5b9914", "id": "SHMT1"}, {"entity_type": "GENOMIC VARIANT", "description": "rs669340 CG is a genomic variant within the SHMT1 gene associated with reduced risk of neural tube defects when mothers are heterozygous and have high dietary folate intake.", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "id": "SNP RS669340 CG"}, {"entity_type": "GENOMIC VARIANT", "description": "rs12939757 AG is a genomic variant within the SHMT1 gene associated with increased risk of neural tube defects in infants with low maternal dietary folate intake.", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "id": "SNP RS12939757 AG"}, {"entity_type": "GENE", "description": "TYMS is a gene whose variants interact with dietary folate to reduce the risk of neural tube defects, especially when mothers have low dietary folate and are heterozygous for specific variants.", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "id": "TYMS"}, {"entity_type": "GENOMIC VARIANT", "description": "rs502396 is a genomic variant within the TYMS gene associated with reduced risk of neural tube defects when mothers have low dietary folate and are heterozygous for this variant.", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "id": "SNP RS502396"}, {"entity_type": "GENOMIC VARIANT", "description": "rs699517 is a genomic variant within the TYMS gene associated with reduced risk of neural tube defects when mothers have low dietary folate and are heterozygous for this variant.", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "id": "SNP RS699517"}, {"entity_type": "GENOMIC VARIANT", "description": "rs2847153 AG is a genomic variant within the TYMS gene associated with reduced risk of neural tube defects in infants when there is low maternal dietary folate intake.", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "id": "SNP RS2847153 AG"}, {"entity_type": "NUTRIENT", "description": "Folate is a critical nutrient involved in DNA synthesis and repair, methylation reactions, and amino acid metabolism.<SEP>Folate is a nutrient essential for one-carbon metabolism, impacting DNA synthesis and repair; its periconceptional use through supplements or diet can influence the risk of neural tube defects based on genetic variations in mothers and infants.<SEP>Folate is a vitamin B essential for DNA synthesis and repair.<SEP>Folate is a crucial nutrient involved in various physiological processes and metabolic pathways related to cardiovascular health and cell metabolism.<SEP>Folate is a vitamin B9 that plays an essential role in various bodily functions including DNA synthesis, repair, and cell division.", "source_id": "chunk-22216738ccbae0a6276bb4499018c434<SEP>chunk-257a38a8ce6582c434f31b023b4a9704<SEP>chunk-c9badb9a0fb813f42383cc8afc57ad45<SEP>chunk-dd3c1834035af8b4436c8058609b6fd8<SEP>chunk-9a35876dc1aaf7342f023cab4f5b9914", "id": "FOLATE"}, {"entity_type": "DISEASE", "description": "Neural tube defects are birth anomalies that occur due to improper closure of the embryonic neural tube, influenced by folate intake and specific gene variants during pregnancy.", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "id": "NEURAL TUBE DEFECTS (NTDS)"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant in the CHI3L1 gene, rs10399931, was examined for its association with T2D and related quantitative traits.", "source_id": "chunk-44a871da300abc9be525b468f502f5cb", "id": "RS10399931"}, {"entity_type": "GENOMIC VARIANT", "description": "Another genomic variant of CHI3L1, rs4950928, was also assessed for an association with type 2 diabetes (T2D) and various quantitative traits.", "source_id": "chunk-44a871da300abc9be525b468f502f5cb", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 42}]", "id": "RS4950928"}, {"entity_type": "GENOMIC VARIANT", "description": "Several tag single nucleotide polymorphisms (tgSNPs) of the CHI3L1 gene were studied for their potential associations with T2D, IFG, IGT, and related quantitative traits.", "source_id": "chunk-44a871da300abc9be525b468f502f5cb", "clusters": "[{level: 0, cluster: 3}]", "id": "CHI3LI TG SNPS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A physiological process indicating an early stage in the development towards type 2 diabetes where fasting glucose levels are higher than normal but not yet diabetic.", "source_id": "chunk-44a871da300abc9be525b468f502f5cb", "id": "IMPAIRED FASTING GLUCOSE (IFG)"}, {"entity_type": "PROTEIN", "description": "A protein that serves as a marker for insulin production; its serum concentration after two hours was found to be significantly associated with the genomic variant rs10399931.", "source_id": "chunk-44a871da300abc9be525b468f502f5cb", "id": "C-PEPTIDE"}, {"entity_type": "DIETARY PATTERN", "description": "The Inter99 cohort is a group of individuals whose clinical characteristics were evaluated for associations with type 2 diabetes (T2D) and related quantitative traits.", "source_id": "chunk-44a871da300abc9be525b468f502f5cb", "clusters": "[{level: 0, cluster: 3}]", "id": "INTER99 COHORT"}, {"entity_type": "DIETARY PATTERN", "description": "Individuals recruited at Steno Diabetes Center are part of the study population used to examine the association between genomic variants and T2D-related factors.", "source_id": "chunk-44a871da300abc9be525b468f502f5cb", "clusters": "[{level: 0, cluster: 3}]", "id": "STENO DIABETES CENTER INDIVIDUALS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Adjustment factors such as age and sex were considered during the analysis of genomic variants\' association with T2D and related quantitative traits.", "source_id": "chunk-44a871da300abc9be525b468f502f5cb", "clusters": "[{level: 0, cluster: 3}]", "id": "AGE AND SEX ADJUSTMENT"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A test used to determine normal glucose tolerance, which was one of the characteristics evaluated in the study for individuals not diagnosed with T2D.", "source_id": "chunk-44a871da300abc9be525b468f502f5cb", "clusters": "[{level: 0, cluster: 3}]", "id": "GLUCOSE TOLERANCE TEST (NGT)"}, {"entity_type": "GENOMIC VARIANT", "description": "The Y402H risk allele of the CFH gene is associated with an increased odds of AMD, especially when combined with low HLS.", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 18}]", "id": "CFH Y402H RISK ALLELE"}, {"entity_type": "GENOMIC VARIANT", "description": "The A69S risk allele in ARMS2 increases the odds for AMD, particularly when combined with poor lifestyle scores and dietary patterns.", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 18}]", "id": "A69S RISK ALLELE (ARMS2)"}, {"entity_type": "GENOMIC VARIANT", "description": "Homozygosity for the G allele of rs641153 is associated with increased odds of AMD in women.", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "id": "RS641153 G ALLELE (CFB/C2)"}, {"entity_type": "DIETARY PATTERN", "description": "The HLS score reflects an individual\'s dietary patterns and lifestyle habits, impacting AMD risk differently based on genetic background.<SEP>The Healthy Lifestyle Score represents an individual\'s adherence to healthy lifestyle patterns which can influence their risk of diseases such as AMD.", "source_id": "chunk-a7d0bfa8b16262a1f313b7e3060969c6<SEP>chunk-23a090455f50ab98c53e8b90941c6da5", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 18}]", "id": "HEALTHY LIFESTYLE SCORE (HLS)"}, {"entity_type": "DISEASE", "description": "AMD is a disease associated with age-related deterioration of the macula that affects central vision.", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 18}]", "id": "AGE-RELATED MACULAR DEGENERATION (AMD)"}, {"entity_type": "NUTRIENT", "description": "A nutrient found in dietary patterns, omega-3 fatty acids were explored for their impact on AMD risk but did not significantly alter the relationship between HLS and AMD.<SEP>Polyunsaturated fatty acids found in fish oil that are used as part of a drug therapy regimen for reducing TG levels.", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86<SEP>chunk-23a090455f50ab98c53e8b90941c6da5", "id": "OMEGA-3 FATTY ACIDS"}, {"entity_type": "NUTRIENT", "description": "Dietary intake of LZ was investigated as a potential mediator of the interaction between genetic risk and lifestyle score regarding AMD risk.", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 20}]", "id": "LUTEIN AND ZEAXANTHIN (LZ)"}, {"entity_type": "GENE", "description": "The CFH gene is associated with AMD risk through specific alleles such as Y402H.", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "id": "CFH GENE (COMPLEMENT FACTOR H)"}, {"entity_type": "GENE", "description": "The ARMS2 gene, particularly the A69S allele, influences AMD risk in combination with lifestyle factors.", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "id": "ARMS2 GENE (AGE-RELATED MACULOPATHY SUSCEPTIBILITY 2)"}, {"entity_type": "GENE", "description": "The C3 gene\'s polymorphisms like rs2230199 influence genetic predisposition to AMD, but effects may vary with lifestyle scores.", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 18}]", "id": "C3 GENE (COMPLEMENT COMPONENT C3)"}, {"entity_type": "GENE", "description": "Variants in the CFI gene do not seem to have a main effect on AMD risk within the study sample.", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "id": "CFI GENE (COMPLEMENT FACTOR I)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Risk phenotypes for AMD involve genetic predispositions and lifestyle factors, which interact differently based on dietary stability.", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "id": "AGE-RELATED MACULAR DEGENERATION RISK PHENOTYPES"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Stable diets limit variation in nutritional intake, potentially clarifying relationships between genetic risk factors and disease status.", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "id": "DIETARY STABILITY"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The main effects refer to the direct influence of specific gene variants on the odds of developing AMD without considering interaction with lifestyle factors.", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "id": "MAIN EFFECTS OF AMD GENOTYPES"}, {"entity_type": "MOLECULAR INTERACTION", "description": "This interaction highlights how genetic predisposition combined with lifestyle affects AMD risk more than either factor alone.", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 18}]", "id": "INTERACTION BETWEEN CFH GENOTYPE AND HEALTHY LIFESTYLE SCORE"}, {"entity_type": "MOLECULAR INTERACTION", "description": "The interaction between ARMS2 genotype and HLS shows varying degrees of synergistic or sub-additive effects on AMD risk.", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 20}]", "id": "INTERACTION BETWEEN ARMS2 GENOTYPE AND HEALTHY LIFESTYLE SCORE"}, {"entity_type": "DISEASE", "description": "Age-related Macular Degeneration (AMD) is a disease that affects central vision due to damage in the macula.", "source_id": "chunk-a7d0bfa8b16262a1f313b7e3060969c6", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 19}]", "id": "AMD"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific variant in the ARMS2 gene that is associated with an increased risk for age-related macular degeneration (AMD).", "source_id": "chunk-a7d0bfa8b16262a1f313b7e3060969c6", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 18}]", "id": "ARMS2 GENOTYPE"}, {"entity_type": "GENOMIC VARIANT", "description": "Variants in the complement pathway genes (CFB/C2, C3 rs2230199, and CFI rs10033900) are examined for their interaction with lifestyle to impact AMD risk.", "source_id": "chunk-a7d0bfa8b16262a1f313b7e3060969c6", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 18}]", "id": "CFB/C2, C3 RS2230199 AND CFI RS10033900 GENOTYPES"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The Synergy Index is a measure used in epidemiology to assess the degree of deviation from an additive model in the joint effect of two or more exposures on disease risk.", "source_id": "chunk-a7d0bfa8b16262a1f313b7e3060969c6", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 19}]", "id": "SYNERGY INDEX (SI)"}, {"entity_type": "DISEASE", "description": "A condition in which blood glucose levels are higher than normal but not yet high enough to be classified as type 2 diabetes.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "id": "PREDIABETES"}, {"entity_type": "DIETARY PATTERN", "description": "The habitual intake of coffee, including black and sugared coffee.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "id": "COFFEE CONSUMPTION"}, {"entity_type": "GENE", "description": "These genes are associated with genetic polymorphisms related to habitual coffee consumption.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "id": "HECTD4, ACAD10, MYL2, CUX2 GENES"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Scores calculated based on the presence and number of risk alleles for certain SNPs in an individual\'s genome.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "id": "GENETIC RISK SCORES"}, {"entity_type": "DIETARY PATTERN", "description": "The regular intake of black coffee, which has been associated with a reduced risk of prediabetes and type 2 diabetes.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "id": "BLACK COFFEE CONSUMPTION "}, {"entity_type": "DIETARY PATTERN", "description": "The regular intake of sugared coffee, also linked to a lower risk of developing prediabetes and type 2 diabetes.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "id": "SUGARED COFFEE CONSUMPTION "}, {"entity_type": "GENOMIC VARIANT", "description": "Variations at the DNA sequence level that are associated with specific traits or conditions.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "id": "GENETIC POLYMORPHISMS"}, {"entity_type": "NUTRIENT", "description": "The regular intake of caffeine, often derived from coffee and other beverages.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "id": "CONTINUOUS CAFFEINE INTAKE"}, {"entity_type": "MOLECULAR INTERACTION", "description": "A graphical method used in genetic studies to display the strength of association between genetic markers and a trait across the genome.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "id": "MANHATTAN PLOT"}, {"entity_type": "MOLECULAR INTERACTION", "description": "A plot that shows the linkage disequilibrium among SNPs around a region on the chromosome.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "id": "REGIONAL ASSOCIATION PLOT "}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A graph used to assess if a set of observed data comes from a distribution with specified parameters, often used in GWAS.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "id": "Q-Q PLOT"}, {"entity_type": "MOLECULAR INTERACTION", "description": "A measure used in GWAS to quantify the degree of inflation or deflation in test statistics due to population stratification or other biases.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "id": "GENOMIC INFLATION FACTOR (\u039b)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Measurements indicating the degree of similarity between two variables, often SNPs, over time.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "id": "PAIRWISE CORRELATIONS "}, {"entity_type": "GENOMIC VARIANT", "description": "SNPs that are strongly related to each other and have been selected for genetic risk score calculations.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "id": "HIGHLY-CORRELATED GENOTYPED SNPS "}, {"entity_type": "DIETARY PATTERN", "description": "Individuals who do not consume black coffee regularly, contrasting with those who do.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "id": "NON-BLACK COFFEE CONSUMERS "}, {"entity_type": "DIETARY PATTERN", "description": "Individuals who do not consume sugared coffee regularly, in contrast to those who do.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "id": "NON-SUGARED COFFEE CONSUMERS "}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A trend where the risk of developing a condition decreases with increasing exposure to a factor.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "id": "INVERSE TREND "}, {"entity_type": "GENOMIC VARIANT", "description": "Specific genetic variations associated with habitual coffee intake patterns.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "id": "GENETIC POLYMORPHISMS RELATED TO COFFEE CONSUMPTION "}, {"entity_type": "GENOMIC VARIANT", "description": "SNPs identified through GWAS as being significantly linked to coffee consumption habits.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "id": "COFFEE-RELATED SNPS "}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Indicates individuals who have a higher number of risk alleles associated with developing type 2 diabetes or prediabetes.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "id": "HIGH GENETIC RISK SCORES "}, {"entity_type": "GENOMIC VARIANT", "description": "A SNP (Single Nucleotide Polymorphism) is mentioned as having an inverse relationship with minor allele type related to a disease state.<SEP>A Single Nucleotide Polymorphism (SNP) is a variation at a single base pair in the DNA sequence that occurs at a particular position within the genome.", "source_id": "chunk-b803830d07bff8ae14550f6458048707", "id": "SNP"}, {"entity_type": "GENOMIC VARIANT", "description": "The minor allele of each SNP refers to the less frequent variant at a specific location in the genome, which can influence disease susceptibility or other traits.", "source_id": "chunk-b803830d07bff8ae14550f6458048707", "id": "MINOR ALLELE OF SNP"}, {"entity_type": "MOLECULAR INTERACTION", "description": "An inverse relationship implies an opposite effect or association, often observed between genetic variants and disease outcomes.", "source_id": "chunk-b803830d07bff8ae14550f6458048707", "id": "INVERSE RELATIONSHIP"}, {"source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "description": "The association between habitual coffee consumption and the risk of developing type 2 diabetes is modified by genetic risk scores.", "entity_type": "UNKNOWN", "id": "GENETIC RISK SCORES "}, {"source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "description": "Certain SNPs located within these genes are associated with habitual coffee consumption and may influence the risk of developing type 2 diabetes.", "entity_type": "UNKNOWN", "id": "HECTD4, ACAD10, MYL2, CUX2 GENES "}, {"source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "description": "Regular black coffee intake is inversely associated with the risk of developing type 2 diabetes, particularly in individuals with high genetic risk scores.", "entity_type": "UNKNOWN", "id": "TYPE 2 DIABETES "}, {"source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "description": "Consumption of sugared coffee is associated with a reduced risk of prediabetes and type 2 diabetes combined.", "entity_type": "UNKNOWN", "id": "PREDIABETES "}, {"source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "description": "Certain genetic polymorphisms are linked to an increased risk of developing type 2 diabetes.", "entity_type": "UNKNOWN", "id": "GENETIC POLYMORPHISMS "}, {"source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "description": "Genome-wide association studies help in identifying SNPs that contribute to the calculation of genetic risk scores.", "entity_type": "UNKNOWN", "id": "GWAS "}, {"source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "description": "The regular intake of caffeine, often through black coffee, is associated with lower risks for type 2 diabetes and prediabetes.", "entity_type": "UNKNOWN", "id": "CONTINUOUS CAFFEINE INTAKE "}, {"source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "description": "A Manhattan plot visually represents the association between genetic polymorphisms and traits or diseases across the genome.", "entity_type": "UNKNOWN", "id": "MANHATTAN PLOT "}, {"source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "description": "A Q-Q plot helps in the assessment of the inflation factor by comparing observed vs. expected test statistics distribution.", "entity_type": "UNKNOWN", "id": "Q-Q PLOT "}, {"entity_type": "GENE", "description": "SENP1 is a gene associated with the regulation of adipogenesis and inflammation in adipose tissues.<SEP>SENP1 is a gene involved in regulating the activation of NF-\u03baB and cytokine production in adipocytes.<SEP>SENP1 is a gene whose expression in adipocytes of non-obese diabetic (NOD) mice and human T1DM patients correlates with disease progression.<SEP>The SENP1 gene is involved in regulating various biological processes including inflammation and diabetes.", "source_id": "chunk-174831b97ed170039b374ba254d4f506<SEP>chunk-a8f2b3b97a70df26efb35263714bf43c<SEP>chunk-f290cff8dac7b522b4f56d03e8df48ce<SEP>chunk-8382a49b61215482f9fc75e3a86cb987", "id": "SENP1"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant using the Adiponectin promoter to drive Cre recombinase expression specifically in adipocytes.", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "id": "ADIPONECTIN GENE PROMOTER (ADIPOQ-CRE)"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant using the PdgfR\u03b1 gene promoter to drive Cre recombinase expression predominantly in bipotent progenitor cells, including white and beige adipocytes.", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "id": "PDGFR\u0391 GENE PROMOTER (PDGFR\u0391-CRE)"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant using the aP2/Fabp4 gene promoter to drive Cre recombinase expression in adipocytes with variable degrees of target gene recombination in macrophages or capillary endothelium.", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "id": "AP2/FABP4 GENE PROMOTER (AP2-CRE)"}, {"entity_type": "TRANSCRIPT", "description": "A transcript that describes adipocyte-specific deletion of the SENP1 gene in mice models using different Cre recombinase promoters.", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "id": "ADIPOCYTE-SPECIFIC DELETION OF SENP1 (SENP1-ADIPOQKO, SENP1-PDGFRKO, AND SENP1-AP2KO)"}, {"entity_type": "PROTEIN", "description": "The protein encoded by the SENP1 gene, which is expressed in adipocytes and involved in regulating inflammation and diabetes development.<SEP>The protein encoded by the SENP1 gene, which is expressed in adipocytes and involved in the regulation of inflammation and diabetes.", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "id": "SENP1 PROTEIN"}, {"entity_type": "DISEASE", "description": "A disease characterized by autoimmune-mediated destruction of pancreatic beta cells leading to deficient insulin production and high blood glucose levels.", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "id": "DIABETES MELLITUS TYPE 1 (T1DM)"}, {"entity_type": "METABOLIC PATHWAY", "description": "A metabolic pathway responsible for regulating glucose metabolism affected by SENP1 deficiency leading to diabetes and high blood sugar levels.<SEP>A metabolic pathway responsible for regulating glucose metabolism, which is affected by SENP1 deficiency leading to diabetes and high blood sugar levels.", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "id": "GLUCOSE METABOLISM REGULATION"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant where the SENP1 gene is specifically deleted in smooth muscle cells or pericytes, not leading to a high-glucose phenotype.", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "id": "ADIPOCYTE-SPECIFIC DELETION OF SENP1 IN SMOOTH MUSCLE CELLS/PERICYTES (SENP1-SMKO)"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant where the SENP1 gene is specifically deleted in vascular endothelial cells, also not leading to a high-glucose phenotype.", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "id": "ADIPOCYTE-SPECIFIC DELETION OF SENP1 IN VASCULAR ENDOTHELIAL CELLS (SENP1-ECKO)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process by which insulin is released from pancreatic beta cells into the bloodstream. Insufficient insulin secretion contributes to diabetes development in SENP1-deficient mice.", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "id": "INSULIN SECRETION"}, {"entity_type": "MOLECULAR INTERACTION", "description": "An assay used to assess the ability of isolated islets to secrete insulin in response to glucose stimulation, revealing reduced insulin secretion in SENP1-deficient islets.", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "id": "GLUCOSE-STIMULATED INSULIN ASSAY"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process involving brown adipose tissue that plays a significant role in thermogenesis and glucose homeostasis, influenced by SENP1 expression.", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "id": "INTERSCAPULAR BROWN ADIPOSE TISSUE (BAT)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "White adipose tissue involved in lipid storage and energy metabolism affected by the deletion of SENP1 gene.", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "id": "PERIGONADAL WHITE ADIPOSE TISSUE (WAT)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Adipose tissue surrounding the pancreas, influenced by changes in SENP1 expression affecting glucose homeostasis.", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "id": "PERIPHERAL PANCREATIC ADIPOSE TISSUE (PAT)"}, {"entity_type": "CELL TYPE", "description": "A type of immune cell involved in inflammation and tissue repair, showing intact SENP1 expression despite adipocyte-specific deletion.", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "id": "MACROPHAGES CD11B+F4/80+ CELLS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The endocrine component of the pancreas that produces insulin; affected by SENP1 deficiency leading to reduced insulin secretion.", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "id": "PANCREATIC ISLETS (\u0392 CELLS)"}, {"entity_type": "GENE", "description": "The SENP1 gene is involved in the development of type-1-like diabetic phenotypes when deficient specifically in adipocytes.<SEP>The SENP1 gene plays a critical role in the development and progression of Type 1 Diabetes (T1DM) in mice.<SEP>The SENP1 gene regulates adipocyte differentiation and inflammation in peri-pancreatic adipose tissue (PATs).", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4<SEP>chunk-fc33d6399ec56e65d007269407f1953d<SEP>chunk-0c1631ae2c195cb68139ea9d75a3b433", "id": "SENP1 GENE"}, {"entity_type": "DISEASE", "description": "A disease characterized by T-cell-mediated destruction of insulin-producing pancreatic \u03b2 cells, leading to hyperglycaemia and islet damage.", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "id": "INSULIN-DEPENDENT DIABETES MELLITUS (TYPE 1)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process where immune system T-cells attack and destroy insulin-producing \u03b2 cells in the pancreas.", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "id": "T-CELL MEDIATED DESTRUCTION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The disruption of pancreatic islet structures with increased apoptosis of \u03b2 cells after onset of diabetes, indicative of insulitis.", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "id": "PANCREATIC ISLETS STRUCTURE DISRUPTION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Cell death mechanism of \u03b2-cells in SENP1-deficient mice as indicated by TUNEL staining.", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "id": "APOPTOSIS OF \u0392 CELLS"}, {"entity_type": "MOLECULAR INTERACTION", "description": "The process where immune cells, such as CD8+ and CD4+ T cells, invade pancreatic tissues causing inflammation and islet damage.", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "id": "IMMUNE CELL INFILTRATION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Autoantibodies directed against \u03b2-cells that appear in the pre-diabetic phase of Type 1 Diabetes Mellitus.", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "id": "INSULIN AUTOANTIBODY (IAA)"}, {"entity_type": "NUTRIENT", "description": "An inflammatory marker used for diagnosing and monitoring diabetes, showing elevated levels in individuals with higher risk of developing T1DM.", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "id": "C-REACTIVE PROTEIN (CRP)"}, {"entity_type": "NUTRIENT", "description": "A ketone body produced when the body loses its ability to absorb glucose properly, often elevated in diabetic patients.", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "id": "\u0392-HYDROXYBUTYRATE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The regulation of immune responses through T-cell subsets such as Th1 and Th17 cells with reduction of regulatory T-cells (Tregs) observed in SENP1-aP2KO mice.", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "id": "IMMUNE SYSTEM REGULATION"}, {"entity_type": "GENOMIC VARIANT", "description": "Mice that are deficient in the SENP1 gene specifically in adipocytes, leading to type-1-like diabetic phenotypes.", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "id": "ADIPOCYTE-SPECIFIC SENP1-DEFICIENT MICE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Apoptosis process marked by TdT-mediated dUTP nick end labelling (TUNEL) positivity indicating cell death.", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "id": "TUNEL POSITIVE APOPTOSIS OF \u0392 CELLS"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Reduction in CD31-positive vascular area within pancreatic islets, indicative of disrupted vasculature and reduced \u03b2-cell function.", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "id": "CD31+ VASCULAR AREA LOSS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process where autoimmune responses lead to damages in tissues and organs, particularly in the context of diabetes development.", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "id": "AUTOIMMUNE MEDIATED DAMAGES"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Decrease in \u03b2-cell mass due to apoptosis and immune cell infiltration leading to reduced insulin production capability.", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "id": "\u0392-CELL MASS REDUCTION"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Invasion of CD8+ T cells into pancreatic islets, a hallmark of type 1 diabetes development.", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "id": "CD8+ T CELLS INFILTRATION"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Presence of CD4+ T cells infiltrating the pancreas as part of autoimmune response in SENP1-aP2KO mice.", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "id": "CD4+ T CELLS INFILTRATION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Immune rejection response observed upon skin transplantation, indicating normal immune system function despite diabetes development.", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "id": "SKIN-REJECTION RESPONSE"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Increased population of MHCII+CD11b+CD11c\u2212 macrophages in the pancreas of SENP1-aP2KO mice, contributing to inflammation.", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "id": "MHCII+CD11B+CD11C\u2212 MACROPHAGES INCREASE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Expansion of Th1 (IFN-\u03b3+CD4+) and Th17 (IL-17+CD4+) effector T-cell subsets in pancreatic lymph nodes.", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "id": "TH1 AND TH17 EFFECTOR T-CELL SUBSETS EXPANSION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Decrease in regulatory T-cells (Tregs) which play a role in immune tolerance, contributing to autoimmune responses.", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "id": "REGULATORY T-CELLS REDUCTION"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Increase in activated dendritic cells in the lymph nodes of pancreases supporting autoimmune processes.", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "id": "ACTIVATED DENDRITIC CELLS INCREASE"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Detection of autoantigen NRP-V7 positive CD8+ T-cells targeting a peptide from islet-specific glucose-6-phosphatase catalytic subunit-related protein, indicative of specific autoimmune response.", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "id": "NRP-V7 POSITIVE CD8+ T-CELLS"}, {"entity_type": "MOLECULAR INTERACTION", "description": "These cells target a peptide from islet-specific glucose-6-phosphatase catalytic subunit-related protein, detected in the pancreatic lymph nodes and spleen of SENP1-aP2KO mice.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433", "id": "NRP-V7 POSITIVE CD8+ T CELLS"}, {"entity_type": "PROTEIN", "description": "This peptide is targeted by autoantigen NRP-V7 positive CD8+ T cells in the context of autoimmune diabetes.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433", "id": "ISLET-SPECIFIC GLUCOSE-6-PHOSPHATASE CATALYTIC SUBUNIT-RELATED PROTEIN PEPTIDE"}, {"entity_type": "MOLECULAR INTERACTION", "description": "These proinflammatory cytokines are significantly elevated in circulating serum and produced locally by peri-pancreatic adipose tissue (PATs) before the onset of T1DM in SENP1-deficient mice.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433", "id": "IL-6, TNF-\u0391 AND IL-1\u0392"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Overproduction of proinflammatory cytokines serves as a main reason for immunological tolerance break and immune cell expansion in diabetes, primarily in early disease phases.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433", "id": "PROINFLAMMATORY CYTOKINE OVERPRODUCTION"}, {"entity_type": "DISEASE", "description": "An autoimmune disease characterized by the destruction of pancreatic \u03b2 cells due to an auto-immune response.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433", "id": "TYPE 1 DIABETES MELLITUS (T1DM)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "This tissue produces high levels of proinflammatory cytokines, inducing local inflammatory responses and contributing significantly to the development of diabetes in SENP1-deficient mice.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433", "id": "PERI-PANCREATIC ADIPOSE TISSUE (PATS)"}, {"entity_type": "PROTEIN", "description": "Chemokine (C-C motif) ligand 5, also known as RANTES, is a protein that plays a role in immune responses by attracting leukocytes to sites of inflammation.<SEP>Upregulated chemokine expressed by pancreatic islets and \u03b2 cells that recruits immune cells, potentially leading to further inflammation and damage of \u03b2 cells.", "source_id": "chunk-8382a49b61215482f9fc75e3a86cb987<SEP>chunk-0c1631ae2c195cb68139ea9d75a3b433", "id": "CCL5"}, {"entity_type": "PROTEIN", "description": "These chemokines are weakly upregulated in pancreatic islets, participating in the recruitment of immune cells to inflammation sites.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433", "id": "CHEMOKINES (E.G., CCL2, CCL21, CXCL19, CXCL10)"}, {"entity_type": "GENOMIC VARIANT", "description": "These mice have a specific genetic variant that leads to deficiencies in SENP1, resulting in increased proinflammatory cytokines and autoimmune responses.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433", "id": "SENP1-AP2KO MICE"}, {"entity_type": "TRANSCRIPT", "description": "The transcript of IL-6 is highly expressed in peri-pancreatic adipose tissue (PATs) from SENP1-aP2KO mice at 7 weeks, contributing to inflammatory responses.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433", "id": "IL-6 TRANSCRIPT"}, {"entity_type": "TRANSCRIPT", "description": "The TNF-\u03b1 transcript is highly expressed in PATs from SENP1-aP2KO mice at 7 weeks, contributing to inflammatory responses.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433", "id": "TNF-\u0391 TRANSCRIPT"}, {"entity_type": "TRANSCRIPT", "description": "The IL-1\u03b2 transcript is highly expressed in PATs from SENP1-aP2KO mice at 7 weeks, contributing to inflammatory responses.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433", "id": "IL-1\u0392 TRANSCRIPT"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Detected site of NRP-V7 positive CD8+ T cells targeting a peptide from the glucose-6-phosphatase catalytic subunit-related protein in SENP1-aP2KO mice at 12 weeks.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433", "id": "PANCREATIC LYMPH NODES"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Detected site of NRP-V7 positive CD8+ T cells targeting a peptide from the glucose-6-phosphatase catalytic subunit-related protein in SENP1-aP2KO mice at 12 weeks.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433", "id": "SPLEEN"}, {"entity_type": "PROTEIN", "description": "Immune cells target and destroy these cells, leading to insulin deficiency characteristic of T1DM.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433", "id": "PANCREATIC \u0392 CELLS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "High levels of local proinflammatory cytokines secreted from peri-pancreatic adipose tissue (PATs) upregulate CCL5 expression in islets, contributing to the recruitment of immune cells into the pancreas and causing damage to \u03b2-cells.<SEP>High levels of local proinflammatory cytokines upregulate CCL5 expression in islets, recruiting immune cells into the pancreas and causing damage to \u03b2-cells.<SEP>Upregulated in pancreatic islets before the onset of diabetes, recruiting immune cells and causing damage to \u03b2 cells.", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4<SEP>chunk-0c1631ae2c195cb68139ea9d75a3b433", "id": "CCL5 EXPRESSION"}, {"entity_type": "PROTEIN", "description": "Site where chemokines such as CCL5 are upregulated in response to proinflammatory cytokines from PATs, contributing to autoimmune responses.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433", "id": "PANCREATIC ISLETS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Recruitment of immune cells into the pancreas due to elevated levels of chemokines like CCL5, leading to \u03b2 cell damage.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433", "id": "IMMUNE CELL RECRUITMENT"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Adipocyte-derived cytokines, such as IL-6, TNF, and IL-1\u03b2, from SENP1-aP2KO adipocytes induce \u03b2-cell death in pancreatic islets.", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "id": "SENP1-AP2KO ADIPOCYTE-DERIVED CYTOKINES"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "NF-\u03baB dependent inflammation is enhanced in adipose tissues of SENP1-aP2KO mice, indicated by increased phosphorylations of IKK, I\u03baB\u03b1, and NF-\u03baB p65/RelA.", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "id": "NF-\u039aB DEPENDENT INFLAMMATION"}, {"entity_type": "MOLECULAR INTERACTION", "description": "SUMOylation of PPAR\u03b3 is not significantly different between control and SENP1-deficient adipocytes, suggesting it does not contribute to reduced adipogenesis or enhanced cytokine production in PATs.", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "id": "PPAR\u0393 SUMOYLATION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "NF-\u03baB activation is increased in adipose tissues of SENP1-aP2KO mice as indicated by chromatin immunoprecipitation (ChIP) assays showing increased p65/RelA binding to the IL-6, IL-1\u03b2, and TNF-\u03b1 promoters.", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "id": "NF-\u039aB ACTIVATION"}, {"entity_type": "MOLECULAR INTERACTION", "description": "These proinflammatory cytokines are secreted from SENP1-aP2KO adipocytes and upregulate CCL5 expression in islets.", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "id": "PROINFLAMMATORY CYTOKINES (IL-6, TNF, IL-1\u0392)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "\u03b2-Cells are crucial for insulin production and are damaged by adipocyte-derived cytokines leading to impaired function.", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "id": "\u0392-CELLS"}, {"entity_type": "MOLECULAR INTERACTION", "description": "The NF-\u03baB pathway, a key regulator of inflammation and immune responses, is activated more intensely in adipose tissues from SENP1-aP2KO mice.", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "id": "NF-\u039aB PATHWAY"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The differentiation of adipocytes is reduced in PATs when SENP1 is deficient, leading to enhanced proinflammatory phenotypes.", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "id": "ADIPOCYTE DIFFERENTIATION"}, {"entity_type": "MOLECULAR INTERACTION", "description": "The phosphorylation of I\u03baB\u03b1 and IKK is elevated in adipose tissues from SENP1-aP2KO mice, contributing to enhanced NF-\u03baB activation.", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "id": "I\u039aB\u0391 AND IKK PHOSPHORYLATION LEVELS"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Phosphorylation and total levels of ERK1/2 proteins remain unchanged in adipose tissues from SENP1-aP2KO mice.", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "id": "ERK1/2 LEVELS"}, {"entity_type": "PROTEIN", "description": "IKK, also known as I\u03baB kinase, plays a role in activating NF-\u03baB by phosphorylating I\u03baB\u03b1, leading to its degradation.", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "id": "IKK"}, {"entity_type": "PROTEIN", "description": "I\u03baB\u03b1 is a protein that inhibits the activation of NF-\u03baB by sequestering it in the cytoplasm until activated.", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "id": "I\u039aB\u0391"}, {"entity_type": "PROTEIN", "description": "NF-\u03baB p65/RelA, also known as RelA, is a subunit of the NF-\u03baB complex involved in immune and inflammatory responses.", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "id": "NF-\u039aB P65/RELA"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "These are proinflammatory cytokines produced at high levels by PATs from SENP1-aP2KO mice under normal chow conditions and further increased under HFD conditions.<SEP>These cytokines are proinflammatory mediators produced by adipocytes that contribute to chronic inflammation and metabolic disorders.", "source_id": "chunk-174831b97ed170039b374ba254d4f506<SEP>chunk-f290cff8dac7b522b4f56d03e8df48ce", "id": "IL-6, TNF-\u0391, IL-1\u0392"}, {"entity_type": "GENOMIC VARIANT", "description": "The NOD mouse is a genetic model used to study type 1 diabetes, characterized by late-onset spontaneous diabetes.", "source_id": "chunk-8382a49b61215482f9fc75e3a86cb987", "id": "NON-OBESE DIABETIC MOUSE (NOD)"}, {"entity_type": "DISEASE", "description": "Type 1 Diabetes Mellitus (T1DM) is an autoimmune disease that destroys insulin-producing beta cells in the pancreas leading to high blood sugar levels.<SEP>Type 1 Diabetes Mellitus, characterized by autoimmune destruction of pancreatic beta cells leading to absolute deficiency of insulin; T1DM phenotypes are augmented by HFD in SENP1-aP2KO mice.", "source_id": "chunk-174831b97ed170039b374ba254d4f506<SEP>chunk-8382a49b61215482f9fc75e3a86cb987", "id": "T1DM"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific genetic modification where the SENP1 gene is deleted only in adipocytes, leading to more severe hyperglycemia and pancreatic islet disruption compared with NOD mice.", "source_id": "chunk-8382a49b61215482f9fc75e3a86cb987", "id": "ADIPOCYTE-SPECIFIC DELETION OF SENP1"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Refers to a group of proteins that play a crucial role in inflammation and immune response. Their levels increase in T1DM patients and SENP1-aP2KO mice, correlating with disease progression.", "source_id": "chunk-8382a49b61215482f9fc75e3a86cb987", "id": "PROINFLAMMATORY CYTOKINES"}, {"entity_type": "PROTEIN", "description": "A hormone produced by the pancreas that regulates blood sugar levels; both insulin and proinsulin are targeted by islet-reactive T-cells in T1DM patients and NOD mice.", "source_id": "chunk-8382a49b61215482f9fc75e3a86cb987", "id": "INSULIN"}, {"entity_type": "DRUG", "description": "An inhibitor used to block NF-\u03baB activity, which ameliorates diabetes progression when administered to SENP1-aP2KO mice.", "source_id": "chunk-8382a49b61215482f9fc75e3a86cb987", "id": "NF-\u039aB ACTIVATION INHIBITOR II JSH-23"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "A dietary pattern characterized by high intake of fats that can exacerbate the diabetic phenotype in SENP1-deficient mice.", "source_id": "chunk-8382a49b61215482f9fc75e3a86cb987", "id": "HIGH-FAT DIET (HFD)"}, {"entity_type": "PROTEIN", "description": "Interferon gamma, an important cytokine involved in innate immunity and the regulation of cell-mediated immune responses.<SEP>Interferon-gamma (IFN-\u03b3) is a protein that plays a key role in the immune system, especially in activating macrophages and initiating inflammatory responses.<SEP>Interferon-gamma is a protein involved in immune responses and inflammation.", "source_id": "chunk-8382a49b61215482f9fc75e3a86cb987<SEP>chunk-0380fd029b3eda680c87c1b8bcbe7f4c<SEP>chunk-883c371ea1f500a1ba8af8366328e8b0", "id": "IFN-\u0393"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "T-cells that react against pancreatic beta cells and are involved in the autoimmune destruction of these cells in type 1 diabetes.", "source_id": "chunk-8382a49b61215482f9fc75e3a86cb987", "id": "ISLET-REACTIVE T CELLS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The programmed cell death of beta cells in the pancreas, which can be triggered by inflammatory processes and contribute to type 1 diabetes development.", "source_id": "chunk-8382a49b61215482f9fc75e3a86cb987", "id": "\u0392-CELL APOPTOSIS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process by which precursor cells differentiate into adipocytes (fat cells), observed to increase under high-fat diet conditions in SENP1-deficient mice.<SEP>The process by which precursor cells differentiate into adipocytes; HFD may stimulate this process in PATs from SENP1-aP2KO mice.", "source_id": "chunk-174831b97ed170039b374ba254d4f506<SEP>chunk-8382a49b61215482f9fc75e3a86cb987", "id": "ADIPOGENESIS"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "High-fat diet (HFD) is an environmental factor that increases fat weight, stimulates cytokine production, disrupts islet structures, causes hyperglycemia, induces insulin resistance, and exacerbates both T1DM and T2DM phenotypes in mice.", "source_id": "chunk-174831b97ed170039b374ba254d4f506", "id": "HFD"}, {"entity_type": "TISSUE", "description": "PATs (peripheral adipose tissues) exhibit smaller cell sizes with higher numbers of cells in SENP1-aP2KO mice compared to control, suggesting an enhanced capacity for adipogenesis.", "source_id": "chunk-174831b97ed170039b374ba254d4f506", "id": "PATS"}, {"entity_type": "ANIMAL MODEL", "description": "Control mice used as a reference group to compare with SENP1-aP2KO mice in studies investigating the effects of HFD on adipose tissue inflammation and insulin resistance.", "source_id": "chunk-174831b97ed170039b374ba254d4f506", "id": "CTRL MICE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process by which pancreatic beta cells release insulin in response to elevated blood glucose levels; this process is significantly reduced in SENP1-aP2KO mice compared to controls under HFD conditions.", "source_id": "chunk-174831b97ed170039b374ba254d4f506", "id": "GLUCOSE-STIMULATED INSULIN SECRETION"}, {"entity_type": "EXPERIMENTAL PROCEDURE", "description": "An assay used to measure the ability of injected insulin to lower blood glucose levels, indicating sensitivity to insulin; similar responses were observed between SENP1-deficient and control mice on standard chow but diverged under HFD conditions.", "source_id": "chunk-174831b97ed170039b374ba254d4f506", "id": "ITT ASSAY (INSULIN TOLERANCE TEST)"}, {"entity_type": "TISSUE STRUCTURE", "description": "Structures within the pancreas containing beta cells responsible for insulin production; disruption of these structures was observed in SENP1-aP2KO mice under HFD conditions.", "source_id": "chunk-174831b97ed170039b374ba254d4f506", "id": "ISLET STRUCTURES"}, {"source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "description": "SENP1-deficient mice exhibit increased water consumption, which is associated with their higher blood glucose levels.)", "entity_type": "UNKNOWN", "id": "ADIPOCYTE-SPECIFIC DELETION OF SENP1 (SENP1-AP2KO)"}, {"source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "description": "SENP1-deficient mice exhibit increased water consumption, which is associated with their higher blood glucose levels.)", "entity_type": "UNKNOWN", "id": "WATER CONSUMPTION"}, {"source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "description": "The SUMOylation modification of NEMO is critical for the activation of IKK-NF-\u03baB signaling.", "entity_type": "UNKNOWN", "id": "NEMO (IKK\u0393)"}, {"source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "description": "The SUMOylation modification of NEMO is critical for the activation of IKK-NF-\u03baB signaling.", "entity_type": "UNKNOWN", "id": "SUMOYLATION"}, {"source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "description": "SENP2 deSUMOylates NEMO, which can inhibit NF-\u03baB activation by modulating p65/RelA activity.", "entity_type": "UNKNOWN", "id": "SENP2"}, {"source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "description": "Etoposide VP16 induces phosphorylation and activation of IKK and NF-\u03baB p65/RelA in adipocytes.", "entity_type": "UNKNOWN", "id": "DNA DAMAGE AGENT ETOPOSIDE VP16"}, {"source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "description": "The NOD mouse model is relevant to human type 1 diabetes as it spontaneously develops autoimmune destruction of insulin-producing cells.", "entity_type": "UNKNOWN", "id": "NON-OBESE DIABETIC (NOD) MOUSE"}, {"source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "description": "Gene knockdown or overexpression affects the levels of SENP1 mRNA, impacting subsequent protein production.", "entity_type": "UNKNOWN", "id": "SENP1 TRANSCRIPT"}, {"source_id": "chunk-8382a49b61215482f9fc75e3a86cb987", "description": "Under HFD conditions, the phenotype of SENP1-deficient mice is exacerbated, suggesting an interaction between dietary factors and genetic predisposition in diabetes development.)", "entity_type": "UNKNOWN", "id": "SENP1 DEFICIENCY"}, {"source_id": "chunk-8382a49b61215482f9fc75e3a86cb987", "description": "NF-\u03baB inhibitors reduce CCL5 expression in islets, indicating that NF-\u03baB activity regulates chemokine production which is important for inflammation and immune cell recruitment.)", "entity_type": "UNKNOWN", "id": "NF-\u039aB INHIBITION"}, {"source_id": "chunk-8382a49b61215482f9fc75e3a86cb987", "description": "High-fat diet exacerbates adipocyte hyperplasia in SENP1-deficient mice, suggesting an interaction between genetic predisposition and environmental factors in promoting obesity and inflammation.)", "entity_type": "UNKNOWN", "id": "SENP1 DEFICIENCY AND HFD"}, {"source_id": "chunk-174831b97ed170039b374ba254d4f506", "description": "Proinflammatory cytokines such as IL-6, TNF-\u03b1 and IL-1\u03b2 are produced at high levels by peripheral adipose tissues in mice deficient for SENP1.)", "entity_type": "UNKNOWN", "id": "SENP1-AP2KO"}, {"source_id": "chunk-174831b97ed170039b374ba254d4f506", "description": "Similar insulin responses were observed between SENP1-deficient and control mice on standard chow; however, HFD induced more severe insulin resistance in SENP1-deficient mice.)", "entity_type": "UNKNOWN", "id": "SENP1-DEFICIENT MICE"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant located at rs2228570 or rs10735810, associated with an increased risk of ovarian cancer.", "source_id": "chunk-1c470c93632f3704d6f3566de7a1dd0c", "id": "FOKI (RS2228570 OR RS10735810)"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant located at rs7975232, evaluated in the context of ovarian cancer risk but found to have no significant association with it.", "source_id": "chunk-1c470c93632f3704d6f3566de7a1dd0c", "id": "APAI (RS7975232)"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant located at rs1544410, assessed for its role in ovarian cancer risk, showing no significant association with the disease.", "source_id": "chunk-1c470c93632f3704d6f3566de7a1dd0c", "id": "BSMI (RS1544410)"}, {"entity_type": "POPULATION GROUP", "description": "Individuals of Caucasian descent, whose genetic data was analyzed separately to evaluate the associations between genomic variants and ovarian cancer risk.", "source_id": "chunk-1c470c93632f3704d6f3566de7a1dd0c", "id": "CAUCASIANS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A principle used in population genetics to describe a condition where allele and genotype frequencies remain constant from one generation to the next, assuming no evolutionary influences such as mutation, selection, or migration. In studies, it is often used to check for consistency of genetic data.<SEP>An assessment method for evaluating genotype frequencies in populations under random mating assumptions, without significant selection or mutation pressures.", "source_id": "chunk-1c470c93632f3704d6f3566de7a1dd0c<SEP>chunk-5c78814fb7c198ee95071ee5a8462070", "id": "HARDY-WEINBERG EQUILIBRIUM (HWE)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The presence of differences in results across multiple studies that may be due to various factors including population genetics, environmental exposures, and study design. Used as a measure of inconsistency among research findings.", "source_id": "chunk-1c470c93632f3704d6f3566de7a1dd0c", "id": "HETEROGENEITY BETWEEN STUDIES"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant in the Cdx-2 gene, specifically rs11568820, has been studied for its association with ovarian cancer risk.", "source_id": "chunk-dc5e8cc04a1b16b1e00f3a4120e004c4", "id": "CDX-2 (RS11568820)"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant in the TaqI gene, specifically rs731236, has been investigated for its role in ovarian cancer risk.", "source_id": "chunk-dc5e8cc04a1b16b1e00f3a4120e004c4", "id": "TAQI (RS731236)"}, {"entity_type": "GENE VARIANT CARRIER STATUS", "description": "Individuals with GG genotype at a specific locus are carriers of this particular gene variant.", "source_id": "chunk-dc5e8cc04a1b16b1e00f3a4120e004c4", "id": "GG CARRIERS"}, {"entity_type": "GENE VARIANT CARRIER STATUS", "description": "Individuals carrying the A allele (GA or AA) show an increased risk of ovarian cancer relative to GG carriers.", "source_id": "chunk-dc5e8cc04a1b16b1e00f3a4120e004c4", "id": "A ALLELE CARRIERS"}, {"entity_type": "SUBPOPULATION", "description": "The Japanese subgroup is a specific population subset used in genetic studies for assessing disease risks.", "source_id": "chunk-dc5e8cc04a1b16b1e00f3a4120e004c4", "id": "JAPANESE SUBGROUP"}, {"entity_type": "SUBPOPULATION", "description": "The NECC subgroup refers to a specific group within the Nurses\' Health Study (NHS) and NHS II, which has been used for evaluating ovarian cancer risk.", "source_id": "chunk-dc5e8cc04a1b16b1e00f3a4120e004c4", "id": "NECC SUBGROUP"}, {"entity_type": "SUBPOPULATION", "description": "This subgroup is from Northern Sweden and was part of a study examining genetic variants in relation to disease risk.", "source_id": "chunk-dc5e8cc04a1b16b1e00f3a4120e004c4", "id": "NORTHERN SWEDEN SUBGROUP"}, {"entity_type": "GENE", "description": "The VDR gene includes the TaqI (rs731236) variant that is studied in relation to susceptibility to degenerative disc disease and HNP.<SEP>The VDR gene is involved in susceptibility to infection by T. cruzi and the development of Chagas cardiomyopathy (CCC).", "source_id": "chunk-ba82b7eb40cf9eea561d839b20584f91<SEP>chunk-6600322cc75094b1c57707e4b9c85954", "id": "VDR GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "These SNPs in the VDR gene did not show a significant association with infection by T. cruzi or susceptibility to CCC.", "source_id": "chunk-6600322cc75094b1c57707e4b9c85954", "id": "RS731236, RS7975232, RS1544410"}, {"entity_type": "GENOMIC VARIANT", "description": "This SNP was significantly associated with both reduced risk of T. cruzi infection and increased risk of developing CCC, suggesting a protective role against the former but not the latter condition.", "source_id": "chunk-6600322cc75094b1c57707e4b9c85954", "id": "RS2228570"}, {"entity_type": "DISEASE", "description": "Susceptibility to infection by Trypanosoma cruzi is influenced by genetic variants in the VDR gene.", "source_id": "chunk-6600322cc75094b1c57707e4b9c85954", "id": "T. CRUZI INFECTION SUSCEPTIBILITY"}, {"entity_type": "DISEASE", "description": "The development of Chagas cardiomyopathy may be associated with certain genotypes of the VDR gene, particularly the rs2228570 SNP.", "source_id": "chunk-6600322cc75094b1c57707e4b9c85954", "id": "CHAGAS CARDIOMYOPATHY (CCC)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The frequency of the rs2228570*A allele was significantly different in seronegative and seropositive individuals, suggesting a potential protective role against T. cruzi infection.", "source_id": "chunk-6600322cc75094b1c57707e4b9c85954", "id": "RS2228570*A ALLELE FREQUENCY"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The comparison between seronegative (no antibodies) and seropositive (antibodies present) individuals helps to identify genetic variants associated with susceptibility to T. cruzi infection.", "source_id": "chunk-6600322cc75094b1c57707e4b9c85954", "id": "SERONEGATIVE INDIVIDUALS VS SEROPOSITIVE INDIVIDUALS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The comparison between asymptomatic patients and those developing Chagas cardiomyopathy aids in identifying genetic factors influencing disease progression.", "source_id": "chunk-6600322cc75094b1c57707e4b9c85954", "id": "ASYMPTOMATIC PATIENTS VS CCC PATIENTS"}, {"entity_type": "GENOMIC VARIANT", "description": "These haplotypes of the VDR gene SNPs were observed in the studied individuals without showing significant associations with T. cruzi infection or CCC development.", "source_id": "chunk-6600322cc75094b1c57707e4b9c85954", "id": "HAPLOTYPE ACC, GAT, AAC"}, {"entity_type": "DISEASE", "description": "The risk assessment for developing Chagas cardiomyopathy involves analyzing genetic variants like rs2228570.", "source_id": "chunk-6600322cc75094b1c57707e4b9c85954", "id": "CHAGAS CARDIOMYOPATHY (CCC) RISK ASSESSMENT"}, {"entity_type": "GENOMIC VARIANT", "description": "The IL-1A -889C>T variant is a genomic variant studied in relation to the risk of Human Nerve Pain (HNP).", "source_id": "chunk-ba82b7eb40cf9eea561d839b20584f91", "id": "IL-1A -889C>T"}, {"entity_type": "GENOMIC VARIANT", "description": "The TNF-A 238G>A variant is another genomic variant under investigation for its potential association with HNP.", "source_id": "chunk-ba82b7eb40cf9eea561d839b20584f91", "id": "TNF-A 238G>A"}, {"entity_type": "GENOMIC VARIANT", "description": "VDR TaqI (rs731236) is a third genomic variant examined in connection to the risk of HNP and degenerative disc disease.", "source_id": "chunk-ba82b7eb40cf9eea561d839b20584f91", "id": "VDR TAQI (RS731236)"}, {"entity_type": "GENE", "description": "The IL-1A gene harbors a polymorphism at position -889C>T that is studied for its potential association with Human Nerve Pain (HNP).", "source_id": "chunk-ba82b7eb40cf9eea561d839b20584f91", "id": "IL-1A GENE"}, {"entity_type": "GENE", "description": "The TNF-A gene has a polymorphism at position 238G>A under investigation for its association with HNP risk.", "source_id": "chunk-ba82b7eb40cf9eea561d839b20584f91", "id": "TNF-A GENE"}, {"source_id": "chunk-ba82b7eb40cf9eea561d839b20584f91", "description": "The TT genotype of IL-1A -889C>T was found to be 1.37 times more frequent in HNP patients than in controls, although overall genotypes and alleles showed no significant association with the risk of HNP.", "entity_type": "UNKNOWN", "id": "HNP"}, {"source_id": "chunk-ba82b7eb40cf9eea561d839b20584f91", "description": "The IL-1A gene variant is investigated for its potential association with Human Nerve Pain (HNP).", "entity_type": "UNKNOWN", "id": "HUMAN NERVE PAIN (HNP)"}, {"source_id": "chunk-ba82b7eb40cf9eea561d839b20584f91", "description": "Genetic variants within the VDR gene are examined for their association with degenerative disc disease and possibly HNP.", "entity_type": "UNKNOWN", "id": "DEGENERATIVE DISC DISEASE (A CONDITION OFTEN ASSOCIATED WITH HNP)"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant in the FUT2 gene associated with maternal serum B12 levels.<SEP>A genomic variant in the FUT2 gene, with significant effects on maternal serum B12 levels.", "source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "id": "FUT2 VARIANT (RS602662)"}, {"entity_type": "GENOMIC VARIANT", "description": "A variant in the MMACHC gene that has minimal effect on fetal birth weight at 28 weeks of gestation.<SEP>A variant in the MMACHC gene that showed little effect on maternal serum B12 levels during pregnancy at 28 weeks of gestation.", "source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "id": "MMACHC VARIANT (RS12272669)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Levels of vitamin B12 in the serum of pregnant women, which do not significantly influence birthweight according to study results.<SEP>Serum B12 levels in pregnant women, which are influenced by genetic variants and can affect offspring birth weight.", "source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "id": "MATERNAL SERUM B12 LEVELS"}, {"entity_type": "NUTRIENT", "description": "Levels of folate in the maternal serum during pregnancy, impacting the birthweight positively.", "source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "id": "FOLATE LEVELS (MATERNAL)"}, {"entity_type": "NUTRIENT", "description": "Levels of folate in the fetus during pregnancy that have been shown to negatively impact birth weight.", "source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "id": "FOLATE LEVELS (FETAL)"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific variant in the MTHFR gene, which can influence maternal serum folate levels and birthweight when included in genetic analyses.<SEP>A variant in the MTHFR gene that significantly influences maternal serum folate levels and birthweight when included in analyses.", "source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "id": "MTHFR SNP RS1801133"}, {"entity_type": "NUTRIENT", "description": "Serum folate levels in pregnant women, which are influenced by genetic variants and can affect offspring birth weight.", "source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "id": "MATERNAL SERUM FOLATE LEVELS"}, {"entity_type": "NUTRIENT", "description": "Levels of folate in the fetus during pregnancy that negatively impact fetal birth weight.", "source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "id": "FETAL FOLATE LEVELS"}, {"entity_type": "NUTRIENT", "description": "B12, also known as cobalamin, is another vitamin B nutrient crucial for red blood cell formation and nerve function.", "source_id": "chunk-22216738ccbae0a6276bb4499018c434", "id": "B12 (COBALAMIN)"}, {"entity_type": "MOLECULAR INTERACTION", "description": "A statistical method used to detect directional pleiotropy in Mendelian randomization studies.", "source_id": "chunk-22216738ccbae0a6276bb4499018c434", "id": "MR EGGER RESULT"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Inverse variance weighted analysis, a technique for estimating causal effects using genetic variants as instrumental variables.", "source_id": "chunk-22216738ccbae0a6276bb4499018c434", "id": "IVW ANALYSIS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The weight of an infant at birth, which can be influenced by maternal and fetal nutrient levels.", "source_id": "chunk-22216738ccbae0a6276bb4499018c434", "id": "BIRTHWEIGHT"}, {"entity_type": "DISEASE", "description": "Birthweight of the offspring is a health outcome potentially affected by maternal B12 and folate levels.", "source_id": "chunk-22216738ccbae0a6276bb4499018c434", "id": "OFFSPRING BIRTHWEIGHT"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The length of pregnancy, which was not found to be causally influenced by maternal or fetal B12 or folate levels according to MR analysis.", "source_id": "chunk-22216738ccbae0a6276bb4499018c434", "id": "GESTATIONAL DURATION"}, {"entity_type": "GENOMIC VARIANT", "description": "Single nucleotide polymorphisms (SNPs) are used as genetic instruments in Mendelian randomization studies.", "source_id": "chunk-22216738ccbae0a6276bb4499018c434", "id": "GENOMIC VARIANT (SNP)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A phenomenon where a gene has effects on a trait other than through its primary biological function, affecting the validity of causal inference in MR studies.", "source_id": "chunk-22216738ccbae0a6276bb4499018c434", "id": "DIRECTIONAL PLEIOTROPY"}, {"entity_type": "MOLECULAR INTERACTION", "description": "The variation in causal estimates across different SNPs can indicate potential issues like pleiotropy or weak instruments in MR analysis.", "source_id": "chunk-22216738ccbae0a6276bb4499018c434", "id": "HETEROGENEITY BETWEEN CAUSAL ESTIMATES AT EACH SNP"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Levels of folate present in the mother during pregnancy, which may influence offspring health outcomes such as birth weight.", "source_id": "chunk-22216738ccbae0a6276bb4499018c434", "id": "MATERNAL FOLATE LEVELS"}, {"entity_type": "NUTRIENT", "description": "Levels of vitamin B12 in the fetus, potentially affecting developmental outcomes.", "source_id": "chunk-22216738ccbae0a6276bb4499018c434", "id": "FETAL B12 LEVELS"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Specific population samples used for research purposes, here focusing on maternal and offspring health.", "source_id": "chunk-22216738ccbae0a6276bb4499018c434", "id": "DANISH COHORTS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Additional tables providing detailed data from the study regarding genetic associations with folate and B12 levels.", "source_id": "chunk-22216738ccbae0a6276bb4499018c434", "id": "SUPPLEMENTARY TABLE S7-S8"}, {"entity_type": "GENOMIC VARIANT", "description": "A genetic variant located at position 677 of the MTHFR gene, which is associated with LV (Leiomyoma of the uterus) patients.<SEP>The MTHFR C677T variant is a common genomic variant associated with an increased risk of thrombosis and cardiovascular disease.", "source_id": "chunk-d0476488384aadcae4630e94d982d2e0<SEP>chunk-b025a32e74a29cbbd5a0ce3d051f3fdb", "id": "MTHFR C677T"}, {"entity_type": "GENOMIC VARIANT", "description": "A genetic variant located at position 1298 of the MTHFR gene, also linked to LV patients.<SEP>The MTHFR A1298C variant is another genomic variant in the methylenetetrahydrofolate reductase gene, associated with reduced enzyme activity and potential health risks.", "source_id": "chunk-d0476488384aadcae4630e94d982d2e0<SEP>chunk-b025a32e74a29cbbd5a0ce3d051f3fdb", "id": "MTHFR A1298C"}, {"entity_type": "GENOMIC VARIANT", "description": "A genetic variant in the PAI-1 (Plasminogen Activator Inhibitor 1) gene associated with LV patients.<SEP>The PAI-1 -675 4G/5G variant is a polymorphism in the plasminogen activator inhibitor-1 gene, which affects fibrinolysis and thrombosis risk.", "source_id": "chunk-d0476488384aadcae4630e94d982d2e0<SEP>chunk-b025a32e74a29cbbd5a0ce3d051f3fdb", "id": "PAI-1 -675 4G/5G"}, {"entity_type": "GENOMIC VARIANT", "description": "A rare genetic variant in the PAI-1 gene, relevant to LV patients.<SEP>The PAI-1 A844G variant is a polymorphism in the plasminogen activator inhibitor-1 gene, which may influence fibrinolytic activity and cardiovascular risk.", "source_id": "chunk-d0476488384aadcae4630e94d982d2e0<SEP>chunk-b025a32e74a29cbbd5a0ce3d051f3fdb", "id": "PAI-1 A844G"}, {"entity_type": "GENOMIC VARIANT", "description": "A genetic variant in the prothrombin gene associated with thrombotic disorders, including relevance to LV conditions.<SEP>A genetic variant in the prothrombin gene associated with thrombotic disorders, including relevance to LV patients.<SEP>The Prothrombin G20210A variant is a genetic polymorphism associated with an increased risk of thrombotic disorders.", "source_id": "chunk-d0476488384aadcae4630e94d982d2e0<SEP>chunk-b025a32e74a29cbbd5a0ce3d051f3fdb", "id": "PROTHROMBIN G20210A"}, {"entity_type": "GENOMIC VARIANT", "description": "A genetic variation in Factor V gene that is less common but relevant to thrombosis and possibly LV conditions.<SEP>The Factor V G1691A variant is a mutation in the coagulation factor V gene, linked to hypercoagulability and an elevated risk for venous thromboembolism.", "source_id": "chunk-d0476488384aadcae4630e94d982d2e0<SEP>chunk-b025a32e74a29cbbd5a0ce3d051f3fdb", "id": "FACTOR V G1691A"}, {"entity_type": "DISEASE", "description": "A benign tumour arising from smooth muscle cells, specifically found in the uterus, associated with certain genotypes and genetic variants.", "source_id": "chunk-b025a32e74a29cbbd5a0ce3d051f3fdb", "id": "LV (LEIOMYOMA OF THE UTERUS)"}, {"entity_type": "GENE", "description": "Plasminogen Activator Inhibitor 1 gene, involved in fibrinolysis and has genetic variants relevant to thrombotic disorders including LV.<SEP>The PAI-1 gene encodes a protein that regulates fibrinolysis and plays a role in the risk of thrombosis due to genetic variants.", "source_id": "chunk-d0476488384aadcae4630e94d982d2e0<SEP>chunk-b025a32e74a29cbbd5a0ce3d051f3fdb", "id": "PAI-1"}, {"entity_type": "GENE", "description": "Coagulation factor V gene that produces a protein essential for blood coagulation; associated with Factor V Leiden mutation contributing to thrombosis risk.", "source_id": "chunk-b025a32e74a29cbbd5a0ce3d051f3fdb", "id": "FACTOR V "}, {"entity_type": "DISEASE", "description": "A benign tumour arising from smooth muscle cells, specifically found in the uterus, associated with certain genotypes and genetic variants.", "source_id": "chunk-b025a32e74a29cbbd5a0ce3d051f3fdb", "id": "LEIOMYOMA OF THE UTERUS (LV)"}, {"entity_type": "DISEASE", "description": "Lipoprotein(a) (LV) is a plasma protein associated with an elevated risk of cardiovascular disease and thrombotic disorders.", "source_id": "chunk-d0476488384aadcae4630e94d982d2e0", "id": "LV"}, {"entity_type": "GENE", "description": "The Prothrombin gene encodes coagulation Factor II and is associated with an increased risk of thrombosis due to genetic variations.", "source_id": "chunk-d0476488384aadcae4630e94d982d2e0", "id": "PROTHROMBIN"}, {"entity_type": "GENE", "description": "The Factor V gene encodes a coagulation factor that is crucial for thrombin generation and its variants can lead to an increased risk of thrombosis.", "source_id": "chunk-d0476488384aadcae4630e94d982d2e0", "id": "FACTOR V"}, {"source_id": "chunk-d0476488384aadcae4630e94d982d2e0", "description": "The PAI-1 -675 4G/5G polymorphism increases the risk of thrombotic events due to its influence on fibrinolysis.<SEP>The PAI-1 -675 4G/5G variant is associated with an increased risk of thrombotic disorders due to its effect on fibrinolysis.", "entity_type": "UNKNOWN", "id": "THROMBOSIS"}, {"source_id": "chunk-d0476488384aadcae4630e94d982d2e0", "description": "The Factor V G1691A mutation leads to a hypercoagulable state and increases the risk for venous thromboembolism.<SEP>The Factor V G1691A mutation leads to hypercoagulability and an increased risk for venous thromboembolism.", "entity_type": "UNKNOWN", "id": "HYPERCOAGULABILITY"}, {"source_id": "chunk-d0476488384aadcae4630e94d982d2e0", "description": "The MTHFR C677T variant is associated with an increased risk of cardiovascular disease due to elevated homocysteine levels.", "entity_type": "UNKNOWN", "id": "CARDIOVASCULAR DISEASE"}, {"entity_type": "NUTRIENT", "description": "Vitamin B12 plays an essential role in the formation of red blood cells and maintenance of the nervous system by acting as a cofactor for enzymes involved in DNA synthesis, repair, and methylation.", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "id": "VITAMIN B12 (COBALAMIN)"}, {"entity_type": "METABOLIC PATHWAY", "description": "tHcy is an intermediate metabolite in the folate and vitamin B12-dependent remethylation pathway that converts homocysteine back to methionine, which is crucial for cellular function.", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "id": "THCY (TOTAL HOMOCYSTEINE)"}, {"source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "description": "Homocysteine metabolism is regulated by MTHFR activity, impacting tHcy levels in the body.", "entity_type": "UNKNOWN", "id": "MTHFR GENE"}, {"source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "description": "The availability of vitamin B12 through TCblR gene expression influences folate-dependent processes and impacts health outcomes including infertility risk.", "entity_type": "UNKNOWN", "id": "B12 TRANSCOBALAMIN RECEPTOR (TCBLR) GENE"}, {"source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "description": "High levels of DNA fragmentation in sperm are strongly associated with reduced fertility, indicating a link between physiological damage to sperm cells and male infertility.", "entity_type": "UNKNOWN", "id": "DNA FRAGMENTATION"}, {"source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "description": "High levels of DNA fragmentation in sperm are strongly associated with reduced fertility, indicating a link between physiological damage to sperm cells and male infertility.", "entity_type": "UNKNOWN", "id": "MALE INFERTILITY"}, {"source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45<SEP>chunk-befd5ea20007b1d02d987897c798dadd", "description": "BMI may influence uric acid levels and HUA risk but was not specifically mentioned in the provided text.<SEP>Higher BMI is associated with an increased risk of male infertility due to metabolic imbalances affecting reproductive health.", "entity_type": "NUTRIENT", "id": "BODY MASS INDEX (BMI)"}, {"entity_type": "GENOMIC VARIANT", "description": "A polymorphism rs1979277 in the SHMT1 gene resulting in Leu435Phe substitution is associated with increased risk for TMD patients compared to controls.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "id": "RS1979277 G ALLELE"}, {"entity_type": "GENOMIC VARIANT", "description": "Polymorphism rs638416 of the SHMT1 promoter region resulting in a significant increase of the C allele and CC genotype in TMD patients compared to healthy controls.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "id": "RS638416 C ALLELE AND CC GENOTYPE"}, {"entity_type": "GENOMIC VARIANT", "description": "Transition from G to A (rs2236225) in the MTHFD1 gene leading to an ARG-653-GLN alteration is associated with susceptibility to neural tube defects and statistical differences were observed in TMD patients compared to healthy controls.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "id": "RS2236225 G ALLELE"}, {"entity_type": "GENOMIC VARIANT", "description": "A deletion of the GSTM1 gene resulting in a null variant, which increases cancer risk and male infertility by altering detoxification efficiency and susceptibility to environmental toxins and carcinogens.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "id": "GSTM1-NULL POLYMORPHISM"}, {"entity_type": "GENOMIC VARIANT", "description": "Substitution of A to G (rs1801394) in the MTRR gene results in an enzyme with less affinity for substrate, observed statistically more frequent among TMD patients compared to controls.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "id": "RS1801394 A ALLELE"}, {"entity_type": "GENOMIC VARIANT", "description": "A 48-bp VNTR in exon 3 of the DRD4 gene that presents statistical differences in genotype frequencies between TMD and control groups, but not a significant increase for S-DRD4 allele.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "id": "DRD4-48BPTR POLYMORPHISM"}, {"entity_type": "PROTEIN", "description": "MTRR is responsible for regenerating Methionine Synthase using SAM as methyl donor through reductive methylation, and its genetic variant impacts disease susceptibility.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "id": "METHIONINE SYNTHASE REDUCTASE (MTRR)"}, {"entity_type": "PROTEIN", "description": "Encodes an enzyme involved in detoxifying electrophilic compounds by conjugation with glutathione, associated with increased cancer risk due to the null variant of GSTM1 gene.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "id": "GLUTATHIONE S-TRANSFERASE MU 1 (GSTM1)"}, {"entity_type": "NUTRIENT", "description": "A key nutrient important for one-carbon metabolism and nucleotide synthesis, involved in methylation reactions catalyzed by enzymes encoded by SHMT1 and MTHFD1 genes.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "id": "TETRAHYDROFOLATE (THF)"}, {"source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "description": "The GSTM1-null polymorphism, a deletion of the GSTM1 gene, was found statistically more frequent in TMD patients compared to control groups, suggesting an increased risk for disease.", "entity_type": "UNKNOWN", "id": "TMD DISEASE"}, {"entity_type": "PHYSIOLOGICAL PROCESS/MOLECULAR INTERACTION", "description": "This method measures serum folate using microbiological assay techniques.", "source_id": "chunk-dd3c1834035af8b4436c8058609b6fd8", "id": "SERUM FOLATE MEASUREMENT METHODS (CDC MBA)"}, {"entity_type": "PHYSIOLOGICAL PROCESS/MOLECULAR INTERACTION", "description": "A chromatographic technique for measuring serum folate levels with high precision and specificity.", "source_id": "chunk-dd3c1834035af8b4436c8058609b6fd8", "id": "SERUM FOLATE MEASUREMENT METHODS (CDC HPLC-MS/MS)"}, {"entity_type": "NUTRIENT", "description": "An active form of folate that is crucial for methylation reactions in the body.", "source_id": "chunk-dd3c1834035af8b4436c8058609b6fd8", "id": "5-METHYLTHF (5-METHYLTETRAHYDROFOLATE)"}, {"entity_type": "NUTRIENT/DIETARY PATTERN", "description": "A calibrator used in laboratory tests to measure folic acid levels, essential for accurate assessment of folate status.<SEP>A standard substance used to calibrate assays measuring folic acid levels.", "source_id": "chunk-7c25217961fba65d15f20beda8a58f1c<SEP>chunk-dd3c1834035af8b4436c8058609b6fd8", "id": "FOLIC ACID CALIBRATOR"}, {"entity_type": "PHYSIOLOGICAL PROCESS/MOLECULAR INTERACTION", "description": "Procedures involving 96-well microplates for sample handling and analysis.", "source_id": "chunk-dd3c1834035af8b4436c8058609b6fd8", "id": "LABORATORY PROCEDURES (MICROPLATE FORMAT)"}, {"entity_type": "PHYSIOLOGICAL PROCESS/MOLECULAR INTERACTION", "description": "A method used to quantify calibrators by measuring absorbance at specific wavelengths.", "source_id": "chunk-dd3c1834035af8b4436c8058609b6fd8", "id": "SPECTROPHOTOMETRY"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The microorganism effect refers to the variability observed in laboratory results due to differences in microbial populations used as standards for measuring nutrients like folate.", "source_id": "chunk-257a38a8ce6582c434f31b023b4a9704", "id": "MICROORGANISM EFFECT"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "The calibrator effect indicates how different types of calibration reagents (IH-CAL, CDC-CAL) influence the accuracy and variability of laboratory measurements for nutrients such as folate.", "source_id": "chunk-257a38a8ce6582c434f31b023b4a9704", "id": "CALIBRATOR EFFECT"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Reagents provided by the CDC (Centers for Disease Control and Prevention) for standardizing measurements across laboratories.", "source_id": "chunk-7c25217961fba65d15f20beda8a58f1c", "id": "CDC REAGENTS"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Reagents used in laboratory tests that are not standardized with CDC reagents, leading to variability in results.", "source_id": "chunk-7c25217961fba65d15f20beda8a58f1c", "id": "IH REAGENTS"}, {"entity_type": "DISEASE", "description": "A target value established by the CDC as a standard for measuring folate levels in laboratories, crucial for diagnosing and managing conditions related to folate deficiency.", "source_id": "chunk-7c25217961fba65d15f20beda8a58f1c", "id": "CDC MBA TARGET VALUE"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Used in laboratory tests with CDC reagents for comparison purposes, ensuring consistency across different testing environments.", "source_id": "chunk-7c25217961fba65d15f20beda8a58f1c", "id": "MICROORGANISM"}, {"entity_type": "METABOLIC PATHWAY", "description": "A measure or pathway associated with serum folate levels used to assess folate status in laboratories.", "source_id": "chunk-7c25217961fba65d15f20beda8a58f1c", "id": "S-FOL"}, {"entity_type": "METABOLIC PATHWAY", "description": "A measure or pathway associated with whole-blood folate levels used to assess folate status in laboratories.", "source_id": "chunk-7c25217961fba65d15f20beda8a58f1c", "id": "WB-FOL"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Specific laboratories that showed deviations from the standard agreement when using CDC reagents for measuring folate levels.", "source_id": "chunk-7c25217961fba65d15f20beda8a58f1c", "id": "LABORATORY #6 AND #9"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Results obtained during two consecutive days of analysis in laboratories, used to assess the variability of measurements.", "source_id": "chunk-7c25217961fba65d15f20beda8a58f1c", "id": "DAY 1 AND DAY 2 ANALYSIS RESULTS"}, {"entity_type": "GENOMIC VARIANT", "description": "A polymorphism in the gene associated with breast cancer risk.", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e", "id": "RS1695 POLYMORPHISM"}, {"entity_type": "DISEASE", "description": "A type of cancer that originates in tissues of the breast.", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e", "id": "BREAST CANCER"}, {"entity_type": "GENOMIC VARIANT", "description": "The homozygote genotype GG is associated with an increased risk of breast cancer according to OR and 95%CI values.", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e", "id": "GG GENOTYPE"}, {"entity_type": "GENOMIC VARIANT", "description": "Allele G is associated with the increased risk of breast cancer according to OR and 95%CI values.", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e", "id": "G ALLELE"}, {"entity_type": "GENOMIC VARIANT", "description": "A polymorphism in a gene not significantly associated with breast cancer risk based on statistical analysis.", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e", "id": "RS1138272 POLYMORPHISM"}, {"entity_type": "GENOMIC VARIANT", "description": "Homozygote TT genotype is not associated with an increased risk of breast cancer according to OR and 95%CI values.<SEP>The TT genotype serves as a reference or control in studies comparing its effects to other genotypes, such as the CT genotype.", "source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59<SEP>chunk-ab5011584b0230efbf80a98b2a693a0e", "id": "TT GENOTYPE"}, {"entity_type": "GENOMIC VARIANT", "description": "The CT genotype is a genetic variant of interest that influences the rewarding effects of alcohol consumption.<SEP>The heterozygote CT genotype is also not associated with a significant risk of breast cancer based on the provided data.", "source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59<SEP>chunk-ab5011584b0230efbf80a98b2a693a0e", "id": "CT GENOTYPE"}, {"entity_type": "GENOMIC VARIANT", "description": "Allele T is not significantly associated with an increased risk of breast cancer according to OR and 95%CI values.<SEP>The T allele was observed to be slightly lower in CRC patients compared to the control group.", "source_id": "chunk-5b0cc96debf110f3544685d3b227ff27<SEP>chunk-ab5011584b0230efbf80a98b2a693a0e", "id": "T ALLELE"}, {"entity_type": "GENOMIC VARIANT", "description": "A single nucleotide polymorphism in the GSTP1 gene that affects protein function.", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e", "id": "ILE105VAL SNP"}, {"entity_type": "PROTEIN", "description": "The GSTP1 protein, whose amyloid propensity is influenced by Ile105Val SNP according to WALTZ analysis.", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e", "id": "GSTP1 PROTEIN"}, {"entity_type": "GENOMIC VARIANT", "description": "The AG genotype of rs1695 polymorphism had frequencies of 44.00% for controls and 49.00% for cases, without significant association to breast cancer risk.", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e", "id": "AG GENOTYPE"}, {"entity_type": "GENOMIC VARIANT", "description": "Homozygote GG genotype in case groups is associated with increased risk of breast cancer according to OR and 95%CI values.", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e", "id": "GG GENOTYPE (CASES)"}, {"entity_type": "GENOMIC VARIANT", "description": "Homozygote GG genotype in control groups has a frequency of 06.00%, not significantly altering the risk of breast cancer alone but contributing when analyzed with cases.", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e", "id": "GG GENOTYPE (CONTROLS)"}, {"entity_type": "GENOMIC VARIANT", "description": "A CC genotype is associated with an increased occurrence of colorectal cancer (CRC).<SEP>The CC genotype of rs1138272 polymorphism had frequencies of 92.00% for controls and 88.00% for cases, showing no significant impact on breast cancer risk.", "source_id": "chunk-5b0cc96debf110f3544685d3b227ff27<SEP>chunk-ab5011584b0230efbf80a98b2a693a0e", "id": "CC GENOTYPE"}, {"entity_type": "GENOMIC VARIANT", "description": "Heterozygote CT genotype in case groups is not associated with increased breast cancer risk according to OR and 95%CI values.", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e", "id": "CT GENOTYPE (CASES)"}, {"entity_type": "GENOMIC VARIANT", "description": "Homozygote TT genotype was not observed in control groups, indicating rare occurrence in controls.", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e", "id": "TT GENOTYPE (CONTROLS)"}, {"entity_type": "GENOMIC VARIANT", "description": "Homozygote TT genotype is found at a frequency of 01.00% in case groups but does not significantly increase breast cancer risk according to OR and 95%CI values.", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e", "id": "TT GENOTYPE (CASES)"}, {"entity_type": "GENOMIC VARIANT", "description": "Carriers of allele C did not show significant differences or associations with increased breast cancer risk compared to carriers of other alleles.", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e", "id": "ALLELE C"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Software used for evaluating the effects of single nucleotide polymorphisms on protein function, including aggregation tendency and chaperone binding tendency.", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e", "id": "SNP ANALYSIS SOFTWARE (SNPEFFECTS)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Algorithm predicting amyloid-forming areas in proteins and estimating changes due to mutations.", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e", "id": "WALTZ ALGORITHM"}, {"entity_type": "MOLECULAR INTERACTION", "description": "The degree to which a protein can form amyloids, influenced by specific mutations like Ile105Val SNP.", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e", "id": "AMYLOID PROPENSITY"}, {"entity_type": "GENOMIC VARIANT", "description": "A pathogenic variant in China associated with three haplogroups A, B, C.<SEP>A pathogenic variant located at residue 778 of a gene, with the genetic code being R (Arginine) replaced by L (Leucine).", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1<SEP>chunk-047f259db19cbb4de945706a1bd1b450", "id": "P.R778L"}, {"entity_type": "GENOMIC VARIANT", "description": "A pathogenic variant located at residue 992 of a gene, with the genetic code being P (Proline) replaced by L (Leucine).<SEP>A pathogenic variant with a more complex haplotype spectrum compared to p.R778L, including six haplogroups.", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1<SEP>chunk-047f259db19cbb4de945706a1bd1b450", "id": "P.P992L"}, {"entity_type": "GENOMIC VARIANT", "description": "A pathogenic variant located at residue 935 of a gene, with the genetic code being T (Threonine) replaced by M (Methionine).<SEP>A pathogenic variant presenting a uniform state in patients with only one kind of haplogroup on WD chromosomes.", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1<SEP>chunk-047f259db19cbb4de945706a1bd1b450", "id": "P.T935M"}, {"entity_type": "DISEASE", "description": "Patients diagnosed with Wilson Disease (WD), a disorder caused by a build-up of copper in the body\'s tissues.", "source_id": "chunk-047f259db19cbb4de945706a1bd1b450", "id": "WD PATIENTS"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "One of five regions where WD patients were predominantly found, located in southeastern China.", "source_id": "chunk-047f259db19cbb4de945706a1bd1b450", "id": "FUJIAN PROVINCE"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "A region contributing a significant number of WD patients and showing varying allelic frequencies for pathogenic variants.", "source_id": "chunk-047f259db19cbb4de945706a1bd1b450", "id": "ZHEJIANG PROVINCE"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "One of the regions with a considerable number of WD patients, particularly those with p.T935M variant.", "source_id": "chunk-047f259db19cbb4de945706a1bd1b450", "id": "JIANGSU PROVINCE"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "A region where WD patients were identified and showed a specific allelic frequency for pathogenic variants.", "source_id": "chunk-047f259db19cbb4de945706a1bd1b450", "id": "SHANGHAI CITY"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "One of the regions included in the study, with notable differences in allelic frequencies for p.P992L compared to other areas.", "source_id": "chunk-047f259db19cbb4de945706a1bd1b450", "id": "JIANGXI PROVINCE"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant with a genetic change from G to T at position 2333 in the DNA sequence, corresponding to p.R778L.", "source_id": "chunk-047f259db19cbb4de945706a1bd1b450", "id": "C.2333G > T"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant with a genetic change from C to T at position 2975 in the DNA sequence, corresponding to p.P992L.", "source_id": "chunk-047f259db19cbb4de945706a1bd1b450", "id": "C.2975C > T"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant with a genetic change from C to T at position 2804 in the DNA sequence, corresponding to p.T935M.", "source_id": "chunk-047f259db19cbb4de945706a1bd1b450", "id": "C.2804C > T"}, {"entity_type": "MARKER", "description": "Microsatellite marker used for analyzing linkage disequilibrium and haplotype associations of pathogenic variants.", "source_id": "chunk-047f259db19cbb4de945706a1bd1b450", "id": "D13S314"}, {"entity_type": "MARKER", "description": "Microsatellite marker utilized in the study to observe allele distribution and linkage disequilibrium with prevalent pathogenic variants.", "source_id": "chunk-047f259db19cbb4de945706a1bd1b450", "id": "D13S301"}, {"entity_type": "MARKER", "description": "Another microsatellite marker used for investigating linkage disequilibrium patterns associated with p.R778L, p.P992L, and p.T935M variants.", "source_id": "chunk-047f259db19cbb4de945706a1bd1b450", "id": "D13S316"}, {"entity_type": "GENOMIC VARIANT HAPLOTYPE GROUP", "description": "A specific haplotype group predominantly found in WD patients for the variant p.R778L.<SEP>The most common haplogroup for p.R778L, found overwhelmingly on WD chromosomes compared to control ones.", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1<SEP>chunk-047f259db19cbb4de945706a1bd1b450", "id": "HAPLOGROUP A"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific variant within haplogroup A that accounts for the largest proportion among patients with p.R778L.", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "id": "VARIANT A1 (10-7-7)"}, {"entity_type": "GENE", "description": "A less common haplogroup compared to haplogroup A in individuals with p.R778L.", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "id": "HAPLOGROUP B (10-7-9)"}, {"entity_type": "GENE", "description": "Another less frequent haplogroup in patients carrying the p.R778L variant.", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "id": "HAPLOGROUP C (12-5-7; 12-6-7)"}, {"entity_type": "GENE", "description": "The most common haplogroup for p.P992L on WD chromosomes, with variant E1 being the main part of this group.", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "id": "HAPLOGROUP E (10-9-5)"}, {"entity_type": "GENOMIC VARIANT", "description": "Main variant within haplogroup E that is significantly more frequent in patients carrying p.P992L compared to controls.", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "id": "VARIANT E1 (10-9-5)"}, {"entity_type": "GENE", "description": "Less common haplogroups for p.P992L, appearing sporadically among WD chromosomes.", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "id": "HAPLOGROUP D (9-7-5), F (10-9-8), G (10-11-5), H (12-4-5; 12-5-5), I (12-5-8)"}, {"entity_type": "GENE", "description": "The sole haplogroup found for p.T935M among WD chromosomes, consisting of two variants J1 and J2.", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "id": "HAPLOGROUP J (12-4-8; 12-5-8)"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Specific chromosomes associated with certain diseases or genetic markers in patients.", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "id": "WD CHROMOSOMES"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Chromosomes used for comparison against patient chromosomes to identify differences in genetic variants and haplogroups.", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "id": "CONTROL ONES (CHROMOSOMES)"}, {"source_id": "chunk-047f259db19cbb4de945706a1bd1b450", "description": "Microsatellite marker D13S314 exhibits significant linkage disequilibrium with the pathogenic variants p.R778L, p.P992L, and p.T935M.", "entity_type": "UNKNOWN", "id": "P.R778L, P.P992L, AND P.T935M"}, {"source_id": "chunk-047f259db19cbb4de945706a1bd1b450", "description": "Marker D13S301 shows significant association with alleles linked to pathogenic variants p.R778L, p.P992L, and p.T935M.", "entity_type": "UNKNOWN", "id": "P.R778L, P.P992L, P.T935M"}, {"entity_type": "GENOMIC VARIANT", "description": "rs1799853 is a single nucleotide polymorphism in CYP2C9 that reduces enzyme activity.", "source_id": "chunk-f433e179cd5e32035a0303b9a14da3f1", "id": "RS1799853"}, {"entity_type": "GENOMIC VARIANT", "description": "rs1057910 is a single nucleotide polymorphism in CYP2C9, contributing to variant group due to low frequency and reduced enzyme activity.", "source_id": "chunk-f433e179cd5e32035a0303b9a14da3f1", "id": "RS1057910"}, {"entity_type": "GENOMIC VARIANT", "description": "rs28371686 is part of the CYP2C9 star variant group linked with lower enzyme function.", "source_id": "chunk-f433e179cd5e32035a0303b9a14da3f1", "id": "RS28371686"}, {"entity_type": "GENOMIC VARIANT", "description": "rs7900194, a member of the CYP2C9 variant group, indicates reduced activity due to genetic variation.", "source_id": "chunk-f433e179cd5e32035a0303b9a14da3f1", "id": "RS7900194"}, {"entity_type": "GENOMIC VARIANT", "description": "A single nucleotide polymorphism in the CYP2C9 gene linked with altered enzyme function and part of a star variant group.", "source_id": "chunk-f433e179cd5e32035a0303b9a14da3f1", "id": "RS28371685"}, {"entity_type": "GENOMIC VARIANT GROUP", "description": "Various alleles of the CYP2C9 gene that collectively indicate reduced activity through genetic variants.", "source_id": "chunk-f433e179cd5e32035a0303b9a14da3f1", "id": "CYP2C9*2, *3, *5, *8, AND *11 "}, {"entity_type": "ALGORITHM", "description": "An algorithm designed to predict warfarin dose based on demographic, clinical, and genetic factors for personalized treatment planning.", "source_id": "chunk-f433e179cd5e32035a0303b9a14da3f1", "id": "WARFARIN DOSING ALGORITHM "}, {"entity_type": "DISEASE", "description": "Deep Vein Thrombosis/Pulmonary Embolism (DVT/PE) is a medical condition often treated with warfarin as an anticoagulant.", "source_id": "chunk-f433e179cd5e32035a0303b9a14da3f1", "id": "DVT/PE "}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Hardy-Weinberg Equilibrium, a measure used in population genetics to assess genetic diversity and allele frequency stability over generations.", "source_id": "chunk-f433e179cd5e32035a0303b9a14da3f1", "id": "HWE "}, {"entity_type": "ALGORITHM", "description": "The IWPC pharmacogenomics algorithm is used to predict therapeutic doses based on genetic information.", "source_id": "chunk-b2730f3087aee6d9cff6e4939b229323", "id": "IWPC PHARMACOGENOMICS ALGORITHM"}, {"entity_type": "ALGORITHM", "description": "A novel algorithm designed for patients of African American (AA) ancestry that predicts therapeutic drug doses more accurately than traditional methods.", "source_id": "chunk-b2730f3087aee6d9cff6e4939b229323", "id": "NOVEL AA ALGORITHM"}, {"entity_type": "ALGORITHM", "description": "The IWPC clinical algorithm is used to predict therapeutic doses based on clinical criteria rather than genetic information.", "source_id": "chunk-b2730f3087aee6d9cff6e4939b229323", "id": "IWPC CLINICAL ALGORITHM"}, {"entity_type": "PATIENT GROUP", "description": "A group of patients requiring high drug dosages, specifically \u226560 mg/week in this context.", "source_id": "chunk-b2730f3087aee6d9cff6e4939b229323", "id": "HIGH-DOSE PATIENTS GROUP"}, {"entity_type": "MEASURE", "description": "Percentage of whole African ancestry in individuals which is measured using AIMs and used to correlate with the efficacy of pharmacogenomics algorithms.", "source_id": "chunk-b2730f3087aee6d9cff6e4939b229323", "id": "WAA (WHOLE AFRICAN ANCESTRY)"}, {"entity_type": "GENETIC MARKER", "description": "Markers that are informative for distinguishing ancestry among populations, particularly useful for studying admixed populations like African Americans.", "source_id": "chunk-b2730f3087aee6d9cff6e4939b229323", "id": "AIMS (ANCESTRY INFORMATIVE MARKERS)"}, {"entity_type": "VARIABLE", "description": "The predicted dose is a variable used to evaluate the performance of pharmacogenomics algorithms.", "source_id": "chunk-b2730f3087aee6d9cff6e4939b229323", "id": "PREDICTED DOSE"}, {"entity_type": "VARIABLE", "description": "The observed dose refers to the actual administered drug dosage for patients, used as a reference in evaluating algorithm precision.", "source_id": "chunk-b2730f3087aee6d9cff6e4939b229323", "id": "OBSERVED DOSE"}, {"entity_type": "MEASURE", "description": "A statistical measure representing the average absolute difference between predicted and observed doses.", "source_id": "chunk-b2730f3087aee6d9cff6e4939b229323", "id": "MAE (MEAN ABSOLUTE ERROR)"}, {"entity_type": "CLINICAL MEASURE", "description": "The number of patients that need to be genotyped to prevent one patient from receiving a dose outside the therapeutic range, indicating clinical benefit.", "source_id": "chunk-b2730f3087aee6d9cff6e4939b229323", "id": "NNG (NUMBER NEEDED TO GENOTYPE)"}, {"entity_type": "MEASURE", "description": "A 20% therapeutic dose range within which doses are considered optimal and safe for treatment.", "source_id": "chunk-b2730f3087aee6d9cff6e4939b229323", "id": "THERAPEUTIC DOSE RANGE"}, {"entity_type": "STATISTICAL METHOD", "description": "A statistical method used to analyze the relationship between percent WAA and predicted dose among high-dose patients.", "source_id": "chunk-b2730f3087aee6d9cff6e4939b229323", "id": "LINEAR REGRESSION ANALYSIS"}, {"entity_type": "MEASURE", "description": "The beta coefficient indicates the strength of an inverse correlation in linear regression analysis, revealing how changes in one variable affect another.", "source_id": "chunk-b2730f3087aee6d9cff6e4939b229323", "id": "\u0392 (BETA COEFFICIENT)"}, {"source_id": "chunk-f433e179cd5e32035a0303b9a14da3f1", "description": "rs1057910 is part of the combined CYP2C9 star variant group due to its low frequency and impact on enzyme activity.", "entity_type": "UNKNOWN", "id": "CYP2C9 STAR VARIANT GROUP "}, {"source_id": "chunk-f433e179cd5e32035a0303b9a14da3f1", "description": "rs1057910 is part of the combined CYP2C9 star variant group due to its low frequency and impact on enzyme activity.", "entity_type": "UNKNOWN", "id": "RS1057910 "}, {"source_id": "chunk-b2730f3087aee6d9cff6e4939b229323", "description": "There is an inverse correlation between percent WAA and predicted dose within the 20% therapeutic range for IWPC pharmacogenomics algorithm, indicating it performs poorly with varying levels of African ancestry among patients.)", "entity_type": "UNKNOWN", "id": "WAA"}, {"source_id": "chunk-b2730f3087aee6d9cff6e4939b229323", "description": "The NNG is calculated based on the need to prevent a dose from falling outside of the therapeutic range, indicating clinical benefit.)", "entity_type": "UNKNOWN", "id": "NNG"}, {"entity_type": "GENOMIC VARIANT", "description": "The CYP24A1 SNP rs927650 is a genomic variant that has a significant association with colorectal adenoma recurrence and advanced adenoma recurrence.", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "id": "CYP24A1 SNP RS927650"}, {"entity_type": "GENOMIC VARIANT", "description": "SNPs in the genes CYP27B1 and CYP24A1 are associated with features of advanced colorectal adenoma recurrence, particularly in relation to 25(OH)D concentrations.", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "id": "CYP27B1 AND CYP24A1 SNPS"}, {"entity_type": "NUTRIENT", "description": "Vitamin D metabolites play a role in the interaction between genetic variants and risk for colorectal adenomas.", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "id": "VITAMIN D METABOLITES"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The recurrence of adenomas is influenced by both genetic factors and vitamin D levels, indicating a complex physiological process.", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "id": "ADENOMA RECURRENCE"}, {"entity_type": "DISEASE", "description": "Advanced adenoma recurrence represents a more severe outcome within the spectrum of colorectal diseases.", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "id": "ADVANCED ADENOMA RECURRENCE"}, {"entity_type": "METABOLIC PATHWAY", "description": "Levels of 25-hydroxyvitamin D (25(OH)D) are part of the metabolic pathway associated with vitamin D\'s effects on health outcomes, such as colorectal adenoma recurrence.", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "id": "25(OH)D CONCENTRATIONS"}, {"entity_type": "METABOLIC PATHWAY", "description": "Levels of 1,25-dihydroxyvitamin D (1,25(OH)2D) are part of the metabolic pathway involved in regulating vitamin D\'s biological activities and health outcomes.", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "id": "1,25(OH)2D CONCENTRATIONS"}, {"entity_type": "GENOMIC VARIANT", "description": "This variant is associated with advanced adenoma recurrence and may affect the risk for more severe colorectal lesions, though its impact varies depending on specific genotypes.", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "id": "CYP24A1 SNP RS35051736"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Deficiency in vitamin D (25(OH)D levels <12 ng/ml) is an environmental factor that influences adenoma recurrence risk, especially when combined with certain genetic variants.", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "id": "VITAMIN D DEFICIENCY"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific variant in CYP27B1 is associated with advanced adenoma recurrence and influences the risk of more severe colorectal lesions.", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "id": "CYP27B1 SNP RS35051736"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The presence of villous histology indicates a higher risk for recurrent adenomas, especially when considering specific genetic variants like CYP24A1 rs2296241.", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "id": "VILLOUS HISTOLOGY"}, {"entity_type": "DISEASE", "description": "Recurrences characterized by larger size or villous histology are more concerning as they indicate a progression towards more severe colorectal diseases.", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "id": "LARGER OR VILLOUS ADENOMA RECURRENCE"}, {"entity_type": "GENOMIC VARIANT", "description": "This variant in CYP27B1 interacts with 1,25(OH)2D levels and influences the risk of adenoma recurrence.", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "id": "CYP27B1 SNP RS2762939"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Individuals with inadequate vitamin D levels (between 12 and <20 ng/ml) are at higher risk for adenoma recurrence, especially if they carry certain genetic variants.", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "id": "INADEQUATE VITAMIN D LEVELS"}, {"source_id": "chunk-2fb95100a1290b27baae869c6560419a", "description": "The number of G alleles in CYP24A1 rs2296241 correlates with higher odds for recurrent adenomas with villous histology, suggesting a genetic influence on this feature.", "entity_type": "UNKNOWN", "id": "CYP24A1 SNPS"}, {"entity_type": "GENE", "description": "The CYP24A1 gene is involved in vitamin D metabolism and has been studied for its genotypes related to specific variants.", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "id": "CYP24A1 GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "This variant in the CYP24A1 gene involves a deletion of three nucleotides (AAG) at position 428-430, leading to changes in genotype interpretation.", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "id": "C.428_430DELAAG VARIANT"}, {"entity_type": "GENOMIC VARIANT", "description": "This variant in the CYP24A1 gene involves a substitution from cytosine (C) to thymine (T) at position 1186.", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "id": "C.1186C\u2009>\u2009T VARIANT"}, {"entity_type": "TRANSCRIPT", "description": "The amplicon associated with rs777676129 variant of CYP24A1 has specific melting temperatures for wt, heterozygous and homozygous genotypes.", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "id": "RS777676129 AMPLICON"}, {"entity_type": "TRANSCRIPT", "description": "The amplicon associated with rs114368325 variant of CYP24A1 also has specific melting temperatures for wt, heterozygous and homozygous genotypes.", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "id": "RS114368325 AMPLICON"}, {"entity_type": "MOLECULAR INTERACTION", "description": "HRMA is a molecular interaction analysis method that allows the identification of genetic variations through high-resolution melting curve analysis.", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "id": "HRMA (HIGH RESOLUTION MELTING ANALYSIS)"}, {"entity_type": "DISEASE", "description": "A condition suspected in some samples, where IIH is associated with specific genetic variants in the CYP24A1 gene.", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "id": "IIH (IDIOPATHIC INFANTILE HYPERCALCEMIA)"}, {"entity_type": "GENOMIC VARIANT", "description": "The wild-type refers to a standard genetic sequence of the CYP24A1 gene without any variants or mutations.", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "id": "WILD-TYPE (WT)"}, {"entity_type": "GENOMIC VARIANT", "description": "A sample that carries two different heterozygous variants in the same gene, typically resulting from inheriting one variant from each parent.", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "id": "COMPOUND HETEROZYGOUS SAMPLE"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Melting curve analysis is used to determine the stability of DNA sequences by measuring their melting temperature (Tm), which is indicative of genetic variations.", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "id": "MELTING CURVE ANALYSIS (TM)"}, {"entity_type": "GENOMIC VARIANT", "description": "The P1001L mutation is a genomic variant located in the ATP7A gene which causes Menkes disease when present.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "id": "P1001L MUTATION"}, {"entity_type": "GENE", "description": "ATP7A is a gene that encodes a protein involved in copper transport and homeostasis, mutations in this gene can lead to Menkes disease.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "id": "ATP7A GENE"}, {"entity_type": "DISEASE", "description": "Menkes disease is a rare X-linked recessive disorder caused by mutations in the ATP7A gene leading to abnormal copper metabolism.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "id": "MENKES DISEASE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The physiological process of copper transport and homeostasis, which is regulated by the protein encoded by the ATP7A gene, is critical for proper cellular function and development.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "id": "COPPER TRANSPORT AND HOMEOSTASIS"}, {"entity_type": "GENOMIC VARIANT", "description": "Mosaicism refers to a genomic variant where different cells within an organism have different genetic sequences, in this case, differing levels of the P1001L mutation were found between blood and fibroblast tissues.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "id": "MOSAICISM"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A developmental screening tool used to assess a child\u2019s progress in areas such as gross motor skills, fine motor skills, language, and personal-social development.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "id": "DENVER DEVELOPMENTAL SCREENING TEST II"}, {"entity_type": "DIAGNOSTIC TEST", "description": "A diagnostic imaging test used to visualize the structure of the brain including signs of atrophy or delayed myelination.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "id": "BRAIN MRI"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "An electrophysiological measurement indicating the strength and conduction velocity of motor nerves in the median nerve pathway.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "id": "MEDIAN NERVE COMPOUND MOTOR ACTION POTENTIALS"}, {"entity_type": "DIAGNOSTIC TEST", "description": "A measure assessing how fast an electrical signal travels along a nerve, used to diagnose neuromuscular disorders.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "id": "MEDIAN NERVE CONDUCTION VELOCITY"}, {"entity_type": "BODY FLUID", "description": "Fluid surrounding the brain and spinal cord that contains important biochemical markers for diagnosing neurological conditions.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "id": "CEREBROSPINAL FLUID (CSF)"}, {"entity_type": "DIAGNOSTIC TEST", "description": "A test measuring the ratio of catecholamines in plasma, reflecting enzyme activity critical to copper metabolism.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "id": "PLASMA CATECHOLAMINE RATIOS"}, {"source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "description": "A brain MRI can detect signs of atrophy and delayed myelination in neurological conditions like Menkes disease.", "entity_type": "UNKNOWN", "id": "ATROPHY AND DELAYED MYELINATION"}, {"source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "description": "The median nerve compound motor action potentials test evaluates the function of the nervous system in conducting motor signals.", "entity_type": "UNKNOWN", "id": "NERVOUS SYSTEM FUNCTION"}, {"source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "description": "Conduction velocity measurements help diagnose neurological disorders by assessing nerve health and integrity.", "entity_type": "UNKNOWN", "id": "NEUROLOGICAL DISORDERS"}, {"source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "description": "CSF contains biochemical markers that are critical for diagnosing Menkes disease, including copper levels and catecholamine ratios.", "entity_type": "UNKNOWN", "id": "MENKES DISEASE DIAGNOSTIC MARKERS"}, {"entity_type": "CELL LINE", "description": "Caco-2 cells are a cell line often used to study intestinal epithelial cells and their functions.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "id": "CACO-2 CELLS"}, {"entity_type": "GENE", "description": "The deiodinase gene (IDI) is responsible for the synthesis of iodothyronine deiodinases, which play key roles in thyroid hormone metabolism.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "id": "DEIODINASE GENE (IDI)"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant in the GPX4 3\u2032 untranslated region (UTR) with two alleles, T and C corresponding to rs713041.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "id": "GPX4 3\u2032UTR VARIANT (T/C)"}, {"entity_type": "TRANSCRIPT", "description": "The IDI transcript associated with the T allele of the GPX4 3\u2032 UTR variant.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "id": "IDI-T TRANSCRIPT"}, {"entity_type": "TRANSCRIPT", "description": "The IDI transcript associated with the C allele of the GPX4 3\u2032 UTR variant.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "id": "IDI-C TRANSCRIPT"}, {"entity_type": "NUTRIENT", "description": "Selenium is an essential micronutrient that plays a critical role in antioxidant defense systems through its incorporation into selenoproteins such as GPx and TR1.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "id": "SELENIUM (SE)"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "A chemical compound often used to induce oxidative stress conditions in cellular experiments, acting as an oxidizing agent.<SEP>Tert-butylhydroperoxide is an oxidizing agent used to induce oxidative stress in cells and assess their antioxidant defenses.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7<SEP>chunk-a908a3115a9120ca2623513fe4a5e13a", "id": "TERT-BUTYLHYDROPEROXIDE (T-BHP)"}, {"entity_type": "PROTEIN", "description": "Glutathione peroxidase 4 is a selenoprotein involved in antioxidant defense systems.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "id": "GPX4 PROTEIN"}, {"entity_type": "PROTEIN", "description": "A selenium-dependent enzyme that plays an important role in redox homeostasis and oxidative stress response.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "id": "THIOREDOXIN REDUCTASE 1 (TR1)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Measurement of reactive oxygen species levels as a way to assess oxidative stress conditions in cells.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "id": "ROS LEVELS"}, {"entity_type": "TRANSCRIPT", "description": "Messenger RNA encoding for selenoprotein H, an important selenoenzyme involved in redox balance and antioxidant defense.<SEP>Selenoprotein H mRNA encodes a protein that is part of the antioxidant defense system, particularly important for protecting against oxidative stress.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7<SEP>chunk-a908a3115a9120ca2623513fe4a5e13a", "id": "SELENOPROTEIN H MRNA"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The ability of cells to survive under different environmental conditions such as oxidative stress induced by t-BHP challenge.<SEP>The measure of how well cells survive under specific conditions such as oxidative challenges.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7<SEP>chunk-a908a3115a9120ca2623513fe4a5e13a", "id": "CELL VIABILITY"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "A challenge to cells using tert-butylhydroperoxide (t-BHP) to induce oxidative stress and test cell viability.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "id": "TERT-BUTYLHYDROPEROXIDE CHALLENGE"}, {"entity_type": "PROTEIN", "description": "An antioxidant protein that is dependent on selenium for its function, involved in maintaining redox balance in the cell.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "id": "SELENOPROTEIN H PROTEIN"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "A challenge to cells using an oxidizing agent (such as tert-butylhydroperoxide) to induce oxidative stress and test cellular responses.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "id": "OXIDATIVE CHALLENGE"}, {"entity_type": "TRANSCRIPT", "description": "The measurement of mRNA levels for selenoprotein H, indicating the transcriptional regulation under different conditions.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "id": "SELENOPROTEIN H MRNA LEVELS"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Cell culture medium lacking sufficient selenium, used to study the impact on cellular processes such as gene expression and protein synthesis.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "id": "SE-DEPLETED MEDIUM"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Cell culture medium with adequate levels of selenium, used for comparing effects under conditions of optimal nutritional supply.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "id": "SE-SUPPLEMENTED MEDIUM"}, {"entity_type": "NUTRIENT", "description": "Selenium is an essential trace element involved in the regulation of selenoprotein expression and cell viability.", "source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "id": "SE (SELENIUM)"}, {"entity_type": "PROTEIN", "description": "GPx4, also known as glutathione peroxidase 4, is a selenoenzyme that plays a role in antioxidant defense by reducing lipid hydroperoxides to their corresponding alcohols using reduced glutathione (GSH) as an electron donor.", "source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "id": "GPX4"}, {"entity_type": "TRANSCRIPT", "description": "The mRNA transcripts of TR1, GPx1, and GPx4 are involved in the regulation of selenoprotein expression.", "source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "id": "TR1, GPX1 AND GPX4 MRNAS"}, {"entity_type": "CELL LINE", "description": "IDI-C cells are a type of cell line that exhibit differential selenoprotein expression patterns compared to IDI-T cells under varying selenium conditions.", "source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "id": "IDI-C CELLS"}, {"entity_type": "CELL LINE", "description": "IDI-T cells are a type of cell line used for comparison with IDI-C cells in experiments assessing the effects of selenium on oxidative stress and viability.", "source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "id": "IDI-T CELLS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Reactive oxygen species are molecules that contain oxygen and can cause cellular damage when present in excessive amounts, playing a role in various physiological processes including cell signaling and death.", "source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "id": "ROS (REACTIVE OXYGEN SPECIES)"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Glutathione peroxidase activity is an enzymatic process involved in the detoxification of hydrogen peroxide and lipid hydroperoxides to reduce oxidative stress.", "source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "id": "GPX ACTIVITY"}, {"entity_type": "TRANSCRIPT", "description": "Levels of the IDI (inositol demethylase) transcript are measured as a proxy for transgene expression levels in cells.", "source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "id": "IDI TRANSCRIPT LEVELS"}, {"entity_type": "GENE", "description": "The IDI gene encodes an enzyme involved in the biosynthesis of myo-inositol, and its overexpression can affect selenoprotein expression and cell responses to oxidative stress.", "source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "id": "INOSITOL DEMETHYLASE (IDI)"}, {"entity_type": "PROTEIN FAMILY", "description": "The glutathione peroxidase family of proteins includes enzymes that protect cells from oxidative damage by reducing hydrogen peroxide and organic hydroperoxides.", "source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "id": "GLUTATHIONE PEROXIDASES (GPX1, GPX4)"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Conditions where selenium is removed or significantly reduced, leading to changes in selenoprotein expression and cell viability.", "source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "id": "SELENIUM DEPLETION"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "A test condition involving exposure to tert-butylhydroperoxide, a powerful oxidizing agent used to induce oxidative stress in cells for study.", "source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "id": "OXIDATIVE CHALLENGE (T-BHP)"}, {"entity_type": "GENE", "description": "CHAT is a gene that encodes choline acetyltransferase (ChAT), an enzyme involved in neurotransmitter synthesis.", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "id": "CHAT GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "A missense mutation p.Val136Met identified in the CHAT gene, observed in three patients and associated with altered protein expression levels.", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "id": "P.VAL136MET MUTATION"}, {"entity_type": "GENOMIC VARIANT", "description": "A missense mutation p.Ala557Thr identified in the CHAT gene, seen in five patients including a homozygous case and linked to reduced ChAT enzyme activity.", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "id": "P.ALA557THR MUTATION"}, {"entity_type": "TRANSCRIPT", "description": "The S-type transcript of the CHAT gene produces two protein isoforms (70 kDa and 74 kDa) due to alternative start sites, with a consistent expression ratio observed in spinal cord tissues.", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "id": "S-TYPE TRANSCRIPT OF CHAT GENE"}, {"entity_type": "PROTEIN", "description": "ChAT is an enzyme that catalyzes the synthesis of acetylcholine from acetyl-CoA and choline. Mutations in CHAT can affect its expression, kinetic properties, and thermal stability.", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "id": "CHOLINE ACETYLTRANSFERASE PROTEIN (CHAT)"}, {"entity_type": "GENOMIC VARIANT", "description": "An additional nonsense mutation affecting the second allele in patient 10 along with p.Ala557Thr, contributing to a specific phenotype observed in this individual.", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "id": "NONSENSE MUTATION ON SECOND ALLELE (P.ALA557THR)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The thermal stability process measures how well mutant ChAT proteins maintain their structure and function at elevated temperatures compared to the wild-type protein.", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "id": "THERMAL STABILITY OF CHAT MUTANT PROTEINS"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Various missense mutations (e.g., p.Trp421Ser, p.Ser498Pro) impact ChAT\'s kinetic parameters and thermal stability, indicating a disruption of normal molecular interactions essential for enzyme function.", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "id": "MISSENSE MUTATIONS IN CHAT GENE"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Expression and purification of histidine-tagged CHAT cDNAs in E. coli to study the kinetic properties and thermal stability of wild-type and mutant ChAT proteins.", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "id": "HISTIDINE-TAGGED CHAT CDNA EXPRESSION IN E. COLI "}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Bosc 23 cells are used as a host for expressing recombinant proteins, including mutant and wild-type CHATs in this study.", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "id": "BOSC 23 CELLS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The kinetic properties include rate constants that determine the speed and efficiency of enzymatic reactions by ChAT proteins under different conditions.", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "id": "KINETIC PROPERTIES OF WILD-TYPE AND MUTANT CHAT PROTEINS "}, {"entity_type": "GENE", "description": "The BCL2-like 11 [apoptosis facilitator] gene is associated with DNA methylation patterns in individuals with oxidative stress markers.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "BCL2L11 GENE"}, {"entity_type": "GENE", "description": "NADH dehydrogenase [ubiquinone] Fe-S protein 7, a mitochondrial complex I subunit that plays a role in cellular energy metabolism and is associated with DNA methylation patterns linked to oxidative stress markers.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "NDUFS7 GENE"}, {"entity_type": "GENE", "description": "Eukaryotic translation initiation factor 3, subunit J (EIF3J) gene shows association with DNA methylation at CpG sites related to oxidative stress markers in individuals from the PIVUS cohort.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "EIF3J GENE"}, {"entity_type": "GENE", "description": "Zinc finger protein 761 (ZNF761) is a gene whose promoter region\'s methylation level is associated with GSSG/GSH ratio, an indicator of oxidative stress state in individuals.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "ZNF761 GENE"}, {"entity_type": "GENE", "description": "Proteasome assembly chaperone 3 (PSMG3) shows significant association between its promoter methylation levels and the GSSG/GSH ratio indicating potential role in oxidative stress regulation.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "PSMG3 GENE"}, {"entity_type": "GENE", "description": "Ent-Homologous domain containing 1 gene is associated with DNA methylation patterns at CpGs related to homocysteine levels, a marker of oxidative stress and cardiovascular risk.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "ENTHD1 GENE"}, {"entity_type": "GENE", "description": "Leucine-rich repeats and immunoglobulin-like domains 1 (LRIG1) gene has methylation sites associated with the amino acid HCY, indicative of signal transduction dysregulation in the context of oxidative stress.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "LRIG1 GENE"}, {"entity_type": "GENE", "description": "Receptor-interacting serine/threonine-protein kinase 3 (RIPK3) gene methylation sites are associated with homocysteine levels, suggesting a role in signal transduction pathways under oxidative conditions.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "RIPK3 GENE"}, {"entity_type": "GENE", "description": "Ribosomal protein S6 kinase BETA-1 (RPS6KC1) gene is linked to DNA methylation patterns associated with both homocysteine levels and lipid-related processes, indicating a broad role in cellular metabolism under oxidative stress.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "RPS6KC1 GENE"}, {"entity_type": "GENE", "description": "ATPase Ca++ transporting 4 (ATP2B4) gene shows association between methylation patterns at CpG sites and homocysteine levels, implicating its role in signal transduction under oxidative stress conditions.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "ATP2B4 GENE"}, {"entity_type": "GENE", "description": "Semaphorin-6A (SEMA6A), a protein with anti-angiogenic function, shows methylation patterns at CpG sites associated with oxidized LDL levels, an indicator of lipid peroxidation and oxidative stress.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "SEMA6A GENE"}, {"entity_type": "GENE", "description": "Tapasin (TAP binding protein) gene\'s 3\'-UTR methylation level is correlated with CD marker levels indicating potential involvement in immune response regulation under oxidative conditions.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "TAPBP GENE"}, {"entity_type": "GENE", "description": "Ral guanine nucleotide dissociation stimulator-like 2 (RGL2) gene has promoter region methylation patterns associated with CD marker, a measure of lipid peroxidation products and oxidative stress state.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "RGL2 GENE"}, {"entity_type": "GENE", "description": "Cytoskeleton associated protein 5 (CKAP5) shows DNA methylation patterns at CpG sites related to BCD-LDL levels, indicating potential involvement in cellular cytoskeletal organization under oxidative conditions.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "CKAP5 GENE"}, {"entity_type": "GENE", "description": "FOS-like antigen 2 (FOSL2) gene\'s methylation level is associated with BCD-LDL levels, suggesting its role in inflammatory response regulation during oxidative stress.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "FOSL2 GENE"}, {"entity_type": "GENE", "description": "Family with sequence similarity 20, member C (FAM20C), a secreted enzyme involved in mineralization, has CpG sites associated with BCD-LDL levels indicating potential role in bone and dental development under oxidative stress.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "FAM20C GENE"}, {"entity_type": "GENE", "description": "FERM domain containing 6 (FRMD6) gene is linked to DNA methylation patterns at CpG sites associated with BCD-LDL, a marker of lipid peroxidation and oxidative stress.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "FRMD6 GENE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Oxidative stress is a physiological process involving the production of reactive oxygen species which can damage cellular components.", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "id": "OXIDATIVE STRESS"}, {"entity_type": "GENOMIC VARIANT", "description": "CpGs are genomic variants that play roles in DNA methylation and gene regulation, potentially influencing oxidative stress-related phenotypes.", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "id": "CPGS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Promoters are regulatory regions of genes that can influence transcriptional activity.", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "id": "PROMOTER REGION"}, {"entity_type": "PROTEIN", "description": "Transcription factors bind to DNA and regulate gene expression, often in response to physiological signals such as oxidative stress.", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "id": "TRANSCRIPTION FACTOR (TF)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Phosphorylation is a post-translational modification involved in signal transduction and regulation of cellular processes.", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "id": "PHOSPHORYLATION"}, {"entity_type": "EPIGENETIC MODIFICATION", "description": "DNA methylation is an epigenetic mechanism that can modify gene expression without changing the DNA sequence, often influenced by environmental factors.<SEP>Increased DNA methylation inhibits CTCF binding at insulator sites, which activates tissue-specific gene expression and facilitates enhancer-promoter interactions.<SEP>The differential DNA methylation in CD4+ and CD8+ T cells affects gene expression levels and contributes to the detection of eQTLs.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b<SEP>chunk-512b044cf65a4e519d519c6239959c6c<SEP>chunk-b05610f4a9a1033449b92655bfb67b28", "id": "DNA METHYLATION"}, {"entity_type": "DISEASE", "description": "Coronary heart disease involves narrowing of coronary arteries due to atherosclerosis, leading to reduced blood flow and oxygen supply to the heart muscle.", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "id": "CHD (CORONARY HEART DISEASE)"}, {"entity_type": "DISEASE", "description": "A metabolic disorder characterized by high blood sugar levels resulting from insulin resistance or insufficient insulin production.", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "id": "T2D (TYPE 2 DIABETES MELLITUS)"}, {"entity_type": "GENE, PROTEIN", "description": "The BCL2L11 gene encodes a protein that plays a role in apoptosis and has been implicated in cardiovascular diseases such as CHD.", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "id": "BCL2L11 GENE/PROTEIN"}, {"entity_type": "MOLECULAR INTERACTION", "description": "E2F1 binding sites are regions of DNA to which the E2F1 transcription factor binds, potentially regulating genes involved in cell cycle progression and cancer development.", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "id": "E2F1 TRANSCRIPTION FACTOR BINDING SITES"}, {"entity_type": "GENOMIC VARIANT", "description": "CpG island shores are regions of DNA adjacent to CpG islands where methylation patterns can influence gene regulation.", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "id": "CPG ISLAND SHORES"}, {"entity_type": "DISEASE", "description": "Atherosclerosis is a disease characterized by the buildup of plaque in arteries, leading to restricted blood flow and potential cardiovascular events.", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "id": "ATHEROSCLEROSIS"}, {"entity_type": "MOLECULAR INTERACTION", "description": "The RegulomeDB score indicates strong evidence that CpG sites are located within functional regulatory elements affecting gene expression.", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "id": "REGULOMEDB SCORE 1A-2C"}, {"entity_type": "DATABASE, MOLECULAR INTERACTION", "description": "A database of transcription factor binding profiles used for identifying TF binding sites on DNA sequences.", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "id": "JASPAR DATABASE"}, {"entity_type": "SOFTWARE, PHYSIOLOGICAL PROCESS", "description": "The DAVID tool clusters genes into functional groups based on their annotations and can identify biological processes enriched among a set of genes.", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "id": "DAVID FUNCTIONAL ANNOTATION CLUSTERING TOOL"}, {"entity_type": "GENOMIC VARIANT", "description": "meQTLs are genetic variants that influence DNA methylation levels at specific CpG sites, affecting gene expression patterns.", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "id": "MEQTL (METHYLATION QUANTITATIVE TRAIT LOCI)"}, {"entity_type": "DATABASE, GWAS STUDY", "description": "A consortium focusing on genome-wide association studies (GWAS) for coronary heart disease to identify genetic risk factors.", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "id": "CARDIOGRAM CONSORTIUM"}, {"entity_type": "DATABASE, GWAS STUDY", "description": "A consortium dedicated to genome-wide association studies for type 2 diabetes mellitus to find genetic variants associated with the disease.", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "id": "DIAGRAM CONSORTIUM"}, {"entity_type": "GENETIC VARIANT", "description": "A proxy SNP (single nucleotide polymorphism) for another SNP (rs726430) showing association with CHD and T2D in GWAS studies.", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "id": "RS6750142 (PROXY OF RS726430)"}, {"entity_type": "GENE", "description": "BCL2L11 is a gene whose CpG site (cg07547695) was associated with methylation variants.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "BCL2L11"}, {"entity_type": "GENE", "description": "CEP55 is a gene associated with methylation at the cg24371383 CpG site.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 42}]", "id": "CEP55"}, {"entity_type": "GENE", "description": "CPB1 is a gene related to methylation at the cg04072156 CpG site.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "CPB1"}, {"entity_type": "GENOMIC VARIANT", "description": "An intergenic site on chromosome 4 (cg14532755) is associated with multiple SNPs and methylation levels.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "CHR. 4 INTERGENIC SITE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "CpG sites associated with oxidative stress markers are tested for disease incidence associations.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "OXIDATIVE STRESS CPGS"}, {"entity_type": "EPIGENETIC MODIFICATION", "description": "Methylation levels in the 3\' untranslated region of HIST1H4D were found to be associated with incident T2D.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 43}]", "id": "HIST1H4D 3\'-UTR METHYLATION"}, {"entity_type": "EPIGENETIC MODIFICATION", "description": "Body methylation of DVL1 was associated with increased risk of T2D.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "DVL1 BODY METHYLATION"}, {"entity_type": "GENOMIC VARIANT", "description": "Methylation levels at the ZNF341 gene body CpG (cg11842944) were associated with heart failure risk.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "ZNF341 CPG CG11842944"}, {"entity_type": "DISEASE", "description": "Cardiovascular Disease, including myocardial infarction, heart failure, and ischemic stroke, was tested for CpG site associations but showed no significant association with methylation levels at phenotype-associated sites.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "CVD"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A type of cardiovascular event associated with a specific CpG site\'s methylation levels in ZNF341 gene body.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "MYOCARDIAL INFARCTION"}, {"entity_type": "DISEASE", "description": "An outcome within CVD where methylation at the cg11842944 CpG was most strongly predictive.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "HEART FAILURE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A cardiovascular event type which had a weaker association with ZNF341 gene body methylation compared to heart failure.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "ISCHAEMIC STROKE"}, {"entity_type": "GENOMIC VARIANT", "description": "A SNP associated with methylation at the BCL2L11 CpG site (cg07547695) is linked to genetic variation in relation to disease risk.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "RS726430"}, {"entity_type": "GENOMIC VARIANT", "description": "A SNP associated with methylation at the CEP55 CpG site (cg24371383) is identified as a potential marker for genetic variation in disease susceptibility.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "RS12782691"}, {"entity_type": "GENOMIC VARIANT", "description": "A SNP linked to methylation at CPB1\'s CpG site (cg04072156) is considered an indicator of genetic influence on health outcomes.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "RS16861015"}, {"entity_type": "GENOMIC VARIANT", "description": "Multiple SNPs within the intergenic region on chromosome 4 are associated with methylation levels at CpG site (cg14532755).", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "CHR. 4 INTERGENIC SNPS"}, {"entity_type": "GENOMIC VARIANT", "description": "Multiple SNPs found within an intergenic region on chromosome 4 are associated with methylation levels at CpG site cg14532755.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "RS1665364, RS2236786, RS3752749, RS732754, RS744658, RS798719, RS798726, RS798727, RS798741, RS798744, RS798751, RS798754, RS798755, RS798756, RS798766, RS811316, RS8389"}, {"entity_type": "GENE", "description": "The gene HIST1H4D\'s 3\'-UTR region showed epigenetic changes linked to T2D risk.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 43}]", "id": "HISTONE CLUSTER 1 H4D (HIST1H4D)"}, {"entity_type": "GENE", "description": "Body methylation of DVL1 is associated with an increased risk for developing Type 2 Diabetes.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "DISHEVELLED-1 (DVL1)"}, {"entity_type": "GENE", "description": "Methylation levels at the body CpG site cg11842944 in ZNF341 gene are linked to heart failure and previously associated with height in GWAS studies.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "ZNF341"}, {"source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "description": "Methylation patterns at CpGs within ENTHD1 gene are associated with homocysteine levels, a marker of oxidative stress and cardiovascular risk.", "entity_type": "UNKNOWN", "id": "HOMOCYSTEINE LEVELS"}, {"source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "description": "The LRIG1 gene\'s methylation sites correlate with homocysteine levels indicating its role in signal transduction dysregulation during oxidative stress conditions.", "entity_type": "UNKNOWN", "id": "SIGNAL TRANSDUCTION DYSREGULATION"}, {"source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "description": "Methylation patterns at CKAP5 gene CpGs are correlated with BCD-LDL, a marker of lipid peroxidation products and oxidative stress state, suggesting its role in cellular cytoskeletal organization under these conditions.", "entity_type": "UNKNOWN", "id": "LIPID PEROXIDATION PRODUCTS"}, {"source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "description": "The FOSL2 gene\'s methylation patterns are associated with BCD-LDL levels indicating potential involvement of AP-1 transcription factors in inflammatory response regulation during oxidative stress.", "entity_type": "UNKNOWN", "id": "INFLAMMATORY RESPONSE REGULATION"}, {"source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "description": "DNA methylation patterns at FRMD6 CpG sites show significant association with BCD-LDL, a marker of lipid peroxidation and oxidative stress, indicating its role in cellular functions under these conditions.", "entity_type": "UNKNOWN", "id": "OXIDATIVE STRESS RESPONSE"}, {"source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "description": "The proxy SNP rs6750142 is nominally associated with CHD and T2D in GWAS studies, indicating potential genetic overlap between these diseases.", "entity_type": "UNKNOWN", "id": "CHD AND T2D"}, {"source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "description": "GWAS can be used to investigate the association of genetic variants (including meQTL SNPs) with disease phenotypes, providing insights into epigenetic influences on diseases.", "entity_type": "UNKNOWN", "id": "MEQTL SNPS"}, {"source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "description": "Multiple intergenic SNPs on chromosome 4 associated with methylation levels in disease contexts suggest a genetic basis for health outcomes.", "entity_type": "UNKNOWN", "id": "T2D, CVD"}, {"source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "description": "Methylation levels at ZNF341\'s cg11842944 site influence risks for cardiovascular events like myocardial infarction and ischaemic stroke.", "entity_type": "UNKNOWN", "id": "ISCHAEMIC STROKE, MYOCARDIAL INFARCTION"}, {"entity_type": "GENE", "description": "The MT-ATP6 gene is located in mitochondrial DNA and encodes for a subunit of ATP synthase involved in the electron transport chain.", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "id": "MT-ATP6 GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "An apparent homoplasmic de novo mutation in mtDNA 8993T>G (c.467T>G, p.Leu156Arg) located within the MT-ATP6 gene.", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "id": "8993T>G VARIANT"}, {"entity_type": "DISEASE", "description": "A neurological disorder due to a defect in oxidative phosphorylation, often caused by mutations in mitochondrial DNA such as 8993T>G in ATP synthase 6 gene (MT-ATP6).", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "id": "LEIGH SYNDROME"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The fifth complex of the electron transport chain that synthesizes ATP from ADP and Pi, which is deficient due to the mutation in MT-ATP6.", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "id": "COMPLEX V (ATP SYNTHASE)"}, {"entity_type": "GENE", "description": "A gene associated with mitochondrial disease encoding a protein (NADH dehydrogenase [ubiquinone] flavoprotein 1) involved in complex I of the electron transport chain.", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "id": "NDUFV1 GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "A missense variant found within NDUFV1 gene that affects a highly conserved codon and is predicted to be damaging according to in silico analysis.", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "id": "C.736G>A, P.GLU246LYS VARIANT"}, {"entity_type": "GENOMIC VARIANT", "description": "Another missense variant identified within the same NDUFV1 gene, affecting a highly conserved codon and associated with mitochondrial disease.", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "id": "C.349G>A, P.ALA117THR VARIANT"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process of sequencing all exons in a genome to identify variants and mutations.", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "id": "EXOME SEQUENCING"}, {"entity_type": "GENE", "description": "The COQ2 gene encodes a protein involved in coenzyme Q10 biosynthesis.", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "id": "COQ2 GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant found within the COQ2 gene that changes serine to asparagine at position 146, potentially causing disease.", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "id": "C.437G>A (SER146ASN)"}, {"entity_type": "DISEASE", "description": "An inherited disorder caused by mutations in genes involved in coenzyme Q10 biosynthesis leading to neurological symptoms and muscle weakness.", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "id": "COENZYME Q10 DEFICIENCY"}, {"entity_type": "GENOMIC VARIANT", "description": "A stop-gain variant found within the COQ2 gene that causes a premature termination codon at position 387, potentially causing disease.", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "id": "C.1159C>T (ARG387X)"}, {"entity_type": "GENE", "description": "The mitochondrial genome-encoded NADH dehydrogenase subunit 1 (MT-ND1) gene is involved in respiratory complex I function and can cause various disorders when mutated.", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "id": "MT-ND1 GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "A novel variant within the MT-ND1 gene found at heteroplasmic levels, potentially causing mitochondrial complex I deficiency or related conditions.", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "id": "3754C>A (MT-ND1)"}, {"entity_type": "DISEASE", "description": "An inherited optic neuropathy caused by mutations in genes encoding for proteins of the respiratory chain.", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "id": "LEBER OPTIC ATROPHY"}, {"entity_type": "DISEASE", "description": "A group of disorders characterized by a deficiency in mitochondrial complex I, leading to energy deficits and various clinical manifestations including neurological symptoms and myopathy.", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "id": "MITOCHONDRIAL COMPLEX I DEFICIENCY"}, {"entity_type": "DISEASE", "description": "A syndrome caused by mutations affecting the respiratory chain in mitochondria resulting in neurodegeneration, lactic acidosis, stroke-like episodes, and other symptoms.", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "id": "MELAS (MITOCHONDRIAL ENCEPHALOMYOPATHY WITH LACTIC ACIDOSIS AND STROKE-LIKE EPISODES)"}, {"entity_type": "PROTEIN", "description": "The protein encoded by the COQ2 gene is involved in coenzyme Q10 biosynthesis.", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "id": "COQ2 HOMOLOG PRENYLTRANSFERASE PROTEIN"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A series of redox reactions within mitochondria that are essential for cellular energy production, involving electron transfer from NADH to oxygen.", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "id": "ELECTRON TRANSPORT CHAIN COMPLEX I (NADH DEHYDROGENASE)"}, {"entity_type": "METABOLIC PATHWAY", "description": "Pathway related to the biosynthesis and deficiency of coenzyme Q10 which is crucial in oxidative phosphorylation.", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "id": "COENZYME Q10 DEFICIENCY PATHWAY"}, {"entity_type": "PROTEIN", "description": "A protein encoded by the MT-ND1 gene which is a subunit of complex I in the mitochondrial electron transport chain.", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "id": "NADH DEHYDROGENASE SUBUNIT 1 (ND1)"}, {"entity_type": "MOLECULAR INTERACTION", "description": "An enzymatic complex that plays a key role in oxidative phosphorylation and is composed of multiple protein subunits, including those encoded by nuclear DNA and mtDNA.", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "id": "COMPLEX I (NADH DEHYDROGENASE)"}, {"entity_type": "GENOMIC VARIANT", "description": "The genetic material found within mitochondria which includes genes like MT-ND1 involved in various physiological processes such as electron transport chain function.", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "id": "MITOCHONDRIAL GENOME-DNA"}, {"source_id": "chunk-b930cdd3706af881cfa771b341af097d", "description": "The next-generation exome sequencing technique detected the 8993T>G variant within the MT-ATP6 gene.", "entity_type": "UNKNOWN", "id": "NEXT-GENERATION EXOME SEQUENCING"}, {"entity_type": "GENE", "description": "The OPRM1 gene is involved in alcohol drinking behavior and its associated variables such as AUDIT score, number of drinking days, and drinks per drinking day.", "source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "id": "OPRM1"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant (rs671) in the ALDH2 gene, which is involved in alcohol metabolism, was controlled for during analyses.", "source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "id": "RS671 ALDH2 VARIANT"}, {"entity_type": "GENOMIC VARIANT", "description": "Another genomic variant (rs1229984) in the ADH1B gene, also involved in alcohol metabolism, was included as a covariate in the analyses.", "source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "id": "RS1229984 ADH1B VARIANT"}, {"entity_type": "DRUG", "description": "Naltrexone is a medication that showed significant association with drowsiness and ringing in the ears side effects during the study.<SEP>Naltrexone is used as a medication in studies examining its effect on alcohol self-administration and consumption behavior.", "source_id": "chunk-62d8719735e6c6eaa899d9ea64143544<SEP>chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6", "id": "NALTREXONE"}, {"entity_type": "THERAPY", "description": "A placebo was used as a control condition to compare against naltrexone\'s effects on alcohol craving, sedation, and stimulation responses.<SEP>The placebo treatment serves as a control condition to compare against drug treatments like naltrexone.", "source_id": "chunk-62d8719735e6c6eaa899d9ea64143544<SEP>chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6", "id": "PLACEBO"}, {"entity_type": "SIDE EFFECT", "description": "Drowsiness is a side effect that occurred significantly more often in participants taking naltrexone compared to placebo.", "source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "id": "DROWSINESS"}, {"entity_type": "SIDE EFFECT", "description": "Ringing in the ears is another significant side effect associated with naltrexone use during the study.", "source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "id": "RINGING IN THE EARS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Alcohol craving is a physiological process that was analyzed for pharmacogenetic effects influenced by OPRM1 genotype and medication status.", "source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "id": "ALCOHOL CRAVING"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Sedation caused by alcohol consumption, which was studied in relation to genetic variants (ADH1B) and baseline sedation levels.", "source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "id": "ALCOHOL-INDUCED SEDATION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Stimulation is a physiological response induced by alcohol intake that varies based on medication and genotype interaction effects.", "source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "id": "ALCOHOL-INDUCED STIMULATION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The OPRM1 gene group differences are physiological processes that influence drinking variables such as AUDIT score, number of drinking days, and drinks per day.", "source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "id": "OPRM1 GENE GROUP DIFFERENCES "}, {"entity_type": "DISEASE RISK INDICATOR", "description": "Number of drinking days is an indicator used to assess risk for alcohol use disorder.", "source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "id": "DRINKING DAYS "}, {"entity_type": "DISEASE RISK INDICATOR", "description": "Drinks consumed per drinking day is another measure utilized in assessing the risk of alcohol-related health issues.", "source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "id": "DRINKS PER DRINKING DAY "}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Subjective response at baseline (BrAC = 0.00 g/dl) is an important physiological process that influences subsequent subjective responses to alcohol infusion.", "source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "id": "BASELINE SUBJECTIVE RESPONSE "}, {"entity_type": "STATISTICAL METHOD", "description": "A statistical test used in small sample sizes to examine the significance of associations between medication side effects and genotypes.", "source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "id": "FISHER\'S EXACT TEST "}, {"entity_type": "ASSESSMENT TOOL", "description": "An assessment tool for identifying potential adverse effects from medications, specifically relevant during alcohol infusion studies.", "source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "id": "SAFTTEE CHECKLIST "}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Cravings induced by alcohol intake are physiological responses that vary based on genotype and medication status.", "source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "id": "ALCOHOL-INDUCED CRAVING "}, {"entity_type": "COVARIATE", "description": "AUQ values at baseline are significant covariates in the analysis of alcohol-induced craving across different genotypes.", "source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "id": "BASELINE AUQ VALUES "}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Smoking status was considered as an environmental factor that could influence subjective responses to alcohol but did not show significant moderation effects.", "source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "id": "NICOTINE SMOKING STATUS "}, {"entity_type": "GENOMIC VARIANT", "description": "The Asn40 homozygote is a genomic variant in ALDH2 that affects alcohol consumption and metabolism.", "source_id": "chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6", "id": "ASN40 HOMOZYGOTES"}, {"entity_type": "GENE", "description": "ALDH2 genotype influences alcohol consumption behavior, with Asp40 carriers consuming fewer drinks compared to Asn40 homozygotes.", "source_id": "chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6", "id": "ALDH2 GENOTYPE"}, {"entity_type": "GENOMIC VARIANT", "description": "The Asp40 carrier is a genomic variant in ALDH2 that influences alcohol consumption behavior, leading to significantly fewer drinks consumed compared to Asn40 homozygotes.", "source_id": "chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6", "id": "ASP40 CARRIERS"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Smoking status was not a significant moderator of the effects on alcohol self-administration and had no effect on medication or genotype results.", "source_id": "chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6", "id": "NICOTINE SMOKING STATUS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The latency to first drink is influenced by ALDH2 genotype, where Asn40 homozygotes have a significantly shorter latency compared to other genotypes.", "source_id": "chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6", "id": "LATENCY TO FIRST DRINK"}, {"entity_type": "NUTRIENT", "description": "Naltrexone mean drinks refers to the average number of drinks consumed under naltrexone treatment condition (mean = 0.93, SD = 1.35).", "source_id": "chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6", "id": "NALTREXONE MEAN DRINKS"}, {"entity_type": "NUTRIENT", "description": "Placebo mean drinks indicates the average number of drinks consumed in the absence of medication (mean = 1.19, SD = 1.43).", "source_id": "chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6", "id": "PLACEBO MEAN DRINKS"}, {"entity_type": "DIETARY PATTERN", "description": "Smokers consumed an average of 1.41 drinks with standard deviation of 1.50 during alcohol self-administration studies.", "source_id": "chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6", "id": "SMOKERS MEAN DRINKS"}, {"entity_type": "DIETARY PATTERN", "description": "Non-smokers consumed an average of 0.83 drinks with a standard deviation of 1.27 during alcohol self-administration studies.", "source_id": "chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6", "id": "NON-SMOKERS MEAN DRINKS"}, {"source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "description": "Controlling for the rs671 variant in ALDH2 helps refine analyses related to alcohol drinking behaviors and their genetic underpinnings.)", "entity_type": "UNKNOWN", "id": "ALCOHOL DRINKING BEHAVIOR "}, {"source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "description": "Controlling for the rs671 variant in ALDH2 helps refine analyses related to alcohol drinking behaviors and their genetic underpinnings.)", "entity_type": "UNKNOWN", "id": "RS671 ALDH2 VARIANT "}, {"source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "description": "The use of naltrexone medication resulted in significantly higher incidence of drowsiness compared to placebo, indicating a drug effect on this side effect.)", "entity_type": "UNKNOWN", "id": "DROWSINESS "}, {"source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "description": "The use of naltrexone medication resulted in significantly higher incidence of drowsiness compared to placebo, indicating a drug effect on this side effect.)", "entity_type": "UNKNOWN", "id": "NALTREXONE "}, {"source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "description": "This genetic variant is associated with alcohol-induced sedation responses in the presence of rising blood alcohol concentration (BrAC).)", "entity_type": "UNKNOWN", "id": "ALCOHOL-INDUCED SEDATION "}, {"source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "description": "This genetic variant is associated with alcohol-induced sedation responses in the presence of rising blood alcohol concentration (BrAC).)", "entity_type": "UNKNOWN", "id": "RS1229984 ADH1B VARIANT "}, {"source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "description": "The baseline subjective response influenced how participants subsequently experienced sedation, stimulation, and craving during alcohol intake.)", "entity_type": "UNKNOWN", "id": "SUBSEQUENT ALCOHOL EFFECTS "}, {"source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "description": "This test was used to determine the significance of genotype-drug interactions in causing side effects such as drowsiness and ringing in ears.)", "entity_type": "UNKNOWN", "id": "GENOTYPE-DRUG INTERACTION "}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant of the ALDH2 gene identified by the rs671 SNP, influencing alcohol consumption and cortisol levels.", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 31}]", "id": "ALDH2 RS671 GENOTYPE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The daily intake of alcohol is a physiological process that varies based on genotype (rs671) and impacts blood cortisol levels.", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 31}]", "id": "DAILY ALCOHOL CONSUMPTION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A measurement of the level of cortisol in the blood, which can be influenced by genetic factors and daily alcohol consumption.", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 31}]", "id": "BLOOD CORTISOL LEVEL"}, {"entity_type": "LIFESTYLE FACTOR", "description": "The level of education attained, which can influence health behaviors and outcomes.", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "id": "EDUCATION STATUS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "An estimate of daily alcohol consumption based on genetic factors influencing drinking behavior.", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 31}]", "id": "GENETICALLY PREDICTED ALCOHOL CONSUMPTION"}, {"entity_type": "LIFESTYLE FACTOR", "description": "Individuals who previously consumed alcohol but no longer do, a lifestyle factor that can influence health outcomes and hormone levels.", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "id": "EX-DRINKERS"}, {"entity_type": "GENE", "description": "The ALDH2 gene is involved in alcohol metabolism and contains the rs671 polymorphism.", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 31}]", "id": "ALDH2 GENE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Levels of cortisol, a stress hormone, vary according to genetic factors such as the ALDH2 rs671 genotype.", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 31}]", "id": "CORTISOL LEVELS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The distribution of age among individuals with different ALDH2 genotypes shows significant differences, particularly in relation to alcohol consumption and physiological processes.", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 31}]", "id": "AGE DISTRIBUTION"}, {"entity_type": "GENE", "description": "ABCG2 is a gene associated with uric acid levels and hyperuricemia (HUA) risk.<SEP>The ABCG2 gene\'s variant (rs2231147) significantly influences the use of CSFs during chemotherapy treatment in ovarian cancer patients.", "source_id": "chunk-befd5ea20007b1d02d987897c798dadd<SEP>chunk-561eacb5d916258d3ed4f08f53587404", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 21}]", "id": "ABCG2"}, {"entity_type": "GENE", "description": "SLC2A9 is a gene linked to serum urate levels and HUA risk, particularly in females.", "source_id": "chunk-befd5ea20007b1d02d987897c798dadd", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 23}]", "id": "SLC2A9"}, {"entity_type": "GENE", "description": "SLC22A12 is associated with serum uric acid (sUA) levels but not significantly with HUA risk.", "source_id": "chunk-befd5ea20007b1d02d987897c798dadd", "id": "SLC22A12"}, {"entity_type": "GENOMIC VARIANT", "description": "The rs3733591 variant of the SLC2A9 gene is associated with increased sUA levels and HUA risk, especially in females.", "source_id": "chunk-befd5ea20007b1d02d987897c798dadd", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 23}]", "id": "RS3733591 SLC2A9"}, {"entity_type": "GENOMIC VARIANT", "description": "The rs2231142 variant of the ABCG2 gene significantly affects sUA levels and increases HUA risk across both genders.", "source_id": "chunk-befd5ea20007b1d02d987897c798dadd", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 21}]", "id": "RS2231142 ABCG2"}, {"entity_type": "GENOMIC VARIANT", "description": "This variant in SLC22A12 shows a minor effect on sUA level but lacks significant association with HUA risk.", "source_id": "chunk-befd5ea20007b1d02d987897c798dadd", "id": "RS893006 SLC22A12"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Treatment for hypertension, such as the use of diuretics, may influence uric acid levels and related conditions like HUA.", "source_id": "chunk-befd5ea20007b1d02d987897c798dadd", "id": "HYPERTENSION TREATMENT"}, {"entity_type": "METABOLIC PATHWAY", "description": "The metabolic pathway involving uric acid is influenced by genetic factors such as ABCG2, SLC2A9, and SLC22A12 variants.", "source_id": "chunk-befd5ea20007b1d02d987897c798dadd", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 21}]", "id": "URIC ACID METABOLISM"}, {"entity_type": "DISEASE", "description": "HUA is a condition characterized by elevated serum urate levels which can lead to various health issues.<SEP>Hyperuricemia is a condition characterized by elevated levels of uric acid in the blood, leading to various health risks.<SEP>Hyperuricemia, a condition characterized by high levels of uric acid in the blood, is associated with cardiovascular disease and can be influenced by genetic factors such as rs2231142 T allele carriers.", "source_id": "chunk-befd5ea20007b1d02d987897c798dadd<SEP>chunk-7091ed039203b69ad83d281b22c89579", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 22}]", "id": "HYPERURICEMIA (HUA)"}, {"entity_type": "NUTRIENT", "description": "Serum creatinine is a measure of kidney function that was found to be higher in HUA cases.", "source_id": "chunk-befd5ea20007b1d02d987897c798dadd", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 22}]", "id": "SERUM CREATININE"}, {"entity_type": "NUTRIENT", "description": "Triglyceride levels were also elevated in the HUA group compared to controls.", "source_id": "chunk-befd5ea20007b1d02d987897c798dadd", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 22}]", "id": "TRIGLYCERIDES (TG)"}, {"entity_type": "NUTRIENT", "description": "Levels of LDL cholesterol were higher among individuals with hyperuricemia.", "source_id": "chunk-befd5ea20007b1d02d987897c798dadd", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 22}]", "id": "LOW-DENSITY LIPOPROTEIN (LDL)"}, {"entity_type": "NUTRIENT", "description": "HUA cases had lower HDL levels compared to controls, indicating poorer lipid profile.", "source_id": "chunk-befd5ea20007b1d02d987897c798dadd", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 22}]", "id": "HIGH-DENSITY LIPOPROTEIN (HDL)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Differences observed in genetic associations between males and females for certain variants.", "source_id": "chunk-befd5ea20007b1d02d987897c798dadd", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 23}]", "id": "GENDER DIFFERENCE"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant in the SLC2A9 gene that influences serum uric acid (sUA) levels.", "source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00", "clusters": "[{level: 0, cluster: 12}]", "id": "SLC2A9 RS3733951"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant in the ABCG2 gene associated with high uric acid levels and hyperuricaemia risk, especially under cardiovascular risk conditions such as obesity, hypertension, higher triglycerides (TG), lower HDL.", "source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00", "clusters": "[{level: 0, cluster: 7}]", "id": "ABCG2 RS2231142"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant in the SLC22A12 gene that does not show significant differences in sUA levels according to posthoc Bonferroni test.", "source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00", "id": "SLC22A12 RS893006"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Serum uric acid (sUA) levels are a physiological process influenced by genetic variants and cardiovascular risk factors such as obesity, hypertension, TG levels, LDL levels, and HDL levels.", "source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00", "clusters": "[{level: 0, cluster: 7}]", "id": "SUA LEVELS"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Cardiovascular risk factors such as obesity, hypertension, higher TG and LDL levels, lower HDL levels significantly influence the genetic risk of hyperuricaemia (HUA) associated with ABCG2 rs2231142 variants.<SEP>Various physiological processes contribute to cardiovascular health risks, including metabolic disorders such as HUA.", "source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00<SEP>chunk-7091ed039203b69ad83d281b22c89579", "clusters": "[{level: 0, cluster: 12}]", "id": "CARDIOVASCULAR RISK FACTORS"}, {"entity_type": "DISEASE", "description": "Hyperuricaemia (HUA) is a disease state characterized by elevated serum uric acid levels, influenced by genetic risk factors and cardiovascular conditions.", "source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00", "clusters": "[{level: 0, cluster: 12}]", "id": "HYPERURICAEMIA RISK (HUA)"}, {"entity_type": "GENOMIC VARIANT", "description": "Individuals with the C/C genotype of SLC2A9 rs3733951 have higher serum uric acid (sUA) levels compared to T/T carriers in females and the whole population.", "source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00", "id": "SLC2A9 C/C CARRIERS"}, {"entity_type": "GENOMIC VARIANT", "description": "The presence of a single T allele in ABCG2 rs2231142 increases hyperuricaemia (HUA) risk, especially under cardiovascular risk conditions such as obesity and hypertension.", "source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00", "clusters": "[{level: 0, cluster: 12}]", "id": "T ALLELE OF ABCG2 RS2231142"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Serum uric acid levels increase linearly with the number of specific risk alleles in SLC2A9, ABCG2, and SLC22A12 genes across both males and females.", "source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00", "clusters": "[{level: 0, cluster: 12}]", "id": "SUA LEVELS INCREASE WITH RISK ALLELES"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Triglyceride (TG) levels are a cardiovascular risk factor significantly associated with increased hyperuricaemia risk and higher sUA levels in both males and females.", "source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00", "clusters": "[{level: 0, cluster: 12}]", "id": "TG LEVELS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "SUA level represents the concentration of uric acid in serum, which is a physiological process indicator associated with HUA risk among certain genotypes.", "source_id": "chunk-7091ed039203b69ad83d281b22c89579", "id": "URIC ACID (SUA)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "SUA level measures the concentration of uric acid in serum and serves as an indicator for HUA risk.", "source_id": "chunk-7091ed039203b69ad83d281b22c89579", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 22}]", "id": "SERUM URIC ACID (SUA)"}, {"entity_type": "GENOMIC VARIANT", "description": "Individuals carrying the rs2231142 T allele have a genetic predisposition to hyperuricemia and higher serum uric acid levels.", "source_id": "chunk-7091ed039203b69ad83d281b22c89579", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 22}]", "id": "RS2231142 T ALLELE CARRIERS"}, {"source_id": "chunk-7091ed039203b69ad83d281b22c89579", "description": "The level of serum uric acid is influenced by carrying the rs2231142 T allele, affecting the risk of hyperuricemia in carriers.", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 22}]", "id": "SUA LEVEL"}, {"entity_type": "GENE", "description": "The LRP2 gene has been identified as a locus associated with kidney function and eGFR across different ancestry groups.", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "id": "LRP2 GENE"}, {"entity_type": "GENE", "description": "The NFATC1 gene is another locus found to be associated with kidney function and eGFR in various ethnic populations, especially those of European and East Asian descent.", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "id": "NFATC1 GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant within the LRP2 locus (rs57989581) shows genome-wide significant association with eGFR in trans-ethnic meta-analysis.", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "id": "RS57989581"}, {"entity_type": "GENOMIC VARIANT", "description": "Another genomic variant at the NFATC1 locus (rs8096658) has also been reported to be significantly associated with eGFR across different ancestries.<SEP>This SNP is found at the NFATC1 locus overlapping fetal kidney cell DHSs, involved in gene regulation.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083<SEP>chunk-3edc72730d68b4c7fd6ba397aa087391", "id": "RS8096658"}, {"entity_type": "GENE", "description": "The UNCX gene is identified as a locus with significant association signals for both eGFR and CKD risk in diabetic individuals.", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "id": "UNCX GENE"}, {"entity_type": "GENE", "description": "The ALMS1 gene, known to be associated with Bardet-Biedl syndrome, also shows evidence of association with kidney function and CKD development.", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "id": "ALMS1 GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "A locus including PDILT and UMOD genes is associated with eGFR and has been identified as a strong signal in CKD risk assessment.", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "id": "PDILT-UMOD LOCUS"}, {"entity_type": "GENOMIC VARIANT", "description": "This variant (rs62435145) at the UNCX gene locus shows significant association with reduced eGFR and increased CKD risk.", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "id": "RS62435145"}, {"entity_type": "GENOMIC VARIANT", "description": "An allele variant within ALMS1 is associated with a decrease in kidney function (eGFR) and an increase in the incidence of chronic kidney disease.", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "id": "RS7587577"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process by which chronic kidney disease develops includes reduced eGFR levels, often influenced by genetic factors such as SNPs at specific loci.", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "id": "CKD DEVELOPMENT"}, {"entity_type": "DISEASE", "description": "Type 2 diabetes (T2D) and Type 1 diabetes (T1D) are both associated with kidney dysfunction and reduced eGFR levels, especially when influenced by genetic variants at loci like PDILT-UMOD.", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "id": "T2D AND T1D DIABETES TYPES"}, {"entity_type": "GENOMIC VARIANT", "description": "This variant (rs77924615) within the PDILT gene is a strong indicator of reduced eGFR and increased risk for chronic kidney disease in both general populations and diabetics.", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "id": "RS77924615"}, {"entity_type": "GENE", "description": "The PRKAG2 gene locus shows evidence of association with eGFR levels, particularly in individuals diagnosed with diabetes.", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "id": "PRKAG2 GENE"}, {"entity_type": "MOLECULAR INTERACTION", "description": "An algorithm used for fine-mapping genetic loci involved in influencing kidney function and disease states by identifying credible sets of variants.", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "id": "MANTRA ALGORITHM"}, {"entity_type": "GENE", "description": "NFATC1 is a gene that plays a central role in inducible gene transcription during immune response and is targeted by cyclosporine A.<SEP>NFATC1 is involved in kidney function and its expression is altered during disease states such as high-salt exposure and chronic kidney disease (CKD).", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083<SEP>chunk-5ac437b050552f5db2abf19f1bf897cf", "id": "NFATC1"}, {"entity_type": "GENE", "description": "SLC34A1 is involved in calcium absorption and transport, with genetic variants associated with eGFR impact.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "id": "SLC34A1"}, {"entity_type": "GENOMIC VARIANT", "description": "DCDC5-MPPED2 refers to a genomic region with variants associated with kidney function but specific mechanisms unclear.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "id": "DCDC5-MPPED2"}, {"entity_type": "GENE", "description": "PIP5K1B is a gene located at one of the five loci with genetic variations influencing eGFR, though its exact role in kidney function is less defined.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "id": "PIP5K1B"}, {"entity_type": "GENOMIC VARIANT", "description": "This missense variant in GCKR gene leads to increased synthesis and export of triglycerides and cholesterol, impacting plasma glucose concentration.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "id": "P.PRO446LEU (RS1260326)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Dynamic regions in kidney cells where DNA is exposed and accessible for regulatory proteins, influencing gene expression.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "id": "KIDNEY DHSS"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Binding sites on the genome for HDAC8 transcription factor, involved in modifying chromatin structure.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "id": "HDAC8 BINDING SITES"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Regulation of kidney function through genetic and epigenetic mechanisms.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "id": "KIDNEY FUNCTION REGULATION"}, {"entity_type": "PROTEIN FAMILY", "description": "Enzymes involved in modification of chromatin structure, playing a role in kidney development and functioning.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "id": "HISTONE DEACETYLASES (HDACS)"}, {"entity_type": "DRUG", "description": "A drug used to suppress immune response after organ transplantation, targeting NFATC1 gene downstream.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "id": "TRANSPLANT IMMUNOSUPPRESSION DRUG CYCLOSPORINE A"}, {"entity_type": "PROTEIN FAMILY", "description": "Family of proteins involved in modulating the activity and signaling of heterotrimeric G-proteins, including RGS14.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "id": "REGULATOR OF G PROTEIN SIGNALING FAMILY (RGS)"}, {"entity_type": "GENOMIC VARIANT", "description": "Variants in Drosophila orthologs of mammalian RGS14 gene that influence salt sensitivity and stress resistance.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "id": "LOCO LOSS-OF-FUNCTION VARIANTS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The physiological response to changes in dietary sodium chloride, influencing lifespan and survival rates under stress conditions.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "id": "SALT SENSITIVITY"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Regulation of the internal osmotic balance within organisms or cells, potentially influenced by genes like NFATC1.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "id": "OSMOTIC REGULATION"}, {"entity_type": "DISEASE SYMPTOM", "description": "A condition where an organism\'s response to dietary salt leads to increased sensitivity and potential health issues.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "id": "INCREASED SALT SENSITIVITY"}, {"entity_type": "GENOMIC VARIANT", "description": "A variant in SLC34A1 gene located within DHSs in RPTECs and HRCEs cells along with HDAC8 binding site.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "id": "RS35716097"}, {"entity_type": "GENE", "description": "Regulator of G protein signaling family member with an unknown function in kidneys but expressed as eQTL at SLC34A1 locus.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "id": "RGS14 (MIM: 602513)"}, {"entity_type": "CELL TYPE", "description": "Cells from kidney tissues where DHSs play a role in gene regulation of genetic variants impacting eGFR.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "id": "ADULT RENAL PROXIMAL TUBULAR EPITHELIAL CELLS (RPTECS)"}, {"entity_type": "CELL TYPE", "description": "Kidney cells associated with significant effects on posterior probability for kidney-specific DHSs.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "id": "RENAL CORTICAL EPITHELIAL CELLS (HRCES)"}, {"entity_type": "CELL TYPE", "description": "Cells from developing kidneys showing significant association with genetic variants impacting eGFR.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "id": "FETAL KIDNEY CELLS"}, {"entity_type": "GENE", "description": "The loco gene has a role in resistance to salt stress as observed in heterozygous mutants.", "source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "id": "LOCOD06164"}, {"entity_type": "GENE", "description": "RGS14 is a gene involved in kidney function whose mRNA expression is significantly decreased under conditions of high salt diet and CKD.", "source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "id": "RGS14"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "A high-salt diet can alter the expression levels of genes such as NFATC1 and RGS14 in renal tissue, contributing to kidney dysfunction.", "source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "id": "HIGH-SALT DIET"}, {"entity_type": "DISEASE", "description": "Glomerulosclerosis is a disease condition that affects kidney function and may involve altered gene expression patterns such as those seen with NFATC1 and RGS14.", "source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "id": "GLOMERULOSCLEROSIS"}, {"entity_type": "DISEASE", "description": "CKD, induced by sub-total nephrectomy, alters the renal mRNA expression of genes like NFATC1 and RGS14, potentially contributing to kidney dysfunction.", "source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "id": "CHRONIC KIDNEY DISEASE (CKD)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A physiological process that induces chronic kidney disease (CKD) by reducing kidney mass and altering gene expression patterns such as those of NFATC1 and RGS14 in renal tissue.", "source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "id": "SUB-TOTAL NEPHRECTOMY"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant of the loco gene, contributing to salt-resistance phenotype when compared with isogenic controls.", "source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "id": "LOCOEY-P283/+"}, {"entity_type": "DIETARY PATTERN", "description": "An isogenic background used for control in experiments studying the effect of NaCl supplementation on survival rates of mutants.", "source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "id": "Y1W1"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Sodium chloride (NaCl) supplements are introduced into the diet to study salt tolerance and resistance mechanisms in loco mutants.", "source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "id": "NACL"}, {"entity_type": "DIETARY PATTERN", "description": "A mouse strain known to be salt-sensitive, used for investigating the role of NFATC1 and RGS14 in kidney function under stress conditions.", "source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "id": "129S6 MOUSE STRAIN"}, {"source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "description": "The missense variant of GCKR impacts triglyceride and cholesterol synthesis, linking to risk factors for chronic kidney disease.", "entity_type": "UNKNOWN", "id": "DISEASE RISK CKD"}, {"source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "description": "The missense variant of GCKR impacts triglyceride and cholesterol synthesis, linking to risk factors for chronic kidney disease.", "entity_type": "UNKNOWN", "id": "GCKR P.PRO446LEU (RS1260326)"}, {"source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "description": "Dynamic regions in kidney cells where DNA is exposed can influence gene regulation relevant to kidney function.", "entity_type": "UNKNOWN", "id": "GENE REGULATION KIDNEY FUNCTION"}, {"source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "description": "Reduced expression or loss-of-function variants in RGS14 orthologs in Drosophila are associated with improved salt sensitivity and stress resistance.", "entity_type": "UNKNOWN", "id": "REGULATOR OF G PROTEIN SIGNALING FAMILY (RGS14)"}, {"source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "description": "Loss of NFATC1 function results in increased salt sensitivity in Drosophila, suggesting its role in ionic or osmotic regulation.", "entity_type": "UNKNOWN", "id": "NFATC1 LOSS-OF-FUNCTION VARIANTS"}, {"source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "description": "This variant overlaps dynamic regions in fetal kidney cells of NFATC1 locus, influencing gene expression.", "entity_type": "UNKNOWN", "id": "NFATC1 LOCUS DHSS"}, {"source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "description": "This variant overlaps dynamic regions in fetal kidney cells of NFATC1 locus, influencing gene expression.", "entity_type": "UNKNOWN", "id": "RS8096658 (\u03a0C = 0.877)"}, {"source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "description": "Encodes a member of RGS family modulating downstream effects of G\u03b1 subunits with unknown function in kidneys.", "entity_type": "UNKNOWN", "id": "REGULATOR OF G PROTEIN SIGNALING"}, {"source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "description": "Cells involved in gene regulation through DHSs, impacting kidney-specific genetic variants and their effects on eGFR.", "entity_type": "UNKNOWN", "id": "DYNAMIC REGIONS KIDNEY GENES"}, {"source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "description": "These cells show significant posterior probability for DHS annotations linked to kidney-specific variants affecting gene regulation.", "entity_type": "UNKNOWN", "id": "DHS ANNOTATIONS"}, {"source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "description": "Genomic variant of the loco gene shows improved survival rate when supplemented with sodium chloride compared to controls.)", "entity_type": "UNKNOWN", "id": "NACL SUPPLEMENTATION"}, {"entity_type": "DISEASE", "description": "Campylobacter infection is a bacterial disease caused by Campylobacter bacteria, often resulting in diarrhea.", "source_id": "chunk-6264e17a8290bc0a9e24c68c21c1f15c", "id": "CAMPYLOBACTER INFECTION"}, {"entity_type": "GENOMIC VARIANT", "description": "Quinolone-resistant isolates of Campylobacter are strains that have developed resistance to quinolone antibiotics.", "source_id": "chunk-6264e17a8290bc0a9e24c68c21c1f15c", "id": "QUINOLONE-RESISTANT CAMPYLOBACTER ISOLATES"}, {"entity_type": "GENOMIC VARIANT", "description": "Erythromycin-resistant isolates are Campylobacter strains that exhibit resistance to the antibiotic erythromycin.", "source_id": "chunk-6264e17a8290bc0a9e24c68c21c1f15c", "id": "ERYTHROMYCIN-RESISTANT ISOLATES"}, {"entity_type": "GENE/PROTEIN", "description": "C. coli, another species within the Campylobacter genus, also causes infections related to campylobacteriosis.<SEP>Campylobacter coli is a species of bacteria causing gastrointestinal infections, some of which have developed resistance to antibiotics like quinolone and erythromycin.", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9<SEP>chunk-6264e17a8290bc0a9e24c68c21c1f15c", "id": "C. COLI"}, {"entity_type": "GENE/PROTEIN", "description": "Campylobacter jejuni is another species of bacteria responsible for many cases of gastroenteritis, with strains showing varying levels of antibiotic resistance.", "source_id": "chunk-6264e17a8290bc0a9e24c68c21c1f15c", "id": "C. JEJUNI"}, {"entity_type": "PHYSIOLOGICAL PROCESS/MOLECULAR INTERACTION", "description": "Quinolone resistance refers to the ability of Campylobacter strains to survive in the presence of quinolone antibiotics due to genetic changes.", "source_id": "chunk-6264e17a8290bc0a9e24c68c21c1f15c", "id": "QUINOLONE RESISTANCE"}, {"entity_type": "PHYSIOLOGICAL PROCESS/MOLECULAR INTERACTION", "description": "A genomic variant indicating resistance to erythromycin, an antibiotic used for treating bacterial infections including those caused by Campylobacter species.<SEP>Erythromycin resistance is a similar process but specific to erythromycin, another antibiotic used against bacterial infections.", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9<SEP>chunk-6264e17a8290bc0a9e24c68c21c1f15c", "id": "ERYTHROMYCIN RESISTANCE"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Traveling to Spain or Portugal represents an environmental exposure linked to the acquisition of quinolone-resistant Campylobacter strains.", "source_id": "chunk-6264e17a8290bc0a9e24c68c21c1f15c", "id": "TRAVEL TO SPAIN AND PORTUGAL"}, {"entity_type": "LIFESTYLE FACTOR/ENVIRONMENTAL FACTOR", "description": "Foreign travel is a lifestyle factor that increases the risk of acquiring antibiotic-resistant bacteria such as those resistant to quinolones and erythromycin.", "source_id": "chunk-6264e17a8290bc0a9e24c68c21c1f15c", "id": "FOREIGN TRAVEL"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Traveling to Southern Europe or Southeast Asia can increase the likelihood of exposure to quinolone-resistant Campylobacter strains.", "source_id": "chunk-6264e17a8290bc0a9e24c68c21c1f15c", "id": "SOUTHERN EUROPE AND SOUTHEAST ASIA"}, {"entity_type": "PHYSIOLOGICAL PROCESS/METABOLIC PATHWAY/DISEASE SYMPTOMS", "description": "These are symptoms commonly associated with Campylobacter infections and can vary in severity depending on the strain\'s antibiotic resistance status.", "source_id": "chunk-6264e17a8290bc0a9e24c68c21c1f15c", "id": "DIARRHEA, BLOOD IN STOOL, ABDOMINAL PAIN, FEVER, VOMITING"}, {"entity_type": "DRUG", "description": "A class of antibiotics used to treat bacterial infections, including those caused by Campylobacter species.<SEP>Fluoroquinolones are a class of antibiotics used to treat bacterial infections, including those caused by Campylobacter.", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9<SEP>chunk-6264e17a8290bc0a9e24c68c21c1f15c", "id": "FLUOROQUINOLONES"}, {"entity_type": "PHYSIOLOGICAL PROCESS/MOLECULAR INTERACTION", "description": "The susceptibility of Campylobacter strains to quinolones can change due to genetic mutations, affecting treatment outcomes.", "source_id": "chunk-6264e17a8290bc0a9e24c68c21c1f15c", "id": "QUINOLONE SUSCEPTIBILITY CATEGORY"}, {"entity_type": "MOLECULAR INTERACTION/MEASUREMENT", "description": "This measurement indicates the sensitivity of a bacterial strain to quinolone antibiotics (Minimum Inhibitory Concentration).", "source_id": "chunk-6264e17a8290bc0a9e24c68c21c1f15c", "id": "MIC OF QUINOLONE = 2 MG/L"}, {"entity_type": "GENOMIC VARIANT/MOLECULAR INTERACTION", "description": "Silent mutations in the gyrA gene do not change the amino acid sequence but may indicate genetic instability or resistance development.", "source_id": "chunk-6264e17a8290bc0a9e24c68c21c1f15c", "id": "THREE SILENT MUTATIONS IN GYRA"}, {"entity_type": "MOLECULAR INTERACTION/MEASUREMENT", "description": "The presence of a normal consensus sequence indicates that the bacterial strain has no mutations conferring antibiotic resistance.", "source_id": "chunk-6264e17a8290bc0a9e24c68c21c1f15c", "id": "NORMAL CONSENSUS SEQUENCE IN THE FORMER STRAIN"}, {"entity_type": "GENOMIC VARIANT/MOLECULAR INTERACTION", "description": "Silent mutations in gyrA gene can suggest genetic changes related to quinolone resistance, even without altering the amino acid sequence.", "source_id": "chunk-6264e17a8290bc0a9e24c68c21c1f15c", "id": "THRE SILENT MUTATIONS IN GYRA IN THE LATTER STRAIN"}, {"entity_type": "GENE", "description": "Campylobacter jejuni is a bacterial genus that can cause campylobacteriosis.", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "id": "CAMPYLOBACTER JEJUNI"}, {"entity_type": "GENOMIC VARIANT", "description": "Quinolone resistance in C. jejuni isolates is a genomic variant that impacts treatment options and infection patterns.", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "id": "QUINOLONE-RESISTANT C. JEJUNI ISOLATES"}, {"entity_type": "DRUG", "description": "Another class of antibiotics that can be used in the treatment of campylobacteriosis.", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "id": "MACROLIDES"}, {"entity_type": "GENOMIC VARIANT", "description": "Indicates resistance to nalidixic acid, a drug commonly used in laboratory settings to assess quinolone susceptibility of bacteria like Campylobacter.", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "id": "NALIDIXIC ACID RESISTANCE"}, {"entity_type": "DIETARY PATTERN", "description": "The dietary pattern involving the consumption of fresh poultry other than chicken and turkey was identified as potentially contributing to infection risk.", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "id": "FRESH POULTRY INTAKE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Infections that occur within a country rather than from imported sources, often linked with local food consumption patterns.", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "id": "DOMESTICALLY ACQUIRED INFECTIONS"}, {"entity_type": "DISEASE", "description": "An infection caused by the bacteria Campylobacter species, typically characterized by gastrointestinal symptoms.", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "id": "CAMPYLOBACTERIOSIS"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Food products sold in retail stores that may serve as a source of Campylobacter infections.", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "id": "RETAIL FOOD PRODUCTS"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Samples from the feces of broiler chickens, which can be used to track and study the spread of Campylobacter species.", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "id": "BROILER CHICKENS FECAL SAMPLES"}, {"entity_type": "TRANSCRIPT", "description": "The transcript of the gene in C. jejuni showing quinolone resistance is influenced by environmental factors like diet and location.", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "id": "TRANSCRIPT"}, {"entity_type": "PROTEIN RESIDUES (E.G., PRO21-VAL22 IN WRNIP1, PRO398-LYS399 IN NEMO-UBZ, GLU636-LYS637 IN POL\u0397)", "description": "Proteins produced from genes associated with antibiotic resistance play a role in bacterial survival and transmission.<SEP>Specific residues such as Pro21-Val22, Pro398-Lys399, and Glu636-Lys637 play crucial roles in protein-protein interactions involving Ub binding.", "source_id": "chunk-5bfe051a79e5e215dd3fc65296825591<SEP>chunk-0d155c005072e55d94179ce7952bf5a9", "id": "PROTEIN"}, {"entity_type": "NUTRIENT", "description": "Dietary nutrients may influence the expression of genomic variants leading to antibiotic resistance in Campylobacter species.", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "id": "NUTRIENT"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The physiological process involved in acquiring quinolone-resistant C. jejuni infections through dietary intake of poultry is under investigation.", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "id": "PHYSIOLOGICAL PROCESS"}, {"entity_type": "MOLECULAR INTERACTION", "description": "The molecular interaction between Campylobacter bacteria and the human host can be influenced by dietary factors.", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "id": "MOLECULAR INTERACTION"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Environmental factors such as food handling practices and antibiotic use in animal farming contribute to the spread of resistant strains.", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "id": "ENVIRONMENTAL FACTOR"}, {"entity_type": "DISEASE", "description": "Campylobacteriosis is a disease caused by Campylobacter bacteria, often linked with quinolone resistance.", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "id": "DISEASE"}, {"source_id": "chunk-6264e17a8290bc0a9e24c68c21c1f15c", "description": "Some strains of Campylobacter coli exhibit erythromycin resistance, highlighting the complexity and variability in antibiotic resistance among different species.", "entity_type": "UNKNOWN", "id": "C. COLI/E. JEJUNI"}, {"source_id": "chunk-6264e17a8290bc0a9e24c68c21c1f15c", "description": "Traveling to Spain or Portugal is associated with a higher risk of acquiring erythromycin-resistant Campylobacter coli strains.", "entity_type": "UNKNOWN", "id": "ERYTHROMYCIN-CRESTANT CAMPYLOBACTER ISOLATES"}, {"source_id": "chunk-6264e17a8290bc0a9e24c68c21c1f15c", "description": "Consuming fresh poultry other than chicken and turkey is associated with an increased risk of acquiring quinolone-resistant C. jejuni infections.", "entity_type": "UNKNOWN", "id": "EATING FRESH POULTRY OTHER THAN CHICKEN AND TURKEY"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant (rs9534511) located on the HTR2A gene is significantly associated with social disinhibition risk.<SEP>A minor allele for rs9534511 is associated with an increased risk of social disinhibition.", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1<SEP>chunk-36d70bb8409856300dd77669e7c1f9ed", "id": "RS9534511"}, {"entity_type": "GENE", "description": "The HTR2A gene, harboring the SNP rs9534511, plays a role in serotonin pathway which influences social behavior and cognitive processes.", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "id": "HTR2A GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "A minor allele for rs4938056 is associated with an increased risk of social disinhibition.<SEP>Another genomic variant (rs4938056) on HTR3B is linked to an increased risk of social disinhibition.", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1<SEP>chunk-36d70bb8409856300dd77669e7c1f9ed", "id": "RS4938056"}, {"entity_type": "GENE", "description": "The HTR3B gene, which contains the SNP rs4938056, contributes to serotonin pathway regulation affecting behavior and cognitive functions.", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "id": "HTR3B GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant (rs1998220) found in an intronic region of OPRM1 is associated with social disinhibition risk.<SEP>A minor allele for rs1998220 is associated with an increased risk of social disinhibition.", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1<SEP>chunk-36d70bb8409856300dd77669e7c1f9ed", "id": "RS1998220"}, {"entity_type": "GENE", "description": "The opioid receptor gene OPRM1, with rs1998220 located within it, impacts pathways involved in reward and addiction behaviors.", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "id": "OPRM1 GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "A SNP (rs1003921) residing in an intronic region of KCNC1 is significantly associated with increased social disinhibition risk.<SEP>A minor allele for rs1003921 is associated with a protective effect against increased social disinhibition score.", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1<SEP>chunk-36d70bb8409856300dd77669e7c1f9ed", "id": "RS1003921"}, {"entity_type": "GENE", "description": "The KCNC1 gene, harboring the SNP rs1003921, contributes to potassium channel function and neural excitability.", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "id": "KCNC1 GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant (rs16116) located in an intergenic region downstream of NPY is linked to social disinhibition risk.<SEP>A minor allele for rs16116 is associated with a protective effect against increased social disinhibition score.", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1<SEP>chunk-36d70bb8409856300dd77669e7c1f9ed", "id": "RS16116"}, {"entity_type": "GENE", "description": "The NPY gene, with rs16116 downstream, influences neuropeptide Y levels affecting various physiological processes such as stress and appetite regulation.", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "id": "NPY GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "A SNP (rs16870286) part of LINC00518 is significantly associated with social disinhibition risk, where LINC00518 codes for an uncharacterized protein.<SEP>A minor allele for rs16870286 is associated with a protective effect against increased social disinhibition score.", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1<SEP>chunk-36d70bb8409856300dd77669e7c1f9ed", "id": "RS16870286"}, {"entity_type": "GENE", "description": "The miscellaneous RNA gene LINC00518, containing rs16870286 and coding for an uncharacterized protein, impacts physiological processes not fully elucidated.", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "id": "LINC00518 GENE"}, {"entity_type": "METABOLIC PATHWAY", "description": "The serotonin pathway involves the synthesis, uptake, metabolism, and receptor signaling of serotonin molecules that influence mood, behavior, and cognitive functions.", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "id": "SEROTONIN PATHWAY"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Social disinhibition refers to a reduced inhibitory control over social behavior, often observed in conditions or contexts affecting neurological regulation.", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "id": "SOCIAL DISINHIBITION"}, {"entity_type": "DIETARY PATTERN", "description": "A linguistic acculturation score measures the degree to which individuals adopt cultural norms of a new culture, impacting behavior and health outcomes such as social disinhibition.", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "id": "LINGUISTIC ACCULTURATION SCORE (TAS)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The DAS scale assesses stress levels in individuals and is associated with psychological conditions that may influence behaviors including social disinhibition.", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "id": "DEPRESSION ANXIETY STRESS SCALES (DAS)"}, {"source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "description": "The OPRM1 gene, with SNP rs1998220 located within it, impacts pathways involved in reward and addiction behaviors.", "entity_type": "UNKNOWN", "id": "REWARD AND ADDICTION BEHAVIORS"}, {"source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "description": "The KCNC1 gene, harboring SNP rs1003921, contributes to potassium channel function and neural excitability.", "entity_type": "UNKNOWN", "id": "NEURAL EXCITABILITY"}, {"source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "description": "The NPY gene, with SNP rs16116 downstream, influences neuropeptide Y levels affecting physiological processes such as stress and appetite regulation.", "entity_type": "UNKNOWN", "id": "STRESS AND APPETITE REGULATION"}, {"source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "description": "The LINC00518 gene, containing SNP rs16870286 and coding for an uncharacterized protein, impacts physiological processes not fully elucidated.", "entity_type": "UNKNOWN", "id": "UNCHARACTERIZED PROTEIN FUNCTION"}, {"source_id": "chunk-36d70bb8409856300dd77669e7c1f9ed", "description": "Neither gender nor parental education is significantly associated with changes in social disinhibition score based on the provided data.)", "entity_type": "UNKNOWN", "id": "SOCIAL DISINHIBITION SCORE"}, {"source_id": "chunk-36d70bb8409856300dd77669e7c1f9ed", "description": "Neither gender nor parental education is significantly associated with changes in social disinhibition score based on the provided data.)", "entity_type": "UNKNOWN", "id": "PARENTAL EDUCATION"}, {"entity_type": "GENE", "description": "The CNR1 gene encodes for cannabinoid receptor type 1, which is involved in modulating neurocircuitry and has been linked to alcohol-related behaviors.", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "id": "CNR1 GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific genomic variant (rs2023239) located upstream of exon 3 of the CNR1 gene, which is associated with CB1 receptor binding levels and differential activation in brain regions involved in alcohol craving.", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "id": "RS2023239 GENOMIC VARIANT"}, {"entity_type": "PROTEIN", "description": "The CB1 receptor protein, encoded by the CNR1 gene, plays a critical role in modulating mesocorticolimbic neurocircuitry associated with drug-seeking behavior and is influenced by genetic variations such as rs2023239.", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "id": "CB1 RECEPTOR PROTEIN"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Exposure to alcohol cues elicits craving behaviors, and differential activation in brain regions between genotypes suggests a role for genetic factors like rs2023239 in modulating these responses.", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "id": "ALCOHOL CUE EXPOSURE"}, {"entity_type": "PHYSIOLOGICAL PROCESS/MOLECULAR INTERACTION", "description": "The NAcc is part of the mesocorticolimbic pathway and shows differential activation in response to alcohol cues, particularly among individuals with a specific genetic variant (rs2023239).", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "id": "NACC (NUCLEUS ACCUMBENS)"}, {"entity_type": "PHYSIOLOGICAL PROCESS/MOLECULAR INTERACTION", "description": "The VMPFC exhibits differential activity related to the rs2023239 genotype when alcohol cues are presented, and this is linked to subjective craving measures.", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "id": "VMPFC (VENTROMEDIAL PREFRONTAL CORTEX)"}, {"entity_type": "PHYSIOLOGICAL PROCESS/MOLECULAR INTERACTION", "description": "The VTA shows altered activation in response to alcohol cues among individuals with the CT genotype of rs2023239 compared to those with the TT genotype, influencing reward processing.", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "id": "VTA (VENTRAL TEGMENTAL AREA)"}, {"entity_type": "PHYSIOLOGICAL PROCESS/MOLECULAR INTERACTION", "description": "The OFC shows differential activation in response to alcohol cues among individuals based on their rs2023239 genotype, correlating with subjective craving measures.", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "id": "OFC (ORBITAL PREFRONTAL CORTEX)"}, {"entity_type": "DISEASE/MEASUREMENT TOOL", "description": "An AUDIT score is used as a measure of alcohol use disorder and correlates with brain activity in the NAcc and VMPFC among individuals with certain genotypes.", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "id": "AUDIT SCORE"}, {"entity_type": "DISEASE/MEASUREMENT TOOL", "description": "The AUQ measures the urge to consume alcohol, which is significantly correlated with activation in specific brain regions like OFC for individuals carrying a particular genetic variant.", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "id": "AUQ (ALCOHOL URGE QUESTIONNAIRE)"}, {"entity_type": "TRANSCRIPT", "description": "The transcript of CNR1 is studied for its association with a specific genomic variant (rs2023239) in regulatory regions upstream of exon 3.", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "id": "CNR1 TRANSCRIPT"}, {"entity_type": "PHYSIOLOGICAL PROCESS/MOLECULAR INTERACTION", "description": "This neurocircuitry, involving areas like NAcc and VTA, is modulated by CB1 receptors and plays a role in drug-seeking behavior influenced by genetic variations such as rs2023239.", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "id": "MESOCORTICOLIMBIC NEUROCIRCUITRY"}, {"entity_type": "PHYSIOLOGICAL PROCESS/MOLECULAR INTERACTION", "description": "The PFC tissue is used to quantify CB1 binding levels and study the effects of genomic variant rs2023239 on receptor protein expression.", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "id": "POSTMORTEM HUMAN PREFRONTAL CORTEX (PFC)"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Used as an appetitive control in experiments, contrasting with alcohol to observe differential brain activation patterns influenced by genetic factors such as rs2023239.", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "id": "LITCHI JUICE"}, {"entity_type": "DISEASE/MEASUREMENT TOOL", "description": "These scales are used to measure subjective reward experiences after alcohol consumption, showing significant differences based on genotype (rs2023239).", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "id": "REWARD AND POSITIVE AFFECT SCALES (POMS)"}, {"entity_type": "DRUG", "description": "Olanzapine is a medication that targets the dopamine system and is used in clinical trials for treatment-seeking alcohol-dependent individuals.", "source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59", "id": "OLANZAPINE"}, {"entity_type": "GENOMIC VARIANT", "description": "CNR1 variation refers to genetic differences within the CNR1 gene, which may interact with olanzapine to influence craving and alcohol consumption behaviors.", "source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59", "id": "CNR1 VARIATION"}, {"entity_type": "DRUG", "description": "Cyproheptadine hydrochloride is used as a control medication in studies comparing its effects to olanzapine on rewarding effects of alcohol consumption.", "source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59", "id": "CYPROHEPTADINE HYDROCHLORIDE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process by which individuals experience increased reward and positive affect after consuming alcoholic beverages, influenced by genotype and medications.", "source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59", "id": "REWARD AND POSITIVE AFFECT"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process by which cues related to alcohol elicit craving in individuals, particularly those with certain genotypes under different medication conditions.<SEP>This is the process where cues related to alcohol elicit craving in treatment-seeking individuals under different medication conditions.", "source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59", "id": "CUE-ELICITED CRAVING"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The measure of how many drinks an individual consumes per day they drink, which can be influenced by genotype and medication interactions.", "source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59", "id": "DRINKS PER DRINKING DAY"}, {"entity_type": "GENOMIC VARIANT", "description": "rs2023239 is a specific genetic marker or variant associated with variations influencing alcohol consumption behaviors.", "source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59", "id": "RS2023239"}, {"entity_type": "GENE", "description": "The LPL gene encodes lipoprotein lipase (LPL), an enzyme crucial for the breakdown of triglyceride-rich lipoproteins.<SEP>The LPL gene encodes lipoprotein lipase, a protein essential for lipid metabolism through the hydrolysis of chylomicrons.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63<SEP>chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "id": "LPL GENE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Chylomicron hydrolysis is a physiological process in which lipoprotein lipase breaks down chylomicrons to release fatty acids and monoglycerides for use by tissues.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "id": "CHYLOMICRON HYDROLYSIS"}, {"entity_type": "DISEASE", "description": "LPL deficiency disorder is an autosomal recessive condition characterized by decreased LPL activity, leading to severe hypertriglyceridemia in homozygous individuals or compound heterozygotes and normal lipids in simple heterozygote carriers.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "id": "LPL DEFICIENCY DISORDER"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Eruptive xanthomas are a clinical feature of LPL deficiency disorder, representing skin lesions due to the deposition of cholesterol esters in the epidermis.<SEP>Eruptive xanthomas are skin lesions that appear when TG levels exceed 2000 mg/dl due to accumulation of lipid-laden macrophages in the dermis.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63<SEP>chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "id": "ERUPTIVE XANTHOMAS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Abdominal pain is one of the symptoms associated with LPL deficiency disorder, often resulting from high triglyceride levels causing pancreatitis or gallstones.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "id": "ABDOMINAL PAIN"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Enlargement of liver and spleen (hepatosplenomegaly) can occur in patients with LPL deficiency due to accumulation of lipids within these organs.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "id": "HEPATOSPLENOMEGALY"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Recurrent pancreatitis is a severe complication that may occur in individuals with LPL deficiency due to high triglyceride levels causing inflammation and damage to the pancreas.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "id": "RECURRENT PANCREATITIS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A condition where lipids accumulate in retinal vessels, visible as a diffuse milky appearance when TG levels exceed 2500 mg/dl.<SEP>Lipemia retinalis, characterized by milky white appearance of the retina caused by lipid droplets in blood vessels, is a clinical sign seen in patients with severe hypertriglyceridemia.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63<SEP>chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "id": "LIPEMIA RETINALIS"}, {"entity_type": "DIETARY PATTERN", "description": "A therapeutic approach to manage hypertriglyceridemia by limiting dietary intake of fats, particularly saturated and trans-fats.<SEP>Restricting dietary fat intake is recommended for managing LPL deficiency to reduce plasma triglyceride levels and alleviate symptoms such as pancreatitis or xanthomas.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63<SEP>chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "id": "DIETARY FAT RESTRICTION"}, {"entity_type": "THERAPY", "description": "Ongoing gene therapy trials aim to treat patients with LPL deficiency by introducing a functional copy of the LPL gene into affected individuals\' cells.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "id": "GENE THERAPY TRIALS"}, {"entity_type": "NUTRIENT", "description": "Medium-chain triglycerides are fats with shorter chain lengths that can be metabolized more easily than long-chain fatty acids, and thus may be used in dietary management of LPL deficiency.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "id": "MEDIUM-CHAIN TRIGLYCERIDES (MCT)"}, {"entity_type": "PROTEIN", "description": "GPIHBP1 binds to lipoprotein lipase, facilitating its transport to the capillary lumen for lipid metabolism.<SEP>GPIHBP1 is a protein responsible for transporting lipoprotein lipase to the capillary lumen where it can hydrolyze chylomicrons, essential for proper lipid metabolism.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "id": "GPIHBP1"}, {"entity_type": "METABOLIC PATHWAY", "description": "A metabolic pathway involving the breakdown, synthesis, and transport of lipids within cells, regulated by various genes including RP genes.<SEP>The metabolic pathway of lipid metabolism involves processes such as synthesis and breakdown of fatty acids and triglycerides in the body\'s tissues.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63<SEP>chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "LIPID METABOLISM"}, {"entity_type": "GENOMIC VARIANT", "description": "This genomic variant refers to the location on chromosome 8 where the LPL gene is situated, spanning approximately 30 kb with ten exons.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "id": "CHROMOSOME 8P21.3"}, {"entity_type": "PROTEIN", "description": "Lipoprotein lipase hydrolyzes triglycerides in chylomicrons and very-low-density lipoproteins to release fatty acids for tissue uptake.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "id": "LPL PROTEIN"}, {"entity_type": "GENOMIC VARIANT", "description": "A heterozygous mutation in exon 5 of the LPL gene (c.644G\u2192A), resulting in a substitution of glycine to glutamic acid at amino acid position 215, causing LPL deficiency.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "id": "MUTATION P.G215E"}, {"entity_type": "GENOMIC VARIANT", "description": "A novel heterozygous mutation in exon 5 of the LPL gene (c.721G\u2192T), resulting in a substitution of glutamine to histidine at amino acid position 240, causing LPL deficiency.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "id": "MUTATION P.Q240H"}, {"entity_type": "GENOMIC VARIANT", "description": "This mutation is a novel variant causing severe hypertriglyceridemia due to its impact on the function or expression of LPL gene products.", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "id": "P.Q240H MUTATION IN EXON 5 OF THE LPL GENE"}, {"entity_type": "PROTEIN", "description": "The protein encoded by the LPL gene, lipoprotein lipase, is essential for breaking down triglyceride-rich lipoproteins to release free fatty acids and glycerol.", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "id": "LIPOPROTEIN LIPASE (LPL) PROTEIN"}, {"entity_type": "DISEASE", "description": "A condition characterized by high levels of triglycerides in the blood, often associated with genetic factors such as mutations in LPL gene.", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "id": "HYPERTRIGLYCERIDEMIA"}, {"entity_type": "DISEASE", "description": "Inflammation of the pancreas associated with elevated triglyceride levels due to hyperviscosity and lipid deposits in pancreatic tissue.", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "id": "PANCREATITIS"}, {"entity_type": "NUTRIENT", "description": "A dietary supplement used for fat restriction therapy in patients with LPL deficiency, absorbed directly into the portal vein without requiring lipoprotein lipase action.", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "id": "MCT (MEDIUM-CHAIN TRIGLYCERIDES)"}, {"entity_type": "DRUG", "description": "An oral medication that inhibits pancreatic and gastrointestinal lipases to reduce fat absorption, thereby lowering blood triglyceride levels.", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "id": "ORLISTAT"}, {"entity_type": "DRUG", "description": "A fibrate drug used for reducing triglycerides and increasing HDL cholesterol in patients with hypertriglyceridemia.", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "id": "GEMFIBROZIL"}, {"entity_type": "PROTEIN", "description": "An enzyme involved in the final step of triglyceride synthesis, being a potential target for therapeutic intervention in managing high TG levels.", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "id": "DIACYLGLYCEROL O-ACYLTRANSFERASE 1 (DGAT1)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Lipoprotein particles rich in triglycerides, which are transported by lipoprotein lipase to release free fatty acids and glycerol for cellular uptake.", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "id": "TRIGLYCERIDE-RICH LIPOPROTEINS (TRL)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Normal growth patterns observed in children with LPL deficiency when dietary fat restriction is adhered to.", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "id": "LINEAR GROWTH"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process of physical changes leading to sexual maturity, typically occurring normally despite dietary restrictions in individuals with LPL deficiency.", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "id": "PUBERTY"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Process by which fats are taken up and metabolized by the body, often targeted for intervention in therapies addressing hypertriglyceridemia.", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "id": "FAT ABSORPTION"}, {"entity_type": "DRUG", "description": "Topiramate is a drug used in clinical trials to treat conditions such as alcohol use disorder.<SEP>Topiramate is a drug used to treat conditions such as alcohol use disorder and epilepsy.", "source_id": "chunk-0c7ab28db433187759e760725a105836", "id": "TOPIRAMATE"}, {"entity_type": "GENOMIC VARIANT", "description": "Rs2832407 is a gene variant that moderates the effect of topiramate in European-American patients.", "source_id": "chunk-0c7ab28db433187759e760725a105836", "id": "RS2832407 GENE VARIANT"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "No HDDs refers to a period where no heavy drinking occurred, indicating efficacy of treatment in reducing alcohol consumption.", "source_id": "chunk-0c7ab28db433187759e760725a105836", "id": "NO HEAVY DRINKING DAYS (HDDS)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Adverse events are unwanted effects or negative health outcomes that occur as a result of drug therapy.", "source_id": "chunk-0c7ab28db433187759e760725a105836", "id": "ADVERSE EVENTS (AE)"}, {"source_id": "chunk-0c7ab28db433187759e760725a105836", "description": "Topiramate treatment is effective in reducing heavy drinking days, indicating its efficacy for treating alcohol use disorder.<SEP>Topiramate treatment leads to a reduction in heavy drinking days, indicating efficacy.", "entity_type": "UNKNOWN", "id": "NO HDDS (EFFICACY)"}, {"entity_type": "GENE", "description": "CYP2D6 is a gene associated with the metabolism of certain drugs, including anti-emetics.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "id": "CYP2D6"}, {"entity_type": "GENOMIC VARIANT", "description": "The genomic variant at position rs1045642 in the ABCB1 gene influences drug transport and can alter patient response to medications.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "id": "ABCB1 ALLELE RS1045642"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Acute nausea severity as reported by patients is a physiological process influenced by various factors including genetic variants.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "id": "PATIENT-REPORTED ACUTE NAUSEA SEVERITY"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "CTCAE grade of acute nausea reflects the severity and impact of nausea on patient quality of life during chemotherapy treatment.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "id": "CTCAE GRADE OF ACUTE NAUSEA"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Delayed nausea severity as reported by patients is a physiological process influenced by factors such as type of chemotherapy administered.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "id": "PATIENT-REPORTED DELAYED NAUSEA SEVERITY"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "CTCAE grade of delayed nausea measures the severity and impact of nausea after initial treatment phase in cancer patients undergoing chemotherapy.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "id": "CTCAE GRADE OF DELAYED NAUSEA"}, {"entity_type": "DISEASE", "description": "Advanced stage cancer indicates later stages of disease progression, characterized by a higher tumor burden and metastasis potential.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "id": "ADVANCED STAGE CANCER"}, {"entity_type": "THERAPY", "description": "A chemotherapy regimen that has a high likelihood of causing nausea and vomiting as side effects.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "id": "HIGHLY EMETOGENIC CHEMOTHERAPY REGIMEN"}, {"entity_type": "GENOMIC VARIANT", "description": "The genomic variant at position rs45460698 in the HTR3B gene is studied for its influence on patient response to certain drugs or therapies.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "id": "HTR3B (RS45460698)"}, {"entity_type": "GENETIC CHARACTERIZATION", "description": "An individual\'s ABCB1 genotype, influenced by variations such as rs1045642, affects drug transport and efficacy.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "id": "ABCB1 GENOTYPE "}, {"entity_type": "GENE", "description": "HTR3B is a gene involved in serotonin receptor function, which can influence patient response to certain drugs or therapies.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "id": "HTR3B"}, {"entity_type": "GENOMIC VARIANT", "description": "The genomic variant at position rs1045642 in the ABCB1 gene influences drug transport and can alter patient response to medications, particularly anti-emetics.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "id": "ABC1 GENOTYPE (RS1045642)"}, {"entity_type": "DRUG", "description": "An antiemetic medication commonly prescribed for preventing nausea during chemotherapy treatment.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "id": "PALONOSETRON"}, {"entity_type": "DRUG", "description": "A steroid used as an anti-inflammatory and anti-emetic agent in chemotherapy regimens.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "id": "DEXAMETHASONE"}, {"entity_type": "DRUG", "description": "Another drug used to treat nausea and vomiting, often prescribed alongside other antiemetics.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "id": "PROCHLORPERAZINE"}, {"entity_type": "DRUG", "description": "An antiemetic medication commonly used for preventing nausea in chemotherapy patients.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "id": "ONDANSETRON"}, {"entity_type": "DRUG", "description": "A drug used to prevent acute and delayed nausea and vomiting associated with cancer treatments.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "id": "FOSAPREPITANT"}, {"source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "description": "Patients receiving highly emetogenic chemotherapy regimens are more likely to report higher CTCAE grades for delayed nausea compared to less aggressive treatment plans.", "entity_type": "UNKNOWN", "id": "HIGHLY EMETOGENIC CHEMOTHERAPY REGIMEN "}, {"source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "description": "Patients receiving highly emetogenic chemotherapy are more likely to experience delayed nausea and vomiting, highlighting the relationship between treatment type and patient outcomes.", "entity_type": "UNKNOWN", "id": "DELAYED CINV"}, {"entity_type": "GENE", "description": "The lactase gene (LCT) is involved in the production of lactase enzyme responsible for digesting lactose in dairy products. The regulation and expression of this gene can vary between individuals, influencing lactose tolerance.", "source_id": "chunk-ec104044b3aa65560be8d81dbb3940d6", "id": "LACTASE GENE (LCT)"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific genomic variant (C/T-13910) located within the MCM6 intron 13-exon 13 region has been linked to lactase persistence and non-persistence in humans.", "source_id": "chunk-ec104044b3aa65560be8d81dbb3940d6", "id": "GENOMIC VARIANT C/T-13910"}, {"entity_type": "TRANSCRIPT", "description": "Levels of LCT mRNA were effectively regulated by LOC100507600 lncRNA in cells relevant to lactase persistence.<SEP>The LCT gene transcript whose expression changes significantly with age depending on the genetic variants (CC vs. TT) at position -13910, influencing lactose digestion ability in humans.<SEP>The LCT mRNA represents the transcript of the lactase gene which is expressed in intestinal epithelial cells. Its levels can vary significantly between individuals, influencing lactose digestion capabilities.", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1<SEP>chunk-512b044cf65a4e519d519c6239959c6c<SEP>chunk-ec104044b3aa65560be8d81dbb3940d6", "id": "LCT MRNA"}, {"entity_type": "EPIGENETIC MODIFICATION", "description": "Epigenetic modifications, such as DNA methylation and histone modification, influence the expression of the LCT gene by altering its regulatory regions and affecting transcriptional processes.", "source_id": "chunk-ec104044b3aa65560be8d81dbb3940d6", "id": "EPIGENETIC MODIFICATION"}, {"entity_type": "DIETARY PATTERN", "description": "The dietary pattern involving lactose intake influences the regulation and expression levels of the lactase gene in individuals, impacting their ability to digest dairy products effectively.", "source_id": "chunk-ec104044b3aa65560be8d81dbb3940d6", "id": "DIETARY PATTERN (LACTOSE INTAKE)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Transcriptional regulation is a physiological process that controls the production of LCT mRNA by modulating epigenetic factors and other regulatory elements within the gene\'s promoter regions.", "source_id": "chunk-ec104044b3aa65560be8d81dbb3940d6", "id": "PHYSIOLOGICAL PROCESS: TRANSCRIPTIONAL REGULATION"}, {"entity_type": "METABOLIC PATHWAY", "description": "Lactose metabolism is a metabolic pathway involving enzymes produced from genes like LCT. The efficiency of this pathway can be influenced by genetic variations and dietary patterns affecting lactase production.", "source_id": "chunk-ec104044b3aa65560be8d81dbb3940d6", "id": "METABOLIC PATHWAY: LACTOSE METABOLISM"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "The environmental factor, age, influences the expression levels of the LCT gene in humans and mice, with a decrease in lactase activity observed post-infancy.", "source_id": "chunk-ec104044b3aa65560be8d81dbb3940d6", "id": "ENVIRONMENTAL FACTOR (AGE)"}, {"entity_type": "DISEASE", "description": "Lactase non-persistence is a condition where individuals lose their ability to digest milk efficiently after infancy due to reduced expression of the LCT gene.<SEP>The condition in which lactase enzyme activity declines after weaning, usually linked to specific genetic variants (e.g., C allele).", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d<SEP>chunk-ec104044b3aa65560be8d81dbb3940d6", "id": "LACTASE NON-PERSISTENCE"}, {"entity_type": "TRANSCRIPT", "description": "The levels of LCT mRNA represent the expression level of the lactase gene transcript in enterocytes. Variations in these levels correlate with differences in lactose digestion capabilities.", "source_id": "chunk-ec104044b3aa65560be8d81dbb3940d6", "id": "LCT MRNA LEVELS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "DNA modification density refers to the degree of DNA methylation within specific regions affecting transcriptional regulation and gene expression, particularly LCT mRNA levels.", "source_id": "chunk-ec104044b3aa65560be8d81dbb3940d6", "id": "DNA MODIFICATION DENSITY"}, {"entity_type": "GENE", "description": "The MCM6 gene is closely associated with the lactase gene (LCT) and harbors a key SNP at C/T-13910 that influences lactose persistence.", "source_id": "chunk-ec104044b3aa65560be8d81dbb3940d6", "id": "MCM6 GENE"}, {"entity_type": "MOLECULAR INTERACTION", "description": "A molecular interaction technique used for high-resolution mapping of DNA methylation patterns within specific genomic regions, aiding in the study of epigenetic regulation.", "source_id": "chunk-ec104044b3aa65560be8d81dbb3940d6", "id": "BISULFITE PADLOCK PROBE SEQUENCING"}, {"entity_type": "TRANSCRIPT", "description": "The levels of Lct mRNA in mice represent expression from the mouse lactase gene (Lct), which decreases with age post-infancy, similar to humans.", "source_id": "chunk-ec104044b3aa65560be8d81dbb3940d6", "id": "LCT MRNA LEVELS IN MICE"}, {"entity_type": "GENE", "description": "LCT is a gene involved in the cell-type specific expression of lactase.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "id": "LCT"}, {"entity_type": "GENE", "description": "MCM6 is a gene located near LCT and exhibits regulatory functions with respect to DNA modifications and chromatin structure.<SEP>MCM6 is a gene that plays a role in the regulation of DNA modifications and protein interactions involved in lactase activity.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d<SEP>chunk-ea45644d73f260cf365527dcc3af86e1", "id": "MCM6"}, {"entity_type": "GENOMIC VARIANT", "description": "Significant differences in DNA modification were observed at 35 CpG sites, indicating specific genomic regions involved in cell-type-specific expression of LCT.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "id": "CPG SITES"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process of measuring and comparing the methylation status across different tissues (e.g., enterocytes vs. jejunum) to understand gene regulation.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "id": "DNA MODIFICATION PROFILES"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Jejunum lacking functional enterocytes serves as a control in studies examining cell-type-specific DNA modifications and gene expression.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "id": "ENTEROCYTE-DEFICIENT JEJUNUM"}, {"entity_type": "TISSUE", "description": "Used to assess whether the observed DNA modifications are unique to intestinal tissues or present across different tissue types.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "id": "WHITE BLOOD CELLS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Sites within the genome that are more accessible to DNase I due to open chromatin structure, indicating potential regulatory elements.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "id": "DNASE I HYPERSENSITIVITY SITES"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Histone modifications indicative of active enhancers, found in specific regions of LCT and MCM6 genes.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "id": "H3K4ME1 AND H3K27AC"}, {"entity_type": "DISEASE STATE", "description": "Conditions characterized by the decline or maintenance of lactose digestion capability into adulthood.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "id": "LACTASE NON-PERSISTENCE AND PERSISTENCE"}, {"entity_type": "GENOMIC VARIANT", "description": "Single nucleotide polymorphisms in MCM6 that correlate with LCT mRNA levels and are linked to lactase persistence or non-persistence.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "id": "MCM6 SNPS (RS4988235, RS182549)"}, {"entity_type": "GENOMIC VARIANT", "description": "A genetic variation in the intron 1 region of the LCT gene, contributing to differential DNA modification and mRNA levels.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "id": "INSERTION-DELETION IN THE 3\u2032 REGION OF LCT INTRON 1"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant within intron 5 of the LCT gene showing significant DNA modification differences.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "id": "INTRON 5 OF LCT"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic region identified with differential DNA modifications compared to other tissues.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "id": "INTRON 3 OF LCT"}, {"entity_type": "GENOMIC VARIANT", "description": "Another region within intron 2 showing significant differences in DNA modification profiles.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "id": "INTRON 2 OF LCT"}, {"entity_type": "GENOMIC VARIANT", "description": "The exon 1 of the LCT gene also showed differential DNA modifications compared to other tissues.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "id": "EXON 1 OF LCT"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic region within intron 13 showing significant changes in DNA modification profiles.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "id": "INTRON 13 OF MCM6"}, {"entity_type": "GENOMIC VARIANT", "description": "An exon within the MCM6 gene overlapping with a long non-coding RNA (lncRNA) LOC100507600.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "id": "EXON 17 OF MCM6"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic region that overlaps with the lncRNA and showed differential DNA modifications.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "id": "EXON 16 OF MCM6"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Regulation of lactase persistence involves genetic and epigenetic factors affecting the expression of LCT mRNA in cells such as Caco-2.<SEP>The state where lactase enzyme activity remains high into adulthood, typically associated with certain genotypes (e.g., T allele).", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d<SEP>chunk-512b044cf65a4e519d519c6239959c6c", "id": "LACTASE PERSISTENCE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Refers to the regulation of LCT gene expression that changes with age, often influenced by epigenetic modifications.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "id": "AGE-DEPENDENT REGULATION OF LCT"}, {"entity_type": "GENE", "description": "The LCT gene encodes for lactase, an enzyme crucial for digesting lactose. The regulation of this gene is associated with age-dependent changes in DNA modification leading to lactase non-persistence or persistence.", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "id": "LCT GENE (LACTASE GENE)"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific genomic variant located at position -13910, which influences the expression and activity of genes such as MCM6 and LCT through epigenetic mechanisms.", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "id": "C-13910"}, {"entity_type": "GENOMIC VARIANT", "description": "Another specific genomic variant located at position -13910, which is associated with lactase persistence in individuals due to its influence on DNA modifications over age.", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "id": "T-13910"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Process through which DNA modifications accumulate or decrease over time and contribute to the downregulation of LCT gene expression in individuals with specific genetic variants.", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "id": "DNA MODIFICATION CHANGES"}, {"entity_type": "CONDITION", "description": "A condition characterized by the inability to digest lactose due to insufficient production of lactase enzyme, often influenced by genetic factors such as variants at position -13910 in the LCT gene.", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "id": "LACTOSE INTOLERANCE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A process involving the addition of a methyl group to DNA or proteins that can lead to changes in gene expression and contribute to lactase persistence or non-persistence.", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "id": "METHYLATION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Changes in histones that affect chromatin structure and gene expression, playing a role in regulating lactase activity through interaction with MCM6 and LCT genes.", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "id": "HISTONE MODIFICATIONS"}, {"entity_type": "EXTERNAL FACTOR", "description": "The amount and frequency of dietary lactose intake, which can influence genetic expression related to lactose digestion efficiency.", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "id": "DIETARY LACTOSE CONSUMPTION"}, {"entity_type": "TISSUE TYPE", "description": "Cells in the intestinal lining responsible for absorbing nutrients and digesting lactose, where genetic and epigenetic factors interact to regulate lactase production.", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "id": "ENTEROCYTES"}, {"entity_type": "CELL LINE", "description": "Human intestinal epithelial cell line Caco-2, which has the TT genotype at SNP -13910.", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "id": "CACO-2 CELL LINE"}, {"entity_type": "TRANSCRIPT", "description": "The mRNA of LOC100507600 was transfected with small-interfering RNAs, resulting in a 20% reduction and concomitant 25% reduction in LCT mRNA.", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "id": "LOC100507600 LNCRNA"}, {"entity_type": "TRANSCRIPT", "description": "The mRNA of MCM6 remained unchanged after silencing of LOC100507600 (Fig. 5b).", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "id": "MCM6 MRNA"}, {"entity_type": "PROTEIN INTERACTION", "description": "A CTCF binding site overlapping the lncRNA promoter is nearly ubiquitous across human tissues.", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "id": "CTCF BINDING SITE"}, {"entity_type": "GENOMIC VARIANT", "description": "Intronic regions in Lct or Mcm6 were deleted using CRISPR-Cas9 technology to determine their impact on steady-state Lct mRNA levels.", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "id": "LCT INTRONIC REGION"}, {"entity_type": "GENOMIC VARIANT", "description": "A region in Mcm6 intron 13 was targeted, which is important for human LCT regulation.", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "id": "MCM6 INTRONIC REGION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Deletion of the Lct promoter element resulted in a significant downregulation of Lct mRNA levels (Fig. 6b, c).", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "id": "LCT PROMOTER ELEMENT"}, {"entity_type": "TECHNIQUE", "description": "Used to determine whether differentially modified DNA regions contribute to Lct regulation.", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "id": "CRISPR-CAS9 GENOME EDITING TECHNOLOGY"}, {"entity_type": "PHYSIOLOGICAL CONDITION", "description": "The mutation in Lct intron 2 produced a significantly greater loss in Lct mRNA in adult intestine compared to infant intestine.", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "id": "ADULT INTESTINE"}, {"entity_type": "GENOMIC VARIANT", "description": "Lct intron 2 establishes stronger control of Lct mRNA expression in adulthood, corroborating aging mouse findings.", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "id": "EVOLVING CONSERVED REGION"}, {"entity_type": "GENOMIC VARIANT", "description": "The Caco-2 cell line has a TT genotype at SNP -13910.", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "id": "SNP -13910 TT GENOTYPE"}, {"entity_type": "TECHNIQUE", "description": "Small-interfering RNAs directed to LOC100507600 reduced its expression by 20% in Caco-2 cells.", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "id": "SIRNAS DIRECTED TO LOC100507600"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Increased DNA methylation facilitates enhancer-promoter interactions, which can affect gene regulation.", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "id": "ENHANCER-PROMOTER INTERACTION"}, {"entity_type": "GENOMIC VARIANT", "description": "A region in Mcm6 intron 13 was targeted for deletion using CRISPR-Cas9 technology to study LCT regulation.", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "id": "LCT INTRONIC REGION 13 "}, {"entity_type": "TECHNIQUE", "description": "Surveyed and did not find any off-target activity of the CRISPR-Cas9 system in 46 candidate regions.", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "id": "CRISPR-CAS9 OFF-TARGET ACTIVITY SURVEY"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The mutation in Lct intron 2 causes a significant difference in Lct mRNA levels between adult and infant intestines.", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "id": "ADULT INTESTINE VS INFANT INTESTINE REGULATION"}, {"entity_type": "GENOMIC VARIANT", "description": "Impact of epigenetically-regulated regions on human LCT expression was examined in cultured Caco-2 cells.", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "id": "EPIGENETICALLY-REGULATED REGIONS"}, {"source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "description": "The regulatory region within intron 5 influences the persistence or decline of lactose digestion capability into adulthood based on genetic variants.", "entity_type": "UNKNOWN", "id": "LACTASE PERSISTENCE AND NON-PERSISTENCE"}, {"source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "description": "The genomic variant C-13910 is linked to lactase non-persistence, as it correlates with increased DNA modification changes and decreased LCT mRNA expression over age.", "entity_type": "UNKNOWN", "id": "LACTASE PERSISTENCE/NON-PERSISTENCE CONDITION"}, {"source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "description": "The lncRNA LOC100507600 is involved in the regulation of LCT mRNA, similar to regulatory elements identified at intron 2 and 8 in mice.", "entity_type": "UNKNOWN", "id": "LCT INTRON 2 AND 8 IN MICE"}, {"source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "description": "The epigenetic interaction between LCT and MCM6 involves age-related DNA modification changes that regulate lactase expression and persistence.", "entity_type": "UNKNOWN", "id": "LCT\u2013MCM6 EPIGENETIC INTERACTION"}, {"source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "description": "These chromatin marks are key histone modifications that contribute to the regulation of lactase expression and persistence by influencing transcriptional activity at specific genomic regions.", "entity_type": "UNKNOWN", "id": "H3K27AC, H3K4ME1, H3K4ME3, POLR2A CHROMATIN MARKS"}, {"source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "description": "The study of enterocytes provides crucial insights into how epigenetic interactions between MCM6 and LCT genes influence lactase persistence or non-persistence conditions in humans.", "entity_type": "UNKNOWN", "id": "ENTEROCYTE SAMPLES"}, {"source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "description": "The deletion of a region in Mcm6 intron 13 is crucial for human LCT expression regulation, as shown by CRISPR-Cas9 experiments.)", "entity_type": "UNKNOWN", "id": "HUMAN LCT REGULATION"}, {"source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "description": "The intronic region influences LCT expression differently between adults and infants.)", "entity_type": "UNKNOWN", "id": "LCT INTRONIC REGION 2 "}, {"entity_type": "GENE", "description": "The T allele of the rs4988235 variant is linked to lactase persistence, a trait allowing continued digestion of lactose into adulthood.", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5", "id": "LACTASE PERSISTENT ALLELE (T)"}, {"entity_type": "GENOMIC VARIANT", "description": "The C allele of the rs4988235 variant is associated with lactase non-persistence, indicating reduced ability to digest milk in adults.", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5", "id": "LACTASE NON-PERSISTENT ALLELE (C)"}, {"entity_type": "DIETARY PATTERN", "description": "A dietary pattern characterized by the consumption or avoidance of milk, influenced by genetic and environmental factors such as lactase persistence genotype.", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5", "id": "MILK CONSUMPTION"}, {"entity_type": "DISEASE", "description": "A type of cancer that begins in the lining of very small tubes (tubules) in the kidney. Individuals with different levels of milk consumption may have varying risks associated with RCC.", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5", "id": "RENAL CELL CARCINOMA (RCC)"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Level of education attained by individuals, which can influence dietary patterns and lifestyle choices such as milk intake.", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5", "id": "EDUCATIONAL ATTAINMENT"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A principle in population genetics that describes an ideal condition for gene and genotype frequencies to remain constant from one generation to the next.<SEP>A principle in population genetics used to analyze genetic variation and equilibrium, relevant for understanding allele frequencies.<SEP>A principle used in population genetics to test if the observed genotype frequencies fit expected values, indicating no natural selection acting on the gene in question.<SEP>A principle stating the expected genotype frequencies in a large, randomly mating population remain constant from generation to generation in the absence of other evolutionary influences.", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5<SEP>chunk-3cf4e094a5312845a1cc4da4304d4bdf<SEP>chunk-84ec948f22126cef7d93b1d7465b79db<SEP>chunk-f02653cb486dbf68cc259f74ea8b2b2e", "id": "HARDY-WEINBERG EQUILIBRIUM"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Characteristics such as age, sex, ethnicity which may influence dietary patterns and genetic studies.", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5", "id": "DESCRIPTIVE CHARACTERISTICS"}, {"entity_type": "GEOGRAPHIC REGION", "description": "Populations residing in Eastern Europe with specific allele frequencies reflecting intermediate frequencies for lactase persistence genotype at rs4988235.", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5", "id": "EASTERN EUROPEAN POPULATIONS"}, {"entity_type": "GENE", "description": "The BCL11A gene harbors SNPs that are associated with baseline, MTD (maximum tolerated dose), and delta hemoglobin F levels.", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "id": "BCL11A GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "This is a specific single nucleotide polymorphism in the BCL11A gene that increases baseline and MTD HbF levels and is associated with increased delta HbF.", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "id": "RS1427407 SNP"}, {"entity_type": "GENOMIC VARIANT", "description": "Another SNP within the BCL11A gene, showing similar associations to rs1427407 for baseline and MTD HbF levels and delta HbF.", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "id": "RS4671393 SNP"}, {"entity_type": "GENOMIC VARIANT", "description": "This is a less significant but still associated variant within the BCL11A gene with effects on MTD and delta HbF values.", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "id": "RS11886868 SNP"}, {"entity_type": "GENE", "description": "The HMIP-2 gene carries SNPs that are correlated with baseline hemoglobin F levels, increasing both the baseline and MTD levels of HbF.", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "id": "HMIP-2 GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "An SNP in the HMIP-2 gene showing association with higher baseline and MTD HbF levels but not delta HbF values, losing significance when corrected for baseline HbF.", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "id": "RS9399137 SNP"}, {"entity_type": "GENOMIC VARIANT", "description": "This SNP within the HMIP-2 gene also increases baseline HbF levels and MTD HbF levels but shows no association with delta HbF, similar to rs9399137.", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "id": "RS9402686 SNP"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A physiological process involving the production of fetal hemoglobin which can be influenced by genetic variants such as SNPs in BCL11A and HMIP-2 genes.", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "id": "HEMOGLOBIN F (HBF)"}, {"entity_type": "THERAPY", "description": "A treatment that leads to improvements in several hematological parameters and is correlated with HbF levels before and after treatment, indicating a role of HU in enhancing hemoglobin F production.", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "id": "HYDROXYUREA TREATMENT (HU)"}, {"entity_type": "PROTEIN", "description": "Hemoglobin is a protein responsible for oxygen transport in red blood cells, closely related to the study of hemoglobin F levels.", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "id": "HEMOGLOBIN (HB)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The absolute neutrophil count is used as a covariate in assessing the impact of genetic variants on HbF levels and hematological parameters.", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "id": "NEUTROPHIL COUNT (ANC)"}, {"entity_type": "THERAPY", "description": "Maximum tolerated dose refers to the highest level of hydroxyurea treatment that can be administered without unacceptable side effects.", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "id": "MAXIMUM TOLERATED DOSE (MTD)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The frequency of an allele within a gene pool, important for studying the impact of specific SNPs like rs1427407 and rs9399137.<SEP>The frequency of occurrence or distribution of different alleles in a population, measured across various genetic loci and polymorphisms such as BDNF rs6265 and rs2049046.", "source_id": "chunk-814fe155e9cb953da61f6a79d1d25784<SEP>chunk-3cf4e094a5312845a1cc4da4304d4bdf", "id": "ALLELE FREQUENCY"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific single nucleotide polymorphism (SNP) within the HMIP-2 locus that has been analyzed for its association with MTD HbF.", "source_id": "chunk-3ae06e9a3330573da28ca0a76aa685ce", "id": "HMIP-2 SNP"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Maternal to fetal transfer of hemoglobin F (HbF), a physiological process influenced by genetic factors such as genomic variants in HMIP-2.", "source_id": "chunk-3ae06e9a3330573da28ca0a76aa685ce", "id": "MTD HBF"}, {"entity_type": "GENOMIC VARIANT", "description": "An observed haplotype consisting of combinations of alleles from the HMIP-2 genomic region.", "source_id": "chunk-3ae06e9a3330573da28ca0a76aa685ce", "id": "C-A HAPLOTYPE"}, {"entity_type": "GENE", "description": "The FANCA gene is one of the known Fanconi anemia genes involved in DNA repair processes.", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "id": "FANCA GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "A mutation in the FANCA gene, c.2574C>G/p.Ser858Arg, previously described in FA patients but not identified as a causative factor in this subject.", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "id": "C.2574C>G/P.SER858ARG MUTATION"}, {"entity_type": "GENE", "description": "The UBE2T gene encodes for an enzyme involved in ubiquitination processes necessary for Fanconi anemia pathway activation.", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "id": "UBE2T GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "A paternally derived deletion of the UBE2T gene, leading to loss of function.", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "id": "G.202332626_202341295DEL DELETION"}, {"entity_type": "GENOMIC VARIANT", "description": "A maternally derived duplication in the UBE2T gene region due to recombination between two AluYa5 repeats.", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "id": "G.202332626_202341295DUP DUPLICATION"}, {"entity_type": "TRANSCRIPT", "description": "A transcript of the UBE2T gene with a duplicated exon 2 spliced to exon 6, resulting in a frameshift and premature stop codon.", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "id": "UBE2T TRANSCRIPT (C.-64_468DUP)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Monoubiquitination of FANCD2 is a critical process for the activation of Fanconi anemia pathway and cellular response to DNA damage.<SEP>The monoubiquitination of FANCD2 is a physiological process that is restored upon overexpression of UBE2T, which is crucial for the FA pathway\'s function in response to DNA damage.", "source_id": "chunk-ffd1276c89bcac745a7e58082e97236f<SEP>chunk-b3b792ab4e6f6251de68ef6e959aee1f", "id": "FANCD2 MONOUBIQUITINATION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "An elevated level of chromosomal breakage in cells treated with crosslinking agents, indicating impaired repair mechanisms.", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "id": "CHROMOSOMAL BREAKAGE"}, {"entity_type": "METABOLIC PATHWAY", "description": "A cellular pathway involved in DNA repair and maintenance, activated by the core FA complex proteins including FANCA and UBE2T.", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "id": "FANCONI ANEMIA PATHWAY"}, {"entity_type": "CELL LINE", "description": "Fibroblast cells derived from a patient with Fanconi anemia, displaying cellular phenotypes consistent with deficiencies in the FA pathway.", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "id": "FIBROBLASTS (RA2627)"}, {"entity_type": "CELL LINE", "description": "A cell line derived from blood of the same patient showing reversion to normal FANCD2 monoubiquitination, indicative of somatic mosaicism.", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "id": "LYMPHOBLASTOID CELL LINE (RA2946)"}, {"entity_type": "DISEASE", "description": "A genetic disorder characterized by bone marrow failure, developmental abnormalities, and cellular hypersensitivity to DNA crosslinking agents.", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "id": "FANCONI ANEMIA (FA)"}, {"entity_type": "PROTEIN", "description": "UBE2T is a gene responsible for the expression of wild type UBE2T protein, which plays a critical role in rescuing cellular defects associated with Fanconi Anemia-T (FA-T) subtype.<SEP>Ube2T is an E2 ubiquitin-conjugating enzyme that binds the RING domain of proteins like FANCL for substrate binding and ubiquitination processes.", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9<SEP>chunk-ffd1276c89bcac745a7e58082e97236f", "id": "UBE2T"}, {"entity_type": "CELL LINE", "description": "RA2627 fibroblasts are cells derived from an individual with UBE2T deficiency and used to model FA-T cellular defects.<SEP>RA2627 fibroblasts are cells derived from an individual with UBE2T deficiency used to model FA-T cellular defects.", "source_id": "chunk-ffd1276c89bcac745a7e58082e97236f", "id": "RA2627 FIBROBLASTS"}, {"entity_type": "PROTEIN", "description": "Expression of wild type UBE2T protein rescues the phenotype associated with UBE2T deficiency, including hypersensitivity to crosslinking agents and G2 arrest following DNA damage.", "source_id": "chunk-ffd1276c89bcac745a7e58082e97236f", "id": "WILD TYPE UBE2T EXPRESSION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The monoubiquitination of FANCI is another physiological process that is recovered with the overexpression of UBE2T, which contributes to the repair of interstrand DNA crosslinks.", "source_id": "chunk-ffd1276c89bcac745a7e58082e97236f", "id": "FANCI MONOUBIQUITINATION"}, {"entity_type": "DISEASE", "description": "Fanconi anemia-T subtype is a genetic disorder caused by mutations in the UBE2T gene leading to cellular hypersensitivity and defects in DNA repair pathways, specifically FANCD2 monoubiquitination.", "source_id": "chunk-ffd1276c89bcac745a7e58082e97236f", "id": "FANCONI ANEMIA-T (FA-T)"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "These agents are environmental factors that cause DNA crosslinks, challenging the FA pathway\'s function. Overexpression of UBE2T restores cell survival and DNA repair efficiency following treatment with these agents.", "source_id": "chunk-ffd1276c89bcac745a7e58082e97236f", "id": "CROSSLINKING AGENTS (MMC, DEB, CISPLATIN)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "G2 arrest is a physiological process induced by DNA damage that prevents cells from entering mitosis with unrepaired DNA. The overexpression of UBE2T rescues G2 arrest in RA2627 fibroblasts.", "source_id": "chunk-ffd1276c89bcac745a7e58082e97236f", "id": "G2 ARREST"}, {"entity_type": "CELL LINE", "description": "BJ cells are normal human fibroblast cell lines used as controls to demonstrate the effects of wild type UBE2T expression in comparison with RA2627 cells.", "source_id": "chunk-ffd1276c89bcac745a7e58082e97236f", "id": "BJ CELLS"}, {"entity_type": "GENE", "description": "The RPS19 gene is associated with Diamond-Blackfan Anemia (DBA) and mutations in this gene cause defects leading to DBA.", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "id": "RPS19 GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "A missense mutation in the RPS19 gene at position Arg62Trp that causes a change from arginine to tryptophan and is associated with DBA.", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "id": "MISSENSE MUTATION P.ARG62TRP"}, {"entity_type": "GENOMIC VARIANT", "description": "A missense mutation in the RPS19 gene at position Arg101His that leads to a change from arginine to histidine, which causes DBA.", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "id": "MISSENSE MUTATION P.ARG101HIS"}, {"entity_type": "GENOMIC VARIANT", "description": "A frameshift mutation in the RPS19 gene characterized by deletion of guanine at position 58 leading to premature termination and associated with DBA.", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "id": "FRAMESHIFT MUTATION C.58DELG"}, {"entity_type": "GENETIC VARIATION", "description": "A splice site mutation affecting the acceptor splice site of intron 1 in the RPS19 gene, resulting in exon skipping and reduced protein function, leading to DBA.", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "id": "SPLICE SITE MUTATION C.1-1G>A"}, {"entity_type": "TRANSCRIPT", "description": "The transcriptome of dermal fibroblasts isolated from patients with mutations in RPS19 shows differential expression patterns compared to healthy controls.", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "id": "DERMAL FIBROBLASTS TRANSCRIPTOME"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A cellular process that targets and degrades mRNAs containing premature stop codons, affecting the levels of RPS19 mRNA in patients with certain mutations.", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "id": "NMD (NONSENSE-MEDIATED DECAY)"}, {"entity_type": "METABOLIC PATHWAY", "description": "The pathway involved in synthesizing charged tRNA molecules carrying amino acids which are essential for protein synthesis and is enriched in DBA patients.", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "id": "AMINOACYL-TRNA BIOSYNTHESIS PATHWAY"}, {"entity_type": "METABOLIC PATHWAY", "description": "Pathways responsible for the metabolism of glycine, serine, and threonine amino acids which are essential for various cellular functions.", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "id": "GLYCINE, SERINE, AND THREONINE METABOLISM PATHWAY"}, {"entity_type": "MOLECULAR INTERACTION", "description": "A signaling pathway activated by death receptors such as TNF-R1 and Fas leading to apoptosis, enriched in genes related to DBA patients.", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "id": "DEATH RECEPTOR SIGNALING PATHWAY"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Pathways involving the protein kinase R (PKR) in interferon induction and antiviral response that are enriched with genes related to DBA pathogenesis.", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "id": "PKR ROLE IN INTERFERON INDUCTION AND ANTIVIRAL RESPONSE PATHWAY"}, {"entity_type": "METABOLIC PATHWAY", "description": "The pathway associated with retinoic acid receptor activation, involved in various cellular functions including differentiation and proliferation.", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "id": "RAR ACTIVATION PATHWAY"}, {"entity_type": "GENE CLUSTER", "description": "A cluster of genes encoding ribosomal proteins which are critical for protein synthesis and show differential expression patterns in DBA patients.", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "id": "RP GENES (RIBOSOMAL PROTEIN)"}, {"entity_type": "METABOLIC PATHWAY", "description": "The pathway involved in lipid metabolism, enriched with differentially expressed genes among DBA patients.", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "id": "LIPID METABOLISM PATHWAY"}, {"entity_type": "GENE", "description": "RPL22 is a gene within a large cluster of ribosomal protein genes (RP genes) involved in molecular functions.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "RPL22"}, {"entity_type": "GENE", "description": "RPL27A is part of a cluster of RP genes related to cellular processes and bio-functions such as cell death, lipid metabolism, and molecular transport.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "RPL27A"}, {"entity_type": "GENE", "description": "RPL29 is an RP gene involved in various cellular functions including the regulation of molecular transport and cellular development.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "RPL29"}, {"entity_type": "GENE", "description": "RPL31 is a ribosomal protein gene contributing to cell death, lipid metabolism, and tissue development processes.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "RPL31"}, {"entity_type": "GENE", "description": "RPL14 is an RP gene implicated in cellular functions such as molecular transport and developmental roles within tissues.<SEP>RPL14 is an RP gene involved in cellular functions such as molecular transport, cell death regulation, and developmental roles within tissues.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "RPL14"}, {"entity_type": "GENE", "description": "RPL18A is a ribosomal protein gene involved in various cell processes including development, death, and lipid metabolism.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "RPL18A"}, {"entity_type": "GENE", "description": "RPS3 is an RP gene important for cellular functions such as molecular transport and cell death regulation.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "RPS3"}, {"entity_type": "GENE", "description": "RPL18 is a ribosomal protein gene involved in cellular development and lipid metabolism processes.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "RPL18"}, {"entity_type": "GENE", "description": "RPL13 is an RP gene contributing to molecular transport, cell death regulation, and tissue developmental functions.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "RPL13"}, {"entity_type": "GENE", "description": "RPL3 is a ribosomal protein gene involved in cellular development processes and lipid metabolism.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "RPL3"}, {"entity_type": "GENE", "description": "RPL34 is an RP gene contributing to molecular transport, cell death regulation, and tissue developmental functions.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "RPL34"}, {"entity_type": "GENE", "description": "RPS2 is a ribosomal protein gene involved in various cellular processes including molecular transport and development.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "RPS2"}, {"entity_type": "GENE", "description": "RPS12 is an RP gene implicated in cell death regulation, lipid metabolism, and tissue developmental functions.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "RPS12"}, {"entity_type": "GENE", "description": "RPL15 is a ribosomal protein gene contributing to molecular transport, cellular development, and lipid metabolism processes.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "RPL15"}, {"entity_type": "GENE", "description": "RPL28 is an RP gene involved in cell death regulation, lipid metabolism, and tissue developmental functions.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "RPL28"}, {"entity_type": "GENE", "description": "AMPD3 is a gene that is up-regulated in Diamond-Blackfan Anemia (DBA) patients relative to controls as shown by RT-PCR validation of microarray data.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "AMPD3"}, {"entity_type": "GENE", "description": "CCND2 is a gene that shows elevated expression levels in DBA patients compared to healthy control subjects, according to qRT-PCR analysis.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "CCND2"}, {"entity_type": "GENE", "description": "SOD2 is an up-regulated gene in Diamond-Blackfan Anemia (DBA) patients as determined by RT-PCR validation of microarray data.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "SOD2"}, {"entity_type": "GENE", "description": "TNFAIP3 is a gene that demonstrates increased expression in DBA patients relative to controls according to RT-PCR analysis and microarray results.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "TNFAIP3"}, {"entity_type": "GENE", "description": "COMP is a gene with decreased expression levels in Diamond-Blackfan Anemia (DBA) patients compared to healthy control subjects, as evidenced by qRT-PCR validation of microarray data.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "COMP"}, {"entity_type": "GENE", "description": "WARS is a gene that shows reduced expression in DBA patients relative to controls based on RT-PCR analysis and microarray results.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "WARS"}, {"entity_type": "GENE", "description": "ZIC1 is down-regulated in Diamond-Blackfan Anemia (DBA) patients compared to healthy control subjects according to qRT-PCR validation of microarray data.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "ZIC1"}, {"entity_type": "GENOMIC VARIANT", "description": "A large cluster of genomic variants associated with ribosomal protein genes contributing to various biological functions including molecular transport, lipid metabolism, and cellular development.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "RIBOSOMAL PROTEIN GENES (RP GENES)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process of cellular development influenced by genetic factors such as RP genes and involved in tissue growth and differentiation.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "CELLULAR DEVELOPMENT"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process involved in the movement of molecules across cell membranes, influenced by cellular functions such as those associated with ribosomal protein genes.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "MOLECULAR TRANSPORT"}, {"entity_type": "BIOLOGICAL PATHWAY", "description": "A category that includes molecular and cellular biological pathways involved in various physiological processes and disease conditions, including cancer-related genes.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "TOP BIO FUNCTIONS CATEGORY MOLECULAR AND CELLULAR FUNCTIONS"}, {"entity_type": "DISEASE", "description": "Genes associated with the development of cancers and related diseases within biological systems.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "CANCER RELATED GENES"}, {"entity_type": "DISEASE", "description": "Disorders affecting blood cells or components, including genetic factors contributing to these conditions.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "HAEMATOLOGICAL DISORDERS"}, {"entity_type": "DISEASE", "description": "Conditions that affect the immune system, with genetic contributions to their development and progression.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "IMMUNOLOGICAL DISORDERS"}, {"entity_type": "DISEASE", "description": "Disorders affecting kidney function, potentially involving genetic influences on disease manifestation.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "RENAL DISORDERS"}, {"entity_type": "DISEASE", "description": "Conditions impacting bone health, possibly influenced by genetic factors contributing to skeletal development and integrity.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "SKELETAL DISORDERS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process involving the formation and growth of embryonic tissues during early stages of development.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "DEVELOPMENT OF EMBRYONIC TISSUES"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Processes involved in the formation, growth, and maintenance of skeletal tissues throughout life.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "DEVELOPMENT OF SKELETAL TISSUES"}, {"entity_type": "MOLECULAR INTERACTION", "description": "A technique used to validate gene expression levels detected by microarray analysis through quantitative real-time PCR experiments.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "QUANTITATIVE RT-PCR VALIDATION"}, {"entity_type": "BIOLOGICAL PATHWAY", "description": "The method of analyzing large-scale gene expression data from microarrays to identify differentially expressed genes and pathways involved in diseases such as Diamond-Blackfan Anemia (DBA).", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "MICROARRAY DATA ANALYSIS"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Quantitative real-time PCR results used for the validation of gene expression patterns observed in microarray data analysis.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "QRT-PCR RESULTS"}, {"entity_type": "DISEASE", "description": "A rare congenital disorder characterized by bone marrow failure, leading to a lack of red blood cells and associated with genetic factors affecting ribosomal protein genes.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "DIAMOND-BLACKFAN ANEMIA (DBA)"}, {"source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "description": "The transcriptome of dermal fibroblasts from patients with RPS19 gene mutations shows differential expression patterns compared to healthy controls.)", "entity_type": "UNKNOWN", "id": "RPS19 GENE MUTATIONS"}, {"source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "description": "The splice site mutation in the RPS19 gene leads to NMD targeting and degradation of mutant mRNA, affecting protein levels.)", "entity_type": "UNKNOWN", "id": "SPLICE SITE MUTATION C.1-1G>A IN RPS19 GENE"}, {"source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "description": "Genes involved in aminoacyl-tRNA biosynthesis show differential expression patterns among DBA patients indicating potential functional alterations.)", "entity_type": "UNKNOWN", "id": "DBA PATIENTS DIFFERENTIALLY EXPRESSED GENES"}, {"entity_type": "GENE", "description": "The BDNF gene is implicated in the development of neurological disorders, including migraine.", "source_id": "chunk-814fe155e9cb953da61f6a79d1d25784", "id": "BDNF GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "A polymorphism (G/A) located within the BDNF gene that has been associated with an increased risk or decreased susceptibility to migraine.", "source_id": "chunk-814fe155e9cb953da61f6a79d1d25784", "id": "RS6265 GENOMIC VARIANT"}, {"entity_type": "GENOMIC VARIANT", "description": "Another polymorphism (A/T) in the BDNF gene that is also associated with susceptibility to migraine.", "source_id": "chunk-814fe155e9cb953da61f6a79d1d25784", "id": "RS2049046 GENOMIC VARIANT"}, {"entity_type": "DISEASE", "description": "A neurological disorder characterized by severe headaches, often accompanied by nausea and sensitivity to light or sound.", "source_id": "chunk-814fe155e9cb953da61f6a79d1d25784", "id": "MIGRAINE"}, {"entity_type": "METABOLIC PATHWAY", "description": "Quality assessment tool for observational studies, indicating good quality of the included studies if scores are no less than 6.", "source_id": "chunk-814fe155e9cb953da61f6a79d1d25784", "id": "NOS SCORE"}, {"entity_type": "POPULATION GROUP", "description": "Five distinct Caucasian groups included in the studies, each contributing to the analysis of BDNF gene polymorphism and migraine association.", "source_id": "chunk-814fe155e9cb953da61f6a79d1d25784", "id": "CAUCASIAN POPULATION GROUPS"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Two specific cohorts from Australia that were part of the five population groups included in the study.", "source_id": "chunk-814fe155e9cb953da61f6a79d1d25784", "id": "AUSTRALIAN-BASED INDEPENDENT COHORTS"}, {"source_id": "chunk-814fe155e9cb953da61f6a79d1d25784", "description": "A high NOS score indicates that the quality of observational studies included in the meta-analysis is good, supporting robust analysis and conclusions.", "entity_type": "UNKNOWN", "id": "STUDY QUALITY ASSESSMENT"}, {"entity_type": "DISEASE", "description": "Psoriasis is a chronic inflammatory disease characterized by skin lesions such as erythemato-scallous plaques and pustular eruptions.", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "id": "PSORIASIS"}, {"entity_type": "DISEASE", "description": "HS is a severe, debilitating skin condition characterized by nodules, fistulas, and sinus tracts in the inguinal, perianal regions among others.", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "id": "HIDRADENITIS SUPPURATIVA (HS)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "These are unexpected reactions where patients develop psoriasis-like symptoms after being treated for HS with biological agents like adalimumab.", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "id": "PARADOXICAL PSORIASIFORM REACTIONS"}, {"entity_type": "DRUG", "description": "An anti-TNF-\u03b1 biologic drug used to treat conditions such as rheumatoid arthritis, ankylosing spondylitis, and moderate to severe plaque psoriasis.", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "id": "ADALIMUMAB"}, {"entity_type": "THERAPY", "description": "Treatment with drugs that block the TNF-\u03b1 protein which is involved in causing inflammation.", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "id": "ANTI-TNF-\u0391 THERAPY"}, {"entity_type": "PROTEIN", "description": "Neutrophils with surface marker CD15, a type of white blood cell involved in the immune response and inflammation.", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "id": "CD15+ NEUTROPHILS"}, {"entity_type": "PROTEIN", "description": "Plasmacytoid dendritic cells expressing BDCA2, known for their role in innate immunity responses.", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "id": "BDCA2+ PDCS"}, {"entity_type": "PROTEIN", "description": "Macrophages that express CD68 marker involved in phagocytosis and immune response.", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "id": "CD68+ MACROPHAGES"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Tumor Necrosis Factor alpha is an inflammatory cytokine involved in systemic inflammation and immune responses.", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "id": "TNF-\u0391"}, {"entity_type": "DISEASE SEVERITY CLASSIFICATION", "description": "A classification stage for hidradenitis suppurativa (HS) characterized by severe disease with multiple interconnected abscesses and sinus tracts.", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "id": "HURLEY STAGE III"}, {"entity_type": "DISEASE SEVERITY CLASSIFICATION", "description": "A scoring system used to assess the severity of HS based on clinical findings such as nodules, sinuses, and fistulas.", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "id": "SARTORIUS SCORE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "An increase in cell number within the epidermis layer of skin tissue, often seen in psoriasis and other inflammatory conditions.", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "id": "EPIDERMAL HYPERPLASIA"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The retention of nuclei in keratinocytes within the stratum corneum, typically observed in various dermatological diseases like psoriasis.", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "id": "PARAKERATOSIS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Enlargement and dilation of blood vessels in the papillary dermis layer, commonly seen in inflammatory skin conditions such as psoriasis.", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "id": "PAPILLARY VESSEL ECTASIA"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "An accumulation of immune cells around small blood vessels, often indicative of an inflammatory response in the skin.", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "id": "PERIVASCULAR INFILTRATE"}, {"entity_type": "PROTEIN", "description": "CD3+ cells are T lymphocytes expressing CD3 surface antigen, involved in cell-mediated immunity.<SEP>T lymphocytes expressing CD3 protein, involved in cellular immunity and activation of T-cell receptors.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a<SEP>chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "id": "CD3+ CELLS"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Interleukin 36 gamma, a cytokine released by neutrophils that plays a role in inflammation and immune responses.", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "id": "IL-36\u0393"}, {"entity_type": "PROTEIN", "description": "Mast cells expressing c-kit (also known as CD117), involved in allergic reactions and inflammatory responses.", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "id": "C-KIT/CD117+ MAST CELLS"}, {"entity_type": "LABORATORY TECHNIQUE", "description": "Fluorescence-activated cell sorting used to isolate and analyze different types of cells based on their fluorescent markers.", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "id": "FACS ANALYSIS"}, {"entity_type": "PROTEIN", "description": "CD8 is a transmembrane protein found on the surface of cytotoxic T cells and helper/inducer T cells.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "CD8+"}, {"entity_type": "PROTEIN", "description": "CD4 is a transmembrane glycoprotein expressed mainly by helper T lymphocytes, macrophages, monocytes, and dendritic cells.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "CD4+"}, {"entity_type": "GENE", "description": "Interferon-beta is a cytokine that plays an important role in the innate immune response against viral infections.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "IFN-\u0392"}, {"entity_type": "GENE", "description": "Interferon-kappa, another type I interferon produced by keratinocytes.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "IFN-\u039a"}, {"entity_type": "GENE", "description": "Interferon-alpha 2A is a cytokine involved in the innate immune response and antiviral activity.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "IFN-\u03912A"}, {"entity_type": "GENE", "description": "Interferon-lambda 1, also known as IL-29, is a type III interferon with roles in host defense against viral infections.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "IFN-\u039b1"}, {"entity_type": "PROTEIN", "description": "LL-37 is an antimicrobial peptide produced by epithelial cells and neutrophils.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "LL-37"}, {"entity_type": "GENE", "description": "Lymphotoxins, also known as tumor necrosis factor-beta and -C, are cytokines involved in immune responses.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "LT-\u0391 AND LT-\u0392 (TNF-\u0392 AND TNF-C)"}, {"entity_type": "GENE", "description": "ERAP1 gene encodes a protein that functions in the processing of peptides for MHC class I antigen presentation.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "ERAP1 GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "HLA-C is a region within the major histocompatibility complex on chromosome 6, important in immune responses and disease susceptibility.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "HLA-C REGION"}, {"entity_type": "GENE", "description": "Cornified Envelope Precursor Protein CDSN involved in skin barrier formation.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "CDSN GENE"}, {"entity_type": "GENE", "description": "Corneodesmosin, a gene important for the integrity of the cornified envelope layer in keratinocytes and corneocytes.<SEP>The CCHCR1 gene contains three SNPs (rs1576/rs130079/rs746647) according to Table 1.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a<SEP>chunk-72f4505e43f67f3564607392cb178656", "id": "CCHCR1 GENE"}, {"entity_type": "GENE", "description": "Tumor necrosis factor alpha-induced protein 3, also known as A20, is an inhibitor of NF-kappaB signaling pathway.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "TNFAIP (A20) GENE"}, {"entity_type": "TRANSCRIPT", "description": "PBMCs include monocytes, lymphocytes and immature dendritic cells collected from the peripheral blood.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "PBMCS (PERIPHERAL BLOOD MONONUCLEAR CELLS)"}, {"entity_type": "GENOMIC VARIANT", "description": "The HLA-B region is part of the major histocompatibility complex on chromosome 6, involved in immune response regulation.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "HLA-B REGION"}, {"entity_type": "GENE", "description": "Tumor Necrosis Factor Alpha (TNF-alpha) gene encodes a cytokine that plays a critical role in systemic inflammation and cell signaling.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "TNF-\u0391 GENE"}, {"entity_type": "GENE", "description": "These genes encode proteins involved in immune responses, such as interleukins and cytokine receptors.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "IL-17F, IL-17RA, IL-23R, IL-12B GENES"}, {"entity_type": "GENE", "description": "The IKB\u03b6 gene encodes a protein that regulates the NF-\u03baB pathway.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "IKB\u0396 GENE (NFKBIZ)"}, {"entity_type": "GENE", "description": "Encodes an inhibitor of TNF-induced apoptosis and is part of negative feedback mechanisms in immune signaling pathways.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "A20 BINDING PROTEIN GENE"}, {"entity_type": "GENE", "description": "Tyrosine kinase 2, a member of the Janus kinases (JAK) family involved in cytokine signaling.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "TYK2 GENE"}, {"entity_type": "GENE", "description": "Encodes A20 protein which functions as an anti-inflammatory regulator by inhibiting NF-kappaB activation.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "TNFAIP GENE (A20)"}, {"entity_type": "GENOMIC VARIANT", "description": "Rs1576 is a SNP located in the CCHCR1 gene.", "source_id": "chunk-72f4505e43f67f3564607392cb178656", "id": "SNP RS1576"}, {"entity_type": "GENOMIC VARIANT", "description": "Rs130079 is a SNP located in the CCHCR1 gene.", "source_id": "chunk-72f4505e43f67f3564607392cb178656", "id": "SNP RS130079"}, {"entity_type": "GENOMIC VARIANT", "description": "Rs746647 is a SNP located in the CCHCR1 gene.", "source_id": "chunk-72f4505e43f67f3564607392cb178656", "id": "SNP RS746647"}, {"entity_type": "GENE", "description": "The IL23R gene contains SNPs that have been previously associated with paradoxical psoriasiform reactions to anti-TNF drugs and was detected in HS patients.", "source_id": "chunk-72f4505e43f67f3564607392cb178656", "id": "IL23R GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "Rs11209026 is a SNP located in the IL23R gene that has been previously associated with paradoxical psoriasiform reactions to anti-TNF drugs but was not found in HS patients.", "source_id": "chunk-72f4505e43f67f3564607392cb178656", "id": "SNP RS11209026"}, {"entity_type": "GENOMIC VARIANT", "description": "Rs72676067 is a SNP located in the IL23R gene that was detected in patient 2.", "source_id": "chunk-72f4505e43f67f3564607392cb178656", "id": "SNP RS72676067"}, {"entity_type": "GENOMIC VARIANT", "description": "Rs1004819 is a SNP located in the IL23R gene that was detected in patient 1.", "source_id": "chunk-72f4505e43f67f3564607392cb178656", "id": "SNP RS1004819"}, {"source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "description": "Mast cells expressing c-kit play important roles in innate immune responses and allergic inflammation.", "entity_type": "UNKNOWN", "id": "INNATE IMMUNITY"}, {"source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "description": "Type I IFN-\u03b2 expression is mainly observed in keratinocytes of paradoxical psoriasis skin lesions.", "entity_type": "UNKNOWN", "id": "KERATINOCYTES"}, {"source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "description": "CD3+ skin T cells from HS patients are enriched in CD8+, reflecting a distinct inflammatory infiltrate pattern.", "entity_type": "UNKNOWN", "id": "SKIN T CELLS"}, {"source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "description": "Patients developing paradoxical psoriasis carry variants of the ERAP1 gene, indicating a genetic predisposition to such reactions.", "entity_type": "UNKNOWN", "id": "SNP VARIANTS"}, {"source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "description": "Variants in the HLA-C region are found consistently among HS patients with paradoxical psoriasis, suggesting an association with disease susceptibility.", "entity_type": "UNKNOWN", "id": "DISEASE SUSCEPTIBILITY"}, {"source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "description": "Variants in the HLA-C region are found consistently among HS patients with paradoxical psoriasis, suggesting an association with disease susceptibility.", "entity_type": "UNKNOWN", "id": "HLA-C REGION SNPS"}, {"source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "description": "Polymorphisms in CDSN gene may affect skin barrier integrity and contribute to the pathogenesis of inflammatory skin conditions like psoriasis.", "entity_type": "UNKNOWN", "id": "CDSN GENE "}, {"source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "description": "Polymorphisms in CDSN gene may affect skin barrier integrity and contribute to the pathogenesis of inflammatory skin conditions like psoriasis.", "entity_type": "UNKNOWN", "id": "SKIN BARRIER FUNCTION"}, {"source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "description": "Levels of IL-22 in PBMCs can serve as a diagnostic marker, showing reduction compared to psoriasiform lesions.", "entity_type": "UNKNOWN", "id": "DIAGNOSTIC MARKER"}, {"source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "description": "Variants in the HLA-B region are associated with genetic predisposition to autoimmune diseases including psoriasis.", "entity_type": "UNKNOWN", "id": "HLA-B REGION SNPS"}, {"source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "description": "Polymorphisms of TNF-\u03b1 gene affect inflammatory responses and may contribute to disease susceptibility.", "entity_type": "UNKNOWN", "id": "TNF-\u0391 GENE VARIANTS"}, {"source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "description": "Variants in these genes influence immune regulation pathways and are associated with autoimmune conditions such as psoriasis.", "entity_type": "UNKNOWN", "id": "IL-23R, IL-17F, IL-17RA GENES "}, {"entity_type": "GENE", "description": "The FANCL gene encodes a protein that plays an essential role in the Fanconi Anemia pathway.", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "id": "FANCL GENE"}, {"entity_type": "PROTEIN", "description": "The DRWD domain is a part of the human FANCL central region, characterized by its fused bilobal structure with dimensions 70 \u00d7 25 \u00d7 20 \u00c5.", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "id": "DRWD DOMAIN (HUMAN)"}, {"entity_type": "PROTEIN", "description": "Drosophila melanogaster (Dm) FANCL is a structural homologue of the human FANCL central domain, differing in secondary structure elements and surface conservation.", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "id": "DMFANCL PROTEIN"}, {"entity_type": "PROTEIN FAMILY", "description": "E2 ubiquitin-conjugating enzymes are structurally similar to both lobes of the human central FANCL domain but predominantly to its C-terminal lobe.", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "id": "E2 UBC ENZYMES"}, {"entity_type": "PROTEIN", "description": "The UBC-RWD domain is a vertebrate-specific feature in FANCL, characterized by an intermediary position between E2 folds and RWD-like folds due to a \u03b2-element swap for the N-terminal lobe\'s helix.", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "id": "URD (UBC-RWD DOMAIN)"}, {"entity_type": "AMINO ACID RESIDUE", "description": "The cysteine residue within the human FANCL domain\'s \u03b2-element is structurally similar to E2 enzyme catalytic sites but does not form a thioester bond with ubiquitin.", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "id": "CYSTEINE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "An assay used to test whether the cysteine residue within URD can form a thioester linkage, revealing it is unable to do so in this case.", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "id": "THIOESTER CHARGE ASSAY"}, {"entity_type": "PROTEIN INTERACTION SITE", "description": "Residues forming the hydrophobic core between N- and C-terminal lobes of FANCL are highly conserved but show differences between vertebrate and invertebrate forms.", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "id": "HYDROPHOBIC CORE RESIDUES"}, {"entity_type": "PROTEIN", "description": "The Drosophila melanogaster DRWD domain is structurally similar to the human FANCL central domain but contains a helix after the four-stranded \u03b2-meander in both lobes.", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "id": "DMDRWD (PROTEIN)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Refers to the process of activating ubiquitin, which involves thioester bond formation between E2 enzymes and ubiquitin.", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "id": "UBQ ACTIVATION PROCESS"}, {"entity_type": "AMINO ACID MOTIF", "description": "A motif found in RWD folds that is present in the human FANCL central domain but not in Drosophila\'s DRWD domain.", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "id": "TRIPLE TURN YPXXXP MOTIF (AMINO ACID MOTIF)"}, {"entity_type": "AMINO ACID MOTIF", "description": "A variant of the YPXXXP motif, located in the C-terminal lobe of the human URD.", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "id": "HPXXXP MOTIF (AMINO ACID MOTIF)"}, {"entity_type": "PROTEIN STRUCTURAL FEATURE", "description": "A structural element found in E2 enzymes and present in the N-terminal lobe of the human FANCL central domain.", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "id": "\u0392-FLAP STRUCTURE (PROTEIN STRUCTURE ELEMENT)"}, {"entity_type": "PROTEIN STRUCTURAL FEATURE", "description": "Refers to the C-terminal lobe of the URD, which lacks a \u03b2-flap and is more similar to RWD folds than E2 enzymes.", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "id": "RWD-LIKE FOLD (PROTEIN STRUCTURAL FEATURE)"}, {"entity_type": "MOLECULAR INTERACTION", "description": "The formation of thioester bonds between cysteine residues in E2 enzymes and ubiquitin.", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "id": "CATALYTIC THIOESTER BOND FORMATION (MOLECULAR INTERACTION)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "An assay used to test the stability of a proposed catalytic site, revealing that URD\'s cysteine cannot form stable thioester linkages with ubiquitin.", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "id": "THIOESTER LINKAGE STABILITY TEST (PHYSIOLOGICAL PROCESS)"}, {"entity_type": "PROTEIN", "description": "The URD is a protein that contains hydrophobic patches and grooves important for its function.", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9", "id": "URD"}, {"entity_type": "PROTEIN", "description": "DmDRWD, the Drosophila DRWD, interacts with the human URD to form part of the FANCL complex.", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9", "id": "DMDRWD"}, {"entity_type": "PROTEIN", "description": "The human RING domain is a protein region essential for binding Ube2T and participating in E3 ligase activity.", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9", "id": "RING DOMAIN (HUMAN)"}, {"entity_type": "PROTEIN", "description": "FANCI is a protein involved in the FA pathway and binds to URD.<SEP>FANCI is part of the Fanconi Anemia pathway and interacts with the URD to form complexes involved in DNA repair processes.", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9<SEP>chunk-6135f8baf39fe26dcea3d987aa6100ac", "id": "FANCI"}, {"entity_type": "PROTEIN", "description": "FANCD2 is another protein that interacts with FANCI in the FA pathway.<SEP>FANCD2 protein forms a complex with FANCI, playing a crucial role in the regulation of genome stability.", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9<SEP>chunk-6135f8baf39fe26dcea3d987aa6100ac", "id": "FANCD2"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Hydrophobic patches and grooves on the URD are critical for substrate binding and protein-protein interactions.", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9", "id": "HYDROPHOBIC PATCHES/GROOVES (URD)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The electrostatic potential differences between the surfaces of human URD and Drosophila DRWD influence their interaction dynamics.", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9", "id": "ELECTROSTATIC POTENTIAL DIFFERENCES (URD/DMDRWD)"}, {"entity_type": "EXPERIMENTAL METHOD", "description": "Techniques used to assess protein-protein interactions, such as binding affinity and complex formation between URD and Ube2T.", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9", "id": "SIZE-EXCLUSION CHROMATOGRAPHY/ISOTHERMAL TITRATION CALORIMETRY (ITC)"}, {"entity_type": "MOLECULAR INTERACTION", "description": "A structural element in URD involving four \u03b2-strands crucial for protein-protein interactions.", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9", "id": "FOUR-STRANDED \u0392-MEANDER (URD)"}, {"entity_type": "PROTEIN REGION", "description": "The N-terminal lobe of the URD contains hydrophobic patches and residues important for substrate binding.", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9", "id": "N-TERMINAL LOBE OF THE URD "}, {"entity_type": "PROTEIN REGION", "description": "This domain of DmDRWD interacts with human URD, contributing to protein-protein interactions.", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9", "id": "C-TERMINAL DOMAIN OF DMDRWD "}, {"entity_type": "MOLECULAR INTERACTION", "description": "Hydrophobic grooves on the C-terminal region of URD are essential for binding substrates like Ube2T and FANCI/FANCD2.", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9", "id": "HYDROPHOBIC GROOVES (URD)"}, {"entity_type": "PROTEIN", "description": "URD, or Ubiquitin-Rich Domain, is a mutant protein subjected to pulldown arrays with FANCI and FANCD2.", "source_id": "chunk-6135f8baf39fe26dcea3d987aa6100ac", "id": "URD (UBIQUITIN-RICH DOMAIN)"}, {"entity_type": "GENOMIC VARIANT", "description": "This variant represents specific mutations in the C-terminal lobe of URD that reduce binding affinity for both FANCI and FANCD2.", "source_id": "chunk-6135f8baf39fe26dcea3d987aa6100ac", "id": "L248A/F252A/L254A/I265A"}, {"entity_type": "GENOMIC VARIANT", "description": "These variants represent specific mutations in the N-terminal lobe of URD but behave as wild type compared to other mutants.", "source_id": "chunk-6135f8baf39fe26dcea3d987aa6100ac", "id": "W212A/L214A"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The hydrophobic patches on the C-terminal lobe are critical for binding substrates like FANCI and FANCD2, indicating their role in the FA pathway.", "source_id": "chunk-6135f8baf39fe26dcea3d987aa6100ac", "id": "HYDROPHOBIC PATCH (C-TERMINAL)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Mutations within the hydrophobic patches of the N-terminal lobe do not affect substrate binding as much as those in the C-terminal lobe.", "source_id": "chunk-6135f8baf39fe26dcea3d987aa6100ac", "id": "HYDROPHOBIC PATCH (N-TERMINAL)"}, {"source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "description": "While both motifs are found in RWD folds, only the human FANCL central domain (URD) contains an HPXXXP motif rather than YPXXXP.", "entity_type": "UNKNOWN", "id": "HPXXXP MOTIF"}, {"source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "description": "While both motifs are found in RWD folds, only the human FANCL central domain (URD) contains an HPXXXP motif rather than YPXXXP.", "entity_type": "UNKNOWN", "id": "TRIPLE TURN YPXXXP MOTIF"}, {"source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "description": "The \u03b2-flap structure in E2 enzymes facilitates thioester bond formation with ubiquitin, a process not observed in the URD due to lack of catalytic cysteine activity.", "entity_type": "UNKNOWN", "id": "CATALYTIC THIOESTER BOND FORMATION"}, {"source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "description": "The \u03b2-flap structure in E2 enzymes facilitates thioester bond formation with ubiquitin, a process not observed in the URD due to lack of catalytic cysteine activity.", "entity_type": "UNKNOWN", "id": "\u0392-FLAP STRUCTURE"}, {"source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "description": "The test was conducted to determine if the cysteine residue in the human FANCL domain could form thioester bonds with ubiquitin, which it cannot.", "entity_type": "UNKNOWN", "id": "CYSTEINE RESIDUE (URD)"}, {"source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "description": "The test was conducted to determine if the cysteine residue in the human FANCL domain could form thioester bonds with ubiquitin, which it cannot.", "entity_type": "UNKNOWN", "id": "THIOESTER LINKAGE STABILITY TEST"}, {"source_id": "chunk-e097891654194982dfc0ef87401d3aa9", "description": "Specific hydrophobic patches on the C-terminal lobe of URD are crucial for binding to FANCI and FANCD2.", "entity_type": "UNKNOWN", "id": "FANCI/FANCD2 BINDING"}, {"source_id": "chunk-e097891654194982dfc0ef87401d3aa9", "description": "Specific hydrophobic grooves on the C-terminal lobe of URD facilitate binding to Ube2T for E3 ligase activity.", "entity_type": "UNKNOWN", "id": "UBE2T BINDING"}, {"entity_type": "GENOMIC VARIANT", "description": "The FGFR4 rs351855 variant is a functional genetic variant associated with differential effects of colesevelam on AC t1/2 and GC24.", "source_id": "chunk-5c78814fb7c198ee95071ee5a8462070", "id": "FGFR4 RS351855 (GLY388ARG)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Colesevelam treatment affects the time to peak concentration (t1/2) and the area under the curve for 24 hours (GC24).", "source_id": "chunk-5c78814fb7c198ee95071ee5a8462070", "id": "COLESEVELAM TREATMENT EFFECTS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The effect of colesevelam on CT is related to changes in AC t1/2 and GC24 values.", "source_id": "chunk-5c78814fb7c198ee95071ee5a8462070", "id": "CT DELAY"}, {"entity_type": "GENOMIC VARIANT", "description": "A variant associated with differential treatment effects on CT, leading to lower GC24 value compared to placebo in the CA/AA genotype group.", "source_id": "chunk-5c78814fb7c198ee95071ee5a8462070", "id": "KLB RS4975017"}, {"entity_type": "GENOMIC VARIANT", "description": "The KLB rs17618244 variant shows modest effects on AC t1/2 and GC24, though not statistically significant.", "source_id": "chunk-5c78814fb7c198ee95071ee5a8462070", "id": "KLB RS17618244 (ARG728GLN)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "GC24 values are measured to assess the impact of colesevelam treatment on drug metabolism.", "source_id": "chunk-5c78814fb7c198ee95071ee5a8462070", "id": "GC24 VALUES"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "AC t1/2 represents the time to peak concentration after administration of a substance, which is affected by genetic variants.", "source_id": "chunk-5c78814fb7c198ee95071ee5a8462070", "id": "AC T1/2 VALUES"}, {"entity_type": "GENE", "description": "The FGFR4 gene contains functional variants such as rs351855 (Gly388Arg) that influence drug metabolism responses.", "source_id": "chunk-5c78814fb7c198ee95071ee5a8462070", "id": "FGFR4 GENE"}, {"entity_type": "GENE", "description": "The KLB gene includes functional variants like rs4975017 and rs17618244 (Arg728Gln), impacting the response to colesevelam treatment.", "source_id": "chunk-5c78814fb7c198ee95071ee5a8462070", "id": "KLB GENE"}, {"entity_type": "DISEASE", "description": "A group of participants used as controls in genetic studies, presumed free from specific conditions relevant to the study.", "source_id": "chunk-5c78814fb7c198ee95071ee5a8462070", "id": "HEALTHY CONTROL PATIENTS"}, {"source_id": "chunk-5c78814fb7c198ee95071ee5a8462070", "description": "Genetic studies involving healthy control patients assess the impact of FGFR4 and KLB variants on drug responses.", "entity_type": "UNKNOWN", "id": "FGFR4 AND KLB GENES "}, {"source_id": "chunk-5c78814fb7c198ee95071ee5a8462070", "description": "The Hardy-Weinberg equilibrium is used to evaluate whether genomic variant frequencies in a population are consistent with random mating, impacting genetic study reliability.", "entity_type": "UNKNOWN", "id": "GENOMIC VARIANT "}, {"entity_type": "PROTEIN", "description": "FGF19 is a protein involved in the regulation of bile acid synthesis and metabolism.", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 33}]", "id": "FGF19"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Serum C4 refers to circulating concentrations of C4, an indicator related to cholesterol 7-alpha-hydroxylase activity, which plays a role in bile acid biosynthesis.", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "id": "SERUM C4 (C4)"}, {"entity_type": "METABOLIC PATHWAY", "description": "The metabolic pathway of bile acids involves their synthesis and excretion for digestion and absorption processes.", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 33}]", "id": "BILE ACIDS (BA)"}, {"entity_type": "GENOMIC VARIANT", "description": "These are genetic variants within the fibroblast growth factor receptor 4 gene that may influence physiological processes such as bile acid metabolism.", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 33}]", "id": "FGFR4 RS1966265, FGFR4 RS351855, FGFR4 RS376618"}, {"entity_type": "GENOMIC VARIANT", "description": "A genetic variant in Klotho, a gene involved in aging and metabolic regulation, potentially affecting pathways related to FGFR4 signaling.<SEP>A genetic variant in Klotho, which is involved in aging and metabolic regulation.", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "id": "KLB RS17618244"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A surgical procedure involving the removal of the gallbladder, which can impact bile acid synthesis and excretion pathways.", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 33}]", "id": "CHOLECYSTECTOMY"}, {"entity_type": "DISEASE", "description": "A condition characterized by chronic abdominal pain or discomfort associated with diarrhea.<SEP>IBS-D is a condition characterized by chronic abdominal pain or discomfort associated with defecation or changes in stool frequency and appearance, often involving diarrhea.", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 33}]", "id": "IBS-D (IRRITABLE BOWEL SYNDROME WITH DIARRHEA)"}, {"entity_type": "DIETARY PATTERN", "description": "A condition characterized by chronic abdominal pain or discomfort associated with constipation.<SEP>A dietary pattern often adopted by individuals suffering from IBS-C to manage symptoms such as bloating and constipation.", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 33}]", "id": "IBS-C (IRRITABLE BOWEL SYNDROME WITH CONSTIPATION)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Individuals who do not have any diagnosed medical conditions, used in studies as a control group for comparison with disease groups like IBS-D and IBS-C.", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "id": "HV (HEALTHY VOLUNTEERS)"}, {"entity_type": "MOLECULAR INTERACTION", "description": "FGF19 circulating in the blood serum, which is involved in regulating bile acid synthesis and metabolism.", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "id": "SERUM FGF19"}, {"entity_type": "METABOLIC PATHWAY", "description": "The metabolic pathway for bile acids that are excreted through stool.", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 33}]", "id": "STOOL BA (BILE ACIDS)"}, {"source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "description": "Increased BMI is positively correlated with higher serum C4, suggesting a relationship between body fat and cholesterol metabolism.", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 33}]", "id": "SERUM C4"}, {"entity_type": "PROTEIN", "description": "FAAP20 is a 20 kDa protein that binds to FANCA through its N-terminal region and contains a conserved UBZ domain in its C-terminal extremity.<SEP>FAAP20 is a protein that localizes to interstrand crosslink (ICL) sites via its UBZ domain after ICL formation due to DNA damage.", "source_id": "chunk-cc528af98598e1adb4684c0166430cf4<SEP>chunk-fa32a208a2f004c10c1b6777c3be13f2", "id": "FAAP20"}, {"entity_type": "GENE", "description": "FANCA is a gene encoding for a protein that interacts with FAAP20, particularly within the context of binding K63-linked ubiquitin chains.", "source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "id": "FANCA"}, {"entity_type": "MOLECULAR INTERACTION", "description": "K63-linked Ub2 represents a type of molecular interaction involving two ubiquitins linked at Lysine 63, which interacts specifically with the UBZ domain of FAAP20.", "source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "id": "K63-LINKED UB2 (K63-UB2)"}, {"entity_type": "PROTEIN REGION", "description": "The UBZ domain is a specific region within FAAP20 that binds to ubiquitin chains and plays a role in cellular processes such as DNA repair and cell cycle regulation.", "source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "id": "UBZ DOMAIN (OF FAAP20)"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Ubiquitin is a small protein that interacts with the UBZ domain of FAAP20 to facilitate its recruitment to DNA damage sites after ICL formation.<SEP>Ubiquitin, commonly referred to as Ub, is involved in protein degradation and signaling pathways through interactions with other proteins like FAAP20-UBZ.", "source_id": "chunk-cc528af98598e1adb4684c0166430cf4<SEP>chunk-fa32a208a2f004c10c1b6777c3be13f2", "id": "UBIQUITIN (UB)"}, {"entity_type": "PROTEIN FRAGMENT", "description": "A specific fragment of FAAP20 that includes residues 143 to 180, which binds specifically to K63-linked Ub2.", "source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "id": "FAAP20-UBZ (RESIDUES 143\u2013180)"}, {"entity_type": "PROTEIN REGION", "description": "The central region of the FAAP20-UBZ fragment is an \u03b1-helix that interacts with one ubiquitin in a K63-linked Ub2 chain.", "source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "id": "CENTRAL \u0391-HELIX (RESIDUES 160\u2013173)"}, {"entity_type": "PROTEIN REGION", "description": "These two loop regions of FAAP20-UBZ interact with the \u03b1-helix and zinc ion, respectively, contributing to its structural stability.", "source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "id": "TWO LOOPS (RESIDUES 143\u2013159 AND 174\u2013180)"}, {"entity_type": "MOLECULAR INTERACTION", "description": "A zinc ion coordinated by specific residues (Cys147, Cys150, His166, Cys170) that bridges the first loop and \u03b1-helix of FAAP20-UBZ.", "source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "id": "ZINC ION"}, {"entity_type": "MOLECULAR INTERACTION", "description": "A hydrophobic patch in ubiquitin centered around Ile44, which interacts with FAAP20-UBZ through hydrophobic interactions.", "source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "id": "ILE44 PATCH"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A post-translational modification involving the covalent attachment of ubiquitin to target proteins, which is crucial for cellular processes like protein degradation and DNA repair.<SEP>The process of adding ubiquitin to proteins to tag them for degradation or to modify their function, often involved in pathways such as DNA repair and cell cycle regulation.", "source_id": "chunk-cc528af98598e1adb4684c0166430cf4<SEP>chunk-fa32a208a2f004c10c1b6777c3be13f2", "id": "UBIQUITINATION"}, {"entity_type": "PROTEIN", "description": "FAAP20-UBZ is a protein whose interaction with Ub involves specific hydrophobic and charged residues crucial for binding.<SEP>The FAAP20-UBZ protein binds ubiquitin (Ub) through a series of intermolecular interactions, including hydrogen bonds and hydrophobic patches.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2<SEP>chunk-5bfe051a79e5e215dd3fc65296825591", "id": "FAAP20-UBZ"}, {"entity_type": "MOLECULAR INTERACTION", "description": "These residues form a hydrophobic patch on ubiquitin that interacts with FAAP20-UBZ via specific hydrogen bonds and hydrophobic contacts.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "id": "LEU8, ILE44, VAL70, THR66, HIS68 (UB)"}, {"entity_type": "MOLECULAR INTERACTION", "description": "These residues of the FAAP20-UBZ protein form key interactions with ubiquitin, including hydrogen bonding with main-chain amide groups and side chains.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "id": "ASP164, TRP180 (FAAP20-UBZ)"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Arginine 72 and glutamine 49 of ubiquitin participate in specific molecular interactions with FAAP20-UBZ, contributing to the protein\'s binding affinity for ubiquitin.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "id": "ARG72, GLN49 (UB)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Sites of DNA damage where FAAP20 accumulates, requiring the interaction between the UBZ domain and ubiquitin for proper localization.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "id": "DNA DAMAGE SITES"}, {"entity_type": "GENOMIC VARIANT", "description": "Mutation at residue Cys150 to Ser150 in FAAP20-UBZ disrupts the bridging between loops and destabilizes the protein structure.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "id": "C150S"}, {"entity_type": "GENOMIC VARIANT", "description": "These mutations reduce binding affinity but do not completely eliminate it; they demonstrate partial functionality in cellular localization.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "id": "L161A, A172L, D177A (MUTATIONS)"}, {"entity_type": "GENOMIC VARIANT", "description": "Complete loss of Ub binding observed with these mutations indicating their critical role in the interaction between FAAP20-UBZ and ubiquitin.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "id": "D164A, A168L, W180A (MUTATIONS)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process by which interstrand crosslinks are formed, leading to DNA damage and repair mechanisms being activated.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "id": "ICL FORMATION"}, {"entity_type": "PROTEIN", "description": "A protein domain that binds ubiquitin, structurally similar to the FAAP20-UBZ but with different specific interactions.<SEP>WRNIP1-UBZ is a protein that interacts with Ub through its \u03b2-loop, differing from Pol\u03b7-UBZ in key binding residues.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2<SEP>chunk-5bfe051a79e5e215dd3fc65296825591", "id": "WRNIP1-UBZ"}, {"entity_type": "PROTEIN", "description": "Another protein domain involved in binding ubiquitin, showing structural conservation with WRNIP1-UBZ and differing from FAAP20-UBZ in certain residues.<SEP>RAD18-UBZ is a protein whose interaction with Ub is distinct from Pol\u03b7-UBZ and NEMO-UBZ due to its unique \u03b2-loop structure.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2<SEP>chunk-5bfe051a79e5e215dd3fc65296825591", "id": "RAD18-UBZ"}, {"entity_type": "PROTEIN", "description": "A UBZ domain associated with the DNA polymerase eta (Pol\u03b7), involved in nucleotide excision repair, has a distinct mode of ubiquitin binding compared to WRNIP1 and RAD18.<SEP>Pol\u03b7-UBZ is a protein whose interaction with Ub resembles FAAP20-UBZ but differs significantly from NEMO-UBZ due to the presence of charged residues and different hydrophobic interactions.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2<SEP>chunk-5bfe051a79e5e215dd3fc65296825591", "id": "POL\u0397-UBZ"}, {"entity_type": "PROTEIN", "description": "NEMO-UBZ is a protein that interacts with Ub in a manner different from RAD18-UBZ and WRNIP1-UBZ.<SEP>The Ubiquitin Binding Zinc Finger domain from the NF-kappa-B essential modulator (NEMO) protein, involved in signaling pathways; shows different structural features when binding ubiquitin compared to WRNIP1 and RAD18.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2<SEP>chunk-5bfe051a79e5e215dd3fc65296825591", "id": "NEMO-UBZ"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A technique used to visualize and quantify the localization of GFP-tagged FAAP20 at DNA damage sites after irradiation with psoralen-UVA.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "id": "CONFOCAL IMAGING"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Ub (ubiquitin) interacts with various UBZ domains in different manners, specifically involving the Ile44 residue of Ub in these interactions.", "source_id": "chunk-5bfe051a79e5e215dd3fc65296825591", "id": "UB"}, {"entity_type": "MOLECULAR INTERACTION", "description": "The presence of charged residues such as Lys399 and Asp652 disrupts hydrophobic interactions, influencing the manner in which proteins interact with Ub.", "source_id": "chunk-5bfe051a79e5e215dd3fc65296825591", "id": "CHARGED RESIDUES"}, {"source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "description": "FAAP20-UBZ specifically binds K63-linked Ub2, which suggests a role in cellular signaling and regulation of protein stability.", "entity_type": "UNKNOWN", "id": "K63-UB2"}, {"source_id": "chunk-5bfe051a79e5e215dd3fc65296825591", "description": "The conservation or replacement of specific FAAP20-UBZ residues in Pol\u03b7-UBZ (e.g., Asp652, Phe655, Ala656) indicates a similar mode of interaction with Ub.", "entity_type": "UNKNOWN", "id": "FAAP20-UBZ RESIDUES"}, {"entity_type": "GENOMIC VARIANT", "description": "The HLA-DQ2.5 haplotype is a genomic variant significantly associated with an increased risk of celiac disease in the patient group compared to healthy controls.", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "id": "HLA-DQ2.5"}, {"entity_type": "GENOMIC VARIANT", "description": "The HLA-DQ8 haplotype, particularly DQ8/DQX, shows a high frequency among CD patients and is significantly different from control groups.", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "id": "HLA-DQ8"}, {"entity_type": "GENOMIC VARIANT", "description": "A genetic variant rs2395182 with the minor \'G\' allele more prevalent in healthy controls compared to CD patients, suggesting a protective role against celiac disease.", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "id": "RS2395182"}, {"entity_type": "GENOMIC VARIANT", "description": "The SNP rs7775228 has a significant difference in frequency of the minor \'C\' allele between healthy controls and CD patients, indicating its relevance to disease susceptibility.", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "id": "RS7775228"}, {"entity_type": "GENOMIC VARIANT", "description": "A genetic variant rs2187668 with the minor \'T\' allele significantly more prevalent in CD patients than in controls, associated with an increased risk of celiac disease.", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "id": "RS2187668"}, {"entity_type": "GENOMIC VARIANT", "description": "The HLA-DQ2.2 haplotype is observed to be frequent among both healthy control and patient groups but more significantly so in the control group than patients.", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "id": "HLA-DQ2.2"}, {"entity_type": "DISEASE", "description": "A disease characterized by chronic diarrhea, abdominal pain, anorexia, and other autoimmune manifestations like type 1 diabetes mellitus, autoimmune thyroiditis, systemic lupus erythematosus, osteomalacia, seizure disorders, and Down syndrome.", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "id": "CELIAC DISEASE (CD)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Autoimmune manifestations are physiological processes resulting from the immune system attacking body tissues leading to conditions such as type 1 diabetes mellitus, autoimmune thyroiditis, and systemic lupus erythematosus in celiac disease patients.", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "id": "AUTOIMMUNE MANIFESTATION"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Analysis of HLA-DQ haplotypes involves molecular interactions between genetic variants and immune responses in the context of celiac disease.", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "id": "HLA-DQ HAPLOTYPE ANALYSIS"}, {"entity_type": "GENOMIC VARIANT", "description": "A genetic variant rs7454108 with no significant difference in minor allele frequency between case and control groups.", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "id": "RS7454108"}, {"entity_type": "MOLECULAR INTERACTION", "description": "The homozygous form of the HLA-DQ2.5 haplotype is a molecular interaction involving genetic variants that significantly increases risk in CD patients compared to healthy controls.", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "id": "HOMOZYGOUS DQ2.5 HAPLOTYPE"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific combination of DQ8 and DQX haplotypes showing significant difference between patient and control groups, higher frequency among CD patients.", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "id": "DQ8/DQX HAPLOTYPE"}, {"entity_type": "MOLECULAR INTERACTION", "description": "The homozygous form of the HLA-DQ2.2 haplotype is a molecular interaction showing higher frequency in healthy controls compared to CD patients, suggesting protection against celiac disease.", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "id": "HOMOZYGOUS DQ2.2 HAPLOTYPE"}, {"entity_type": "MOLECULAR INTERACTION", "description": "The heterozygous form of the HLA-DQ2.2 haplotype is a molecular interaction with similar frequency in both CD patients and healthy controls, indicating no significant risk or protective role.", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "id": "HETEROZYGOUS DQ2.2 HAPLOTYPE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The extremely low-risk group characterized by the absence of all high-risk HLA alleles is a physiological process showing lower incidence among both patient and control groups.", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "id": "EXTREMELY LOW RISK GROUP (DQX)"}, {"entity_type": "GENOMIC VARIANT", "description": "The rs1128503 variant in the ABCB1 gene is significantly associated with grade 3\u20134 anemia.", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "id": "RS1128503"}, {"entity_type": "GENOMIC VARIANT", "description": "The rs12762549 variant in the ABCC2 gene is significantly associated with grade 3\u20134 anemia and has a lower odds ratio compared to other variants for this condition.", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "id": "RS12762549"}, {"entity_type": "GENOMIC VARIANT", "description": "The rs363717 variant in the ABCA1 gene is significantly linked to grade 3-4 anemia, increasing the risk of developing this type of toxicity.", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "id": "RS363717"}, {"entity_type": "GENOMIC VARIANT", "description": "The rs11615 variant in the ERCC1 gene shows a significant correlation with grade 3\u20134 anemia and is associated with higher odds ratios for hematological toxicities.", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "id": "RS11615"}, {"entity_type": "GENOMIC VARIANT", "description": "This CYP3A4 rs4986910 variant correlates significantly with thrombocytopenia grade 3-4, before and after adjusting for covariates.", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "id": "RS4986910"}, {"entity_type": "GENOMIC VARIANT", "description": "The rs2074087 variant in the ABCC1 gene is associated with increased use of erythropoiesis-stimulating agents (ESAs) after correction for covariates.", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "id": "RS2074087"}, {"entity_type": "GENOMIC VARIANT", "description": "The rs2073337 variant in the ABCC2 gene is significantly correlated with CSF use during chemotherapy treatment, adjusting for relevant covariates.", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "id": "RS2073337"}, {"entity_type": "GENOMIC VARIANT", "description": "This GSTP1 variant (rs1695) shows a significant association with increased use of colony-stimulating factors (CSFs).", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "id": "RS1695"}, {"entity_type": "GENOMIC VARIANT", "description": "The ERCC2 rs1799793 variant is significantly linked to CSF usage and progression-free interval (PFI) in patients undergoing chemotherapy.", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "id": "RS1799793"}, {"entity_type": "GENE", "description": "ABCB1 gene harbors the rs1128503 variant which is associated with hematological toxicities such as anemia.", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "id": "ABCB1"}, {"entity_type": "GENE", "description": "ABCC2 gene has two variants (rs12762549 and rs4986910) significantly linked to grade 3-4 anemia and thrombocytopenia respectively, after adjusting for covariates.", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "id": "ABCC2"}, {"entity_type": "GENE", "description": "The ABCA1 gene contains the variant (rs363717), which is associated with hematological toxicity specifically grade 3-4 anemia.", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "id": "ABCA1"}, {"entity_type": "GENE", "description": "ERCC1 harbors the rs11615 variant, significantly linked to an increased risk of grade 3\u20134 anemia in patients undergoing chemotherapy.", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "id": "ERCC1"}, {"entity_type": "GENE", "description": "The CYP3A4 gene is associated with thrombocytopenia through its variant rs4986910, which has a strong association even after covariate adjustment.", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "id": "CYP3A4"}, {"entity_type": "GENE", "description": "ABCC1 gene\'s variant (rs2074087) is linked to increased use of ESAs during chemotherapy treatment in ovarian cancer patients.", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "id": "ABCC1"}, {"entity_type": "GENE", "description": "The GSTP1 gene harbors the rs1695 variant, which is significantly correlated with CSF usage after covariate adjustment.", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "id": "GSTP1"}, {"entity_type": "GENE", "description": "ERCC2 gene\'s variant (rs1799793) affects both CSF use and progression-free interval in patients undergoing chemotherapy for ovarian cancer.", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "id": "ERCC2"}, {"entity_type": "THERAPY", "description": "ESAs are used to manage hematological toxicity such as anemia during chemotherapy, with their use being predicted by genetic variants like rs2074087 in ABCC1.", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "id": "ERYTHROPOIESIS-STIMULATING AGENTS (ESA)"}, {"entity_type": "THERAPY", "description": "CSFs are administered to manage blood cell counts; the need for CSFs is influenced by genetic factors such as those found in variants like rs1695 and rs1799793.", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "id": "COLONY-STIMULATING FACTORS (CSF)"}, {"entity_type": "CONDITION", "description": "Grade 3-4 anemia is a significant hematological toxicity observed among patients, whose risk can be predicted by genetic variants such as rs12762549 in ABCC2 and rs11615 in ERCC1.", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "id": "ANEMIA"}, {"entity_type": "CONDITION", "description": "Grade 3-4 thrombocytopenia is a hematological toxicity associated with the CYP3A4 variant (rs4986910) before and after adjusting for covariates.", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "id": "THROMBOCYTOPENIA"}, {"entity_type": "CONDITION", "description": "While neutropenia was examined, no significant associations were found between genetic variants and grade 4 or febrile neutropenia.", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "id": "NEUTROPENIA"}, {"entity_type": "CONDITION", "description": "No significant association was observed between the genetic variants studied and sensory neuropathy in patients receiving chemotherapy for ovarian cancer.", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "id": "SENSORY NEUROPATHY"}, {"entity_type": "GENOMIC VARIANT", "description": "This variant (rs3739087) in ABCC1 is significantly associated with neutropenia grade 4 and febrile neutropenia, despite no significant association found for other hematological toxicities.", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "id": "RS3739087"}, {"entity_type": "GENE", "description": "The SLCO1B1 gene harbors the rs4149048 variant which is associated with thrombocytopenia grade 2-3 and anemia grade 3-4 after adjusting for covariates.", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "id": "SLCO1B1"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant in ERCC2 gene, specifically G\u2009>\u2009A at position rs1799793, is significantly correlated with Platinum-Free Interval (PFI) in patients.", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3", "id": "ERCC2 G>A (RS1799793)"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant in ABCC2 gene, specifically A\u2009>\u2009G at position rs12762549, is significantly associated with PFI in the fully-adjusted model.", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3", "id": "ABCC2 A>G (RS12762549)"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant in SERPINB2 gene, specifically C\u2009>\u2009G at position rs6104, is significantly associated with PFI in the fully-adjusted model.", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3", "id": "SERPINB2 C>G (RS6104)"}, {"entity_type": "PHYSIOLOGICAL PROCESS/METABOLIC PATHWAY", "description": "Platinum-free interval refers to the time from the last day of platinum-based chemotherapy until recurrence or progression of cancer. It is a critical measure used in clinical trials and patient prognosis analysis.", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3", "id": "PLATINUM-FREE INTERVAL (PFI)"}, {"entity_type": "GENE", "description": "The ERCC2 gene (also known as XPD) plays an essential role in DNA repair and transcription.<SEP>The ERCC2 gene, also known as XPD, encodes for a DNA helicase that plays a role in nucleotide excision repair and transcription regulation.", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3", "id": "ERCC2 GENE"}, {"entity_type": "GENE", "description": "The ABCC2 gene is involved in the ATP-binding cassette transporter superfamily and is known to play a role in drug resistance by transporting various drugs out of cells, including platinum-based chemotherapy drugs.<SEP>The ABCC2 gene, also known as MRP2, encodes a protein involved in the transport of various drugs out of cells, including those used for chemotherapy.", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3", "id": "ABCC2 GENE (MRP2)"}, {"entity_type": "GENE", "description": "SERPINB2 gene encodes for members of the serine peptidase inhibitor family that are involved in inflammation and tissue remodeling.<SEP>The SERPINB2 gene is associated with inflammation and tissue remodeling processes.", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3", "id": "SERPINB2 GENE"}, {"entity_type": "PHYSIOLOGICAL PROCESS/METABOLIC PATHWAY", "description": "Tumor grade indicates the level of differentiation or malignancy of a tumor based on cell appearance under microscopy.", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3", "id": "TUMOR GRADE"}, {"entity_type": "PHYSIOLOGICAL PROCESS/METABOLIC PATHWAY", "description": "The amount and extent of cancer remaining after surgery is termed residual disease, influencing prognosis and treatment decisions.", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3", "id": "RESIDUAL DISEASE AFTER DEBULKING SURGERY"}, {"entity_type": "DISEASE", "description": "FIGO stage refers to the classification system used for gynecological cancers to indicate tumor size, involvement of nearby organs, lymph node spread, and metastasis.", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3", "id": "FIGO STAGE"}, {"entity_type": "GENE", "description": "UMPS is a RefSeq gene located within a deletion on chromosome 3 that potentially contributes to phenotypic changes observed in patients.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "id": "UMPS GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "A de novo deletion spanning over 6.4 Mb on chromosome 3, containing more than 40 RefSeq genes including UMPS.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "id": "DELETION CHR3:121233326-127618464"}, {"entity_type": "GENOMIC VARIANT", "description": "A heterozygous alteration in the UMPS gene leading to a premature stop codon predicted by protein truncation or nonsense-mediated mRNA decay, found in individual I4.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "id": "C.302DELA (P.LYS101ARGFS*9)"}, {"entity_type": "GENOMIC VARIANT", "description": "A heterozygous alteration in the UMPS gene leading to a premature stop codon predicted by protein truncation or nonsense-mediated mRNA decay, found maternally inherited in individual I7 and also present in their healthy brother.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "id": "C.385G>T (P.GLY129*) "}, {"entity_type": "GENOMIC VARIANT", "description": "A heterozygous alteration in the UMPS gene leading to a premature stop codon predicted by protein truncation or nonsense-mediated mRNA decay, found maternally inherited in individual I10 and paternally inherited in individual I11.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "id": "C.889G>T (P.GLU297*) "}, {"entity_type": "GENOMIC VARIANT", "description": "A heterozygous missense alteration predicted to be pathogenic by software programs, found in 12 family members from pedigree 2.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "id": "C.224C>A (P.PRO75HIS)"}, {"entity_type": "GENOMIC VARIANT", "description": "Two heterozygous missense alterations found in the UMPS gene of individual I3 and his healthy mother M3, likely on the same allele.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "id": "C.286A>G (P.ARG96GLY) AND C.1285G>C (P.GLY429ARG)"}, {"entity_type": "GENOMIC VARIANT", "description": "A heterozygous missense alteration predicted to be pathogenic by software programs found in individual I5.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "id": "C.310G>A (P.GLY104ARG)"}, {"entity_type": "GENOMIC VARIANT", "description": "Two heterozygous missense alterations predicted to be pathogenic by software programs found maternally inherited in individuals I6 and I7.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "id": "C.689G>A (P.ARG230HIS) AND C.688C>T (P.ARG230CYS)"}, {"entity_type": "GENOMIC VARIANT", "description": "Two heterozygous missense alterations predicted to be pathogenic by software programs found in individuals I9 and I11 respectively.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "id": "C.857T>A (P.ILE286ASN) AND C.451G>A (P.VAL151MET)"}, {"entity_type": "GENOMIC VARIANT", "description": "A synonymous change variant inherited maternally, identified additionally in individual I6.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "id": "C.360A>G (P.LEU120LEU)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Protein truncation or nonsense-mediated mRNA decay processes that occur due to genomic variants leading to a premature stop codon in UMPS gene.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "id": "UMPS PROTEIN TRUNCATION AND NMD"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Software programs used to predict the pathogenicity of missense alterations found in the UMPS gene.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "id": "POLYPHEN-2, SIFT, MUTATIONTASTER PREDICTIONS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Conservation studies showing that amino acids affected by mutations are well-preserved across species from humans to fruit flies and roundworms indicating their importance in protein function.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "id": "H. SAPIENS, D. MELANOGASTER, C. ELEGANS CONSERVATION"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "The Exac browser database used for checking the frequency of identified variants, with most variant frequencies below 0.001.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "id": "EXAC BROWSER VARIANTS FREQUENCY"}, {"source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "description": "Software programs predict the pathogenicity of missense alterations in UMPS gene including c.857T>A.", "entity_type": "UNKNOWN", "id": "C.857T>A (P.ILE286ASN)"}, {"source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "description": "Software programs predict the pathogenicity of missense alterations in UMPS gene including c.451G>A.", "entity_type": "UNKNOWN", "id": "C.451G>A (P.VAL151MET)"}, {"entity_type": "GENE", "description": "The IL-8 gene contains a polymorphism at rs4073 in its promoter region.", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "id": "IL-8 GENE (RS4073)"}, {"entity_type": "GENOMIC VARIANT", "description": "A single nucleotide polymorphism (SNP) in the IL-8 gene, located at position rs4073, involves a transition from thymine to adenine.", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "id": "RS4073 T/A POLYMORPHISM"}, {"entity_type": "GENE", "description": "The IL-10 gene has a polymorphism in its promoter region identified by the SNP rs1800896.", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "id": "IL-10 GENE (RS1800896)"}, {"entity_type": "GENOMIC VARIANT", "description": "A single nucleotide polymorphism (SNP) in the IL-10 gene, located at position rs1800896, involves a transition from adenine to guanine.", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "id": "RS1800896 A/G POLYMORPHISM"}, {"entity_type": "GENE", "description": "The IL-22 gene contains a polymorphism in its promoter region identified by the SNP rs1179251.", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "id": "IL-22 GENE (RS1179251)"}, {"entity_type": "GENOMIC VARIANT", "description": "A single nucleotide polymorphism (SNP) in the IL-22 gene, located at position rs1179251, involves a transition from cytosine to guanine.", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "id": "RS1179251 C/G POLYMORPHISM"}, {"entity_type": "GENE", "description": "The IL-22 gene contains another polymorphism in its promoter region identified by the SNP rs2227485.", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "id": "IL-22 GENE (RS2227485)"}, {"entity_type": "GENOMIC VARIANT", "description": "A single nucleotide polymorphism (SNP) in the IL-22 gene, located at position rs2227485, involves a transition from cytosine to thymine.", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "id": "RS2227485 C/T POLYMORPHISM"}, {"entity_type": "GENE", "description": "The IL-27 gene has a polymorphism in its promoter region identified by the SNP rs17855750.", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "id": "IL-27 GENE (RS17855750)"}, {"entity_type": "GENOMIC VARIANT", "description": "A single nucleotide polymorphism (SNP) in the IL-27 gene, located at position rs17855750, involves a transition from thymine to guanine.", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "id": "RS17855750 T/G POLYMORPHISM"}, {"entity_type": "GENE", "description": "The TGF-\u03b21 gene has a polymorphism in its promoter region identified by the SNP rs1800469.", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "id": "TGFSS1 GENE (RS1800469)"}, {"entity_type": "GENOMIC VARIANT", "description": "A single nucleotide polymorphism (SNP) in the TGF-\u03b21 gene, located at position rs1800469, involves a transition from cytosine to thymine.", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "id": "RS1800469 C/T POLYMORPHISM"}, {"entity_type": "DISEASE", "description": "Colorectal cancer (CRC) is a disease characterized by uncontrolled cell growth in the colon or rectum.", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "id": "CRC"}, {"entity_type": "DISEASE", "description": "Colorectal cancer (CRC) is a disease associated with certain genotypes and alleles, particularly the CC genotype according to this text.", "source_id": "chunk-5b0cc96debf110f3544685d3b227ff27", "id": "COLORECTAL CANCER (CRC)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The occurrence of colorectal cancer is influenced by genomic variants such as the CC genotype and T allele.", "source_id": "chunk-5b0cc96debf110f3544685d3b227ff27", "id": "OCCURRENCE OF CRC"}, {"entity_type": "GENE", "description": "The TSLP gene is implicated in asthma susceptibility through specific SNPs and haplotypes.", "source_id": "chunk-6f7ce1c71bd46f223756da44b0d0bb2c", "id": "TSLP GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "A SNP in the TSLP gene (rs1898671) shows a significant association with asthma risk, particularly among ex-smokers.", "source_id": "chunk-6f7ce1c71bd46f223756da44b0d0bb2c", "id": "RS1898671"}, {"entity_type": "PROTEIN", "description": "The TSLP protein, encoded by the TSLP gene, is involved in immune responses and plays a role in asthma pathogenesis.", "source_id": "chunk-6f7ce1c71bd46f223756da44b0d0bb2c", "id": "TSLP PROTEIN"}, {"entity_type": "DISEASE", "description": "A chronic inflammatory disorder of the airways characterized by variable airflow obstruction and bronchospasm.<SEP>Asthma is a chronic respiratory condition that affects lung function and was considered in sub-analyses for genetic associations.", "source_id": "chunk-6f7ce1c71bd46f223756da44b0d0bb2c<SEP>chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "id": "ASTHMA"}, {"entity_type": "LIFESTYLE FACTOR", "description": "Individuals who have previously smoked but are no longer smoking, a factor influencing asthma risk with TSLP gene variants.", "source_id": "chunk-6f7ce1c71bd46f223756da44b0d0bb2c", "id": "EX-SMOKERS"}, {"entity_type": "LIFESTYLE FACTOR", "description": "Individuals who have never smoked and show different asthma susceptibility patterns compared to ex-smokers in relation to the TSLP gene.", "source_id": "chunk-6f7ce1c71bd46f223756da44b0d0bb2c", "id": "NEVER-SMOKERS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "An antibody involved in allergy and asthma pathogenesis. The total IgE levels were significantly higher among cases compared to controls.", "source_id": "chunk-6f7ce1c71bd46f223756da44b0d0bb2c", "id": "IGE (IMMUNOGLOBULIN E)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A measure of lung function that is reduced in asthmatic patients compared to healthy individuals.", "source_id": "chunk-6f7ce1c71bd46f223756da44b0d0bb2c", "id": "FEV1/FVC RATIO (FORCED EXPIRATORY VOLUME IN ONE SECOND/ FORCED VITAL CAPACITY RATIO)"}, {"entity_type": "MOLECULAR INTERACTION", "description": "A statistical method used for identifying patterns within a dataset, here applied to detect population stratification among the study participants.", "source_id": "chunk-6f7ce1c71bd46f223756da44b0d0bb2c", "id": "PRINCIPAL COMPONENT ANALYSIS (PCA)"}, {"entity_type": "MOLECULAR INTERACTION", "description": "A computational approach used in population genetics for estimating ancestry and detecting genetic admixture. Used alongside PCA in this analysis.", "source_id": "chunk-6f7ce1c71bd46f223756da44b0d0bb2c", "id": "STRUCTURE METHOD"}, {"source_id": "chunk-7efd4f037425eeac77e329347b16beb2<SEP>chunk-6f7ce1c71bd46f223756da44b0d0bb2c<SEP>chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "description": "FEV1/FVC ratio is a measure used to assess lung function, particularly for diagnosing obstructive airway diseases such as asthma and chronic obstructive pulmonary disease (COPD).<SEP>Reduced FEV1/FVC ratio is a hallmark sign of obstructive airway disease, such as asthma.<SEP>The FEV1/FVC ratio is used to diagnose and monitor conditions such as asthma and chronic obstructive pulmonary disease (COPD).", "entity_type": "PHYSIOLOGICAL PROCESS", "id": "FEV1/FVC RATIO"}, {"source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a<SEP>chunk-6f7ce1c71bd46f223756da44b0d0bb2c", "description": "PCA is used to identify and quantify population stratification in genetic association studies.<SEP>The signal from population stratification was negligible, with lambda (\u03bb) = 1.001 indicating no significant inflation.", "entity_type": "ENVIRONMENTAL FACTOR", "id": "POPULATION STRATIFICATION"}, {"entity_type": "GENE", "description": "The PTPN2 gene is associated with autoimmune diseases such as celiac disease, inflammatory bowel disease, rheumatoid arthritis and type 1 diabetes.<SEP>The gene associated with the SNP rs478582.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1<SEP>chunk-84ec948f22126cef7d93b1d7465b79db", "id": "PTPN2 GENE"}, {"entity_type": "GENE", "description": "The gene associated with SNPs including rs2476601.", "source_id": "chunk-84ec948f22126cef7d93b1d7465b79db", "id": "PTPN22 GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "A SNP in the PTPN2 gene found significant in Crohn\'s Disease (CD) subjects compared to healthy controls.", "source_id": "chunk-84ec948f22126cef7d93b1d7465b79db", "id": "RS478582"}, {"entity_type": "GENOMIC VARIANT", "description": "A SNP in the PTPN22 gene that is not significant in CD but is relevant for other inflammatory autoimmune diseases.<SEP>This is a risk variant in the PTPN22 gene associated with autoimmune disorders.", "source_id": "chunk-dee0a8a550579bff19f48d41446e842d<SEP>chunk-84ec948f22126cef7d93b1d7465b79db", "id": "RS2476601"}, {"entity_type": "TRANSCRIPT", "description": "The transcript of the PTPN2 gene, which showed lower expression levels in Crohn\'s Disease subjects compared to healthy controls.", "source_id": "chunk-84ec948f22126cef7d93b1d7465b79db", "id": "PTPN2 TRANSCRIPT"}, {"entity_type": "TRANSCRIPT", "description": "The transcript of the PTPN22 gene that also showed lower expression levels in CD subjects relative to healthy controls.", "source_id": "chunk-84ec948f22126cef7d93b1d7465b79db", "id": "PTPN22 TRANSCRIPT"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Expression level of IFN-\u03b3, which was evaluated for its relationship with SNPs rs478582 and rs2476601 but no specific data on differential expression is provided in the given text.<SEP>The expression level of IFN-\u03b3 increases in CD subjects with both MAPbacteremia and specific genotypes (e.g., heterozygous or minor alleles at rs478582) compared to those without these conditions.", "source_id": "chunk-84ec948f22126cef7d93b1d7465b79db<SEP>chunk-6a657cd0a000b6df4db8f1305b795021", "id": "IFN-\u0393 GENE EXPRESSION"}, {"entity_type": "DISEASE", "description": "A chronic inflammatory condition of the gastrointestinal tract that affects individuals with specific genetic predispositions.<SEP>A chronic inflammatory condition of the gastrointestinal tract, characterized by a higher prevalence of certain genotypes and increased susceptibility to MAPbacteremia.<SEP>An inflammatory bowel disease that shows significant genetic variations compared to healthy controls.", "source_id": "chunk-6cb127717713bd0ab5be9436fc0c7568<SEP>chunk-84ec948f22126cef7d93b1d7465b79db<SEP>chunk-6a657cd0a000b6df4db8f1305b795021", "id": "CROHN\'S DISEASE (CD)"}, {"entity_type": "HAPLOTYPE COMBINATION", "description": "The haplotype combination involving major alleles of PTPN2 SNP rs478582 (T) and PTPN22 SNP rs2476601 (G), found more significantly in healthy controls than CD subjects.", "source_id": "chunk-84ec948f22126cef7d93b1d7465b79db", "id": "PTPN2:RS478582 HAPLOTYPE T-G"}, {"entity_type": "HAPLOTYPE COMBINATION", "description": "The haplotype combination involving heterozygous or minor alleles of PTPN2 SNP rs478582 (C) and major allele of PTPN22 SNP rs2476601 (G), found more significantly in CD subjects than healthy controls.", "source_id": "chunk-84ec948f22126cef7d93b1d7465b79db", "id": "PTPN2:RS478582 HAPLOTYPE C-G"}, {"entity_type": "HAPLOTYPE COMBINATION", "description": "The haplotype combination involving major alleles of PTPN2 SNP rs478582 (T) and heterozygous or minor allele of PTPN22 SNP rs2476601 (A), found less in CD subjects compared to healthy controls.", "source_id": "chunk-84ec948f22126cef7d93b1d7465b79db", "id": "PTPN2:RS478582 HAPLOTYPE T-A"}, {"entity_type": "HAPLOTYPE COMBINATION", "description": "The haplotype combination involving heterozygous or minor alleles of both PTPN2 SNP rs478582 (C) and PTPN22 SNP rs2476601 (A), found more significantly in CD subjects than healthy controls.", "source_id": "chunk-84ec948f22126cef7d93b1d7465b79db", "id": "PTPN2:RS478582 HAPLOTYPE C-A"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The level of gene expression, measured here as relative gene expression levels of PTPN2/PTPN22 and IFN-\u03b3, showing differential patterns between Crohn\'s Disease (CD) patients and healthy controls.", "source_id": "chunk-84ec948f22126cef7d93b1d7465b79db", "id": "GENE EXPRESSION LEVEL"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant at the PTPN2 gene locus with heterozygous (TC) or minor (CC) alleles is associated with decreased average relative gene expression and increased susceptibility to MAP infection in Crohn\'s Disease (CD) subjects.<SEP>A genomic variant located at rs478582 on the PTPN2 gene associated with increased susceptibility to MAPbacteremia in Crohn\'s disease (CD) subjects.<SEP>A genomic variant located within the PTPN2 gene, influencing T-cell functionality and IFN-\u03b3 expression.", "source_id": "chunk-6cb127717713bd0ab5be9436fc0c7568<SEP>chunk-6a657cd0a000b6df4db8f1305b795021<SEP>chunk-883c371ea1f500a1ba8af8366328e8b0", "id": "PTPN2:RS478582"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant at the PTPN22 gene locus with heterozygous (GA) or minor (AA) alleles is associated with decreased average relative gene expression of PTPN22 in CD subjects but does not significantly change IFN-\u03b3 relative gene expression.<SEP>A genomic variant located at rs2476601 on the PTPN22 gene associated with increased susceptibility to MAPbacteremia in Crohn\'s disease (CD) subjects.<SEP>Another genomic variant that affects T-cell proliferation response in CD subjects with MAPbacteremia.", "source_id": "chunk-6cb127717713bd0ab5be9436fc0c7568<SEP>chunk-6a657cd0a000b6df4db8f1305b795021<SEP>chunk-883c371ea1f500a1ba8af8366328e8b0", "id": "PTPN22:RS2476601"}, {"entity_type": "TRANSCRIPT", "description": "Expression levels of the PTPN2 gene are significantly reduced in CD subjects compared to healthy controls irrespective of MAPbacteremia status.<SEP>Relative gene expression of the PTPN2 transcript is lower in Crohn\'s Disease (CD) subjects compared to healthy controls with similar genotypes, especially those carrying heterozygous or minor alleles at rs478582.", "source_id": "chunk-6cb127717713bd0ab5be9436fc0c7568<SEP>chunk-6a657cd0a000b6df4db8f1305b795021", "id": "PTPN2 GENE EXPRESSION"}, {"entity_type": "TRANSCRIPT", "description": "Expression levels of the PTPN22 gene show a reduction in CD subjects with MAPbacteremia presence and certain genotypes.<SEP>Relative gene expression of the PTPN22 transcript is lower in CD subjects with heterozygous (GA) or minor (AA) alleles compared to healthy controls, particularly for IFN-\u03b3 expression.", "source_id": "chunk-6cb127717713bd0ab5be9436fc0c7568<SEP>chunk-6a657cd0a000b6df4db8f1305b795021", "id": "PTPN22 GENE EXPRESSION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The relative gene expression of IFN-\u03b3 is increased in CD subjects carrying the PTPN2:rs478582 heterozygous (TC) or minor (CC) alleles compared to those with normal alleles.", "source_id": "chunk-6cb127717713bd0ab5be9436fc0c7568", "id": "IFN-\u0393 RELATIVE GENE EXPRESSION"}, {"entity_type": "DISEASE", "description": "Crohn\'s Disease (CD) subjects are more susceptible to Mycobacterium avium subspecies paratuberculosis (MAP) infection, especially when carrying the PTPN2:rs478582 heterozygous or minor alleles.", "source_id": "chunk-6cb127717713bd0ab5be9436fc0c7568", "id": "MAP INFECTION SUSCEPTIBILITY"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "MAP is an environmental factor that can cause bacteremia and is more prevalent in CD subjects with specific genotypes at PTPN2:rs478582.", "source_id": "chunk-6cb127717713bd0ab5be9436fc0c7568", "id": "MYCOBACTERIUM AVIUM SUBSPECIES PARATUBERCULOSIS (MAP)"}, {"entity_type": "PROTEIN", "description": "The protein encoded by PTPN2 is influenced by genomic variants at rs478582, affecting physiological processes in Crohn\'s Disease (CD) subjects.", "source_id": "chunk-6cb127717713bd0ab5be9436fc0c7568", "id": "PTPN2 PROTEIN"}, {"entity_type": "PROTEIN", "description": "The protein encoded by PTPN22 is affected by genomic variants at rs2476601, influencing gene expression patterns and disease susceptibility.", "source_id": "chunk-6cb127717713bd0ab5be9436fc0c7568", "id": "PTPN22 PROTEIN"}, {"entity_type": "MOLECULAR INTERACTION", "description": "The haplotype combination of heterozygous or minor/major alleles at rs478582 and rs2476601 increases the risk of MAPbacteremia in CD subjects compared to healthy controls.", "source_id": "chunk-6a657cd0a000b6df4db8f1305b795021", "id": "HAPLOTYPE C-G"}, {"entity_type": "MOLECULAR INTERACTION", "description": "The haplotype combination of major/heterozygous or minor alleles at rs478582 and rs2476601 shows a higher prevalence of MAPbacteremia in CD subjects compared to healthy controls.", "source_id": "chunk-6a657cd0a000b6df4db8f1305b795021", "id": "HAPLOTYPE T-A"}, {"entity_type": "MOLECULAR INTERACTION", "description": "The haplotype combination of heterozygous or minor/heterozygous or minor alleles at rs478582 and rs2476601 has a moderate prevalence in CD subjects with MAPbacteremia.", "source_id": "chunk-6a657cd0a000b6df4db8f1305b795021", "id": "HAPLOTYPE C-A"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The expression of PTPN2 and PTPN22 genes is significantly lower in CD subjects compared to healthy controls regardless of the presence or absence of MAPbacteremia, indicating a relationship between these variants and disease susceptibility.", "source_id": "chunk-6a657cd0a000b6df4db8f1305b795021", "id": "PTPN2/22 GENE EXPRESSION"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "The presence of Mycobacterium avium subsp. Paratuberculosis (MAP) bacteria in blood samples from CD patients is associated with specific genetic variants and altered gene expression patterns.", "source_id": "chunk-6a657cd0a000b6df4db8f1305b795021", "id": "MAPBACTEREMIA PRESENCE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Higher IFN-\u03b3 expression is observed in CD patients with both MAPbacteremia and specific genotypic variants compared to those without these conditions.", "source_id": "chunk-6a657cd0a000b6df4db8f1305b795021", "id": "IFN-\u0393 EXPRESSION LEVELS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process by which T-cells multiply and grow, influenced by genetic variants and environmental factors like MAPbacteremia.", "source_id": "chunk-883c371ea1f500a1ba8af8366328e8b0", "id": "T-CELL PROLIFERATION RESPONSE"}, {"entity_type": "DIETARY PATTERN", "description": "A specific group of individuals carrying certain genetic variants that affects their immune response and T-cell functionality.", "source_id": "chunk-883c371ea1f500a1ba8af8366328e8b0", "id": "CD SUBJECTS WITH SNPS IN PTPN2:RS478582 OR PTPN22:RS2476601"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "The presence of Mycobacterium avium subspecies paratuberculosis bacteria, which can influence the expression of IFN-\u03b3 in CD subjects.", "source_id": "chunk-883c371ea1f500a1ba8af8366328e8b0", "id": "MAPBACTEREMIA"}, {"entity_type": "MOLECULAR INTERACTION", "description": "A treatment involving phytohemagglutinin to stimulate T-cell proliferation and response.", "source_id": "chunk-883c371ea1f500a1ba8af8366328e8b0", "id": "PHA TREATMENT"}, {"entity_type": "MOLECULAR INTERACTION", "description": "A treatment simulating the presence of MAP bacteria to test T-cell responses.", "source_id": "chunk-883c371ea1f500a1ba8af8366328e8b0", "id": "MAP PPD-LIKE TREATMENT"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The overall functionality of T-cells, affected by genetic variants and environmental exposures such as MAPbacteremia.", "source_id": "chunk-883c371ea1f500a1ba8af8366328e8b0", "id": "T-CELLS FUNCTIONALITY"}, {"entity_type": "DISEASE", "description": "Subjects with Crohn\u2019s disease (CD) who do not exhibit evidence of Mycobacterium avium subspecies paratuberculosis (MAP).", "source_id": "chunk-883c371ea1f500a1ba8af8366328e8b0", "id": "CD SUBJECTS WITHOUT MAPBACTEREMIA"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Individuals without any known genetic or environmental factors affecting T-cell functionality.", "source_id": "chunk-883c371ea1f500a1ba8af8366328e8b0", "id": "HEALTHY CONTROL SUBJECTS"}, {"entity_type": "GENE", "description": "PTPN22 is a gene that is more highly expressed in regulatory T cells (Treg) compared to conventional T cells (Tconv).<SEP>PTPN22 is a gene whose expression varies among different lymphocyte subsets and activation states.", "source_id": "chunk-dee0a8a550579bff19f48d41446e842d<SEP>chunk-daf8d8b6d90cc3f92b645357f7c1294b", "id": "PTPN22"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Lymphocyte subsets, including na\u00efve, memory, and regulatory CD4+ T cell subsets, exhibit differential PTPN22 expression patterns at rest and following in vitro activation.", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "id": "LYMPHOCYTE SUBSET"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The activation state of lymphocytes influences the transcriptional profile and expression levels of PTPN22.", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "id": "ACTIVATION STATE"}, {"entity_type": "GENOMIC VARIANT", "description": "This allele, encoding LYP-620R, is associated with a lower risk for type 1 diabetes compared to the risk variant.", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "id": "T1D NON-RISK ALLELE (LYP-620R)"}, {"entity_type": "MOLECULAR INTERACTION", "description": "The interaction between TCR and its ligands initiates downstream signaling pathways like calcium flux and MAPK/ERK pathway in lymphocytes.<SEP>The process of T cell receptor activation and subsequent intracellular signaling events.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7<SEP>chunk-daf8d8b6d90cc3f92b645357f7c1294b", "id": "TCR SIGNALING"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Calcium flux is a physiological process initiated by TCR ligation, which is modulated differently by the risk (LYP-620W) and non-risk (LYP-620R) variants of PTPN22.", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "id": "CALCIUM FLUX"}, {"entity_type": "MOLECULAR INTERACTION", "description": "The MAP kinase ERK pathway is involved in signal transduction initiated by TCR ligation and modulated by PTPN22 variants.<SEP>The MAPK/ERK pathway is a downstream signaling pathway activated following TCR ligation, influenced by the expression levels of LYP (PTPN22).", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "id": "MAPK/ERK PATHWAY"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Surface expression of activation markers such as CD69, ICOS, and CD226 on lymphocytes indicates their level of activation following TCR ligation.", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "id": "ACTIVATION MARKERS"}, {"entity_type": "TRANSCRIPT", "description": "The transcript levels of PTPN22 vary among different T cell subsets at rest and after activation.", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "id": "TRANSCRIPT OF PTPN22"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Na\u00efve CD4+ T cells exhibit specific patterns of PTPN22 expression which change with activation state.", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "id": "TCONV (NA\u00cfVE CD4+ T CELLS)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Memory CD4+ T cells have distinct patterns of PTPN22 expression compared to other subsets at rest and during activation.", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "id": "MEMORY TCONV CELLS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Regulatory CD4+ T cells exhibit unique characteristics regarding the level of PTPN22 transcription and function in response to activation.", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "id": "TREGS (REGULATORY CD4+ T CELLS)"}, {"entity_type": "GENOMIC VARIANT", "description": "The risk variant LYP-620W is associated with less effective regulation of TCR signaling pathways compared to the non-risk variant LYP-620R.", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "id": "RISK VARIANT LYP-620W"}, {"entity_type": "PROTEIN", "description": "The T cell receptor initiates downstream signaling upon ligand binding, influencing various cellular functions and processes.", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "id": "TCR (T CELL RECEPTOR)"}, {"entity_type": "MOLECULAR INTERACTION", "description": "The assembly of the LAT signalosome is a critical step in initiating downstream signaling following TCR ligation.", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "id": "LAT SIGNALOSOME"}, {"entity_type": "METABOLIC PATHWAY", "description": "Calcium signaling pathway is activated after TCR stimulation, influencing various cellular processes including activation and proliferation.", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "id": "CALCIUM SIGNALING PATHWAY"}, {"entity_type": "PROTEIN", "description": "CD69 is a protein expressed on activated T cells and other immune cells.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "id": "CD69"}, {"entity_type": "PROTEIN", "description": "Inducible Costimulator (ICOS) is a protein that plays a role in the activation of T cells and B cells.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "id": "ICOS"}, {"entity_type": "GENE", "description": "CD25, also known as IL-2 receptor alpha chain gene, encodes the high-affinity interleukin 2 receptor.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "id": "CD25"}, {"entity_type": "PROTEIN", "description": "CD226 is a protein involved in T cell activation and adhesion to antigen-presenting cells.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "id": "CD226"}, {"entity_type": "GENE", "description": "Programmed Death-1 (PD-1) gene encodes the PD-1 receptor, which plays a role in inhibiting immune responses.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "id": "PD-1"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Conventional T cells (Tconv) are compared to regulatory T cells in terms of PTPN22 expression levels.<SEP>Conventional T cells (Tconv) are contrasted with regulatory T cells for expression levels of PTPN22.<SEP>Tconv represents the process of conventional T cell activation and proliferation.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7<SEP>chunk-dee0a8a550579bff19f48d41446e842d", "id": "TCONV"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Tregs refers to regulatory T cells that suppress immune responses.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "id": "TREGS"}, {"entity_type": "PROTEIN", "description": "LYP-620R is a variant of the LYP protein that significantly represses Tresp proliferation.<SEP>LYP-620R is a variant of the LYP protein with a specific amino acid change at position 620.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7<SEP>chunk-dee0a8a550579bff19f48d41446e842d", "id": "LYP-620R"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant in the PTPN22 gene that increases risk for autoimmune disorders.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "id": "PTPN22 RISK VARIANT"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Markers expressed on T cells during their activation process, such as CD69 and ICOS.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "id": "T CELL ACTIVATION MARKERS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process of T cell proliferation induced by antigen-presenting cells (APCs).", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "id": "APC-MEDIATED PROLIFERATION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Proliferation induced in T cells through stimulation with phorbol myristate acetate and ionomycin.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "id": "PMA/IONOMYCIN-INDUCED PROLIFERATION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Activation of T cells using beads coated with antibodies against CD3 and CD28.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "id": "MICROBEAD ACTIVATION"}, {"entity_type": "METABOLIC PATHWAY", "description": "The metabolic pathway involving the net accumulation of IL-2 in response to T cell activation.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "id": "IL-2 ACCUMULATION"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Secretion of interferon gamma, an important cytokine involved in immune responses.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "id": "IFN\u0393 SECRETION"}, {"entity_type": "GENE", "description": "CTLA-4 gene encodes the cytotoxic T lymphocyte-associated protein 4, a key molecule involved in regulating immune responses.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "id": "CTLA-4"}, {"entity_type": "PROTEIN", "description": "LYP-620W is another variant of the LYP protein with different functional properties compared to LYP-620R.<SEP>LYP-620W is another variant of the LYP protein with reduced capacity to suppress Tresp proliferation compared to LYP-620R.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7<SEP>chunk-dee0a8a550579bff19f48d41446e842d", "id": "LYP-620W"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant associated with autoimmune disorders, specifically within the PTPN22 gene.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "id": "RS2476601 RISK VARIANT"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Signaling pathways involving calcium ions (Ca<sup>2+</sup>) and phosphorylated extracellular signal-regulated kinases (pERK) in T cell activation.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "id": "CA<SUP>2+</SUP> AND PERK SIGNALING"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A method used to assess cell proliferation by monitoring the dilution of a fluorescent dye over time.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "id": "CELL TRACKING DYE DILUTION"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Cytokines produced by T cells involved in regulating immune responses.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "id": "IL-4, IL-5, IL-9, IL-10, AND IL-13"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Immune responses mediated by Th1 (T helper 1) and Th2 (T helper 2) subsets of CD4+ effector T cells.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "id": "TH1 AND TH2-ASSOCIATED IMMUNITY"}, {"entity_type": "PROTEIN", "description": "LYP is a protein whose variants (LYP-620R and LYP-620W) influence the proliferation of Tresp cells.", "source_id": "chunk-dee0a8a550579bff19f48d41446e842d", "id": "LYP"}, {"entity_type": "GENOMIC VARIANT", "description": "A risk variant of the PTPN22 gene, specifically rs2476601, has been implicated in autoimmune disorders.", "source_id": "chunk-dee0a8a550579bff19f48d41446e842d", "id": "RISK VARIANT"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Interferon gamma (IFN\u03b3) secretion was not altered by overexpression of either LYP variant according to the data presented.", "source_id": "chunk-dee0a8a550579bff19f48d41446e842d", "id": "IFN\u0393"}, {"entity_type": "MOLECULAR INTERACTION", "description": "This refers to the interaction where regulatory T cells suppress effector T cell responses, which is influenced by PTPN22 and its variants.", "source_id": "chunk-dee0a8a550579bff19f48d41446e842d", "id": "TREG-MEDIATED SUPPRESSION"}, {"entity_type": "DISEASE", "description": "Several autoimmune diseases are associated with the risk variant of PTPN22 (rs2476601).", "source_id": "chunk-dee0a8a550579bff19f48d41446e842d", "id": "AUTOIMMUNE DISORDERS"}, {"entity_type": "PROTEIN", "description": "Tresp represents effector T cells whose proliferation and activation is regulated by LYP variants.", "source_id": "chunk-dee0a8a550579bff19f48d41446e842d", "id": "TRESP"}, {"entity_type": "CELL TYPE", "description": "Antigen-presenting cells (APCs) are used in the co-culture experiments involving Treg and Tresp cells.", "source_id": "chunk-dee0a8a550579bff19f48d41446e842d", "id": "APCS"}, {"entity_type": "CELL TYPE", "description": "Regulatory T cells (Treg) are involved in suppressing effector T cell responses and their function is influenced by PTPN22 variants.", "source_id": "chunk-dee0a8a550579bff19f48d41446e842d", "id": "TREG"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The Th1 signature, involved in immune responses, has been implicated in several autoimmune disorders linked to the rs2476601 variant.", "source_id": "chunk-dee0a8a550579bff19f48d41446e842d", "id": "TH1 SIGNATURE"}, {"entity_type": "EXPERIMENTAL MODEL", "description": "Studies on Ptpn22 knockout mice have shown that overexpression of LYP variants does not alter IFN\u03b3 secretion, supporting similar findings in human cells.", "source_id": "chunk-dee0a8a550579bff19f48d41446e842d", "id": "PTPN22 KNOCKOUT MICE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "This process refers to the secretion of cytokines by effector T cells (Tresp), which is shown to be unaffected by LYP variant overexpression.", "source_id": "chunk-dee0a8a550579bff19f48d41446e842d", "id": "EFFECTOR CYTOKINE SECRETION"}, {"entity_type": "CELL TYPE", "description": "Autologous antigen-presenting cells used in co-culture experiments to assess the effects of LYP variants on T cell responses.", "source_id": "chunk-dee0a8a550579bff19f48d41446e842d", "id": "AUTOLOGOUS APCS"}, {"source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "description": "Net accumulation of IL-2 is influenced by LYP variant expression, affecting T cell cytokine production dynamics.)", "entity_type": "UNKNOWN", "id": "T CELL CYTOKINE PRODUCTION"}, {"source_id": "chunk-dee0a8a550579bff19f48d41446e842d", "description": "The overexpression of LYP-620R significantly represses the proliferation of effector T cells (Tresp).", "entity_type": "UNKNOWN", "id": "TRESP PROLIFERATION"}, {"source_id": "chunk-dee0a8a550579bff19f48d41446e842d", "description": "Overexpressing LYP-620W in regulatory T cells slightly enhances their suppressive capacity over basal levels.", "entity_type": "UNKNOWN", "id": "TREG SUPPRESSIVE CAPACITY"}, {"source_id": "chunk-dee0a8a550579bff19f48d41446e842d", "description": "The risk variant of PTPN22 is associated with an increased risk for autoimmune disorders due to its influence on Treg-mediated suppression.", "entity_type": "UNKNOWN", "id": "PTPN22 RISK VARIANT (RS2476601)"}, {"source_id": "chunk-dee0a8a550579bff19f48d41446e842d", "description": "Neither LYP-620R nor LYP-620W variants significantly altered the secretion of IFN\u03b3 according to experimental data.", "entity_type": "UNKNOWN", "id": "LYP VARIANTS"}, {"source_id": "chunk-dee0a8a550579bff19f48d41446e842d", "description": "The expression level of PTPN22 in regulatory T cells (Treg) is higher than that in conventional T cells (Tconv), influencing the suppressive capacity of Tregs.", "entity_type": "UNKNOWN", "id": "PTPN22 GENE EXPRESSION LEVELS"}, {"source_id": "chunk-dee0a8a550579bff19f48d41446e842d", "description": "Overexpressing LYP-620W leads to reduced control over activation, proliferation, and effector mechanisms in conventional T cells (Tconv).", "entity_type": "UNKNOWN", "id": "TRESP ACTIVATION"}, {"source_id": "chunk-dee0a8a550579bff19f48d41446e842d", "description": "APCs are used in the Treg suppression assay to assess the suppressive capacity of regulatory T cells when co-cultured with effector T cells.", "entity_type": "UNKNOWN", "id": "TREG SUPPRESSION ASSAY"}, {"entity_type": "GENE", "description": "TAG72 is a gene encoding a glycoprotein (tumor-associated antigen) that is highly expressed in ovarian cancer cells.<SEP>TAG72 is a gene that encodes for a protein expressed in various cancers, used as a target for CAR T cell therapy.<SEP>The TAG72 gene is identified as a potential target antigen in ovarian cancer therapy.", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0<SEP>chunk-7fe5e7a40fe11afeb152e614de7ef1cf<SEP>chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "id": "TAG72"}, {"entity_type": "PROTEIN", "description": "The 4-1BB intracellular co-stimulatory domain is part of the second-generation TAG72-BB\u03b6 CAR construct that enhances T cell activation and anti-tumor activity.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "id": "4-1BB INTRACELLULAR CO-STIMULATORY DOMAIN"}, {"entity_type": "TRANSCRIPT", "description": "Humanized single-chain variable fragment (scFv) derived from CC49 antibody, used in the construction of the TAG72-BB\u03b6 CAR to recognize TAG72 antigen on tumor cells.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "id": "CC49 SCFV"}, {"entity_type": "PROTEIN", "description": "The CD3\u03b6 cytosolic domain is part of the T cell receptor complex and is included in the TAG72-BB\u03b6 CAR construct for cytotoxic activity against tumors expressing TAG72 antigen.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "id": "CD3\u0396 CYTOLYTIC DOMAIN"}, {"entity_type": "PROTEIN", "description": "CAR T cells engineered to express TAG72-specific chimeric antigen receptors (BB\u03b6) for targeting and killing ovarian cancer cells expressing TAG72.<SEP>CAR T cells engineered to express the BB\u03b6 signaling domain and target the TAG72 antigen, used in this study for treating ovarian cancer.<SEP>CAR T cells modified with a chimeric antigen receptor (CAR) targeting the TAG72 antigen, containing components such as CC49 scFv and 4-1BB co-stimulatory domain for enhanced anti-tumor activity.", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0<SEP>chunk-7fe5e7a40fe11afeb152e614de7ef1cf<SEP>chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "id": "TAG72-BB\u0396 CAR T CELLS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process of expressing the TAG72 protein on the surface or intracellularly in various cancer cells, particularly ovarian and colon cancers, as a target for CAR T cell therapy.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "id": "TAG72 EXPRESSION"}, {"entity_type": "DISEASE", "description": "Cells derived from tumors originating in the ovaries that express TAG72 antigen and can be targeted by TAG72-BB\u03b6 CAR T cells.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "id": "OVARIAN CANCER CELLS"}, {"entity_type": "DISEASE", "description": "Specific cell lines derived from ovarian and colon cancers that express varying levels of TAG72 antigen used in experiments to assess the efficacy of TAG72-BB\u03b6 CAR T cells.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "id": "SKOV3, OVCAR8, COV362.4, OVCAR3, OV90, LS174T"}, {"entity_type": "DISEASE", "description": "Cells obtained from fluid accumulated in the peritoneal cavity of patients with advanced-stage ovarian cancer, expressing TAG72 and targeted by TAG72-BB\u03b6 CAR T cells.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "id": "ASCITES CELLS"}, {"entity_type": "DISEASE", "description": "Peripheral blood mononuclear cells derived from healthy donors that are used as a source for generating CAR T cells.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "id": "HEALTHY DONOR-DERIVED PERIPHERAL BLOOD MONONUCLEAR CELLS (DPBMC)"}, {"entity_type": "GENOMIC VARIANT", "description": "Cell types depleted from peripheral blood mononuclear cells to generate CAR T cells, representing specific cell populations.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "id": "CD14+ AND CD25+"}, {"entity_type": "PROTEIN", "description": "A truncated version of the CD19 protein used as a marker for tracking CAR T cells during their manufacturing process.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "id": "TRUNCATED CD19 (CD19T)"}, {"entity_type": "MOLECULAR INTERACTION", "description": "The process of introducing the TAG72-BB\u03b6 CAR construct into target cells, typically through viral vectors, to generate CAR T cells.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "id": "CAR TRANSDUCTION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Experimental method used to assess the anti-tumor activity and specificity of TAG72-BB\u03b6 CAR T cells by co-culturing them with tumor targets.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "id": "CO-CULTURE ASSAYS"}, {"entity_type": "MOLECULAR INTERACTION", "description": "The ratio of effector (CAR) T cells to target (tumor) cells used in assays to evaluate the cytotoxic activity of CAR T cells.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "id": "E:T RATIO"}, {"entity_type": "DISEASE", "description": "Patient ascites samples from individuals with ovarian cancer used in vitro assays to evaluate the cytolytic activity of CAR T cells against TAG72-positive and negative tumor cells.", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "id": "OAS3, OAS4, OAS7"}, {"entity_type": "CELL LINE", "description": "A human ovarian cancer cell line used for establishing tumors in immune-compromised mice to assess the therapeutic potential of TAG72-BB\u03b6 CAR T cells.", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "id": "OVCAR3 CELLS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process of delivering substances directly into the abdominal cavity, commonly used for treating peritoneal tumors in ovarian cancer models.", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "id": "I.P. (INTRAPERITONEAL) INJECTION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The method of administering therapeutic agents such as CAR T cells through the bloodstream to reach target organs and tissues.", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "id": "I.V. (INTRAVENOUS) DELIVERY"}, {"entity_type": "MODEL ORGANISM", "description": "NOD-scid IL2r\u03b3null (NSG) mice, used in research for xenograft studies due to their highly compromised immune system allowing human cell engraftment.", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "id": "NSG MICE"}, {"entity_type": "PROTEIN", "description": "Enhanced Green Fluorescent Protein and firefly luciferase proteins, transduced into OVCAR3 cells for non-invasive imaging of tumor growth in mice.", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "id": "EGFP/FFLUC"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The therapeutic strategy involving the intraperitoneal injection of CAR T cells directly to the abdominal cavity where peritoneal tumors are located, enhancing anti-tumor efficacy.", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "id": "REGIONAL I.P. DELIVERY"}, {"entity_type": "THERAPY", "description": "Administering multiple doses of CAR T cells over an extended period to achieve more durable and effective anti-tumor responses in mice models.", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "id": "REPEAT DOSING OF TAG72-BB\u0396 CAR T CELLS"}, {"entity_type": "THERAPY", "description": "A form of immunotherapy where T cells are engineered to express chimeric antigen receptors for targeted cancer treatment.", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "id": "CAR T CELL THERAPY"}, {"entity_type": "PROTEIN", "description": "Cytokine produced by CAR T cells after interacting with TAG72-positive tumor cells, indicating anti-tumor activity.", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "id": "IFN\u0393 (INTERFERON GAMMA)"}, {"entity_type": "PROTEIN", "description": "A cytokine secreted by activated T and NK cells that supports their proliferation and function in immune responses.", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "id": "IL-2 (INTERLEUKIN 2)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Fluid accumulated within the peritoneal cavity due to cancer, often containing malignant cells and proteins indicative of disease progression.", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "id": "HUMAN OVARIAN CANCER ASCITES"}, {"entity_type": "DISEASE", "description": "A mouse xenograft model using human OVCAR3 ovarian cancer cells transplanted into NSG mice for studying therapeutic efficacy.", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "id": "OVCAR3 TUMORS"}, {"entity_type": "DISEASE MODEL", "description": "An aggressive ovarian cancer xenograft model used in the study.", "source_id": "chunk-7fe5e7a40fe11afeb152e614de7ef1cf", "id": "OV90 MODEL"}, {"entity_type": "DISEASE MODEL", "description": "A less aggressive ovarian cancer cell line model used in the study for comparison with OV90.", "source_id": "chunk-7fe5e7a40fe11afeb152e614de7ef1cf", "id": "OVCAR3 MODEL"}, {"entity_type": "GENE", "description": "Genes encoding cell surface antigens that are also potential targets for ovarian cancer immunotherapy.", "source_id": "chunk-7fe5e7a40fe11afeb152e614de7ef1cf", "id": "MUC1, MUC16"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The effectiveness of CAR T cells in targeting and suppressing tumor growth in xenograft models.", "source_id": "chunk-7fe5e7a40fe11afeb152e614de7ef1cf", "id": "CAR T CELLS EFFICACY"}, {"entity_type": "DISEASE FEATURE", "description": "A characteristic of solid tumors where they can express varying levels or lose expression of specific antigens over time, leading to resistance against targeted therapies.", "source_id": "chunk-7fe5e7a40fe11afeb152e614de7ef1cf", "id": "TUMOR ANTIGEN HETEROGENEITY"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The observed decrease in TAG72 antigen expression on tumor cells following TAG72-BB\u03b6 CAR T cell therapy.", "source_id": "chunk-7fe5e7a40fe11afeb152e614de7ef1cf", "id": "TAG72 EXPRESSION REDUCTION"}, {"entity_type": "DISEASE FEATURE", "description": "Sites where residual or recurrent cancer can be found, characterized by the presence of solid tumors and fluid accumulation (ascites) in abdominal cavities.", "source_id": "chunk-7fe5e7a40fe11afeb152e614de7ef1cf", "id": "SOLID TUMORS AND ASCITES"}, {"source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "description": "Intraperitoneal injection of tumor cells into NSG mice is used to establish models for evaluating the therapeutic potential of TAG72-BB\u03b6 CAR T cells.", "entity_type": "UNKNOWN", "id": "I.P. INJECTION"}, {"source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "description": "Regional intraperitoneal delivery of TAG72-BB\u03b6 CAR T cells exhibits potent anti-tumor activity, extending survival in ovarian ascites-bearing mice compared to systemic i.v. delivery.", "entity_type": "UNKNOWN", "id": "I.P. DELIVERY"}, {"source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "description": "Upon interaction with TAG72-positive tumor cells, TAG72-BB\u03b6 CAR T cells produce cytokines like IFN\u03b3 and IL-2 as part of their anti-tumor activity.", "entity_type": "UNKNOWN", "id": "IFN\u0393, IL-2"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant at this locus is associated with FEV1/FVC in the Hutterite population.", "source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "id": "THSD4-UACA-TLE3 LOCUS ON CHROMOSOME 15Q23"}, {"entity_type": "GENOMIC VARIANT", "description": "This SNP explains a significant portion of the residual variance in FEV1/FVC among Hutterites.", "source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "id": "RS12441227"}, {"entity_type": "GENE", "description": "The C10orf11 gene is associated with FEV1 and its downstream SNPs are associated with FEV1/FVC in Hutterites.", "source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "id": "C10ORF11 GENE ON CHROMOSOME 10Q22.3"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant at this locus shows evidence of association with FEV1/FVC.", "source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "id": "CCL23-CCL18 ON CHROMOSOME 17Q12"}, {"entity_type": "GENOMIC VARIANT", "description": "The PITPNC1 locus is associated with FEV1/FVC in Hutterites.", "source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "id": "PITPNC1 LOCUS ON CHROMOSOME 17Q24.2"}, {"entity_type": "GENE", "description": "A genomic variant near this gene shows evidence of association with FEV1/FVC.", "source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "id": "CHAF1B ON CHROMOSOME 21Q22.13"}, {"entity_type": "GENE", "description": "The IL37 gene is associated with reduced FEV1 in Hutterites.", "source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "id": "IL37 GENE ON CHROMOSOME 2Q13"}, {"entity_type": "GENE", "description": "A genomic variant within the ASXL3 gene shows evidence of association with FVC.", "source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "id": "ASXL3 ON CHROMOSOME 18Q12.1"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Forced Expiratory Volume in one second (FEV1) is a measure of lung function used to assess airway obstruction.", "source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "id": "FEV1"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Forced Vital Capacity (FVC) measures the total volume of air that can be exhaled after full inhalation, another key indicator of lung health.", "source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "id": "FVC"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Genetic variation contributes significantly to the heritability of lung function measures such as FEV1, FVC, and FEV1/FVC ratio.", "source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "id": "GENETIC VARIATION"}, {"entity_type": "GENOMIC VARIANT", "description": "Alleles associated with low FEV1/FVC ratio contribute to genetic predisposition towards reduced lung function.", "source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "id": "LOW FEV1/FVC ALLELES"}, {"entity_type": "GENE", "description": "A family of genes encoding small cysteine-rich peptides that play a role in the innate immune system by defending against invading pathogens.", "source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "id": "\u0392-DEFENSIN GENES"}, {"entity_type": "GENE", "description": "Genes coding for chemokines, which are cytokines that induce directed chemotactic migration of inflammatory cells towards a site of inflammation or infection.", "source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "id": "CHEMOKINE GENES (CCL18 AND CXCL12)"}, {"entity_type": "GENE", "description": "A gene encoding the transmembrane protein Tumor Necrosis Factor Receptor Superfamily Member 13B, involved in immune responses and regulation of B-cell development and function.", "source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "id": "TNFRSF13B GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic locus identified as part of a genetic association study (GWAS) showing potential for being linked with specific traits or diseases related to lung function.", "source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "id": "THSD4-UACA-TLE3 LOCUS"}, {"entity_type": "GENE/LOCUS", "description": "A gene or chromosomal region associated with particular phenotypes, in this case identified through GWAS but not found to be functionally connected to other genes of interest.", "source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "id": "C10ORF11 GENE/LOCUS"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic locus that includes both CCL23 and CCL18 genes and is associated with lung function variance, notably through interaction with \u03b2-defensin genes and CXCL12.", "source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "id": "CCL23-CCL18 LOCUS"}, {"entity_type": "POPULATION", "description": "An isolated population originating from the Anabaptist tradition, known for their unique genetic background and consistent lifestyle.", "source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "id": "HUTTERITES"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The variability in FEV1/FVC ratio that remains unexplained after accounting for major factors like age and sex.", "source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "id": "RESIDUAL FEV1/FVC VARIANCE"}, {"entity_type": "ALGORITHM/TOOL", "description": "An algorithm designed for mining gene ontology databases to find functional connections between genes based on their molecular and cellular functions, biological processes, and subcellular locations.", "source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "id": "GRAIL ALGORITHM"}, {"source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "description": "The PITPNC1 locus shows evidence of association with FEV1/FVC in Hutterites, indicating genetic influence.", "entity_type": "UNKNOWN", "id": "FEV1/FVC"}, {"source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "description": "This genomic variant is associated with both FVC and FEV1/FVC, indicating a role in lung function genetics.", "entity_type": "UNKNOWN", "id": "FVC AND FEV1/FVC"}, {"source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "description": "Genetic variation explains a significant portion of the variance in these physiological measures.", "entity_type": "UNKNOWN", "id": "FEV1, FVC, FEV1/FVC RATIO"}, {"source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "description": "Sub-analyses excluding individuals with asthma showed persistent genetic associations, indicating disease independence.", "entity_type": "UNKNOWN", "id": "FVC AND FEV1/FVC RATIO"}, {"source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "description": "The GRAIL algorithm was used to analyze the Gene Ontology database for functional connections between genes near predictive SNPs identified through GWAS.", "entity_type": "UNKNOWN", "id": "GENE ONTOLOGY DATABASE"}, {"entity_type": "GENE", "description": "The CTLA4 gene is associated with autoimmune diseases such as Type 1 Diabetes and Rheumatoid Arthritis, playing a role in immune regulation.<SEP>The CTLA4 gene is associated with susceptibility to primary biliary cholangitis (PBC).", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca<SEP>chunk-f02653cb486dbf68cc259f74ea8b2b2e", "id": "CTLA4 GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "This SNP in the CTLA4 gene is significantly associated with PBC susceptibility, showing an increased risk in various genetic models.", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "id": "RS231775"}, {"entity_type": "GENOMIC VARIANT", "description": "Another SNP within the CTLA4 gene that also shows significant association with PBC susceptibility, though less frequently reported than rs231775.", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "id": "RS231725"}, {"entity_type": "GENOMIC VARIANT", "description": "This variant in the CTLA4 gene does not show a significant association with PBC susceptibility according to this analysis.", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "id": "RS3087243"}, {"entity_type": "GENOMIC VARIANT", "description": "Yet another SNP within the CTLA4 gene, found not to be significantly associated with PBC risk in this study.", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "id": "RS5742909"}, {"entity_type": "DISEASE", "description": "Primary biliary cholangitis (PBC) is a liver disease that may have genetic components influencing susceptibility.", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "id": "PBC SUSCEPTIBILITY"}, {"entity_type": "MOLECULAR INTERACTION", "description": "The phenomenon where certain combinations of genetic variants are observed more or less often than would be expected by chance alone due to physical proximity on a chromosome.", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "id": "LINKAGE DISEQUILIBRIUM"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A method for assessing the robustness of study results by excluding one study at a time and observing how much this exclusion affects overall findings.", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "id": "SENSITIVITY ANALYSIS"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "A form of bias in meta-analysis studies where there is an imbalance between published positive or negative results, affecting overall conclusions.", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "id": "PUBLICATION BIAS "}, {"entity_type": "GENOMIC VARIANT", "description": "This polymorphism in CTLA4 does not show significant association with PBC susceptibility but was extensively studied.", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "id": "RS3087243 POLYMORPHISM"}, {"entity_type": "GENOMIC VARIANT", "description": "Another polymorphism in CTLA4 that does not show a significant association with PBC susceptibility but was investigated.", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "id": "RS5742909 POLYMORPHISM"}, {"entity_type": "DISEASE", "description": "A chronic liver disease characterized by the destruction of small bile ducts within the liver, with genetic factors playing a role in susceptibility.", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "id": "PRIMARY BILIARY CHOLANGITIS (PBC)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The genotypes observed in control groups were generally consistent with Hardy-Weinberg equilibrium expectations.", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "id": "GENOTYPES OF CONTROLS"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Used to generate confidence intervals when heterogeneity is present among studies, such as for rs231775, rs3087243, and rs5742909 polymorphisms.", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "id": "RANDOM-EFFECT MODEL"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Used when there is little to no heterogeneity among studies for other polymorphisms like rs231725.", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "id": "FIXED-EFFECTS MODEL"}, {"entity_type": "MOLECULAR INTERACTION", "description": "A table summarizing the linkage disequilibrium values among four SNPs in CTLA4.", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "id": "LINKAGE DISEQUILIBRIUM TABLE (TABLE 4)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The findings from sensitivity analysis indicate that results are stable and reliable for rs231775 and rs231725 when excluding individual studies.", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "id": "SENSITIVITY ANALYSIS RESULTS"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "A statistical test used to detect publication bias in meta-analysis, with p-values indicating the lack of significant bias for most SNPs.", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "id": "EGGER\'S TEST"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "A visual representation used to assess publication bias in meta-analysis, showing no evidence of bias for the majority of SNPs.", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "id": "BEGG\'S FUNNEL PLOT"}, {"source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "description": "There is no significant linkage disequilibrium observed between these four SNPs in the CTLA4 gene.", "entity_type": "UNKNOWN", "id": "RS231775, RS231725, RS3087243, AND RS5742909"}, {"source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "description": "Results from sensitivity analyses suggest that associations of rs231775 and rs231725 with PBC susceptibility are robust to the exclusion of individual studies.", "entity_type": "UNKNOWN", "id": "RS231775, RS231725"}, {"source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "description": "The findings from sensitivity analysis indicate that results are stable and reliable for these two SNPs when excluding individual studies.", "entity_type": "UNKNOWN", "id": "STABILITY OF FINDINGS FOR RS231775 AND RS231725"}, {"source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "description": "A statistical test used to detect publication bias in meta-analysis, showing no significant evidence of bias for most SNP analyses.", "entity_type": "UNKNOWN", "id": "PUBLICATION BIAS ASSESSMENT"}, {"source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "description": "A visual representation used to assess publication bias in meta-analysis, indicating the lack of significant bias for the majority of SNPs.", "entity_type": "UNKNOWN", "id": "VISUAL REPRESENTATION OF PUBLICATION BIAS"}, {"entity_type": "GENOMIC VARIANT", "description": "This variant is associated with T1D and RA and influences the expression levels of CTLA4.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "id": "RS231775 (+49A/G)"}, {"entity_type": "GENOMIC VARIANT", "description": "A genetic variant in strong linkage disequilibrium with rs231806, influencing CTLA4 mRNA expression.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "id": "RS3087243 (CT60A/G)"}, {"entity_type": "GENOMIC VARIANT", "description": "This SNP is strongly linked to rs3087243 and affects the expression of the CTLA4 gene in T cells.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "id": "RS231806 (MH30C/G)"}, {"entity_type": "GENOMIC VARIANT", "description": "Another variant associated with autoimmune diseases, showing strong linkage disequilibrium with MH30 and CT60 SNPs.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "id": "RS231735 "}, {"entity_type": "PROTEIN", "description": "The CTLA4 protein is involved in immune regulation and plays a critical role in T cell function and differentiation.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "id": "CTLA4 PROTEIN "}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Expression levels of inhibitory checkpoint genes like CTLA4 are regulated by genetic factors and influence immune responses.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "id": "INHIBITORY IMMUNE CHECKPOINT GENE EXPRESSION LEVELS "}, {"entity_type": "DISEASE", "description": "Type 1 Diabetes, an autoimmune disease influenced by genetic variants affecting the expression of CTLA4 in T cells.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "id": "T1D "}, {"entity_type": "DISEASE", "description": "Rheumatoid Arthritis, another autoimmune condition associated with genetic regulation and expression of CTLA4 in T cells.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "id": "RA "}, {"entity_type": "TRANSCRIPT", "description": "The 3\' untranslated region (UTR) of the CTLA4 gene includes a variable number of AT repeats that influence mRNA stability and expression levels.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "id": "3\u2019UTR OF CTLA4 "}, {"entity_type": "CELL TYPE", "description": "CD4+ T cells are involved in immune regulation and express genes like CTLA4 which play roles in autoimmune responses.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "id": "CD4+ T CELLS "}, {"entity_type": "CELL TYPE", "description": "These T cells also express genes such as CTLA4, but their expression levels may differ due to differential DNA methylation compared to CD4+ T cells.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "id": "CD8+ T CELLS "}, {"entity_type": "MOLECULAR INTERACTION", "description": "cis-eQTLs represent genetic variations in close proximity that influence gene expression within a 1Mb interval, impacting cellular functions like immune regulation.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "id": "CIS-EQTLS "}, {"entity_type": "GENE", "description": "The FCGR3B gene encodes for a receptor involved in immune cell activation and regulation.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "id": "IGG FC\u0393 RECEPTOR IIIB (FCGR3B)"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "A specific CpG site near the second exon of CTLA4 that influences its expression through methylation patterns.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "id": "CPG SITE (CG26091609)"}, {"entity_type": "TRANSCRIPT", "description": "RP11\u2212534L20.5 is a long non-coding RNA located downstream of the IKBKE gene, which regulates inflammatory responses.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "id": "LONG CODING RNA RP11\u2212534L20.5 "}, {"entity_type": "GENE", "description": "The IKBKE gene plays an essential role in regulating immune responses to viral infections.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "id": "IKBKE GENE "}, {"entity_type": "GENE", "description": "STAT6 is a transcriptional activator involved in T cell differentiation and function.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "id": "STAT6 "}, {"entity_type": "GENE", "description": "STX2 encodes for syntaxin 2, which is involved in intracellular vesicle transport within cells.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "id": "STX2 (SYNTAXIN 2)"}, {"entity_type": "GENE", "description": "CTLA4 is a gene whose expression levels are inversely correlated with DNA methylation in CD4+ and CD8+ T cells.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "id": "CTLA4"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific CpG site (cg26091609) associated with CTLA4 expression levels in T cells.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "id": "CG26091609"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Processes involving differentiation and function of CD4+ and CD8+ T lymphocytes are influenced by the expression patterns of various genes, including CTLA4.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "id": "CD4+ AND CD8+ T CELLS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A process where genetic variation affects the expression of a gene located at a distant chromosomal location compared to the variant\'s physical location.<SEP>Transcriptional regulation influenced by distant genetic variants that affect gene expression patterns in specific cell types, such as T1D-related genes.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b<SEP>chunk-1b40d071abac0ba432a9fb0096796f45", "id": "TRANS-EQTL EFFECTS"}, {"entity_type": "GENOMIC VARIANT", "description": "A SNP located within the 5\u2019UTR of RPS26 and associated with broad-range effects on hundreds of genes in CD4+ and CD8+ T cells, influencing diseases like Type 1 Diabetes (T1D).", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "id": "RS1131017"}, {"entity_type": "GENE", "description": "The ribosomal small subunit protein RPS26 gene is affected by the trans-eQTL SNP rs1131017.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "id": "RPS26 GENE"}, {"entity_type": "MOLECULAR INTERACTION", "description": "A genomic region impacting hundreds of genes in T cells, with SNPs implicated in autoimmune and inflammatory diseases due to their strong linkage disequilibrium (LD) with GWAS SNPs associated with these conditions.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "id": "CHR12Q13.2 LOCUS"}, {"entity_type": "GENE", "description": "The IL-27 gene is associated with a trans-eQTL effect linked to lower expression of IRF1, STAT1, and REC8 in CD4+ T cells and reduced risk for Type 1 Diabetes (T1D).", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "id": "IL27 GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "A SNP near the IL27 gene associated with lower expression of IRF1 and STAT1, contributing to a decreased risk for T1D in CD4+ T cells.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "id": "RS4788084[T]"}, {"entity_type": "GENE", "description": "IRF1 is a gene involved in immune response and is regulated by signaling pathways such as STAT1.<SEP>Interferon regulatory factor 1 (IRF1) is downregulated by the trans-eQTL effect of rs4788084[T] near IL27 and rs181206[G], indicating its role in T1D susceptibility.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b<SEP>chunk-1b40d071abac0ba432a9fb0096796f45", "id": "IRF1"}, {"entity_type": "GENE", "description": "STAT1 is a gene that encodes the signal transducer and activator of transcription 1, which plays a role in cytokine signaling and regulation of immune responses.<SEP>Signal Transducer and Activator of Transcription 1 (STAT1) is downregulated by the trans-eQTL effect of rs4788084[T] near IL27, contributing to lower risk for T1D in CD4+ T cells.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b<SEP>chunk-1b40d071abac0ba432a9fb0096796f45", "id": "STAT1"}, {"entity_type": "GENOMIC VARIANT", "description": "A missense SNP within the IL-27 gene causing an amino acid change from Leu119Pro, associated with reduced IRF1 and STAT1 expression in CD4+ T cells.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "id": "RS181206[G]"}, {"entity_type": "DISEASE", "description": "Type 1 Diabetes (T1D) is influenced by genetic variants like rs181206[G] and the IL-27 gene, contributing to altered immune function.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "id": "T1D"}, {"entity_type": "GENE", "description": "A gene located in the trans-acting region identified at chr12q13.2, involved in cell cycle regulation.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "id": "CDK2 GENE"}, {"entity_type": "GENE", "description": "A gene within the trans-acting region at chr12q13.2 that affects multiple genes\' expression levels in T cells.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "id": "RAB5B GENE"}, {"entity_type": "GENE", "description": "Sulfite oxidase (SUOX) is a gene found in the broad-range regulatory locus at chr12q13.2, influencing various downstream genes.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "id": "SUOX GENE"}, {"entity_type": "GENE", "description": "A gene located within the trans-acting region at chr12q13.2 that influences the expression of multiple genes in T cells.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "id": "IKZF4 GENE"}, {"entity_type": "GENE", "description": "Epidermal growth factor receptor 3 (ERBB3) is part of the regulatory locus affecting hundreds of genes\' expression in CD4+ and CD8+ T cells.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "id": "ERBB3 GENE"}, {"entity_type": "GENE", "description": "Genes highly expressed in T cells that are influenced by the trans-acting locus at chr12q13.2.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "id": "GZMA, GZMB, GZMH, GNLY, CD8A GENES"}, {"entity_type": "GENOMIC VARIANT", "description": "A genetic variant within IL27 causing a Leu119Pro change, significantly influencing IRF1 and STAT1 expression levels in CD4+ T cells.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "id": "IL27 MISSENSE VARIANT RS181206[G]"}, {"entity_type": "GENOMIC VARIANT", "description": "A missense SNP located at position rs181206 that influences the expression levels of IRF1 and STAT1 genes.", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "id": "SNP RS181206[G]"}, {"entity_type": "PROTEIN", "description": "The receptor for IL-27, which together with gp130 (encoded by IL6ST) forms a complex necessary for the signal transduction of IL-27.", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "id": "IL27RA"}, {"entity_type": "PROTEIN", "description": "A subunit protein that along with IL27RA acts as a receptor for the IL-27 cytokine to activate downstream signaling pathways.", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "id": "GP130 (IL6ST)"}, {"entity_type": "GENE", "description": "Encodes one component of the IL-12 family cytokines, which heterodimerizes with IL-27 to form a functional cytokine involved in immune regulation.", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "id": "EBI3"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A group of genes activated by interferons and their signaling pathways, including IRF1 and STAT1, play critical roles in antiviral defense and immunomodulation.", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "id": "INTERFERON-INDUCED GENES"}, {"entity_type": "MOLECULAR INTERACTION", "description": "The signal transducer and activator of transcription 1/3 pathway is a key mediator of cytokine signaling, involved in cell growth, differentiation, survival, and immune responses.", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "id": "STAT1/STAT3 PATHWAY"}, {"entity_type": "CELL TYPE", "description": "Helper T cells that play a central role in immune regulation, including the production of cytokines such as IL-27.", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "id": "CD4+ T CELLS"}, {"entity_type": "CELL TYPE", "description": "Cytotoxic T lymphocytes that directly kill virus-infected and tumor cells; distinct from CD4+ T helper cells which regulate immune responses.", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "id": "CD8+ T CELLS"}, {"entity_type": "DISEASE", "description": "The genetic predisposition towards developing type 1 diabetes, influenced by variants in genes such as IRF1 and STAT1.", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "id": "T1D SUSCEPTIBILITY"}, {"entity_type": "PROTEIN VARIANT", "description": "The wild-type variant of IL-27 with Leucine at position 119, involved in signaling through the IL-27 receptor to activate downstream pathways.", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "id": "IL-27 (LEU119)"}, {"entity_type": "PROTEIN VARIANT", "description": "A missense variant of IL-27 where Proline replaces Leucine at position 119, leading to decreased STAT1 and IRF1 expression levels.", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "id": "IL-27 (PRO119)"}, {"entity_type": "CELL TYPE", "description": "Peripheral blood mononuclear cells, which include lymphocytes such as T cells, B cells, and NK cells, used in experiments for studying immune responses.", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "id": "PBMCS"}, {"source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "description": "Methylation at this CpG site inversely correlates with CTLA4 mRNA expression levels in CD4+ and CD8+ T cells, affecting immune function.", "entity_type": "UNKNOWN", "id": "CTLA4 GENE "}, {"source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "description": "STAT6 plays a critical role in T cell differentiation, with genetic variants influencing this process through eQTL effects.", "entity_type": "UNKNOWN", "id": "T CELL DIFFERENTIATION "}, {"source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "description": "The gene STX2 encodes syntaxin 2, which is essential for the proper functioning of vesicle transport within cells, impacting various cellular processes including immune responses.", "entity_type": "UNKNOWN", "id": "INTRACELLULAR VESICLE TRANSPORT "}, {"source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "description": "The gene STX2 encodes syntaxin 2, which is essential for the proper functioning of vesicle transport within cells, impacting various cellular processes including immune responses.", "entity_type": "UNKNOWN", "id": "STX2 (SYNTAXIN 7)"}, {"source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "description": "The IL-27 gene region harbors genetic variants that influence the expression of IRF1 and STAT1, contributing to reduced risk for Type 1 Diabetes (T1D).", "entity_type": "UNKNOWN", "id": "IL-27 GENE"}, {"source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "description": "The CDK2 gene within the regulatory locus at chr12q13.2 influences transcriptional regulation, affecting multiple genes\' expression levels in T cells.", "entity_type": "UNKNOWN", "id": "TRANSCRIPTIONAL REGULATION IN T CELLS"}, {"source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "description": "The IL-27 missense SNP influences the activation of STAT1 and STAT3 pathways, affecting downstream gene expression.", "entity_type": "UNKNOWN", "id": "IL-27 SNP RS181206[G]"}, {"entity_type": "GENE", "description": "The IL-8 gene encodes the Interleukin-8 protein, which is involved in immune and inflammatory responses.", "source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68", "id": "IL-8 GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "A polymorphism located within the IL-8 gene that influences asthma risk when present as a homozygous TT genotype.", "source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68", "id": "RS4073 GENOMIC VARIANT"}, {"entity_type": "GENOMIC VARIANT", "description": "Another polymorphism in the IL-8 gene, associated with increased risk of developing asthma when certain genotypes are present.", "source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68", "id": "RS2227306 GENOMIC VARIANT"}, {"entity_type": "PROTEIN", "description": "Interleukin-8 protein is elevated in serum levels among individuals suffering from asthma compared to healthy controls.", "source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68", "id": "IL-8 PROTEIN"}, {"entity_type": "DISEASE", "description": "A chronic respiratory condition characterized by increased IL-8 expression and severity associated with certain genetic variants.", "source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68", "id": "ASTHMA DISEASE"}, {"entity_type": "TRANSCRIPT", "description": "The level of IL-8 mRNA is significantly higher in patients than in healthy controls, correlating with the clinical severity of asthma.", "source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68", "id": "IL-8 MRNA EXPRESSION"}, {"entity_type": "TRANSCRIPT", "description": "The level of IL-8 mRNA is significantly higher in patients than in controls, especially among those with moderate-to-severe asthma.", "source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68", "id": "IL-8 MRNA LEVELS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Peripheral blood mononuclear cells (PBMCs) composition was analyzed for differences between asthmatic and healthy children, but no significant difference was found.", "source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68", "id": "PBMC COMPOSITION"}, {"entity_type": "GENOMIC VARIANT", "description": "The distribution of genotypes for IL-8 gene polymorphisms (rs4073 and rs2227306) differed significantly between asthmatic children and healthy controls.", "source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68", "id": "IL-8 GENOTYPE DISTRIBUTION"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Frequencies of haplotypes derived from the analysis of IL-8 gene polymorphisms were assessed for their association with asthma risk in the study population.", "source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68", "id": "HAPLOTYPE FREQUENCIES"}, {"entity_type": "GENE", "description": "The ASAH1 gene is located on chromosome 8p22-p21.3 and consists of 86 HapMap SNPs and 14 typed SNPs.", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "id": "ASAH1 GENE"}, {"entity_type": "MOLECULAR INTERACTION", "description": "A SNP-set test using a kernel machine approach that evaluates the combined effect of multiple SNPs in a gene region.", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "id": "SNP-SET TEST (KERNEL MACHINE)"}, {"entity_type": "MOLECULAR INTERACTION", "description": "A single SNP-based test that identifies the minimum p-value among individual SNPs within a set.", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "id": "MIN TEST (SINGLE SNP-BASED)"}, {"entity_type": "GENE", "description": "The NAT2 gene is located on chromosome 8p22 and consists of 22 HapMap SNPs with only 4 typed SNPs (rs1390358, rs1112005, rs7832071, and rs1208).", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "id": "NAT2 GENE"}, {"entity_type": "GENE", "description": "A gene located on a chromosome, for which the SNP-set test performance was compared with min tests in regions of high and weak LD.", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "id": "FGFR2 GENE"}, {"entity_type": "GENE", "description": "The HLA-B gene is part of the human leukocyte antigen complex located on 6p21.3, involving only 6 HapMap SNPs with 2 typed SNPs.", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "id": "HLA-B GENE (HUMAN LEUKOCYTE ANTIGEN B)"}, {"entity_type": "NUTRIENT", "description": "The frequency of the less common allele for a particular SNP within a population used to weight rare alleles in genetic studies.", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "id": "MAF (MINOR ALLELE FREQUENCY)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A measure that reflects how often two SNPs are inherited together, indicating a non-random association between gene variants.", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "id": "LD (LINKAGE DISEQUILIBRIUM)"}, {"entity_type": "GENOMIC VARIANT", "description": "A set of single nucleotide polymorphisms identified in the HapMap project for genetic variation studies.", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "id": "HAPMAP SNPS"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "A genotyping chip used to identify and measure genetic variations across multiple SNPs.", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "id": "ILLUMINA HUMANHAP550 ARRAY"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The probability of incorrectly rejecting a true null hypothesis at the significance level \u03b1 = 0.05.", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "id": "TYPE 1 ERROR RATE (\u0391 = 0.05)"}, {"entity_type": "MOLECULAR INTERACTION", "description": "A measure indicating how well a statistical test can correctly identify a true effect, typically evaluated through simulations.", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "id": "EMPIRICAL POWER"}, {"entity_type": "METABOLIC PATHWAY", "description": "A type of kernel function used in machine learning algorithms for SNP-set analysis, reflecting linear genetic effects.", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "id": "LINEAR KERNEL"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Kernels used in SNP-set tests to measure similarity between individuals based on their genotypes.", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "id": "IBS KERNEL AND WEIGHTED IBS KERNEL"}, {"entity_type": "GENE", "description": "The ASAH1 gene is involved in simulations testing genetic effects and interactions.", "source_id": "chunk-076f6aeeb369546413bc63c9f305553a", "id": "ASAH1"}, {"entity_type": "DISEASE, GENE", "description": "The ASAH1 gene effect is studied in simulations for testing genetic effects and interactions.", "source_id": "chunk-076f6aeeb369546413bc63c9f305553a", "id": "ASAH1 GENE EFFECT"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The power of the IBS kernel is used to measure genetic effect sizes accurately.", "source_id": "chunk-076f6aeeb369546413bc63c9f305553a", "id": "IBS KERNEL POWER"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Incorporating rare variants importance into the weighted IBS kernel enhances its performance in detecting genetic effects.", "source_id": "chunk-076f6aeeb369546413bc63c9f305553a", "id": "WEIGHTED IBS KERNEL RARE VARIANTS IMPORTANCE"}, {"entity_type": "GENOMIC VARIANT, PHYSIOLOGICAL PROCESS", "description": "Downweighting common causal SNPs with higher minor allele frequency affects the power of the weighted IBS kernel.", "source_id": "chunk-076f6aeeb369546413bc63c9f305553a", "id": "DOWNWEIGHTED COMMON CAUSAL SNPS MAF HIGHER SNP"}, {"entity_type": "DISEASE, PHYSIOLOGICAL PROCESS", "description": "The linear kernel and min test suffer from significant loss in power when the genetic model is mis-specified.", "source_id": "chunk-076f6aeeb369546413bc63c9f305553a", "id": "LINEAR KERNEL POWER LOSS"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Empirical type 1 error rates for the min test are influenced by the choice of kernel functions used in simulations.", "source_id": "chunk-076f6aeeb369546413bc63c9f305553a", "id": "MIN TEST EMPIRICAL TYPE 1 ERROR RATES"}, {"entity_type": "MOLECULAR INTERACTION, PHYSIOLOGICAL PROCESS", "description": "The overall effect testing for the ASAH1 gene shows that the kernel machine SNP-set test outperforms other methods when there is a good linkage disequilibrium structure.", "source_id": "chunk-076f6aeeb369546413bc63c9f305553a", "id": "GOOD LD STRUCTURE ASAH1 GENE SNP-SET TEST"}, {"source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "description": "This array includes typed SNPs from the ASAH1 and NAT2 genes used in SNP-set tests.", "entity_type": "UNKNOWN", "id": "TYPED SNPS"}, {"source_id": "chunk-076f6aeeb369546413bc63c9f305553a", "description": "Incorporating rare variants importance into the weighted IBS kernel increases its effectiveness.", "entity_type": "UNKNOWN", "id": "RARE VARIANTS IMPORTANCE"}, {"source_id": "chunk-076f6aeeb369546413bc63c9f305553a", "description": "Incorporating rare variants importance into the weighted IBS kernel increases its effectiveness.", "entity_type": "UNKNOWN", "id": "WEIGHTED IBS KERNEL"}, {"entity_type": "GENOMIC VARIANT", "description": "A SNP (Single Nucleotide Polymorphism) mapped to the PTPN2 gene that shows a significant association with non-response to anti-CTLA-4 treatment in metastatic melanoma patients.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "id": "RS1893217"}, {"entity_type": "THERAPY", "description": "Treatment involving immune checkpoint inhibitors targeting CTLA-4, used for treating metastatic melanoma patients.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "id": "ANTI-CTLA-4 TREATMENT"}, {"entity_type": "GENOMIC VARIANT", "description": "A SNP located in the genomic region containing IL2, ADAD1 and IL21 genes, showing a significant association with response to anti-PD-1 treatment.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "id": "RS17388568"}, {"entity_type": "GENOMIC REGION", "description": "A genomic locus associated with allergy, colitis, and type 1 diabetes, where the SNP rs17388568 is located.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "id": "IL2/ADAD1/IL21 LOCUS"}, {"entity_type": "THERAPY", "description": "Treatment involving immune checkpoint inhibitors targeting PD-1, used for treating metastatic melanoma patients.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "id": "ANTI-PD-1 TREATMENT"}, {"entity_type": "THERAPY", "description": "A therapeutic approach combining anti-CTLA-4 and anti-PD-1 treatments for metastatic melanoma patients.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "id": "COMBINATION THERAPY"}, {"entity_type": "DISEASE", "description": "The population under study includes patients diagnosed with metastatic melanoma.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "id": "METASTATIC MELANOMA PATIENTS"}, {"entity_type": "THERAPY", "description": "A type of immunotherapy targeting the CTLA-4 protein in order to boost the immune system\'s ability to fight cancer.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "id": "ANTI-CTLA-4 TREATMENTS (IPILIMUMAB, TREMELIMUMAB)"}, {"entity_type": "THERAPY", "description": "Immunotherapies that block the PD-1 receptor to enhance T cell activity against tumors.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "id": "ANTI-PD-1 TREATMENTS (NIVOLUMAB, PEMBROLIZUMAB)"}, {"entity_type": "ENVIRONMENTAL FACTOR - TREATMENT LOCATION", "description": "Locations where samples were collected from patients receiving treatment for metastatic melanoma.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "id": "NYULH, UCLA, MGH"}, {"entity_type": "PHYSIOLOGICAL PROCESS - AGE FACTOR", "description": "The median age of the patients in the study was 62.85 years, with a range spanning from 19 to 90.2 years old.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "id": "AGE DISTRIBUTION (62.85 YEARS MEDIAN AGE)"}, {"entity_type": "PHYSIOLOGICAL PROCESS - SEX FACTOR", "description": "A larger proportion of metastatic melanoma patients in the study were males (67%).", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "id": "SEX DISTRIBUTION (67% MALE)"}, {"entity_type": "PHYSIOLOGICAL PROCESS - TREATMENT RESPONSE EVALUATION", "description": "Testing the efficacy of Immune Checkpoint Inhibitors (ICIs) in patients with metastatic melanoma.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "id": "ICI EFFICACY TESTING"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The grouping of patients treated with anti-CTLA-4, anti-PD-1, and combination therapies for pooled association analysis adjusted for age, sex, and treatment drugs.", "source_id": "chunk-0d49552280a277a8a26456d06f8f26a8", "id": "ANTI-CTLA-4, ANTI-PD-1 AND COMBINATION-THERAPY TREATED PATIENTS GROUPING"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Analysis aimed to find associations between genomic variants (SNPs) and treatment response in patients treated with different immunotherapies.", "source_id": "chunk-0d49552280a277a8a26456d06f8f26a8", "id": "TREATMENT RESPONSE ASSOCIATION ANALYSIS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A cohort of patients treated with a combination therapy for immunotherapy analysis.", "source_id": "chunk-0d49552280a277a8a26456d06f8f26a8", "id": "COMBINATION THERAPY COHORT"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Adjustments made in the pooled association analysis to control for age, sex, and treatment drugs as environmental factors.", "source_id": "chunk-0d49552280a277a8a26456d06f8f26a8", "id": "AGE, SEX AND TREATMENT DRUGS ADJUSTMENT"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Indication of limited statistical power due to small sample size shown through wide confidence intervals.", "source_id": "chunk-0d49552280a277a8a26456d06f8f26a8", "id": "WIDE CONFIDENCE INTERVALS"}, {"source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "description": "Specific SNPs are mapped to genomic regions such as the PTPN2 gene and the IL2/ADAD1/IL21 locus, indicating their potential influence on disease susceptibility or treatment response.", "entity_type": "UNKNOWN", "id": "PTPN2 GENE, IL2/ADAD1/IL21 LOCUS"}, {"entity_type": "PROTEIN", "description": "EBNA2 is a gene that interacts with MS risk loci and alters allelic expression based on genotype.<SEP>EBNA2 is a protein that binds chromatin at multiple sclerosis (MS) risk loci dependent on the MS risk allele.", "source_id": "chunk-bb351b97d99fce93d17df522db92dda7<SEP>chunk-03962ffc6066ee5da582bdc89310b1d6", "id": "EBNA2"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant located in TRAF3/RCOR1, associated with increased EBNA2 binding at a MS risk locus when carrying the risk allele.", "source_id": "chunk-bb351b97d99fce93d17df522db92dda7", "id": "TRAF3/RCOR1 SNP (RS1258869)"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant in CD40, linked to preferential EBNA2 binding to the risk allele compared to protective alleles.", "source_id": "chunk-bb351b97d99fce93d17df522db92dda7", "id": "CD40 SNP (RS1883832)"}, {"entity_type": "GENOMIC VARIANT", "description": "A SNP at the TNFAIP8 locus with preferential EBNA2 binding to the protective allele, implicated in MS risk.", "source_id": "chunk-bb351b97d99fce93d17df522db92dda7", "id": "TNFAIP8 LOCUS SNP (RS32658)"}, {"entity_type": "GENOMIC VARIANT", "description": "SNP located at TNFRSF1A locus showing preferential EBNA2 binding to the protective allele relative to the risk allele.", "source_id": "chunk-bb351b97d99fce93d17df522db92dda7", "id": "TNFRSF1A LOCUS SNP (RS180069)"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant within TBX6, associated with EBNA2 binding preference towards the protective allele at a MS risk locus.", "source_id": "chunk-bb351b97d99fce93d17df522db92dda7", "id": "TBX6 SNP (RS3809627)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The EBV latency III growth program is significantly inhibited by EBNA2-TAT treatment in LCLs, affecting cell proliferation and morphology.", "source_id": "chunk-bb351b97d99fce93d17df522db92dda7", "id": "EBV LATENCY III GROWTH PROGRAM"}, {"entity_type": "MOLECULAR INTERACTION", "description": "EBNA2-TAT inhibits the EBNA2 transcriptional function and affects expression of MS risk genes without causing cytotoxicity at moderate concentrations.", "source_id": "chunk-bb351b97d99fce93d17df522db92dda7", "id": "EBNA2-TAT"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Regulation of LMP1 gene expression by EBNA2, inhibited by EBNA2-TAT treatment indicating disruption of EBV latency III growth program.", "source_id": "chunk-bb351b97d99fce93d17df522db92dda7", "id": "LMP1 GENE EXPRESSION REGULATION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Gene expression regulation by EBNA2 for MS-associated genes in LCLs is affected upon inhibition of EBNA2 interaction with RBP-J\u03ba.", "source_id": "chunk-bb351b97d99fce93d17df522db92dda7", "id": "TRAF3, CD40, CLECL1, TNFAIP8, AND TNFRSF1A GENE EXPRESSION REGULATION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "EBV DNA copy number serves as a stable phenotype in LCLs and its alteration can be influenced by genetic factors and transcriptional regulation.", "source_id": "chunk-bb351b97d99fce93d17df522db92dda7", "id": "EBV DNA COPY NUMBER STABILITY"}, {"entity_type": "GENE EXPRESSION REGULATION", "description": "Expression of these genes in LCLs is regulated by EBNA2, with alterations observed upon inhibition.", "source_id": "chunk-bb351b97d99fce93d17df522db92dda7", "id": "MS RISK GENES (TRAF3, CD40, CLECL1, TNFAIP8, AND TNFRSF1A)"}, {"entity_type": "MOLECULAR INTERACTION", "description": "EBNA2 interacts with RBP-J\u03ba to regulate gene expression, inhibited by EBNA2-TAT treatment.", "source_id": "chunk-bb351b97d99fce93d17df522db92dda7", "id": "RBP-J\u039a SITE BINDING"}, {"entity_type": "GENE", "description": "TRAF3 is a gene that has an altered expression due to EBNA2 preferential binding, which could contribute to increased immune evasion in the context of MS risk.", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "id": "TRAF3"}, {"entity_type": "GENE", "description": "CD40 is a gene whose allelic expression changes directionally with EBNA2 interaction compared to B cells, affecting immune evasion and MS risk.", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "id": "CD40"}, {"entity_type": "GENE", "description": "TNFAIP8 is a gene that shows altered expression due to preferential binding by EBNA2, influencing the host\'s immune response in the context of multiple sclerosis (MS) risk.", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "id": "TNFAIP8"}, {"entity_type": "GENE", "description": "TNFRSF1A is a gene with an allelic association altered by EBNA2 interaction, which may affect MS risk through immune evasion mechanisms.", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "id": "TNFRSF1A"}, {"entity_type": "GENE", "description": "TBX6 is a gene mentioned in the text as having its expression affected by EBNA2 binding preferences but without providing specific details about the nature of this alteration.", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "id": "TBX6"}, {"entity_type": "GENE", "description": "RCOR1 is a gene with altered expression due to preferential EBNA2 binding, impacting immune evasion and MS risk.", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "id": "RCOR1"}, {"entity_type": "GENE", "description": "CLECL1 shows increased expression due to the effect of EBNA2 on risk alleles, potentially contributing to enhanced immune evasion in multiple sclerosis (MS) context.", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "id": "CLECL1"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The EBV latency III program is a physiological process involving key genes like LMP1 and LMP2 that are influenced by the interaction between EBNA2 and MS risk loci, potentially contributing to immune evasion.", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "id": "EBV LATENCY III PROGRAM"}, {"entity_type": "GENOMIC VARIANT", "description": "MS risk loci are genomic variants associated with an increased risk of multiple sclerosis (MS), which interact with EBNA2 leading to altered gene expression and potential immune evasion mechanisms.", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "id": "MS RISK LOCI"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The EBV infection cycle, particularly latency III, is a physiological process influenced by the regulation of MS risk genes through EBNA2 interaction, affecting immune response evasion.", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "id": "EBV INFECTION CYCLE"}, {"entity_type": "THERAPY", "description": "Treatment with EBNA2-TAT inhibits the effect of EBNA2 on gene expression, demonstrating its role in altering MS risk loci.", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "id": "EBNA2-TAT TREATMENT"}, {"entity_type": "GENE", "description": "LMP1 is a gene involved in the EBV latency III program that interacts proximally to MS risk genes regulated by EBNA2.", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "id": "LMP1"}, {"entity_type": "GENE", "description": "LMP2 is a gene involved in the EBV latency III program, interacting with MS risk genes influenced by EBNA2 binding.", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "id": "LMP2"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process of immune evasion involves mechanisms by which pathogens, such as EBV, avoid or suppress host immune responses.", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "id": "IMMUNE EVASION"}, {"source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "description": "The effect of EBNA2-TAT treatment on MS risk loci suggests that EBNA2\'s interaction with these genomic variants is crucial for regulating gene expression involved in immune evasion.", "entity_type": "UNKNOWN", "id": "EBNATBXTAT TREATMENT"}, {"source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "description": "EBNA2/risk gene interactions within the EBV latency III program are proposed to increase or decrease gene expression, influencing the virus\'s ability to evade host immunity.", "entity_type": "UNKNOWN", "id": "MS RISK GENES"}, {"source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "description": "Treatment with EBNA2-TAT modulates gene expression in a way that suggests it affects the interaction between EBNA2 and MS risk alleles.", "entity_type": "UNKNOWN", "id": "GENE EXPRESSION"}, {"source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "description": "Increased TNFAIP8 expression due to EBNA2 interaction may serve as a viral survival strategy by altering host inflammatory responses.", "entity_type": "UNKNOWN", "id": "VIRAL SURVIVAL STRATEGY"}, {"source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "description": "Decreased TNFRSF1A expression from preferential EBNA2 binding may suppress immune defense mechanisms, aiding in the virus\'s evasion of detection.", "entity_type": "UNKNOWN", "id": "IMMUNE DEFENSE SUPPRESSION"}, {"source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "description": "Proximal interactions of LMP2 with MS risk genes, regulated by EBNA2, suggest roles in immune evasion mechanisms.", "entity_type": "UNKNOWN", "id": "IMMUNE EVASION MECHANISM"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant in the COX-1 gene that was examined for its association with aspirin insensitivity.", "source_id": "chunk-54c4fede216a6c4183b95ee1a2edcb17", "id": "RS3842787"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant associated with differences in percentage of CAD between patients and controls.<SEP>A genomic variant in the COX-2 gene associated with increased risk of aspirin insensitivity.", "source_id": "chunk-54c4fede216a6c4183b95ee1a2edcb17<SEP>chunk-734cac289b42d37dad32bd51ea24a1ea", "id": "RS20417"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant that was examined for its association with aspirin insensitivity, but no significant findings were reported.", "source_id": "chunk-54c4fede216a6c4183b95ee1a2edcb17", "id": "RS20118426"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant associated with the averaged platelet number, contributing significantly to heterogeneity.<SEP>A genomic variant in the ITGA2 gene associated with a high risk of aspirin insensitivity.", "source_id": "chunk-54c4fede216a6c4183b95ee1a2edcb17<SEP>chunk-734cac289b42d37dad32bd51ea24a1ea", "id": "RS1126643"}, {"entity_type": "DISEASE", "description": "A condition characterized by an inadequate response to aspirin therapy, which can increase cardiovascular risks.", "source_id": "chunk-54c4fede216a6c4183b95ee1a2edcb17", "id": "ASPIRIN INSENSITIVITY"}, {"entity_type": "POPULATION GROUP", "description": "Individuals of Caucasian ethnicity used as controls or subjects in the studies examining genetic polymorphisms associated with aspirin insensitivity.", "source_id": "chunk-54c4fede216a6c4183b95ee1a2edcb17", "id": "CAUCASIAN PATIENTS AND CONTROLS"}, {"entity_type": "POPULATION GROUP", "description": "Individuals of Chinese ethnicity used as controls or subjects in the studies examining genetic polymorphisms associated with aspirin insensitivity.", "source_id": "chunk-54c4fede216a6c4183b95ee1a2edcb17", "id": "CHINESE PATIENTS AND CONTROLS"}, {"entity_type": "GENE", "description": "The COX-1 gene is one of the genes examined for its polymorphisms\' association with aspirin insensitivity.", "source_id": "chunk-54c4fede216a6c4183b95ee1a2edcb17", "id": "COX-1 GENE"}, {"entity_type": "GENE", "description": "The COX-2 gene contains a polymorphism (rs20417) that has been shown to be significantly associated with increased risk of aspirin insensitivity.", "source_id": "chunk-54c4fede216a6c4183b95ee1a2edcb17", "id": "COX-2 GENE"}, {"entity_type": "GENE", "description": "A gene containing the rs1126643 variant, which is strongly associated with higher risks for aspirin insensitivity.", "source_id": "chunk-54c4fede216a6c4183b95ee1a2edcb17", "id": "ITGA2 GENE"}, {"entity_type": "DISEASE", "description": "Coronary Artery Disease (CAD) is a condition characterized by the buildup of plaque inside the heart\'s arteries, leading to reduced blood flow.", "source_id": "chunk-734cac289b42d37dad32bd51ea24a1ea", "id": "CAD"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The averaged platelet number is a physiological measure that contributes to heterogeneity in genomic variant rs1126643.", "source_id": "chunk-734cac289b42d37dad32bd51ea24a1ea", "id": "AVERAGED PLATELET NUMBER"}, {"entity_type": "MOLECULAR INTERACTION", "description": "The meta-regression model is used to analyze and interpret data from multiple studies to understand the relationship between variables.", "source_id": "chunk-734cac289b42d37dad32bd51ea24a1ea", "id": "META-REGRESSION MODEL"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Continuous covariates at the study level, such as patient characteristics or environmental factors, are included in the analysis to account for variability.", "source_id": "chunk-734cac289b42d37dad32bd51ea24a1ea", "id": "STUDY-LEVEL CONTINUOUS COVARIATES"}, {"source_id": "chunk-54c4fede216a6c4183b95ee1a2edcb17", "description": "The T allele of the rs1126643 variant is strongly associated with a higher risk of aspirin insensitivity, especially under dominant genetic models.", "entity_type": "UNKNOWN", "id": "RS1126643-T ALLELE"}, {"source_id": "chunk-54c4fede216a6c4183b95ee1a2edcb17", "description": "Deviations from Hardy-Weinberg equilibrium were observed for the genomic variants rs20118426 and rs1126643 in some comparisons.", "entity_type": "UNKNOWN", "id": "HARDY-WEINBERG EQUILIBRIUM DEVIATIONS"}, {"source_id": "chunk-54c4fede216a6c4183b95ee1a2edcb17", "description": "Deviations from Hardy-Weinberg equilibrium were observed for the genomic variants rs20118426 and rs1126643 in some comparisons.", "entity_type": "UNKNOWN", "id": "RS20118426 AND RS1126643"}, {"source_id": "chunk-54c4fede216a6c4183b95ee1a2edcb17", "description": "The risk estimates associated with the T allele of rs1126643 were notably high for aspirin insensitivity, especially under a dominant genetic model.", "entity_type": "UNKNOWN", "id": "RISK ESTIMATES"}, {"entity_type": "GENE", "description": "The STAT5B gene is a critical gene involved in growth hormone signaling and immune regulation.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "id": "STAT5B GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "A homozygous nonsense variant (p.W631*) located at c.1892G>A in the STAT5B gene that results in a truncated protein lacking critical functional domains.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "id": "C.1892G>A VARIANT"}, {"entity_type": "DRUG", "description": "A drug used to treat growth hormone insensitivity syndrome by improving growth and immune function in patients with STAT5B mutations.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "id": "RECOMBINANT HUMAN INSULIN-LIKE GROWTH FACTOR 1 (RHIGF-1)"}, {"entity_type": "DISEASE", "description": "A condition characterized by low levels of IGF-1, IGF-BP3, and ALS, leading to severe short stature and immunological impairments.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "id": "GROWTH HORMONE INSENSITIVITY SYNDROME (GHI)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The measurement of growth hormone (GH) levels in the blood, which were found to be normal in patients despite their clinical phenotype indicative of GHI.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "id": "SERUM GH LEVELS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A physiological process indicating the level of insulin-like growth factor 1, crucial for proper growth and development.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "id": "IGF-1 LEVELS"}, {"entity_type": "DISEASE", "description": "An autoimmune condition characterized by inflammation in the thyroid gland, treated with levothyroxine to manage symptoms.<SEP>An autoimmune condition where the immune system attacks the thyroid gland, leading to inflammation and typically treated with levothyroxine.<SEP>Autoimmune thyroiditis is characterized by the presence of autoantibodies such as anti-thyroglobulin and anti-thyroid peroxidase antibodies, which are found in patients with STAT5B deficiency.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5<SEP>chunk-e323b0d4f82733a78f687e51f47b500a", "id": "AUTOIMMUNE THYROIDITIS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A process indicating an abnormal enlargement of lymph nodes, observed in some patients but not all three siblings.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "id": "LYMPHADENOPATHY"}, {"entity_type": "DISEASE", "description": "A chronic skin condition characterized by inflammation and irritation, often associated with atopic conditions such as asthma or allergic rhinitis.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "id": "CHRONIC ECZEMA"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A physiological process indicative of inflammation and hyperreactivity in the airways, often treated with corticosteroids.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "id": "REACTIVE AIRWAY DISEASE"}, {"entity_type": "DISEASE", "description": "A condition characterized by significantly below average height relative to age and gender peers due to genetic or other medical causes.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "id": "SEVERE SHORT STATURE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Processes indicating recurrent infections of various body parts requiring antibiotic treatments.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "id": "INFECTIONS (SKIN, URINARY TRACT, PULMONARY)"}, {"entity_type": "DISEASE", "description": "A disease characterized by the backflow of stomach acid into the esophagus, causing heartburn and discomfort.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "id": "GASTROESOPHAGEAL REFLUX DISEASE"}, {"entity_type": "BIOLOGICAL SAMPLE", "description": "Samples derived from skin cells used to confirm genetic mutations in siblings.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "id": "FIBROBLAST CULTURES"}, {"entity_type": "MEDICAL PROCEDURE", "description": "A medical procedure used for fertility treatment that involves retrieving eggs from a woman\u2019s ovaries and fertilizing them with sperm in a laboratory setting.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "id": "IN-VITRO FERTILIZATION (IVF)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The birth of an infant before 37 weeks of gestation, which can affect growth and development.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "id": "PREMATURE BIRTH"}, {"entity_type": "DISEASE", "description": "A serious medical condition characterized by inflammation of the lungs (pneumonia) and systemic infection (sepsis).", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "id": "PNEUMONIA WITH SEPSIS"}, {"entity_type": "MEDICAL TREATMENT", "description": "Additional oxygen supplied to help patients with respiratory difficulties breathe more easily.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "id": "SUPPLEMENTAL OXYGEN"}, {"entity_type": "DRUG", "description": "A medication used to treat hypothyroidism by providing an adequate amount of thyroxine hormone.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "id": "LEVOTHYROXINE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A hormone responsible for stimulating growth, cell reproduction, and regeneration in humans and other animals.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "id": "GROWTH HORMONE (GH)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A protein that binds to IGFs and regulates their activity by controlling the availability of free IGFs.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "id": "IGF BINDING PROTEIN-3 (IGFBP3)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A glycoprotein that forms a ternary complex with IGF-I/II and IGFBPs, playing a role in regulating the bioavailability of these growth factors.)", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "id": "ACID LABILE SUBUNIT (ALS)"}, {"entity_type": "BIOLOGICAL SAMPLE", "description": "Skin cells that produce collagen and other fibers to maintain skin structure.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "id": "DERMAL FIBROBLASTS"}, {"entity_type": "PROTEIN STRUCTURE", "description": "A conserved protein domain involved in signal transduction processes through interactions with phosphotyrosine-containing peptides.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "id": "SRC HOMOLOGY 2 (SH2) DOMAIN"}, {"entity_type": "PROTEIN STRUCTURE", "description": "The region of a transcription factor that binds to DNA and promotes gene expression.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "id": "TRANSACTIVATION DOMAIN (TAD)"}, {"entity_type": "BIOLOGICAL PROCESS", "description": "A process where two different molecules or proteins bind together to form a heterodimer, often involved in signal transduction pathways.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "id": "HETERODIMER FORMATION"}, {"entity_type": "CELL LINE", "description": "Human Embryonic Kidney cells expressing the growth hormone receptor used for research purposes.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "id": "HEK-GHRS"}, {"entity_type": "GENE", "description": "STAT5B is a gene important for immune cell function, including the maintenance of T cells and NK cells.<SEP>The STAT5B gene plays a critical role in the regulation of CD8+ T cell activation and homeostasis.", "source_id": "chunk-4389e37ac64d551cdf89e7f4230a3589<SEP>chunk-e323b0d4f82733a78f687e51f47b500a", "id": "STAT5B"}, {"entity_type": "GENOMIC VARIANT", "description": "The p.W631* variant in STAT5B leads to reduced expression and impaired phosphorylation or trafficking into the nucleus upon GH stimulation.", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "id": "P.W631* VARIANT STAT5B"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Sustained B cell hyperactivity is associated with atopy and autoimmunity, particularly in individuals with a loss-of-function (LOF) STAT5B variant.", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "id": "B CELL HYPERACTIVITY"}, {"entity_type": "DISEASE", "description": "Atopy refers to a genetic tendency towards developing allergic reactions. In the context of the text, it\'s linked to elevated IgE levels and chronic eczema/reactive airway disease in individuals with a LOF STAT5B mutation.", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "id": "ATOPY"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A reduction in T cells, particularly CD3+, CD4+, and CD8+ T cells, is observed in individuals with a loss-of-function (LOF) STAT5B variant. This may be due to impaired thymic T cell production or peripheral destruction.", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "id": "T CELL LYMPHOPENIA"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "STAT5B deficient patients often exhibit pronounced dysregulation in memory CD8+ T cells, including reductions in na\u00efve T cells and increases in effector memory cells with age.", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "id": "MEMORY CD8+ T CELLS DYSREGULATION"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Growth hormone regulates various physiological processes, including cell growth and reproduction; in this context, it affects the expression and phosphorylation state of STAT5B protein variants.", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "id": "GH (GROWTH HORMONE)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "NK cells are immune cells that play a crucial role in the host\'s defense against tumors and virally infected cells. Reductions in NK cell counts are observed in individuals with STAT5B deficiency.", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "id": "NK CELLS (NATURAL KILLER CELLS)"}, {"entity_type": "MOLECULAR TARGET", "description": "An autoantigen in autoimmune thyroiditis, identified by anti-thyroglobulin antibodies in patients with STAT5B deficiency.", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "id": "THYROGLOBULIN"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Different classes of antibodies involved in immune responses; IgE levels are particularly elevated and associated with allergic conditions like chronic eczema in individuals with a LOF (loss-of-function) STAT5B variant.", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "id": "IGG, IGA, IGM, IGE"}, {"entity_type": "MOLECULAR INTERACTION", "description": "A molecular interaction pathway activated by interleukin 2 that leads to the induction of FOXP3 and regulatory T cell functions, impaired in patients with STAT5B deficiency.", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "id": "IL-2 SIGNALING PATHWAY"}, {"entity_type": "GENOMIC VARIANT", "description": "A loss-of-function (LOF) variant of the STAT5B gene that leads to dysregulation of CD8+ T cells.", "source_id": "chunk-4389e37ac64d551cdf89e7f4230a3589", "id": "LOF STAT5B VARIANT"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The CD4+ effector memory T cell subset remains unaffected by alterations in the STAT5B variant, maintaining its proportion normally.<SEP>The proportion of CD4+ effector memory (TEM) T cells remains within normal ranges in patients with a genomic variant in the STAT5B gene.", "source_id": "chunk-4389e37ac64d551cdf89e7f4230a3589", "id": "CD4+ TEM CELLS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Increases in the percentage of CD8+ TEM cells become clinically significant with age, indicating a dysregulation specific to this cell type.", "source_id": "chunk-4389e37ac64d551cdf89e7f4230a3589", "id": "CD8+ TEM CELLS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Elevations in the percentage of CD8+ terminally differentiated effector memory (TEMRA) T cells are detected during infancy but normalize around age 4.", "source_id": "chunk-4389e37ac64d551cdf89e7f4230a3589", "id": "CD8+ TEMRA CELLS"}, {"entity_type": "MOLECULAR INTERACTION", "description": "A dysregulation noted despite normal CD4+ memory T cell subsets, indicating a specific issue with the regulation and function of CD8+ T cells.", "source_id": "chunk-4389e37ac64d551cdf89e7f4230a3589", "id": "DYSREGULATION OF CD8+ T CELLS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Elevated proportions of these cells beginning in infancy suggest an essential role for STAT5B in their activation and maintenance.", "source_id": "chunk-4389e37ac64d551cdf89e7f4230a3589", "id": "CD8+ MEMORY T CELLS"}, {"entity_type": "INDIVIDUALS", "description": "Patients 2 and 3 experienced elevations in the percentage of CD8+ TEMRA cells during infancy.", "source_id": "chunk-4389e37ac64d551cdf89e7f4230a3589", "id": "P2 AND P3"}, {"entity_type": "INDIVIDUALS", "description": "Patient 1 had normalized proportions of CD8+ TEMRA cells from early childhood onwards, indicating stability post-infancy.", "source_id": "chunk-4389e37ac64d551cdf89e7f4230a3589", "id": "P1"}, {"source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "description": "This disease affects physical comfort, impacting quality of life in patients with STAT5B mutations.", "entity_type": "UNKNOWN", "id": "PHYSICAL COMFORT"}, {"source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "description": "Used to identify and confirm the presence of genetic variants, including those affecting STAT5B.", "entity_type": "UNKNOWN", "id": "GENETIC VARIANT IDENTIFICATION"}, {"source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "description": "Fibroblast cultures from affected individuals confirmed the homozygous mutation in STAT5B through sequencing.", "entity_type": "UNKNOWN", "id": "MUTATION CONFIRMATION"}, {"source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "description": "The SH2 domain is crucial for STAT5B activation and function; mutations affecting it impair protein activity.", "entity_type": "UNKNOWN", "id": "STAT5B FUNCTIONALITY"}, {"source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "description": "TADs regulate gene expression by binding to DNA and promoting transcription, which is affected in the p.W631* variant.", "entity_type": "UNKNOWN", "id": "GENE EXPRESSION REGULATION"}, {"source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "description": "The presence of anti-thyroglobulin antibodies is a hallmark of autoimmune thyroiditis, which can develop in individuals with STAT5B deficiency.)", "entity_type": "UNKNOWN", "id": "ANTI-THYROGLOBULIN ANTIBODIES"}, {"source_id": "chunk-4389e37ac64d551cdf89e7f4230a3589", "description": "Proportion of CD4+ TEM cells remains within normal ranges despite the genomic variant, indicating no significant impact on this subset.", "entity_type": "UNKNOWN", "id": "NORMAL RANGE"}, {"source_id": "chunk-4389e37ac64d551cdf89e7f4230a3589", "description": "Increase in CD8+ TEM cell proportions with age is clinically significant and linked to dysregulation due to STAT5B deficiency.", "entity_type": "UNKNOWN", "id": "DYSREGULATION"}, {"source_id": "chunk-4389e37ac64d551cdf89e7f4230a3589", "description": "Elevations during infancy normalize around age 4, suggesting a developmental impact of the LOF variant on CD8+ TEMRA cell regulation.", "entity_type": "UNKNOWN", "id": "NORMALIZATION"}, {"source_id": "chunk-4389e37ac64d551cdf89e7f4230a3589", "description": "Proportion of CD4+ TEM cells does not alter with age, indicating that the STAT5B variant has no significant impact on these T cell subsets.", "entity_type": "UNKNOWN", "id": "NO ALTERATION"}, {"entity_type": "GENE", "description": "HLA-DRB1*07:01 is a specific allele within the HLA-DRB1 gene that plays a significant role in determining susceptibility to certain diseases.", "source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "id": "HLA-DRB1*07:01"}, {"entity_type": "GENOMIC VARIANT", "description": "These are SNPs (Single Nucleotide Polymorphisms) that are being studied as potential predictors for HLA-DRB1*07:01-DQA1*02:01-DQB1*02:02 carrier status.", "source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "id": "RS28383172, RS2395182, RS4713586, RS7775228"}, {"entity_type": "GENE", "description": "These genes are part of the human leukocyte antigen (HLA) complex and encode proteins that play a crucial role in immune responses.", "source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "id": "HLA-DQA1, HLA-DQB1"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Linkage disequilibrium refers to the non-random association of alleles at different loci that are in close proximity on the same chromosome, which can influence genetic analysis and interpretation of genotyping results.", "source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "id": "LINKAGE DISEQUILIBRIUM (LD)"}, {"entity_type": "DISEASE", "description": "This specific HLA haplotype is associated with certain diseases and can be used as a marker for disease susceptibility.", "source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "id": "HLA-DRB1*07:01-DQA1*02:01-DQB1*02:02 HAPLOTYPE CARRIER STATUS"}, {"entity_type": "MOLECULAR INTERACTION", "description": "These are molecular interaction techniques used to genotype SNPs in DNA samples.", "source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "id": "CUSTOM TAQMAN SNP GENOTYPING ASSAY, KASPAR-ON-DEMAND PREVALIDATED ASSAYS"}, {"entity_type": "TRANSCRIPT", "description": "This specific exon in the HLA-DRB1 gene is targeted for genotyping to determine its association with disease susceptibility.", "source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "id": "EXON 2 OF HLA-DRB1 GENE"}, {"entity_type": "TRANSCRIPT", "description": "These specific exons in the HLA-DQB1 gene are studied alongside exon 2 of HLA-DRB1 for their potential role in determining genetic predispositions to certain diseases.", "source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "id": "EXONS 2 AND 3 OF HLA-DQB1 GENE"}, {"entity_type": "GENE", "description": "These are specific alleles within the HLA complex that form part of the haplotype being studied for its association with disease susceptibility.", "source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "id": "HLA-DQA1*02:01, HLA-DQB1*02:02 ALLELES"}, {"entity_type": "GENOMIC VARIANT", "description": "This genomic variant represents a specific haplotype involving the genes DRB1, DQA1, and DQB1.", "source_id": "chunk-1f50436a36721971a0a256131d7fca62", "id": "HLA-DRB1*07:01-DQA1*02:01-DQB1*02:02 HAPLOTYPE"}, {"entity_type": "DISEASE", "description": "E. coli ASP hypersensitivity is a disease characterized by an allergic reaction to E. coli-derived antigenic substances.", "source_id": "chunk-1f50436a36721971a0a256131d7fca62", "id": "E. COLI ASP HYPERSENSITIVITY"}, {"entity_type": "POPULATION GROUP", "description": "A subpopulation of individuals genotyped for single nucleotide polymorphisms (SNPs) in the context of evaluating genetic markers.", "source_id": "chunk-1f50436a36721971a0a256131d7fca62", "id": "SNP-GENOTYPED SUBPOPULATION"}, {"entity_type": "ALGORITHM", "description": "An algorithm designed to identify tagging SNPs within a genomic region, used as part of a screening test for E. coli ASP hypersensitivity.", "source_id": "chunk-1f50436a36721971a0a256131d7fca62", "id": "2-SNP TAGGING ALGORITHM V"}, {"entity_type": "ALGORITHM", "description": "One of several algorithms evaluated in the context of identifying genetic markers and screening tests for disease.", "source_id": "chunk-1f50436a36721971a0a256131d7fca62", "id": "ALGORITHM II"}, {"entity_type": "ALGORITHM", "description": "An algorithm compared to others for its performance in identifying genetic markers relevant to E. coli ASP hypersensitivity.", "source_id": "chunk-1f50436a36721971a0a256131d7fca62", "id": "ALGORITHM III"}, {"entity_type": "ALGORITHM", "description": "A comparative algorithm used to evaluate the effectiveness of different approaches to tagging SNPs and screening for disease.", "source_id": "chunk-1f50436a36721971a0a256131d7fca62", "id": "ALGORITHM IV"}, {"source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "description": "The genetic variants in these exons are crucial for determining the carrier status of the specific haplotype associated with certain diseases.", "entity_type": "UNKNOWN", "id": "EXON 2 OF HLA-DRB1 GENE, EXONS 2 AND 3 OF HLA-DQB1 GENE"}, {"source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "description": "The presence of these genotypes is associated with a high likelihood of being a carrier for the specific HLA haplotype.", "entity_type": "UNKNOWN", "id": "RS28383172 AG OR GG GENOTYPES"}, {"source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "description": "These specific combinations of genotypes are strongly associated with the HLA haplotype carrier status.", "entity_type": "UNKNOWN", "id": "RS2395182 TT OR TG AND RS4713586 TT AND RS7775228 TC OR CC GENOTYPES"}, {"source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "description": "The G allele of rs28383172 is in perfect concordance with the HLA-DRB1*07:01 allele carrier status.", "entity_type": "UNKNOWN", "id": "HLA-DRB1*07:01 ALLELE CARRIER STATUS"}, {"source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "description": "These genotyping techniques are used to accurately determine the presence of specific SNPs and alleles within the HLA complex.", "entity_type": "UNKNOWN", "id": "HLA-DQA1*02:01, HLA-DQB1*02:02 ALLELES, RS28383172, RS2395182, RS4713586, RS7775228"}, {"entity_type": "GENOMIC VARIANT", "description": "Polymorphism rs179008 in the TLR7 gene was found to follow Hardy-Weinberg equilibrium and show significant genotype distribution differences between HIV-infected individuals and healthy controls.", "source_id": "chunk-05d583f893b703816ad8de9561aa5292", "id": "TLR7 (RS179008)"}, {"entity_type": "GENOMIC VARIANT", "description": "Polymorphism rs179009 in the TLR7 gene also followed Hardy-Weinberg equilibrium but showed significant genotype distribution differences between HIV-infected individuals and healthy controls.", "source_id": "chunk-05d583f893b703816ad8de9561aa5292", "id": "TLR7 (RS179009)"}, {"entity_type": "GENE", "description": "The TLR7 gene is involved in the immune response and has polymorphisms that show different distributions among HIV-infected individuals compared to healthy controls.", "source_id": "chunk-05d583f893b703816ad8de9561aa5292", "id": "TLR7 GENE "}, {"entity_type": "DISEASE STAGE", "description": "Different stages of HIV disease are associated with varying frequencies of specific genotypes, such as TLR7 rs179009 AG and GG genotypes.", "source_id": "chunk-05d583f893b703816ad8de9561aa5292", "id": "HIV DISEASE STAGE "}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Exposure to tobacco or alcohol did not significantly alter the distribution of TLR7 polymorphisms in HIV-infected individuals compared to non-users, though some trends were observed.", "source_id": "chunk-05d583f893b703816ad8de9561aa5292", "id": "ENVIRONMENTAL FACTORS (TOBACCO & ALCOHOL)"}, {"entity_type": "GENOMIC VARIANT", "description": "The AA genotype of TLR7 rs179008 showed similar distribution among tobacco-consuming HIV-infected individuals compared to non-users.", "source_id": "chunk-05d583f893b703816ad8de9561aa5292", "id": "TLR7 RS179008 AA GENOTYPE "}, {"entity_type": "GENOMIC VARIANT", "description": "The CC genotype of TLR7 rs179008 showed similar distribution between tobacco-consuming and non-consuming HIV-infected individuals.", "source_id": "chunk-05d583f893b703816ad8de9561aa5292", "id": "TLR7 RS179008 CC GENOTYPE "}, {"entity_type": "GENOMIC VARIANT", "description": "The CT genotype of TLR7 rs179008 was present in both tobacco-consuming and non-consumers with similar frequency among HIV-infected individuals.", "source_id": "chunk-05d583f893b703816ad8de9561aa5292", "id": "TLR7 RS179008 CT GENOTYPE "}, {"entity_type": "GENOMIC VARIANT", "description": "The distribution of the AA genotype for TLR7 rs179009 was almost identical between alcohol-consuming and non-consuming HIV-infected individuals.", "source_id": "chunk-05d583f893b703816ad8de9561aa5292", "id": "TLR7 RS179009 AA GENOTYPE "}, {"entity_type": "GENOMIC VARIANT", "description": "Higher frequency of the AG genotype in tobacco consumers compared to non-users among HIV-infected individuals, though not statistically significant.", "source_id": "chunk-05d583f893b703816ad8de9561aa5292", "id": "TLR7 RS179009 AG GENOTYPE "}, {"entity_type": "GENOMIC VARIANT", "description": "The GG genotype for TLR7 rs179009 was less common in advanced HIV disease stages compared to healthy controls.", "source_id": "chunk-05d583f893b703816ad8de9561aa5292", "id": "TLR7 RS179009 GG GENOTYPE "}, {"entity_type": "GENE", "description": "TLR7 is a gene associated with immune response and has polymorphisms that are studied in relation to HIV disease progression.", "source_id": "chunk-2c91cdebb36ef064eb01a7021a961302", "id": "TLR7"}, {"entity_type": "GENOMIC VARIANT", "description": "rs179008 is a genomic variant within the TLR7 gene that is investigated for its role in HIV disease progression.", "source_id": "chunk-2c91cdebb36ef064eb01a7021a961302", "id": "RS179008"}, {"entity_type": "GENOMIC VARIANT", "description": "rs179009 is another genomic variant within the TLR7 gene studied in connection with HIV disease progression.", "source_id": "chunk-2c91cdebb36ef064eb01a7021a961302", "id": "RS179009"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Tobacco usage is an environmental factor that may influence the risk of HIV disease progression.", "source_id": "chunk-2c91cdebb36ef064eb01a7021a961302", "clusters": "[{level: 0, cluster: 2}, {level: 1, cluster: 26}]", "id": "TOBACCO USAGE"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Alcohol usage, as another environmental factor, is examined for its potential impact on HIV disease progression.", "source_id": "chunk-2c91cdebb36ef064eb01a7021a961302", "clusters": "[{level: 0, cluster: 2}, {level: 1, cluster: 26}]", "id": "ALCOHOL USAGE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "CD4 counts at baseline are a critical physiological measurement used to assess the stage of HIV infection and predict disease progression.", "source_id": "chunk-2c91cdebb36ef064eb01a7021a961302", "clusters": "[{level: 0, cluster: 2}, {level: 1, cluster: 26}]", "id": "BASELINE CD4 COUNTS"}, {"entity_type": "DISEASE", "description": "HIV disease progression refers to how quickly HIV advances from initial infection to AIDS, influenced by genetic and environmental factors.", "source_id": "chunk-2c91cdebb36ef064eb01a7021a961302", "clusters": "[{level: 0, cluster: 2}, {level: 1, cluster: 26}]", "id": "HIV DISEASE PROGRESSION"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Statistical association or correlation is a measure indicating how two variables are related.", "source_id": "chunk-2c91cdebb36ef064eb01a7021a961302", "id": "CORRELATION"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "A risk factor is any attribute, characteristic, or exposure of an individual that increases the likelihood of developing a disease or injury.", "source_id": "chunk-2c91cdebb36ef064eb01a7021a961302", "id": "RISK FACTOR"}, {"entity_type": "DISEASE PROGRESSION ASSESSMENT TOOL", "description": "Refers to a table containing detailed data about various factors and their correlation with HIV disease progression not presented in the text.", "source_id": "chunk-2c91cdebb36ef064eb01a7021a961302", "id": "TABLE NOT SHOWN"}, {"source_id": "chunk-05d583f893b703816ad8de9561aa5292", "description": "The distribution of rs179008 polymorphism in healthy controls follows Hardy-Weinberg equilibrium and shows a significant difference compared to HIV-infected individuals.)", "entity_type": "UNKNOWN", "id": "GENOMIC VARIANT (RS179008)"}, {"source_id": "chunk-05d583f893b703816ad8de9561aa5292", "description": "The distribution of rs179008 polymorphism in healthy controls follows Hardy-Weinberg equilibrium and shows a significant difference compared to HIV-infected individuals.)", "entity_type": "UNKNOWN", "id": "HEALTHY CONTROL "}, {"source_id": "chunk-05d583f893b703816ad8de9561aa5292", "description": "The distribution of rs179009 polymorphism in healthy controls follows Hardy-Weinberg equilibrium and shows a significant difference compared to HIV-infected individuals.)", "entity_type": "UNKNOWN", "id": "GENOMIC VARIANT (RS179009)"}, {"source_id": "chunk-05d583f893b703816ad8de9561aa5292", "description": "The AA genotype of TLR7 rs179008 is distributed similarly among tobacco-consuming and non-consuming HIV-infected individuals.)", "entity_type": "UNKNOWN", "id": "GENOMIC VARIANT (RS179008 AA)"}, {"source_id": "chunk-05d583f893b703816ad8de9561aa5292", "description": "The CC genotype of TLR7 rs179008 did not show significant differences in distribution among tobacco-using and non-consuming HIV-infected individuals.)", "entity_type": "UNKNOWN", "id": "GENOMIC VARIANT (RS179008 CC)"}, {"source_id": "chunk-05d583f893b703816ad8de9561aa5292", "description": "The CT genotype of TLR7 rs179008 was present with similar frequency in both tobacco-using and non-consumers among HIV-infected individuals.)", "entity_type": "UNKNOWN", "id": "GENOMIC VARIANT (RS179008 CT)"}, {"source_id": "chunk-05d583f893b703816ad8de9561aa5292", "description": "The distribution of the AA genotype for TLR7 rs179009 was similar between alcohol-consuming and non-consuming HIV-infected individuals, indicating no significant environmental impact.)", "entity_type": "UNKNOWN", "id": "GENOMIC VARIANT (RS179009 AA)"}, {"source_id": "chunk-05d583f893b703816ad8de9561aa5292", "description": "Higher frequency of the AG genotype in tobacco consumers compared to non-users among HIV-infected individuals, although not statistically significant.)", "entity_type": "UNKNOWN", "id": "GENOMIC VARIANT (RS179009 AG)"}, {"source_id": "chunk-05d583f893b703816ad8de9561aa5292", "description": "The GG genotype for TLR7 rs179009 showed reduced frequency in advanced stages of HIV disease compared to healthy controls, suggesting potential association with progression.)", "entity_type": "UNKNOWN", "id": "GENOMIC VARIANT (RS179009 GG)"}, {"source_id": "chunk-2c91cdebb36ef064eb01a7021a961302", "description": "Polymorphisms within the TLR7 gene were examined but not found to be significant independent risk factors for HIV disease progression.", "entity_type": "UNKNOWN", "id": "RISK FACTOR FOR HIV DISEASE PROGRESSION"}, {"source_id": "chunk-2c91cdebb36ef064eb01a7021a961302", "description": "Polymorphisms within the TLR7 gene were examined but not found to be significant independent risk factors for HIV disease progression.", "entity_type": "UNKNOWN", "id": "TLR7 POLYMORPHISMS (RS179008, RS179009)"}, {"source_id": "chunk-2c91cdebb36ef064eb01a7021a961302", "description": "CD4 counts are a key variable analyzed using multivariate logistic regression in studies of HIV disease progression.", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 2}, {level: 1, cluster: 26}]", "id": "MULTIVARIATE LOGISTIC REGRESSION ANALYSIS"}, {"source_id": "chunk-2c91cdebb36ef064eb01a7021a961302", "description": "The table not shown contains results of risk factor assessment concerning factors like TLR7 polymorphisms and CD4 counts.", "entity_type": "UNKNOWN", "id": "RISK FACTOR ASSESSMENT RESULTS FOR HIV DISEASE PROGRESSION"}, {"entity_type": "GENOMIC VARIANT", "description": "An activating mutation in the ALK gene at position R1275Q.", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "id": "ALK R1275Q"}, {"entity_type": "GENOMIC VARIANT", "description": "A well-known activating mutation in the NRAS gene, present in melanoma and other cancers.", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "id": "NRAS Q61K"}, {"entity_type": "TOOL/SOFTWARE", "description": "A software tool used for identifying neoepitopes generated by mutations in cancer samples.", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "id": "PROTECT SOFTWARE"}, {"entity_type": "DISEASE", "description": "Neuroblastoma is a type of cancer that typically develops from immature nerve cells and often affects children.", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "id": "NBL (NEUROBLASTOMA)"}, {"entity_type": "PROTEIN", "description": "HLA-B*15:01 is a protein involved in presenting peptides to T-cell receptors (TCRs) and plays a crucial role in immune recognition.<SEP>HLA-B*15:01 is a protein that forms part of the major histocompatibility complex (MHC) and binds to tumor neoepitopes.<SEP>HLA-B*15:01 is another protein encoded by the HLA-B gene, which also forms p/MHC complexes but with different stability characteristics compared to HLA-A*01:01.<SEP>Human leukocyte antigen B15:01, an HLA allele involved in immune responses to certain peptides.", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2<SEP>chunk-830d8819004960d1d149ac70149c72a0<SEP>chunk-d3a9c93928447522ce3df4209f8ac803<SEP>chunk-de413ae6100407d8dadd5bdee87c1074", "id": "HLA-B*15:01"}, {"entity_type": "MOLECULAR INTERACTION", "description": "A neoepitope derived from the ALK R1275Q mutation that binds HLA-B*15:01.", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "id": "MAQDIYRASY (NEOEPITOPE)"}, {"entity_type": "MOLECULAR INTERACTION", "description": "A neoepitope arising from the ALK R1275Q mutation that has a strong binding affinity for HLA-B*15:01.", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "id": "AQDIYRASYY (NEOEPITOPE)"}, {"entity_type": "MOLECULAR INTERACTION", "description": "A nonamer neoepitope arising from the ALK R1275Q mutation, predicted to bind HLA-A*02:01.", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "id": "GMAQDIYRA (NEOEPITOPE)"}, {"entity_type": "MOLECULAR INTERACTION", "description": "An NRAS-derived neoepitope that binds HLA-A*01:01 and is associated with a specific T cell response in melanoma cells.", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "id": "ILDTAGKEEY (NEOEPITOPE)"}, {"entity_type": "PROTEIN", "description": "Human leukocyte antigen A2:01, an allele commonly found in Caucasian populations.", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "id": "HLA-A*02:01"}, {"entity_type": "GENOMIC VARIANT", "description": "A mutation in the ZNF717 gene observed in a subset of neuroblastoma samples.", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "id": "ZNF717 Q716 MUTATION"}, {"entity_type": "GENOMIC VARIANT", "description": "Multiple mutations in the ALK gene at position 1174, observed in different samples within the cohort.", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "id": "ALK F1174L/I/C MUTATIONS"}, {"entity_type": "PROTEIN", "description": "Human leukocyte antigen B15:03, a close relative of HLA-B*15:01, found to bind certain peptides.", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "id": "HLA-B*15:03"}, {"entity_type": "MOLECULAR INTERACTION", "description": "A self-antigen derived from the ALK mutation that is less likely to form stable complexes with HLA proteins compared to neoepitopes.", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "id": "ARDIYRASYY (SELF-ANTIGEN)"}, {"entity_type": "PROTEIN", "description": "HLA-A*01:01 is a protein encoded by the HLA-A gene that forms p/MHC complexes with ALK-derived peptides for structural and functional studies.<SEP>Human leukocyte antigen A1:01, an allele involved in immune responses to specific peptides.", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2<SEP>chunk-d3a9c93928447522ce3df4209f8ac803", "id": "HLA-A*01:01"}, {"entity_type": "TOOL/SOFTWARE", "description": "A technique used for separating molecules based on size and shape, applied here to purify p/MHC complexes.", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "id": "SEC (SIZE EXCLUSION CHROMATOGRAPHY)"}, {"entity_type": "TOOL/SOFTWARE", "description": "An analytical method combining liquid chromatography with mass spectrometry used to confirm the presence of peptides in MHC samples.", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "id": "LC\u2013MS (LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY)"}, {"entity_type": "PEPTIDE", "description": "The nonamer peptide AQDIYRASY binds to HLA-B*15:01 with a canonical extended conformation.", "source_id": "chunk-830d8819004960d1d149ac70149c72a0", "id": "NONAMER PEPTIDE AQDIYRASY"}, {"entity_type": "PROTEIN", "description": "A decamer peptide derived from ALK that binds to HLA proteins and is recognized by CD8+ T cells.<SEP>The decamer peptide AQDIYRASYY binds to HLA-B*15:01 in a short 310 helical backbone conformation, replacing the C-terminal anchor residue compared to its nonamer counterpart.", "source_id": "chunk-830d8819004960d1d149ac70149c72a0<SEP>chunk-d3a9c93928447522ce3df4209f8ac803", "id": "DECAMER PEPTIDE AQDIYRASYY"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Neoepitopes are peptides derived from tumor cells that can be recognized by T-cells through their interaction with HLA molecules.", "source_id": "chunk-830d8819004960d1d149ac70149c72a0", "id": "NEOEPITOPES"}, {"entity_type": "PROTEIN", "description": "TCRs are proteins on the surface of T-cells that recognize and bind to antigen-MHC complexes, including neoepitopes bound to HLA-B*15:01.", "source_id": "chunk-830d8819004960d1d149ac70149c72a0", "id": "T-CELL RECEPTORS (TCRS)"}, {"entity_type": "PEPTIDE", "description": "This epitope from Epstein\u2013Barr virus binds in an extended conformation within the HLA groove, similar to the nonamer peptide AQDIYRASY.", "source_id": "chunk-830d8819004960d1d149ac70149c72a0", "id": "EPSTEIN\u2013BARR VIRUS EPITOPE LEKARGSTY"}, {"entity_type": "PEPTIDE", "description": "This epitope from human ubiquitin-conjugating enzyme-E2 binds in an extended conformation within the HLA groove, similar to the nonamer peptide AQDIYRASY.", "source_id": "chunk-830d8819004960d1d149ac70149c72a0", "id": "HUMAN UBIQUITIN-CONJUGATING ENZYME-E2 EPITOPE ILGPPGSVY"}, {"entity_type": "PEPTIDE", "description": "This epitope from SARS coronavirus binds in an extended conformation within the HLA groove, similar to the nonamer peptide AQDIYRASY.", "source_id": "chunk-830d8819004960d1d149ac70149c72a0", "id": "SARS CORONAVIRUS EPITOPE VQQESSFVM"}, {"entity_type": "MOLECULAR INTERACTION", "description": "The nonamer peptide binding mode involves a canonical extended conformation within the HLA groove.", "source_id": "chunk-830d8819004960d1d149ac70149c72a0", "id": "NONAMER BINDING MODE"}, {"entity_type": "MOLECULAR INTERACTION", "description": "The decamer peptide binding mode involves a short 310 helical backbone conformation with residues buried deeper in the MHC groove.", "source_id": "chunk-830d8819004960d1d149ac70149c72a0", "id": "DECAMER BINDING MODE"}, {"entity_type": "MOLECULAR INTERACTION", "description": "TCRs recognize neoepitopes presented by HLA-B*15:01, leading to an immune response against tumor cells.", "source_id": "chunk-830d8819004960d1d149ac70149c72a0", "id": "T-CELL RECOGNITION"}, {"entity_type": "PEPTIDE-MHC COMPLEX", "description": "This epitope binds in a canonical extended conformation within the HLA groove similar to other nonamer peptides.", "source_id": "chunk-830d8819004960d1d149ac70149c72a0", "id": "EPSTEIN\u2013BARR VIRUS EPITOPE LEKARGSTY BINDING MODE"}, {"entity_type": "PEPTIDE-MHC COMPLEX", "description": "This epitope also adopts an extended backbone conformation when bound in the MHC groove, similar to other nonamer peptides.", "source_id": "chunk-830d8819004960d1d149ac70149c72a0", "id": "HUMAN UBIQUITIN-CONJUGATING ENZYME-E2 EPITOPE ILGPPGSVY BINDING MODE"}, {"entity_type": "PEPTIDE-MHC COMPLEX", "description": "Similar binding mode as previously mentioned peptides within HLA-B*15:01 groove.", "source_id": "chunk-830d8819004960d1d149ac70149c72a0", "id": "SARS CORONAVIRUS EPITOPE VQQESSFVM BINDING MODE"}, {"entity_type": "MOLECULAR INTERACTION", "description": "The ALK R1275Q neoepitope is a molecular interaction involving the mutated peptide sequence that can be recognized by T cells and forms stable complexes with HLA-B*15:01.", "source_id": "chunk-de413ae6100407d8dadd5bdee87c1074", "id": "ALK R1275Q NEOEPITOPE"}, {"entity_type": "MOLECULAR INTERACTION", "description": "The self-peptide ARDIYRASY represents a molecular interaction within the context of immune tolerance mechanisms where its binding to HLA-B*15:01 is structurally compromised due to steric hindrance.", "source_id": "chunk-de413ae6100407d8dadd5bdee87c1074", "id": "SELF-PEPTIDE ARDIYRASY"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process involving the compaction of peptide tertiary structure, leading to changes in hydrogen bonding and hydrophobic interactions that improve stability with HLA-B*15:01.", "source_id": "chunk-de413ae6100407d8dadd5bdee87c1074", "id": "TERTIARY STRUCTURE COMPACTION"}, {"entity_type": "GENOMIC VARIANT", "description": "HLA alleles play a critical role in determining the outcome of targeted cancer immunotherapies, particularly with regard to peptide/HLA interactions.", "source_id": "chunk-614333487e4b92705503909d34155179", "id": "HLA ALLELES"}, {"entity_type": "PROTEIN", "description": "Neoepitopes derived from ALK (Anaplastic Lymphoma Kinase) are peptides that can be recognized by T cells in cancer immunotherapy, specifically the variant at position 1275.", "source_id": "chunk-614333487e4b92705503909d34155179", "id": "ALK R1275Q NEOEPITOPES"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "T cell receptors (TCRs) play a role in recognizing and binding to neoepitopes presented by HLA molecules, which is crucial for immune response against cancers.", "source_id": "chunk-614333487e4b92705503909d34155179", "id": "TCRS"}, {"entity_type": "MOLECULAR INTERACTION", "description": "The high-resolution X-ray structure of the HLA-B*15:01 allele provides a template for predicting peptide/HLA interactions and understanding surface features of peptides poised for TCR interaction.", "source_id": "chunk-614333487e4b92705503909d34155179", "id": "HLA-B*15:01 STRUCTURE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A method used to predict how peptides bind to HLA molecules, critical in understanding the presentation of neoepitopes and immune response.", "source_id": "chunk-614333487e4b92705503909d34155179", "id": "PEPTIDE DOCKING APPROACH"}, {"entity_type": "MOLECULAR INTERACTION", "description": "X-ray crystallographic structures of nonamers bound to HLA-B*15:01 alleles, which demonstrate consistent peptide backbone conformations essential for docking models.", "source_id": "chunk-614333487e4b92705503909d34155179", "id": "NONAMER/HLA-B*15:01 STRUCTURES"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Peptide conformations that are maintained in the context of HLA molecules when bound to ALK-derived peptides, important for T cell recognition.", "source_id": "chunk-614333487e4b92705503909d34155179", "id": "EXTENDED AND 310 HELICAL CONFORMATIONS"}, {"entity_type": "GENOMIC VARIANT", "description": "Specific alleles within the HLA-B*15 group showing high binding affinities with nonamer and decamer peptides derived from ALK R1275Q neoepitopes.", "source_id": "chunk-614333487e4b92705503909d34155179", "id": "HLA-B*15 ALLELES"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Specific residues in the HLA peptide-binding groove that play a crucial role in binding to and stabilizing peptides, affecting immune response specificity.", "source_id": "chunk-614333487e4b92705503909d34155179", "id": "HLA-A*01:01 BINDING POCKET RESIDUES"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Interactions between specific amino acid residues within the HLA peptide-binding pockets, which are critical for stable binding of peptides and thus immune recognition.", "source_id": "chunk-614333487e4b92705503909d34155179", "id": "POLAR CONTACTS"}, {"entity_type": "GENOMIC VARIANT", "description": "Specific alleles within the HLA-A group that exhibit binding affinities with ALK-derived peptides.", "source_id": "chunk-614333487e4b92705503909d34155179", "id": "HLA-A ALLELES"}, {"entity_type": "GENOMIC VARIANT", "description": "Specific alleles within the HLA-B group that exhibit binding affinities with ALK-derived peptides.", "source_id": "chunk-614333487e4b92705503909d34155179", "id": "HLA-B ALLELES"}, {"entity_type": "GENOMIC VARIANT", "description": "Specific alleles within the HLA-C group that exhibit binding affinities with ALK-derived peptides.", "source_id": "chunk-614333487e4b92705503909d34155179", "id": "HLA-C ALLELES"}, {"entity_type": "PROTEIN", "description": "A peptide of nine amino acids derived from the ALK protein, which interacts with various HLA molecules to be presented on cell surfaces for immune recognition.", "source_id": "chunk-614333487e4b92705503909d34155179", "id": "NONAMER PEPTIDE "}, {"entity_type": "PROTEIN", "description": "A peptide of ten amino acids derived from the ALK protein, also interacting with HLA molecules and contributing to immune response specificity.", "source_id": "chunk-614333487e4b92705503909d34155179", "id": "DECAMER PEPTIDE "}, {"entity_type": "GENOMIC VARIANT", "description": "An allele within the HLA-B group that shows a low binding energy for the decamer peptide.", "source_id": "chunk-614333487e4b92705503909d34155179", "id": "HLA-B*15:84"}, {"entity_type": "GENOMIC VARIANT", "description": "An allele within the HLA-B group that shows a low binding energy for the nonamer peptide.", "source_id": "chunk-614333487e4b92705503909d34155179", "id": "HLA-B*15:107"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A control model used to study peptide binding, characterized by all residues in the MHC-binding groove being mutated to alanine.", "source_id": "chunk-614333487e4b92705503909d34155179", "id": "MOCK POLYALA HLA "}, {"entity_type": "MOLECULAR INTERACTION", "description": "A method for visualizing preferred residue frequencies at specific positions within HLA peptide-binding grooves, aiding in understanding binding specificity.", "source_id": "chunk-614333487e4b92705503909d34155179", "id": "KULLBACK\u2013LEIBLER SEQUENCE LOGO "}, {"entity_type": "GENE", "description": "The ALK gene encodes the anaplastic lymphoma kinase, which can produce neoepitopes recognized by CD8+ T cells.", "source_id": "chunk-d3a9c93928447522ce3df4209f8ac803", "id": "ALK GENE"}, {"entity_type": "PROTEIN", "description": "Another shortened version of an ALK-derived peptide that forms stable complexes with MHC molecules and is also recognized by immune cells.", "source_id": "chunk-d3a9c93928447522ce3df4209f8ac803", "id": "NONAMER PEPTIDE (NOT SPECIFIED)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process of forming peptide-MHC (p/MHC) complexes, which are crucial for the presentation of antigens to T cells.", "source_id": "chunk-d3a9c93928447522ce3df4209f8ac803", "id": "MHC COMPLEX FORMATION "}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The recognition and response by CD8+ T cells to altered-self neoepitopes presented via MHC tetramers in immune assays.", "source_id": "chunk-d3a9c93928447522ce3df4209f8ac803", "id": "CD8+ T CELL RECOGNITION"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Specific molecular interactions between peptides, HLA proteins, \u03b22-microglobulin (\u03b22m), and T cell receptors during antigen presentation and recognition.", "source_id": "chunk-d3a9c93928447522ce3df4209f8ac803", "id": "MOLECULAR INTERACTION "}, {"entity_type": "PROTEIN", "description": "A well-characterized peptide from SARS-CoV that serves as a positive control in tetramer staining experiments for identifying CD8+ T cells reactive to specific epitopes.", "source_id": "chunk-d3a9c93928447522ce3df4209f8ac803", "id": "SARS CORONAVIRUS-DERIVED EPITOPE VQQESSFVM "}, {"entity_type": "PROTEIN", "description": "An integral component of MHC class I molecules involved in peptide binding and presentation on the cell surface.", "source_id": "chunk-d3a9c93928447522ce3df4209f8ac803", "id": "\u03922-MICROGLOBULIN (\u03922M)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A technique used to detect and quantify T cells specific for a given antigen by staining them with labeled MHC tetramers.", "source_id": "chunk-d3a9c93928447522ce3df4209f8ac803", "id": "TETRAMER STAINING ASSAY "}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "An analysis method that allows the simultaneous measurement of multiple parameters on individual cells, often used in conjunction with tetramer staining to identify T cell populations reactive to specific antigens.", "source_id": "chunk-d3a9c93928447522ce3df4209f8ac803", "id": "MULTICHANNEL FLOW CYTOMETRY ANALYSIS "}, {"entity_type": "PROTEIN", "description": "A population of blood cells isolated from whole blood that includes lymphocytes and monocytes, essential for conducting immune assays such as tetramer staining.", "source_id": "chunk-d3a9c93928447522ce3df4209f8ac803", "id": "PERIPHERAL BLOOD MONONUCLEAR CELLS (PBMCS)"}, {"source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "description": "LC-MS confirmed the presence of AQDIYRASYY in HLA-B*15:01 complexes, validating its binding affinity.", "entity_type": "UNKNOWN", "id": "AQDIYRASY (NEOEPITOPE)"}, {"source_id": "chunk-830d8819004960d1d149ac70149c72a0", "description": "The nonamer peptide fits established HLA-B*15:01-binding motifs with preferred anchor residues at positions 2 and 9.", "entity_type": "UNKNOWN", "id": "HLA-B*15:01 BINDING MOTIF"}, {"source_id": "chunk-830d8819004960d1d149ac70149c72a0", "description": "The decamer peptide forms a more compact helical structure compared to the extended backbone of the nonamer peptide, indicating distinct binding modes within HLA-B*15:01.", "entity_type": "UNKNOWN", "id": "NONAMER PEPTIDE AQDIYRASY BINDING MODE"}, {"source_id": "chunk-830d8819004960d1d149ac70149c72a0", "description": "The binding groove accommodates the extended conformation of nonamer peptides, with specific anchor residues deeply embedded in pockets.", "entity_type": "UNKNOWN", "id": "HLA-B*15:01 BINDING GROOVE"}, {"source_id": "chunk-830d8819004960d1d149ac70149c72a0", "description": "The binding groove adapts to accommodate the compact 310 helical conformation of decamer peptides, with a more buried and amphipathic structure.", "entity_type": "UNKNOWN", "id": "DECAMER PEPTIDE AQDIYRASYY BINDING MODE"}, {"source_id": "chunk-614333487e4b92705503909d34155179", "description": "HLA-C alleles also exhibit lower binding energies than initial templates for both nonamer and decamer peptides, contributing to the broader HLA display of ALK-derived neoepitopes.", "entity_type": "UNKNOWN", "id": "NONAMER/DECAMER PEPTIDES "}, {"source_id": "chunk-614333487e4b92705503909d34155179", "description": "The sequence logo reveals key residues that allow peptides to be accommodated in the MHC groove, including those specific for high-affinity binders like HLA-B*15:84 and B*15:107.", "entity_type": "UNKNOWN", "id": "HLA-B*15:84 AND HLA-B*15:107 "}, {"source_id": "chunk-d3a9c93928447522ce3df4209f8ac803", "description": "Formed stable p/MHC complexes with the decamer peptide for structural and functional characterization.", "entity_type": "UNKNOWN", "id": "DECAMER PEPTIDE AQDIYRASYY "}, {"source_id": "chunk-d3a9c93928447522ce3df4209f8ac803", "description": "The formation of p/MHC complexes is essential for the presentation and recognition by CD8+ T cells.", "entity_type": "UNKNOWN", "id": "CD8+ T CELL RECOGNITION "}, {"source_id": "chunk-d3a9c93928447522ce3df4209f8ac803", "description": "Binds to HLA proteins as part of the MHC class I complex for peptide presentation.", "entity_type": "UNKNOWN", "id": "HLA-A*01:01, HLA-B*15:01 "}, {"entity_type": "GENOMIC VARIANT", "description": "A single nucleotide polymorphism (SNP) rs74420772 in 3p14.1 achieved genome-wide significance in the TwinGene study.", "source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a", "id": "RS74420772"}, {"entity_type": "GENOMIC VARIANT", "description": "The leading SNP rs35923643-G in 11q24.1 has an allelic effect size (\u03b2) of 0.19 [95% CI 0.13\u20130.24, P = 4.3 \u00d7 10\u221211] on the rank order normalized standard deviation of IgM anti-PC per allele.", "source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a", "id": "RS35923643-G"}, {"entity_type": "GENE", "description": "The six SNPs in strong linkage disequilibrium within a 131 kb block overlap with the GRAM domain containing 1B (GRAMD1B) gene.", "source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a", "id": "GRAMD1B GENE"}, {"entity_type": "DISEASE", "description": "Chronic lymphocytic leukemia (CLL) is associated with genetic variants such as rs35923643-G.", "source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a", "id": "CLL"}, {"entity_type": "GENOMIC VARIANT", "description": "A proxy SNP for rs35923643-G, which has also been recognized as a risk allele for CLL and is associated with general IgM levels.", "source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a", "id": "RS735665-A"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The levels of IgM anti-PC are influenced by genetic variants such as rs35923643-G and rs735665-A.", "source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a", "id": "IGM ANTI-PC LEVELS"}, {"entity_type": "DIETARY PATTERN", "description": "A method to quantify the cumulative effect of multiple genetic risk factors on disease susceptibility or physiological processes like IgM anti-PC levels.", "source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a", "id": "POLYGENIC RISK SCORE (PRS)"}, {"entity_type": "METABOLIC PATHWAY", "description": "The discovery phase of GWAS focusing on IgM anti-PC levels identified several significant SNPs.", "source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a", "id": "IGM ANTI-PC DISCOVERY GWAS"}, {"entity_type": "GENOMIC VARIANT", "description": "SNPs located in the 1p31.3 region were not replicated in the validation cohort.", "source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a", "id": "1P31.3 SNPS"}, {"entity_type": "GENOMIC VARIANT", "description": "Six SNPs located in the 11q24.1 region achieved genome-wide significance and were successfully validated.", "source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a", "id": "11Q24.1 SNPS"}, {"entity_type": "THERAPY", "description": "A meta-analysis of six GWASs identified the top risk allele for CLL as rs35923643-G or its proxy SNP rs735665-A.", "source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a", "id": "CLL GWAS META-ANALYSIS"}, {"entity_type": "DISEASE", "description": "The latest GWAS on general immunoglobulin levels found that rs735665-A is a main genetic variant specific for general IgM, distinguishing it from other immunoglobulins like IgA and IgG.", "source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a", "id": "GENERAL IGM LEVELS GWAS"}, {"entity_type": "THERAPY", "description": "Polygenic risk score (PRS) analysis was used to investigate the association between IgM anti-PC levels and CLL risk.", "source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a", "id": "PRS ANALYSIS OF IGM ANTI-PC"}, {"entity_type": "DISEASE", "description": "Some SNPs like rs2476601 and rs735665 achieved nominal significance in the GWAS of general IgM, suggesting their potential roles in disease susceptibility.", "source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a", "id": "NOMINAL SIGNIFICANCE IN GWAS"}, {"entity_type": "THERAPY", "description": "The Nagelkerke r^2 statistic was used to measure the variance explained by PRSs on CLL risk.", "source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a", "id": "NAGELKERKE R^2 "}, {"entity_type": "FUNCTIONAL PREDICTION", "description": "These marks were scanned in leukemia- or immune-cell lines to predict regulatory functions of variants at the 11q24.1 locus.", "source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a", "id": "HISTONE MARK H3K4ME1 AND DNASEI HYPERSENSITIVITY"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant located in the LD block at locus 11q24.1 shared between IgM anti-PC and CLL.", "source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b", "id": "RS35923643"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Monomethylated histone H3 lysine 4, a chromatin mark associated with regulatory regions in GM12878 cells.", "source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b", "id": "H3K4ME1"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Peaks of DNaseI hypersensitivity identified at the genomic position of rs35923643 in cell lines, indicating regulatory potential.", "source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b", "id": "DNASEI HYPERSENSITIVITY"}, {"entity_type": "PROTEIN", "description": "Binding sites for 22 different transcription factors were found within ~700bp region around rs35923643 in ENCODE ChIP-seq experiments.", "source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b", "id": "TRANSCRIPTION FACTORS (TFS)"}, {"entity_type": "MOLECULAR INTERACTION", "description": "A binding motif for the RUNX3 transcription factor including SNP rs35923643, with reduced predicted binding affinity due to an allele switch from T/A to C/G.", "source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b", "id": "RUNX3 BINDING MOTIF"}, {"entity_type": "PROTEIN", "description": "Binding motifs identified by FIMO tool, showing strong signals for SPI1 transcription factor in the region around rs35923643.", "source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b", "id": "SPI1 (PU.1)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Phenotypic association between IgM anti-PC levels being lower in prevalent CLL cases compared to matched controls, but not significantly different for incident cases.", "source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b", "id": "IGM ANTI-PC AND CLL ASSOCIATION"}, {"entity_type": "GENOMIC VARIANT", "description": "A linkage disequilibrium block located at chromosome 11 position q24.1 shared between IgM anti-PC levels and Chronic Lymphocytic Leukemia (CLL).", "source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b", "id": "LD BLOCK AT 11Q24.1"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A technique used to identify the genomic binding sites of DNA-associated proteins, such as transcription factors.", "source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b", "id": "CHROMATIN IMMUNOPRECIPITATION-SEQUENCING (CHIP-SEQ)"}, {"entity_type": "METABOLIC PATHWAY", "description": "A comprehensive catalog of functional elements encoded in the human genome that includes data from ChIP-seq experiments on regulatory regions and TF binding sites.", "source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b", "id": "ENCYCLOPEDIA OF DNA ELEMENTS (ENCODE)"}, {"entity_type": "MOLECULAR INTERACTION", "description": "A tool used to find occurrences of motifs from a JASPAR or Transfac matrix database within a set of sequences, in this case identifying the strongest signals for RUNX3 and SPI1 binding.", "source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b", "id": "FIND INDIVIDUAL MOTIF OCCURRENCES (FIMO)"}, {"entity_type": "METABOLIC PATHWAY", "description": "A database that provides an integrated model predicting transcription factor binding motifs across various genomic regions, providing evidence for rs35923643 affecting TF binding.", "source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b", "id": "REGULOMEDB DATABASE"}, {"source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a", "description": "The rs735665-A SNP is a key genetic variant specific for general IgM, as identified in GWAS analyses.", "entity_type": "UNKNOWN", "id": "GENERAL IGM LEVELS"}, {"source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a", "description": "SNPs in the 1p31.3 region were not replicated, indicating a lack of consistent association across different cohorts.", "entity_type": "UNKNOWN", "id": "VALIDATION COHORT"}, {"source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a", "description": "Negligible population stratification ensures accurate interpretation of GWAS results for genetic variants like rs35923643-G and rs735665-A.", "entity_type": "UNKNOWN", "id": "GWAS RESULTS INTERPRETATION"}, {"source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a", "description": "The meta-analysis of CLL GWASs identified the risk allele rs735665-A, contributing to understanding genetic predisposition to CLL.", "entity_type": "UNKNOWN", "id": "RS735665-A RISK ALLELE"}, {"source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a", "description": "The GWAS results indicate that rs735665-A is specific for general IgM levels, distinguishing it from other immunoglobulin types.", "entity_type": "UNKNOWN", "id": "RS735665-A SPECIFICITY FOR GENERAL IGM"}, {"source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a", "description": "PRS analysis based on IgM anti-PC increasing alleles predicts higher risk of CLL, linking physiological processes to disease susceptibility.", "entity_type": "UNKNOWN", "id": "CLL RISK PREDICTION"}, {"source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a", "description": "The Nagelkerke r^2 statistic measures how well PRSs explain variance in CLL risk, indicating the cumulative impact of genetic variants.", "entity_type": "UNKNOWN", "id": "VARIANCE EXPLAINED BY PRSS"}, {"source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a", "description": "These marks predict potential regulatory functions of genetic variants within the 11q24.1 locus, aiding in understanding their roles in physiological processes.", "entity_type": "UNKNOWN", "id": "REGULATORY FUNCTION PREDICTION"}], "links": [{"weight": 20.0, "description": "An imbalance in the gut microbiota is associated with an increased risk of developing metabolic syndrome, indicating a link between microbiome composition and systemic diseases.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "order": 1, "source": "METABOLIC SYNDROME", "target": "MICROBIOTA DYSBIOSIS"}, {"weight": 3.0, "description": "Women have higher serum total cholesterol and LDL levels than men in this study.)", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "order": 1, "source": "SERUM TOTAL CHOLESTEROL", "target": "GENDER DIFFERENCES"}, {"weight": 4.0, "description": "Females exhibit higher LDL concentrations compared to males, contributing to gender-specific cardiovascular risk profiles.)", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "order": 1, "source": "LDL CONCENTRATIONS", "target": "GENDER DIFFERENCES"}, {"weight": 3.0, "description": "Men have higher serum triglyceride levels than women in this study, reflecting sex-based differences in lipid metabolism.)", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "order": 1, "source": "SERUM TRIGLYCERIDE CONCENTRATIONS", "target": "GENDER DIFFERENCES"}, {"weight": 4.0, "description": "Women show higher HDL concentrations compared to men, indicating gender-specific variations in cholesterol transport and cardiovascular risk.)", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "order": 1, "source": "HDL CONCENTRATIONS", "target": "GENDER DIFFERENCES"}, {"weight": 5.0, "description": "Higher blood pressure is observed in obese groups across both genders, suggesting a strong link between obesity and hypertension risk.)", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "order": 1, "source": "BLOOD PRESSURE", "target": "OBESITY RISK"}, {"weight": 3.0, "description": "Estimated glomerular filtration rate is lower in the obese group than nonobese participants, indicating potential kidney function issues associated with obesity.)", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "order": 1, "source": "EGFR", "target": "OBESITY STATUS"}, {"weight": 4.0, "description": "Increased daily energy intake is associated with a higher risk of obesity in both men and women.)", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "order": 1, "source": "DAILY ENERGY INTAKE", "target": "OBESITY RISK"}, {"weight": 3.0, "description": "Higher protein intake correlates with elevated obesity risk, particularly in women.)", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "order": 1, "source": "PROTEIN INTAKE", "target": "OBESITY RISK"}, {"weight": 10.0, "description": "The rs2943641 variant in the IRS1 gene shows interaction with carbohydrate intake on T2D risk, though lacking validation.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "order": 1, "source": "CARBOHYDRATE INTAKE", "target": "IRS1 GENE (RS2943641)"}, {"weight": 5.0, "description": "The rs545389 variant in GLUT2 shows interaction with carbohydrate intake on T2D risk.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "order": 1, "source": "CARBOHYDRATE INTAKE", "target": "GLUT2 GENE (RS545389)"}, {"weight": 4.0, "description": "Intake of fats like saturated fatty acids shows sex-specific associations, being higher among men and contrasting patterns among women.)", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "order": 1, "source": "FAT INTAKE", "target": "SEX DIFFERENCES"}, {"weight": 5.0, "description": "Higher intake of fried foods is associated with increased obesity risk in both genders.)", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "order": 1, "source": "FRIED-FOOD INTAKE", "target": "OBESITY RISK"}, {"weight": 2.5, "description": "Higher fried-food intake is associated with higher BMI and offsets the impact of PRS on obesity risk.", "source_id": "chunk-3ad8ef794841d749e48b3223741e91d3", "order": 1, "source": "FRIED-FOOD INTAKE", "target": "BMI"}, {"weight": 3.0, "description": "Women exhibit higher consumption of sugar-containing foods compared to men, affecting dietary patterns and health outcomes differently between sexes.)", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "order": 1, "source": "SUGAR-CONTAINING FOODS INTAKE", "target": "GENDER DIFFERENCES"}, {"weight": 4.0, "description": "Men\'s diets are more likely to include a Korean balanced diet and Western-style meals, contributing to higher obesity risk compared to plant-based or rice-based diets.)", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "order": 1, "source": "KOREAN BALANCED DIET AND WESTERN-STYLE DIET INTAKE", "target": "OBESITY STATUS"}, {"weight": 3.0, "description": "Women show distinct dietary patterns with lower intake of plant-based foods and higher consumption of Korean balanced diet compared to men.)", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "order": 1, "source": "PLANT-BASED DIET AND RICE-BASED DIET INTAKE", "target": "GENDER DIFFERENCES"}, {"weight": 4.0, "description": "Higher alcohol consumption is linked to increased obesity risk, more pronounced in men.)", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "order": 1, "source": "ALCOHOL INTAKE", "target": "OBESITY RISK"}, {"weight": 7.0, "description": "Moderate to high alcohol intake increasing T2D risk among individuals with high genetic predisposition.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "order": 1, "source": "ALCOHOL INTAKE", "target": "GENETIC RISK SCORE (T2D-GRES)"}, {"weight": 3.0, "description": "Men exhibit a higher rate of current smoking than women, which may influence obesity and other health risks differently between sexes.)", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "order": 1, "source": "CURRENT SMOKERS", "target": "GENDER DIFFERENCES"}, {"weight": 4.0, "description": "Women who engage in regular exercise show lower incidence of obesity compared to men where no significant association is observed.)", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "order": 1, "source": "REGULAR EXERCISE", "target": "OBESITY STATUS"}, {"weight": 3.0, "description": "A DNAJC27 genetic variant contributes to the risk of obesity through modulation of transcription factors influencing metabolic processes.", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "order": 1, "source": "DNAJC27 (RS713586)", "target": "OBESITY RISK"}, {"weight": 2.0, "description": "The CDKAL1 genomic variant affects energy regulation by modulating transcriptional mechanisms involved in metabolic pathways.", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "order": 1, "source": "CDKAL1 (RS9356744)", "target": "ENERGY REGULATION"}, {"weight": 3.0, "description": "Genetic variation in TFAP2B impacts the function of Transcription factor AP-2 Beta, influencing energy intake and obesity risk.", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "order": 1, "source": "TFAP2B (RS2206277)", "target": "TRANSCRIPTION FACTOR AP-2 BETA"}, {"weight": 4.0, "description": "A BDNF genetic variant influences metabolic processes through modulation of transcriptional regulatory networks related to energy balance.", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "order": 1, "source": "BDNF (RS6265)", "target": "METABOLIC PROCESSES"}, {"weight": 3.0, "description": "Genetic variation in MYL2 impacts muscle function and contributes to obesity risk through effects on energy expenditure.", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "order": 1, "source": "MYL2 (RS3782889)", "target": "MUSCLE FUNCTION"}, {"weight": 2.0, "description": "The OLFM4 gene influences energy regulation by genetic variants, contributing to the risk of obesity.", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "order": 1, "source": "OLFM4 (RS9568856)", "target": "ENERGY REGULATION"}, {"weight": 3.0, "description": "A FTO genetic variant modulates transcription factors related to energy regulation, affecting the risk of obesity.", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "order": 1, "source": "FTO (RS1421085)", "target": "TRANSCRIPTION FACTORS"}, {"weight": 4.0, "description": "The MC4R gene affects metabolic pathways and is a hub gene influencing obesity risk through genetic variation.", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "order": 1, "source": "MC4R (RS6567160)", "target": "METABOLIC PATHWAY"}, {"weight": 2.0, "description": "Genetic variation in GIPR impacts energy balance by modulating the effects of gastric inhibitory polypeptide.", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "order": 1, "source": "GIPR (RS1444988703)", "target": "ENERGY BALANCE"}, {"weight": 2.0, "description": "The presence of one or two A-alleles in the FTO SNP is associated with higher BMI in individuals without university education but not in those with a university degree.)", "source_id": "chunk-3135befd0c3140ad097d96ace6de86a1", "order": 1, "source": "BMI (BODY MASS INDEX)", "target": "FTO RS9939609 POLYMORPHISM"}, {"weight": 2.0, "description": "Higher adherence to the Mediterranean diet is associated with lower BMI values.", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "order": 1, "source": "BMI (BODY MASS INDEX)", "target": "MEDITERRANEAN DIET (MD)"}, {"weight": 5.0, "description": "Genetic variation within FADS1/2 was associated with a lower BMI, suggesting genetic effects on body composition factors independent of dietary patterns.", "source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "order": 1, "source": "BMI (BODY MASS INDEX)", "target": "FADS1/2 HAPLOTYPE"}, {"weight": 1.0, "description": "GWAS stratified by sex revealed that adjusting for BMI slightly reduces SNP heritability of snoring in both males and females.", "source_id": "chunk-a34b927ed42ff0917960122b4d203f83", "order": 1, "source": "BMI (BODY MASS INDEX)", "target": "SEX STRATIFIED GWAS"}, {"weight": 3.0, "description": "Higher BMI levels in colorectal cancer patients suggest that obesity may be a risk factor for this type of cancer.", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "order": 1, "source": "BMI (BODY MASS INDEX)", "target": "COLORECTAL CANCER"}, {"weight": 5.0, "description": "The analysis included examination of the relationship between Body Mass Index and CHI3L1 genomic variants in relation to type 2 diabetes risk.", "source_id": "chunk-44a871da300abc9be525b468f502f5cb", "order": 1, "source": "BMI (BODY MASS INDEX)", "target": "CHI3LI TG SNPS"}, {"weight": 4.0, "description": "Genetic variations such as the rs671 polymorphism can influence BMI through their impact on metabolic processes and physiological responses to environmental factors.", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "order": 1, "source": "BMI (BODY MASS INDEX)", "target": "ALDH2 RS671 GENOTYPE"}, {"weight": 3.0, "description": "Increased BMI is positively correlated with higher serum C4, suggesting a relationship between body fat and cholesterol metabolism.", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "order": 1, "source": "BMI (BODY MASS INDEX)", "target": "SERUM C4"}, {"weight": 1.0, "description": "There was no significant association between fasting serum FGF19 and subgroup classifications suggesting no direct link in the context of IBS subtypes.", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "order": 1, "source": "BMI (BODY MASS INDEX)", "target": "FGF19"}, {"weight": 5.0, "description": "The BMI in IBS-D was approximately 4 higher than in other subgroups like IBS-C, indicating a relationship between body mass index and the disease.", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "order": 1, "source": "BMI (BODY MASS INDEX)", "target": "IBS-D (IRRITABLE BOWEL SYNDROME WITH DIARRHEA)"}, {"weight": 2.5, "description": "Individuals with early menarche age show a higher impact of PRS on BMI compared to those with late menarche age.", "source_id": "chunk-3ad8ef794841d749e48b3223741e91d3", "order": 1, "source": "PRS", "target": "EARLY MENARCHE AGE"}, {"weight": 2.0, "description": "Different dietary patterns have varying impacts on BMI, especially in combination with genetic factors (PRS).", "source_id": "chunk-3ad8ef794841d749e48b3223741e91d3", "order": 1, "source": "BMI", "target": "DIETARY PATTERNS"}, {"weight": 3.0, "description": "The Body Mass Index (BMI) was assessed in relation to the genetic effects from the TCF7L2 gene without finding a significant interaction effect.", "source_id": "chunk-6a7c69534e11aa2fc4bd948484aa81c4", "order": 1, "source": "BMI", "target": "TCF7L2 GENE"}, {"weight": 4.0, "description": "Impaired Fasting Glucose and Impaired Glucose Tolerance (IFG/IGT) status at baseline is positively associated with BMI levels but negatively correlated with changes in BMI during follow-up periods.", "source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "order": 1, "source": "BMI", "target": "IFG/IGT"}, {"weight": 16.0, "description": "Additional copies of the minor (G) allele in SNP rs4771122 were associated with larger percentage weight loss after adjustment for pre-surgical BMI, indicating a genetic influence on weight loss trajectories.)", "source_id": "chunk-b3d775642c43fa3524a531a3f6ec1e41", "order": 1, "source": "BMI", "target": "RS4771122"}, {"weight": 3.0, "description": "Body Mass Index positively correlates with habitual snoring prevalence in both sexes.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "order": 1, "source": "BMI", "target": "SNORING"}, {"weight": 1.0, "description": "None of the CHI3L1 tgSNPs showed any associations with BMI or other T2D-related quantitative traits such as HbA1c, fasting glucose, and 2-hour post-load glucose levels.)", "source_id": "chunk-44a871da300abc9be525b468f502f5cb", "order": 1, "source": "BMI", "target": "T2D"}, {"weight": 7.0, "description": "Body mass index (BMI) is associated with higher serum uric acid (sUA) levels in both males and females carrying T alleles of the ABCG2 rs2231142 variant.", "source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00", "order": 1, "source": "BMI", "target": "SUA LEVELS"}, {"weight": 3.0, "description": "High plant-based diet intake can mitigate the obesity risk in individuals with high PRS.", "source_id": "chunk-3ad8ef794841d749e48b3223741e91d3", "order": 1, "source": "PLANT-BASED DIET INTAKE", "target": "OBESITY RISK"}, {"weight": 5.0, "description": "Higher liver enzymes (ALT and AST) are observed in obese groups compared to nonobese individuals across genders, highlighting the impact of obesity on liver health.)", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "order": 1, "source": "OBESITY RISK", "target": "SERUM ALT AND AST CONCENTRATIONS"}, {"weight": 1.5, "description": "Various nutrient intakes can influence the relationship between PRS and obesity risk.", "source_id": "chunk-3ad8ef794841d749e48b3223741e91d3", "order": 1, "source": "OBESITY RISK", "target": "NUTRIENT INTAKE"}, {"weight": 3.0, "description": "Higher education level is associated with a lower risk of obesity, indicating that lifestyle factors including education can influence genetic susceptibility to diseases like obesity.)", "source_id": "chunk-3135befd0c3140ad097d96ace6de86a1", "order": 1, "source": "OBESITY RISK", "target": "EDUCATION LEVEL"}, {"weight": 3.0, "description": "Age acts as an environmental factor influencing obesity risk; different age groups exhibit varying levels of genetic susceptibility to diseases like obesity due to polymorphisms in the FTO gene.", "source_id": "chunk-3135befd0c3140ad097d96ace6de86a1", "order": 1, "source": "OBESITY RISK", "target": "AGE"}, {"weight": 4.0, "description": "The FTO SNP is associated with increased risk of obesity, especially in individuals without university education.<SEP>The presence of the FTO SNP is associated with increased obesity risk.", "source_id": "chunk-63d0b5be485a69f44e2799ccc9510487", "order": 1, "source": "OBESITY RISK", "target": "FTO SNP"}, {"weight": 3.0, "description": "Men have a higher DII score compared to women, indicating a more inflammatory diet for males.)", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "order": 1, "source": "GENDER DIFFERENCES", "target": "DII"}, {"weight": 4.0, "description": "Proteins involved in antibiotic resistance interact with metabolic pathways to maintain bacterial survival.)", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "order": 1, "source": "METABOLIC PATHWAY", "target": "PROTEIN"}, {"weight": 3.0, "description": "The high-protein diet interacts with the risk allele (A) of the FTO rs1558902 to result in greater weight loss compared to those on a low-protein diet.", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "order": 1, "source": "FTO RS1558902", "target": "HIGH-PROTEIN DIET"}, {"weight": 4.0, "description": "The presence of the risk allele (A) in FTO rs1558902 is associated with greater weight loss when participants follow a high-protein diet.", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "order": 1, "source": "FTO RS1558902", "target": "WEIGHT LOSS"}, {"weight": 5.0, "description": "Participants on a high-protein diet, particularly those carrying the risk allele (A), experienced more significant changes in lean muscle mass compared to non-carriers.", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "order": 1, "source": "HIGH-PROTEIN DIET", "target": "LEAN MASS CHANGES"}, {"weight": 4.0, "description": "When individuals follow a high-protein diet and carry the risk allele (A) of FTO rs1558902, they experience more significant reductions in total body fat.", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "order": 1, "source": "HIGH-PROTEIN DIET", "target": "TOTAL FAT LOSS"}, {"weight": 3.0, "description": "Individuals with the AA genotype showed greater decreases in fat distribution when following a high-protein diet compared to those without this genotype, indicating an interaction between genotype and dietary pattern.)", "source_id": "chunk-a321a6d63755366a1fc3eafbd9fbce83", "order": 1, "source": "HIGH-PROTEIN DIET", "target": "AA GENOTYPE"}, {"weight": 4.0, "description": "Participants with the AA genotype experienced less loss in TAT and SAT when on a low-protein diet compared to other genotypes, showing differential effects of protein intake on fat distribution based on genetic variation.)", "source_id": "chunk-a321a6d63755366a1fc3eafbd9fbce83", "order": 1, "source": "LOW-PROTEIN DIET", "target": "FAT DISTRIBUTION"}, {"weight": 3.0, "description": "A low-protein diet is prescribed as a therapeutic intervention for patients who have genetic defects in the GLUD1 gene leading to hyperinsulinism and hypoglycemia.", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "order": 1, "source": "LOW-PROTEIN DIET", "target": "GLUD1"}, {"weight": 9.0, "description": "Weight loss is a physiological process significantly influenced by bariatric surgery procedures which induce metabolic and structural changes in the digestive system.)", "source_id": "chunk-b3d775642c43fa3524a531a3f6ec1e41", "order": 1, "source": "WEIGHT LOSS", "target": "BARIATRIC SURGERY"}, {"weight": 4.0, "description": "Individuals carrying the risk allele of the FTO rs1558902 show greater loss in total fat when following a high-protein diet compared to those on low-protein diets.", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "order": 1, "source": "TOTAL FAT LOSS", "target": "FTO RS1558902 GENOTYPE"}, {"weight": 3.0, "description": "The genotype of FTO rs1558902 influences changes in lean muscle mass, especially when combined with high-protein dietary interventions.", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "order": 1, "source": "LEAN MASS CHANGES", "target": "FTO RS1558902 GENOTYPE"}, {"weight": 3.0, "description": "The genetic variant affects the change in waist circumference, particularly in response to dietary protein intake.", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "order": 1, "source": "FTO RS1558902 GENOTYPE", "target": "WAIST CIRCUMFERENCE CHANGES"}, {"weight": 1.0, "description": "Individuals adhering more closely to the MD tend to have smaller waist circumferences.", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "order": 1, "source": "WC (WAIST CIRCUMFERENCE)", "target": "MEDITERRADIAN DIET (MD)"}, {"weight": 1.0, "description": "There is an interaction between the AA genotype and dietary patterns (low-fat diets), influencing changes in total body fat over time.)", "source_id": "chunk-a321a6d63755366a1fc3eafbd9fbce83", "order": 1, "source": "AA GENOTYPE", "target": "TOTAL FAT"}, {"weight": 2.0, "description": "Participants with the AA genotype showed differential responses to low-fat diet interventions, specifically affecting their fat mass percentage compared to other genotypes.)", "source_id": "chunk-a321a6d63755366a1fc3eafbd9fbce83", "order": 1, "source": "LOW-FAT DIET", "target": "FM%"}, {"weight": 1.0, "description": "Changes in trunk fat distribution were observed in individuals with the AA genotype in response to low-fat dietary patterns.)", "source_id": "chunk-a321a6d63755366a1fc3eafbd9fbce83", "order": 1, "source": "LOW-FAT DIET", "target": "TRUNK FAT DISTRIBUTION"}, {"weight": 4.0, "description": "The A-allele carriers of FTO SNP have an increased risk of obesity, especially among subjects lacking higher educational attainment.)", "source_id": "chunk-3135befd0c3140ad097d96ace6de86a1", "order": 1, "source": "FTO RS9939609 POLYMORPHISM", "target": "OBESITY"}, {"weight": 5.0, "description": "The FTO gene harbors a polymorphism (rs9939609) that influences anthropometric variables such as weight, BMI and waist circumference.", "source_id": "chunk-3135befd0c3140ad097d96ace6de86a1", "order": 1, "source": "FTO RS9939609 POLYMORPHISM", "target": "FTO GENE"}, {"weight": 4.0, "description": "The presence of one or two A-alleles in the FTO SNP is associated with increased values for anthropometric variables like weight, BMI and waist circumference.", "source_id": "chunk-3135befd0c3140ad097d96ace6de86a1", "order": 1, "source": "FTO RS9939609 POLYMORPHISM", "target": "ANTHROPOMETRIC VARIABLES"}, {"weight": 2.0, "description": "Statistical adjustments for sex differences reveal that the impact of the FTO SNP on anthropometric variables is consistent across different genders.", "source_id": "chunk-3135befd0c3140ad097d96ace6de86a1", "order": 1, "source": "FTO RS9939609 POLYMORPHISM", "target": "SEX"}, {"weight": 2.0, "description": "Adjustments for smoking status in statistical models help isolate the independent effect of the FTO SNP on BMI and obesity risk, showing its significant influence even after controlling for environmental factors like smoking.", "source_id": "chunk-3135befd0c3140ad097d96ace6de86a1", "order": 1, "source": "FTO RS9939609 POLYMORPHISM", "target": "SMOKING STATUS"}, {"weight": 1.0, "description": "Adjustments for diabetes status in models reveal that the FTO SNP influences obesity risk independently of pre-existing conditions, highlighting its role in genetic predisposition to obesity.", "source_id": "chunk-3135befd0c3140ad097d96ace6de86a1", "order": 1, "source": "FTO RS9939609 POLYMORPHISM", "target": "DIABETES"}, {"weight": 2.0, "description": "Statistical interaction between PA levels and the FTO SNP indicates that physical activity modifies the effect of the polymorphism on BMI and obesity risk, showing lifestyle factors\' importance.", "source_id": "chunk-3135befd0c3140ad097d96ace6de86a1", "order": 1, "source": "FTO RS9939609 POLYMORPHISM", "target": "PHYSICAL ACTIVITY (PA)"}, {"weight": 4.0, "description": "Individuals with primary studies education level exhibit a significant interaction between educational attainment and FTO SNP in determining higher BMI compared to university-level educated individuals.", "source_id": "chunk-3135befd0c3140ad097d96ace6de86a1", "order": 1, "source": "FTO RS9939609 POLYMORPHISM", "target": "PRIMARY STUDIES EDUCATION LEVEL"}, {"weight": 4.0, "description": "Similarly, secondary studies education level shows a significant association with the impact of FTO SNP on obesity risk in contrast to higher educational attainment levels.", "source_id": "chunk-3135befd0c3140ad097d96ace6de86a1", "order": 1, "source": "FTO RS9939609 POLYMORPHISM", "target": "SECONDARY STUDIES EDUCATION LEVEL"}, {"weight": 4.0, "description": "Individuals with university-level education exhibit lessened or reversed effects of the FTO SNP on obesity risk, indicating that lifestyle factors like education can mitigate genetic predisposition to obesity.", "source_id": "chunk-3135befd0c3140ad097d96ace6de86a1", "order": 1, "source": "FTO RS9939609 POLYMORPHISM", "target": "UNIVERSITY-LEVEL EDUCATION"}, {"weight": 10.0, "description": "Variants in the APOBR gene are associated with an increased risk of obesity, particularly in children and adolescents.", "source_id": "chunk-7ca64f92964b051cfb1c43f967f243a5", "order": 1, "source": "OBESITY", "target": "APOBR"}, {"weight": 3.0, "description": "Effects of the FTO gene on cardiometabolic phenotypes diminish significantly after adjustment for BMI, indicating mediation through this physiological process.)", "source_id": "chunk-372184452f1f9156514992455057f843", "order": 1, "source": "FTO GENE", "target": "BMI PHYSIOLOGICAL PROCESS"}, {"weight": 2.0, "description": "The FTO gene is associated with cardiometabolic traits and diseases through its influence on snoring predisposition.)", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "order": 1, "source": "FTO GENE", "target": "CARDIOMETABOLIC TRAITS AND DISEASES (DISEASE)"}, {"weight": 5.0, "description": "No significant interaction was observed between the degree of age and the genetic effects from the TCF7L2 gene.", "source_id": "chunk-6a7c69534e11aa2fc4bd948484aa81c4", "order": 1, "source": "AGE", "target": "TCF7L2 GENE"}, {"weight": 0.0, "description": "The mean age of both cases and controls was almost identical, indicating no significant difference in age-related risks for IA.", "source_id": "chunk-055177812e320344d131432b292111b0", "order": 1, "source": "AGE", "target": "IA (INTRACRANIAL ANEURYSM)"}, {"weight": 1.0, "description": "The prevalence of habitual snoring increases slightly with age.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "order": 1, "source": "AGE", "target": "SNORING"}, {"weight": 16.0, "description": "The composition of the gut microbiota changes with age, impacting its role in health and disease.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "order": 1, "source": "AGE", "target": "GUT MICROBIOTA DYNAMICS"}, {"weight": 4.0, "description": "Age is a significant factor that correlates with and influences the rate of HIV disease progression.", "source_id": "chunk-2c91cdebb36ef064eb01a7021a961302", "order": 1, "source": "AGE", "target": "HIV DISEASE PROGRESSION"}, {"weight": 4.0, "description": "Testing for sex as an environmental factor did not reveal a significant influence on the genetic risk associated with the TCF7L2 gene.", "source_id": "chunk-6a7c69534e11aa2fc4bd948484aa81c4", "order": 1, "source": "SEX", "target": "TCF7L2 GENE"}, {"weight": -1.0, "description": "No significant association was found between sex and IA risk based on the study conducted.", "source_id": "chunk-055177812e320344d131432b292111b0", "order": 1, "source": "SEX", "target": "IA (INTRACRANIAL ANEURYSM)"}, {"weight": 2.0, "description": "Being male significantly increases the risk of being a habitual snorer due to physiological reasons.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "order": 1, "source": "SEX", "target": "SNORING"}, {"weight": 3.0, "description": "The impact of sex on disease progression in HIV patients is under investigation to determine its role as an independent risk factor.", "source_id": "chunk-2c91cdebb36ef064eb01a7021a961302", "order": 1, "source": "SEX", "target": "HIV DISEASE PROGRESSION"}, {"weight": 1.0, "description": "The smoking status (smoker vs. non-smoker) was analyzed for its role in gene-diet interactions affecting health outcomes.)", "source_id": "chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6", "order": 1, "source": "SMOKING STATUS", "target": "GENE-DIET INTERACTION"}, {"weight": 1.0, "description": "Smoking status may modify the effect of Gene X on health outcomes through gene-diet interactions.)", "source_id": "chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6", "order": 1, "source": "SMOKING STATUS", "target": "GENE X"}, {"weight": 3.0, "description": "Smoking status is a physiological process that can increase the risk of developing hypertension, influencing overall cardiovascular health.", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "order": 1, "source": "SMOKING STATUS", "target": "HYPERTENSION"}, {"weight": 5.0, "description": "HCR data can influence the assessment of PA\'s impact on health outcomes, including obesity risk.", "source_id": "chunk-63d0b5be485a69f44e2799ccc9510487", "order": 1, "source": "PHYSICAL ACTIVITY (PA)", "target": "HEALTH CARE RECORDS (HCR)"}, {"weight": 1.5, "description": "Both fiber intake and physical activity are lifestyle factors that interact with specific genetic variants to influence type 2 diabetes risk.", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "order": 1, "source": "PHYSICAL ACTIVITY (PA)", "target": "FIBER INTAKE"}, {"weight": 1.0, "description": "Physical activity and dietary patterns are lifestyle factors that often interact to influence health outcomes such as type 2 diabetes risk.", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "order": 1, "source": "PHYSICAL ACTIVITY (PA)", "target": "DIETARY PATTERN"}, {"weight": 7.0, "description": "The protective effect of physical activity against T2D is weaker in individuals with high genetic risk score.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "order": 1, "source": "PHYSICAL ACTIVITY (PA)", "target": "T2D-GRS"}, {"weight": 7.0, "description": "The protective effect of physical activity against T2D is lessened in individuals carrying this genetic variant.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "order": 1, "source": "PHYSICAL ACTIVITY (PA)", "target": "IGF2BP2 VARIANT RS11075984"}, {"weight": 3.0, "description": "There is a significant interaction between educational level and the FTO SNP in determining obesity risk.", "source_id": "chunk-63d0b5be485a69f44e2799ccc9510487", "order": 1, "source": "FTO SNP", "target": "EDUCATION"}, {"weight": 3.0, "description": "Individuals with university studies show no significant association between the FTO SNP and obesity, indicating a modifying effect.", "source_id": "chunk-63d0b5be485a69f44e2799ccc9510487", "order": 1, "source": "FTO SNP", "target": "UNIVERSITY STUDIES"}, {"weight": 4.0, "description": "The GP interacts with OHP to determine obesity risk in populations.", "source_id": "chunk-63d0b5be485a69f44e2799ccc9510487", "order": 1, "source": "GENETIC POLYMORPHISM (GP)", "target": "OBESITY RISK ASSESSMENT (OHP)"}, {"weight": 5.0, "description": "The TCF7L2 gene is significantly associated with the development of Type 2 Diabetes, which can progress to End Stage Renal Disease.", "source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "order": 1, "source": "TCF7L2 GENE", "target": "TYPE 2 DIABETES AND END STAGE RENAL DISEASE (T2D-ESRD)"}, {"weight": 2.0, "description": "No significant interaction between the degree of African ancestry and the genetic risk associated with the TCF7L2 gene was observed.", "source_id": "chunk-6a7c69534e11aa2fc4bd948484aa81c4", "order": 1, "source": "TCF7L2 GENE", "target": "AFRICAN ANCESTRY DEGREE"}, {"weight": 2.5, "description": "The consumption of whole grains interacts with genetic variants associated with the development of type 2 diabetes.", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "order": 1, "source": "GENETIC VARIANT (G \u00d7 D)", "target": "WHOLE GRAINS"}, {"weight": 10.0, "description": "The rs7903146 variant in the TCF7L2 gene shows interaction with dietary fiber intake, modifying its association with Type 2 Diabetes risk.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "order": 1, "source": "FIBER INTAKE", "target": "TCF7L2 GENE (RS7903146)"}, {"weight": 8.0, "description": "The rs10923931 variant in the NOTCH2 gene shows interaction with dietary fiber intake, impacting T2D risk.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "order": 1, "source": "FIBER INTAKE", "target": "NOTCH2 GENE (RS10923931)"}, {"weight": 8.0, "description": "The rs4457053 variant in ZBED3 gene interacts with dietary fiber intake on T2D risk, though replication was not observed.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "order": 1, "source": "FIBER INTAKE", "target": "ZBED3 GENE (RS4457053)"}, {"weight": 3.5, "description": "High glycemic load, in conjunction with specific genetic variants, increases the risk of developing type 2 diabetes.", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "order": 1, "source": "TYPE 2 DIABETES (T2D)", "target": "GLYCEMIC LOAD (GL)"}, {"weight": 5.0, "description": "Elevated FPG levels are indicative of pre-diabetic conditions like IFG and are predictive markers for the development of T2D in follow-up studies.", "source_id": "chunk-f2e122f964bade37f487049bd69a3f9f", "order": 1, "source": "TYPE 2 DIABETES (T2D)", "target": "FASTING PLASMA GLUCOSE (FPG)"}, {"weight": 5.0, "description": "The presence of high KB levels is a risk factor for T2D development, especially after adjustment for confounders like age and BMI.", "source_id": "chunk-f2e122f964bade37f487049bd69a3f9f", "order": 1, "source": "TYPE 2 DIABETES (T2D)", "target": "KETONE BODIES (KBS)"}, {"weight": 4.0, "description": "Lower IS measured by Matsuda ISI correlates with higher levels of KBs, increasing the risk of converting to T2D after a five-year follow-up.", "source_id": "chunk-f2e122f964bade37f487049bd69a3f9f", "order": 1, "source": "TYPE 2 DIABETES (T2D)", "target": "INSULIN SENSITIVITY (IS)"}, {"weight": 4.0, "description": "These genetic variations are linked to an increased risk of developing T2D and correlate with elevated levels of AcAc and BHB, contributing to the metabolic phenotype.", "source_id": "chunk-f2e122f964bade37f487049bd69a3f9f", "order": 1, "source": "TYPE 2 DIABETES (T2D)", "target": "RISK SNPS FOR TYPE 2 DIABETES OR HYPERGLYCEMIA"}, {"weight": 5.0, "description": "Higher AUC values measured over time predict an increased risk of developing T2D, especially when combined with elevated AcAc and BHB levels.", "source_id": "chunk-f2e122f964bade37f487049bd69a3f9f", "order": 1, "source": "TYPE 2 DIABETES (T2D)", "target": "GLUCOSE AREA UNDER THE CURVE (AUC)"}, {"weight": 1.5, "description": "Both NHS and HPFS are cohort studies that investigate the interaction of dietary patterns with genetic factors affecting health outcomes.", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "order": 1, "source": "NURSES\' HEALTH STUDY (NHS)", "target": "HEALTH PROFESSIONALS FOLLOW-UP STUDY (HPFS)"}, {"weight": 1.5, "description": "These cohort studies, MDCS and EPIC-Interact, explore the interaction of environmental factors with genetic predispositions in relation to disease risk.", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "order": 1, "source": "MALM\u00d6 DIET AND CANCER STUDY (MDCS)", "target": "EUROPEAN PROSPECTIVE INVESTIGATION INTO CANCER (EPIC)\u2010INTERACT "}, {"weight": 2.0, "description": "Both studies investigate genetic variants associated with diabetes but focus on different ethnic populations, providing insights into genetic-environment interactions.", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "order": 1, "source": "SHANGHAI DIABETES GWAS STUDY ", "target": "KOREAN GENOME AND EPIDEMIOLOGY STUDY (KOGES)"}, {"weight": 3.5, "description": "These RCTs evaluate the effectiveness of lifestyle interventions in preventing type 2 diabetes across different populations and settings.", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "order": 1, "source": "FINISH DIABETES PREVENTION STUDY (DPS)", "target": "AMERICAN DIABETES PREVENTION PROJECT (DPP)"}, {"weight": 2.0, "description": "Both studies assess dietary patterns and their interaction with metabolic factors to prevent cardiovascular diseases and diabetes risk.", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "order": 1, "source": "PREVENCI\u00d3N CON DIETA MEDITERR\u00c1NEA (PREDIMED)", "target": "STUDY IN ITALIANS FROM ASTI "}, {"weight": 10.0, "description": "The rs10423928 variant in the GIPR gene interacts with fat intake on T2D risk, lacking consistent evidence.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "order": 1, "source": "GIPR GENE (RS10423928)", "target": "FAT INTAKE (TOTAL AND SATURATED)"}, {"weight": 10.0, "description": "The rs1801282 variant in the PPAR\u03b3 gene shows a trend for interaction with dietary fat intake on T2D risk.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "order": 1, "source": "PPAR\u0393 GENE (RS1801282)", "target": "FAT INTAKE (TOTAL AND SATURATED)"}, {"weight": 10.0, "description": "The rs1799945 variant in the HFE gene modifies the association of heme iron with T2D incidence, particularly among women.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "order": 1, "source": "HFE GENE (RS1799945)", "target": "HEME IRON INTAKE"}, {"weight": 10.0, "description": "The *1/*2 variants in the ADH1C gene modify the association between alcohol consumption and T2D risk, specifically in US women carrying allele *2.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "order": 1, "source": "ADH1C GENE (*1/*2)", "target": "ALCOHOL CONSUMPTION"}, {"weight": 10.0, "description": "The rs7903146 variant in the TCF7L2 gene interacts with whole grain intake, impacting Type 1 Diabetes risk.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "order": 1, "source": "WHOLE GRAIN CONSUMPTION", "target": "TCF7L2 GENE (RS7903146)"}, {"weight": 7.0, "description": "Interaction between this genetic variant and dietary heme iron intake influencing T2D risk in men.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "order": 1, "source": "SLC40A1 RS744653 VARIANT", "target": "HEME IRON INTAKE"}, {"weight": 6.0, "description": "Intake of zinc interacts with SLC30A8 variants but without clear trend for type 2 diabetes association.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "order": 1, "source": "SLC30A8 VARIANTS (ZINC TRANSPORTER)", "target": "ZINC INTAKE"}, {"weight": 9.0, "description": "High intake of red meat increases T2D risk among individuals with high genetic risk score (T2D-GRS).", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "order": 1, "source": "RED MEAT", "target": "T2D-GRS"}, {"weight": 8.0, "description": "Interaction between consumption of a Mediterranean diet and CLOCK variant to lower type 2 diabetes incidence.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "order": 1, "source": "MEDITERRANEAN DIET", "target": "CLOCK VARIANT RS4580704"}, {"weight": 6.0, "description": "The Mediterranean diet impacts arachidonic acid concentrations in the colon, especially in individuals with no minor alleles in FADS1/2.", "source_id": "chunk-e1b4f4dac52e806f19c580640a50c729", "order": 1, "source": "MEDITERRANEAN DIET", "target": "COLON AA CONCENTRATIONS"}, {"weight": 8.0, "description": "Change in LTPA modifies the risk of type 2 diabetes incidence based on specific genetic variants.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "order": 1, "source": "LTPA (LEISURE-TIME PHYSICAL ACTIVITY)", "target": "TYPE 2 DIABETES RISK"}, {"weight": 9.0, "description": "Interaction between CLOCK variant and dietary patterns to modify the incidence rate of type 2 diabetes.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "order": 1, "source": "T2D INCIDENCE", "target": "CLOCK VARIANT RS4580704"}, {"weight": 9.0, "description": "Consumption of fruits and vegetables showing a significant interaction with genetic factors to lower the incidence rate of type 2 diabetes.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "order": 1, "source": "FRUITS AND VEGETABLES", "target": "TYPE 2 DIABETES INCIDENCE"}, {"weight": 5.0, "description": "The rs12255372 variant in the TCF7L2 gene interacts with glycemic load intake, affecting T2D risk.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "order": 1, "source": "GLYCEMIC LOAD INTAKE", "target": "TCF7L2 GENE (RS12255372)"}, {"weight": 5.0, "description": "The rs13266634 variant in SLC30A8 shows interaction with saturated fat intake on T2D risk.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "order": 1, "source": "FAT INTAKE (SATURATED)", "target": "SLC30A8 GENE (RS13266634)"}, {"weight": 5.0, "description": "The rs2237892 variant in KCNQ1 interacts with total fat intake, affecting insulin resistance and T2D risk.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "order": 1, "source": "FAT INTAKE (TOTAL)", "target": "KCNQ1 GENE (RS2237892)"}, {"weight": 4.0, "description": "A specific variant (rs10010131) in the WFS1 gene is associated with an increased risk of developing T2D-ESRD, although this association was weaker compared to European populations.", "source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "order": 1, "source": "WFS1 GENE", "target": "RS10010131 GENOMIC VARIANT"}, {"weight": 4.0, "description": "The WFS1 gene is implicated in the progression from Type 2 Diabetes towards End Stage Renal Disease, though its association varies across populations.", "source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "order": 1, "source": "WFS1 GENE", "target": "TYPE 2 DIABETES AND END STAGE RENAL DISEASE (T2D-ESRD)"}, {"weight": 5.0, "description": "The rs10946398 variant in the CDKAL1 gene is associated with an increased risk of developing T2D-ESRD, consistent with previous findings in European samples.", "source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "order": 1, "source": "CDKAL1 GENE", "target": "RS10946398 GENOMIC VARIANT"}, {"weight": 5.0, "description": "The CDKAL1 gene is associated with an increased risk of developing Type 2 Diabetes, which can progress to End Stage Renal Disease.", "source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "order": 1, "source": "CDKAL1 GENE", "target": "TYPE 2 DIABETES AND END STAGE RENAL DISEASE (T2D-ESRD)"}, {"weight": 5.0, "description": "The rs864745 variant in the JAZF1 gene is associated with an increased risk of developing T2D-ESRD, similar to results observed in European populations.", "source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "order": 1, "source": "JAZF1 GENE", "target": "RS864745 GENOMIC VARIANT"}, {"weight": 5.0, "description": "The JAZF1 gene is associated with an increased risk of developing Type 2 Diabetes, which can progress to End Stage Renal Disease.", "source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "order": 1, "source": "JAZF1 GENE", "target": "TYPE 2 DIABETES AND END STAGE RENAL DISEASE (T2D-ESRD)"}, {"weight": 4.0, "description": "A variant (rs4607103) in the ADAMTS9 gene is associated with T2D-ESRD risk, but this association differs directionally from that found in European populations.", "source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "order": 1, "source": "ADAMTS9 GENE", "target": "RS4607103 GENOMIC VARIANT"}, {"weight": 4.0, "description": "The ADAMTS9 gene has a variant that affects the risk of developing Type 2 Diabetes, which can progress to End Stage Renal Disease.", "source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "order": 1, "source": "ADAMTS9 GENE", "target": "TYPE 2 DIABETES AND END STAGE RENAL DISEASE (T2D-ESRD)"}, {"weight": 3.0, "description": "The proportion of African ancestry in individuals\' genetic makeup did not significantly affect the risk of developing T2D-ESRD, suggesting similar susceptibility across ethnic backgrounds.", "source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "order": 1, "source": "TYPE 2 DIABETES AND END STAGE RENAL DISEASE (T2D-ESRD)", "target": "AFRICAN ANCESTRY PROPORTION"}, {"weight": 8.0, "description": "The count of risk alleles is associated with the TCF7L2 risk variant rs7903146 in association analyses.", "source_id": "chunk-6a7c69534e11aa2fc4bd948484aa81c4", "order": 1, "source": "RISK ALLELE COUNT", "target": "TCF7L2 RISK VARIANT RS7903146 ASSOCIATION ANALYSIS RESULTS"}, {"weight": 7.0, "description": "The unweighted odds ratio analysis results indicate the interaction between risk alleles and TCF7L2 variant for disease association.", "source_id": "chunk-6a7c69534e11aa2fc4bd948484aa81c4", "order": 1, "source": "UNWEIGHTED OR (ODDS RATIO)", "target": "TCF7L2 RISK VARIANT RS7903146 ASSOCIATION ANALYSIS RESULTS"}, {"weight": 6.0, "description": "The weighted odds ratio analysis results provide adjusted interaction measures considering genetic background with the TCF7L2 variant.", "source_id": "chunk-6a7c69534e11aa2fc4bd948484aa81c4", "order": 1, "source": "WEIGHTED OR (ODDS RATIO)", "target": "TCF7L2 RISK VARIANT RS7903146 ASSOCIATION ANALYSIS RESULTS"}, {"weight": 4.0, "description": "Both IFG/IGT and T2D represent pre-diabetic or diabetic states that influence metabolic pathways related to obesity, such as BMI levels and changes.", "source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "order": 1, "source": "T2D", "target": "IFG/IGT"}, {"weight": 3.0, "description": "In East Asian populations, there\'s a specific distribution pattern of Type 2 Diabetes (T2D), showing lower prevalence compared to some other ethnic groups.", "source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "order": 1, "source": "T2D", "target": "EAST ASIAN"}, {"weight": 4.0, "description": "Individuals from Native North America exhibit specific rates of T2D which differ from those observed in other populations, indicating unique risk factors.", "source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "order": 1, "source": "T2D", "target": "NATIVE NORTH AMERICAN"}, {"weight": 4.0, "description": "The South Asian population has higher rates of T2D compared to other groups, indicating genetic and lifestyle factors contributing to increased risk.", "source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "order": 1, "source": "T2D", "target": "SOUTH ASIAN"}, {"weight": 1.0, "description": "Similarly, the genomic variant rs4950928 also did not show a significant association with T2D when adjusted for age, sex, BMI and glucose tolerance.)", "source_id": "chunk-44a871da300abc9be525b468f502f5cb", "order": 1, "source": "T2D", "target": "RS4950928"}, {"weight": 1.0, "description": "Association found between methylation levels of CEP55 gene and T2D risk, though not statistically significant after permutation test.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "order": 1, "source": "T2D", "target": "CEP55"}, {"weight": 5.0, "description": "Lower methylation levels in the HIST1H4D 3\' UTR region are linked to a higher risk of developing T2D.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "order": 1, "source": "T2D", "target": "HIST1H4D 3\'-UTR METHYLATION"}, {"weight": 4.0, "description": "Individuals with normal glucose tolerance (NGT) represent the baseline against which impaired fasting glucose/impaired glucose tolerance (IFG/IGT) status is assessed for changes in BMI and other metabolic parameters.", "source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "order": 1, "source": "IFG/IGT", "target": "NGT"}, {"weight": 4.0, "description": "Individuals with African ancestry have a higher incidence of Impaired Fasting Glucose and Impaired Glucose Tolerance (IFG/IGT), indicating significant ethnic differences in metabolic conditions.", "source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "order": 1, "source": "IFG/IGT", "target": "AFRICAN"}, {"weight": 3.0, "description": "Europeans show distinct patterns in the prevalence of IFG/IGT compared to other ethnicities, reflecting genetic and environmental influences on metabolic health.", "source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "order": 1, "source": "IFG/IGT", "target": "EUROPEAN"}, {"weight": 3.0, "description": "Latino Americans have a particular prevalence rate for IFG/IGT, highlighting the importance of considering ethnic background in metabolic health assessments.", "source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "order": 1, "source": "IFG/IGT", "target": "LATINO AMERICAN"}, {"weight": 4.0, "description": "In the context of glycemic status and BMI changes, females generally show higher percentages across all categories, while males have a higher likelihood of IFG/IGT or T2D compared to normal glucose tolerance (NGT).", "source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "order": 1, "source": "FEMALES", "target": "MALES"}, {"weight": 10.0, "description": "The FTO gene variant, rs9939609, is significantly associated with an elevated baseline body mass index (BMI).)", "source_id": "chunk-1fde08e52a188ac6a549e7c11d59a092", "order": 1, "source": "BMI BASELINE", "target": "FTO RS9939609"}, {"weight": 12.0, "description": "rs2984618 in TAL1 shows significant association with increased BMI at baseline.)", "source_id": "chunk-1fde08e52a188ac6a549e7c11d59a092", "order": 1, "source": "BMI BASELINE", "target": "TAL1 RS2984618"}, {"weight": 14.0, "description": "The TCF7L2 gene variant, rs7903146, is associated with an elevated body mass index (BMI) at baseline.)", "source_id": "chunk-1fde08e52a188ac6a549e7c11d59a092", "order": 1, "source": "BMI BASELINE", "target": "TCF7L2 RS7903146"}, {"weight": 16.0, "description": "Genotype risk score (GRS), derived from multiple obesity-associated SNPs, is significantly linked to increased BMI at baseline.)", "source_id": "chunk-1fde08e52a188ac6a549e7c11d59a092", "order": 1, "source": "BMI BASELINE", "target": "GRS"}, {"weight": 3.0, "description": "Traits related to glycemic status significantly interact with obesity predisposing SNPs to affect BMI at baseline.)", "source_id": "chunk-1fde08e52a188ac6a549e7c11d59a092", "order": 1, "source": "BMI BASELINE", "target": "GLYCEMIC STATUS TRAITS"}, {"weight": 1.0, "description": "The analysis focused on 23 SNPs as potential genomic variants associated with treatment response.", "source_id": "chunk-0d49552280a277a8a26456d06f8f26a8", "order": 1, "source": "SNPS", "target": "GENOMIC VARIANT"}, {"weight": 1.0, "description": "The combination therapy cohort included 43 patients, with no significant associations found for SNPs tested in the study.", "source_id": "chunk-0d49552280a277a8a26456d06f8f26a8", "order": 1, "source": "SNPS", "target": "COMBINATION THERAPY COHORT"}, {"weight": 12.0, "description": "The GRS is significantly associated with performance on TMTA and TMTB but not with other assessments such as PEGDH or DIG.", "source_id": "chunk-ea6355aaf22d7cdd3331602638122ed7", "order": 1, "source": "GRS", "target": "TMTA, PEGDH, PEGNDH, DIG, CFL"}, {"weight": 8.0, "description": "There is no observed association between Genetic Risk Score (GRS) and performance on the DIVERGT battery despite its relevance to assessing neurotoxicity-related impairments.", "source_id": "chunk-ea6355aaf22d7cdd3331602638122ed7", "order": 1, "source": "GRS", "target": "DIVERGT BATTERY"}, {"weight": 8.0, "description": "Higher Genetic Risk Score (GRS) values are associated with increased risk of MTX-related neurotoxicity as evidenced by lower scores on specific cognitive tests.", "source_id": "chunk-ea6355aaf22d7cdd3331602638122ed7", "order": 1, "source": "GRS", "target": "MTX-RELATED NEUROTOXICITY"}, {"weight": 8.0, "description": "Higher GRS values are associated with significantly lower scores on TMTB, indicating poorer executive function and processing speed.", "source_id": "chunk-ea6355aaf22d7cdd3331602638122ed7", "order": 1, "source": "GRS", "target": "TMTB (TRAIL MAKING TEST PART B)"}, {"weight": 18.0, "description": "The interaction effect of LEPR variant rs1011527 and fasting plasma glucose (FPG) on baseline body mass index (BMI) is significant, indicating a potential genetic-environmental interaction.)", "source_id": "chunk-1fde08e52a188ac6a549e7c11d59a092", "order": 1, "source": "LEPR RS1011527", "target": "FPG"}, {"weight": 4.0, "description": "The interaction between fasting plasma glucose (FPG) levels and the LEPR gene variant, rs1011527, is significant for predicting changes in body mass index (BMI).)", "source_id": "chunk-1fde08e52a188ac6a549e7c11d59a092", "order": 1, "source": "LEPR RS1011527", "target": "FPG LEVELS"}, {"weight": 3.0, "description": "Both fasting plasma glucose (FPG) and two-hour plasma glucose (2hPG) are measures of blood sugar regulation, where high values in both correlate positively with baseline BMI but negatively predict changes in BMI over time.", "source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "order": 1, "source": "2HPG", "target": "FPG"}, {"weight": 4.0, "description": "Survivors with the MTHFR 1298AC/CC genotypes have a significantly higher likelihood of meeting criteria for impairment on the DIVERGT battery.", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "order": 1, "source": "MTHFR 1298A>C", "target": "DIVERGT BATTERY"}, {"weight": 6.0, "description": "Individuals with the MS 2756AA genotype demonstrate lower PEGNDH scores compared to those with other genotypes.", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "order": 1, "source": "MS 2756A>G", "target": "PEGNDH"}, {"weight": 8.0, "description": "Survivors with MTRR 66AA genotype perform worse on CFL test compared to those with the MTRR 66AG/GG genotypes.", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "order": 1, "source": "MTRR 66A>G", "target": "CFL"}, {"weight": 10.0, "description": "Individuals with TSER 2R/3R and 3R/3R genotypes score lower on TMTB than those with the 2R/2R genotype.", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "order": 1, "source": "TSER POLYMORPHISMS", "target": "TMTB"}, {"weight": 12.0, "description": "Early MTX-related neurotoxicity is predictive of long-term neurocognitive impairment as assessed by the DIVERGT battery.", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "order": 1, "source": "DIVERGT BATTERY", "target": "EARLY MTX-RELATED NEUROTOXICITY"}, {"weight": 8.0, "description": "The Divergt battery is used for assessing long-term neurological and cognitive impacts of ALL treatment, particularly in children.", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "order": 1, "source": "DIVERGT BATTERY", "target": "ALL (ACUTE LYMPHOBLASTIC LEUKEMIA)"}, {"weight": 5.0, "description": "Administration of methotrexate early in treatment can lead to neurotoxic effects which may impact long-term cognitive function.", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "order": 1, "source": "EARLY MTX-RELATED NEUROTOXICITY", "target": "MTX (METHOTREXATE)"}, {"weight": 10.0, "description": "Higher genetic risk scores correlate with worse performance on certain cognitive tests and a higher likelihood of neurocognitive impairment.", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "order": 1, "source": "GENETIC RISK SCORE (GRS)", "target": "NEUROCOGNITIVE IMPAIRMENT"}, {"weight": 10.0, "description": "Both intrathecal and cumulative IV exposures to methotrexate are environmental factors that contribute to the risk of neurotoxicity but do not necessarily correlate with cognitive impairment as measured by certain tests.", "source_id": "chunk-ea6355aaf22d7cdd3331602638122ed7", "order": 1, "source": "INTRATHECAL MTX EXPOSURE", "target": "CUMULATIVE IV MTX EXPOSURE"}, {"weight": 7.0, "description": "A polymorphism contributes to the calculation of GRS, which in turn predicts neurotoxicity-related cognitive impairment.", "source_id": "chunk-ea6355aaf22d7cdd3331602638122ed7", "order": 1, "source": "POLYMORPHISM", "target": "GENOMIC VARIANT"}, {"weight": 6.0, "description": "Survivors show varying levels of cognitive impairment based on their Genetic Risk Score (GRS).", "source_id": "chunk-ea6355aaf22d7cdd3331602638122ed7", "order": 1, "source": "SURVIVORS", "target": "COGNITIVE IMPAIRMENT"}, {"weight": 4.0, "description": "A genomic variant within the FADS1/2 gene cluster modulates the response to dietary interventions affecting fatty acid metabolism.", "source_id": "chunk-e1b4f4dac52e806f19c580640a50c729", "order": 1, "source": "GENOMIC VARIANT", "target": "FADS1/2 GENE CLUSTER"}, {"weight": 4.0, "description": "Each genomic variant evaluated for its association with ovarian cancer risk was checked against Hardy-Weinberg equilibrium to ensure genetic data consistency within control populations.", "source_id": "chunk-1c470c93632f3704d6f3566de7a1dd0c", "order": 1, "source": "GENOMIC VARIANT", "target": "HARDY-WEINBERG EQUILIBRIUM (HWE)"}, {"weight": 5.0, "description": "The SLC30A8 variant is associated with higher fasting proinsulin levels at baseline, which decrease after intervention.", "source_id": "chunk-8f23bd741f82dc8ca1e2600d790b690f", "order": 1, "source": "SLC30A8 RS13266634", "target": "FASTING PROINSULIN LEVELS"}, {"weight": 8.0, "description": "The presence of the SLC30A8 risk allele did not interact with treatment type to modify proinsulin reduction, indicating consistent efficacy across genotypes.", "source_id": "chunk-8f23bd741f82dc8ca1e2600d790b690f", "order": 1, "source": "SLC30A8 RS13266634", "target": "GENOTYPE \u00d7 TREATMENT INTERACTION"}, {"weight": 7.0, "description": "Treatment with troglitazone reduced fasting proinsulin levels, though not as effectively as lifestyle intervention.", "source_id": "chunk-8f23bd741f82dc8ca1e2600d790b690f", "order": 1, "source": "FASTING PROINSULIN LEVELS", "target": "TROGLITAZONE"}, {"weight": 6.0, "description": "The lifestyle intervention was more effective than metformin in reducing proinsulin levels after one year of treatment.", "source_id": "chunk-8f23bd741f82dc8ca1e2600d790b690f", "order": 1, "source": "LIFESTYLE INTERVENTION", "target": "METFORMIN"}, {"weight": 7.0, "description": "The comparison between placebo and lifestyle intervention shows a significant reduction in proinsulin levels with active intervention.", "source_id": "chunk-8f23bd741f82dc8ca1e2600d790b690f", "order": 1, "source": "LIFESTYLE INTERVENTION", "target": "PLACEBO GROUP"}, {"weight": 5.0, "description": "Adjusting for fasting insulin helps isolate the effect of SLC30A8 risk alleles on proinsulin levels.", "source_id": "chunk-8f23bd741f82dc8ca1e2600d790b690f", "order": 1, "source": "FASTING INSULIN", "target": "PROINSULIN LEVELS"}, {"weight": 6.0, "description": "Controlling for demographic factors ensures that the observed effects are due to interventions rather than confounding variables.", "source_id": "chunk-8f23bd741f82dc8ca1e2600d790b690f", "order": 1, "source": "AGE, SEX, ETHNICITY", "target": "PROINSULIN LEVELS"}, {"weight": 2.0, "description": "Inclusion of lipid emulsion attenuates the induction of PNPLA3 mRNA levels caused by a high carbohydrate diet.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "order": 1, "source": "PNPLA3", "target": "LIPID EMULSION (LE)"}, {"weight": 4.0, "description": "There is a positive correlation between the mRNA levels of PNPLA3 and SREBP1c, indicating they are co-regulated in mouse liver.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "order": 1, "source": "PNPLA3", "target": "SREBP1C (STEROL REGULATORY ELEMENT BINDING PROTEIN 1C)"}, {"weight": 5.0, "description": "Similarly, there is a positive correlation between the mRNA levels of PNPLA3 and ACC-1, suggesting their co-regulation in mouse liver.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "order": 1, "source": "PNPLA3", "target": "ACC-1 (ACETYL-COA CARBOXYLASE 1)"}, {"weight": 6.0, "description": "In HepG2 cells exposed to glucose depletion-refeeding conditions, PNPLA3 gene expression is regulated by glucose levels.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "order": 1, "source": "PNPLA3", "target": "HEPG2 CELLS"}, {"weight": 7.0, "description": "PNPLA3 and ChREBP exhibit similar patterns of expression in response to glucose changes in HepG2 cells, indicating a possible regulatory relationship.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "order": 1, "source": "PNPLA3", "target": "CHREBP (CARBOHYDRATE RESPONSE ELEMENT BINDING PROTEIN)"}, {"weight": 9.0, "description": "Treatment with 2-deoxy-D-glucose suppresses SREBP1c gene expression, indicating its role in glucose metabolism.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "order": 1, "source": "SREBP1C (STEROL REGULATORY ELEMENT BINDING PROTEIN 1C)", "target": "2-DEOXY-D-GLUCOSE (2DG)"}, {"weight": 3.0, "description": "Treatment with 2-deoxy-D-glucose suppresses SREBP1c gene expression, indicating it blocks the induction by high glucose.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "order": 1, "source": "SREBP1C (STEROL REGULATORY ELEMENT BINDING PROTEIN 1C)", "target": "NON-METABOLIZABLE GLUCOSE ANALOG (2DG)"}, {"weight": 3.0, "description": "Voluntary exercise reduces PNPLA3 expression in mice fed a high fat diet.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "order": 1, "source": "HIGH FAT DIET (HF)", "target": "PHYSICAL ACTIVITY (EXERCISE)"}, {"weight": 8.0, "description": "Mice fed a high fat diet develop fatty liver, characterized by increased hepatic triglyceride content.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "order": 1, "source": "HIGH FAT DIET (HF)", "target": "FATTY LIVER"}, {"weight": 10.0, "description": "Voluntary exercise significantly reduces PNPLA3 mRNA levels and inhibits the development of fatty liver caused by a high fat diet.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "order": 1, "source": "PHYSICAL ACTIVITY (EXERCISE)", "target": "FATTY LIVER"}, {"weight": 4.0, "description": "Increased hepatic TG content is associated with the development of fatty liver in mice fed a high fat diet.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "order": 1, "source": "FATTY LIVER", "target": "TG (TRIGLYCERIDES)"}, {"weight": 11.0, "description": "Expression of the insulin receptor protein does not lead to upregulation of the PNPLA3 gene upon insulin treatment in HepG2 cells, suggesting a lack of direct response mechanism.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "order": 1, "source": "HEPG2 CELLS", "target": "INSULIN RECEPTOR PROTEIN"}, {"weight": 2.0, "description": "Under depletion-refeeding conditions, ChREBP gene expression shows a similar pattern to PNPLA3 in HepG2 cells.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "order": 1, "source": "CHREBP (CARBOHYDRATE RESPONSE ELEMENT BINDING PROTEIN)", "target": "DEPLETION-REFEEDING CONDITIONS"}, {"weight": 7.0, "description": "Treatment with LA suppresses the expression of PNPLA3 in HepG2 cells, demonstrating a regulatory role for this fatty acid on PNPLA3 levels.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "order": 1, "source": "LINOLEIC ACID (LA)", "target": "PNPLA3 GENE"}, {"weight": 8.0, "description": "Similar to LA treatment, OA also suppresses the expression of PNPLA3, indicating that both types of unsaturated fatty acids have a similar effect on PNPLA3 regulation.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "order": 1, "source": "OLEIC ACID (OA)", "target": "PNPLA3 GENE"}, {"weight": 9.0, "description": "Treatment with EPA led to reduced expression levels of the PNPLA3 gene, indicating EPA\'s regulatory role in suppressing PNPLA3 mRNA.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "order": 1, "source": "EICOSAPENTAENOIC ACID (EPA)", "target": "PNPLA3 GENE"}, {"weight": 10.0, "description": "Like EPA, DHA treatment also resulted in reduced levels of PNPLA3 mRNA expression under both high and low glucose conditions.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "order": 1, "source": "DOCOSAHEXAENOIC ACID (DHA)", "target": "PNPLA3 GENE"}, {"weight": 6.0, "description": "Under high glucose condition, although lipid accumulation increased, there was no significant effect on PNPLA3 mRNA levels as opposed to expected upregulation of FAS or ACC-1.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "order": 1, "source": "HIGH GLUCOSE CONDITION", "target": "PNPLA3 GENE"}, {"weight": 13.0, "description": "Induced PNPLA3 gene expression which was reversed by Intralipid\u00ae treatment, demonstrating dietary effects on hepatic lipid metabolism.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "order": 1, "source": "HIGH GLUCOSE DIET (HC-DIET)", "target": "MOUSE LIVER"}, {"weight": 14.0, "description": "When combined with OA and LA but not ALA, significantly suppressed PNPLA3 mRNA levels in HepG2 cells under both glucose conditions, indicating a complex interaction.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "order": 1, "source": "INTRALIPID\u00ae", "target": "FATTY ACIDS (OA, LA, ALA)"}, {"weight": 15.0, "description": "Knockdown of FAS did not affect the expression level of PNPLA3, highlighting specificity in regulatory pathways.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "order": 1, "source": "KNOCKDOWN OF FAS (FASN)", "target": "PNPLA3 GENE"}, {"weight": 16.0, "description": "No difference was observed in lipid accumulation between knocked down PNPLA3 cells and controls, indicating that knockdown did not affect lipid storage capacity.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "order": 1, "source": "OIL RED O STAINING", "target": "HEPG2 CELLS WITH KNOCKED DOWN PNPLA3"}, {"weight": 5.0, "description": "FAS protein is upregulated by insulin treatment, contrasting with no change observed for the PNPLA3 gene expression under similar conditions.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "order": 1, "source": "FAS PROTEIN", "target": "INSULIN TREATMENT"}, {"weight": 3.0, "description": "The hippocampus displays increased FoxO1 expression following PNS (Psychological stress).", "source_id": "chunk-704d1bc6fcda99ac888bd36c954fdb98", "order": 1, "source": "PNS", "target": "HIPPOCAMPUS"}, {"weight": 6.0, "description": "Prenatal stress-induced changes in miRNA levels directly target hippocampal transcripts identified from transcriptomics analysis.)", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "order": 1, "source": "HIPPOCAMPUS TRANSCRIPTOME", "target": "MIRNOME CHANGES"}, {"weight": 3.0, "description": "Both signaling pathways are part of neurodevelopment processes and were affected by PNS exposure according to pathway analysis.)", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "order": 1, "source": "AXONAL GUIDANCE SIGNALING PATHWAY", "target": "PROTEIN KINASE A SIGNALING PATHWAY"}, {"weight": 4.0, "description": "These two pathways, involved in neuronal development, have been found altered due to prenatal stress exposure according to the pathway analysis performed.)", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "order": 1, "source": "GLUTAMATE RECEPTOR SIGNALING PATHWAY", "target": "WNT/\u0392-CATENIN SIGNALING PATHWAY"}, {"weight": 5.0, "description": "Both inflammatory signaling pathways were affected by PNS according to pathway analysis and are part of a broader immune response system.)", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "order": 1, "source": "IL-8 SIGNALING PATHWAY", "target": "STAT3 PATHWAY"}, {"weight": 0.8, "description": "In Rag1\u2212/\u2212 mice, IL-6 signaling appears more critical compared to IL-1 for inducing colonic inflammation due to IL-10 suppression.)", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c", "order": 1, "source": "IL-6 SIGNALING PATHWAY", "target": "RAG1\u2212/\u2212 MICE"}, {"weight": 7.0, "description": "Exposure to early life trauma influences the eNOS signaling pathway, a critical pathway involved in inflammation and cardiovascular health.)", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "order": 1, "source": "EARLY LIFE TRAUMA EXPOSURE", "target": "ENOS SIGNALING PATHWAY"}, {"weight": 3.0, "description": "The pathway list includes pathways found in both rat studies after PNS exposure and human blood transcriptome analysis after early life trauma exposure, indicating shared biological mechanisms.)", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "order": 1, "source": "42 PATHWAYS INVOLVED IN NEURODEVELOPMENT AND INFLAMMATION", "target": "BLOOD TRANSCRIPTOMICS OF EARLY LIFE TRAUMA"}, {"weight": 4.0, "description": "Panel of significant genes from the PNS model\'s combined mRNA-miRNA analysis that were also modulated in individuals exposed to early-life trauma.)", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "order": 1, "source": "528 SIGNIFICANT GENES PANEL", "target": "PRENATAL STRESS MODEL"}, {"weight": 5.0, "description": "Validation of integrated data sets through real-time PCR confirmed the directionality of gene expression changes identified in microarray studies for 22 common genes.)", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "order": 1, "source": "INTEGRATED DATA SET FROM ANIMAL AND HUMAN STUDIES", "target": "REAL-TIME PCR VALIDATION"}, {"weight": 4.0, "description": "Both ISOC1 and TGF-\u03b21 show modulated expression patterns under similar conditions, indicating possible interaction or common pathways.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "order": 1, "source": "ISOC1", "target": "TGF-\u03921"}, {"weight": 5.0, "description": "LDLRAP1 and FoxO1 are both part of gene networks involved in cellular signaling processes under stress conditions.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "order": 1, "source": "LDLRAP1", "target": "FOXO1"}, {"weight": 6.0, "description": "Both TGF-\u03b21 and A2M play roles in immune response pathways, indicating a possible interaction or overlapping functions.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "order": 1, "source": "TGF-\u03921", "target": "A2M"}, {"weight": 6.0, "description": "Transforming growth factor beta 1 (TGF-\u03b21) is involved in GxE interaction studies, showing significant associations with emotional stress and depressive symptoms in adulthood.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "order": 1, "source": "TGF-\u03921", "target": "GXE INTERACTION STUDIES"}, {"weight": 8.0, "description": "The FoxO1 gene interacts with SNP rs17592371 to predict depressive symptoms in adulthood due to childhood emotional stress.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "order": 1, "source": "FOXO1", "target": "SNP RS17592371"}, {"weight": 7.0, "description": "FoxO1 activation occurs in hippocampal progenitor stem cells following cortisol exposure, indicating its role as a mediator between stress and neurogenesis.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "order": 1, "source": "FOXO1", "target": "CORTISOL EXPOSURE"}, {"weight": 4.0, "description": "FoxO1 expression and activity are regulated by cortisol exposure, affecting neurogenesis and neuronal proliferation.", "source_id": "chunk-704d1bc6fcda99ac888bd36c954fdb98", "order": 1, "source": "FOXO1", "target": "CORTISOL"}, {"weight": 2.0, "description": "Exposure to childhood trauma leads to elevated levels of the FoxO1 gene in blood samples, indicating a link between psychological trauma and brain function.", "source_id": "chunk-704d1bc6fcda99ac888bd36c954fdb98", "order": 1, "source": "FOXO1", "target": "CHILDHOOD TRAUMA"}, {"weight": 4.0, "description": "Cortisol upregulates the expression of SGK-1, a gene involved in mediating some effects of glucocorticoids on brain function.", "source_id": "chunk-704d1bc6fcda99ac888bd36c954fdb98", "order": 1, "source": "CORTISOL", "target": "SGK-1 (SERUM GLUCOCORTICOID KINASE 1)"}, {"weight": 4.0, "description": "Cortisol negatively affects neurogenesis through the mediation of FoxO1, impacting neuronal proliferation and differentiation.", "source_id": "chunk-704d1bc6fcda99ac888bd36c954fdb98", "order": 1, "source": "CORTISOL", "target": "NEUROGENESIS"}, {"weight": 8.0, "description": "Single nucleotide polymorphisms within the FoxO1 gene interact significantly with childhood trauma to predict higher levels of depressive symptoms in adulthood.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "order": 1, "source": "CHILDHOOD TRAUMA", "target": "FOXO1 SNPS"}, {"weight": 3.0, "description": "The inhibitor AS1842856 blocks cortisol-induced reduction of neuronal proliferation by inhibiting FoxO1 activity.", "source_id": "chunk-704d1bc6fcda99ac888bd36c954fdb98", "order": 1, "source": "AS1842856", "target": "NEURONAL PROLIFERATION"}, {"weight": 3.0, "description": "The activation of the FoxO1 protein in hippocampal progenitor stem cells leads to changes affecting neurogenesis.", "source_id": "chunk-704d1bc6fcda99ac888bd36c954fdb98", "order": 1, "source": "FOXO1 PROTEIN", "target": "HIPPOCAMPAL PROGENITOR STEM CELLS"}, {"weight": 3.0, "description": "Under baseline conditions, the FoxO1 protein does not significantly affect neuronal proliferation, indicating its activity is stress-dependent.", "source_id": "chunk-704d1bc6fcda99ac888bd36c954fdb98", "order": 1, "source": "FOXO1 PROTEIN", "target": "BASELINE CONDITIONS"}, {"weight": 9.0, "description": "The TGF-\u03b21 signaling pathway is involved in cytokine signaling, indicating interconnected pathways that play a role in cellular communication and stress responses.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "order": 1, "source": "CYTOKINES SIGNALING PATHWAY", "target": "TGF-\u03921 SIGNALING PATHWAY"}, {"weight": 16.0, "description": "The minor (G) allele of SNP rs4771122 is associated with larger percentage weight lost after bariatric surgery, adjusted for several variables including pre-surgical BMI.)", "source_id": "chunk-b3d775642c43fa3524a531a3f6ec1e41", "order": 1, "source": "RS4771122", "target": "LONG-TERM WEIGHT LOSS AFTER BARIATRIC SURGERY"}, {"weight": 16.0, "description": "Additional copies of the minor (G) allele in SNP rs4771122 were significantly associated with increased pre-surgical weight, indicating a relationship between genotypic variation and baseline characteristics.)", "source_id": "chunk-b3d775642c43fa3524a531a3f6ec1e41", "order": 1, "source": "RS4771122", "target": "PRE-SURGICAL WEIGHT"}, {"weight": 3.0, "description": "Clinical information for a subset of probands with GCK variants was available and analyzed.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "order": 1, "source": "PROBAND", "target": "CLINICAL INFORMATION"}, {"weight": 4.0, "description": "A de novo mutation in the proband was identified without it being present in parental DNA.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "order": 1, "source": "PROBAND", "target": "DE NOVO MUTATION"}, {"weight": 4.0, "description": "The proband exhibits stable levels of fasting hyperglycemia associated with GCK variants.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "order": 1, "source": "PROBAND", "target": "FASTING HYPERGLYCEMIA"}, {"weight": 4.0, "description": "Sanger sequencing is used to identify variants in the GCK gene.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "order": 1, "source": "GCK GENE", "target": "SANGER SEQUENCING"}, {"weight": 2.0, "description": "The University of Chicago uses Sanger sequencing to identify GCK variants.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "order": 1, "source": "SANGER SEQUENCING", "target": "UNIVERSITY OF CHICAGO"}, {"weight": 6.0, "description": "HRMA and Sanger sequencing are both utilized for verifying genetic variants, with HRMA providing a rapid method for initial genotyping while Sanger sequencing offers precise validation.", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "order": 1, "source": "SANGER SEQUENCING", "target": "HRMA (HIGH RESOLUTION MELTING ANALYSIS)"}, {"weight": 4.0, "description": "Used to identify and confirm the presence of genetic variants, including those affecting STAT5B.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "order": 1, "source": "SANGER SEQUENCING", "target": "GENETIC VARIANT IDENTIFICATION"}, {"weight": 3.0, "description": "ACMG guidelines are used to classify and interpret the significance of pathogenic variants in clinical settings.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "order": 1, "source": "ACMG GUIDELINES", "target": "PATHOGENIC VARIANTS"}, {"weight": 2.0, "description": "Variants not meeting criteria for pathogenicity or benign but classified as VUS based on limited evidence.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "order": 1, "source": "LIKELY PATHOGENIC VARIANTS", "target": "VUS"}, {"weight": 2.0, "description": "Computational tools predict the impact of VUS on protein function but do not classify them as pathogenic.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "order": 1, "source": "IN-SILICO TOOLS", "target": "VUS"}, {"weight": 3.0, "description": "HbA1c levels in individuals with GCK-MODY may be lower than expected due to mild hyperglycemia.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "order": 1, "source": "GCK-MODY", "target": "HBA1C LEVEL"}, {"weight": 4.0, "description": "Nonsense variants can lead to truncated proteins, impacting their function and contributing to disease.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "order": 1, "source": "NONSENSE VARIANT", "target": "PROTEIN FUNCTION"}, {"weight": 3.0, "description": "Missense variants result in single amino acid changes that may alter protein structure or function.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "order": 1, "source": "MISSENSE VARIANT", "target": "AMINO ACID CHANGE"}, {"weight": 2.0, "description": "Splice site variants can affect mRNA splicing and subsequently impact the efficiency of protein synthesis.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "order": 1, "source": "SPLICE SITE VARIANT", "target": "PROTEIN SYNTHESIS"}, {"weight": 3.0, "description": "These genomic changes maintain the reading frame but may alter amino acid sequence, potentially affecting protein function.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "order": 1, "source": "IN-FRAME DELETION/DUPLICATION", "target": "READING FRAME"}, {"weight": 2.0, "description": "Indels can introduce frameshift mutations or simply alter amino acid sequences without disrupting the coding frame.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "order": 1, "source": "INSERTION/DELETION (INDEL)", "target": "AMINO ACID SEQUENCE"}, {"weight": 4.0, "description": "Adherence to the Mediterranean diet positively correlates with higher HDL cholesterol levels.", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "order": 1, "source": "MEDITERRANEAN DIET (MD)", "target": "HDL-C (HIGH-DENSITY LIPOPROTEIN CHOLESTEROL)"}, {"weight": 3.0, "description": "The apoB:apoA-1 ratio is significantly lower in individuals adhering more closely to the Mediterranean diet.", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "order": 1, "source": "MEDITERRANEAN DIET (MD)", "target": "APOB:APOA-1 RATIO"}, {"weight": 2.0, "description": "Adherence to the Mediterranean diet has been shown to reduce HbA1c concentrations, reflecting improved glycemic control.", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "order": 1, "source": "MEDITERRANEAN DIET (MD)", "target": "HBA1C (GLYCATED HEMOGLOBIN)"}, {"weight": 2.0, "description": "Individuals who are more physically active tend to adhere better to dietary patterns like the Mediterranean diet, impacting metabolic health.", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "order": 1, "source": "MEDITERRANEAN DIET (MD)", "target": "PHYSICAL ACTIVITY LEVEL"}, {"weight": 3.0, "description": "Adherence to the MD positively influences total cholesterol levels by improving HDL and lowering LDL cholesterol.", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "order": 1, "source": "MEDITERRANEAN DIET (MD)", "target": "TC (TOTAL CHOLESTEROL)"}, {"weight": 2.0, "description": "Adherence to MD significantly reduces the odds of developing hypertriacylglycerolaemia compared to lower adherence.", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "order": 1, "source": "MEDITERRANEAN DIET (MD)", "target": "HYPERTRIACYLGLYCEROLAEMIA"}, {"weight": 3.0, "description": "The genetic variant rs780094 within the GCKR gene is associated with higher triglyceride concentrations compared to other genotypes.", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "order": 1, "source": "TAG (TRIGLYCERIDES)", "target": "GENETIC VARIANT (RS780094 SNP IN GCKR GENE)"}, {"weight": 2.0, "description": "The genetic variant rs780094 is also associated with higher levels of LDL cholesterol, contributing to cardiovascular risk.", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "order": 1, "source": "GENETIC VARIANT (RS780094 SNP IN GCKR GENE)", "target": "LDL-C (LOW-DENSITY LIPOPROTEIN CHOLESTEROL)"}, {"weight": 3.0, "description": "Individuals carrying the AA genotype of rs780094 are at a greater risk for hypertriacylglycerolaemia compared to GG individuals.", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "order": 1, "source": "GENETIC VARIANT (RS780094 SNP IN GCKR GENE)", "target": "HYPERTRIACYLGLYCEROLAEMIA"}, {"weight": 2.0, "description": "Genotypes can influence TAG levels, which may differ based on an individual\'s diet and genetic predisposition.)", "source_id": "chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6", "order": 1, "source": "GENOTYPE", "target": "TAG LEVELS"}, {"weight": 2.0, "description": "The interaction between a specific genotype and dietary factor Y can influence TAG levels.)", "source_id": "chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6", "order": 1, "source": "GENOTYPE", "target": "DIETARY FACTOR Y"}, {"weight": 4.0, "description": "Diazoxide is used in the treatment of CHI by targeting ABCC8 gene mutations for better insulin regulation and glucose metabolism.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "order": 1, "source": "ABCC8 GENE", "target": "DIAZOXIDE THERAPY"}, {"weight": 3.0, "description": "Both mutations contribute to CHI but affect different genes, illustrating the genetic complexity of this condition.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "order": 1, "source": "ABCC8 MUTATION C.3224-3226DELACC INS CAGCCAGGAACTG (P.THR1042GLNFSX75)", "target": "GLUD1 MUTATION P.ARG322 HIS"}, {"weight": 5.0, "description": "This mutation leads to hyperinsulinism, which is associated with hypoglycemia in CHI patients.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "order": 1, "source": "GLUD1 MUTATION P.ARG322 HIS", "target": "HYPOGLYCEMIA (HI)"}, {"weight": 6.0, "description": "Patients with high birth weight are more likely to have mutations affecting the ABCC8 gene.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "order": 1, "source": "MACROSOMIC PATIENTS", "target": "ABCC8 GENE MUTATIONS"}, {"weight": 7.0, "description": "The scan can detect focal lesions in the pancreas, which may indicate diffuse pancreatic disease in CHI patients.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "order": 1, "source": "18F-DOPA PET/CT SCAN", "target": "DIFFUSE PANCREATIC DISEASE"}, {"weight": 2.0, "description": "Symptoms of CHI can begin to appear during the neonatal period, characterized by episodes of hypoglycemia.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "order": 1, "source": "CHI (CONGENITAL HYPERINSULINISM)", "target": "NEONATAL PERIOD SYMPTOMS"}, {"weight": 3.0, "description": "CHI symptoms persisting beyond infancy may continue or worsen into early childhood.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "order": 1, "source": "INFANCY PERIOD (1-12 MONTHS)", "target": "CHILDHOOD (>12 MONTHS)"}, {"weight": 4.0, "description": "This therapy is used to manage hypoglycemic episodes by maintaining consistent blood glucose levels through regular feeding.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "order": 1, "source": "FREQUENT FEEDING THERAPY (SOLIDS AND COW\'S MILK)", "target": "HYPOGLYCEMIA MANAGEMENT"}, {"weight": 5.0, "description": "Used in combination with frequent feedings, this therapy helps maintain stable blood sugar levels over extended periods, preventing hypoglycemic episodes at night or during fasting.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "order": 1, "source": "UNCOOKED CORNSTARCH THERAPY (1.6 G/KG)", "target": "LONG-TERM BLOOD GLUCOSE CONTROL"}, {"weight": 6.0, "description": "The enlargement of pancreatic cells\' nuclei is often a result of specific genetic mutations found in CHI patients, particularly those with compound heterozygous ABCC8 mutations.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "order": 1, "source": "PANCREATIC \u0392-CELL NUCLEI ENLARGEMENT", "target": "GENETIC MUTATIONS"}, {"weight": 2.0, "description": "Both mutations are distinct genomic variants in the GLUD1 gene, each identified in separate patients with HI/HA syndrome.", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "order": 1, "source": "P.SER498LEU MUTATION", "target": "P.ASN463ASP MUTATION"}, {"weight": 5.0, "description": "Diazoxide is used to manage hypoglycemia caused by mutations affecting the GLUD1 gene.", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "order": 1, "source": "HYPOGLYCAEMIA", "target": "DIAZOXIDE"}, {"weight": 5.0, "description": "High serum ammonia levels are indicative of hypoglycaemia in patients with GLUD1 gene mutations, highlighting metabolic dysfunction.", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "order": 1, "source": "HYPOGLYCAEMIA", "target": "SERUM AMMONIA CONCENTRATION"}, {"weight": 6.0, "description": "In cases where HI does not respond well to medical management, surgical intervention such as pancreatectomy may be necessary.", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "order": 1, "source": "HYPERINSULINISM (HI)", "target": "PANCREATECTOMY"}, {"weight": 6.0, "description": "The use of diazoxide therapy leads to various side effects such as gastrointestinal disturbances and hypertrichosis.", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "order": 1, "source": "DIAZOXIDE", "target": "DIAZOXIDE THERAPY SIDE EFFECTS"}, {"weight": 7.0, "description": "Some patients do not respond well to octreotide treatment, suggesting its limited efficacy in managing hypoglycaemia caused by GLUD1 mutations.", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "order": 1, "source": "OCTREOTIDE", "target": "OCTREOTIDE TREATMENT FAILURE"}, {"weight": 9.0, "description": "Surgical intervention such as pancreatectomy may result in the development of diabetes mellitus in some patients.", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "order": 1, "source": "PANCREATECTOMY", "target": "DIABETES MELLITUS POST-SURGERY"}, {"weight": 8.0, "description": "Severe side effects like thrombocytopenic purpura can occur with diazoxide therapy, impacting patient care.", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "order": 1, "source": "DIAZOXIDE THERAPY SIDE EFFECTS", "target": "THROMBOCYTOPENIC PURPURA"}, {"weight": 1.5, "description": "These two molecular entities are closely related in the metabolic pathway of ketone body formation and breakdown, highlighting their interdependence in metabolic regulation.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "order": 1, "source": "ACETOACETATE (ACAC)", "target": "BETA-HYDROXYBUTYRATE (BHB)"}, {"weight": 4.0, "description": "Levels of BHB increase in IGT subjects and are predictive indicators for the development of type 2 diabetes over time.", "source_id": "chunk-f2e122f964bade37f487049bd69a3f9f", "order": 1, "source": "BETA-HYDROXYBUTYRATE (BHB)", "target": "IMPAIRED GLUCOSE TOLERANCE (IGT)"}, {"weight": 3.0, "description": "Individuals with IFG show higher levels of AcAc and BHB, inversely correlated with IS as measured by Matsuda ISI.", "source_id": "chunk-f2e122f964bade37f487049bd69a3f9f", "order": 1, "source": "IMPAIRED FASTING GLYCAEMIA (IFG)", "target": "INSULIN SENSITIVITY (IS)"}, {"weight": 3.0, "description": "The GTT can identify individuals at risk for IFG by assessing their blood glucose levels after fasting and consuming a sugary drink.", "source_id": "chunk-f2e122f964bade37f487049bd69a3f9f", "order": 1, "source": "IMPAIRED FASTING GLYCAEMIA (IFG)", "target": "GLUCOSE TOLERANCE TEST (GTT)"}, {"weight": 4.0, "description": "Persistent hyperglycemia is a precursor to IGT and further development into full-blown type 2 diabetes, often correlated with rising ketone body levels.", "source_id": "chunk-f2e122f964bade37f487049bd69a3f9f", "order": 1, "source": "IMPAIRED GLUCOSE TOLERANCE (IGT)", "target": "HYPERGLYCEMIA"}, {"weight": 4.0, "description": "Increased insulin resistance correlates with higher levels of AcAc and BHB, as cells fail to use glucose effectively leading to greater reliance on ketone bodies for energy.", "source_id": "chunk-f2e122f964bade37f487049bd69a3f9f", "order": 1, "source": "KETONE BODIES (KBS)", "target": "INSULIN RESISTANCE"}, {"weight": 7.0, "description": "High-fat diet induces insulin resistance in both control mice and those deficient for SENP1, but the phenotype is more pronounced in the latter group.)", "source_id": "chunk-174831b97ed170039b374ba254d4f506", "order": 1, "source": "INSULIN RESISTANCE", "target": "HFD"}, {"weight": 3.0, "description": "Deletion of the SENP1 gene specifically in adipocytes leads to increased hyperglycemia compared to control NOD mice at similar age stages.)", "source_id": "chunk-8382a49b61215482f9fc75e3a86cb987", "order": 1, "source": "HYPERGLYCEMIA", "target": "ADIPOCYTE-SPECIFIC DELETION OF SENP1"}, {"weight": 6.0, "description": "Mice deficient for the SENP1 gene exhibit an earlier onset and more severe hyperglycemia when exposed to a high-fat diet.)", "source_id": "chunk-174831b97ed170039b374ba254d4f506", "order": 1, "source": "HYPERGLYCEMIA", "target": "SENP1-AP2KO"}, {"weight": 2.0, "description": "The C allele of the GCKR gene variant rs780094 shows a significant increase in BHB levels, suggesting its role in regulating ketone body metabolism.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "order": 1, "source": "GCKR GENE", "target": "BHB LEVELS"}, {"weight": 10.0, "description": "The FXR/RXR pathway is enriched in the analysis of GCKR and other pleiotropic genes involved in metabolic pathways.)", "source_id": "chunk-372184452f1f9156514992455057f843", "order": 1, "source": "GCKR GENE", "target": "FXR/RXR PATHWAY"}, {"weight": 1.8, "description": "Variants in FADS1 have been associated with the level of AcAc, indicating their involvement in fatty acid and lipid metabolism.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "order": 1, "source": "FADS1 GENE", "target": "ACAC LEVELS"}, {"weight": 1.0, "description": "The HMGA2 gene is significantly associated with height and impacts dental development through this association.)", "source_id": "chunk-c63d60b991cd7442f690dcc364af47dd", "order": 1, "source": "HMGA2 GENE", "target": "HEIGHT"}, {"weight": 1.0, "description": "The HMGA2 gene shows evidence of association with the number of teeth, though this relationship is not as strong after removing specific SNPs.)", "source_id": "chunk-c63d60b991cd7442f690dcc364af47dd", "order": 1, "source": "HMGA2 GENE", "target": "NUMBER OF TEETH GWAS"}, {"weight": 2.0, "description": "The enzyme catalyzed by OXCT1 is involved in ketone body synthesis as part of the metabolic pathway known as ketogenesis.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "order": 1, "source": "KETOGENESIS", "target": "3-OXOACID COA TRANSFERASE 1 PROTEIN (OXCT1)"}, {"weight": 2.5, "description": "Expression levels of CPT1A are positively correlated with glucose AUC, suggesting a link between fatty acid metabolism and glucose regulation.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "order": 1, "source": "CPT1A GENE (CARNITINE PALMITOYLTRANSFERASE 1A)", "target": "GLUCOSE AUC PARAMETER"}, {"weight": 3.0, "description": "Expression of ACAT1 is positively correlated with insulin sensitivity, indicating its role in maintaining metabolic health.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "order": 1, "source": "ACAT1 GENE (ACETYL-COA ACETYLTRANSFERASE 1)", "target": "INSULIN SENSITIVITY PARAMETER (MATSUDA ISI)"}, {"weight": 2.0, "description": "Inverse correlation between BDH1 expression and glucose AUC suggests a protective effect of ketolysis on insulin resistance or impaired glucose tolerance.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "order": 1, "source": "BDH1 GENE (BHB DEHYDROGENASE, TYPE 1)", "target": "GLUCOSE AUC PARAMETER"}, {"weight": 2.0, "description": "OXCT1 plays a role in the catabolism of short-chain fatty acids, linking its activity to the metabolism and regulation of FFAs.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "order": 1, "source": "3-OXOACID COA TRANSFERASE 1 PROTEIN (OXCT1)", "target": "FATTY ACIDS (FFAS)"}, {"weight": 4.0, "description": "Individuals with prediabetes have an increased risk of progressing to type 2 diabetes if left untreated or unmanaged.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "order": 1, "source": "TYPE 2 DIABETES", "target": "PREDIABETES"}, {"weight": 1.0, "description": "The minor allele of each SNP shows an inverse relationship with type 2 diabetes risk.", "source_id": "chunk-b803830d07bff8ae14550f6458048707", "order": 1, "source": "TYPE 2 DIABETES", "target": "MINOR ALLELE OF SNP"}, {"weight": 4.0, "description": "The HNF1A locus has a SNP that influences CRP but also inversely impacts LDL-cholesterol and total cholesterol levels.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "order": 1, "source": "CRP GWAS SNPS", "target": "HNF1A GENE"}, {"weight": 5.0, "description": "SNPs in the APOC1 gene increase CRP while decreasing levels of LDL-cholesterol and total cholesterol, indicating complex regulatory interactions.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "order": 1, "source": "APOC1 GENE", "target": "LDL-CHOLESTEROL AND TOTAL CHOLESTEROL LEVELS"}, {"weight": 9.0, "description": "SNPs in APOC1 gene influence both total cholesterol and triglyceride levels inversely to CRP levels, indicating complex regulatory pathways.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "order": 1, "source": "APOC1 GENE", "target": "TOTAL CHOLESTEROL AND TRIGLYCERIDES LEVELS"}, {"weight": 6.0, "description": "SNP rs4420638 near APOC1 increases CRP levels but reduces the risk of type 2 diabetes.)", "source_id": "chunk-372184452f1f9156514992455057f843", "order": 1, "source": "APOC1 GENE", "target": "T2D DISEASE"}, {"weight": 6.0, "description": "The HNF1A locus shows a SNP that influences both CRP and cardiometabolic traits like lipid levels.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "order": 1, "source": "HNF1A GENE", "target": "CRP LEVELS"}, {"weight": 5.0, "description": "The HNF1A gene\'s variant rs1183910 is linked to increased serum CRP and lower risk of CAD.)", "source_id": "chunk-372184452f1f9156514992455057f843", "order": 1, "source": "HNF1A GENE", "target": "CAD DISEASE"}, {"weight": 7.0, "description": "Lower linkage disequilibrium between top SNPs of the IL6R gene in CRP GWAS compared to CAD GWAS indicates different functional relevance.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "order": 1, "source": "IL6R GENE", "target": "CARDIOMETABOLIC PHENOTYPES GWAS"}, {"weight": 7.0, "description": "The IL6R gene shows biological pleiotropy in association with CRP and cardiometabolic phenotypes after adjusting for mediators like BMI, cholesterol levels.)", "source_id": "chunk-372184452f1f9156514992455057f843", "order": 1, "source": "IL6R GENE", "target": "CRP PROTEIN"}, {"weight": 3.0, "description": "The HNF4A gene is involved in the regulation of cardiometabolic phenotypes.)", "source_id": "chunk-372184452f1f9156514992455057f843", "order": 1, "source": "HNF4A GENE", "target": "CARDIOMETABOLIC PHENOTYPE"}, {"weight": 2.0, "description": "The effects observed from TMEM18 are mainly mediated by BMI, suggesting its role in metabolic phenotypes through body mass index.)", "source_id": "chunk-372184452f1f9156514992455057f843", "order": 1, "source": "TMEM18 GENE", "target": "BMI PHYSIOLOGICAL PROCESS"}, {"weight": 9.0, "description": "Similar to MC4R, PLTP does not show a significant relationship with CRP levels after correction.)", "source_id": "chunk-372184452f1f9156514992455057f843", "order": 1, "source": "PLTP GENE", "target": "CRP PROTEIN"}, {"weight": 8.0, "description": "No significant association found between MC4R and CRP levels after correction for multiple testing.)", "source_id": "chunk-372184452f1f9156514992455057f843", "order": 1, "source": "MC4R GENE", "target": "CRP PROTEIN"}, {"weight": 8.0, "description": "GWAS for cardiometabolic traits and CRP levels show significant overlap, indicating shared genetic basis.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "order": 1, "source": "CARDIOMETABOLIC PHENOTYPES GWAS", "target": "CRP LEVELS"}, {"weight": 10.0, "description": "Genetic variants influencing fasting glucose and insulin also affect cardiometabolic traits such as cholesterol levels, illustrating pleiotropy.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "order": 1, "source": "CARDIOMETABOLIC PHENOTYPES GWAS", "target": "FASTING GLUCOSE AND INSULIN LEVELS"}, {"weight": 7.0, "description": "SNPs near BCL7B show associations with CRP, indicating its involvement in metabolic pathways regulating inflammation markers.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "order": 1, "source": "CRP LEVELS", "target": "BCL7B GENE"}, {"weight": 6.0, "description": "This gene was newly identified through the analysis of SNPs affecting both CRP and specific cardiometabolic phenotypes such as cholesterol levels.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "order": 1, "source": "IL1F10 GENE", "target": "CARDIOMETABOLIC TRAITS GWAS"}, {"weight": 2.0, "description": "The IL1F10 gene was not identified in a previous GWAS for association between SNPs and CRP, but has been found to be significant with cholesterol levels.)", "source_id": "chunk-372184452f1f9156514992455057f843", "order": 1, "source": "IL1F10 GENE", "target": "GWAS STUDY"}, {"weight": 4.0, "description": "Effects on CRP levels from BCL7B decrease significantly when adjusted for CRP, indicating potential mediation through lipids.)", "source_id": "chunk-372184452f1f9156514992455057f843", "order": 1, "source": "BCL7B GENE", "target": "CRP PROTEIN"}, {"weight": 8.0, "description": "The association of 18 CRP SNPs with cardiometabolic traits is significant across multiple phenotypes, suggesting shared genetic underpinnings.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "order": 1, "source": "CARDIOMETABOLIC TRAITS GWAS", "target": "CRP SNPS"}, {"weight": 4.0, "description": "Lipids, particularly cholesterol levels, mediate pleiotropic effects observed from genetic loci on cardiometabolic phenotypes.)", "source_id": "chunk-372184452f1f9156514992455057f843", "order": 1, "source": "CHOLESTEROL LEVELS", "target": "GENETIC LOCI MEDIATION"}, {"weight": 5.0, "description": "Adjustment for HbA1c leads to significant reduction in the association between APOC1 and type 2 diabetes, indicating mediation through glycemic control.)", "source_id": "chunk-372184452f1f9156514992455057f843", "order": 1, "source": "APOC1 GENE AND T2D DISEASE RELATIONSHIP", "target": "HBA1C PHYSIOLOGICAL PROCESS"}, {"weight": 6.0, "description": "Adjustment for triglyceride levels leads to significant reduction in the association between PABPC4 gene and metabolic phenotypes, indicating mediation through this physiological process.)", "source_id": "chunk-372184452f1f9156514992455057f843", "order": 1, "source": "PABPC4 GENE AND METABOLIC PHENOTYPE RELATIONSHIP", "target": "TRIGLYCERIDES PHYSIOLOGICAL PROCESS"}, {"weight": 7.0, "description": "Adjustment for HDL-cholesterol levels leads to significant reduction in the association between BCL7B gene and metabolic phenotypes, indicating mediation through this physiological process.)", "source_id": "chunk-372184452f1f9156514992455057f843", "order": 1, "source": "BCL7B GENE AND METABOLIC PHENOTYPE RELATIONSHIP", "target": "HDL-CHOLESTEROL PHYSIOLOGICAL PROCESS"}, {"weight": 8.0, "description": "Adjusting for BMI significantly affects the pleiotropic effects observed from genetic loci on cardiometabolic phenotypes.)", "source_id": "chunk-372184452f1f9156514992455057f843", "order": 1, "source": "BMI ADJUSTMENT PHYSIOLOGICAL PROCESS", "target": "PLEIOTROPIC EFFECTS OF GENETIC LOCI"}, {"weight": 10.0, "description": "The CC genotype of miR-34b/c rs4938723 is significantly associated with a decreased risk of IA compared to the TT genotype.", "source_id": "chunk-055177812e320344d131432b292111b0", "order": 1, "source": "MIR-34B/C RS4938723", "target": "IA (INTRACRANIAL ANEURYSM)"}, {"weight": -2.0, "description": "No significant association between the number of aneurysms and miR-34b/c rs4938723 genotypes was observed.", "source_id": "chunk-055177812e320344d131432b292111b0", "order": 1, "source": "MIR-34B/C RS4938723", "target": "NUMBER OF ANEURYSMS"}, {"weight": -2.0, "description": "No association was observed between TP53 Arg72Pro and IA risk for genotypic or allelic analysis.", "source_id": "chunk-055177812e320344d131432b292111b0", "order": 1, "source": "TP53 ARG72PRO", "target": "IA (INTRACRANIAL ANEURYSM)"}, {"weight": -2.0, "description": "No significant association between the number of aneurysms and TP53 Arg72Pro genotypes was observed.", "source_id": "chunk-055177812e320344d131432b292111b0", "order": 1, "source": "TP53 ARG72PRO", "target": "NUMBER OF ANEURYSMS"}, {"weight": 6.0, "description": "The combined genotype of miR-34b/c rs4938723 CC and TP53 Arg72Pro CG/CC/GG is associated with a decreased risk of IA compared to the combined genotypes CT/TT\u2009+\u2009CG/CC/GG.", "source_id": "chunk-055177812e320344d131432b292111b0", "order": 1, "source": "MIR-34B/C RS4938723 CC", "target": "TP53 ARG72PRO CG/CC/GG"}, {"weight": 2.0, "description": "A SNP in C21orf34\'s intronic region was detected for respiratory quotient during sleep.", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "order": 1, "source": "C21ORF34", "target": "RESPIRATORY QUOTIENT (RQ)"}, {"weight": 2.0, "description": "A variant in RPL7P3\u2019s 5\u2032UTR region is associated with accelerometer-measured light activity.", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "order": 1, "source": "RPL7P3", "target": "LIGHT ACTIVITY"}, {"weight": 2.0, "description": "Variants in CTCFL\'s 3\u2032UTR region were linked to sedentary-light activity.", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "order": 1, "source": "CTCFL", "target": "SEDENTARY-LIGHT ACTIVITY"}, {"weight": 2.0, "description": "Significant variants for MATK on chromosome 19 are associated with total energy expenditure after adjusting for body weight.", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "order": 1, "source": "MATK", "target": "TOTAL ENERGY EXPENDITURE"}, {"weight": 2.0, "description": "Variants in CHRNA3 on chromosome 15 are linked to sleeping energy expenditure, after controlling for body weight.", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "order": 1, "source": "CHRNA3", "target": "SLEEPING ENERGY EXPENDITURE"}, {"weight": 2.0, "description": "An intronic variant in the gene ARHGAP11A on chromosome 15 is associated with sleep duration.", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "order": 1, "source": "INTRONIC VARIANT OF ARHGAP11A", "target": "SLEEP DURATION"}, {"weight": 2.0, "description": "This SNP is linked to respiratory quotient during sleep, indicating a genetic influence on metabolic rate during rest.", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "order": 1, "source": "SNP IN C21ORF34 INTRONIC REGION", "target": "RESPIRATORY QUOTIENT (RQ)"}, {"weight": 2.0, "description": "A variant in the 5\u2032UTR region of RPL7P3 is associated with accelerometer-measured light activity, reflecting genetic impact on physical activity levels during sedentary periods.", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "order": 1, "source": "VARIANT IN 5\u2032UTR OF RPL7P3", "target": "LIGHT ACTIVITY"}, {"weight": 2.0, "description": "The variant influences sedentary-light activity levels through its effect on the expression or regulation of the CTCFL gene.", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "order": 1, "source": "VARIANT IN 3\u2032UTR OF CTCFL", "target": "SEDENTARY-LIGHT ACTIVITY"}, {"weight": 2.0, "description": "After adjusting for body weight, variants in MATK are associated with total energy expenditure, indicating a complex genetic and environmental interaction affecting metabolic rate.", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "order": 1, "source": "TOTAL ENERGY EXPENDITURE VARIANTS FOR MATK", "target": "BODY WEIGHT"}, {"weight": 2.0, "description": "Variants in the gene CHRNA3 influence sleeping energy expenditure, suggesting that body weight adjustment can reveal significant genetic associations related to resting metabolism.", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "order": 1, "source": "SLEEPING ENERGY EXPENDITURE VARIANTS FOR CHRNA3", "target": "BODY WEIGHT"}, {"weight": 8.0, "description": "APOBR gene variants affect the protein sequence of APOBR which influences lipid metabolism.", "source_id": "chunk-7ca64f92964b051cfb1c43f967f243a5", "order": 1, "source": "APOBR", "target": "RS3833080: P.GLY369_ASP370DEL9, RS180743: P.PRO428ALA, AND RS368546180: P.THR321_GLY329DEL9"}, {"weight": 4.0, "description": "Bioinformatics tools are used to predict the functional impact of these protein variants.", "source_id": "chunk-7ca64f92964b051cfb1c43f967f243a5", "order": 1, "source": "RS3833080: P.GLY369_ASP370DEL9, RS180743: P.PRO428ALA, AND RS368546180: P.THR321_GLY329DEL9", "target": "MUTATION TASTER, SIFT, POLYPHEN2, PANTHER, SNAP, PMUT, PROVEAN"}, {"weight": 6.0, "description": "The dietary pattern contributing to obesity may include excessive intake of fatty acids affecting lipid metabolism.", "source_id": "chunk-7ca64f92964b051cfb1c43f967f243a5", "order": 1, "source": "FATTY ACIDS (LIPIDS)", "target": "EXTREMELY OBESE CHILDREN AND ADOLESCENTS DIETARY PATTERN"}, {"weight": 5.0, "description": "These studies confirm associations between genetic variants and obesity in families.", "source_id": "chunk-7ca64f92964b051cfb1c43f967f243a5", "order": 1, "source": "FAMILY-BASED ASSOCIATION STUDIES (FBAT)", "target": "RS3833080 AND RS180743"}, {"weight": 5.0, "description": "This analysis showed nominal associations between these genetic variants and obesity.", "source_id": "chunk-7ca64f92964b051cfb1c43f967f243a5", "order": 1, "source": "CASE-CONTROL ASSOCIATION ANALYSIS", "target": "RS180743: P.PRO428ALA AND RS3833080: P.GLY369_ASP370DEL9"}, {"weight": 4.0, "description": "The synonymous variant predicted to affect splicing and transcription factor binding sites, altering the gene\u2019s regulatory regions.", "source_id": "chunk-607feda7df4db8151b99560074c91eea", "order": 1, "source": "SULT1A1 GENE", "target": "P.PRO200 = (RS3176926)"}, {"weight": 5.0, "description": "These variants in SULT1A2 were studied for their potential functional impact on the gene\'s activity and protein binding sites.", "source_id": "chunk-607feda7df4db8151b99560074c91eea", "order": 1, "source": "SULT1A2 GENE", "target": "RS4149403: P.ILE7THR, RS10797300: P.PRO19LEU, ETC."}, {"weight": 7.0, "description": "The variant in TUFM predicted to alter splicing regulator or transcription factor binding sites, indicating a role in regulatory function.", "source_id": "chunk-607feda7df4db8151b99560074c91eea", "order": 1, "source": "TUFM GENE", "target": "C.3536C>G VARIANT"}, {"weight": 4.0, "description": "The TUFM gene harbors a variant rs61737565 that is predicted to lead to altered splicing regulator or transcription factor binding sites.", "source_id": "chunk-fde6653b9d9013ed054505cfe4cd1455", "order": 1, "source": "RS61737565: C.922+29C>G", "target": "TUFM"}, {"weight": 5.0, "description": "The genomic variant rs8061877 disrupts a transcription factor binding site for SRY, HFH 2, and HMG-IY proteins.", "source_id": "chunk-fde6653b9d9013ed054505cfe4cd1455", "order": 1, "source": "RS8061877", "target": "SRY, HFH 2, HMG-IY TRANSCRIPTION FACTORS"}, {"weight": 13.0, "description": "The variant g.28854194C/G alters splice enhancer binding sites according to in silico predictions.<SEP>The variant g.28854194C/G alters splice enhancer binding sites, impacting splicing efficiency and mRNA maturation.", "source_id": "chunk-fde6653b9d9013ed054505cfe4cd1455", "order": 1, "source": "G.28854194C/G", "target": "SPLICE ENHANCER BINDING SITES"}, {"weight": 7.0, "description": "In silico predictions suggest that the variant g.28854194C/G changes splicing silencer sites, affecting RNA processing.", "source_id": "chunk-fde6653b9d9013ed054505cfe4cd1455", "order": 1, "source": "G.28854194C/G", "target": "SPLICING SILENCER SITES"}, {"weight": 6.0, "description": "The genomic variant g.28854194C/G is located in the non-coding 3\' UTR region of the TUFM transcript.", "source_id": "chunk-fde6653b9d9013ed054505cfe4cd1455", "order": 1, "source": "G.28854194C/G", "target": "3\u2019 UTR OF TUFM"}, {"weight": 2.0, "description": "This SNP in nitric oxide synthase 3 is associated with a decreased risk of ovarian cancer, showing an odds ratio of 0.79 at p=0.003.", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "order": 1, "source": "NOS3 SNP RS743507", "target": "OVARIAN CANCER RISK"}, {"weight": 3.0, "description": "This missense variant in the IL1A gene is associated with a decreased risk of ovarian cancer, showing an odds ratio of 0.90 at p=0.005.", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "order": 1, "source": "IL1A SNP RS17561", "target": "OVARIAN CANCER RISK"}, {"weight": 1.0, "description": "This variant in IL1B is associated with increased risk of ovarian cancer, showing a significant result (p=0.02).", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "order": 1, "source": "IL1B SNP RS7596684", "target": "OVARIAN CANCER RISK"}, {"weight": 6.0, "description": "The Cdx-2 genomic variant is studied to understand its potential association with the increased risk of developing ovarian cancer.)", "source_id": "chunk-dc5e8cc04a1b16b1e00f3a4120e004c4", "order": 1, "source": "OVARIAN CANCER", "target": "CDX-2 (RS11568820)"}, {"weight": 6.0, "description": "The TaqI genomic variant has been investigated for its role in influencing the risk of ovarian cancer, though no significant association was found under certain genetic models.)", "source_id": "chunk-dc5e8cc04a1b16b1e00f3a4120e004c4", "order": 1, "source": "OVARIAN CANCER", "target": "TAQI (RS731236)"}, {"weight": 4.0, "description": "Individuals with GG genotype at a specific locus have a different risk profile compared to A allele carriers for ovarian cancer.)", "source_id": "chunk-dc5e8cc04a1b16b1e00f3a4120e004c4", "order": 1, "source": "OVARIAN CANCER", "target": "GG CARRIERS"}, {"weight": 5.0, "description": "Carrying the A allele in certain genomic variants is associated with an increased risk of ovarian cancer relative to GG carriers.)", "source_id": "chunk-dc5e8cc04a1b16b1e00f3a4120e004c4", "order": 1, "source": "OVARIAN CANCER", "target": "A ALLELE CARRIERS"}, {"weight": 5.0, "description": "The genomic variant rs7596684 in IL1B is associated with ovarian cancer risk.<SEP>The genomic variant rs7596684 in IL1B is suggested to be associated with an increased risk of ovarian cancer.", "source_id": "chunk-b6ea16f7f7eb8bc6f36f2be03fe62403", "order": 1, "source": "IL1B (INTERLEUKIN 1, BETA)", "target": "RS7596684"}, {"weight": 7.0, "description": "A study suggests a variant in the IL1B gene may associate with an elevated risk for ovarian cancer.<SEP>A study suggests that a variant within IL1B gene may be linked to higher risks of ovarian cancer development.", "source_id": "chunk-b6ea16f7f7eb8bc6f36f2be03fe62403", "order": 1, "source": "IL1B (INTERLEUKIN 1, BETA)", "target": "OVARIAN CANCER RISK"}, {"weight": 5.0, "description": "The genomic variant rs2282169 in PTGS1 is associated with ovarian cancer risk.<SEP>The genomic variant rs2282169 in PTGS1 is suggested to be associated with an increased risk of ovarian cancer.", "source_id": "chunk-b6ea16f7f7eb8bc6f36f2be03fe62403", "order": 1, "source": "PTGS1 (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE 1)", "target": "RS2282169"}, {"weight": 7.0, "description": "A study indicates that a variant in PTGS1 could contribute to an increased risk for ovarian cancer.<SEP>A study indicates that a variant within PTGS1 might be linked to higher risks of ovarian cancer development.", "source_id": "chunk-b6ea16f7f7eb8bc6f36f2be03fe62403", "order": 1, "source": "PTGS1 (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE 1)", "target": "OVARIAN CANCER RISK"}, {"weight": 2.0, "description": "The ALOX15 gene plays a role in inflammation and lipid metabolism, influencing the body\'s inflammatory response.", "source_id": "chunk-b6ea16f7f7eb8bc6f36f2be03fe62403", "order": 1, "source": "ALOX15", "target": "INFLAMMATION"}, {"weight": 3.0, "description": "CCL2 is involved in immune cell recruitment during inflammation and infection responses.", "source_id": "chunk-b6ea16f7f7eb8bc6f36f2be03fe62403", "order": 1, "source": "CCL2 (CHEMOKINE LIGAND 2)", "target": "IMMUNE RESPONSE"}, {"weight": 4.0, "description": "CRP protein levels increase in response to inflammatory stimuli, indicating an active inflammatory process.", "source_id": "chunk-b6ea16f7f7eb8bc6f36f2be03fe62403", "order": 1, "source": "CRP (C-REACTIVE PROTEIN)", "target": "INFLAMMATION"}, {"weight": 3.0, "description": "IL18 is a cytokine that modulates immune responses and inflammation-related processes.", "source_id": "chunk-b6ea16f7f7eb8bc6f36f2be03fe62403", "order": 1, "source": "IL18 (INTERLEUKIN 18)", "target": "IMMUNE RESPONSE"}, {"weight": 2.0, "description": "A genetic variant in the CRP gene, which codes for C-reactive protein, shows an association with ovarian cancer risk.", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "order": 1, "source": "OVARIAN CANCER RISK", "target": "CRP SNP "}, {"weight": 3.0, "description": "This variant in IL1B is associated with increased ovarian cancer risk, showing a significant result (p=0.02).", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "order": 1, "source": "OVARIAN CANCER RISK", "target": "IL1B SNP RS7596684 "}, {"weight": 12.0, "description": "The FokI variant is significantly associated with an increased risk of ovarian cancer according to the meta-analysis conducted.", "source_id": "chunk-1c470c93632f3704d6f3566de7a1dd0c", "order": 1, "source": "OVARIAN CANCER RISK", "target": "FOKI (RS2228570 OR RS10735810)"}, {"weight": 3.0, "description": "There was no significant association found between ApaI and ovarian cancer risk in the evaluated studies.", "source_id": "chunk-1c470c93632f3704d6f3566de7a1dd0c", "order": 1, "source": "OVARIAN CANCER RISK", "target": "APAI (RS7975232)"}, {"weight": 3.0, "description": "The genomic variant BsmI showed no significant association with ovarian cancer risk, according to the meta-analysis results.", "source_id": "chunk-1c470c93632f3704d6f3566de7a1dd0c", "order": 1, "source": "OVARIAN CANCER RISK", "target": "BSMI (RS1544410)"}, {"weight": 4.0, "description": "The association of certain genomic variants with ovarian cancer risk varied when analyzing data restricted to Caucasian populations compared to broader ethnic groups.", "source_id": "chunk-1c470c93632f3704d6f3566de7a1dd0c", "order": 1, "source": "OVARIAN CANCER RISK", "target": "CAUCASIANS"}, {"weight": 3.0, "description": "The production of IL-6 is associated with increased inflammation, particularly in relation to Th17 cell activity and immune response regulation.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "order": 1, "source": "INFLAMMATION", "target": "IL-6"}, {"weight": 3.0, "description": "The elevated expression of IL-1\u03b2 is associated with enhanced inflammatory processes, particularly in immune-mediated pathologies.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "order": 1, "source": "INFLAMMATION", "target": "IL-1\u0392 (INTERLEUKIN 1 BETA)"}, {"weight": 4.0, "description": "Macrophage populations such as LPM\u03d5s contribute to the production of pro-inflammatory cytokines and thus play a significant role in driving inflammatory processes.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "order": 1, "source": "INFLAMMATION", "target": "LPM\u03a6S (LY6C+ PERITONEAL MACROPHAGES)"}, {"weight": 2.0, "description": "Reduced arginase expression can indicate a shift towards pro-inflammatory macrophage phenotypes and increased inflammatory activity.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "order": 1, "source": "INFLAMMATION", "target": "ARGINASE"}, {"weight": 2.0, "description": "High TNF-\u03b1 levels contribute to the amplification of inflammatory responses and cellular damage during disease states.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "order": 1, "source": "IMMUNE RESPONSE", "target": "TNF-\u0391 (TUMOR NECROSIS FACTOR ALPHA)"}, {"weight": 3.0, "description": "The upregulation of IL-23p19 is indicative of an enhanced immune response, particularly in the context of Th17 cell-mediated inflammation.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "order": 1, "source": "IMMUNE RESPONSE", "target": "IL-23P19"}, {"weight": 6.0, "description": "EBNA2\'s effect on CD40 expression influences the host\'s immune response, potentially aiding viral survival through altered gene regulation.", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "order": 1, "source": "IMMUNE RESPONSE", "target": "CD40"}, {"weight": 1.5, "description": "Analysis of SNPs within MTHFD2 indicates potential associations with increased risk of developing childhood ALL.", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "order": 1, "source": "MTHFD2 GENE", "target": "CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)"}, {"weight": 1.5, "description": "SNPs in BHMT2 were analyzed for their association with the disease, suggesting a possible genetic link to increased risk of developing childhood ALL.", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "order": 1, "source": "BHMT2 GENE", "target": "CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)"}, {"weight": 2.5, "description": "The SNP rs3918186 in the NOS3 gene was found to have a significant association with an increased risk of childhood ALL, suggesting a direct genetic influence on disease susceptibility.", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "order": 1, "source": "NOS3 GENE (RS3918186)", "target": "CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)"}, {"weight": 2.5, "description": "The SNP rs3918186 in NOS3 gene, involved in the nitric oxide synthesis pathway, was found to significantly increase the risk of childhood ALL.", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "order": 1, "source": "NOS3 GENE (RS3918186)", "target": "FOLATE METABOLIC PATHWAY"}, {"weight": 2.0, "description": "The SNP rs1051266 in the SLC19A1 gene was found to have a less strong but still notable association with an increased risk of childhood ALL, indicating potential genetic influence on disease development.", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "order": 1, "source": "SLC19A1 GENE (RS1051266)", "target": "CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)"}, {"weight": 2.0, "description": "The SNP rs1051266 in SLC19A1 gene, associated with folate transport and metabolism, was found to increase the risk of childhood ALL.", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "order": 1, "source": "SLC19A1 GENE (RS1051266)", "target": "FOLATE METABOLIC PATHWAY"}, {"weight": 4.0, "description": "SNPs in folate metabolic genes were analyzed for their associations with an increased risk of developing childhood ALL.", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "order": 1, "source": "CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)", "target": "FOLATE METABOLIC GENES SNPS"}, {"weight": 3.0, "description": "The Bayesian analysis model was applied to evaluate the SNPs in folate metabolic genes for their associations with childhood ALL, aiming to uncover genetic risk factors linked to the disease.", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "order": 1, "source": "FOLATE METABOLIC GENES", "target": "BAYESIAN ANALYSIS MODEL"}, {"weight": 4.0, "description": "The 16 folate metabolic genes were the source of tagging SNPs analyzed for their association with childhood ALL.", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "order": 1, "source": "FOLATE METABOLIC GENES", "target": "FOLATE METABOLIC GENES SNPS"}, {"weight": 3.0, "description": "Similar to the Healthy Eating group, genetic variation in FADS1/2 had an impact on serum AA and 18:3 n-3 concentrations in this dietary pattern.", "source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "order": 1, "source": "FADS1/2 HAPLOTYPE", "target": "MEDITERRANEAN DIET GROUP"}, {"weight": 4.0, "description": "The baseline concentration of AA was significantly influenced by the number of minor alleles within FADS1/2 haplotype SNPs, reflecting a genetic effect on its level.", "source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "order": 1, "source": "FADS1/2 HAPLOTYPE", "target": "AA (ARACHIDONIC ACID)"}, {"weight": 3.0, "description": "No significant association was found between the genotype and EPA concentration at baseline or after dietary intervention.", "source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "order": 1, "source": "FADS1/2 HAPLOTYPE", "target": "EPA (EICOSAPENTAENOIC ACID)"}, {"weight": 5.0, "description": "Dietary intake of long chain n-3 fatty acids was a strong predictor of serum levels in this diet group, highlighting the role of nutrition over genetics.", "source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "order": 1, "source": "HEALTHY EATING DIET GROUP", "target": "LONG CHAIN N-3 FATTY ACIDS"}, {"weight": 4.0, "description": "Similar to the Healthy Eating group, dietary intake significantly predicted baseline concentrations of long chain n-3 fatty acids in this diet pattern.", "source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "order": 1, "source": "MEDITERRANEAN DIET GROUP", "target": "LONG CHAIN N-3 FATTY ACIDS"}, {"weight": 4.0, "description": "The Healthy Eating dietary pattern aims to improve the polyunsaturated fat:saturated fat ratio, though results were non-significant.", "source_id": "chunk-e1b4f4dac52e806f19c580640a50c729", "order": 1, "source": "POLYUNSATURATED FAT:SATURATED FAT RATIO", "target": "HEALTHY EATING DIET"}, {"weight": 10.0, "description": "Decreased 18:2 n-6 levels are associated with increased MUFA and n-3 PUFAs in the Mediterranean diet intervention.", "source_id": "chunk-e1b4f4dac52e806f19c580640a50c729", "order": 1, "source": "18:2 N-6", "target": "MUFA AND N-3 PUFA"}, {"weight": 12.0, "description": "The increase of n-3 PUFA leads to an increase in long chain n-3 PUFA, impacting inflammatory processes and cardiovascular health.", "source_id": "chunk-e1b4f4dac52e806f19c580640a50c729", "order": 1, "source": "N-3 PUFA", "target": "LONG CHAIN N-3 PUFA"}, {"weight": 7.0, "description": "Statistical analysis reveals significant interactions between genotype (FADS1/2 gene cluster) and diet interventions affecting fatty acid concentrations in the colon.", "source_id": "chunk-e1b4f4dac52e806f19c580640a50c729", "order": 1, "source": "GENOTYPE BY DIET INTERACTION", "target": "LINEAR MIXED MODEL RESULTS"}, {"weight": 4.0, "description": "Lower SES is associated with higher risk of habitual snoring, especially among males.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "order": 1, "source": "SNORING", "target": "SES"}, {"weight": 5.0, "description": "Higher smoking frequency correlates positively with the prevalence of habitual snoring in females and to a lesser extent in males.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "order": 1, "source": "SNORING", "target": "SMOKING FREQUENCY"}, {"weight": 6.0, "description": "Frequency of alcohol consumption is correlated more strongly with snoring in males than in females.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "order": 1, "source": "SNORING", "target": "ALCOHOL CONSUMPTION FREQUENCY"}, {"weight": 7.0, "description": "Higher whole-body fat mass is positively associated with habitual snoring prevalence.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "order": 1, "source": "SNORING", "target": "WHOLE-BODY FAT MASS"}, {"weight": 8.0, "description": "These loci contain genetic variants that increase the risk of being a habitual snorer.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "order": 1, "source": "SNORING", "target": "GENOMIC RISK LOCI "}, {"weight": 9.0, "description": "Habitual snoring has high genetic correlation with self-reported sleep apnea, indicating shared genetic factors.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "order": 1, "source": "SNORING", "target": "SELF-REPORTED SLEEP APNOEA "}, {"weight": 2.0, "description": "Risk loci identified through GWAS contain variants with specific odds ratios indicating the increased likelihood of snoring.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "order": 1, "source": "GENOMIC RISK LOCI ", "target": "ODDS RATIO (OR)"}, {"weight": 4.0, "description": "There is a high genetic correlation between self-reported sleep apnea and habitual snoring, suggesting shared underlying genetic risk factors (rG=0.78).", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "order": 1, "source": "SELF-REPORTED SLEEP APNOEA ", "target": "GENETIC CORRELATION (RG)"}, {"weight": 10.0, "description": "Traits like BMI and heart disease are genetically correlated to habitual snoring, suggesting common underlying genetic risk factors.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "order": 1, "source": "GENETIC CORRELATION ", "target": "BMI AND HEART DISEASE "}, {"weight": 1.0, "description": "The GWAS study uncovered 127 independent genome-wide significant associations across 41 genomic risk loci for snoring.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "order": 1, "source": "GWAS STUDY ", "target": "SNORING "}, {"weight": 4.0, "description": "The Synergy Index measures the interaction effect in terms of odds ratios, evaluating how two factors together influence disease risk compared to their individual effects.", "source_id": "chunk-a7d0bfa8b16262a1f313b7e3060969c6", "order": 1, "source": "ODDS RATIO (OR)", "target": "SYNERGY INDEX (SI)"}, {"weight": 3.0, "description": "The Odds Ratio is used to quantify the relationship between AMD and various risk factors such as genetic variants and lifestyle scores.", "source_id": "chunk-a7d0bfa8b16262a1f313b7e3060969c6", "order": 1, "source": "ODDS RATIO (OR)", "target": "AMD"}, {"weight": 3.0, "description": "The overall SNP heritability for habitual snoring was 9.9% on the liability scale, indicating a substantial genetic component to the trait.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "order": 1, "source": "SNP HERITABILITY (H2SNP)", "target": "SNORING "}, {"weight": 5.0, "description": "Measures of oxyhemoglobin saturation during sleep show moderate significant genetic correlations with habitual snoring, indicating their importance as proxies for sleep-disordered breathing.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "order": 1, "source": "OXYHEMOGLOBIN SATURATION ", "target": "SNORING "}, {"weight": 2.0, "description": "The MSRB3 gene contributes to genetic predisposition towards snoring and its associated traits.)", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "order": 1, "source": "MSRB3 GENE", "target": "SNORING (PHYSIOLOGICAL PROCESS)"}, {"weight": 3.0, "description": "Specific SNPs are identified through eQTL mapping as influencing gene expression relevant to snoring.)", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "order": 1, "source": "SNP (GENOMIC VARIANT)", "target": "EQTL MAPPING"}, {"weight": 2.0, "description": "Genes identified through eQTL mapping are associated with cardiometabolic traits and diseases, suggesting shared genetic predispositions.)", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "order": 1, "source": "EQTL MAPPING", "target": "CARDIOMETABOLIC TRAITS AND DISEASES (DISEASE)"}, {"weight": 4.0, "description": "BMI is an environmental factor that influences the genetic predisposition towards snoring, indicating complex interactions between genetics and environment.)", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "order": 1, "source": "BMI (ENVIRONMENTAL FACTOR)", "target": "SNORING (PHYSIOLOGICAL PROCESS)"}, {"weight": 4.0, "description": "Gene expression in blood vessel tissues is linked to the physiological process of snoring, after adjusting for BMI.)", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "order": 1, "source": "SNORING (PHYSIOLOGICAL PROCESS)", "target": "BLOOD VESSEL TISSUE EXPRESSION"}, {"weight": 4.0, "description": "There is a genetic correlation between pulse rate and snoring, suggesting physiological interdependence.)", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "order": 1, "source": "SNORING (PHYSIOLOGICAL PROCESS)", "target": "PULSE RATE (PHYSIOLOGICAL PROCESS)"}, {"weight": 3.0, "description": "Specific genomic variants are associated with cardiometabolic diseases through their impact on snoring predisposition.)", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "order": 1, "source": "GENOME-WIDE SIGNIFICANT SNP (GENOMIC VARIANT)", "target": "CARDIOMETABOLIC TRAITS AND DISEASES (DISEASE)"}, {"weight": 3.0, "description": "This genomic variant is associated with recent snoring in males, suggesting a genetic predisposition to the condition.", "source_id": "chunk-a34b927ed42ff0917960122b4d203f83", "order": 1, "source": "RS199797821", "target": "RECENT SNORING"}, {"weight": 3.0, "description": "This genomic variant is associated with recent snoring in females, indicating a sex-specific genetic influence on the condition.", "source_id": "chunk-a34b927ed42ff0917960122b4d203f83", "order": 1, "source": "RS200391180", "target": "RECENT SNORING"}, {"weight": 4.0, "description": "The polygenic score derived from GWAS summary statistics significantly predicts the prevalence of recent snoring in an independent sample.", "source_id": "chunk-a34b927ed42ff0917960122b4d203f83", "order": 1, "source": "PGS (POLYGENIC SCORE)", "target": "RECENT SNORING"}, {"weight": 5.0, "description": "The AGDS sample was used to derive PGS for recent snoring, demonstrating predictive power independent of discovery GWAS.", "source_id": "chunk-a34b927ed42ff0917960122b4d203f83", "order": 1, "source": "PGS (POLYGENIC SCORE)", "target": "AGDS (AUSTRALIAN GENETICS OF DEPRESSION STUDY)"}, {"weight": 2.0, "description": "Severe cases of recent snoring may indicate probable obstructive sleep apnea, characterized by breathing cessation and choking during sleep.", "source_id": "chunk-a34b927ed42ff0917960122b4d203f83", "order": 1, "source": "RECENT SNORING", "target": "PROBABLE OSA"}, {"weight": 3.0, "description": "Genetic loci with significant associations in GWAS are critical in predicting recent snoring and its severity.", "source_id": "chunk-a34b927ed42ff0917960122b4d203f83", "order": 1, "source": "RECENT SNORING", "target": "TOP HITS"}, {"weight": 4.0, "description": "The GWAS identifies genetic variants that contribute to the SNP heritability of snoring, indicating a strong genetic component.", "source_id": "chunk-a34b927ed42ff0917960122b4d203f83", "order": 1, "source": "GWAS (GENOME-WIDE ASSOCIATION STUDY)", "target": "H2SNP (SNP HERITABILITY)"}, {"weight": 13.0, "description": "GWAS can be used to investigate the association of genetic variants (including meQTL SNPs) with disease phenotypes, providing insights into epigenetic influences on diseases.", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "order": 1, "source": "GWAS (GENOME-WIDE ASSOCIATION STUDY)", "target": "MEQTL SNPS"}, {"weight": 6.0, "description": "GWAS studies use SNPs to identify genomic regions associated with specific traits or diseases, such as lung function in this case.", "source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "order": 1, "source": "GWAS (GENOME-WIDE ASSOCIATION STUDY)", "target": "SNP (SINGLE NUCLEOTIDE POLYMORPHISM)"}, {"weight": 4.0, "description": "In GWAS, understanding LD helps in interpreting genetic associations across the genome.", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "order": 1, "source": "GWAS (GENOME-WIDE ASSOCIATION STUDY)", "target": "LD (LINKAGE DISEQUILIBRIUM)"}, {"weight": 6.0, "description": "Forced expiratory volume in 1 second (FEV1) and forced vital capacity (FVC) show negative genetic correlations with snoring, highlighting their importance in lung function.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "order": 1, "source": "SNORING ", "target": "FEV1 AND FVC "}, {"weight": 4.0, "description": "Different single nucleotide polymorphisms within the VDBP gene can influence vitamin D metabolism and binding.", "source_id": "chunk-617cab4d8c10048a1335bf565693bf97", "order": 1, "source": "VDBP", "target": "SINGLE NUCLEOTIDE POLYMORPHISMS (SNPS)"}, {"weight": 3.0, "description": "The levels of total 25(OH)D are adjusted for physiological factors like maternal height and pre-pregnancy BMI to account for their influence on vitamin D status.", "source_id": "chunk-617cab4d8c10048a1335bf565693bf97", "order": 1, "source": "TOTAL 25(OH)D", "target": "MATERNAL HEIGHT, PRE-PREGNANCY BMI, TERMINAL BMI, UVB, WEEKS OF GESTATION"}, {"weight": 4.0, "description": "Certain maternal VDBP polymorphisms are associated with higher levels of total 25(OH)D at birth, as shown by the statistical analysis.", "source_id": "chunk-617cab4d8c10048a1335bf565693bf97", "order": 1, "source": "TOTAL 25(OH)D", "target": "MATERNAL VDBP POLYMORPHISMS "}, {"weight": 1.0, "description": "Variations in neonates\' VDBP gene do not significantly influence their total 25(OH)D levels at birth, based on the data provided.", "source_id": "chunk-617cab4d8c10048a1335bf565693bf97", "order": 1, "source": "TOTAL 25(OH)D", "target": "NEONATAL VDBP POLYMORPHISMS "}, {"weight": 4.0, "description": "The level of total 25-hydroxyvitamin D is a primary indicator for assessing an individual\'s vitamin D status.", "source_id": "chunk-617cab4d8c10048a1335bf565693bf97", "order": 1, "source": "TOTAL 25(OH)D", "target": "VITAMIN D STATUS"}, {"weight": 4.0, "description": "Threshold values for neonatal total 25-hydroxyvitamin D are used to classify the vitamin D status of newborns at birth.", "source_id": "chunk-617cab4d8c10048a1335bf565693bf97", "order": 1, "source": "TOTAL 25(OH)D", "target": "NEONATAL VITAMIN D CUT-OFFS "}, {"weight": 3.0, "description": "Cut-off values are used to categorize maternal vitamin D levels as sufficient, deficient, or toxic during pregnancy.", "source_id": "chunk-617cab4d8c10048a1335bf565693bf97", "order": 1, "source": "VITAMIN D STATUS", "target": "MATERNAL VITAMIN D CUT-OFFS "}, {"weight": 3.0, "description": "Women with PCOS exhibit higher insulin resistance index as indicated by HOMA-IR measurements.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "order": 1, "source": "PCOS", "target": "INSULIN RESISTANCE INDEX (HOMA-IR)"}, {"weight": 3.0, "description": "Levels of SHBG are significantly lower in women with PCOS than controls, affecting sex hormone bioavailability.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "order": 1, "source": "PCOS", "target": "SHBG (SEX HORMONE-BINDING GLOBULIN)"}, {"weight": 2.0, "description": "Total testosterone levels may be elevated in women with PCOS compared to control subjects.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "order": 1, "source": "PCOS", "target": "TOTAL TESTOSTERONE"}, {"weight": 4.0, "description": "Higher FAI values are associated with PCOS, indicating elevated free androgen levels.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "order": 1, "source": "PCOS", "target": "FREE ANDROGEN INDEX (FAI)"}, {"weight": 2.0, "description": "TSH levels may be higher in women with PCOS, though still within the reference range, suggesting thyroid involvement.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "order": 1, "source": "PCOS", "target": "TSH (THYROID-STIMULATING HORMONE)"}, {"weight": 4.0, "description": "The rs3025020 SNP in the VEGFA gene influences serum levels of VEGF protein in women with PCOS.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "order": 1, "source": "RS3025020 (-583T>C)", "target": "VEGF PROTEIN"}, {"weight": 4.0, "description": "The rs2010963 SNP influences serum levels of VEGF protein inversely in women with PCOS.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "order": 1, "source": "RS2010963 (-634C>G)", "target": "VEGF PROTEIN"}, {"weight": 5.0, "description": "Levels of free testosterone are associated with bioactive testosterone in women, reflecting hormonal imbalances seen in PCOS.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "order": 1, "source": "FREE TESTOSTERONE", "target": "BIOACTIVE TESTOSTERONE"}, {"weight": 3.0, "description": "The LH/FSH ratio is often higher in women with PCOS, reflecting hormonal imbalances.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "order": 1, "source": "LH (LUTEINIZING HORMONE)", "target": "FSH (FOLLICLE-STIMULATING HORMONE)"}, {"weight": 6.0, "description": "Participants with the iso homozygote genotype tend to select lower levels of shock intensity compared to val carriers, suggesting differential sensitivity to aversive stimuli based on genotype.)", "source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647", "order": 1, "source": "ISO HOMOZYGOTE GENOTYPE", "target": "SHOCK INTENSITY SELECTION BEHAVIOR"}, {"weight": 4.0, "description": "Behavioral processes such as response bias can influence reported STAI scores under different conditions and over time.)", "source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647", "order": 1, "source": "RESPONSE BIAS", "target": "STAI SCORES"}, {"weight": 4.0, "description": "Carriers of the val variant show a significant reduction in response bias toward more frequently rewarded stimuli under stressful conditions compared to no-stress conditions.", "source_id": "chunk-5e709975097a773fb3d31e265d76a71b", "order": 1, "source": "RESPONSE BIAS", "target": "VAL CARRIER"}, {"weight": 3.0, "description": "Individuals homozygous for the isoleucine allele do not show as marked a change in response bias between stress and no-stress conditions.", "source_id": "chunk-5e709975097a773fb3d31e265d76a71b", "order": 1, "source": "RESPONSE BIAS", "target": "ISO HOMOZYGOTE"}, {"weight": 4.0, "description": "Different experimental conditions (stress vs. no-stress) significantly influence the level of response bias towards rewarded stimuli.", "source_id": "chunk-5e709975097a773fb3d31e265d76a71b", "order": 1, "source": "RESPONSE BIAS", "target": "CONDITION"}, {"weight": 4.0, "description": "Single nucleotide polymorphisms within the CRHR1 gene can influence the degree of reduction in response bias during stressful conditions, independent of other confounding factors.", "source_id": "chunk-5e709975097a773fb3d31e265d76a71b", "order": 1, "source": "RESPONSE BIAS", "target": "CRHR1 SNPS"}, {"weight": 4.0, "description": "Individuals with certain genetic variants, such as those associated with the COMT and CRHR1 genes, exhibit altered reward learning under stress conditions.", "source_id": "chunk-5e709975097a773fb3d31e265d76a71b", "order": 1, "source": "RESPONSE BIAS", "target": "STRESS-INDUCED REWARD LEARNING DEFICITS"}, {"weight": 6.0, "description": "The selection of shock intensity behavior influences the negative affect (NA) experienced during stress tasks, modulated by genotype differences.)", "source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647", "order": 1, "source": "SHOCK INTENSITY SELECTION BEHAVIOR", "target": "PANAS NA SCORES"}, {"weight": 8.0, "description": "Increased STAI scores correlate with higher non-specific skin conductance responses, indicating a physiological linkage between reported anxiety and arousal levels.)", "source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647", "order": 1, "source": "STAI SCORES", "target": "NON-SPECIFIC SC RESPONSES"}, {"weight": 3.0, "description": "Minor pre-stress differences suggest baseline physiological arousal, which can influence later skin conductance responses during actual stress conditions.)", "source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647", "order": 1, "source": "NON-SPECIFIC SC RESPONSES", "target": "PRE-STRESS ASSESSMENT DIFFERENCES"}, {"weight": 3.0, "description": "Genetic variations within the CRHR1 gene may influence response bias in individuals who are homozygous for a specific allele.", "source_id": "chunk-5e709975097a773fb3d31e265d76a71b", "order": 1, "source": "ISO HOMOZYGOTE", "target": "CRHR1 GENE"}, {"weight": 3.0, "description": "Increased skin conductance responses correlate with heightened stress conditions affecting physiological measures and potentially altering behavioral outcomes.", "source_id": "chunk-5e709975097a773fb3d31e265d76a71b", "order": 1, "source": "CONDITION", "target": "SKIN CONDUCTANCE RESPONSES"}, {"weight": 2.0, "description": "The ability to discriminate between reward contingencies is influenced by the intensity of applied shocks during experimental trials, though not due to genetic differences.", "source_id": "chunk-5e709975097a773fb3d31e265d76a71b", "order": 1, "source": "DISCRIMINABILITY", "target": "SHOCK INTENSITY"}, {"weight": 2.0, "description": "rs10740993 is significantly associated with the age of eruption of primary teeth.)", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "order": 1, "source": "CACNB2 RS10740993", "target": "AGE AT FIRST TOOTH"}, {"weight": 2.0, "description": "rs4937076 is linked to \'number of teeth\' and may influence tooth development or number.)", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "order": 1, "source": "CDON RS4937076", "target": "NUMBER OF TEETH"}, {"weight": 2.0, "description": "rs1799922 has a significant association with the age at which primary teeth erupt, suggesting an influence on tooth development timing.)", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "order": 1, "source": "CALU/OPN1SW RS1799922", "target": "AGE AT FIRST TOOTH"}, {"weight": 2.0, "description": "rs997154 is significantly associated with \'age at first tooth\', affecting dental eruption age.)", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "order": 1, "source": "AJUBA/C14ORF93 RS997154", "target": "AGE AT FIRST TOOTH"}, {"weight": 3.0, "description": "This SNP affects both the number of teeth and the timing of their emergence, suggesting a role in overall dentition development.)", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "order": 1, "source": "ADK RS7924176", "target": "NUMBER OF TEETH AND AGE AT FIRST TOOTH"}, {"weight": 2.0, "description": "rs412000 is associated with \'age at first tooth\' and influences the timing of dental eruption.)", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "order": 1, "source": "TEX14/RAD51C RS412000", "target": "AGE AT FIRST TOOTH"}, {"weight": 2.0, "description": "This SNP in DLEU7 affects the number of teeth, impacting overall dentition.)", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "order": 1, "source": "DLEU7 RS9316505", "target": "NUMBER OF TEETH"}, {"weight": 2.0, "description": "rs17101923 is linked to \'number of teeth\' and influences tooth count in individuals.)", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "order": 1, "source": "HMGA2 RS17101923", "target": "NUMBER OF TEETH"}, {"weight": 3.0, "description": "These SNPs near KCNJ2 are significant for both timing and number, indicating a complex role in dentition.)", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "order": 1, "source": "KCNJ2 RS17105278 AND RS9788982", "target": "AGE AT FIRST TOOTH AND NUMBER OF TEETH"}, {"weight": 2.0, "description": "rs1458991 is associated with \'age at first tooth\' and influences dental eruption timing.)", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "order": 1, "source": "MSRB3 RS1458991", "target": "AGE AT FIRST TOOTH"}, {"weight": 3.0, "description": "These SNPs in IGF2BP1 affect both the number and timing of teeth, indicating a role in dentition development.)", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "order": 1, "source": "IGF2BP1 RS10932688 AND RS9894411", "target": "AGE AT FIRST TOOTH AND NUMBER OF TEETH"}, {"weight": 3.0, "description": "These SNPs near EDA influence both the number and timing of teeth, suggesting a complex genetic control over dental traits.)", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "order": 1, "source": "EDA RS2520397 AND RS2804391", "target": "AGE AT FIRST TOOTH AND NUMBER OF TEETH"}, {"weight": 3.0, "description": "These SNPs in RAD51L1 show suggestive evidence for affecting both the timing and number of teeth.)", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "order": 1, "source": "RAD51L1 RS17105278 AND RS1956529", "target": "AGE AT FIRST TOOTH AND NUMBER OF TEETH"}, {"weight": 2.0, "description": "SNPs in this region are associated with a lower level of significance but may still influence tooth count, suggesting further research needed.)", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "order": 1, "source": "TMEM9 REGION SNP(S)", "target": "NUMBER OF TEETH"}, {"weight": 4.0, "description": "The BMP4 gene variant is associated with earlier tooth eruption, indicating a genetic influence on the timing of primary tooth development.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "order": 1, "source": "BMP4", "target": "AGE AT FIRST TOOTH"}, {"weight": 5.0, "description": "Genomic variants in HMGA2 are significantly linked to both early tooth eruption and higher counts of permanent teeth, suggesting a broad role in dental health.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "order": 1, "source": "HMGA2", "target": "NUMBER OF TEETH"}, {"weight": 7.0, "description": "The HMGA2 gene\'s variants show strong associations with both height and tooth eruption timing, suggesting overlapping genetic influences between these traits.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "order": 1, "source": "HMGA2", "target": "HEIGHT-ASSOCIATED SNPS IN DENTAL PHENOTYPES"}, {"weight": 6.0, "description": "The ADK gene\'s variant affects the width of the nose, indicating a genetic influence on craniofacial morphology related to tooth eruption timing.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "order": 1, "source": "ADK", "target": "FACE WIDTH"}, {"weight": 7.0, "description": "Genomic variants in AJUBA are linked to increased mid-brow height and prominence, suggesting a role in craniofacial development.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "order": 1, "source": "AJUBA", "target": "MID-BROW HEIGHT"}, {"weight": 8.0, "description": "The MSRB3 gene\'s variant is associated with \'number of primary teeth\', highlighting its involvement in early dental development.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "order": 1, "source": "MSRB3", "target": "NUMBER OF PRIMARY TEETH"}, {"weight": 3.0, "description": "Genomic variant rs1472259 in HMGA2 shows associations with both early tooth eruption and permanent teeth count, suggesting a broad genetic influence on dental health.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "order": 1, "source": "RS1472259", "target": "AGE AT FIRST TOOTH AND NUMBER OF PERMANENT TEETH"}, {"weight": 4.0, "description": "The genomic variant rs8069452 near IGF2BP1 is linked to \'age at first tooth\', reflecting its role in the timing of primary tooth development.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "order": 1, "source": "RS8069452", "target": "AGE AT FIRST TOOTH"}, {"weight": 5.0, "description": "Genomic variant rs7924176 in ADK affects both face width and measures related to tooth eruption timing, indicating its role in craniofacial morphology.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "order": 1, "source": "RS7924176", "target": "FACE WIDTH AND TOOTH ERUPTION TIMING"}, {"weight": 6.0, "description": "Genomic variant rs997154 near AJUBA influences mid-brow height and prominence, highlighting its role in craniofacial development.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "order": 1, "source": "RS997154", "target": "MID-BROW HEIGHT AND CRANIOFACIAL DEVELOPMENT"}, {"weight": 2.0, "description": "The BMP4 gene plays a role in bone and tooth formation, influencing the \'Number of Teeth\' trait.)", "source_id": "chunk-c63d60b991cd7442f690dcc364af47dd", "order": 1, "source": "BMP4 GENE", "target": "BONE AND TOOTH FORMATION"}, {"weight": 2.0, "description": "The BMP4 gene influences age at first tooth development and its variants are associated with height.)", "source_id": "chunk-c63d60b991cd7442f690dcc364af47dd", "order": 1, "source": "BMP4 GENE", "target": "AGE AT FIRST TOOTH GWAS"}, {"weight": 3.0, "description": "Significant SNPs for dental traits contribute to PMETA scores which measure association strength with height; removing HMGA2 and BMP4 variants weakens these associations.)", "source_id": "chunk-c63d60b991cd7442f690dcc364af47dd", "order": 1, "source": "GENOME-WIDE SIGNIFICANT SNPS", "target": "PMETA SCORE"}, {"weight": 3.0, "description": "Significant SNPs identified in the \'number of teeth\' GWAS, though no pathways showed significant over-representation after pathway analysis.)", "source_id": "chunk-c63d60b991cd7442f690dcc364af47dd", "order": 1, "source": "GENOME-WIDE SIGNIFICANT SNPS", "target": "NUMBER OF TEETH GWAS"}, {"weight": 8.0, "description": "Pathway analysis using ALLIGATOR identified significant pathways for \'age at first tooth\', indicating over-representation of genes linked to dental development.)<SEP>Pathway analysis using ALLIGATOR software reveals significant enrichment of certain genes in pathways linked to age at first tooth development.)", "source_id": "chunk-c63d60b991cd7442f690dcc364af47dd", "order": 1, "source": "AGE AT FIRST TOOTH GWAS PATHWAYS", "target": "ALLIGATOR SOFTWARE ANALYSIS"}, {"weight": 5.0, "description": "Specific SNPs are mapped to genomic regions such as the PTPN2 gene and the IL2/ADAD1/IL21 locus, indicating their potential influence on disease susceptibility or treatment response.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "order": 1, "source": "SNPS (SINGLE NUCLEOTIDE POLYMORPHISMS)", "target": "PTPN2 GENE, IL2/ADAD1/IL21 LOCUS"}, {"weight": 6.0, "description": "Testing for ICI efficacy involves evaluating how specific genetic variations (SNPs) may impact the effectiveness of treatments in metastatic melanoma patients.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "order": 1, "source": "SNPS (SINGLE NUCLEOTIDE POLYMORPHISMS)", "target": "ICI EFFICACY TESTING"}, {"weight": 3.0, "description": "Genomic variants in FAM155E-EDA are linked to \'number of teeth\', reflecting its role in craniofacial traits related to tooth count.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "order": 1, "source": "NUMBER OF TEETH", "target": "FAM155E-EDA"}, {"weight": 5.0, "description": "Interleukin-10 binds and activates the IL-10 receptor alpha subunit (IL-10R\u03b1), initiating downstream anti-inflammatory signaling pathways.", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "order": 1, "source": "IL-10R\u0391", "target": "IL-10"}, {"weight": 3.0, "description": "Global deletion of IL-10R\u03b1 in Rag1-deficient mice mimics the T cell transfer model but lacks specific cellular targeting, leading to similar disease outcomes as observed with conditional deletions.", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "order": 1, "source": "T CELL TRANSFER-COLITIS MODEL", "target": "IL-10R\u0391\u2212/\u2212RAG1\u2212/\u2212"}, {"weight": 13.0, "description": "IL-10 signaling through its receptor is shown to mitigate colonic inflammation, thereby playing a protective role against the progression of colitis.<SEP>IL-10 signaling through its receptor plays a protective role by mitigating colonic inflammation, thereby reducing the severity of colitis.<SEP>The IL-10-mediated immunoprotection can largely be attributed to its effects on macrophages, mitigating colonic inflammation and reducing disease severity.", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "order": 1, "source": "COLONIC INFLAMMATION", "target": "IL-10 SIGNALING"}, {"weight": 10.0, "description": "The IL-10 signaling pathway is assessed using a CX3CR1-driven Cre line to specifically delete IL-10R\u03b1 in myeloid cells, particularly macrophages.<SEP>The IL-10 signaling pathway\'s impact is assessed using CX3CR1-driven Cre lines that specifically delete IL-10R\u03b1 in myeloid cells, particularly macrophages.", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "order": 1, "source": "IL-10 SIGNALING", "target": "CX3CR1-CRE DRIVER LINE"}, {"weight": 4.0, "description": "STAT3 is a key downstream effector in IL-10 signaling pathways, regulating anti-inflammatory responses through gene expression.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "order": 1, "source": "IL-10 SIGNALING", "target": "STAT3"}, {"weight": 9.0, "description": "Macrophages are essential in modulating disease severity within the DSS-induced acute colitis model.<SEP>Macrophages play an important role in modulating disease severity within this toxin-induced model of acute colitis.", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "order": 1, "source": "MACROPHAGE (M\u03a6)", "target": "DSS COLITIS MODEL"}, {"weight": 5.0, "description": "Interleukin-10 plays a critical role in regulating inflammation, and its dysregulation is associated with increased susceptibility to inflammatory diseases such as colitis.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "order": 1, "source": "IL-10", "target": "COLITIS"}, {"weight": 4.0, "description": "IL-10 modulates macrophage activity, reducing their pro-inflammatory response while enhancing anti-inflammatory functions.)", "source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "order": 1, "source": "IL-10", "target": "M\u03a6 (MACROPHAGES)"}, {"weight": 1.0, "description": "IL-10 regulates the production of pro-IL-1\u03b2 by inhibiting it in macrophages from Rag1\u2212/\u2212 mice but not IL-10R\u03b1MdelRag1\u2212/\u2212 mice.)", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c", "order": 1, "source": "IL-10", "target": "PRO-IL-1\u0392 PRODUCTION"}, {"weight": 5.0, "description": "This genetic driver line is used specifically in LPM\u03d5s to assess the role of IL-10R\u03b1 deletion on colitis development and inflammation regulation.", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "order": 1, "source": "LPM\u03a6S (LYMPHOID TISSUE RESIDENT MACROPHAGES)", "target": "CX3CR1-DRIVEN CRE DRIVER LINE"}, {"weight": 4.0, "description": "The genetic variant IL-10R\u03b1MdelRag1\u2212/\u2212 leads to an increased number and activation of lamina propria macrophages, contributing to exacerbated disease severity.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "order": 1, "source": "IL-10R\u0391MDELRAG1\u2212/\u2212", "target": "LPM\u03a6S (LAMINA PROPRIA MACROPHAGES)"}, {"weight": 2.0, "description": "The IL-10R\u03b1MdelRag1\u2212/\u2212 genetic variant does not overtly impact the function or suppressive activity of regulatory T cells, indicating that these cells can still suppress disease in this context.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "order": 1, "source": "IL-10R\u0391MDELRAG1\u2212/\u2212", "target": "TREGS (REGULATORY T CELLS)"}, {"weight": 3.0, "description": "The IL-10R\u03b1MdelRag1\u2212/\u2212 genetic variant does not affect the number of circulating neutrophils, indicating that changes in other immune cells are responsible for disease exacerbation.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "order": 1, "source": "IL-10R\u0391MDELRAG1\u2212/\u2212", "target": "NEUTROPHILS"}, {"weight": 3.0, "description": "This genomic variant is associated with susceptibility to colitis, as it alters the immune response pathway leading to inflammation in the colon.)", "source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "order": 1, "source": "IL-10R\u0391MDELRAG1\u2212/\u2212", "target": "COLITIS"}, {"weight": 3.0, "description": "In IL-10R\u03b1MdelRag1\u2212/\u2212 mice, the requirement for IL-6 in supporting Th17 cell formation and colitis is lessened compared to other conditions.)", "source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "order": 1, "source": "IL-10R\u0391MDELRAG1\u2212/\u2212", "target": "IL-6R\u0391\u2212/\u2212 T CELLS"}, {"weight": 3.0, "description": "Wild-type naive T cells transferred into IL-10R\u03b1MdelRag1\u2212/\u2212 mice still show differential responses, indicating specific immune pathway modifications in this model.)", "source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "order": 1, "source": "IL-10R\u0391MDELRAG1\u2212/\u2212", "target": "WT NAIVE T CELLS"}, {"weight": 3.0, "description": "Foxp3+ iTreg represents a subset of regulatory T cells that are induced in response to antigen exposure and play an essential role in maintaining immune tolerance.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "order": 1, "source": "FOXP3+ ITREG", "target": "TREGS (REGULATORY T CELLS)"}, {"weight": 4.0, "description": "The lack of IL-10R\u03b2 disrupts the generation and function of induced regulatory T cells, which are critical for immune regulation.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "order": 1, "source": "TREGS (REGULATORY T CELLS)", "target": "IL-10R\u0392"}, {"weight": 3.0, "description": "STAT5B gene is essential for the maintenance and function of regulatory T cells, critical for immune tolerance. Deficiency leads to impaired regulation over time.)", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "order": 1, "source": "TREGS (REGULATORY T CELLS)", "target": "STAT5B GENE"}, {"weight": 5.0, "description": "Mice with the Rag1\u2212/\u2212 variant show altered immune system development which can lead to increased susceptibility to colitis, particularly in conjunction with other genetic or environmental factors.)", "source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "order": 1, "source": "COLITIS", "target": "RAG1\u2212/\u2212"}, {"weight": 5.0, "description": "IL-1\u03b2 promotes colitis development through its role in innate immunity, particularly in IL-10R\u03b1MdelRag1\u2212/\u2212 mice where it can compensate for the absence of IL-6 dependence.)", "source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "order": 1, "source": "COLITIS", "target": "IL-1\u0392"}, {"weight": 7.0, "description": "IL-6 is crucial for robust T cell expansion leading to severe disease in Rag1\u2212/\u2212 mice but not essential in IL-10R\u03b1MdelRag1\u2212/\u2212 mice due to compensatory mechanisms like increased IL-1\u03b2.)", "source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "order": 1, "source": "COLITIS", "target": "T CELL EXPANSION"}, {"weight": 5.0, "description": "Transferring IL-6R\u03b1\u2212/\u2212 T cells into mice models reduces the severity of colitis, indicating a critical role for IL-6 signaling in disease progression.)", "source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "order": 1, "source": "COLITIS", "target": "IL-6R\u0391\u2212/\u2212 T CELLS"}, {"weight": 0.75, "description": "The role of IL-6 is more critical than IL-1 in inducing colonic inflammation in Rag1\u2212/\u2212 mice due to the suppression by IL-10.)", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c", "order": 1, "source": "COLITIS", "target": "IL-6"}, {"weight": 0.92, "description": "Colon-resident macrophages are a primary source of IL-1\u03b2 production in the context of colonic inflammation.)", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c", "order": 1, "source": "COLITIS", "target": "LPM\u03a6S (LY6G\u2212/LOSIGLECF\u2212 M\u03a6)"}, {"weight": 12.0, "description": "The composition and stability of gut microbiota influence susceptibility to colitis, particularly in the absence of CARD9.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "order": 1, "source": "COLITIS", "target": "GUT MICROBIOTA"}, {"weight": 5.0, "description": "Ly6G serves as a specific surface protein marker to identify neutrophils and other granulocytes in immune responses.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "order": 1, "source": "NEUTROPHILS", "target": "LY6G"}, {"weight": 3.0, "description": "CD64 expression on macrophages indicates their activation status and potential role in inflammation or immune response regulation.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "order": 1, "source": "CD64", "target": "MACROPHAGES"}, {"weight": 4.0, "description": "Expression of CD103 marks epithelial tissue-resident T cells, which play a role in immune surveillance and regulation within the gut.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "order": 1, "source": "CD103", "target": "EPITHELIAL T CELLS"}, {"weight": 4.0, "description": "Expression of SiglecF on eosinophils modulates their functional capabilities, impacting immune responses and inflammation.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "order": 1, "source": "SIGLECF", "target": "EOSINOPHILS"}, {"weight": 5.0, "description": "Expression of CD80 on antigen-presenting cells facilitates T cell receptor signaling, enhancing the immune response and promoting T cell proliferation.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "order": 1, "source": "CD80", "target": "T CELLS"}, {"weight": 5.0, "description": "Expression of CD86 on antigen-presenting cells provides an additional co-stimulatory signal to activate and enhance the proliferation of T cells.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "order": 1, "source": "CD86", "target": "T CELLS"}, {"weight": 4.0, "description": "The absence of recombination activating gene 2 results in a significant impairment of adaptive immune responses, leading to severe immunodeficiency.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "order": 1, "source": "RAG2\u2212/\u2212", "target": "IMMUNODEFICIENCY"}, {"weight": 3.0, "description": "The production of IL-10 by T cells does not affect disease severity, suggesting that other cell types or mechanisms are more critical for controlling inflammatory processes.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "order": 1, "source": "T CELLS", "target": "IL-10 PRODUCTION"}, {"weight": 4.0, "description": "Increased numbers and activity of Th17 cells correlate with elevated colonic infiltration in the context of heightened inflammation and disease progression.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "order": 1, "source": "COLONIC INFILTRATION", "target": "TH17 CELLS"}, {"weight": 4.0, "description": "Th17 cells require IL-6 for their development and function, playing a crucial role in autoimmune responses but also dependent on other cytokines like IL-1\u03b2.)", "source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "order": 1, "source": "TH17 CELLS", "target": "IL-6"}, {"weight": 4.0, "description": "The IL-6 receptor alpha subunit is essential for the signaling pathway that supports Th17 cell development and maintenance of autoimmune inflammation.)", "source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "order": 1, "source": "TH17 CELLS", "target": "IL-6R\u0391\u2212/\u2212"}, {"weight": 5.0, "description": "ROR\u03b3T is essential for the development and function of Th17 cells in autoimmune responses.)", "source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "order": 1, "source": "TH17 CELLS", "target": "ROR\u0393T"}, {"weight": 0.8, "description": "The transfer of IL-1R\u2212/\u2212 T cells resulted in a significant reduction in Th17 cell numbers in the colon, indicating an impact on their response.)", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c", "order": 1, "source": "TH17 CELLS", "target": "IL-1R\u2212/\u2212 T CELLS"}, {"weight": 0.9, "description": "Increased levels of IL-1\u03b2 support Th17 cell responses at sites of autoinflammatory disease.)", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c", "order": 1, "source": "TH17 CELLS", "target": "IL-1\u0392"}, {"weight": 0.5, "description": "Wild-type T cells are used as baseline controls to evaluate the effects of genetic alterations on Th17 cell responses.)", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c", "order": 1, "source": "TH17 CELLS", "target": "WT T CELLS"}, {"weight": 3.0, "description": "IL-6 has a role in promoting Th17 cell development but its effect is modulated by other cytokines such as IL-10.", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "order": 1, "source": "IL-6", "target": "TH17 CELL MATURATION"}, {"weight": 2.0, "description": "MCP-1 facilitates the recruitment of monocytes and other immune cells to sites of inflammation, contributing to the amplification of inflammatory responses.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "order": 1, "source": "MCP-1 (MONOCYTE CHEMOATTRACTANT PROTEIN-1)", "target": "IMMUNE RECRUITMENT"}, {"weight": 4.0, "description": "Increased IL-17 levels are indicative of heightened Th17 cell activity, which is critical for exacerbating inflammatory processes and disease progression.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "order": 1, "source": "IL-17", "target": "INFLAMMATORY RESPONSE"}, {"weight": 2.0, "description": "IFN-\u03b3 plays a regulatory role in immune responses but its levels are not increased during Th17-dependent colitis, suggesting other cytokines are more influential.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "order": 1, "source": "IFN-\u0393 (INTERFERON GAMMA)", "target": "IMMUNE REGULATION"}, {"weight": 3.0, "description": "Increased iNOS activity suggests an enhancement in the inflammatory response, contributing to immune-mediated pathology.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "order": 1, "source": "INOS (INDUCIBLE NITRIC OXIDE SYNTHASE)", "target": "INFLAMMATORY RESPONSE"}, {"weight": 3.0, "description": "NF-\u03baB activation is crucial for the transcription of pro-inflammatory genes, contributing to inflammation and disease progression.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "order": 1, "source": "NF-\u039aB", "target": "IMMUNE RESPONSE REGULATION"}, {"weight": 4.0, "description": "Activation of NF-\u03baB is elevated in the absence of SENP1, contributing to inflammatory processes and disease progression in these mice.)", "source_id": "chunk-8382a49b61215482f9fc75e3a86cb987", "order": 1, "source": "NF-\u039aB", "target": "SENP1-AP2KO MICE"}, {"weight": 5.0, "description": "Tregs play a critical role in suppressing excessive immune responses and limiting tissue damage during inflammatory conditions like colitis.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "order": 1, "source": "FOXP3+ TREGS (REGULATORY T CELLS)", "target": "INFLAMMATION REGULATION"}, {"weight": 3.0, "description": "IL-27 can inhibit Th17 cell differentiation and promote alternative T cell lineages, thus modulating inflammatory processes.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "order": 1, "source": "IL-27", "target": "TH17 DIFFERENTIATION"}, {"weight": 8.0, "description": "IL-27 activates the STAT1/STAT3 pathway which induces transcription of several genes including STAT1 itself.", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "order": 1, "source": "IL-27", "target": "STAT1"}, {"weight": 2.0, "description": "IDO activity leads to tryptophan depletion in the microenvironment, inducing immunosuppressive effects and limiting inflammation.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "order": 1, "source": "IDO (INDOLEAMINE 2,3-DIOXYGENASE)", "target": "IMMUNOSUPPRESSION"}, {"weight": 4.0, "description": "The absence of IL-10R\u03b1 in these mice leads to severe colitis, highlighting the importance of IL-10 signaling in controlling inflammation.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "order": 1, "source": "IL-10R\u0391MDEL MICE", "target": "COLITIS SEVERITY"}, {"weight": 8.0, "description": "This protein regulates the expression of antimicrobial peptides by intestinal epithelial cells during inflammation.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "order": 1, "source": "IL-22", "target": "INTESTINAL EPITHELIAL CELLS"}, {"weight": 4.0, "description": "Interleukin-22 is necessary for the production of AHR ligands by gut microbiota.)", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "order": 1, "source": "IL-22", "target": "AHR LIGAND PRODUCTION"}, {"weight": 5.0, "description": "The absence of Rag1 leads to impaired T cell expansion and differentiation in the immune system.)", "source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "order": 1, "source": "RAG1\u2212/\u2212", "target": "T CELL EXPANSION"}, {"weight": 6.0, "description": "IL-1\u03b2 does not significantly skew the maturation pathways of Foxp3+ regulatory T cells, unlike its effects on Th17 cell development and colitis progression.)", "source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "order": 1, "source": "IL-1\u0392", "target": "FOXP3+ CD4+ T CELLS"}, {"weight": 0.65, "description": "The transfer of these cells resulted in reduced severity of colitis, indicating their role in mediating inflammatory responses.)", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c", "order": 1, "source": "IL-1R\u2212/\u2212 T CELLS", "target": "COLITIS SEVERITY"}, {"weight": 1.0, "description": "In IL-10R\u03b1MdelRag1\u2212/\u2212 mice, the production of pro-IL-1\u03b2 was increased in colons compared to Rag1\u2212/\u2212 controls.)", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c", "order": 1, "source": "IL-10R\u0391MDELRAG1\u2212/\u2212 MICE", "target": "PRO-IL-1\u0392 PRODUCTION"}, {"weight": 4.0, "description": "The presence of TGF\u03b2 affects the maturation of Th17 cells in a context dependent manner, influenced by genetic background and cytokine signaling.", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "order": 1, "source": "IL-10R\u0391MDELRAG1\u2212/\u2212 MICE", "target": "TGF\u0392"}, {"weight": 0.95, "description": "Activation of caspase-1 is necessary for the conversion and release of pro-IL-1\u03b2 into its active form.)", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c", "order": 1, "source": "CASPASE-1", "target": "PRO-IL-1\u0392 PRODUCTION"}, {"weight": 1.0, "description": "The inflammasome activates caspase-1, which is crucial for processing IL-1\u03b2 from the inactive precursor pro-IL-1\u03b2.)", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c", "order": 1, "source": "CASPASE-1", "target": "INFLAMMASOME"}, {"weight": 4.0, "description": "The cleavage and activation of caspase-1 are necessary for processing pro-IL-1\u03b2 into mature IL-1\u03b2, highlighting the relationship between these proteins in inflammation.", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "order": 1, "source": "CASPASE-1", "target": "IL-1\u0392 LEVELS"}, {"weight": 0.7, "description": "In these mice, pro-IL-1\u03b2 levels were higher in colon macrophages, suggesting a role for IL-1 signaling in its regulation.)", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c", "order": 1, "source": "PRO-IL-1\u0392 PRODUCTION", "target": "IL-1R\u2212/\u2212 MICE"}, {"weight": 0.85, "description": "IL-10 signaling pathway regulates pro-IL-1\u03b2 production in colon macrophages, attenuating inflammatory responses.)", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c", "order": 1, "source": "PRO-IL-1\u0392 PRODUCTION", "target": "IL-10 SIGNALING PATHWAY"}, {"weight": 0.9, "description": "Increased IL-1\u03b2 levels and Th17 cell activity are associated with the pathogenesis of colonic inflammation.)", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c", "order": 1, "source": "TH17 RESPONSE MEDIATION", "target": "COLITIS PATHOGENESIS"}, {"weight": 3.0, "description": "Cultures from Rag1 knockout mice show different responses compared to those with IL-10 receptor mutations, indicating the role of IL-10 signaling in immune regulation.", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "order": 1, "source": "RAG1\u2212/\u2212 CULTURES", "target": "IL-10R\u0391MDELRAG1\u2212/\u2212-DERIVED M\u03a6S"}, {"weight": 2.0, "description": "Stimulation with LPS and ATP leads to differential responses in macrophages from IL-10 receptor mutated mice, demonstrating the importance of IL-10 signaling.", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "order": 1, "source": "IL-10R\u0391MDELRAG1\u2212/\u2212-DERIVED M\u03a6S", "target": "LPS AND ATP STIMULATION"}, {"weight": 4.0, "description": "The cleavage of caspase-1 is essential for the maturation of pro-IL-1\u03b2 into active IL-1\u03b2, a process inhibited by IL-10 signaling.", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "order": 1, "source": "IL-1\u0392 MATURATION", "target": "CASPASE-1 CLEAVAGE"}, {"weight": 3.0, "description": "Blocking IL-6R\u03b1 can inhibit Th17 cell development both in vitro and in vivo, showing its importance in immune regulation.", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "order": 1, "source": "IL-6R\u0391 BLOCKING ANTIBODY", "target": "TH17 CELL MATURATION IN VIVO"}, {"weight": 5.0, "description": "Together, dendritic cells and macrophages play critical roles in the stimulation of IL-22-producing cells through cytokine production such as IL-23.)", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "order": 1, "source": "MACROPHAGES", "target": "INTESTINAL DENDRITIC CELLS"}, {"weight": 5.0, "description": "Incorporation of BrdU into DNA is used to measure and quantify cell proliferation, particularly in immune cells like macrophages.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "order": 1, "source": "BRDU (BROMODEOXYURIDINE)", "target": "CELL PROLIFERATION"}, {"weight": 4.0, "description": "Polymorphisms of TNF-\u03b1 gene affect inflammatory responses and may contribute to disease susceptibility.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "order": 1, "source": "INFLAMMATORY RESPONSE", "target": "TNF-\u0391 GENE VARIANTS"}, {"weight": 5.0, "description": "Variants in these genes influence immune regulation pathways and are associated with autoimmune conditions such as psoriasis.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "order": 1, "source": "IMMUNE REGULATION", "target": "IL-23R, IL-17F, IL-17RA GENES "}, {"weight": 8.0, "description": "The metabolism of tryptophan via IDO1 activity plays a crucial role in regulating immune responses and AHR activation.)", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "order": 1, "source": "IMMUNE RESPONSE REGULATION", "target": "TRYPTOPHAN METABOLISM"}, {"weight": 1.0, "description": "The abundance and distribution of Bacteroides within the gut microbiota can influence protein metabolism processes.)", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "order": 1, "source": "BACTEROIDES", "target": "PROTEIN METABOLISM"}, {"weight": 2.0, "description": "Both Faecalibacterium and Eubacterium are part of the core microbiota identified in homogeneous clusters, contributing to similar metabolic functions within the gut environment.)", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "order": 1, "source": "FAECALIBACTERIUM", "target": "EUBACTERIUM"}, {"weight": 3.0, "description": "The presence of Blautia reflects broader patterns of heterogeneity observed in microbiome studies across different cohorts and populations.)", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "order": 1, "source": "BLAUTIA", "target": "MICROBIOME HETEROGENEITY"}, {"weight": 4.0, "description": "Both Alistipes and Ruminiclostridium 9 are bacterial taxa whose abundance might be influenced by genetic factors, showing heritability in certain cohorts.)", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "order": 1, "source": "ALISTIPES", "target": "RUMINICLOSTRIDIUM 9"}, {"weight": 5.0, "description": "The presence of Fusicatenibacter within core microbiota supports the production of short-chain fatty acids, beneficial for gut health and metabolism.)", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "order": 1, "source": "FUSICATENIBACTER", "target": "SHORT-CHAIN FATTY ACIDS PRODUCTION"}, {"weight": 6.0, "description": "Butyricicoccus is part of the core taxa found in homogeneous clusters, indicating its role in maintaining stable microbial communities under various conditions.)", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "order": 1, "source": "BUTYRICICOCCUS", "target": "MICROBIOME CORE TAXA"}, {"weight": 7.0, "description": "The distribution and abundance of Eubacterium can be influenced by environmental factors such as diet and geography.)", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "order": 1, "source": "EUBACTERIUM", "target": "ENVIRONMENTAL FACTORS"}, {"weight": 9.0, "description": "The DNA extraction method significantly contributes to heterogeneity in microbiome studies by affecting microbial composition variance across studies.)", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "order": 1, "source": "DNA EXTRACTION METHOD", "target": "HETEROGENEITY IN MICROBIOME STUDIES"}, {"weight": 11.0, "description": "Veillonella plays a key role in carbohydrate fermentation, producing short-chain fatty acids that support gut health.)", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "order": 1, "source": "VEILLONELLA", "target": "CARBOHYDRATE FERMENTATION"}, {"weight": 12.0, "description": "Roseburia is particularly noted for its ability to produce butyrate, which supports colonic epithelial cell integrity and function.)", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "order": 1, "source": "ROSEBURIA", "target": "BUTYRATE PRODUCTION"}, {"weight": 13.0, "description": "The presence of Coprococcus within the gut microbiota indicates a more diverse microbial community capable of metabolizing complex carbohydrates.)", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "order": 1, "source": "COPROCOCCUS", "target": "MICROBIOME DIVERSITY"}, {"weight": 14.0, "description": "Consumption of dietary fiber influences the diversity and abundance of bacteria in the gut, promoting health benefits.)", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "order": 1, "source": "DIETARY FIBER", "target": "GUT MICROBIOTA COMPOSITION"}, {"weight": 15.0, "description": "Antibiotic use can reduce microbial diversity within the gut microbiome, affecting core taxa presence and stability.)", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "order": 1, "source": "ANTIBIOTICS", "target": "MICROBIAL DIVERSITY REDUCTION"}, {"weight": 17.0, "description": "Gender differences influence microbial abundance within the gut microbiome, reflecting sex-specific factors.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "order": 1, "source": "GENDER", "target": "MICROBIAL ABUNDANCE VARIATIONS"}, {"weight": 0.0, "description": "Neither gender nor parental education is significantly associated with changes in social disinhibition score based on the provided data.)", "source_id": "chunk-36d70bb8409856300dd77669e7c1f9ed", "order": 1, "source": "GENDER", "target": "SOCIAL DISINHIBITION SCORE"}, {"weight": 18.0, "description": "Stability of the gut microbiome is influenced by various environmental factors including diet and antibiotic exposure.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "order": 1, "source": "MICROBIOME STABILITY", "target": "ENVIRONMENTAL INFLUENCES"}, {"weight": 19.0, "description": "Maintaining a healthy gut microbial composition supports overall health, affecting metabolic processes and immune responses.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "order": 1, "source": "GUT HEALTH", "target": "MICROBIAL COMPOSITION IMPACT"}, {"weight": 2.0, "description": "Both genes are suggested to be functionally relevant variants affecting gut microbiota variation under different studies.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "order": 1, "source": "LCT GENE", "target": "FUT2 GENE"}, {"weight": 4.0, "description": "Both loci are functionally relevant and show strong associations with microbial taxa abundance variations.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "order": 1, "source": "FUT2 GENE", "target": "LCT LOCUS"}, {"weight": 7.0, "description": "Dietary patterns such as fruit intake correlate with the genetic effect on gut microbiota composition through FUT2 gene.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "order": 1, "source": "FUT2 GENE", "target": "FRUIT INTAKE"}, {"weight": 3.0, "description": "The abundance of Bifidobacterium positively correlates with the intake of milk products, especially in individuals carrying specific genotypes related to low-function LCT haplotype.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "order": 1, "source": "BIFIDOBACTERIUM ABUNDANCE", "target": "MILK PRODUCTS INTAKE"}, {"weight": 5.0, "description": "The effect of age and ethnicity interaction modulates the impact of specific genetic variants on Bifidobacterium abundance, with differential effects seen between adult and younger populations.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "order": 1, "source": "BIFIDOBACTERIUM ABUNDANCE", "target": "AGE AND ETHNICITY INTERACTION"}, {"weight": 4.0, "description": "Both genetic variants are associated with higher Bifidobacterium abundance, particularly in adults carrying the CC genotype.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "order": 1, "source": "RS182549", "target": "NC_000002.11:G.136616754CC (RS182549)"}, {"weight": 5.0, "description": "These genetic variants are highly correlated, indicating similar functional impacts on gut microbiota composition.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "order": 1, "source": "RS182549", "target": "RS4988235"}, {"weight": 2.0, "description": "The Shannon index and Simpson\u2019s index complement each other in evaluating microbial diversity.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "order": 1, "source": "SIMPSON DIVERSITY INDEX", "target": "SHANNON DIVERSITY INDEX"}, {"weight": 3.0, "description": "Genetic analyses using mbQTL methods correlate with twin-based heritability data, indicating the genetic basis of microbiota composition.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "order": 1, "source": "MBQTL MAPPING ANALYSIS", "target": "TWIN-BASED HERITABILITY CORRELATION"}, {"weight": 7.0, "description": "Ethnic heterogeneity significantly influences genetic associations with Bifidobacterium abundance, highlighting the importance of considering ethnic factors in genetic studies.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "order": 1, "source": "LCT LOCUS", "target": "MULTI-ETHNICITY "}, {"weight": 1.0, "description": "The rs4988235 variant is associated with milk consumption patterns in different populations.", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5", "order": 1, "source": "RS4988235", "target": "MILK CONSUMPTION"}, {"weight": 6.0, "description": "Allele frequencies for rs4988235 within Eastern European populations reflect intermediate frequencies consistent with regional genetic profiles.", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5", "order": 1, "source": "RS4988235", "target": "EASTERN EUROPEAN POPULATIONS"}, {"weight": 6.0, "description": "Both cohorts contribute to the understanding of gene-environment interactions affecting gut microbial diversity and abundance.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "order": 1, "source": "COPSAC2010 COHORT", "target": "GEM COHORT"}, {"weight": 5.0, "description": "Genetic variation in rs601338 affects the secretion of mucus glycans, impacting gut microbiota composition.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "order": 1, "source": "FUT2 SNP (RS601338)", "target": "MUCUS GLYCANS PRODUCTION"}, {"weight": 6.0, "description": "The abundance of R. gnavus group is influenced by genetic variation affecting mucus glycans production.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "order": 1, "source": "RUMINOCOCCUS GNAVUS GROUP", "target": "MUCUS GLYCANS PRODUCTION"}, {"weight": 8.0, "description": "Genetic variants in 9q21 locus impact the abundance of Allisonella through riboflavin and mucin biosynthesis.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "order": 1, "source": "ALLISONELLA ABUNDANCE", "target": "9Q21 LOCUS (PCSK5, RFK, GCNT1)"}, {"weight": 9.0, "description": "Genetic variations regulating cobalamin metabolism affect the composition of Peptostreptococcaceae family in gut microbiota.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "order": 1, "source": "COBALAMIN ABSORPTION AND METABOLISM PATHWAY", "target": "PEPTOSTREPTOCOCCACEAE FAMILY"}, {"weight": 10.0, "description": "Genetic regulation of cobalamin absorption is linked to development of B12 deficient anemia.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "order": 1, "source": "COBALAMIN ABSORPTION AND METABOLISM PATHWAY", "target": "B12-DEFICIENT ANEMIA"}, {"weight": 5.0, "description": "These bacteria are specialized in breaking down complex carbohydrates, supporting their role in metabolic pathways within the gut.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "order": 1, "source": "RUMINOCOCCUS SP.", "target": "COMPLEX CARBOHYDRATES DEGRADATION"}, {"weight": 6.0, "description": "The genetic locus involved in regulating riboflavin metabolism and mucin biosynthesis contributes to host-microbiota interactions within the intestine.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "order": 1, "source": "9Q21 LOCUS (PCSK5, RFK)", "target": "HOST-MICROBIOME CROSSTALK"}, {"weight": 8.0, "description": "The glycosylation pathway regulated by GCNT1 impacts the composition of intestinal microbiota through mucin production.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "order": 1, "source": "MUCIN BIOSYNTHESIS PATHWAY", "target": "INTESTINAL MICROBIOTA COMPOSITION"}, {"weight": 2.0, "description": "Decreased chromogranin A levels correlate inversely with ulcerative colitis severity, suggesting an impact of gut microbiota (Peptococcaceae family).", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "order": 1, "source": "CHROMOGRANIN A LEVELS", "target": "ULCERATIVE COLITIS"}, {"weight": 3.0, "description": "Negative association between calprotectin levels and the presence of Peptococcaceae suggests a role in mitigating ulcerative colitis symptoms.", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "order": 1, "source": "CALPROTECTIN LEVELS", "target": "ULCERATIVE COLITIS"}, {"weight": 7.0, "description": "Higher levels of Bifidobacterium are associated with lower risk of developing ulcerative colitis, indicating a protective role for this genus against the disease.)", "source_id": "chunk-159d4c797dae6eb825c74067af703228", "order": 1, "source": "ULCERATIVE COLITIS", "target": "BIFIDOBACTERIUM GENUS"}, {"weight": 6.0, "description": "Increased abundance of Oxalobacteraceae is linked to reduced likelihood of rheumatoid arthritis, suggesting a protective effect of this microbial family on autoimmune health.)", "source_id": "chunk-159d4c797dae6eb825c74067af703228", "order": 1, "source": "OXALOBACTERACEAE FAMILY", "target": "RHEUMATOID ARTHRITIS"}, {"weight": 9.0, "description": "Genetic variants such as SNPs are used to investigate potential causal relationships between host genetics and gut microbial composition.)", "source_id": "chunk-159d4c797dae6eb825c74067af703228", "order": 1, "source": "SNP (SINGLE NUCLEOTIDE POLYMORPHISM)", "target": "GUT MICROBIAL TAXA"}, {"weight": 5.0, "description": "Certain SNPs located within these genes are associated with habitual coffee consumption and may influence the risk of developing type 2 diabetes.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "order": 1, "source": "SNP (SINGLE NUCLEOTIDE POLYMORPHISM)", "target": "HECTD4, ACAD10, MYL2, CUX2 GENES "}, {"weight": 8.0, "description": "Despite the search, no evidence was found for a causal relationship between dietary preferences and changes in gut microbial taxa.)", "source_id": "chunk-159d4c797dae6eb825c74067af703228", "order": 1, "source": "GUT MICROBIAL TAXA", "target": "DIETARY PREFERENCES"}, {"weight": 5.0, "description": "The abundance or presence of certain microbial taxa can influence metabolic diseases through various physiological processes.)", "source_id": "chunk-159d4c797dae6eb825c74067af703228", "order": 1, "source": "GUT MICROBIAL TAXA", "target": "METABOLIC DISEASES"}, {"weight": 7.0, "description": "The genetic makeup of an individual can influence their susceptibility to autoimmune diseases through interactions with gut microbiota.)", "source_id": "chunk-159d4c797dae6eb825c74067af703228", "order": 1, "source": "AUTOIMMUNE DISEASES", "target": "HOST GENETICS"}, {"weight": 6.0, "description": "There is a complex relationship between cardiovascular health, host genetics, and the composition of the gut microbiome.)", "source_id": "chunk-159d4c797dae6eb825c74067af703228", "order": 1, "source": "CARDIOVASCULAR DISEASES", "target": "HOST GENETICS AND GUT MICROBIAL TAXA"}, {"weight": 4.0, "description": "There is emerging evidence suggesting a link between gut microbiota, genetic predisposition, and the development of psychiatric disorders.)", "source_id": "chunk-159d4c797dae6eb825c74067af703228", "order": 1, "source": "PSYCHIATRIC DISORDERS", "target": "GUT MICROBIAL TAXA AND HOST GENETICS"}, {"weight": 8.0, "description": "Sequencing the 16S rRNA gene helps in profiling microbial diversity, identifying core microbiota across different populations and cohorts.)", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "order": 1, "source": "16S RRNA GENE SEQUENCING", "target": "MICROBIOME PROFILING"}, {"weight": 10.0, "description": "Prevotella\'s abundance is often linked to high-fiber diets due to its ability to ferment complex carbohydrates.)", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "order": 1, "source": "DIETARY FIBER METABOLISM", "target": "PREVOTELLA"}, {"weight": 7.0, "description": "Genetic variation affecting cobalamin absorption via CUBN gene is linked to albuminuria, indicating a role in metabolic regulation.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "order": 1, "source": "ALBUMINURIA REGULATION", "target": "COBALAMIN ABSORPTION PATHWAY"}, {"weight": 4.0, "description": "Genetic variation near IRF1 influences susceptibility to T2DM, indicating potential pathways linking gene function with metabolic diseases.", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "order": 1, "source": "IRF1 GENE", "target": "TYPE 2 DIABETES MELLITUS (T2DM)"}, {"weight": 12.0, "description": "Individuals with the rs4988235 T allele consume more milk compared to those without this variant.", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "order": 1, "source": "RS4988235 T/T GENOTYPE", "target": "MILK INTAKE"}, {"weight": 12.0, "description": "Individuals carrying the rs4988235 T allele have modestly lower HDL cholesterol levels compared to non-carriers.", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "order": 1, "source": "RS4988235 T/T GENOTYPE", "target": "HDL CHOLESTEROL"}, {"weight": 6.0, "description": "No significant association was found between energy intake and the LP genetic variant in this study.", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "order": 1, "source": "RS4988235 T/T GENOTYPE", "target": "ENERGY INTAKE"}, {"weight": 6.0, "description": "People carrying the rs4988235 T allele consumed fewer non-alcoholic beverages than those without this variant.", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "order": 1, "source": "RS4988235 T/T GENOTYPE", "target": "NON-ALCOHOLIC BEVERAGES INTAKE"}, {"weight": 8.0, "description": "The LP gene influences plasma levels of C15:0, a fatty acid associated with dietary patterns and metabolic pathways.", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "order": 1, "source": "LP (LACTASE PERSISTENCE)", "target": "C15:0"}, {"weight": 4.0, "description": "Individuals with the LP gene showed a slight reduction in poultry consumption compared to those without it.", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "order": 1, "source": "LP (LACTASE PERSISTENCE)", "target": "POULTRY CONSUMPTION"}, {"weight": 8.0, "description": "Intake of dairy products is associated with higher plasma C15:0 levels, reflecting metabolic pathways influenced by dietary habits.", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "order": 1, "source": "DAIRY PRODUCTS INTAKE", "target": "C15:0 LEVELS"}, {"weight": 10.0, "description": "HbA1c levels are a risk factor for diabetes and were not significantly altered by LP genotypes in this study.", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "order": 1, "source": "DIABETES RISK FACTORS", "target": "BASELINE HBA1C LEVELS"}, {"weight": 6.0, "description": "Infants treated with choline showed a higher proportion meeting criteria for conditioning compared to placebo, indicating an effect on learning and memory functions.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "order": 1, "source": "CHOLINE", "target": "EYEBLINK CONDITIONING"}, {"weight": 6.0, "description": "Maternal dietary choline intake during pregnancy impacts FASD diagnosis outcomes for infants.)", "source_id": "chunk-d594d57f0043cce2b3d29c80323b1a11", "order": 1, "source": "CHOLINE", "target": "FASD DIAGNOSIS"}, {"weight": 8.0, "description": "The PEMT enzyme variant affects endogenous choline synthesis, impacting the effectiveness of dietary choline intake during pregnancy.)", "source_id": "chunk-d594d57f0043cce2b3d29c80323b1a11", "order": 1, "source": "CHOLINE", "target": "PEMT ENZYME VARIANT (RS12325817)"}, {"weight": 8.0, "description": "High levels of alcohol consumption during pregnancy are linked to the development of FASD in children.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "order": 1, "source": "FETAL ALCOHOL SPECTRUM DISORDER (FASD)", "target": "MATERNAL ALCOHOL CONSUMPTION"}, {"weight": 4.0, "description": "Infants with FASD may have lower novelty preference scores, indicating impaired visual recognition memory compared to peers without FASD.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "order": 1, "source": "FETAL ALCOHOL SPECTRUM DISORDER (FASD)", "target": "NOVELTY PREFERENCE SCORE"}, {"weight": 6.0, "description": "Performance on eyeblink conditioning tests is indicative of an infant\u2019s visual recognition memory function.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "order": 1, "source": "EYEBLINK CONDITIONING", "target": "VISUAL RECOGNITION MEMORY FUNCTION"}, {"weight": 3.0, "description": "Prenatal exposure to heavy alcohol consumption is associated with a higher incidence of low birth weight in infants.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "order": 1, "source": "HEAVY ALCOHOL CONSUMPTION", "target": "BIRTH WEIGHT"}, {"weight": 2.0, "description": "Maternal smoking can contribute to developmental delays and other adverse outcomes in children exposed to prenatal nicotine.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "order": 1, "source": "SMOKING", "target": "FETAL DEVELOPMENT"}, {"weight": 1.0, "description": "Smoking can negatively impact semen quality and fertility by causing oxidative stress, DNA damage, and other physiological changes that impair sperm function.", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "order": 1, "source": "SMOKING", "target": "MALE INFERTILITY"}, {"weight": 8.0, "description": "Both educational attainment and smoking are lifestyle factors that can influence milk consumption patterns and potentially impact disease risk.", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5", "order": 1, "source": "SMOKING", "target": "EDUCATIONAL ATTAINMENT"}, {"weight": 3.0, "description": "Use of illicit drugs during pregnancy may lead to poor developmental outcomes, including lower cognitive abilities in infants.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "order": 1, "source": "ILLICIT DRUG USE", "target": "DEVELOPMENTAL OUTCOMES"}, {"weight": 9.0, "description": "The MMACHC variant\'s effect on birth weight is less pronounced during pregnancy at 28 weeks, showing no significant change.<SEP>The effect of this variant on fetal birth weight at 28 weeks is negligible, indicating limited influence.", "source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "order": 1, "source": "BIRTH WEIGHT", "target": "MMACHC VARIANT (RS12272669)"}, {"weight": 5.0, "description": "High maternal serum B12 levels do not significantly affect offspring birthweight according to the study\'s findings.", "source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "order": 1, "source": "BIRTH WEIGHT", "target": "MATERNAL SERUM B12 LEVELS"}, {"weight": 7.0, "description": "Positive causal effect of higher maternal folate levels on offspring birth weight, a significant finding in the study.", "source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "order": 1, "source": "BIRTH WEIGHT", "target": "FOLATE LEVELS (MATERNAL)"}, {"weight": 8.0, "description": "Negative impact of high fetal folate levels on birthweight, though with smaller effect size compared to maternal levels.", "source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "order": 1, "source": "BIRTH WEIGHT", "target": "FOLATE LEVELS (FETAL)"}, {"weight": 6.0, "description": "Increased maternal serum folate levels positively affect offspring birthweight according to the study findings.", "source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "order": 1, "source": "BIRTH WEIGHT", "target": "MATERNAL SERUM FOLATE LEVELS"}, {"weight": 7.0, "description": "Higher fetal folate levels negatively impact fetal birth weight, though with a smaller effect size compared to maternal levels.", "source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "order": 1, "source": "BIRTH WEIGHT", "target": "FETAL FOLATE LEVELS"}, {"weight": 4.0, "description": "Infants receiving choline supplementation showed improved growth patterns compared to those without supplementation.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "order": 1, "source": "CATCH-UP GROWTH", "target": "CHOLINE SUPPLEMENTATION"}, {"weight": 6.0, "description": "Inadequate maternal dietary choline status is associated with increased risk for FASD diagnosis in infants.)", "source_id": "chunk-d594d57f0043cce2b3d29c80323b1a11", "order": 1, "source": "FASD DIAGNOSIS", "target": "MATERNAL DIETARY CHOLINE STATUS"}, {"weight": 8.0, "description": "This genomic variant affects the capacity of the PEMT enzyme to synthesize choline endogenously, impacting dietary choline requirements.)", "source_id": "chunk-d594d57f0043cce2b3d29c80323b1a11", "order": 1, "source": "PEMT ENZYME VARIANT (RS12325817)", "target": "ENDOGENOUS CHOLINE SYNTHESIS"}, {"weight": 8.0, "description": "Both conditions fall under the broader category of Fetal Alcohol Spectrum Disorders but differ in severity and symptoms present.)", "source_id": "chunk-d594d57f0043cce2b3d29c80323b1a11", "order": 1, "source": "FAS (FETAL ALCOHOL SYNDROME)", "target": "PFAS (PARTIAL FETAL ALCOHOL SYNDROME)"}, {"weight": 6.0, "description": "Comparing outcomes between infants whose mothers received choline supplementation versus a placebo during pregnancy.)", "source_id": "chunk-d594d57f0043cce2b3d29c80323b1a11", "order": 1, "source": "PLACEBO ARM", "target": "CHOLINE-TREATED GROUP"}, {"weight": 4.0, "description": "The presence of GRK5 (CA)16 allele polymorphisms is significantly associated with increased risk for prediabetes and type 2 diabetes mellitus.", "source_id": "chunk-66f614368ca7f1bd578d9eb259083dd9", "order": 1, "source": "GRK5 (CA)N POLYMORPHISM", "target": "IFG, IGT, T2DM"}, {"weight": 3.0, "description": "The variation in CA repeat sequences within the GRK5 gene is a form of genomic polymorphism that affects glucose metabolism risk.", "source_id": "chunk-66f614368ca7f1bd578d9eb259083dd9", "order": 1, "source": "GRK5 (CA)N POLYMORPHISM", "target": "CA REPEAT SEQUENCES"}, {"weight": 4.0, "description": "Logistic regression analysis is used to study the association between specific alleles of GRK5 (like (CA)16) and disease risk.", "source_id": "chunk-66f614368ca7f1bd578d9eb259083dd9", "order": 1, "source": "GRK5 (CA)N POLYMORPHISM", "target": "LOGISTIC REGRESSION ANALYSIS"}, {"weight": 4.0, "description": "The genetic variation within the GRK5 gene is assessed using PIC values to determine polymorphism.", "source_id": "chunk-66f614368ca7f1bd578d9eb259083dd9", "order": 1, "source": "PIC VALUES", "target": "GRK5 GENE"}, {"weight": 4.0, "description": "The PIC values indicate significant differences in the frequency distribution of specific alleles like (CA)16 and (CA)17 across different groups.", "source_id": "chunk-66f614368ca7f1bd578d9eb259083dd9", "order": 1, "source": "PIC VALUES", "target": "(CA)16, (CA)17 ALLELES)"}, {"weight": 4.0, "description": "The presence of the (CA)16 allele is significantly negatively correlated with Type 2 Diabetes Mellitus, suggesting a protective effect against developing T2DM.", "source_id": "chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9", "order": 1, "source": "T2DM", "target": "(CA)16 ALLELE"}, {"weight": 8.0, "description": "Mice deficient for the SENP1 gene exhibit a heightened susceptibility to Type 2 Diabetes Mellitus phenotypes under conditions of high-fat diet exposure.)", "source_id": "chunk-174831b97ed170039b374ba254d4f506", "order": 1, "source": "T2DM", "target": "SENP1-AP2KO"}, {"weight": 2.0, "description": "There are no significant associations between the (CA)16 allele and abnormal blood glucose conditions, indicating that this allele does not significantly influence these conditions.", "source_id": "chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9", "order": 1, "source": "(CA)16 ALLELE", "target": "ABNORMAL BLOOD GLUCOSE"}, {"weight": 4.0, "description": "The multiple alleles are significantly negatively correlated with Impaired Fasting Glucose, indicating a protective effect against IFG.", "source_id": "chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9", "order": 1, "source": "IFG", "target": "MULTIPLE ALLELES INCLUDING (CA)15, (CA)17, (CA)18, AND (CA)19"}, {"weight": 2.0, "description": "None of the tag single nucleotide polymorphisms (tgSNPs) in CHI3L1 showed an association with impaired fasting glucose (IFG).)", "source_id": "chunk-44a871da300abc9be525b468f502f5cb", "order": 1, "source": "IFG", "target": "CHI3LI TG SNPS"}, {"weight": 4.0, "description": "The multiple alleles are significantly negatively correlated with Impaired Glucose Tolerance, suggesting a protective effect against IGT.", "source_id": "chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9", "order": 1, "source": "IGT", "target": "MULTIPLE ALLELES INCLUDING (CA)15, (CA)17, (CA)18, AND (CA)19"}, {"weight": 2.0, "description": "A borderline protective association was found between one of the tgSNPs, rs12123883, and impaired glucose tolerance (IGT), though it did not reach statistical significance.)", "source_id": "chunk-44a871da300abc9be525b468f502f5cb", "order": 1, "source": "IGT", "target": "CHI3LI TG SNPS"}, {"weight": 3.0, "description": "The NFG group is used as a control to compare against multiple alleles which show significant negative correlations with IFG, IGT, and T2DM.", "source_id": "chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9", "order": 1, "source": "MULTIPLE ALLELES INCLUDING (CA)15, (CA)17, (CA)18, AND (CA)19", "target": "NFG GROUP"}, {"weight": 4.0, "description": "Abnormal glucose metabolism as seen in IFG, IGT, and T2DM leads to an increase in clinical parameters such as waist circumference, BMI, SBP, DBP, FPG, and 2 h PG.", "source_id": "chunk-66f614368ca7f1bd578d9eb259083dd9", "order": 1, "source": "IFG, IGT, T2DM", "target": "CLINICAL PARAMETERS"}, {"weight": 2.0, "description": "A specific SNP within the GPX4 gene has been identified as having an impact on the risk of developing colorectal cancer.", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "order": 1, "source": "GPX4 GENE", "target": "SNP IN GPX4 GENE (RS8178974)"}, {"weight": 1.0, "description": "Use of selenium supplements did not show a significant difference in colorectal cancer risk compared to controls.", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "order": 1, "source": "SELENIUM SUPPLEMENTS", "target": "COLORECTAL CANCER"}, {"weight": 2.0, "description": "While there was no strong evidence for an association between serum selenium and overall colorectal cancer risk, it showed a marginal positive trend with colon cancer specifically.", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "order": 1, "source": "COLORECTAL CANCER", "target": "SERUM SELENIUM CONCENTRATION"}, {"weight": 1.0, "description": "Similar NSAID use among cases and controls suggests that these drugs may not play a significant role in modifying the risk of developing colorectal cancer.", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "order": 1, "source": "COLORECTAL CANCER", "target": "NSAIDS (NONSTEROIDAL ANTI-INFLAMMATORY DRUGS)"}, {"weight": 2.0, "description": "Less frequent postmenopausal hormone use among cases compared to controls hints at hormonal factors possibly influencing disease development.", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "order": 1, "source": "COLORECTAL CANCER", "target": "POSTMENOPAUSAL HORMONE USE"}, {"weight": 2.0, "description": "Lower physical activity among cases compared to controls implies reduced exercise could increase the likelihood of developing colorectal cancer.", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "order": 1, "source": "COLORECTAL CANCER", "target": "PHYSICAL ACTIVITY"}, {"weight": 3.0, "description": "The positive association between serum selenium concentration and colon cancer was marginally significant, suggesting a possible role for this nutrient in cancer development or detection timing.", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "order": 1, "source": "SERUM SELENIUM CONCENTRATION", "target": "COLON CANCER"}, {"weight": 1.0, "description": "The genetic variants within selenoenzyme genes did not modify the observed association between serum selenium and colorectal cancer.", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "order": 1, "source": "SERUM SELENIUM CONCENTRATION", "target": "GENOMIC VARIANTS IN SELENOENZYMES"}, {"weight": 1.0, "description": "Both calcium intake and dietary fiber intake were lower in cases of colorectal cancer compared to controls, indicating potential nutritional factors influencing disease risk.", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "order": 1, "source": "CALCIUM INTAKE", "target": "DIETARY FIBER INTAKE"}, {"weight": 2.0, "description": "The ALDH2 genotype may indirectly influence physical activity through its effects on alcohol intake and overall health behavior.", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "order": 1, "source": "PHYSICAL ACTIVITY", "target": "ALDH2 RS671 GENOTYPE"}, {"weight": 8.0, "description": "Interleukin 1beta gene activity increases as a response to inflammation caused by DSS in colitis.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "order": 1, "source": "IL1B", "target": "DSS-INDUCED COLITIS"}, {"weight": 10.0, "description": "These transcripts are part of immune pathways that become more active during DSS-induced colitis in Card9\u2212/\u2212 mice.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "order": 1, "source": "REG3G, REG3B, AND IL22", "target": "IMMUNE-RELATED PATHWAYS"}, {"weight": 3.0, "description": "IL-17A positivity is observed in T-cells isolated from patients with psoriasiform lesions, indicating its role in the inflammatory processes associated with this condition.", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "order": 1, "source": "IL-17A", "target": "PSORIASIS"}, {"weight": 4.0, "description": "Wild-type mice recover better from DSS-induced colitis compared to Card9\u2212/\u2212 mice.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "order": 1, "source": "DSS-INDUCED COLITIS", "target": "WT MICE (WILD-TYPE MICE)"}, {"weight": 7.0, "description": "Low levels of IAA, a metabolite from gut bacteria tryptophan metabolism, correlate with increased susceptibility to DSS-induced colitis in Card9\u2212/\u2212 mice.)", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "order": 1, "source": "DSS-INDUCED COLITIS", "target": "INDOLE-3-ACETIC ACID (IAA)"}, {"weight": 5.0, "description": "The CD3\u2212CD4\u2212NKp46\u2212 subset is a subpopulation of IL-22+ cells that plays a crucial role in the immune response to colitis.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "order": 1, "source": "CD3\u2212CD4\u2212NKP46\u2212 SUBSET", "target": "IL-22+ CELLS"}, {"weight": 4.0, "description": "The expression of IL-22 is impaired in the context of CARD9 deficiency, suggesting a functional link between these two entities during colitis development and recovery.", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "order": 1, "source": "CARD9 GENE", "target": "IL-22 GENE"}, {"weight": 2.0, "description": "In GF mice colonized with Card9\u2212/\u2212 microbiota and exposed to DSS, the phenotype observed mimics that seen in Card9\u2212/\u2212 mice directly.", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "order": 1, "source": "GERM-FREE (GF) MICE", "target": "DEXTRAN SODIUM SULFATE (DSS)"}, {"weight": 3.0, "description": "CXCL1 and CXCL5 are downstream effectors of IL-22 signaling pathways, their altered expression indicating a compromised inflammatory response mechanism in Card9\u2212/\u2212 mice.", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "order": 1, "source": "IL-22 GENE", "target": "CYTOKINES (CXCL1, CXCL5)"}, {"weight": 3.0, "description": "FOS is a transcription factor that regulates the expression of many genes involved in inflammation. Its decreased expression in Card9\u2212/\u2212\u2192GF mice suggests it plays a role downstream of IL-22 signaling.", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "order": 1, "source": "IL-22 GENE", "target": "TRANSCRIPTION FACTOR (FOS)"}, {"weight": 4.0, "description": "REG3G and REG3B are induced by IL-22 for anti-fungal defense. Their reduced expression in Card9\u2212/\u2212\u2192GF mice indicates a deficiency in this protective mechanism.", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "order": 1, "source": "IL-22 GENE", "target": "REG3G AND REG3B GENES"}, {"weight": 2.0, "description": "The unaltered levels of IL-17 production indicate that the defect seen in Card9\u2212/\u2212\u2192GF mice might be specific to pathways other than those regulated by IL-17.", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "order": 1, "source": "INTERLEUKIN-17 (IL-17)", "target": "CARD9 GENE "}, {"weight": 4.0, "description": "ILC function is compromised in the production of IL-22, indicating a critical role for these cells in maintaining gut homeostasis through this cytokine.", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "order": 1, "source": "INNATE LYMPHOID CELLS (ILCS)", "target": "IL-22 GENE "}, {"weight": 3.0, "description": "While the IL-23 pathway is intact in Card9\u2212/\u2212\u2192GF mice, the inability of ILCs to produce sufficient IL-22 indicates a specific defect downstream of this pathway.", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "order": 1, "source": "INNATE LYMPHOID CELLS (ILCS)", "target": "IL-23 SIGNALING PATHWAY "}, {"weight": 4.0, "description": "TH22 cell dysfunction leads to decreased production of REG3G and REG3B, highlighting the importance of IL-22 for maintaining anti-fungal defense mechanisms in the gut.", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "order": 1, "source": "TH22 CELLS", "target": "REG3G AND REG3B GENES "}, {"weight": 4.0, "description": "The reduction of Adlercreutzia in Card9\u2212/\u2212 mice microbiota suggests its important role in maintaining gut homeostasis and immune balance, influenced by CARD9 deficiency.", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "order": 1, "source": "ADLERCREUTZIA (GENUS)", "target": "CARD9 GENE "}, {"weight": 3.0, "description": "The phylum Actinobacteria includes Adlercreutzia and other bacteria crucial for maintaining a healthy gut microbiota, with deficiencies observed in the absence of CARD9.", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "order": 1, "source": "ADLERCREUTZIA (GENUS)", "target": "ACTINOBACTERIA (PHYLUM)"}, {"weight": 3.0, "description": "The specific reduction of Lactobacillus reuteri within Actinobacteria phylum highlights its unique role in gut health and the regulation by CARD9.", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "order": 1, "source": "ACTINOBACTERIA (PHYLUM)", "target": "LACTOBACILLUS REUTERI (SPECIES)"}, {"weight": 4.0, "description": "Together, IL-1\u03b2 and TNF-\u03b1 form a cytokine network critical for initiating inflammation in the body. Their roles are intertwined with those of CARD9 during colitis.", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "order": 1, "source": "INTERLEUKIN-1\u0392 (IL-1\u0392)", "target": "TNF-\u0391 GENE "}, {"weight": 3.0, "description": "Both NOD2 and CARD9 genes play crucial roles in innate immune responses but target different pathogens, highlighting the complexity of gut microbiota regulation.", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "order": 1, "source": "NOD2 GENE", "target": "CARD9 GENE "}, {"weight": 4.0, "description": "The reduction or alteration of Bifidobacterium longum in CARD9-deficient mice indicates its role in maintaining a healthy microbial balance influenced by the CARD9 gene.", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "order": 1, "source": "BIFIDOBACTERIUM LONGUM (SPECIES)", "target": "CARD9 GENE "}, {"weight": 4.0, "description": "FGF15 expression changes due to CARD9 deficiency suggest that this factor plays an essential role in regulating intestinal inflammation and metabolism, affected by the presence of CARD9.", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "order": 1, "source": "FIBROBLAST GROWTH FACTOR 15 (FGF15)", "target": "CARD9 GENE "}, {"weight": 10.0, "description": "Defective tryptophan metabolism leads to reduced activation of Aryl Hydrocarbon Receptor (AHR).)<SEP>Impaired tryptophan metabolism within the gut microbiota affects AHR activation and consequently influences local IL-22 production.)", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd<SEP>chunk-29025895ac187b8e88dec5cea9478842", "order": 1, "source": "TRYPTOPHAN METABOLISM", "target": "AHR ACTIVATION"}, {"weight": 6.0, "description": "IDO1 enzymatic activity is crucial for the conversion of tryptophan into kynurenine in host cells as part of immune regulation.)", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "order": 1, "source": "TRYPTOPHAN METABOLISM", "target": "INDOLEAMINE 2,3-DIOXYGENASE 1 (IDO1)"}, {"weight": 7.0, "description": "Deficiency in Ido1 results in alterations in tryptophan metabolism pathways and affects AHR activity as well as IL-22 production in the gut.)", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "order": 1, "source": "TRYPTOPHAN METABOLISM", "target": "IDO1\u2212/\u2212 MICE"}, {"weight": 3.0, "description": "Impaired tryptophan metabolism by the gut microbiota leads to defective AHR activation and increased susceptibility to IBD.)", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "order": 1, "source": "TRYPTOPHAN METABOLISM", "target": "GUT MICROBIOTA FUNCTION"}, {"weight": 9.0, "description": "Supplementation with specific Lactobacillus strains can restore AHR activation and improve IL-22 production, reducing the severity of DSS-induced colitis in Card9\u2212/\u2212 mice.)", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "order": 1, "source": "AHR ACTIVATION", "target": "LACTOBACILLUS STRAINS"}, {"weight": 8.0, "description": "These bacterial strains are pivotal for their ability to activate AHR, contributing significantly to the regulation of colitis susceptibility through IL-22 signaling pathways.)", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "order": 1, "source": "AHR ACTIVATION", "target": "L. REUTERI AND ALLOBACULUM SP."}, {"weight": 8.0, "description": "The production of Kyn through IDO1 activity modulates IL-22 levels, impacting the susceptibility to DSS-induced colitis in Card9\u2212/\u2212 mice.)", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "order": 1, "source": "KYNURENINE (KYN)", "target": "IL-22 PRODUCTION"}, {"weight": 6.0, "description": "The microbiota influences intestinal dendritic cells to produce IL-23, which is crucial for the activation and differentiation of immune responses in the gut.)", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "order": 1, "source": "IL-23 PRODUCTION", "target": "MICROBIOTA"}, {"weight": 9.0, "description": "Deficiency in Il22 impacts the gut microbiota composition and function, leading to decreased AHR activity and reduced levels of IAA, affecting susceptibility to DSS-induced colitis.)", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "order": 1, "source": "MICROBIOTA", "target": "IL22\u2212/\u2212 MICE"}, {"weight": 4.0, "description": "Decreased proliferation (Ki-67) and increased apoptosis (cleaved caspase 3) indicate impaired intestinal healing in Card9\u2212/\u2212 mice.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "order": 1, "source": "DSS-INDUCED COLITIS RECOVERY", "target": "KI67 AND CLEAVED CASPASE 3"}, {"weight": 6.0, "description": "IDO1 is responsible for converting tryptophan into Kynurenine, a process that is impaired in subjects with IBD.)", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "order": 1, "source": "IDO1 PROTEIN", "target": "KYNURENINE PRODUCTION"}, {"weight": 7.0, "description": "A specific genetic variant within CARD9 affects the ability of gut microbiota to produce AHR ligands, influencing disease susceptibility in IBD patients.)", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "order": 1, "source": "CARD9 GENE EXPRESSION", "target": "IBD-ASSOCIATED SNP (RS10781499)"}, {"weight": 4.0, "description": "Fecal samples from patients with IBD show reduced ability to activate Aryl Hydrocarbon Receptor (AHR), indicating impaired tryptophan metabolism and microbiota function.)", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "order": 1, "source": "AHR ACTIVATION ", "target": "IBD-DERIVED FECAL SAMPLES"}, {"weight": 7.0, "description": "Activation of Aryl Hydrocarbon Receptor (AHR) regulates immune responses through metabolites produced by tryptophan metabolism.)", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "order": 1, "source": "AHR ACTIVATION ", "target": "IMMUNE RESPONSE REGULATION "}, {"weight": 5.0, "description": "An SNP within CARD9 associated with increased susceptibility to IBD, affecting AHR activation by gut microbiota-derived metabolites.)", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "order": 1, "source": "CARD9 GENE VARIANT (RS10781499)", "target": "IBD SUSCEPTIBILITY "}, {"weight": 6.0, "description": "The enzymatic activity of IDO1 is crucial for converting tryptophan into Kynurenine, a process that is impaired in subjects with IBD.)", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "order": 1, "source": "IDO1 ENZYMATIC ACTIVITY", "target": "TRYPTOPHAN METABOLISM "}, {"weight": 3.0, "description": "SH2B3 protein normally constrains \u03b22M expression in response to hypertensive stimuli.)", "source_id": "chunk-c29d575e156569afaa1ca3d6418a71b9", "order": 1, "source": "\u03922M GENE", "target": "SH2B3 PROTEIN"}, {"weight": 2.0, "description": "The rs3184504 polymorphism is genetically linked to decreased SH2B3 expression, which in turn influences \u03b22M levels and hypertension risk.)", "source_id": "chunk-c29d575e156569afaa1ca3d6418a71b9", "order": 1, "source": "RS3184504 POLYMORPHISM", "target": "SH2B3 EXPRESSION"}, {"weight": 2.0, "description": "Genetic variations in the SH2B3 gene influence its expression level, affecting subsequent \u03b22M levels and potentially influencing hypertension development.)", "source_id": "chunk-c29d575e156569afaa1ca3d6418a71b9", "order": 1, "source": "SH2B3 EXPRESSION", "target": "SH2B3 GENE"}, {"weight": 1.0, "description": "Elevated levels of \u03b22M protein are associated with increased risk of developing new-onset hypertension over time.)", "source_id": "chunk-c29d575e156569afaa1ca3d6418a71b9", "order": 1, "source": "HYPERTENSION", "target": "\u03922M PROTEIN"}, {"weight": 3.0, "description": "The presence of albuminuria is often indicative of kidney damage that can exacerbate or be exacerbated by hypertension.)", "source_id": "chunk-c29d575e156569afaa1ca3d6418a71b9", "order": 1, "source": "HYPERTENSION", "target": "ALBUMINURIA"}, {"weight": 4.0, "description": "Individuals with low eGFR, indicating poor kidney function, are at higher risk for developing hypertension and its complications.)", "source_id": "chunk-c29d575e156569afaa1ca3d6418a71b9", "order": 1, "source": "HYPERTENSION", "target": "LOW EGFR (ESTIMATED GLOMERULAR FILTRATION RATE)"}, {"weight": 5.0, "description": "While statins primarily lower cholesterol levels, their use is often considered in the context of overall cardiovascular health alongside factors like \u03b22M levels.)", "source_id": "chunk-c29d575e156569afaa1ca3d6418a71b9", "order": 1, "source": "HYPERTENSION", "target": "STATIN USE"}, {"weight": 4.0, "description": "The model using angiotensin II induces hypertension and subsequent renal/vascular dysfunctions in mice.)", "source_id": "chunk-c29d575e156569afaa1ca3d6418a71b9", "order": 1, "source": "ANGIOTENSIN II-INDUCED HYPERTENSION MODEL", "target": "RENAL/VASCULAR DYSFUNCTION"}, {"weight": 6.0, "description": "In experimental settings, Angiotensin II can induce hypertension and is used to study the mechanisms of hypertensive responses in mice models.)", "source_id": "chunk-c29d575e156569afaa1ca3d6418a71b9", "order": 1, "source": "ANGIOTENSIN II-INDUCED HYPERTENSION MODEL", "target": "ANGIOTENSIN II"}, {"weight": 5.0, "description": "Mice lacking SH2B3 protein show higher \u03b22M levels in response to angiotensin II-induced hypertension, linking to increased hypertensive responses and end-organ damage.)", "source_id": "chunk-c29d575e156569afaa1ca3d6418a71b9", "order": 1, "source": "CIRCULATING BETA-2-MICROGLOBULIN LEVELS", "target": "SH2B3\u2212/\u2212 MOUSE MODEL"}, {"weight": 5.0, "description": "The MTHFD1 gene contains a genomic variant (rs2236225) that is associated with increased risk of neural tube defects in infants with low maternal folate intake.", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "order": 1, "source": "MTHFD1", "target": "SNP RS2236225"}, {"weight": 5.0, "description": "The MTHFD1 gene contains a genomic variant (rs11627387) that is associated with increased risk of neural tube defects in infants when maternal folate intake is low.", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "order": 1, "source": "MTHFD1", "target": "SNP RS11627387"}, {"weight": 2.0, "description": "The rs2236225 polymorphism in MTHFD1 gene leading to ARG-653-GLN alteration is associated with higher susceptibility to neural tube defects and statistical differences were observed among TMD patients compared to healthy controls.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "order": 1, "source": "MTHFD1", "target": "RS2236225 G ALLELE"}, {"weight": 5.0, "description": "The MTHFR gene contains a genomic variant (rs1476413) that shows reduced risk of neural tube defects in mothers with high dietary folate intake and heterozygous genotype.", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "order": 1, "source": "MTHFR", "target": "SNP RS1476413"}, {"weight": 5.0, "description": "The MTHFR gene contains a genomic variant (rs1801131) that shows reduced risk of neural tube defects in mothers with high dietary folate intake and heterozygous genotype.", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "order": 1, "source": "MTHFR", "target": "SNP RS1801131"}, {"weight": 5.0, "description": "The MTHFR gene contains a genomic variant (rs1801133) that shows reduced risk of neural tube defects in mothers with high dietary folate intake and heterozygous genotype.", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "order": 1, "source": "MTHFR", "target": "SNP RS1801133"}, {"weight": 5.0, "description": "The SHMT1 gene contains a genomic variant (rs669340 CG) associated with reduced risk of neural tube defects in mothers but increased risk in infants, depending on maternal folate intake levels.", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "order": 1, "source": "SHMT1", "target": "SNP RS669340 CG"}, {"weight": 5.0, "description": "The SHMT1 gene contains a genomic variant (rs12939757 AG) associated with increased risk of neural tube defects in infants with low maternal dietary folate intake.", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "order": 1, "source": "SHMT1", "target": "SNP RS12939757 AG"}, {"weight": 2.0, "description": "The presence of the rs1979277 polymorphism associated with Leu435Phe substitution in SHMT1 is linked to increased risk for TMD disease compared to control groups.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "order": 1, "source": "SHMT1", "target": "RS1979277 G ALLELE"}, {"weight": 2.0, "description": "The rs638416 polymorphism in the SHMT1 promoter region is associated with significant increases of the C allele and CC genotype among TMD patients compared to healthy controls.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "order": 1, "source": "SHMT1", "target": "RS638416 C ALLELE AND CC GENOTYPE"}, {"weight": 5.0, "description": "The TYMS gene contains a genomic variant (rs502396) that reduces the risk of neural tube defects when mothers have low dietary folate and are heterozygous for this variant.", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "order": 1, "source": "TYMS", "target": "SNP RS502396"}, {"weight": 5.0, "description": "The TYMS gene contains a genomic variant (rs699517) that reduces the risk of neural tube defects when mothers have low dietary folate and are heterozygous for this variant.", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "order": 1, "source": "TYMS", "target": "SNP RS699517"}, {"weight": 5.0, "description": "The TYMS gene contains a genomic variant (rs2847153 AG) that reduces the risk of neural tube defects in infants when there is low maternal dietary folate intake.", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "order": 1, "source": "TYMS", "target": "SNP RS2847153 AG"}, {"weight": 3.0, "description": "The availability of vitamin B12 through TCblR gene expression influences folate-dependent processes and impacts health outcomes including infertility risk.", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "order": 1, "source": "FOLATE", "target": "B12 TRANSCOBALAMIN RECEPTOR (TCBLR) GENE"}, {"weight": 2.0, "description": "The CDC HPLC-MS/MS method quantitatively measures folic acid and 5-methylTHF in serum with high accuracy.)", "source_id": "chunk-dd3c1834035af8b4436c8058609b6fd8", "order": 1, "source": "FOLATE", "target": "SERUM FOLATE MEASUREMENT METHODS (CDC HPLC-MS/MS)"}, {"weight": 6.0, "description": "Variability in folate measurement results is significantly influenced by differences in microorganisms used as standards in laboratory settings.)", "source_id": "chunk-257a38a8ce6582c434f31b023b4a9704", "order": 1, "source": "FOLATE", "target": "MICROORGANISM EFFECT"}, {"weight": 4.0, "description": "The choice of calibrators (such as 10-formyltetrahydrofolate or folic acid) significantly affects the accuracy and variability of folate measurement results in laboratories.)", "source_id": "chunk-257a38a8ce6582c434f31b023b4a9704", "order": 1, "source": "FOLATE", "target": "CALIBRATOR EFFECT"}, {"weight": 3.0, "description": "The genomic variant rs10399931 showed a significant association with the serum C-peptide concentration after two hours, indicating an effect on insulin production.)", "source_id": "chunk-44a871da300abc9be525b468f502f5cb", "order": 1, "source": "RS10399931", "target": "C-PEPTIDE"}, {"weight": 4.0, "description": "The Inter99 cohort contributed data on the association between CHI3L1 tgSNPs and T2D-related factors, including BMI and glucose tolerance test results.", "source_id": "chunk-44a871da300abc9be525b468f502f5cb", "order": 1, "source": "CHI3LI TG SNPS", "target": "INTER99 COHORT"}, {"weight": 4.0, "description": "Data from individuals recruited at Steno Diabetes Center were used to study the association between CHI3L1 tgSNPs and T2D-related factors, such as BMI and glucose tolerance.", "source_id": "chunk-44a871da300abc9be525b468f502f5cb", "order": 1, "source": "CHI3LI TG SNPS", "target": "STENO DIABETES CENTER INDIVIDUALS"}, {"weight": 6.0, "description": "Adjustments for age and sex were made to ensure accurate assessment of the association between CHI3L1 tgSNPs and T2D-related factors such as BMI, serum C-peptide levels.", "source_id": "chunk-44a871da300abc9be525b468f502f5cb", "order": 1, "source": "CHI3LI TG SNPS", "target": "AGE AND SEX ADJUSTMENT"}, {"weight": 6.0, "description": "The glucose tolerance test was used to identify individuals without diabetes (Normal Glucose Tolerance - NGT), and their data were analyzed for association with CHI3L1 genomic variants.", "source_id": "chunk-44a871da300abc9be525b468f502f5cb", "order": 1, "source": "CHI3LI TG SNPS", "target": "GLUCOSE TOLERANCE TEST (NGT)"}, {"weight": 7.0, "description": "The joint effect of poor lifestyle and high-risk CFH genotype increases the odds for AMD more than additive effects, suggesting synergy between genetic risk and poor lifestyle.", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "order": 1, "source": "CFH Y402H RISK ALLELE", "target": "HEALTHY LIFESTYLE SCORE (HLS)"}, {"weight": 4.0, "description": "The A69S risk allele of ARMS2 is associated with increased odds for AMD, especially when combined with low HLS.", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "order": 1, "source": "A69S RISK ALLELE (ARMS2)", "target": "AGE-RELATED MACULAR DEGENERATION (AMD)"}, {"weight": 8.0, "description": "The combination of low HLS and at least one A69S allele increases AMD risk, though the effect is sub-additive compared to individual effects.", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "order": 1, "source": "A69S RISK ALLELE (ARMS2)", "target": "HEALTHY LIFESTYLE SCORE (HLS)"}, {"weight": 6.0, "description": "Women with high HLS scores had lower odds of AMD compared to those with low HLS, indicating the protective effect of a healthy lifestyle against genetic risk factors for AMD.", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "order": 1, "source": "HEALTHY LIFESTYLE SCORE (HLS)", "target": "AGE-RELATED MACULAR DEGENERATION (AMD)"}, {"weight": 3.0, "description": "Higher status for LZ among women with high HLS partially explains the protective effect of a healthy lifestyle against genetic risk factors for AMD.", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "order": 1, "source": "HEALTHY LIFESTYLE SCORE (HLS)", "target": "LUTEIN AND ZEAXANTHIN (LZ)"}, {"weight": 6.0, "description": "While genetic predispositions from the C3 gene exist, dietary stability appears to influence how these genes affect AMD risk.", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "order": 1, "source": "HEALTHY LIFESTYLE SCORE (HLS)", "target": "C3 GENE (COMPLEMENT COMPONENT C3)"}, {"weight": 3.0, "description": "The joint effect of HLS and high-risk CFH genotype increases AMD risk more than additive effects, indicating synergy between genetic predisposition and lifestyle.", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "order": 1, "source": "HEALTHY LIFESTYLE SCORE (HLS)", "target": "INTERACTION BETWEEN CFH GENOTYPE AND HEALTHY LIFESTYLE SCORE"}, {"weight": 4.0, "description": "There is evidence suggesting that adherence to healthy lifestyle patterns can modify the risk of AMD, particularly when considered alongside genetic predispositions.", "source_id": "chunk-a7d0bfa8b16262a1f313b7e3060969c6", "order": 1, "source": "HEALTHY LIFESTYLE SCORE (HLS)", "target": "AMD"}, {"weight": 3.0, "description": "No significant interaction was found between the ARMS2 genotype and HLS regarding the additive or multiplicative effects on AMD risk.", "source_id": "chunk-a7d0bfa8b16262a1f313b7e3060969c6", "order": 1, "source": "HEALTHY LIFESTYLE SCORE (HLS)", "target": "ARMS2 GENOTYPE"}, {"weight": 2.0, "description": "Interactions between these genotypes and HLS had unreliable estimates due to a lack of main effects for the SNPs and variable combinations leading to the lowest odds for AMD.", "source_id": "chunk-a7d0bfa8b16262a1f313b7e3060969c6", "order": 1, "source": "HEALTHY LIFESTYLE SCORE (HLS)", "target": "CFB/C2, C3 RS2230199 AND CFI RS10033900 GENOTYPES"}, {"weight": 7.0, "description": "In combination with dietary changes, omega-3 fatty acids help reduce TG levels and manage hypertriglyceridemia.", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "order": 1, "source": "OMEGA-3 FATTY ACIDS", "target": "HYPERTRIGLYCERIDEMIA"}, {"weight": 9.0, "description": "Higher dietary intake of LZ among women with high HLS partially explains protective benefits against AMD in the context of genetic risk factors.", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "order": 1, "source": "LUTEIN AND ZEAXANTHIN (LZ)", "target": "INTERACTION BETWEEN ARMS2 GENOTYPE AND HEALTHY LIFESTYLE SCORE"}, {"weight": 5.0, "description": "Variants in the CFH gene contribute to different risk phenotypes for AMD, particularly when combined with lifestyle factors.", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "order": 1, "source": "CFH GENE (COMPLEMENT FACTOR H)", "target": "AGE-RELATED MACULAR DEGENERATION RISK PHENOTYPES"}, {"weight": 4.0, "description": "The ARMS2 gene\'s impact on risk phenotypes is modified by lifestyle and dietary patterns.", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "order": 1, "source": "ARMS2 GENE (AGE-RELATED MACULOPATHY SUSCEPTIBILITY 2)", "target": "AGE-RELATED MACULAR DEGENERATION RISK PHENOTYPES"}, {"weight": 7.0, "description": "Variants in CFI do not significantly impact AMD risk even under conditions of stable diet and lifestyle.", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "order": 1, "source": "CFI GENE (COMPLEMENT FACTOR I)", "target": "DIETARY STABILITY"}, {"weight": 8.0, "description": "Risk phenotypes for AMD are influenced by the main effects of genetic variants, which can be modified by additional factors such as lifestyle.", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "order": 1, "source": "AGE-RELATED MACULAR DEGENERATION RISK PHENOTYPES", "target": "MAIN EFFECTS OF AMD GENOTYPES"}, {"weight": 3.0, "description": "The association between habitual coffee consumption and the risk of developing type 2 diabetes is modified by genetic risk scores.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "order": 1, "source": "COFFEE CONSUMPTION", "target": "GENETIC RISK SCORES "}, {"weight": 3.0, "description": "Regular black coffee intake is inversely associated with the risk of developing type 2 diabetes, particularly in individuals with high genetic risk scores.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "order": 1, "source": "BLACK COFFEE CONSUMPTION ", "target": "TYPE 2 DIABETES "}, {"weight": 3.0, "description": "The regular intake of caffeine, often through black coffee, is associated with lower risks for type 2 diabetes and prediabetes.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "order": 1, "source": "BLACK COFFEE CONSUMPTION ", "target": "CONTINUOUS CAFFEINE INTAKE "}, {"weight": 4.0, "description": "Consumption of sugared coffee is associated with a reduced risk of prediabetes and type 2 diabetes combined.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "order": 1, "source": "SUGARED COFFEE CONSUMPTION ", "target": "PREDIABETES "}, {"weight": 3.0, "description": "An inverse trend suggests that regular consumption of sugared coffee may inversely correlate with the risk of developing prediabetes and type 2 diabetes.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "order": 1, "source": "SUGARED COFFEE CONSUMPTION ", "target": "INVERSE TREND "}, {"weight": 4.0, "description": "This plot is derived from GWAS data to show associations within a specific genomic region, highlighting potential causal variants.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "order": 1, "source": "REGIONAL ASSOCIATION PLOT ", "target": "GWAS "}, {"weight": 5.0, "description": "A Q-Q plot helps in the assessment of the inflation factor by comparing observed vs. expected test statistics distribution.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "order": 1, "source": "GENOMIC INFLATION FACTOR (\u039b)", "target": "Q-Q PLOT "}, {"weight": 4.0, "description": "The identification and analysis of pairwise correlations aid in selecting highly-correlated genotyped SNPs for genetic risk score calculations.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "order": 1, "source": "PAIRWISE CORRELATIONS ", "target": "HIGHLY-CORRELATED GENOTYPED SNPS "}, {"weight": 3.0, "description": "Individuals who do not consume black coffee regularly may have different risks for type 2 diabetes compared to regular consumers.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "order": 1, "source": "NON-BLACK COFFEE CONSUMERS ", "target": "TYPE 2 DIABETES "}, {"weight": 4.0, "description": "Those who don\u2019t consume sugared coffee might exhibit varying degrees of risk for prediabetes depending on their dietary patterns and genetic factors.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "order": 1, "source": "NON-SUGARED COFFEE CONSUMERS ", "target": "PREDIABETES "}, {"weight": 4.0, "description": "These polymorphisms help identify specific SNPs related to habitual coffee intake patterns, influencing genetic risk scores.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "order": 1, "source": "GENETIC POLYMORPHISMS RELATED TO COFFEE CONSUMPTION ", "target": "COFFEE-RELATED SNPS "}, {"weight": 1.0, "description": "The SNP is associated through its minor allele in an inverse manner with the incidence or progression of type 2 diabetes.", "source_id": "chunk-b803830d07bff8ae14550f6458048707", "order": 1, "source": "SNP", "target": "INVERSE RELATIONSHIP"}, {"weight": 5.0, "description": "Genome-wide association studies help in identifying SNPs that contribute to the calculation of genetic risk scores.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "order": 1, "source": "GENETIC RISK SCORES ", "target": "GWAS "}, {"weight": 4.0, "description": "Certain genetic polymorphisms are linked to an increased risk of developing type 2 diabetes.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "order": 1, "source": "TYPE 2 DIABETES ", "target": "GENETIC POLYMORPHISMS "}, {"weight": 5.0, "description": "A Manhattan plot visually represents the association between genetic polymorphisms and traits or diseases across the genome.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "order": 1, "source": "GENETIC POLYMORPHISMS ", "target": "MANHATTAN PLOT "}, {"weight": 5.0, "description": "SENP1 plays a role in the regulation of NEMO SUMOylation status, influencing NF-\u03baB signaling.", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "order": 1, "source": "SENP1", "target": "NEMO (IKK\u0393)"}, {"weight": 4.0, "description": "The expression level of SENP1 correlates with disease progression in T1DM patients and NOD mouse models, indicating its role in diabetes pathogenesis.)", "source_id": "chunk-8382a49b61215482f9fc75e3a86cb987", "order": 1, "source": "SENP1", "target": "T1DM"}, {"weight": 5.0, "description": "The SENP1 protein plays a role in regulating glucose metabolism by modulating inflammation and diabetes pathways.)", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "order": 1, "source": "SENP1 PROTEIN", "target": "GLUCOSE METABOLISM REGULATION"}, {"weight": 3.0, "description": "The deficiency of SENP1 protein leads to reduced insulin secretion from pancreatic islets contributing to diabetes development.)", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "order": 1, "source": "SENP1 PROTEIN", "target": "PANCREATIC ISLETS (\u0392 CELLS)"}, {"weight": 4.0, "description": "The deficiency of SENP1 affects insulin secretion from pancreatic islets, contributing to the development of diabetes.)", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "order": 1, "source": "INSULIN SECRETION", "target": "ADIPOCYTE-SPECIFIC DELETION OF SENP1"}, {"weight": 5.0, "description": "The SENP1 gene deficiency leads to increased risk and development of Type 1 Diabetes Mellitus.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433", "order": 1, "source": "SENP1 GENE", "target": "T1DM"}, {"weight": 4.0, "description": "The process of T-cell mediated destruction contributes to apoptosis of \u03b2-cells, leading to loss of function in the \u03b2 cell with disrupted vasculatures.", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "order": 1, "source": "T-CELL MEDIATED DESTRUCTION", "target": "APOPTOSIS OF \u0392 CELLS"}, {"weight": 3.0, "description": "Immune cells infiltrating into pancreatic tissues cause structural disruption and damages to islet structures.", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "order": 1, "source": "PANCREATIC ISLETS STRUCTURE DISRUPTION", "target": "IMMUNE CELL INFILTRATION"}, {"weight": 2.0, "description": "The presence of IAA along with elevated CRP levels are indicative markers for the diagnosis and progression of Type 1 Diabetes Mellitus.", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "order": 1, "source": "INSULIN AUTOANTIBODY (IAA)", "target": "C-REACTIVE PROTEIN (CRP)"}, {"weight": 3.0, "description": "Elevated \u03b2-hydroxybutyrate levels in SENP1-aP2KO mice suggest metabolic changes that contribute to immune dysregulation, supporting the development of T-cell mediated autoimmune responses.", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "order": 1, "source": "\u0392-HYDROXYBUTYRATE", "target": "IMMUNE SYSTEM REGULATION"}, {"weight": 5.0, "description": "The presence of a normal skin-rejection response indicates that the immune system in SENP1-aP2KO mice maintains its ability for immune regulation, despite developing autoimmune diabetes.", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "order": 1, "source": "IMMUNE SYSTEM REGULATION", "target": "SKIN-REJECTION RESPONSE"}, {"weight": 2.0, "description": "These cytokines are upregulated in adipocytes of mice with SENP1 deficiency, contributing to proinflammatory state.", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "order": 1, "source": "ADIPOCYTE-SPECIFIC SENP1-DEFICIENT MICE", "target": "IL-6, TNF-\u0391, IL-1\u0392"}, {"weight": 3.0, "description": "Studying these mice provides insights into the role of adipocyte-specific SENP1 deficiency in T1DM pathogenesis.", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "order": 1, "source": "ADIPOCYTE-SPECIFIC SENP1-DEFICIENT MICE", "target": "TYPE 1 DIABETES MELLITUS (T1DM)"}, {"weight": 3.0, "description": "Gene knockdown or overexpression affects the levels of SENP1 mRNA, impacting subsequent protein production.", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "order": 1, "source": "ADIPOCYTE-SPECIFIC SENP1-DEFICIENT MICE", "target": "SENP1 TRANSCRIPT"}, {"weight": 4.0, "description": "The loss of CD31-positive vascular area contributes significantly to the reduction in \u03b2-cell mass and function, leading to diabetic phenotypes.", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "order": 1, "source": "CD31+ VASCULAR AREA LOSS", "target": "\u0392-CELL MASS REDUCTION"}, {"weight": 3.0, "description": "Invasion by CD8+ T cells is a critical component of autoimmune mediated damages contributing to pancreatic islet destruction.", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "order": 1, "source": "AUTOIMMUNE MEDIATED DAMAGES", "target": "CD8+ T CELLS INFILTRATION"}, {"weight": 4.0, "description": "Increased MHCII+CD11b+CD11c\u2212 macrophages contribute to the reduction in regulatory T-cells, leading to a shift towards pro-inflammatory immune responses.", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "order": 1, "source": "MHCII+CD11B+CD11C\u2212 MACROPHAGES INCREASE", "target": "REGULATORY T-CELLS REDUCTION"}, {"weight": 4.0, "description": "Expansion of Th1 and Th17 effector T-cell subsets is supported by increased activation of dendritic cells, contributing to the autoimmune response.", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "order": 1, "source": "TH1 AND TH17 EFFECTOR T-CELL SUBSETS EXPANSION", "target": "ACTIVATED DENDRITIC CELLS INCREASE"}, {"weight": 3.0, "description": "Detection of NRP-V7 positive CD8+ T-cells indicates specific autoantigen recognition and supports the reduced regulatory T-cell population observed in autoimmune responses.", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "order": 1, "source": "REGULATORY T-CELLS REDUCTION", "target": "NRP-V7 POSITIVE CD8+ T-CELLS"}, {"weight": 4.0, "description": "These cells target the peptide, suggesting an autoimmune response targeting this protein in pancreatic islets.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433", "order": 1, "source": "NRP-V7 POSITIVE CD8+ T CELLS", "target": "ISLET-SPECIFIC GLUCOSE-6-PHOSPHATASE CATALYTIC SUBUNIT-RELATED PROTEIN PEPTIDE"}, {"weight": 3.0, "description": "The overproduction of these cytokines indicates a significant role in breaking immunological tolerance and initiating immune cell expansion early in disease phases.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433", "order": 1, "source": "IL-6, TNF-\u0391 AND IL-1\u0392", "target": "PROINFLAMMATORY CYTOKINE OVERPRODUCTION"}, {"weight": 4.0, "description": "PATs express high levels of these cytokines before the onset of diabetes, contributing to local inflammation and autoimmune responses.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433", "order": 1, "source": "IL-6, TNF-\u0391 AND IL-1\u0392", "target": "PERI-PANCREATIC ADIPOSE TISSUE (PATS)"}, {"weight": 3.0, "description": "High CCL5 expression in islets recruits immune cells into pancreas, causing damages of \u03b2 cells that lead to T1DM development.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433", "order": 1, "source": "TYPE 1 DIABETES MELLITUS (T1DM)", "target": "CCL5"}, {"weight": 4.0, "description": "The NOD mouse model is relevant to human type 1 diabetes as it spontaneously develops autoimmune destruction of insulin-producing cells.", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "order": 1, "source": "TYPE 1 DIABETES MELLITUS (T1DM)", "target": "NON-OBESE DIABETIC (NOD) MOUSE"}, {"weight": 4.0, "description": "High expression of this transcript contributes to increased production of IL-6 cytokine, leading to inflammatory responses in PATs.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433", "order": 1, "source": "PERI-PANCREATIC ADIPOSE TISSUE (PATS)", "target": "IL-6 TRANSCRIPT"}, {"weight": 3.0, "description": "High expression of this transcript leads to elevated levels of TNF-\u03b1 cytokine, contributing to inflammation and autoimmune processes.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433", "order": 1, "source": "PERI-PANCREATIC ADIPOSE TISSUE (PATS)", "target": "TNF-\u0391 TRANSCRIPT"}, {"weight": 4.0, "description": "High expression of this transcript results in increased IL-1\u03b2 production, furthering inflammatory responses and immune cell recruitment.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433", "order": 1, "source": "PERI-PANCREATIC ADIPOSE TISSUE (PATS)", "target": "IL-1\u0392 TRANSCRIPT"}, {"weight": 3.0, "description": "NF-\u03baB inhibitors reduce CCL5 expression in islets, indicating that NF-\u03baB activity regulates chemokine production which is important for inflammation and immune cell recruitment.)", "source_id": "chunk-8382a49b61215482f9fc75e3a86cb987", "order": 1, "source": "CCL5", "target": "NF-\u039aB INHIBITION"}, {"weight": 3.0, "description": "Detected presence of NRP-V7 positive CD8+ T cells targeting a peptide in these lymph nodes from SENP1-aP2KO mice.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433", "order": 1, "source": "SENP1-AP2KO MICE", "target": "PANCREATIC LYMPH NODES"}, {"weight": 4.0, "description": "Administration of insulin in SENP1-deficient mice only partially ameliorates the development of T1DM phenotypes, suggesting a complex interaction between insulin and disease progression.)", "source_id": "chunk-8382a49b61215482f9fc75e3a86cb987", "order": 1, "source": "SENP1-AP2KO MICE", "target": "INSULIN"}, {"weight": 5.0, "description": "Treatment with NF-\u03baB inhibitor JSH-23 in SENP1-aP2KO mice ameliorates diabetic phenotypes, indicating a critical role of NF-\u03baB activity mediated by SENP1.)", "source_id": "chunk-8382a49b61215482f9fc75e3a86cb987", "order": 1, "source": "SENP1-AP2KO MICE", "target": "NF-\u039aB ACTIVATION INHIBITOR II JSH-23"}, {"weight": 3.0, "description": "Both sites are involved in the detection of NRP-V7 positive CD8+ T cells targeting a peptide from islet-specific glucose-6-phosphatase catalytic subunit-related protein.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433", "order": 1, "source": "PANCREATIC LYMPH NODES", "target": "SPLEEN"}, {"weight": 4.0, "description": "Upregulation of CCL5 in these sites leads to recruitment of immune cells and subsequent damage to pancreatic \u03b2 cells, contributing to T1DM development.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433", "order": 1, "source": "CCL5 EXPRESSION", "target": "PANCREATIC ISLETS"}, {"weight": 4.0, "description": "NF-\u03baB dependent inflammation upregulates CCL5 expression, which recruits immune cells into the pancreas causing damage to \u03b2-cells.)", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "order": 1, "source": "CCL5 EXPRESSION", "target": "NF-\u039aB DEPENDENT INFLAMMATION"}, {"weight": 3.0, "description": "Adipocyte-derived cytokines induce upregulation of CCL5 expression in islets, which recruits immune cells into the pancreas causing damage to \u03b2-cells.)", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "order": 1, "source": "CCL5 EXPRESSION", "target": "SENP1-AP2KO ADIPOCYTE-DERIVED CYTOKINES"}, {"weight": 2.0, "description": "While PPAR\u03b3 SUMOylation does not contribute significantly to adipocyte differentiation or cytokine production, NF-\u03baB dependent inflammation is elevated in SENP1-aP2KO mice.)", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "order": 1, "source": "NF-\u039aB DEPENDENT INFLAMMATION", "target": "PPAR\u0393 SUMOYLATION"}, {"weight": 5.0, "description": "Increased NF-\u03baB activation leads to enhanced NF-\u03baB dependent inflammation in adipose tissues of SENP1-aP2KO mice.)", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "order": 1, "source": "NF-\u039aB DEPENDENT INFLAMMATION", "target": "NF-\u039aB ACTIVATION"}, {"weight": 3.0, "description": "IKK phosphorylates I\u03baB\u03b1, leading to its degradation and subsequent nuclear translocation of NF-\u03baB.", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "order": 1, "source": "IKK", "target": "I\u039aB\u0391"}, {"weight": 3.0, "description": "SENP2 deSUMOylates NEMO, which can inhibit NF-\u03baB activation by modulating p65/RelA activity.", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "order": 1, "source": "NF-\u039aB P65/RELA", "target": "SENP2"}, {"weight": 2.0, "description": "Etoposide VP16 induces phosphorylation and activation of IKK and NF-\u03baB p65/RelA in adipocytes.", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "order": 1, "source": "NF-\u039aB P65/RELA", "target": "DNA DAMAGE AGENT ETOPOSIDE VP16"}, {"weight": 4.0, "description": "Proinflammatory cytokines such as IL-6, TNF-\u03b1 and IL-1\u03b2 are produced at high levels by peripheral adipose tissues in mice deficient for SENP1.)", "source_id": "chunk-174831b97ed170039b374ba254d4f506", "order": 1, "source": "IL-6, TNF-\u0391, IL-1\u0392", "target": "SENP1-AP2KO"}, {"weight": 5.0, "description": "Increased plasma levels of proinflammatory cytokines are observed in T1DM patients and correlate with disease progression, as well as with the diabetes phenotype seen in SENP1-aP2KO mice.)", "source_id": "chunk-8382a49b61215482f9fc75e3a86cb987", "order": 1, "source": "T1DM", "target": "PROINFLAMMATORY CYTOKINES"}, {"weight": 3.0, "description": "Elevated levels of IFN-\u03b3 are associated with T1DM pathogenesis, particularly in NOD mouse models where it contributes to inflammation and immune cell activation.)", "source_id": "chunk-8382a49b61215482f9fc75e3a86cb987", "order": 1, "source": "T1DM", "target": "IFN-\u0393"}, {"weight": 5.0, "description": "Increased levels of pro-inflammatory cytokines promote \u03b2-cell apoptosis, leading to a decline in insulin-producing cells seen in T1DM progression.)", "source_id": "chunk-8382a49b61215482f9fc75e3a86cb987", "order": 1, "source": "PROINFLAMMATORY CYTOKINES", "target": "\u0392-CELL APOPTOSIS"}, {"weight": 4.0, "description": "These T-cells recognize insulin as a target antigen, leading to the destruction of beta cells and contributing to the autoimmune nature of type 1 diabetes.)", "source_id": "chunk-8382a49b61215482f9fc75e3a86cb987", "order": 1, "source": "INSULIN", "target": "ISLET-REACTIVE T CELLS"}, {"weight": 4.0, "description": "Under HFD conditions, the phenotype of SENP1-deficient mice is exacerbated, suggesting an interaction between dietary factors and genetic predisposition in diabetes development.)", "source_id": "chunk-8382a49b61215482f9fc75e3a86cb987", "order": 1, "source": "HIGH-FAT DIET (HFD)", "target": "SENP1 DEFICIENCY"}, {"weight": 5.0, "description": "Both IFN-\u03b3 and TNF-\u03b1 are crucial cytokines involved in inflammatory responses; their expression patterns differ between classical psoriasis and paradoxical reactions, indicating differential regulation of immune cells.", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "order": 1, "source": "IFN-\u0393", "target": "TNF-\u0391"}, {"weight": 4.0, "description": "The expression level of IFN-\u03b3 in CD subjects is lower compared to those with MAPbacteremia, indicating a relationship between MAP presence and IFN-\u03b3 levels.", "source_id": "chunk-883c371ea1f500a1ba8af8366328e8b0", "order": 1, "source": "IFN-\u0393", "target": "CD SUBJECTS WITHOUT MAPBACTEREMIA"}, {"weight": 4.0, "description": "High-fat diet exacerbates adipocyte hyperplasia in SENP1-deficient mice, suggesting an interaction between genetic predisposition and environmental factors in promoting obesity and inflammation.)", "source_id": "chunk-8382a49b61215482f9fc75e3a86cb987", "order": 1, "source": "ADIPOGENESIS", "target": "SENP1 DEFICIENCY AND HFD"}, {"weight": 5.0, "description": "High-fat diet (HFD) stimulates adipogenesis in perigonadal fat tissues of SENP1-aP2KO mice compared to control mice under similar conditions.)", "source_id": "chunk-174831b97ed170039b374ba254d4f506", "order": 1, "source": "ADIPOGENESIS", "target": "HFD"}, {"weight": 5.0, "description": "High-fat diet reduces glucose-stimulated insulin secretion in SENP1-aP2KO mice, exacerbating the development of diabetes phenotypes.)", "source_id": "chunk-174831b97ed170039b374ba254d4f506", "order": 1, "source": "HFD", "target": "GLUCOSE-STIMULATED INSULIN SECRETION"}, {"weight": 7.0, "description": "High-fat diet disrupts islet structures in SENP1-aP2KO mice, contributing to the development of diabetes phenotypes.)", "source_id": "chunk-174831b97ed170039b374ba254d4f506", "order": 1, "source": "HFD", "target": "ISLET STRUCTURES"}, {"weight": 6.0, "description": "Similar insulin responses were observed between SENP1-deficient and control mice on standard chow; however, HFD induced more severe insulin resistance in SENP1-deficient mice.)", "source_id": "chunk-174831b97ed170039b374ba254d4f506", "order": 1, "source": "ITT ASSAY (INSULIN TOLERANCE TEST)", "target": "SENP1-DEFICIENT MICE"}, {"weight": 6.0, "description": "SENP1-deficient mice exhibit increased water consumption, which is associated with their higher blood glucose levels.)", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "order": 1, "source": "ADIPOCYTE-SPECIFIC DELETION OF SENP1 (SENP1-AP2KO)", "target": "WATER CONSUMPTION"}, {"weight": 4.0, "description": "The SUMOylation modification of NEMO is critical for the activation of IKK-NF-\u03baB signaling.", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "order": 1, "source": "NEMO (IKK\u0393)", "target": "SUMOYLATION"}, {"weight": 8.0, "description": "The FokI variant was found to be significantly associated with an increased risk of ovarian cancer in a subgroup analysis limited to Caucasians.", "source_id": "chunk-1c470c93632f3704d6f3566de7a1dd0c", "order": 1, "source": "FOKI (RS2228570 OR RS10735810)", "target": "CAUCASIANS"}, {"weight": 8.0, "description": "Genetic data for ApaI was consistent with Hardy-Weinberg equilibrium within control populations, supporting the validity of its association studies.", "source_id": "chunk-1c470c93632f3704d6f3566de7a1dd0c", "order": 1, "source": "APAI (RS7975232)", "target": "HARDY-WEINBERG EQUILIBRIUM (HWE)"}, {"weight": 10.0, "description": "Significant heterogeneity between studies evaluating BsmI and ovarian cancer risk was observed, particularly in the African American subgroup by Grant et al., which contributed to the overall inconsistency.<SEP>The heterogeneity observed across studies evaluating BsmI and ovarian cancer risk was likely influenced by population genetics factors affecting the variant\'s association.", "source_id": "chunk-1c470c93632f3704d6f3566de7a1dd0c", "order": 1, "source": "BSMI (RS1544410)", "target": "HETEROGENEITY BETWEEN STUDIES"}, {"weight": 6.0, "description": "Genetic data for BsmI was inconsistent with Hardy-Weinberg equilibrium in some control populations, indicating potential issues in genetic consistency.", "source_id": "chunk-1c470c93632f3704d6f3566de7a1dd0c", "order": 1, "source": "BSMI (RS1544410)", "target": "HARDY-WEINBERG EQUILIBRIUM (HWE)"}, {"weight": 4.0, "description": "The genetic studies of BDNF polymorphisms comply with Hardy-Weinberg equilibrium principles, ensuring accurate assessment of allele frequencies.", "source_id": "chunk-814fe155e9cb953da61f6a79d1d25784", "order": 1, "source": "HARDY-WEINBERG EQUILIBRIUM (HWE)", "target": "BDNF GENE"}, {"weight": 4.0, "description": "Assessment of allele frequency in the context of HWE ensures accurate interpretation of genetic variation within populations studied for BDNF polymorphisms.", "source_id": "chunk-814fe155e9cb953da61f6a79d1d25784", "order": 1, "source": "HARDY-WEINBERG EQUILIBRIUM (HWE)", "target": "ALLELE FREQUENCY"}, {"weight": 6.0, "description": "The Hardy-Weinberg equilibrium is used to evaluate whether genomic variant frequencies in a population are consistent with random mating, impacting genetic study reliability.", "source_id": "chunk-5c78814fb7c198ee95071ee5a8462070", "order": 1, "source": "HARDY-WEINBERG EQUILIBRIUM (HWE)", "target": "GENOMIC VARIANT "}, {"weight": 4.0, "description": "The Japanese subgroup has been used to assess the association between Cdx-2 variant and ovarian cancer risk, showing deviation from Hardy-Weinberg equilibrium.)", "source_id": "chunk-dc5e8cc04a1b16b1e00f3a4120e004c4", "order": 1, "source": "CDX-2 (RS11568820)", "target": "JAPANESE SUBGROUP"}, {"weight": 4.0, "description": "The NECC subgroup also evaluated the impact of Cdx-2 variant on ovarian cancer risk, showing deviation from Hardy-Weinberg equilibrium.)", "source_id": "chunk-dc5e8cc04a1b16b1e00f3a4120e004c4", "order": 1, "source": "CDX-2 (RS11568820)", "target": "NECC SUBGROUP"}, {"weight": 5.0, "description": "This subgroup was used to study TaqI variant in relation to ovarian cancer risk and showed deviations from Hardy-Weinberg equilibrium.)", "source_id": "chunk-dc5e8cc04a1b16b1e00f3a4120e004c4", "order": 1, "source": "TAQI (RS731236)", "target": "NORTHERN SWEDEN SUBGROUP"}, {"weight": 4.0, "description": "The VDR gene harbors a SNP (rs2228570) that has been associated with both lower risk of T. cruzi infection and higher risk of developing Chagas cardiomyopathy.", "source_id": "chunk-6600322cc75094b1c57707e4b9c85954", "order": 1, "source": "VDR GENE", "target": "RS2228570"}, {"weight": 2.0, "description": "These SNPs in the VDR gene did not show a significant association with T. cruzi infection or CCC development.", "source_id": "chunk-6600322cc75094b1c57707e4b9c85954", "order": 1, "source": "VDR GENE", "target": "RS731236, RS7975232, RS1544410"}, {"weight": 3.0, "description": "The rs2228570 SNP, particularly its minor allele (A), shows an increased frequency in seronegative individuals compared to those with T. cruzi infection.", "source_id": "chunk-6600322cc75094b1c57707e4b9c85954", "order": 1, "source": "VDR GENE", "target": "RS2228570*A ALLELE FREQUENCY"}, {"weight": 3.0, "description": "The VDR TaqI (rs731236) polymorphism occurs within the VDR gene.", "source_id": "chunk-ba82b7eb40cf9eea561d839b20584f91", "order": 1, "source": "VDR GENE", "target": "VDR TAQI (RS731236)"}, {"weight": 2.0, "description": "Genetic variants within the VDR gene are examined for their association with degenerative disc disease and possibly HNP.", "source_id": "chunk-ba82b7eb40cf9eea561d839b20584f91", "order": 1, "source": "VDR GENE", "target": "DEGENERATIVE DISC DISEASE (A CONDITION OFTEN ASSOCIATED WITH HNP)"}, {"weight": 3.0, "description": "The minor allele of the rs2228570 SNP was overrepresented in individuals seronegative for T. cruzi infection, suggesting a protective effect.", "source_id": "chunk-6600322cc75094b1c57707e4b9c85954", "order": 1, "source": "RS2228570", "target": "T. CRUZI INFECTION SUSCEPTIBILITY"}, {"weight": 3.0, "description": "The frequency of the rs2228570*A allele was lower in asymptomatic patients compared to those with CCC, indicating an increased risk for CCC development.", "source_id": "chunk-6600322cc75094b1c57707e4b9c85954", "order": 1, "source": "RS2228570", "target": "CHAGAS CARDIOMYOPATHY (CCC)"}, {"weight": 2.0, "description": "No significant associations were found between these haplotypes and either T. cruzi infection or Chagas cardiomyopathy development.", "source_id": "chunk-6600322cc75094b1c57707e4b9c85954", "order": 1, "source": "CHAGAS CARDIOMYOPATHY (CCC)", "target": "HAPLOTYPE ACC, GAT, AAC"}, {"weight": 3.0, "description": "The minor allele of rs2228570 is overrepresented in seronegative individuals, indicating a protective effect against T. cruzi infection.", "source_id": "chunk-6600322cc75094b1c57707e4b9c85954", "order": 1, "source": "RS2228570*A ALLELE FREQUENCY", "target": "SERONEGATIVE INDIVIDUALS VS SEROPOSITIVE INDIVIDUALS"}, {"weight": 3.0, "description": "The frequency of rs2228570*A allele is lower in asymptomatic patients compared to those with Chagas cardiomyopathy, suggesting a higher risk for the latter.", "source_id": "chunk-6600322cc75094b1c57707e4b9c85954", "order": 1, "source": "RS2228570*A ALLELE FREQUENCY", "target": "ASYMPTOMATIC PATIENTS VS CCC PATIENTS"}, {"weight": 2.0, "description": "The TT genotype of IL-1A -889C>T was found to be 1.37 times more frequent in HNP patients than in controls, although overall genotypes and alleles showed no significant association with the risk of HNP.", "source_id": "chunk-ba82b7eb40cf9eea561d839b20584f91", "order": 1, "source": "IL-1A -889C>T", "target": "HNP"}, {"weight": 3.0, "description": "The IL-1A -889C>T variant occurs within the IL-1A gene.", "source_id": "chunk-ba82b7eb40cf9eea561d839b20584f91", "order": 1, "source": "IL-1A -889C>T", "target": "IL-1A GENE"}, {"weight": 1.0, "description": "The CT genotype and T allele of TNF-A 238G>A were more frequent in healthy controls than in HNP cases, but no significant association was found between the variant\'s alleles or genotypes and HNP risk.", "source_id": "chunk-ba82b7eb40cf9eea561d839b20584f91", "order": 1, "source": "TNF-A 238G>A", "target": "HNP"}, {"weight": 3.0, "description": "The TNF-A 238G>A variant is located in the TNF-A gene.", "source_id": "chunk-ba82b7eb40cf9eea561d839b20584f91", "order": 1, "source": "TNF-A 238G>A", "target": "TNF-A GENE"}, {"weight": 0.0, "description": "No significant associations were observed between VDR TaqI variants and susceptibility to HNP, nor with degenerative disc disease.", "source_id": "chunk-ba82b7eb40cf9eea561d839b20584f91", "order": 1, "source": "VDR TAQI (RS731236)", "target": "HNP"}, {"weight": 4.0, "description": "The IL-1A gene variant is investigated for its potential association with Human Nerve Pain (HNP).", "source_id": "chunk-ba82b7eb40cf9eea561d839b20584f91", "order": 1, "source": "IL-1A GENE", "target": "HUMAN NERVE PAIN (HNP)"}, {"weight": 3.0, "description": "The TNF-A gene variant is studied in relation to the risk of HNP.", "source_id": "chunk-ba82b7eb40cf9eea561d839b20584f91", "order": 1, "source": "TNF-A GENE", "target": "HUMAN NERVE PAIN (HNP)"}, {"weight": 4.0, "description": "This genomic variant explains part of the variation in maternal serum B12 levels observed in studies.", "source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "order": 1, "source": "FUT2 VARIANT (RS602662)", "target": "MATERNAL SERUM B12 LEVELS"}, {"weight": 4.0, "description": "Exclusion of the MTHFR variant attenuates the causal effect of maternal serum folate on birth weight, indicating its influence.<SEP>This variant significantly influences the causal effect of maternal serum folate on birthweight when included in analyses, indicating its importance.", "source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "order": 1, "source": "MTHFR SNP RS1801133", "target": "MATERNAL SERUM FOLATE LEVELS"}, {"weight": 4.0, "description": "The MR Egger result provides information about potential bias or pleiotropy affecting the results of IVW analysis.)", "source_id": "chunk-22216738ccbae0a6276bb4499018c434", "order": 1, "source": "MR EGGER RESULT", "target": "IVW ANALYSIS"}, {"weight": 8.0, "description": "The MTHFR C677T variant is significantly more common among LV patients compared to general population estimates, indicating a strong link between this genetic variant and the disease.", "source_id": "chunk-b025a32e74a29cbbd5a0ce3d051f3fdb", "order": 1, "source": "MTHFR C677T", "target": "LV"}, {"weight": 2.0, "description": "The MTHFR C677T variant is associated with an increased risk of cardiovascular disease due to elevated homocysteine levels.", "source_id": "chunk-d0476488384aadcae4630e94d982d2e0", "order": 1, "source": "MTHFR C677T", "target": "CARDIOVASCULAR DISEASE"}, {"weight": 6.0, "description": "Like its counterpart at position 677 of MTHFR gene, the A1298C variant also shows an increased carrier rate among LV patients, suggesting genetic predisposition to this condition.", "source_id": "chunk-b025a32e74a29cbbd5a0ce3d051f3fdb", "order": 1, "source": "MTHFR A1298C", "target": "LV"}, {"weight": 10.0, "description": "This PAI-1 variant is observed at a very high carrier rate in LV patient populations, making it a key genetic marker for the disease.", "source_id": "chunk-b025a32e74a29cbbd5a0ce3d051f3fdb", "order": 1, "source": "PAI-1 -675 4G/5G", "target": "LV"}, {"weight": 5.0, "description": "The PAI-1 -675 4G/5G polymorphism increases the risk of thrombotic events due to its influence on fibrinolysis.<SEP>The PAI-1 -675 4G/5G variant is associated with an increased risk of thrombotic disorders due to its effect on fibrinolysis.", "source_id": "chunk-d0476488384aadcae4630e94d982d2e0", "order": 1, "source": "PAI-1 -675 4G/5G", "target": "THROMBOSIS"}, {"weight": 3.0, "description": "The PAI-1 A844G polymorphism may affect fibrinolysis and thus influences the risk of thrombosis.", "source_id": "chunk-d0476488384aadcae4630e94d982d2e0", "order": 1, "source": "PAI-1 A844G", "target": "THROMBOSIS"}, {"weight": 4.0, "description": "The Prothrombin G20210A variant has one of the lowest carrier rates among LV patients, but is still notable in its association with the condition.", "source_id": "chunk-b025a32e74a29cbbd5a0ce3d051f3fdb", "order": 1, "source": "PROTHROMBIN G20210A", "target": "LV"}, {"weight": 7.0, "description": "The Prothrombin G20210A mutation significantly increases the risk of venous thromboembolism and other thrombotic conditions.<SEP>The Prothrombin G20210A variant is a well-known genetic risk factor for thrombotic disorders, particularly venous thromboembolism.", "source_id": "chunk-d0476488384aadcae4630e94d982d2e0", "order": 1, "source": "PROTHROMBIN G20210A", "target": "THROMBOSIS"}, {"weight": 2.0, "description": "Although less prevalent than other variants, Factor V G1691A shows an association with LV conditions, indicating a role in disease predisposition.", "source_id": "chunk-b025a32e74a29cbbd5a0ce3d051f3fdb", "order": 1, "source": "FACTOR V G1691A", "target": "LV"}, {"weight": 8.0, "description": "The Factor V G1691A mutation leads to a hypercoagulable state and increases the risk for venous thromboembolism.<SEP>The Factor V G1691A mutation leads to hypercoagulability and an increased risk for venous thromboembolism.", "source_id": "chunk-d0476488384aadcae4630e94d982d2e0", "order": 1, "source": "FACTOR V G1691A", "target": "HYPERCOAGULABILITY"}, {"weight": 5.0, "description": "Homocysteine metabolism is regulated by MTHFR activity, impacting tHcy levels in the body.", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "order": 1, "source": "THCY (TOTAL HOMOCYSTEINE)", "target": "MTHFR GENE"}, {"weight": 7.0, "description": "High levels of DNA fragmentation in sperm are strongly associated with reduced fertility, indicating a link between physiological damage to sperm cells and male infertility.", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "order": 1, "source": "DNA FRAGMENTATION", "target": "MALE INFERTILITY"}, {"weight": 2.0, "description": "Higher BMI is associated with an increased risk of male infertility due to metabolic imbalances affecting reproductive health.", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "order": 1, "source": "MALE INFERTILITY", "target": "BODY MASS INDEX (BMI)"}, {"weight": 2.0, "description": "The GSTM1-null polymorphism, a deletion of the GSTM1 gene, was found statistically more frequent in TMD patients compared to control groups, suggesting an increased risk for disease.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "order": 1, "source": "GSTM1-NULL POLYMORPHISM", "target": "TMD DISEASE"}, {"weight": 2.0, "description": "The rs1801394 genetic variant in MTRR gene leading to reduced enzyme affinity was observed statistically more frequent among TMD patients compared to controls, indicating potential involvement in disease susceptibility.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "order": 1, "source": "RS1801394 A ALLELE", "target": "TMD DISEASE"}, {"weight": 2.0, "description": "The genetic variant rs1801394 in MTRR gene producing an enzyme with less substrate affinity was associated with increased disease risk among TMD patients compared to controls.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "order": 1, "source": "RS1801394 A ALLELE", "target": "METHIONINE SYNTHASE REDUCTASE (MTRR)"}, {"weight": 1.0, "description": "Statistical differences were found for DRD4-48bptr genotype frequencies between TMD and control groups, though no significant increase was observed for S-DRD4 allele in patient group.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "order": 1, "source": "DRD4-48BPTR POLYMORPHISM", "target": "TMD DISEASE"}, {"weight": 2.0, "description": "The CDC HPLC-MS/MS method can specifically measure 5-methylTHF in serum samples.)", "source_id": "chunk-dd3c1834035af8b4436c8058609b6fd8", "order": 1, "source": "SERUM FOLATE MEASUREMENT METHODS (CDC HPLC-MS/MS)", "target": "5-METHYLTHF (5-METHYLTETRAHYDROFOLATE)"}, {"weight": 2.0, "description": "Spectrophotometric measurements are often performed using microplates for precise quantification of calibrators.)", "source_id": "chunk-dd3c1834035af8b4436c8058609b6fd8", "order": 1, "source": "LABORATORY PROCEDURES (MICROPLATE FORMAT)", "target": "SPECTROPHOTOMETRY"}, {"weight": 4.0, "description": "The use of microorganisms in conjunction with CDC reagents helps in achieving consistency and comparability across different testing environments and laboratories.)", "source_id": "chunk-7c25217961fba65d15f20beda8a58f1c", "order": 1, "source": "CDC REAGENTS", "target": "MICROORGANISM"}, {"weight": 6.0, "description": "The use of CDC reagents in day-to-day analysis helps reduce variability between results obtained on different days.)", "source_id": "chunk-7c25217961fba65d15f20beda8a58f1c", "order": 1, "source": "CDC REAGENTS", "target": "DAY 1 AND DAY 2 ANALYSIS RESULTS"}, {"weight": 2.0, "description": "Results obtained using IH reagents deviate from the CDC MBA target value, indicating a need for standardization with CDC reagents to ensure consistent results across different laboratories.)", "source_id": "chunk-7c25217961fba65d15f20beda8a58f1c", "order": 1, "source": "IH REAGENTS", "target": "CDC MBA TARGET VALUE"}, {"weight": 1.0, "description": "Laboratories #6 and #9 deviated significantly from the CDC MBA target value under harmonized conditions, indicating inconsistencies in measurements.)", "source_id": "chunk-7c25217961fba65d15f20beda8a58f1c", "order": 1, "source": "CDC MBA TARGET VALUE", "target": "LABORATORY #6 AND #9"}, {"weight": 2.0, "description": "Carriers of allele G have a higher frequency in patient populations and are significantly associated with an increased risk of breast cancer.", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e", "order": 1, "source": "BREAST CANCER", "target": "G ALLELE"}, {"weight": -1.0, "description": "The rs1138272 polymorphism is not significantly associated with breast cancer risk based on the provided statistical analysis.", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e", "order": 1, "source": "BREAST CANCER", "target": "RS1138272 POLYMORPHISM"}, {"weight": -0.5, "description": "While the AG genotype does not significantly increase breast cancer risk, it shows a non-significant trend indicating possible interaction under certain conditions.", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e", "order": 1, "source": "BREAST CANCER", "target": "AG GENOTYPE"}, {"weight": 3.0, "description": "The GG genotype in case groups is associated with increased breast cancer risk according to statistical analysis results.", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e", "order": 1, "source": "BREAST CANCER", "target": "GG GENOTYPE (CASES)"}, {"weight": 5.0, "description": "Individuals with the CT genotype report significantly greater reward and positive affect after drinking alcohol compared to those without this variant.", "source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59", "order": 1, "source": "CT GENOTYPE", "target": "REWARD AND POSITIVE AFFECT"}, {"weight": 7.0, "description": "Individuals with the CT (or CC) genotype who receive placebo report higher drinks per drinking day compared to those receiving olanzapine or having TT genotype.", "source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59", "order": 1, "source": "CT GENOTYPE", "target": "DRINKS PER DRINKING DAY"}, {"weight": 4.0, "description": "Individuals with the CT genotype have a specific genetic variant rs2023239 that influences their response to alcohol and medications.", "source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59", "order": 1, "source": "CT GENOTYPE", "target": "RS2023239"}, {"weight": 1.0, "description": "A lower frequency of the T allele was noted in CRC patients compared to controls, though this did not reach statistical significance.", "source_id": "chunk-5b0cc96debf110f3544685d3b227ff27", "order": 1, "source": "T ALLELE", "target": "COLORECTAL CANCER (CRC)"}, {"weight": 3.0, "description": "The Ile105Val SNP decreases the amyloid propensity of the GSTP1 protein, as shown by WALTZ analysis.", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e", "order": 1, "source": "ILE105VAL SNP", "target": "GSTP1 PROTEIN"}, {"weight": 2.0, "description": "Homozygote TT genotype in cases affects the amyloid propensity of GSTP1 protein through Ile105Val SNP, as predicted by WALTZ algorithm.", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e", "order": 1, "source": "GSTP1 PROTEIN", "target": "TT GENOTYPE (CASES)"}, {"weight": -1.0, "description": "The CC genotype has higher frequencies compared to CT genotypes, both showing no significant association with breast cancer risk but indicating population variation.", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e", "order": 1, "source": "CC GENOTYPE", "target": "CT GENOTYPE (CASES)"}, {"weight": 1.0, "description": "The presence of a CC genotype was observed to be associated with an increased occurrence of colorectal cancer.", "source_id": "chunk-5b0cc96debf110f3544685d3b227ff27", "order": 1, "source": "CC GENOTYPE", "target": "COLORECTAL CANCER (CRC)"}, {"weight": 3.0, "description": "The WALTZ algorithm predicts and evaluates changes in amyloid propensity due to specific mutations or polymorphisms like Ile105Val SNP in GSTP1 protein.", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e", "order": 1, "source": "WALTZ ALGORITHM", "target": "AMYLOID PROPENSITY"}, {"weight": 3.0, "description": "The p.R778L variant is one of three prevalent pathogenic variants among WD patients and contributes significantly to the disease.", "source_id": "chunk-047f259db19cbb4de945706a1bd1b450", "order": 1, "source": "P.R778L", "target": "WD PATIENTS"}, {"weight": 4.0, "description": "The genomic variant c.2333G > T corresponds to the pathogenic variant p.R778L.", "source_id": "chunk-047f259db19cbb4de945706a1bd1b450", "order": 1, "source": "P.R778L", "target": "C.2333G > T"}, {"weight": 3.0, "description": "Haplogroup A is predominantly associated with the pathogenic variant p.R778L in WD patients.", "source_id": "chunk-047f259db19cbb4de945706a1bd1b450", "order": 1, "source": "P.R778L", "target": "HAPLOGROUP A"}, {"weight": 4.0, "description": "WD chromosomes carry the p.R778L variant more frequently compared to control ones.", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "order": 1, "source": "P.R778L", "target": "WD CHROMOSOMES"}, {"weight": 3.0, "description": "Control chromosomes show a much lower frequency of the haplogroup A carrying the p.R778L variant in comparison to WD chromosomes.", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "order": 1, "source": "P.R778L", "target": "CONTROL ONES (CHROMOSOMES)"}, {"weight": 4.0, "description": "The p.P992L variant is a major contributor among WD patients, showing regional variations in allelic frequency.", "source_id": "chunk-047f259db19cbb4de945706a1bd1b450", "order": 1, "source": "P.P992L", "target": "WD PATIENTS"}, {"weight": 3.0, "description": "Patients in Zhejiang province have a lower allelic frequency of p.P992L than those from Jiangxi, indicating regional genetic variations.", "source_id": "chunk-047f259db19cbb4de945706a1bd1b450", "order": 1, "source": "P.P992L", "target": "ZHEJIANG PROVINCE"}, {"weight": 3.0, "description": "The genomic variant c.2975C > T is associated with the pathogenic variant p.P992L.", "source_id": "chunk-047f259db19cbb4de945706a1bd1b450", "order": 1, "source": "P.P992L", "target": "C.2975C > T"}, {"weight": 4.5, "description": "The pathogenic variant p.P992L is most commonly associated with haplogroup E in patients on WD chromosomes compared to controls.)", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "order": 1, "source": "P.P992L", "target": "HAPLOGROUP E (10-9-5)"}, {"weight": 2.0, "description": "The p.T935M variant is less frequent but shows high aggregation in specific regions among WD patients.", "source_id": "chunk-047f259db19cbb4de945706a1bd1b450", "order": 1, "source": "P.T935M", "target": "WD PATIENTS"}, {"weight": 4.0, "description": "Patients from Fujian province exhibit a significantly higher allelic frequency of the p.T935M variant compared to other provinces.", "source_id": "chunk-047f259db19cbb4de945706a1bd1b450", "order": 1, "source": "P.T935M", "target": "FUJIAN PROVINCE"}, {"weight": 2.0, "description": "The genomic variant c.2804C > T represents the genetic change for the pathogenic variant p.T935M.", "source_id": "chunk-047f259db19cbb4de945706a1bd1b450", "order": 1, "source": "P.T935M", "target": "C.2804C > T"}, {"weight": 4.0, "description": "The pathogenic variant p.T935M is exclusively associated with haplogroup J among WD chromosomes.)", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "order": 1, "source": "P.T935M", "target": "HAPLOGROUP J (12-4-8; 12-5-8)"}, {"weight": 4.0, "description": "WD chromosomes are exclusively associated with the uniform state presenting only one kind of haplogroup J for p.T935M.", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "order": 1, "source": "P.T935M", "target": "WD CHROMOSOMES"}, {"weight": 2.0, "description": "Control chromosomes show a significantly lower frequency of haplogroup J carrying the p.T935M variant compared to WD chromosomes.", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "order": 1, "source": "P.T935M", "target": "CONTROL ONES (CHROMOSOMES)"}, {"weight": 5.0, "description": "Microsatellite marker D13S314 exhibits significant linkage disequilibrium with the pathogenic variants p.R778L, p.P992L, and p.T935M.", "source_id": "chunk-047f259db19cbb4de945706a1bd1b450", "order": 1, "source": "D13S314", "target": "P.R778L, P.P992L, AND P.T935M"}, {"weight": 4.0, "description": "Marker D13S301 shows significant association with alleles linked to pathogenic variants p.R778L, p.P992L, and p.T935M.", "source_id": "chunk-047f259db19cbb4de945706a1bd1b450", "order": 1, "source": "D13S301", "target": "P.R778L, P.P992L, P.T935M"}, {"weight": 4.0, "description": "Microsatellite marker D13S316 demonstrates significant linkage distribution for alleles linked to pathogenic variants p.R778L, p.P992L, and p.T935M.", "source_id": "chunk-047f259db19cbb4de945706a1bd1b450", "order": 1, "source": "D13S316", "target": "P.R778L, P.P992L, P.T935M"}, {"weight": 3.5, "description": "Variant A1 accounts for the largest proportion within haplogroup A, significantly more common on WD chromosomes compared to controls.)", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "order": 1, "source": "HAPLOGROUP A", "target": "VARIANT A1 (10-7-7)"}, {"weight": 3.75, "description": "The main variant within the common haplogroup for p.P992L on WD chromosomes.)", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "order": 1, "source": "HAPLOGROUP E (10-9-5)", "target": "VARIANT E1 (10-9-5)"}, {"weight": 4.5, "description": "WD chromosomes are significantly more likely to carry haplogroup E compared to control ones.", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "order": 1, "source": "HAPLOGROUP E (10-9-5)", "target": "WD CHROMOSOMES"}, {"weight": 3.0, "description": "Control chromosomes show a much lower frequency of haplogroup E carrying the p.P992L variant in comparison to WD chromosomes.", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "order": 1, "source": "HAPLOGROUP E (10-9-5)", "target": "CONTROL ONES (CHROMOSOMES)"}, {"weight": 2.0, "description": "The algorithm may be used for patients starting warfarin therapy due to Deep Vein Thrombosis or Pulmonary Embolism (59.7% of cases).", "source_id": "chunk-f433e179cd5e32035a0303b9a14da3f1", "order": 1, "source": "WARFARIN DOSING ALGORITHM ", "target": "DVT/PE "}, {"weight": 6.0, "description": "There is an inverse correlation between percent WAA and predicted dose within the 20% therapeutic range for IWPC pharmacogenomics algorithm, indicating it performs poorly with varying levels of African ancestry among patients.)", "source_id": "chunk-b2730f3087aee6d9cff6e4939b229323", "order": 1, "source": "IWPC PHARMACOGENOMICS ALGORITHM", "target": "WAA"}, {"weight": 10.0, "description": "Our novel AA algorithm does not show an association between percent WAA and predicted dose because it incorporates population-specific variables, providing better performance across different levels of African ancestry.)", "source_id": "chunk-b2730f3087aee6d9cff6e4939b229323", "order": 1, "source": "NOVEL AA ALGORITHM", "target": "WAA"}, {"weight": 8.0, "description": "Linear regression analysis revealed an inverse correlation between WAA and predicted doses within the therapeutic range for high-dose patients.)", "source_id": "chunk-b2730f3087aee6d9cff6e4939b229323", "order": 1, "source": "WAA (WHOLE AFRICAN ANCESTRY)", "target": "LINEAR REGRESSION ANALYSIS"}, {"weight": 8.0, "description": "Predicted doses are compared with observed doses to evaluate algorithm accuracy and precision.)", "source_id": "chunk-b2730f3087aee6d9cff6e4939b229323", "order": 1, "source": "PREDICTED DOSE", "target": "OBSERVED DOSE"}, {"weight": 6.0, "description": "The NNG is calculated based on the need to prevent a dose from falling outside of the therapeutic range, indicating clinical benefit.)", "source_id": "chunk-b2730f3087aee6d9cff6e4939b229323", "order": 1, "source": "THERAPEUTIC DOSE RANGE", "target": "NNG"}, {"weight": 1.0, "description": "rs1057910 is part of the combined CYP2C9 star variant group due to its low frequency and impact on enzyme activity.", "source_id": "chunk-f433e179cd5e32035a0303b9a14da3f1", "order": 1, "source": "CYP2C9 STAR VARIANT GROUP ", "target": "RS1057910 "}, {"weight": 3.0, "description": "SNPs in both the CYP27B1 and CYP24A1 genes are implicated in advanced adenoma recurrence, suggesting a genetic basis for more severe disease outcomes.", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "order": 1, "source": "CYP27B1 AND CYP24A1 SNPS", "target": "ADVANCED ADENOMA RECURRENCE"}, {"weight": 3.0, "description": "Specific genotypes in both CYP27B1 and CYP24A1 genes are linked to larger or villous adenomas upon follow-up, indicating a genetic predisposition for more severe outcomes.", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "order": 1, "source": "CYP27B1 AND CYP24A1 SNPS", "target": "LARGER OR VILLOUS ADENOMA RECURRENCE"}, {"weight": 3.0, "description": "The interaction between vitamin D metabolite concentrations and certain SNPs (such as CYP24A1 rs2296241) affects the risk of adenoma recurrence, highlighting a metabolic pathway\'s role in disease.", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "order": 1, "source": "VITAMIN D METABOLITES", "target": "ADENOMA RECURRENCE"}, {"weight": 3.0, "description": "Interactions between this SNP and 1,25(OH)2D levels affect the risk of adenoma recurrence, showing a complex interplay between genetic and environmental factors.", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "order": 1, "source": "VITAMIN D METABOLITES", "target": "CYP27B1 SNP RS2762939"}, {"weight": 4.0, "description": "Individuals deficient in vitamin D have an increased risk for advanced adenomas when carrying specific genetic variants, indicating the combined effect of environmental and genetic factors on disease progression.", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "order": 1, "source": "ADVANCED ADENOMA RECURRENCE", "target": "VITAMIN D DEFICIENCY"}, {"weight": 3.0, "description": "The number of G alleles in CYP24A1 rs2296241 correlates with higher odds for recurrent adenomas with villous histology, suggesting a genetic influence on this feature.", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "order": 1, "source": "VILLOUS HISTOLOGY", "target": "CYP24A1 SNPS"}, {"weight": 2.0, "description": "The c.1186C\u2009>\u2009T variant in CYP24A1 represents a nucleotide substitution that impacts the genotyping results and analysis.", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "order": 1, "source": "CYP24A1 GENE", "target": "C.1186C\u2009>\u2009T VARIANT"}, {"weight": 8.0, "description": "The CYP24A1 gene is associated with IIH, where specific genetic variants can influence the disease risk.", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "order": 1, "source": "CYP24A1 GENE", "target": "IIH (IDIOPATHIC INFANTILE HYPERCALCEMIA)"}, {"weight": 2.0, "description": "The wild-type status refers to a CYP24A1 gene without any known variants, used as a control in studies.", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "order": 1, "source": "CYP24A1 GENE", "target": "WILD-TYPE (WT)"}, {"weight": 4.0, "description": "The rs777676129 amplicon is used to detect the c.428_430delAAG variant in HRMA analysis.", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "order": 1, "source": "C.428_430DELAAG VARIANT", "target": "RS777676129 AMPLICON"}, {"weight": 4.0, "description": "A compound heterozygous sample can carry the c.428_430delAAG variant along with another variant in CYP24A1, affecting its genotype.", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "order": 1, "source": "C.428_430DELAAG VARIANT", "target": "COMPOUND HETEROZYGOUS SAMPLE"}, {"weight": 6.0, "description": "The Tm analysis for the c.428_430delAAG variant reveals specific melting temperatures, allowing differentiation from wild-type samples.", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "order": 1, "source": "C.428_430DELAAG VARIANT", "target": "MELTING CURVE ANALYSIS (TM)"}, {"weight": 4.0, "description": "The rs114368325 amplicon is used to detect the c.1186C\u2009>\u2009T variant in HRMA analysis.", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "order": 1, "source": "C.1186C\u2009>\u2009T VARIANT", "target": "RS114368325 AMPLICON"}, {"weight": 4.0, "description": "The compound heterozygous sample can also carry the c.1186C\u2009>\u2009T variant in addition to another variant, influencing its genotype.", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "order": 1, "source": "C.1186C\u2009>\u2009T VARIANT", "target": "COMPOUND HETEROZYGOUS SAMPLE"}, {"weight": 6.0, "description": "The Tm analysis for the c.1186C\u2009>\u2009T variant also reveals specific melting temperatures, aiding in genotyping differentiation.", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "order": 1, "source": "C.1186C\u2009>\u2009T VARIANT", "target": "MELTING CURVE ANALYSIS (TM)"}, {"weight": 5.0, "description": "The P1001L mutation is causative for Menkes disease when present in an individual.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "order": 1, "source": "P1001L MUTATION", "target": "MENKES DISEASE"}, {"weight": 4.0, "description": "Disruption of copper transport and homeostasis, due to mutations in the ATP7A gene, leads to Menkes disease.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "order": 1, "source": "MENKES DISEASE", "target": "COPPER TRANSPORT AND HOMEOSTASIS"}, {"weight": 5.0, "description": "A brain MRI can detect signs of atrophy and delayed myelination in neurological conditions like Menkes disease.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "order": 1, "source": "BRAIN MRI", "target": "ATROPHY AND DELAYED MYELINATION"}, {"weight": 3.0, "description": "The median nerve compound motor action potentials test evaluates the function of the nervous system in conducting motor signals.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "order": 1, "source": "MEDIAN NERVE COMPOUND MOTOR ACTION POTENTIALS", "target": "NERVOUS SYSTEM FUNCTION"}, {"weight": 4.0, "description": "Conduction velocity measurements help diagnose neurological disorders by assessing nerve health and integrity.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "order": 1, "source": "MEDIAN NERVE CONDUCTION VELOCITY", "target": "NEUROLOGICAL DISORDERS"}, {"weight": 5.0, "description": "CSF contains biochemical markers that are critical for diagnosing Menkes disease, including copper levels and catecholamine ratios.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "order": 1, "source": "CEREBROSPINAL FLUID (CSF)", "target": "MENKES DISEASE DIAGNOSTIC MARKERS"}, {"weight": 4.0, "description": "Measuring ROS levels is crucial for understanding the impact of different genetic variants on cell viability and oxidative stress response in Caco-2 cells.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "order": 1, "source": "CACO-2 CELLS", "target": "ROS LEVELS"}, {"weight": 5.0, "description": "The genomic variant in GPX4 3\u2032 UTR affects the expression of IDI gene transcripts, indicating differential effects on cellular function.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "order": 1, "source": "DEIODINASE GENE (IDI)", "target": "GPX4 3\u2032UTR VARIANT (T/C)"}, {"weight": 7.0, "description": "Expression levels of IDI-T transcript correlate with GPx4 protein content under certain conditions (e.g., selenium supply).", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "order": 1, "source": "IDI-T TRANSCRIPT", "target": "GPX4 PROTEIN"}, {"weight": 6.0, "description": "The level of selenium affects the expression and function of GPX4 protein in cells.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "order": 1, "source": "SELENIUM (SE)", "target": "GPX4 PROTEIN"}, {"weight": 13.0, "description": "Exposure to t-BHP leads to increased ROS levels in both IDI-C and IDI-T cells, with a greater increase observed in IDI-C cells under low Se conditions.<SEP>Exposure to tert-butylhydroperoxide increases reactive oxygen species levels as a measure of oxidative stress induced by the compound.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7<SEP>chunk-a908a3115a9120ca2623513fe4a5e13a", "order": 1, "source": "TERT-BUTYLHYDROPEROXIDE (T-BHP)", "target": "ROS LEVELS"}, {"weight": 4.0, "description": "Cells are challenged using tert-butylhydroperoxide to induce oxidative stress, impacting ROS production and cell viability.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "order": 1, "source": "TERT-BUTYLHYDROPEROXIDE (T-BHP)", "target": "OXIDATIVE CHALLENGE"}, {"weight": 7.0, "description": "Both GPX4 and TR1 are selenoproteins involved in redox homeostasis, but their expression levels can be affected differently by selenium supply or oxidative stress.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "order": 1, "source": "GPX4 PROTEIN", "target": "THIOREDOXIN REDUCTASE 1 (TR1)"}, {"weight": 4.0, "description": "Cells exposed to tert-butylhydroperoxide exhibit increased ROS levels, reflecting their response to oxidative stress.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "order": 1, "source": "ROS LEVELS", "target": "TERT-BUTYLHYDROPEROXIDE CHALLENGE"}, {"weight": 12.0, "description": "Increased ROS levels correlate with changes in GPx activity, indicating a relationship between cellular antioxidant capacity and oxidative stress management.", "source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "order": 1, "source": "ROS LEVELS", "target": "GPX ACTIVITY"}, {"weight": 6.0, "description": "The level of Selenoprotein H mRNA is significantly lower in IDI-C cells compared to IDI-T cells, regardless of Se supply status.", "source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "order": 1, "source": "SELENOPROTEIN H MRNA", "target": "IDI-C CELLS"}, {"weight": 8.0, "description": "Selenium influences cell viability under oxidative stress conditions by modulating the expression and activity of selenoproteins such as GPx4.", "source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "order": 1, "source": "CELL VIABILITY", "target": "SE (SELENIUM)"}, {"weight": 5.0, "description": "The protein content of selenoprotein H correlates with its mRNA expression levels under different selenium conditions.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "order": 1, "source": "SELENOPROTEIN H PROTEIN", "target": "SELENOPROTEIN H MRNA LEVELS"}, {"weight": 5.0, "description": "Under conditions of sufficient selenium supply, the expression levels of selenoprotein H protein in cells are maintained or enhanced.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "order": 1, "source": "SELENOPROTEIN H PROTEIN", "target": "SE-SUPPLEMENTED MEDIUM"}, {"weight": 4.0, "description": "The mRNA levels of TR1, GPx1, and GPx4 are similar between IDI-C cells grown in Se-depleted or supplemented medium but vary in relation to selenoprotein H expression.", "source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "order": 1, "source": "TR1, GPX1 AND GPX4 MRNAS", "target": "IDI-C CELLS"}, {"weight": 10.0, "description": "IDI-C cells show differential responses to oxidative stress compared to IDI-T cells when grown in different Se concentrations.", "source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "order": 1, "source": "IDI-C CELLS", "target": "IDI-T CELLS"}, {"weight": 14.0, "description": "Cells expressing similar IDI transcript levels show marked differences in GPx activity, suggesting that transgene expression impacts endogenous GPx function.", "source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "order": 1, "source": "GPX ACTIVITY", "target": "IDI TRANSCRIPT LEVELS"}, {"weight": 9.0, "description": "Overexpression of IDI affects the regulation and expression levels of glutathione peroxidases like GPx1 and GPx4 in response to oxidative stress.", "source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "order": 1, "source": "INOSITOL DEMETHYLASE (IDI)", "target": "GLUTATHIONE PEROXIDASES (GPX1, GPX4)"}, {"weight": 4.0, "description": "The p.Val136Met mutation affects the CHAT gene\'s protein expression level, contributing to its role in neurotransmitter synthesis.", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "order": 1, "source": "CHAT GENE", "target": "P.VAL136MET MUTATION"}, {"weight": 6.0, "description": "This mutation alters the expression of the S-type transcript, affecting the production and activity of ChAT proteins.", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "order": 1, "source": "P.ALA557THR MUTATION", "target": "S-TYPE TRANSCRIPT OF CHAT GENE"}, {"weight": 1.0, "description": "Bosc 23 cells are used to express the S-type transcript, aiding in the study of alternative start sites and protein isoforms.", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "order": 1, "source": "S-TYPE TRANSCRIPT OF CHAT GENE", "target": "BOSC 23 CELLS"}, {"weight": 8.0, "description": "The nonsense mutation affects ChAT\'s functionality by altering its kinetic parameters and thermal stability.", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "order": 1, "source": "CHOLINE ACETYLTRANSFERASE PROTEIN (CHAT)", "target": "NONSENSE MUTATION ON SECOND ALLELE (P.ALA557THR)"}, {"weight": 10.0, "description": "Mutations in the CHAT gene influence the thermal stability of ChAT proteins, impacting their function at higher temperatures.", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "order": 1, "source": "THERMAL STABILITY OF CHAT MUTANT PROTEINS", "target": "MISSENSE MUTATIONS IN CHAT GENE"}, {"weight": 12.0, "description": "Expression and purification studies using histidine-tagged CHAT cDNAs reveal the effects of missense mutations on ChAT\'s kinetic properties.", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "order": 1, "source": "MISSENSE MUTATIONS IN CHAT GENE", "target": "HISTIDINE-TAGGED CHAT CDNA EXPRESSION IN E. COLI "}, {"weight": 2.0, "description": "Mutations alter kinetic properties, impacting enzyme efficiency and substrate affinity for catalyzing acetylcholine synthesis.", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "order": 1, "source": "MISSENSE MUTATIONS IN CHAT GENE", "target": "KINETIC PROPERTIES OF WILD-TYPE AND MUTANT CHAT PROTEINS "}, {"weight": 8.0, "description": "Methylation patterns at CpGs within the NDUFS7 gene are associated with indicators of oxidative stress, suggesting a role in energy metabolism under oxidative conditions.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "order": 1, "source": "NDUFS7 GENE", "target": "OXIDATIVE STRESS"}, {"weight": 10.0, "description": "The EIF3J gene exhibits methylation site associations with oxidative stress markers like TGSH and GSSG/GSH ratio indicating its involvement in translation initiation regulation during oxidative stress.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "order": 1, "source": "EIF3J GENE", "target": "OXIDATIVE STRESS"}, {"weight": 8.0, "description": "Methylation patterns at ZNF761 promoter region show significant association with GSSG/GSH ratio, an indicator of cellular redox status under oxidative conditions.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "order": 1, "source": "ZNF761 GENE", "target": "OXIDATIVE STRESS"}, {"weight": 10.0, "description": "The PSMG3 gene\'s promoter methylation is correlated with the GSSG/GSH ratio indicating its role in regulating proteasome activity during oxidative stress response.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "order": 1, "source": "PSMG3 GENE", "target": "OXIDATIVE STRESS"}, {"weight": 6.0, "description": "Methylation patterns at CpGs within ENTHD1 gene are associated with homocysteine levels, a marker of oxidative stress and cardiovascular risk.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "order": 1, "source": "ENTHD1 GENE", "target": "HOMOCYSTEINE LEVELS"}, {"weight": 8.0, "description": "The LRIG1 gene\'s methylation sites correlate with homocysteine levels indicating its role in signal transduction dysregulation during oxidative stress conditions.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "order": 1, "source": "LRIG1 GENE", "target": "SIGNAL TRANSDUCTION DYSREGULATION"}, {"weight": 10.0, "description": "Methylation patterns at RIPK3 gene CpG sites are associated with HCY levels suggesting a link between methylation and regulation of signal transduction pathways under oxidative stress.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "order": 1, "source": "RIPK3 GENE", "target": "HOMOCYSTEINE LEVELS"}, {"weight": 6.0, "description": "The ATP2B4 gene\'s methylation patterns correlate with homocysteine levels indicating its role in calcium signaling during oxidative conditions.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "order": 1, "source": "ATP2B4 GENE", "target": "SIGNAL TRANSDUCTION DYSREGULATION"}, {"weight": 8.0, "description": "DNA methylation at SEMA6A 5\'-UTR is associated with oxidized LDL, an indicator of lipid peroxidation and oxidative stress, suggesting its role in anti-angiogenic function under these conditions.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "order": 1, "source": "SEMA6A GENE", "target": "OXIDATIVE STRESS"}, {"weight": 10.0, "description": "The TAPBP gene\'s methylation level at 3\'-UTR is associated with CD marker levels indicating potential involvement of tapasin in immune response regulation during oxidative stress.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "order": 1, "source": "TAPBP GENE", "target": "OXIDATIVE STRESS"}, {"weight": 8.0, "description": "Methylation patterns at CKAP5 gene CpGs are correlated with BCD-LDL, a marker of lipid peroxidation products and oxidative stress state, suggesting its role in cellular cytoskeletal organization under these conditions.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "order": 1, "source": "CKAP5 GENE", "target": "LIPID PEROXIDATION PRODUCTS"}, {"weight": 10.0, "description": "The FOSL2 gene\'s methylation patterns are associated with BCD-LDL levels indicating potential involvement of AP-1 transcription factors in inflammatory response regulation during oxidative stress.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "order": 1, "source": "FOSL2 GENE", "target": "INFLAMMATORY RESPONSE REGULATION"}, {"weight": 8.0, "description": "DNA methylation patterns at FRMD6 CpG sites show significant association with BCD-LDL, a marker of lipid peroxidation and oxidative stress, indicating its role in cellular functions under these conditions.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "order": 1, "source": "FRMD6 GENE", "target": "OXIDATIVE STRESS RESPONSE"}, {"weight": 3.0, "description": "DNA methylation at CpG sites is associated with oxidative stress markers, indicating a role in oxidative stress regulation.", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "order": 1, "source": "OXIDATIVE STRESS", "target": "CPGS"}, {"weight": 6.0, "description": "High RegulomeDB scores indicate strong evidence that CpG sites are located within functional regulatory elements, influencing gene regulation.", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "order": 1, "source": "CPGS", "target": "REGULOMEDB SCORE 1A-2C"}, {"weight": 4.0, "description": "The promoter region of genes can be regulated by transcription factors to influence gene expression under conditions such as oxidative stress.", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "order": 1, "source": "PROMOTER REGION", "target": "TRANSCRIPTION FACTOR (TF)"}, {"weight": 4.0, "description": "CpG island shores are often in close proximity to promoter regions and can influence their methylation status, affecting gene expression.", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "order": 1, "source": "PROMOTER REGION", "target": "CPG ISLAND SHORES"}, {"weight": 5.0, "description": "Phosphorylation events can influence DNA methylation patterns, thereby affecting the regulation of cellular processes including those related to oxidative stress.", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "order": 1, "source": "PHOSPHORYLATION", "target": "DNA METHYLATION"}, {"weight": 8.0, "description": "The DAVID tool can be used to cluster genes involved in phosphorylation processes, identifying pathways and biological functions related to cellular regulation.", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "order": 1, "source": "PHOSPHORYLATION", "target": "DAVID FUNCTIONAL ANNOTATION CLUSTERING TOOL"}, {"weight": 9.0, "description": "Genetic variants identified as meQTLs influence DNA methylation levels at specific CpG sites, affecting gene expression patterns in diseases like CHD and T2D.", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "order": 1, "source": "DNA METHYLATION", "target": "MEQTL (METHYLATION QUANTITATIVE TRAIT LOCI)"}, {"weight": 3.0, "description": "Increased DNA methylation inhibits CTCF binding at insulator sites in the promoter region of LOC100507600, affecting gene expression.)", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "order": 1, "source": "DNA METHYLATION", "target": "CTCF BINDING SITE"}, {"weight": 2.0, "description": "Deletion of intronic regions using CRISPR-Cas9 technology affects Lct mRNA levels and demonstrates the importance of DNA methylation in regulation.)", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "order": 1, "source": "DNA METHYLATION", "target": "LCT INTRONIC REGION"}, {"weight": 2.0, "description": "Increased methylation facilitates enhancer-promoter interactions, impacting gene regulation mechanisms.)", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "order": 1, "source": "DNA METHYLATION", "target": "ENHANCER-PROMOTER INTERACTION"}, {"weight": 6.0, "description": "The BCL2L11 gene/protein is associated with coronary heart disease through its role in apoptosis and regulation of cardiovascular health.", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "order": 1, "source": "CHD (CORONARY HEART DISEASE)", "target": "BCL2L11 GENE/PROTEIN"}, {"weight": 5.0, "description": "Atherosclerosis is a major contributing factor to the development of coronary heart disease through plaque buildup in arteries.", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "order": 1, "source": "CHD (CORONARY HEART DISEASE)", "target": "ATHEROSCLEROSIS"}, {"weight": 10.0, "description": "The CARDIoGRAM consortium conducts genome-wide association studies to identify genetic risk factors for coronary heart disease.", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "order": 1, "source": "CHD (CORONARY HEART DISEASE)", "target": "CARDIOGRAM CONSORTIUM"}, {"weight": 11.0, "description": "The DIAGRAM consortium focuses on GWAS studies for type 2 diabetes mellitus, identifying genetic variants associated with the disease.", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "order": 1, "source": "T2D (TYPE 2 DIABETES MELLITUS)", "target": "DIAGRAM CONSORTIUM"}, {"weight": 7.0, "description": "Transcription factor binding sites for E2F1 are enriched among genes involved in atherosclerosis pathways.", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "order": 1, "source": "E2F1 TRANSCRIPTION FACTOR BINDING SITES", "target": "ATHEROSCLEROSIS"}, {"weight": 7.0, "description": "The JASPAR database is used to identify and analyze binding sites for transcription factors such as E2F1 in genes related to diseases like atherosclerosis.", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "order": 1, "source": "E2F1 TRANSCRIPTION FACTOR BINDING SITES", "target": "JASPAR DATABASE"}, {"weight": 12.0, "description": "The proxy SNP rs6750142 is nominally associated with CHD and T2D in GWAS studies, indicating potential genetic overlap between these diseases.", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "order": 1, "source": "RS6750142 (PROXY OF RS726430)", "target": "CHD AND T2D"}, {"weight": 3.0, "description": "Methylation level at CPB1\'s CpG site is studied in relation to oxidative stress-associated diseases.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "order": 1, "source": "CPB1", "target": "OXIDATIVE STRESS CPGS"}, {"weight": 7.0, "description": "Methylation changes in the 3\' UTR of HIST1H4D are directly linked to Type 2 Diabetes risk, highlighting gene-specific epigenetic regulation.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "order": 1, "source": "HIST1H4D 3\'-UTR METHYLATION", "target": "HISTONE CLUSTER 1 H4D (HIST1H4D)"}, {"weight": 7.0, "description": "Methylation at ZNF341\'s CpG site is most predictive for heart failure, indicating its role in cardiovascular disease risk.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "order": 1, "source": "ZNF341 CPG CG11842944", "target": "HEART FAILURE"}, {"weight": 7.0, "description": "Methylation levels at ZNF341\'s cg11842944 site influence risks for cardiovascular events like myocardial infarction and ischaemic stroke.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "order": 1, "source": "ZNF341 CPG CG11842944", "target": "ISCHAEMIC STROKE, MYOCARDIAL INFARCTION"}, {"weight": 5.0, "description": "Multiple intergenic SNPs on chromosome 4 associated with methylation levels in disease contexts suggest a genetic basis for health outcomes.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "order": 1, "source": "CHR. 4 INTERGENIC SNPS", "target": "T2D, CVD"}, {"weight": 5.0, "description": "The MT-ATP6 gene contains an 8993T>G variant that is responsible for Leigh syndrome in 10\u201320% of cases.", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "order": 1, "source": "MT-ATP6 GENE", "target": "8993T>G VARIANT"}, {"weight": 4.0, "description": "Mutations within the MT-ATP6 gene, like the 8993T>G mutation, are a causative factor for Leigh syndrome.", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "order": 1, "source": "MT-ATP6 GENE", "target": "LEIGH SYNDROME"}, {"weight": 5.0, "description": "The ATP synthase subunit encoded by MT-ATP6 is part of complex V in the electron transport chain that synthesizes ATP.", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "order": 1, "source": "MT-ATP6 GENE", "target": "COMPLEX V (ATP SYNTHASE)"}, {"weight": 5.0, "description": "The next-generation exome sequencing technique detected the 8993T>G variant within the MT-ATP6 gene.", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "order": 1, "source": "8993T>G VARIANT", "target": "NEXT-GENERATION EXOME SEQUENCING"}, {"weight": 4.0, "description": "Deficient activity of complex V in the electron transport chain due to mutations such as 8993T>G leads to Leigh syndrome.", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "order": 1, "source": "LEIGH SYNDROME", "target": "COMPLEX V (ATP SYNTHASE)"}, {"weight": 5.0, "description": "The NDUFV1 gene harbors a variant c.736G>A, p.Glu246Lys that is predicted to be damaging and associated with mitochondrial disease.", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "order": 1, "source": "NDUFV1 GENE", "target": "C.736G>A, P.GLU246LYS VARIANT"}, {"weight": 5.0, "description": "The NDUFV1 gene also includes a variant c.349G>A, p.Ala117Thr that is highly conserved and linked to mitochondrial disease.", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "order": 1, "source": "NDUFV1 GENE", "target": "C.349G>A, P.ALA117THR VARIANT"}, {"weight": 4.0, "description": "The COQ2 gene has another variant that results in premature termination of the protein at position 387, potentially leading to coenzyme Q10 deficiency.", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "order": 1, "source": "COQ2 GENE", "target": "C.1159C>T (ARG387X)"}, {"weight": 5.0, "description": "The c.437G>A variant in the COQ2 gene is associated with coenzyme Q10 deficiency, a condition characterized by neurological symptoms and muscle weakness.", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "order": 1, "source": "C.437G>A (SER146ASN)", "target": "COENZYME Q10 DEFICIENCY"}, {"weight": 2.0, "description": "The MT-ND1 gene contains a novel heteroplasmic variant that may contribute to mitochondrial complex I dysfunction or related disorders.", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "order": 1, "source": "MT-ND1 GENE", "target": "3754C>A (MT-ND1)"}, {"weight": 4.0, "description": "The MT-ND1 gene encodes for subunits of complex I which is vital to the electron transport chain function.", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "order": 1, "source": "MT-ND1 GENE", "target": "ELECTRON TRANSPORT CHAIN COMPLEX I (NADH DEHYDROGENASE)"}, {"weight": 5.0, "description": "Protein encoded by the COQ2 gene functions in coenzyme Q10 biosynthesis, a pathway deficient in certain disease states.", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "order": 1, "source": "COQ2 HOMOLOG PRENYLTRANSFERASE PROTEIN", "target": "COENZYME Q10 DEFICIENCY PATHWAY"}, {"weight": 4.0, "description": "The baseline subjective response influenced how participants subsequently experienced sedation, stimulation, and craving during alcohol intake.)", "source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "order": 1, "source": "BASELINE SUBJECTIVE RESPONSE ", "target": "SUBSEQUENT ALCOHOL EFFECTS "}, {"weight": 5.0, "description": "This test was used to determine the significance of genotype-drug interactions in causing side effects such as drowsiness and ringing in ears.)", "source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "order": 1, "source": "FISHER\'S EXACT TEST ", "target": "GENOTYPE-DRUG INTERACTION "}, {"weight": 3.0, "description": "Naltrexone was evaluated using the SAFTTEE checklist to identify adverse effects during alcohol infusion studies.)", "source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "order": 1, "source": "SAFTTEE CHECKLIST ", "target": "NALTREXONE "}, {"weight": 6.0, "description": "The ALDH2 genotype affects alcohol consumption, with Asn40 homozygotes consuming more drinks compared to other genotypes.", "source_id": "chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6", "order": 1, "source": "ASN40 HOMOZYGOTES", "target": "ALDH2 GENOTYPE"}, {"weight": 10.0, "description": "ALDH2 genotype significantly influences the latency to first drink, especially in Asn40 homozygotes.", "source_id": "chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6", "order": 1, "source": "ALDH2 GENOTYPE", "target": "LATENCY TO FIRST DRINK"}, {"weight": 1.0, "description": "Smoking status was associated with marginally shorter latency to drink, but did not significantly moderate the effects of genotype or medication.", "source_id": "chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6", "order": 1, "source": "ALDH2 GENOTYPE", "target": "NICOTINE SMOKING STATUS"}, {"weight": 3.0, "description": "The effect of naltrexone on alcohol consumption varies based on the individual\'s ALDH2 genotype.", "source_id": "chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6", "order": 1, "source": "ALDH2 GENOTYPE", "target": "NALTREXONE MEAN DRINKS"}, {"weight": 5.0, "description": "The mean drinks under placebo conditions are influenced by the ALDH2 genotype of individuals.", "source_id": "chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6", "order": 1, "source": "ALDH2 GENOTYPE", "target": "PLACEBO MEAN DRINKS"}, {"weight": 4.0, "description": "The mean drinks under naltrexone treatment and placebo conditions are compared to evaluate the effect of medication on alcohol consumption.", "source_id": "chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6", "order": 1, "source": "NALTREXONE MEAN DRINKS", "target": "PLACEBO MEAN DRINKS"}, {"weight": 8.0, "description": "Comparing smokers\' and non-smokers\' drink means helps assess how smoking status influences alcohol self-administration.", "source_id": "chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6", "order": 1, "source": "SMOKERS MEAN DRINKS", "target": "NON-SMOKERS MEAN DRINKS"}, {"weight": 3.0, "description": "Controlling for the rs671 variant in ALDH2 helps refine analyses related to alcohol drinking behaviors and their genetic underpinnings.)", "source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "order": 1, "source": "ALCOHOL DRINKING BEHAVIOR ", "target": "RS671 ALDH2 VARIANT "}, {"weight": 4.0, "description": "The use of naltrexone medication resulted in significantly higher incidence of drowsiness compared to placebo, indicating a drug effect on this side effect.)", "source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "order": 1, "source": "DROWSINESS ", "target": "NALTREXONE "}, {"weight": 5.0, "description": "This genetic variant is associated with alcohol-induced sedation responses in the presence of rising blood alcohol concentration (BrAC).)", "source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "order": 1, "source": "ALCOHOL-INDUCED SEDATION ", "target": "RS1229984 ADH1B VARIANT "}, {"weight": 4.0, "description": "The ALDH2 gene includes the rs671 polymorphism, influencing alcohol metabolism and related physiological processes.", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "order": 1, "source": "ALDH2 RS671 GENOTYPE", "target": "ALDH2 GENE"}, {"weight": 4.0, "description": "Genetic variations in the ALDH2 rs671 genotype affect cortisol levels through their influence on alcohol consumption and metabolic processes.", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "order": 1, "source": "ALDH2 RS671 GENOTYPE", "target": "CORTISOL LEVELS"}, {"weight": 3.0, "description": "The distribution of age among individuals with different ALDH2 genotypes varies significantly, reflecting differences in lifestyle factors like alcohol consumption.", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "order": 1, "source": "ALDH2 RS671 GENOTYPE", "target": "AGE DISTRIBUTION"}, {"weight": 3.0, "description": "Higher daily alcohol consumption is positively associated with increased blood cortisol levels in both men and women, after adjusting for other factors.", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "order": 1, "source": "DAILY ALCOHOL CONSUMPTION", "target": "BLOOD CORTISOL LEVEL"}, {"weight": 3.0, "description": "Alcohol consumption is regulated by genetic factors such as variants in the ALDH2 gene, affecting overall health outcomes.", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "order": 1, "source": "DAILY ALCOHOL CONSUMPTION", "target": "ALDH2 GENE"}, {"weight": 2.0, "description": "In men, genetically predicted daily alcohol consumption positively associates with blood cortisol levels; however, this relationship was not observed in women.", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "order": 1, "source": "BLOOD CORTISOL LEVEL", "target": "GENETICALLY PREDICTED ALCOHOL CONSUMPTION"}, {"weight": 9.0, "description": "The rs2231142 variant of the ABCG2 gene significantly affects sUA levels and increases HUA risk.", "source_id": "chunk-befd5ea20007b1d02d987897c798dadd", "order": 1, "source": "ABCG2", "target": "RS2231142 ABCG2"}, {"weight": 9.0, "description": "Variants in the ABCG2 gene are associated with increased risk and severity of HUA.", "source_id": "chunk-befd5ea20007b1d02d987897c798dadd", "order": 1, "source": "ABCG2", "target": "HYPERURICEMIA (HUA)"}, {"weight": 8.0, "description": "The rs3733591 variant in SLC2A9 is associated with increased sUA levels and HUA, particularly in females.", "source_id": "chunk-befd5ea20007b1d02d987897c798dadd", "order": 1, "source": "SLC2A9", "target": "RS3733591 SLC2A9"}, {"weight": 8.0, "description": "The SLC2A9 gene variant increases the likelihood and severity of HUA, especially among females.", "source_id": "chunk-befd5ea20007b1d02d987897c798dadd", "order": 1, "source": "SLC2A9", "target": "HYPERURICEMIA (HUA)"}, {"weight": 8.0, "description": "The risk allele in SLC2A9 is more significantly linked to HUA and sUA levels in females compared to males.", "source_id": "chunk-befd5ea20007b1d02d987897c798dadd", "order": 1, "source": "SLC2A9", "target": "GENDER DIFFERENCE"}, {"weight": 7.0, "description": "The rs893006 variant of SLC22A12 affects sUA levels but does not significantly influence HUA risk.", "source_id": "chunk-befd5ea20007b1d02d987897c798dadd", "order": 1, "source": "SLC22A12", "target": "RS893006 SLC22A12"}, {"weight": 7.0, "description": "This genomic variant affects uric acid metabolism and levels in the body.", "source_id": "chunk-befd5ea20007b1d02d987897c798dadd", "order": 1, "source": "RS3733591 SLC2A9", "target": "URIC ACID METABOLISM"}, {"weight": 9.0, "description": "The rs2231142 variant impacts the metabolic pathway of uric acid, affecting its concentration in blood.", "source_id": "chunk-befd5ea20007b1d02d987897c798dadd", "order": 1, "source": "RS2231142 ABCG2", "target": "URIC ACID METABOLISM"}, {"weight": 7.0, "description": "Higher serum creatinine levels are associated with an increased risk of HUA.", "source_id": "chunk-befd5ea20007b1d02d987897c798dadd", "order": 1, "source": "HYPERURICEMIA (HUA)", "target": "SERUM CREATININE"}, {"weight": 6.0, "description": "Elevated triglyceride levels correlate with a higher incidence of hyperuricemia.", "source_id": "chunk-befd5ea20007b1d02d987897c798dadd", "order": 1, "source": "HYPERURICEMIA (HUA)", "target": "TRIGLYCERIDES (TG)"}, {"weight": 7.0, "description": "Increased LDL cholesterol is linked to elevated uric acid and HUA risk.", "source_id": "chunk-befd5ea20007b1d02d987897c798dadd", "order": 1, "source": "HYPERURICEMIA (HUA)", "target": "LOW-DENSITY LIPOPROTEIN (LDL)"}, {"weight": 6.0, "description": "Lower HDL levels are associated with increased likelihood of hyperuricemia.", "source_id": "chunk-befd5ea20007b1d02d987897c798dadd", "order": 1, "source": "HYPERURICEMIA (HUA)", "target": "HIGH-DENSITY LIPOPROTEIN (HDL)"}, {"weight": 4.0, "description": "High levels of serum uric acid are indicative of a higher risk for developing hyperuricemia.", "source_id": "chunk-7091ed039203b69ad83d281b22c89579", "order": 1, "source": "HYPERURICEMIA (HUA)", "target": "SUA LEVEL"}, {"weight": 5.0, "description": "High levels of serum uric acid are strongly associated with the risk of developing hyperuricemia.", "source_id": "chunk-7091ed039203b69ad83d281b22c89579", "order": 1, "source": "HYPERURICEMIA (HUA)", "target": "SERUM URIC ACID (SUA)"}, {"weight": 5.0, "description": "Carrying the rs2231142 T allele increases the risk for hyperuricemia, indicating a genetic influence on disease susceptibility.", "source_id": "chunk-7091ed039203b69ad83d281b22c89579", "order": 1, "source": "HYPERURICEMIA (HUA)", "target": "RS2231142 T ALLELE CARRIERS"}, {"weight": 3.0, "description": "Certain cardiovascular risk factors do not influence the association between sUA and hyperuricemia risk among individuals with specific genetic markers.", "source_id": "chunk-7091ed039203b69ad83d281b22c89579", "order": 1, "source": "HYPERURICEMIA (HUA)", "target": "CARDIOVASCULAR RISK FACTORS"}, {"weight": 6.0, "description": "The C allele of SLC2A9 rs3733951 is associated with an increased risk of hyperuricaemia (HUA) due to its influence on serum uric acid levels.", "source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00", "order": 1, "source": "SLC2A9 RS3733951", "target": "HYPERURICAEMIA RISK (HUA)"}, {"weight": 5.0, "description": "The T allele of ABCG2 rs2231142 increases the risk of hyperuricaemia (HUA) when accounting for cardiovascular risks such as obesity, hypertension, higher TG levels and LDL levels, lower HDL levels.", "source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00", "order": 1, "source": "ABCG2 RS2231142", "target": "CARDIOVASCULAR RISK FACTORS"}, {"weight": 7.0, "description": "The T allele in ABCG2 rs2231142 is associated with higher sUA levels, especially among individuals with cardiovascular risk factors such as obesity and high TG.", "source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00", "order": 1, "source": "ABCG2 RS2231142", "target": "SUA LEVELS"}, {"weight": 8.0, "description": "Individuals with cardiovascular risk factors have a significantly increased OR of HUA associated with the T allele in ABCG2 rs2231142 compared to those without such risks.", "source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00", "order": 1, "source": "CARDIOVASCULAR RISK FACTORS", "target": "HYPERURICAEMIA RISK (HUA)"}, {"weight": 5.0, "description": "The presence of a T allele in ABCG2 rs2231142 increases hyperuricaemia risk significantly when individuals are under cardiovascular risk factors such as obesity and hypertension.", "source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00", "order": 1, "source": "CARDIOVASCULAR RISK FACTORS", "target": "T ALLELE OF ABCG2 RS2231142"}, {"weight": 6.0, "description": "An increase in serum uric acid levels correlates directly with the number of specific genetic risk alleles, thereby increasing hyperuricaemia risk across different populations.", "source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00", "order": 1, "source": "HYPERURICAEMIA RISK (HUA)", "target": "SUA LEVELS INCREASE WITH RISK ALLELES"}, {"weight": 8.0, "description": "Higher triglyceride (TG) levels significantly increase hyperuricaemia risk in both males and females carrying T alleles of the ABCG2 rs2231142 variant.", "source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00", "order": 1, "source": "HYPERURICAEMIA RISK (HUA)", "target": "TG LEVELS"}, {"weight": 5.0, "description": "Carrying the rs2231142 T allele is linked to higher serum uric acid levels, which may exacerbate HUA risk.", "source_id": "chunk-7091ed039203b69ad83d281b22c89579", "order": 1, "source": "SERUM URIC ACID (SUA)", "target": "RS2231142 T ALLELE CARRIERS"}, {"weight": 5.0, "description": "The level of serum uric acid is influenced by carrying the rs2231142 T allele, affecting the risk of hyperuricemia in carriers.", "source_id": "chunk-7091ed039203b69ad83d281b22c89579", "order": 1, "source": "RS2231142 T ALLELE CARRIERS", "target": "SUA LEVEL"}, {"weight": 4.0, "description": "The LRP2 gene contains a genomic variant (rs57989581) that is significantly associated with eGFR levels, indicating its role in kidney function regulation.", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "order": 1, "source": "LRP2 GENE", "target": "RS57989581"}, {"weight": 8.0, "description": "The NFATC1 gene harbors a significant variant (rs8096658) that influences eGFR levels across diverse ethnic groups, highlighting its importance in kidney health.", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "order": 1, "source": "NFATC1 GENE", "target": "RS8096658"}, {"weight": 4.0, "description": "The NFATC1 gene plays a role in regulating kidney function, with its variants contributing to the risk of developing chronic kidney disease.", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "order": 1, "source": "NFATC1 GENE", "target": "CKD DEVELOPMENT"}, {"weight": 8.0, "description": "The UNCX gene is associated with a specific variant (rs62435145), which impacts eGFR and increases the risk of CKD, particularly in diabetic populations.", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "order": 1, "source": "UNCX GENE", "target": "RS62435145"}, {"weight": 4.0, "description": "The UNCX gene locus is associated with eGFR levels in both Type 2 and Type 1 diabetic patients, influencing their risk for CKD development.", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "order": 1, "source": "UNCX GENE", "target": "T2D AND T1D DIABETES TYPES"}, {"weight": 8.0, "description": "The ALMS1 gene contains a variant (rs7587577) that is linked to reduced eGFR and heightened CKD risk, indicating its role in kidney function regulation.", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "order": 1, "source": "ALMS1 GENE", "target": "RS7587577"}, {"weight": 4.0, "description": "The ALMS1 gene influences kidney function through its association with reduced eGFR levels, thereby increasing the risk of chronic kidney disease.", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "order": 1, "source": "ALMS1 GENE", "target": "CKD DEVELOPMENT"}, {"weight": 16.0, "description": "The PDILT-UMOD locus harbors a key variant (rs77924615) that strongly influences eGFR and CKD risk, particularly in diabetic individuals.<SEP>The variant rs77924615 within the PDILT gene is part of a credible set identified through fine mapping, indicating its strong role in kidney function regulation at this locus.", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "order": 1, "source": "PDILT-UMOD LOCUS", "target": "RS77924615"}, {"weight": 8.0, "description": "Both Type 2 diabetes and Type 1 diabetes are associated with higher risks of developing chronic kidney disease due to reduced eGFR levels influenced by genetic variants at specific loci.", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "order": 1, "source": "CKD DEVELOPMENT", "target": "T2D AND T1D DIABETES TYPES"}, {"weight": 6.0, "description": "The PRKAG2 gene locus shows association with eGFR levels influenced by the variant rs77924615, highlighting its importance in regulating kidney function in diabetes patients.", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "order": 1, "source": "RS77924615", "target": "PRKAG2 GENE"}, {"weight": 6.0, "description": "The MANTRA algorithm identified precise localization of the PDILT-UMOD locus variant (rs77924615), demonstrating its utility in fine-mapping kidney function-associated loci.", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "order": 1, "source": "RS77924615", "target": "MANTRA ALGORITHM"}, {"weight": 8.0, "description": "NFATC1 renal mRNA expression is significantly decreased after a 2-week exposure to high-salt diet, indicating its involvement in kidney function under stress conditions.)", "source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "order": 1, "source": "NFATC1", "target": "HIGH-SALT DIET"}, {"weight": 6.0, "description": "Renal mRNA expression of NFATC1 trends downward in chronic kidney disease models, indicating potential involvement in disease progression or response to injury.)", "source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "order": 1, "source": "NFATC1", "target": "CHRONIC KIDNEY DISEASE (CKD)"}, {"weight": 6.0, "description": "Dynamic regions in kidney cells where DNA is exposed can influence gene regulation relevant to kidney function.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "order": 1, "source": "KIDNEY DHSS", "target": "GENE REGULATION KIDNEY FUNCTION"}, {"weight": 7.0, "description": "Binding sites on the genome for HDAC8 transcription factors, playing a role in kidney function through chromatin modification.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "order": 1, "source": "HDAC8 BINDING SITES", "target": "HISTONE DEACETYLASES (HDACS)"}, {"weight": 7.0, "description": "The variant impacts the role of HDAC8 in chromatin modification, affecting gene regulation and expression.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "order": 1, "source": "HISTONE DEACETYLASES (HDACS)", "target": "GCKR P.PRO446LEU (RS1260326)"}, {"weight": 8.0, "description": "Reduced expression or loss-of-function variants in RGS14 orthologs in Drosophila are associated with improved salt sensitivity and stress resistance.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "order": 1, "source": "SALT SENSITIVITY", "target": "REGULATOR OF G PROTEIN SIGNALING FAMILY (RGS14)"}, {"weight": 9.0, "description": "Loss of NFATC1 function results in increased salt sensitivity in Drosophila, suggesting its role in ionic or osmotic regulation.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "order": 1, "source": "INCREASED SALT SENSITIVITY", "target": "NFATC1 LOSS-OF-FUNCTION VARIANTS"}, {"weight": 5.0, "description": "Cells involved in gene regulation through DHSs, impacting kidney-specific genetic variants and their effects on eGFR.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "order": 1, "source": "ADULT RENAL PROXIMAL TUBULAR EPITHELIAL CELLS (RPTECS)", "target": "DYNAMIC REGIONS KIDNEY GENES"}, {"weight": 4.0, "description": "These cells show significant posterior probability for DHS annotations linked to kidney-specific variants affecting gene regulation.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "order": 1, "source": "RENAL CORTICAL EPITHELIAL CELLS (HRCES)", "target": "DHS ANNOTATIONS"}, {"weight": 6.0, "description": "Encodes a member of RGS family modulating downstream effects of G\u03b1 subunits with unknown function in kidneys.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "order": 1, "source": "RGS14", "target": "REGULATOR OF G PROTEIN SIGNALING"}, {"weight": 10.0, "description": "RGS14 renal mRNA expression is markedly reduced after high salt diet exposure, suggesting its role in kidney dysfunction induced by environmental factors such as dietary changes.)", "source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "order": 1, "source": "RGS14", "target": "HIGH-SALT DIET"}, {"weight": 10.0, "description": "Reduced RGS14 mRNA levels are observed during CKD induced by sub-total nephrectomy, suggesting its role in kidney pathology and function regulation.)", "source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "order": 1, "source": "RGS14", "target": "CHRONIC KIDNEY DISEASE (CKD)"}, {"weight": 4.0, "description": "Genomic variant of the loco gene shows improved survival rate when supplemented with sodium chloride compared to controls.)", "source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "order": 1, "source": "LOCOEY-P283/+", "target": "NACL SUPPLEMENTATION"}, {"weight": 5.0, "description": "Isogenic background y1w1 does not show significant changes in viability under non-supplemented food conditions but serves as a control in high NaCl experiments.)", "source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "order": 1, "source": "Y1W1", "target": "NACL SUPPLEMENTATION"}, {"weight": 5.0, "description": "The missense variant of GCKR impacts triglyceride and cholesterol synthesis, linking to risk factors for chronic kidney disease.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "order": 1, "source": "DISEASE RISK CKD", "target": "GCKR P.PRO446LEU (RS1260326)"}, {"weight": 9.0, "description": "This variant overlaps dynamic regions in fetal kidney cells of NFATC1 locus, influencing gene expression.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "order": 1, "source": "NFATC1 LOCUS DHSS", "target": "RS8096658 (\u03a0C = 0.877)"}, {"weight": 3.0, "description": "Fluoroquinolones are used to treat campylobacter infections, although resistance may limit their effectiveness in certain cases.", "source_id": "chunk-6264e17a8290bc0a9e24c68c21c1f15c", "order": 1, "source": "CAMPYLOBACTER INFECTION", "target": "FLUOROQUINOLONES"}, {"weight": 5.0, "description": "Traveling to southern Europe or Southeast Asia is significantly associated with a higher risk of acquiring quinolone-resistant Campylobacter infections.", "source_id": "chunk-6264e17a8290bc0a9e24c68c21c1f15c", "order": 1, "source": "QUINOLONE-RESISTANT CAMPYLOBACTER ISOLATES", "target": "SOUTHERN EUROPE AND SOUTHEAST ASIA"}, {"weight": 3.0, "description": "Some strains of Campylobacter coli exhibit erythromycin resistance, highlighting the complexity and variability in antibiotic resistance among different species.", "source_id": "chunk-6264e17a8290bc0a9e24c68c21c1f15c", "order": 1, "source": "ERYTHROMYCIN-RESISTANT ISOLATES", "target": "C. COLI/E. JEJUNI"}, {"weight": 5.0, "description": "Foreign travel, particularly to regions with high quinolone-resistant Campylobacter strains, increases the risk of acquiring such infections.", "source_id": "chunk-6264e17a8290bc0a9e24c68c21c1f15c", "order": 1, "source": "QUINOLONE RESISTANCE", "target": "FOREIGN TRAVEL"}, {"weight": 4.0, "description": "Consuming fresh poultry other than chicken and turkey is associated with an increased risk of acquiring quinolone-resistant C. jejuni infections.", "source_id": "chunk-6264e17a8290bc0a9e24c68c21c1f15c", "order": 1, "source": "QUINOLONE RESISTANCE", "target": "EATING FRESH POULTRY OTHER THAN CHICKEN AND TURKEY"}, {"weight": 3.0, "description": "Traveling to Spain or Portugal is associated with a higher risk of acquiring erythromycin-resistant Campylobacter coli strains.", "source_id": "chunk-6264e17a8290bc0a9e24c68c21c1f15c", "order": 1, "source": "TRAVEL TO SPAIN AND PORTUGAL", "target": "ERYTHROMYCIN-CRESTANT CAMPYLOBACTER ISOLATES"}, {"weight": 3.0, "description": "Traveling to regions with high resistance may expose individuals to strains carrying silent mutations in gyrA gene, affecting treatment.", "source_id": "chunk-6264e17a8290bc0a9e24c68c21c1f15c", "order": 1, "source": "TRAVEL TO SPAIN AND PORTUGAL", "target": "THRE SILENT MUTATIONS IN GYRA IN THE LATTER STRAIN"}, {"weight": 2.0, "description": "Quinolone resistance in C. jejuni isolates affects their response to fluoroquinolone treatments.)", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "order": 1, "source": "FLUOROQUINOLONES", "target": "QUINOLONE-RESISTANT C. JEJUNI ISOLATES"}, {"weight": 4.0, "description": "Strains with a normal consensus sequence typically exhibit sensitivity to quinolones as indicated by low MIC values.", "source_id": "chunk-6264e17a8290bc0a9e24c68c21c1f15c", "order": 1, "source": "MIC OF QUINOLONE = 2 MG/L", "target": "NORMAL CONSENSUS SEQUENCE IN THE FORMER STRAIN"}, {"weight": 4.0, "description": "Silent mutations in gyrA can result in higher MIC values for quinolones, indicating resistance despite no change in amino acid sequence.", "source_id": "chunk-6264e17a8290bc0a9e24c68c21c1f15c", "order": 1, "source": "MIC OF QUINOLONE = 2 MG/L", "target": "THRE SILENT MUTATIONS IN GYRA IN THE LATTER STRAIN"}, {"weight": 3.0, "description": "Consumption of fresh poultry other than chicken and turkey is linked with domestically acquired Campylobacter infections.)", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "order": 1, "source": "FRESH POULTRY INTAKE", "target": "DOMESTICALLY ACQUIRED INFECTIONS"}, {"weight": 2.0, "description": "Infections caused by Campylobacter bacteria can originate from contaminated retail food products, such as chickens or turkeys.)", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "order": 1, "source": "CAMPYLOBACTERIOSIS", "target": "RETAIL FOOD PRODUCTS"}, {"weight": 3.0, "description": "The expression level of certain transcripts can be modulated by dietary nutrients, affecting antibiotic resistance.)", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "order": 1, "source": "TRANSCRIPT", "target": "NUTRIENT"}, {"weight": 3.0, "description": "The physiological process of infection is influenced by molecular interactions between Campylobacter bacteria and the human host immune system.)", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "order": 1, "source": "PHYSIOLOGICAL PROCESS", "target": "MOLECULAR INTERACTION"}, {"weight": 10.0, "description": "SNP rs9534511 in the HTR2A gene is significantly associated with increased risk of social disinhibition.<SEP>The minor allele of rs9534511 increases the risk of social disinhibition.)", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1<SEP>chunk-36d70bb8409856300dd77669e7c1f9ed", "order": 1, "source": "RS9534511", "target": "SOCIAL DISINHIBITION"}, {"weight": 10.0, "description": "SNP rs4938056 in the HTR3B gene is linked to an increased risk of social disinhibition.<SEP>The minor allele of rs4938056 increases the risk of social disinhibition.)", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1<SEP>chunk-36d70bb8409856300dd77669e7c1f9ed", "order": 1, "source": "RS4938056", "target": "SOCIAL DISINHIBITION"}, {"weight": 7.0, "description": "The HTR3B gene, harboring SNP rs4938056, contributes to serotonin pathway regulation affecting behavior and cognitive functions.", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "order": 1, "source": "HTR3B GENE", "target": "SEROTONIN PATHWAY"}, {"weight": 10.0, "description": "A minor allele for this SNP is associated with increased risk of social disinhibition.<SEP>The minor allele of rs1998220 increases the risk of social disinhibition.)", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1<SEP>chunk-36d70bb8409856300dd77669e7c1f9ed", "order": 1, "source": "RS1998220", "target": "SOCIAL DISINHIBITION"}, {"weight": 7.0, "description": "The OPRM1 gene, with SNP rs1998220 located within it, impacts pathways involved in reward and addiction behaviors.", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "order": 1, "source": "OPRM1 GENE", "target": "REWARD AND ADDICTION BEHAVIORS"}, {"weight": 7.0, "description": "SNP rs1003921 in the KCNC1 gene is significantly associated with increased social disinhibition risk.<SEP>The minor allele of rs1003921 has a protective effect against increased social disinhibition score.)", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1<SEP>chunk-36d70bb8409856300dd77669e7c1f9ed", "order": 1, "source": "RS1003921", "target": "SOCIAL DISINHIBITION"}, {"weight": 7.0, "description": "The KCNC1 gene, harboring SNP rs1003921, contributes to potassium channel function and neural excitability.", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "order": 1, "source": "KCNC1 GENE", "target": "NEURAL EXCITABILITY"}, {"weight": 7.0, "description": "A genomic variant (rs16116) is linked to social disinhibition risk.<SEP>The minor allele of rs16116 has a protective effect against increased social disinhibition score.)", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1<SEP>chunk-36d70bb8409856300dd77669e7c1f9ed", "order": 1, "source": "RS16116", "target": "SOCIAL DISINHIBITION"}, {"weight": 7.0, "description": "The NPY gene, with SNP rs16116 downstream, influences neuropeptide Y levels affecting physiological processes such as stress and appetite regulation.", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "order": 1, "source": "NPY GENE", "target": "STRESS AND APPETITE REGULATION"}, {"weight": 7.0, "description": "SNP (rs16870286) is significantly associated with social disinhibition risk.<SEP>The minor allele of rs16870286 has a protective effect against increased social disinhibition score.)", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1<SEP>chunk-36d70bb8409856300dd77669e7c1f9ed", "order": 1, "source": "RS16870286", "target": "SOCIAL DISINHIBITION"}, {"weight": 7.0, "description": "The LINC00518 gene, containing SNP rs16870286 and coding for an uncharacterized protein, impacts physiological processes not fully elucidated.", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "order": 1, "source": "LINC00518 GENE", "target": "UNCHARACTERIZED PROTEIN FUNCTION"}, {"weight": 0.0, "description": "Neither gender nor parental education is significantly associated with changes in social disinhibition score based on the provided data.)", "source_id": "chunk-36d70bb8409856300dd77669e7c1f9ed", "order": 1, "source": "SOCIAL DISINHIBITION SCORE", "target": "PARENTAL EDUCATION"}, {"weight": 8.0, "description": "The CNR1 gene\'s expression and its variant rs2023239 are studied in PFC tissue to understand the effects on CB1 receptor binding levels.", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "order": 1, "source": "CNR1 GENE", "target": "POSTMORTEM HUMAN PREFRONTAL CORTEX (PFC)"}, {"weight": 8.0, "description": "Genetic variation at rs2023239 affects CB1 receptor protein levels, impacting neurocircuitry involved in drug-seeking behavior and alcohol craving.", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "order": 1, "source": "RS2023239 GENOMIC VARIANT", "target": "CB1 RECEPTOR PROTEIN"}, {"weight": 8.0, "description": "The rs2023239 variant is associated with differential activation in the NAcc during exposure to alcohol cues, indicating a genetic influence on reward processing.", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "order": 1, "source": "RS2023239 GENOMIC VARIANT", "target": "NACC (NUCLEUS ACCUMBENS)"}, {"weight": 8.0, "description": "Differences in VMPFC activation are observed based on the rs2023239 genotype, suggesting genetic modulation of craving behavior.", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "order": 1, "source": "RS2023239 GENOMIC VARIANT", "target": "VMPFC (VENTROMEDIAL PREFRONTAL CORTEX)"}, {"weight": 8.0, "description": "Genetic variation at rs2023239 correlates with differential activation in the OFC, linked to alcohol craving measures.", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "order": 1, "source": "RS2023239 GENOMIC VARIANT", "target": "OFC (ORBITAL PREFRONTAL CORTEX)"}, {"weight": 8.0, "description": "The genomic variant rs2023239 impacts CB1 receptor binding levels in PFC tissue, providing insights into its role in neurocircuitry modulation.", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "order": 1, "source": "RS2023239 GENOMIC VARIANT", "target": "POSTMORTEM HUMAN PREFRONTAL CORTEX (PFC)"}, {"weight": 7.0, "description": "Alcohol use disorder scores as measured by AUDIT correlate with brain activity related to CB1 receptor signaling influenced by genetic variants like rs2023239.", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "order": 1, "source": "CB1 RECEPTOR PROTEIN", "target": "AUDIT SCORE"}, {"weight": 8.0, "description": "Activation of VTA during alcohol exposure correlates with subjective reward measures from POMS scales, indicating a role for genetic factors in modulating reward processing.", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "order": 1, "source": "VTA (VENTRAL TEGMENTAL AREA)", "target": "REWARD AND POSITIVE AFFECT SCALES (POMS)"}, {"weight": 8.0, "description": "Differential activation of OFC correlates with subjective measures from POMS scales, suggesting a role for genetic variations in reward processing.", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "order": 1, "source": "OFC (ORBITAL PREFRONTAL CORTEX)", "target": "REWARD AND POSITIVE AFFECT SCALES (POMS)"}, {"weight": 8.0, "description": "Both AUDIT scores for alcohol use disorder and subjective reward measures from POMS scales are correlated with brain activity patterns in individuals carrying the rs2023239 variant.", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "order": 1, "source": "AUDIT SCORE", "target": "REWARD AND POSITIVE AFFECT SCALES (POMS)"}, {"weight": 8.0, "description": "Expression of CNR1 transcript, influenced by variants such as rs2023239, affects neurocircuitries involved in drug-seeking behaviors and alcohol craving.", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "order": 1, "source": "CNR1 TRANSCRIPT", "target": "MESOCORTICOLIMBIC NEUROCIRCUITRY"}, {"weight": 8.0, "description": "Contrast between alcohol and litchi juice appetitive controls reveals differential activation patterns in mesocorticolimbic areas influenced by genetic variations like rs2023239.", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "order": 1, "source": "MESOCORTICOLIMBIC NEUROCIRCUITRY", "target": "LITCHI JUICE"}, {"weight": 11.0, "description": "There is an interaction between CNR1 variation and olanzapine that influences cue-elicited craving in individuals with the CT genotype.<SEP>There is an interaction between CNR1 variation and olanzapine, affecting cue-elicited craving in treatment-seeking alcohol-dependent individuals.", "source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59", "order": 1, "source": "OLANZAPINE", "target": "CNR1 VARIATION"}, {"weight": 1.0, "description": "The p.Q240H mutation is a specific genomic variant within the LPL gene that causes functional impairment leading to hypertriglyceridemia.", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "order": 1, "source": "LPL GENE", "target": "P.Q240H MUTATION IN EXON 5 OF THE LPL GENE"}, {"weight": 3.0, "description": "Chylomicron hydrolysis is an integral part of lipid metabolism, breaking down triglycerides and fatty acids for use by tissues.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "order": 1, "source": "CHYLOMICRON HYDROLYSIS", "target": "LIPID METABOLISM"}, {"weight": 5.0, "description": "Lipoprotein lipase (LPL) is crucial in the process of chylomicron hydrolysis, breaking down triglycerides for tissue use.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "order": 1, "source": "CHYLOMICRON HYDROLYSIS", "target": "LPL PROTEIN"}, {"weight": 4.0, "description": "Patients with LPL deficiency disorder often exhibit hypertriglyceridemia due to impaired lipoprotein lipase activity leading to accumulation of chylomicrons in the bloodstream.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "order": 1, "source": "LPL DEFICIENCY DISORDER", "target": "HYPERTRIGLYCERIDEMIA"}, {"weight": 2.0, "description": "Restricting dietary fat can help manage LPL deficiency disorder by reducing plasma triglyceride levels and alleviating symptoms such as pancreatitis.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "order": 1, "source": "LPL DEFICIENCY DISORDER", "target": "DIETARY FAT RESTRICTION"}, {"weight": 3.0, "description": "High TG levels (> 2000 mg/dl) trigger the formation and appearance of eruptive xanthomas on skin surfaces.", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "order": 1, "source": "ERUPTIVE XANTHOMAS", "target": "HYPERTRIGLYCERIDEMIA"}, {"weight": 4.0, "description": "When triglyceride concentrations surpass 2500 mg/dl, lipids in peripheral retinal vessels become visible as lipemia retinalis.", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "order": 1, "source": "LIPEMIA RETINALIS", "target": "HYPERTRIGLYCERIDEMIA"}, {"weight": 6.0, "description": "Supplementation with MCT allows patients to adhere better to dietary fat restriction while maintaining adequate nutrition.", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "order": 1, "source": "DIETARY FAT RESTRICTION", "target": "MCT (MEDIUM-CHAIN TRIGLYCERIDES)"}, {"weight": 8.0, "description": "Orlistat enhances the effectiveness of dietary fat restriction by further limiting fat absorption in the digestive system.", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "order": 1, "source": "DIETARY FAT RESTRICTION", "target": "ORLISTAT"}, {"weight": 12.0, "description": "Despite dietary fat restriction, children with LPL deficiency can maintain normal linear growth patterns.", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "order": 1, "source": "DIETARY FAT RESTRICTION", "target": "LINEAR GROWTH"}, {"weight": 13.0, "description": "Individuals with LPL deficiency undergoing dietary fat restrictions often experience normal puberty stages.", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "order": 1, "source": "DIETARY FAT RESTRICTION", "target": "PUBERTY"}, {"weight": 7.0, "description": "GPIHBP1 facilitates the transport of lipoprotein lipase to the capillary lumen, essential for proper lipid metabolism.<SEP>The protein GPIHBP1 facilitates lipid metabolism through its role in transporting lipoprotein lipase to the capillary lumen for chylomicron hydrolysis.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "order": 1, "source": "GPIHBP1", "target": "LIPID METABOLISM"}, {"weight": 5.0, "description": "The lipid metabolism pathway is involved in the transport of lipids across cell membranes, regulated by physiological processes such as molecular transport.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "order": 1, "source": "LIPID METABOLISM", "target": "MOLECULAR TRANSPORT"}, {"weight": 3.0, "description": "The mutation p.Q240H disrupts normal protein function, leading to decreased lipoprotein lipase activity.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "order": 1, "source": "LPL PROTEIN", "target": "MUTATION P.Q240H"}, {"weight": 2.0, "description": "Dysfunction or deficiency of lipoprotein lipase leads to impaired breakdown of triglyceride-rich lipoproteins, resulting in hypertriglyceridemia.", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "order": 1, "source": "LIPOPROTEIN LIPASE (LPL) PROTEIN", "target": "HYPERTRIGLYCERIDEMIA"}, {"weight": 11.0, "description": "The lipoprotein lipase protein acts on triglyceride-rich lipoproteins to release free fatty acids and glycerol for cellular uptake.", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "order": 1, "source": "LIPOPROTEIN LIPASE (LPL) PROTEIN", "target": "TRIGLYCERIDE-RICH LIPOPROTEINS (TRL)"}, {"weight": 5.0, "description": "Increased levels of TG are a major risk factor for the development and exacerbation of pancreatitis.", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "order": 1, "source": "HYPERTRIGLYCERIDEMIA", "target": "PANCREATITIS"}, {"weight": 9.0, "description": "Gemfibrozil is used to decrease TG levels and manage hypertriglyceridemia when lifestyle modifications are insufficient.", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "order": 1, "source": "HYPERTRIGLYCERIDEMIA", "target": "GEMFIBROZIL"}, {"weight": 10.0, "description": "Inhibition of DGAT1 is being explored as a novel therapeutic strategy to reduce triglyceride synthesis and manage hypertriglyceridemia.", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "order": 1, "source": "HYPERTRIGLYCERIDEMIA", "target": "DIACYLGLYCEROL O-ACYLTRANSFERASE 1 (DGAT1)"}, {"weight": 14.0, "description": "Inhibition of DGAT1 affects the final step of triglyceride synthesis during fat absorption, impacting overall fat metabolism.", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "order": 1, "source": "DIACYLGLYCEROL O-ACYLTRANSFERASE 1 (DGAT1)", "target": "FAT ABSORPTION"}, {"weight": 12.0, "description": "Topiramate treatment is effective in reducing heavy drinking days, indicating its efficacy for treating alcohol use disorder.<SEP>Topiramate treatment leads to a reduction in heavy drinking days, indicating efficacy.", "source_id": "chunk-0c7ab28db433187759e760725a105836", "order": 1, "source": "TOPIRAMATE", "target": "NO HDDS (EFFICACY)"}, {"weight": 5.0, "description": "The presence of the rs2832407 gene variant affects the occurrence and severity of adverse events in patients treated with topiramate.", "source_id": "chunk-0c7ab28db433187759e760725a105836", "order": 1, "source": "RS2832407 GENE VARIANT", "target": "ADVERSE EVENTS (AE)"}, {"weight": 3.0, "description": "Variation in CYP2D6 gene activity influences the patient-reported severity of acute nausea during chemotherapy treatment.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "order": 1, "source": "CYP2D6", "target": "PATIENT-REPORTED ACUTE NAUSEA SEVERITY"}, {"weight": 3.0, "description": "Genetic variation at position rs1045642 in the ABCB1 gene is associated with CTCAE grade severity for acute nausea.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "order": 1, "source": "ABCB1 ALLELE RS1045642", "target": "CTCAE GRADE OF ACUTE NAUSEA"}, {"weight": 1.0, "description": "The presence of the ABCB1 variant at rs1045642 is not significantly associated with advanced stage cancer, but may influence response to treatment in such patients.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "order": 1, "source": "ABCB1 ALLELE RS1045642", "target": "ADVANCED STAGE CANCER"}, {"weight": 2.0, "description": "The HTR3B variant at rs45460698 does not show significant associations with patient-reported acute nausea severity, suggesting limited influence on this aspect.<SEP>While no direct association was found, variations in HTR3B could indirectly affect acute nausea through serotonin pathways.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "order": 1, "source": "PATIENT-REPORTED ACUTE NAUSEA SEVERITY", "target": "HTR3B (RS45460698)"}, {"weight": 3.0, "description": "Use of dexamethasone is aimed at reducing acute nausea severity as reported by patients during chemotherapy treatment.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "order": 1, "source": "PATIENT-REPORTED ACUTE NAUSEA SEVERITY", "target": "DEXAMETHASONE"}, {"weight": 3.0, "description": "Prochlorperazine is used to manage acute nausea severity as reported by patients undergoing chemotherapy.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "order": 1, "source": "PATIENT-REPORTED ACUTE NAUSEA SEVERITY", "target": "PROCHLORPERAZINE"}, {"weight": 4.0, "description": "The use of palonosetron is aimed at reducing the CTCAE grade of acute nausea in patients undergoing chemotherapy.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "order": 1, "source": "CTCAE GRADE OF ACUTE NAUSEA", "target": "PALONOSETRON"}, {"weight": 2.0, "description": "The genotype of patients at rs1045642 does not influence delayed nausea as strongly as it does acute nausea, indicating differential impact on various phases of treatment.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "order": 1, "source": "PATIENT-REPORTED DELAYED NAUSEA SEVERITY", "target": "ABCB1 GENOTYPE "}, {"weight": 4.0, "description": "Patients receiving highly emetogenic chemotherapy regimens are more likely to report higher CTCAE grades for delayed nausea compared to less aggressive treatment plans.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "order": 1, "source": "CTCAE GRADE OF DELAYED NAUSEA", "target": "HIGHLY EMETOGENIC CHEMOTHERAPY REGIMEN "}, {"weight": 4.0, "description": "On the use of ondansetron for managing delayed CINV, indicating its efficacy in reducing CTCAE grade of delayed nausea.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "order": 1, "source": "CTCAE GRADE OF DELAYED NAUSEA", "target": "ONDANSETRON"}, {"weight": 4.0, "description": "Patients receiving highly emetogenic chemotherapy are more likely to experience delayed nausea and vomiting, highlighting the relationship between treatment type and patient outcomes.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "order": 1, "source": "HIGHLY EMETOGENIC CHEMOTHERAPY REGIMEN ", "target": "DELAYED CINV"}, {"weight": 3.0, "description": "The dietary pattern involving regular intake of lactose influences the regulatory mechanisms controlling the LCT gene expression levels.", "source_id": "chunk-ec104044b3aa65560be8d81dbb3940d6", "order": 1, "source": "LACTASE GENE (LCT)", "target": "DIETARY PATTERN (LACTOSE INTAKE)"}, {"weight": 6.0, "description": "The age-related decline observed in LCT mRNA levels suggests that aging is an environmental factor influencing the expression and regulation of the lactase gene.", "source_id": "chunk-ec104044b3aa65560be8d81dbb3940d6", "order": 1, "source": "LACTASE GENE (LCT)", "target": "ENVIRONMENTAL FACTOR (AGE)"}, {"weight": 3.0, "description": "The technique is used to fine-map regions around the LCT gene for high-resolution analysis of DNA methylation patterns, crucial for understanding its regulatory mechanisms.", "source_id": "chunk-ec104044b3aa65560be8d81dbb3940d6", "order": 1, "source": "LACTASE GENE (LCT)", "target": "BISULFITE PADLOCK PROBE SEQUENCING"}, {"weight": 2.0, "description": "The MCM6 gene contains a genomic variant (C/T-13910), which influences lactose persistence and non-persistence by affecting the regulatory mechanism of LCT.", "source_id": "chunk-ec104044b3aa65560be8d81dbb3940d6", "order": 1, "source": "GENOMIC VARIANT C/T-13910", "target": "MCM6 GENE"}, {"weight": 6.0, "description": "Changes in LCT mRNA levels are significantly influenced by the accumulation of DNA modifications across regulatory regions in individuals with specific genotypes (-13910 C vs. T).", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "order": 1, "source": "LCT MRNA", "target": "DNA MODIFICATION CHANGES"}, {"weight": 12.0, "description": "Increased dietary lactose consumption can lead to higher levels of LCT mRNA expression, although this effect is also heavily dependent on individual genotype at specific loci such as -13910.", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "order": 1, "source": "LCT MRNA", "target": "DIETARY LACTOSE CONSUMPTION"}, {"weight": 3.0, "description": "The expression of LOC100507600 lncRNA regulates the levels of LCT mRNA in cells relevant to lactase persistence.)", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "order": 1, "source": "LCT MRNA", "target": "LOC100507600 LNCRNA"}, {"weight": 3.0, "description": "These siRNAs reduced LCT mRNA levels in conjunction with the reduction in LOC100507600 lncRNA expression.)", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "order": 1, "source": "LCT MRNA", "target": "SIRNAS DIRECTED TO LOC100507600"}, {"weight": 4.0, "description": "Epigenetic modifications play a crucial role in regulating transcriptional processes that control the production and stability of LCT mRNA.", "source_id": "chunk-ec104044b3aa65560be8d81dbb3940d6", "order": 1, "source": "EPIGENETIC MODIFICATION", "target": "PHYSIOLOGICAL PROCESS: TRANSCRIPTIONAL REGULATION"}, {"weight": 5.0, "description": "Dysregulation or reduced expression of the lactase gene leads to impaired lactose metabolism, resulting in symptoms associated with lactase non-persistence.", "source_id": "chunk-ec104044b3aa65560be8d81dbb3940d6", "order": 1, "source": "METABOLIC PATHWAY: LACTOSE METABOLISM", "target": "LACTASE NON-PERSISTENCE"}, {"weight": 4.0, "description": "Age affects the levels of Lct mRNA in mice, similar to humans, indicating a conserved regulation mechanism across species.", "source_id": "chunk-ec104044b3aa65560be8d81dbb3940d6", "order": 1, "source": "ENVIRONMENTAL FACTOR (AGE)", "target": "LCT MRNA LEVELS IN MICE"}, {"weight": 6.0, "description": "The CpG sites identified are crucial for understanding how DNA modifications regulate cell-type-specific expression of LCT.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "order": 1, "source": "CPG SITES", "target": "DNA MODIFICATION PROFILES"}, {"weight": 4.0, "description": "Comparison between these tissues highlights the cell-type specificity in DNA modification patterns associated with LCT.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "order": 1, "source": "ENTEROCYTE-DEFICIENT JEJUNUM", "target": "WHITE BLOOD CELLS"}, {"weight": 6.0, "description": "These sites often coincide with regions marked by histone modifications indicative of active enhancers, suggesting regulatory functions.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "order": 1, "source": "DNASE I HYPERSENSITIVITY SITES", "target": "H3K4ME1 AND H3K27AC"}, {"weight": 8.0, "description": "The genotypes defined by these SNPs are associated with lactase persistence or non-persistence conditions.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "order": 1, "source": "LACTASE NON-PERSISTENCE AND PERSISTENCE", "target": "MCM6 SNPS (RS4988235, RS182549)"}, {"weight": 8.0, "description": "Genetic variations in both MCM6 and LCT influence mRNA levels and are thus related to differential DNA modifications.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "order": 1, "source": "MCM6 SNPS (RS4988235, RS182549)", "target": "INSERTION-DELETION IN THE 3\u2032 REGION OF LCT INTRON 1"}, {"weight": 3.0, "description": "The regulatory region within intron 5 influences the persistence or decline of lactose digestion capability into adulthood based on genetic variants.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "order": 1, "source": "INTRON 5 OF LCT", "target": "LACTASE PERSISTENCE AND NON-PERSISTENCE"}, {"weight": 4.0, "description": "This genomic variant shows age-dependent changes in DNA modifications, influencing the expression of LCT and affecting lactase persistence/non-persistence.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "order": 1, "source": "INTRON 13 OF MCM6", "target": "AGE-DEPENDENT REGULATION OF LCT"}, {"weight": 5.0, "description": "Investigations into lactase persistence often utilize Caco-2 cell line models to assess gene regulatory mechanisms.)", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "order": 1, "source": "LACTASE PERSISTENCE", "target": "CACO-2 CELL LINE"}, {"weight": 9.0, "description": "The LCT gene\'s expression level is directly linked to the development of lactose intolerance, particularly in individuals with specific genetic variants such as C-13910 at position -13910.", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "order": 1, "source": "LCT GENE (LACTASE GENE)", "target": "LACTOSE INTOLERANCE"}, {"weight": 7.0, "description": "The genomic variants C-13910 and T-13910 at position -13910 are associated with differential DNA modification patterns over age, leading to differences in lactase persistence or non-persistence conditions.", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "order": 1, "source": "C-13910", "target": "T-13910"}, {"weight": 5.0, "description": "The genomic variant C-13910 is linked to lactase non-persistence, as it correlates with increased DNA modification changes and decreased LCT mRNA expression over age.", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "order": 1, "source": "C-13910", "target": "LACTASE PERSISTENCE/NON-PERSISTENCE CONDITION"}, {"weight": 4.0, "description": "The genomic variant T-13910 is associated with lactase persistence, characterized by protected MCM6 and LCT regulatory elements from epigenetic inactivation.", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "order": 1, "source": "T-13910", "target": "LACTASE PERSISTENCE/NON-PERSISTENCE CONDITION"}, {"weight": 2.0, "description": "The epigenetic interaction between LCT and MCM6 involves age-related DNA modification changes that regulate lactase expression and persistence.", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "order": 1, "source": "DNA MODIFICATION CHANGES", "target": "LCT\u2013MCM6 EPIGENETIC INTERACTION"}, {"weight": 10.0, "description": "The process of methylation is a significant component of DNA modification changes, particularly influencing lactase enzyme production through the LCT gene.", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "order": 1, "source": "DNA MODIFICATION CHANGES", "target": "METHYLATION"}, {"weight": 11.0, "description": "These chromatin marks are key histone modifications that contribute to the regulation of lactase expression and persistence by influencing transcriptional activity at specific genomic regions.", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "order": 1, "source": "HISTONE MODIFICATIONS", "target": "H3K27AC, H3K4ME1, H3K4ME3, POLR2A CHROMATIN MARKS"}, {"weight": 5.0, "description": "Cells were used to assess the impact of epigenetic regulation on human LCT expression after CRISPR-Cas9 deletions.)", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "order": 1, "source": "CACO-2 CELL LINE", "target": "EPIGENETICALLY-REGULATED REGIONS"}, {"weight": 3.0, "description": "The lncRNA LOC100507600 is involved in the regulation of LCT mRNA, similar to regulatory elements identified at intron 2 and 8 in mice.", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "order": 1, "source": "LOC100507600 LNCRNA", "target": "LCT INTRON 2 AND 8 IN MICE"}, {"weight": 2.0, "description": "The silencing of LOC100507600 did not affect MCM6 mRNA levels, indicating specific regulation of LCT by this lncRNA.)", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "order": 1, "source": "LOC100507600 LNCRNA", "target": "MCM6 MRNA"}, {"weight": 3.0, "description": "The technology was used to delete specific intronic regions in order to understand their role in the regulation of LCT expression.)", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "order": 1, "source": "LCT INTRONIC REGION", "target": "CRISPR-CAS9 GENOME EDITING TECHNOLOGY"}, {"weight": 4.0, "description": "The deletion of a region in Mcm6 intron 13 is crucial for human LCT expression regulation, as shown by CRISPR-Cas9 experiments.)", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "order": 1, "source": "MCM6 INTRONIC REGION", "target": "HUMAN LCT REGULATION"}, {"weight": 4.0, "description": "Used to confirm the specificity and accuracy of CRISPR-Cas9 deletions in genomic regions.)", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "order": 1, "source": "CRISPR-CAS9 GENOME EDITING TECHNOLOGY", "target": "CRISPR-CAS9 OFF-TARGET ACTIVITY SURVEY"}, {"weight": 3.0, "description": "The intronic region influences LCT expression differently between adults and infants.)", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "order": 1, "source": "ADULT INTESTINE VS INFANT INTESTINE REGULATION", "target": "LCT INTRONIC REGION 2 "}, {"weight": 13.0, "description": "The study of enterocytes provides crucial insights into how epigenetic interactions between MCM6 and LCT genes influence lactase persistence or non-persistence conditions in humans.", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "order": 1, "source": "LCT\u2013MCM6 EPIGENETIC INTERACTION", "target": "ENTEROCYTE SAMPLES"}, {"weight": 4.0, "description": "Individuals carrying the T allele of rs4988235 tend to consume more milk than those without it.", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5", "order": 1, "source": "LACTASE PERSISTENT ALLELE (T)", "target": "MILK CONSUMPTION"}, {"weight": 6.0, "description": "Increased consumption of milk is associated with an elevated risk of RCC, particularly in populations with high adherence to lactase persistence genotype.", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5", "order": 1, "source": "MILK CONSUMPTION", "target": "RENAL CELL CARCINOMA (RCC)"}, {"weight": 5.0, "description": "The Hardy-Weinberg equilibrium is used to assess genetic consistency in populations, including descriptive characteristics such as allele frequencies in the context of lactase persistence.", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5", "order": 1, "source": "HARDY-WEINBERG EQUILIBRIUM", "target": "DESCRIPTIVE CHARACTERISTICS"}, {"weight": 4.0, "description": "Analysis of Hardy-Weinberg equilibrium helps in determining the allele frequencies and genetic variation in a population, crucial for SNP studies.", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "order": 1, "source": "HARDY-WEINBERG EQUILIBRIUM", "target": "ALLELE FREQUENCY"}, {"weight": 1.0, "description": "Genetic variations in the PTPN2 gene adhere to Hardy-Weinberg equilibrium principles within the studied population.", "source_id": "chunk-84ec948f22126cef7d93b1d7465b79db", "order": 1, "source": "HARDY-WEINBERG EQUILIBRIUM", "target": "PTPN2 GENE"}, {"weight": 14.0, "description": "Genotypes of rs231775 in control samples were generally consistent with Hardy-Weinberg equilibrium principles.", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "order": 1, "source": "HARDY-WEINBERG EQUILIBRIUM", "target": "RS231775"}, {"weight": 3.0, "description": "The BCL11A gene also contains the rs4671393 SNP, showing similar correlations with baseline and MTD HbF levels.", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "order": 1, "source": "BCL11A GENE", "target": "RS4671393 SNP"}, {"weight": 2.0, "description": "The BCL11A gene is also associated with rs11886868 SNP, influencing the delta HbF level in a less pronounced manner.", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "order": 1, "source": "BCL11A GENE", "target": "RS11886868 SNP"}, {"weight": 3.0, "description": "The HMIP-2 gene harbors the rs9399137 SNP that is correlated with higher baseline and MTD HbF levels but not delta HbF.", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "order": 1, "source": "HMIP-2 GENE", "target": "RS9399137 SNP"}, {"weight": 3.0, "description": "The HMIP-2 gene also includes the rs9402686 SNP, showing similar associations to rs9399137 for baseline and MTD HbF levels.", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "order": 1, "source": "HMIP-2 GENE", "target": "RS9402686 SNP"}, {"weight": 4.0, "description": "The use of hydroxyurea treatment correlates with increased hemoglobin F levels in patients, indicating its role in enhancing fetal hemoglobin production or stability.", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "order": 1, "source": "HEMOGLOBIN F (HBF)", "target": "HYDROXYUREA TREATMENT (HU)"}, {"weight": 4.0, "description": "Changes in MTD levels of hemoglobin F are observed and analyzed as part of the study on genetic variants and hydroxyurea treatment effects.", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "order": 1, "source": "HEMOGLOBIN F (HBF)", "target": "MAXIMUM TOLERATED DOSE (MTD)"}, {"weight": 4.0, "description": "The assessment of HU\'s effects on hematological parameters includes monitoring neutrophil count to ensure safety during treatment.", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "order": 1, "source": "HYDROXYUREA TREATMENT (HU)", "target": "NEUTROPHIL COUNT (ANC)"}, {"weight": 6.0, "description": "The association between the HMIP-2 SNP and MTD HbF was observed but lost significance after correcting for baseline hemoglobin F levels.)", "source_id": "chunk-3ae06e9a3330573da28ca0a76aa685ce", "order": 1, "source": "HMIP-2 SNP", "target": "MTD HBF"}, {"weight": 6.0, "description": "An analysis of haplotypes in the HMIP-2 region revealed that the C-A haplotype is associated with MTD HbF, though this association loses significance after correction for baseline hemoglobin F levels.)", "source_id": "chunk-3ae06e9a3330573da28ca0a76aa685ce", "order": 1, "source": "MTD HBF", "target": "C-A HAPLOTYPE"}, {"weight": 2.0, "description": "The deletion in UBE2T gene is expected to be null, as it leads to loss of a majority of the gene including the start codon.", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "order": 1, "source": "UBE2T GENE", "target": "G.202332626_202341295DEL DELETION"}, {"weight": 3.0, "description": "The duplication in UBE2T gene, resulting from recombination between two AluYa5 repeats, leads to a frameshift and premature stop codon.", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "order": 1, "source": "UBE2T GENE", "target": "G.202332626_202341295DUP DUPLICATION"}, {"weight": 4.0, "description": "The transcript of the UBE2T gene with a duplication includes the noncoding region from exon 2, causing a frameshift and premature stop codon.", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "order": 1, "source": "G.202332626_202341295DUP DUPLICATION", "target": "UBE2T TRANSCRIPT (C.-64_468DUP)"}, {"weight": 5.0, "description": "Monoubiquitination of FANCD2 is a key step in the activation of Fanconi anemia pathway for cellular response to DNA damage.", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "order": 1, "source": "FANCD2 MONOUBIQUITINATION", "target": "FANCONI ANEMIA PATHWAY"}, {"weight": 8.0, "description": "Overexpression of wild type UBE2T protein restores FANCD2 monoubiquitination, which is crucial for the FA pathway\'s function in response to DNA damage.", "source_id": "chunk-ffd1276c89bcac745a7e58082e97236f", "order": 1, "source": "FANCD2 MONOUBIQUITINATION", "target": "WILD TYPE UBE2T EXPRESSION"}, {"weight": 6.0, "description": "Elevated chromosomal breakage levels indicate deficiencies in DNA repair mechanisms associated with the FA pathway.", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "order": 1, "source": "CHROMOSOMAL BREAKAGE", "target": "FANCONI ANEMIA PATHWAY"}, {"weight": 8.0, "description": "Deficiencies in genes involved in this pathway lead to Fanconi anemia, characterized by bone marrow failure and cellular hypersensitivity.", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "order": 1, "source": "FANCONI ANEMIA PATHWAY", "target": "FANCONI ANEMIA (FA)"}, {"weight": 7.0, "description": "The fibroblast cells and lymphoblastoid cell line from the same patient show differences in FA pathway activation, indicating somatic mosaicism.", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "order": 1, "source": "FIBROBLASTS (RA2627)", "target": "LYMPHOBLASTOID CELL LINE (RA2946)"}, {"weight": 10.0, "description": "Deficiency or mutations in the UBE2T gene result in Fanconi anemia-T subtype, characterized by cellular hypersensitivity and defects in DNA repair pathways.", "source_id": "chunk-ffd1276c89bcac745a7e58082e97236f", "order": 1, "source": "UBE2T", "target": "FANCONI ANEMIA-T (FA-T)"}, {"weight": 8.0, "description": "Overexpression of wild type UBE2T protein also restores FANCI monoubiquitination, contributing further to the repair of interstrand DNA crosslinks.", "source_id": "chunk-ffd1276c89bcac745a7e58082e97236f", "order": 1, "source": "WILD TYPE UBE2T EXPRESSION", "target": "FANCI MONOUBIQUITINATION"}, {"weight": 10.0, "description": "Overexpression of wild type UBE2T protein rescues cells from the detrimental effects of crosslinking agents and restores cell survival and DNA repair efficiency.", "source_id": "chunk-ffd1276c89bcac745a7e58082e97236f", "order": 1, "source": "WILD TYPE UBE2T EXPRESSION", "target": "CROSSLINKING AGENTS (MMC, DEB, CISPLATIN)"}, {"weight": 3.0, "description": "The expression of wild type UBE2T in BJ cells serves as a control to compare with RA2627 fibroblasts to assess the rescue effect on cellular hypersensitivity and DNA repair.", "source_id": "chunk-ffd1276c89bcac745a7e58082e97236f", "order": 1, "source": "WILD TYPE UBE2T EXPRESSION", "target": "BJ CELLS"}, {"weight": 6.0, "description": "Treatment with crosslinking agents causes G2 arrest in RA2627 fibroblasts due to cellular hypersensitivity and defects in DNA repair pathways.", "source_id": "chunk-ffd1276c89bcac745a7e58082e97236f", "order": 1, "source": "CROSSLINKING AGENTS (MMC, DEB, CISPLATIN)", "target": "G2 ARREST"}, {"weight": 3.0, "description": "The RPS19 gene carries a missense mutation at position Arg101His resulting in substitution from arginine to histidine, contributing to the pathogenesis of DBA.)", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "order": 1, "source": "RPS19 GENE", "target": "MISSENSE MUTATION P.ARG101HIS"}, {"weight": 3.0, "description": "The RPS19 gene has a frameshift mutation characterized by deletion of guanine at position 58 which leads to a premature stop codon and reduced protein function in DBA.)", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "order": 1, "source": "RPS19 GENE", "target": "FRAMESHIFT MUTATION C.58DELG"}, {"weight": 3.0, "description": "The RPS19 gene contains a splice site mutation at position -1G>A affecting intron 1, leading to exon skipping and reduced protein function in DBA.)", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "order": 1, "source": "RPS19 GENE", "target": "SPLICE SITE MUTATION C.1-1G>A"}, {"weight": 4.0, "description": "The transcriptome of dermal fibroblasts from patients with RPS19 gene mutations shows differential expression patterns compared to healthy controls.)", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "order": 1, "source": "DERMAL FIBROBLASTS TRANSCRIPTOME", "target": "RPS19 GENE MUTATIONS"}, {"weight": 4.0, "description": "The splice site mutation in the RPS19 gene leads to NMD targeting and degradation of mutant mRNA, affecting protein levels.)", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "order": 1, "source": "NMD (NONSENSE-MEDIATED DECAY)", "target": "SPLICE SITE MUTATION C.1-1G>A IN RPS19 GENE"}, {"weight": 3.0, "description": "Genes involved in aminoacyl-tRNA biosynthesis show differential expression patterns among DBA patients indicating potential functional alterations.)", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "order": 1, "source": "AMINOACYL-TRNA BIOSYNTHESIS PATHWAY", "target": "DBA PATIENTS DIFFERENTIALLY EXPRESSED GENES"}, {"weight": 3.0, "description": "Genes involved in the metabolism of glycine, serine, and threonine show differential expression patterns among DBA patients indicating potential functional alterations.)", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "order": 1, "source": "GLYCINE, SERINE, AND THREONINE METABOLISM PATHWAY", "target": "DBA PATIENTS DIFFERENTIALLY EXPRESSED GENES"}, {"weight": 3.0, "description": "Enrichment of death receptor signaling pathway genes indicates activation or alteration in this pathway among DBA patients due to differential expression.)", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "order": 1, "source": "DEATH RECEPTOR SIGNALING PATHWAY", "target": "DBA PATIENTS DIFFERENTIALLY EXPRESSED GENES"}, {"weight": 3.0, "description": "Genes involved in PKR-mediated interferon induction and antiviral response pathways show enrichment among DBA patients.)", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "order": 1, "source": "PKR ROLE IN INTERFERON INDUCTION AND ANTIVIRAL RESPONSE PATHWAY", "target": "DBA PATIENTS DIFFERENTIALLY EXPRESSED GENES"}, {"weight": 3.0, "description": "Enrichment of genes involved in RAR activation pathway among DBA patients indicates potential alterations in retinoic acid signaling.)", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "order": 1, "source": "RAR ACTIVATION PATHWAY", "target": "DBA PATIENTS DIFFERENTIALLY EXPRESSED GENES"}, {"weight": 4.0, "description": "The ribosomal protein gene cluster shows differential expression patterns among DBA patients indicating involvement in the pathogenesis of DBA.)", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "order": 1, "source": "RP GENES (RIBOSOMAL PROTEIN)", "target": "DBA PATIENTS DIFFERENTIALLY EXPRESSED GENES"}, {"weight": 3.0, "description": "Genes involved in lipid metabolism show differential expression patterns among DBA patients indicating potential alterations in lipid-related processes.)", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "order": 1, "source": "LIPID METABOLISM PATHWAY", "target": "DBA PATIENTS DIFFERENTIALLY EXPRESSED GENES"}, {"weight": 3.0, "description": "The RPL14 gene is involved in cellular functions such as molecular transport, contributing to the movement of molecules across cell membranes.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "order": 1, "source": "RPL14", "target": "MOLECULAR TRANSPORT"}, {"weight": 4.0, "description": "Up-regulation of AMPD3 is noted in DBA patients relative to healthy subjects, as validated by RT-PCR analysis.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "order": 1, "source": "AMPD3", "target": "DIAMOND-BLACKFAN ANEMIA (DBA)"}, {"weight": 5.0, "description": "Increased CCND2 expression levels correlate with DBA patient status relative to controls.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "order": 1, "source": "CCND2", "target": "DIAMOND-BLACKFAN ANEMIA (DBA)"}, {"weight": 4.0, "description": "Up-regulation of SOD2 is observed in DBA patients compared to healthy individuals, according to RT-PCR validation.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "order": 1, "source": "SOD2", "target": "DIAMOND-BLACKFAN ANEMIA (DBA)"}, {"weight": 5.0, "description": "Elevated TNFAIP3 expression levels are associated with the condition of Diamond-Blackfan Anemia in patients compared to controls.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "order": 1, "source": "TNFAIP3", "target": "DIAMOND-BLACKFAN ANEMIA (DBA)"}, {"weight": 4.0, "description": "RP genes contribute to the process of cellular development and tissue growth within organisms.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "order": 1, "source": "RIBOSOMAL PROTEIN GENES (RP GENES)", "target": "CELLULAR DEVELOPMENT"}, {"weight": 4.0, "description": "This category includes biological pathways that involve cancer-related genes contributing to disease development and progression.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "order": 1, "source": "TOP BIO FUNCTIONS CATEGORY MOLECULAR AND CELLULAR FUNCTIONS", "target": "CANCER RELATED GENES"}, {"weight": 3.0, "description": "Genetic factors influencing the development of haematological disorders may also contribute to renal conditions, affecting overall health.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "order": 1, "source": "HAEMATOLOGICAL DISORDERS", "target": "RENAL DISORDERS"}, {"weight": 4.0, "description": "Processes involved in embryonic tissue formation can impact skeletal integrity and development, potentially leading to skeletal disorders.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "order": 1, "source": "SKELETAL DISORDERS", "target": "DEVELOPMENT OF EMBRYONIC TISSUES"}, {"weight": 8.0, "description": "The BDNF gene contains the rs6265 polymorphism which has a significant association with migraine susceptibility.", "source_id": "chunk-814fe155e9cb953da61f6a79d1d25784", "order": 1, "source": "BDNF GENE", "target": "RS6265 GENOMIC VARIANT"}, {"weight": 8.0, "description": "Another variant (A/T) within the BDNF gene, rs2049046, is also associated with migraine susceptibility.", "source_id": "chunk-814fe155e9cb953da61f6a79d1d25784", "order": 1, "source": "BDNF GENE", "target": "RS2049046 GENOMIC VARIANT"}, {"weight": 6.0, "description": "The presence of the G/A polymorphism in the rs6265 site is significantly associated with an increased risk or reduced resistance to developing migraines.", "source_id": "chunk-814fe155e9cb953da61f6a79d1d25784", "order": 1, "source": "RS6265 GENOMIC VARIANT", "target": "MIGRAINE"}, {"weight": 6.0, "description": "The presence of the A/T polymorphism in the rs2049046 site has a significant association with susceptibility to migraines.", "source_id": "chunk-814fe155e9cb953da61f6a79d1d25784", "order": 1, "source": "RS2049046 GENOMIC VARIANT", "target": "MIGRAINE"}, {"weight": 5.0, "description": "A high NOS score indicates that the quality of observational studies included in the meta-analysis is good, supporting robust analysis and conclusions.", "source_id": "chunk-814fe155e9cb953da61f6a79d1d25784", "order": 1, "source": "NOS SCORE", "target": "STUDY QUALITY ASSESSMENT"}, {"weight": 2.0, "description": "Neutrophils are highly abundant in the dermis of paradoxical skin reactions and play a significant role in the inflammatory response associated with psoriasis.", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "order": 1, "source": "PSORIASIS", "target": "CD15+ NEUTROPHILS"}, {"weight": 3.0, "description": "Epidermal hyperplasia is a common histological finding in psoriasis, indicating increased cell proliferation within the epidermis.", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "order": 1, "source": "PSORIASIS", "target": "EPIDERMAL HYPERPLASIA"}, {"weight": 2.0, "description": "Parakeratosis is often observed in psoriatic lesions and indicates incomplete keratinocyte differentiation.", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "order": 1, "source": "PSORIASIS", "target": "PARAKERATOSIS"}, {"weight": 3.0, "description": "Enlargement of blood vessels in the papillary dermis layer can be a characteristic feature of psoriatic inflammation.", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "order": 1, "source": "PSORIASIS", "target": "PAPILLARY VESSEL ECTASIA"}, {"weight": 4.0, "description": "The presence of perivascular infiltrates with immune cells is typical in inflammatory skin conditions like psoriasis.", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "order": 1, "source": "PSORIASIS", "target": "PERIVASCULAR INFILTRATE"}, {"weight": 4.0, "description": "The Sartorius score is used to assess the severity of HS based on clinical findings such as nodules, sinuses, and fistulas.", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "order": 1, "source": "HIDRADENITIS SUPPURATIVA (HS)", "target": "SARTORIUS SCORE"}, {"weight": 4.0, "description": "Treatment with adalimumab in patients with HS leads to paradoxical psoriasiform reactions, demonstrating that these drugs can cause unexpected immune responses.", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "order": 1, "source": "PARADOXICAL PSORIASIFORM REACTIONS", "target": "ADALIMUMAB"}, {"weight": 4.0, "description": "Plasmacytoid dendritic cells significantly infiltrate the dermis during paradoxical psoriasiform reactions, contributing to an enhanced immune response in these conditions.", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "order": 1, "source": "PARADOXICAL PSORIASIFORM REACTIONS", "target": "BDCA2+ PDCS"}, {"weight": 4.0, "description": "Neutrophils are a significant source of IL-36\u03b3, contributing to the inflammatory response observed in paradoxical psoriasiform reactions.", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "order": 1, "source": "CD15+ NEUTROPHILS", "target": "IL-36\u0393"}, {"weight": 3.0, "description": "Mast cells expressing c-kit play important roles in innate immune responses and allergic inflammation.", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "order": 1, "source": "C-KIT/CD117+ MAST CELLS", "target": "INNATE IMMUNITY"}, {"weight": 5.0, "description": "CD3+ skin T cells from HS patients are enriched in CD8+, reflecting a distinct inflammatory infiltrate pattern.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "order": 1, "source": "CD8+", "target": "SKIN T CELLS"}, {"weight": 4.0, "description": "Type I IFN-\u03b2 expression is mainly observed in keratinocytes of paradoxical psoriasis skin lesions.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "order": 1, "source": "IFN-\u0392", "target": "KERATINOCYTES"}, {"weight": 6.0, "description": "Interferon-kappa is expressed by keratinocytes and shows differential subcellular localization between psoriasiform and classical psoriasis lesions.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "order": 1, "source": "IFN-\u039a", "target": "KERATINOCYTES"}, {"weight": 7.0, "description": "Patients developing paradoxical psoriasis carry variants of the ERAP1 gene, indicating a genetic predisposition to such reactions.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "order": 1, "source": "ERAP1 GENE", "target": "SNP VARIANTS"}, {"weight": 2.0, "description": "The CCHCR1 gene contains SNP rs1576.", "source_id": "chunk-72f4505e43f67f3564607392cb178656", "order": 1, "source": "CCHCR1 GENE", "target": "SNP RS1576"}, {"weight": 1.0, "description": "The CCHCR1 gene contains SNP rs130079.", "source_id": "chunk-72f4505e43f67f3564607392cb178656", "order": 1, "source": "CCHCR1 GENE", "target": "SNP RS130079"}, {"weight": 1.0, "description": "The CCHCR1 gene contains SNP rs746647.", "source_id": "chunk-72f4505e43f67f3564607392cb178656", "order": 1, "source": "CCHCR1 GENE", "target": "SNP RS746647"}, {"weight": 2.0, "description": "Levels of IL-22 in PBMCs can serve as a diagnostic marker, showing reduction compared to psoriasiform lesions.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "order": 1, "source": "PBMCS (PERIPHERAL BLOOD MONONUCLEAR CELLS)", "target": "DIAGNOSTIC MARKER"}, {"weight": 2.0, "description": "Rs11209026 is a previously studied SNP in the IL23R gene linked to paradoxical reactions but not found in HS patients.", "source_id": "chunk-72f4505e43f67f3564607392cb178656", "order": 1, "source": "IL23R GENE", "target": "SNP RS11209026"}, {"weight": 3.0, "description": "Rs72676067 is a detected SNP in patient 2 located within the IL23R gene.", "source_id": "chunk-72f4505e43f67f3564607392cb178656", "order": 1, "source": "IL23R GENE", "target": "SNP RS72676067"}, {"weight": 3.0, "description": "Rs1004819 is a detected SNP in patient 1 located within the IL23R gene.", "source_id": "chunk-72f4505e43f67f3564607392cb178656", "order": 1, "source": "IL23R GENE", "target": "SNP RS1004819"}, {"weight": 8.0, "description": "Variants in the HLA-C region are found consistently among HS patients with paradoxical psoriasis, suggesting an association with disease susceptibility.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "order": 1, "source": "DISEASE SUSCEPTIBILITY", "target": "HLA-C REGION SNPS"}, {"weight": 3.0, "description": "Variants in the HLA-B region are associated with genetic predisposition to autoimmune diseases including psoriasis.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "order": 1, "source": "DISEASE SUSCEPTIBILITY", "target": "HLA-B REGION SNPS"}, {"weight": 8.0, "description": "SNPs achieving nominal significance in the GWAS of general IgM suggest their potential roles in contributing to disease susceptibility.", "source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a", "order": 1, "source": "DISEASE SUSCEPTIBILITY", "target": "NOMINAL SIGNIFICANCE IN GWAS"}, {"weight": 9.0, "description": "Polymorphisms in CDSN gene may affect skin barrier integrity and contribute to the pathogenesis of inflammatory skin conditions like psoriasis.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "order": 1, "source": "CDSN GENE ", "target": "SKIN BARRIER FUNCTION"}, {"weight": 4.0, "description": "The DRWD domain is part of the human protein encoded by the FANCL gene, playing a role in the Fanconi Anemia pathway.", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "order": 1, "source": "FANCL GENE", "target": "DRWD DOMAIN (HUMAN)"}, {"weight": 10.0, "description": "The hydrophobic core residues are conserved between DmFANCL and human FANCL, reflecting their role in protein-protein interactions critical for the Fanconi Anemia pathway.", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "order": 1, "source": "FANCL GENE", "target": "HYDROPHOBIC CORE RESIDUES"}, {"weight": 8.0, "description": "A cysteine residue is present in the \u03b2-element of the human DRWD domain, similar to the catalytic site of E2s but inactive for thioester formation.", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "order": 1, "source": "DRWD DOMAIN (HUMAN)", "target": "CYSTEINE"}, {"weight": 6.0, "description": "The URD shares structural similarity with E2 enzymes, particularly with their C-terminal lobe.", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "order": 1, "source": "E2 UBC ENZYMES", "target": "URD (UBC-RWD DOMAIN)"}, {"weight": 7.0, "description": "The human FANCL domain (URD) is structurally different from the Drosophila version, particularly in its N-terminal lobe which lacks a helix.", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "order": 1, "source": "URD (UBC-RWD DOMAIN)", "target": "DMDRWD (PROTEIN)"}, {"weight": 12.0, "description": "The thioester charge assay was used to determine whether the cysteine residue forms a thioester bond with ubiquitin, which it does not.", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "order": 1, "source": "CYSTEINE", "target": "THIOESTER CHARGE ASSAY"}, {"weight": 7.0, "description": "The Drosophila DRWD binds and interacts with human URD to form part of the larger FANCL complex.", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9", "order": 1, "source": "URD", "target": "DMDRWD"}, {"weight": 4.0, "description": "The C-terminal domain of DmDRWD interacts extensively with the human URD, forming part of the larger FANCL complex.", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9", "order": 1, "source": "URD", "target": "C-TERMINAL DOMAIN OF DMDRWD "}, {"weight": 2.0, "description": "FANCI binds to URD as indicated in the text by pulldown array experiments.<SEP>FANCI binds to URD, and this interaction is reduced when specific mutants are present in the hydrophobic patches of URD.", "source_id": "chunk-6135f8baf39fe26dcea3d987aa6100ac", "order": 1, "source": "URD", "target": "FANCI"}, {"weight": 2.0, "description": "FANCD2 also binds to URD, similar to FANCI, but both show reduced binding with specific mutants of URD.<SEP>FANCD2 also binds to URD, similarly affected by mutations in the C-terminal lobe hydrophobic patches but not in the N-terminal ones.", "source_id": "chunk-6135f8baf39fe26dcea3d987aa6100ac", "order": 1, "source": "URD", "target": "FANCD2"}, {"weight": 1.0, "description": "These mutations represent genomic variants that significantly reduce the binding affinity between URD and both FANCI and FANCD2.", "source_id": "chunk-6135f8baf39fe26dcea3d987aa6100ac", "order": 1, "source": "URD", "target": "L248A/F252A/L254A/I265A"}, {"weight": 1.0, "description": "Mutations in this group do not affect the binding of URD to FANCI or FANCD2 as much, indicating less impact on the function compared to L248A/F252A/L254A/I265A.", "source_id": "chunk-6135f8baf39fe26dcea3d987aa6100ac", "order": 1, "source": "URD", "target": "W212A/L214A"}, {"weight": 1.0, "description": "The hydrophobic patches in the C-terminal lobe of URD are crucial for maintaining binding affinity with FANCI and FANCD2, whereas those in the N-terminal do not significantly impact binding.", "source_id": "chunk-6135f8baf39fe26dcea3d987aa6100ac", "order": 1, "source": "URD", "target": "HYDROPHOBIC PATCH (C-TERMINAL)"}, {"weight": 1.0, "description": "Mutations in the hydrophobic patches of the N-terminal lobe of URD are less disruptive to substrate binding compared to mutations in the C-terminal lobe.", "source_id": "chunk-6135f8baf39fe26dcea3d987aa6100ac", "order": 1, "source": "URD", "target": "HYDROPHOBIC PATCH (N-TERMINAL)"}, {"weight": 8.0, "description": "The RING domain of FANCL interacts with FANCI and FANCD2 in the Fanconi Anemia pathway.", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9", "order": 1, "source": "RING DOMAIN (HUMAN)", "target": "FANCI"}, {"weight": 4.0, "description": "FANCI and FANCD2 form a complex that is critical for genome stability in the Fanconi Anemia pathway.", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9", "order": 1, "source": "FANCI", "target": "FANCD2"}, {"weight": 6.0, "description": "Specific hydrophobic patches on the C-terminal lobe of URD are crucial for binding to FANCI and FANCD2.", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9", "order": 1, "source": "HYDROPHOBIC PATCHES/GROOVES (URD)", "target": "FANCI/FANCD2 BINDING"}, {"weight": 5.0, "description": "The differences in electrostatic potential between human URD and Drosophila DRWD influence the interaction patterns of hydrophobic patches.", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9", "order": 1, "source": "HYDROPHOBIC PATCHES/GROOVES (URD)", "target": "ELECTROSTATIC POTENTIAL DIFFERENCES (URD/DMDRWD)"}, {"weight": 5.0, "description": "Specific hydrophobic grooves on the C-terminal lobe of URD facilitate binding to Ube2T for E3 ligase activity.", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9", "order": 1, "source": "HYDROPHOBIC GROOVES (URD)", "target": "UBE2T BINDING"}, {"weight": 8.0, "description": "While both motifs are found in RWD folds, only the human FANCL central domain (URD) contains an HPXXXP motif rather than YPXXXP.", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "order": 1, "source": "HPXXXP MOTIF", "target": "TRIPLE TURN YPXXXP MOTIF"}, {"weight": 9.0, "description": "The \u03b2-flap structure in E2 enzymes facilitates thioester bond formation with ubiquitin, a process not observed in the URD due to lack of catalytic cysteine activity.", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "order": 1, "source": "CATALYTIC THIOESTER BOND FORMATION", "target": "\u0392-FLAP STRUCTURE"}, {"weight": 10.0, "description": "The test was conducted to determine if the cysteine residue in the human FANCL domain could form thioester bonds with ubiquitin, which it cannot.", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "order": 1, "source": "CYSTEINE RESIDUE (URD)", "target": "THIOESTER LINKAGE STABILITY TEST"}, {"weight": 9.0, "description": "In the GA/AA genotype group, colesevelam significantly delays CT by increasing AC t1/2 and decreasing GC24.", "source_id": "chunk-5c78814fb7c198ee95071ee5a8462070", "order": 1, "source": "FGFR4 RS351855 (GLY388ARG)", "target": "CT DELAY"}, {"weight": 8.0, "description": "The KLB variant impacts the effect of colesevelam on CT, showing lower GC24 values in the CA/AA genotype group.", "source_id": "chunk-5c78814fb7c198ee95071ee5a8462070", "order": 1, "source": "COLESEVELAM TREATMENT EFFECTS", "target": "KLB RS4975017"}, {"weight": 7.0, "description": "This variant shows modest effects of colesevelam on AC t1/2 and GC24, but no significant effect in the GA/AA genotype group.", "source_id": "chunk-5c78814fb7c198ee95071ee5a8462070", "order": 1, "source": "COLESEVELAM TREATMENT EFFECTS", "target": "KLB RS17618244 (ARG728GLN)"}, {"weight": 8.0, "description": "The KLB gene includes a variant associated with differential colesevelam treatment effects on CT.", "source_id": "chunk-5c78814fb7c198ee95071ee5a8462070", "order": 1, "source": "KLB RS4975017", "target": "KLB GENE"}, {"weight": 7.0, "description": "Genetic studies involving healthy control patients assess the impact of FGFR4 and KLB variants on drug responses.", "source_id": "chunk-5c78814fb7c198ee95071ee5a8462070", "order": 1, "source": "HEALTHY CONTROL PATIENTS", "target": "FGFR4 AND KLB GENES "}, {"weight": 3.0, "description": "There were numerical differences in stool fat but no significant association with FGF19 levels across subgroups indicating the complexity of metabolic pathways involved.", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "order": 1, "source": "FGF19", "target": "STOOL BA (BILE ACIDS)"}, {"weight": 2.0, "description": "Genetic variants within the FGFR4 gene are marginally associated with stool BA levels but not with serum C4.", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "order": 1, "source": "BILE ACIDS (BA)", "target": "FGFR4 RS1966265, FGFR4 RS351855, FGFR4 RS376618"}, {"weight": 2.0, "description": "Patients with IBS-C had lower levels of 48-hour stool BA compared to HV, indicating a differential impact on bile acid excretion patterns.", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "order": 1, "source": "BILE ACIDS (BA)", "target": "IBS-C (IRRITABLE BOWEL SYNDROME WITH CONSTIPATION)"}, {"weight": 6.0, "description": "Previous cholecystectomies were more prevalent in IBS-D patients but did not significantly affect their symptoms, indicating a complex relationship between gallbladder removal and IBS.<SEP>Previous cholecystectomies were recorded in 23% of IBS-D patients, showing a potential relationship between gallbladder removal and the disease.", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "order": 1, "source": "CHOLECYSTECTOMY", "target": "IBS-D (IRRITABLE BOWEL SYNDROME WITH DIARRHEA)"}, {"weight": 3.0, "description": "Previous cholecystectomies were recorded in approximately 4% of IBS-C patients, indicating a lower prevalence compared to IBS-D.", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "order": 1, "source": "CHOLECYSTECTOMY", "target": "IBS-C (IRRITABLE BOWEL SYNDROME WITH CONSTIPATION)"}, {"weight": 5.0, "description": "Patients with IBS-D had significantly higher 48-hour stool bile acid levels compared to IBS-C, indicating a differential impact on excretion.", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "order": 1, "source": "IBS-D (IRRITABLE BOWEL SYNDROME WITH DIARRHEA)", "target": "STOOL BA (BILE ACIDS)"}, {"weight": 4.0, "description": "There was an overall association of serum C4 with subgroup based on stool bile acid levels, suggesting a correlation between these biomarkers.", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "order": 1, "source": "STOOL BA (BILE ACIDS)", "target": "SERUM C4"}, {"weight": 4.0, "description": "The interaction between the N-terminal region of FAAP20 and FANCA is crucial for DNA repair processes.", "source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "order": 1, "source": "FAAP20", "target": "FANCA"}, {"weight": 1.0, "description": "The UBZ domain of FAAP20 interacts with ubiquitin to facilitate the protein\'s localization at sites of DNA damage, ensuring proper repair mechanisms are initiated.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "order": 1, "source": "FAAP20", "target": "DNA DAMAGE SITES"}, {"weight": 3.0, "description": "The interaction between FANCA and ubiquitin may involve the UBZ domain of FAAP20 to modulate DNA repair pathways.", "source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "order": 1, "source": "FANCA", "target": "UBIQUITIN (UB)"}, {"weight": 5.0, "description": "FAAP20-UBZ specifically binds K63-linked Ub2, which suggests a role in cellular signaling and regulation of protein stability.", "source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "order": 1, "source": "UBZ DOMAIN (OF FAAP20)", "target": "K63-UB2"}, {"weight": 1.0, "description": "Specific residues in the FAAP20-UBZ protein interact with ubiquitin via hydrogen bonds and hydrophobic interactions to stabilize the binding complex.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "order": 1, "source": "UBIQUITIN (UB)", "target": "ASP164, TRP180 (FAAP20-UBZ)"}, {"weight": 4.0, "description": "The central \u03b1-helix is a critical part of the FAAP20-UBZ structure that interacts specifically with ubiquitin in K63-linked Ub2 chains.", "source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "order": 1, "source": "FAAP20-UBZ (RESIDUES 143\u2013180)", "target": "CENTRAL \u0391-HELIX (RESIDUES 160\u2013173)"}, {"weight": 6.0, "description": "The interaction between FAAP20-UBZ and ubiquitin chains is a part of the broader process of ubiquitination, involved in cellular signaling and regulation.", "source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "order": 1, "source": "FAAP20-UBZ (RESIDUES 143\u2013180)", "target": "UBIQUITINATION"}, {"weight": 5.0, "description": "The central \u03b1-helix interacts hydrophobically with the Ile44 patch of ubiquitin, contributing to the binding specificity of FAAP20-UBZ.", "source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "order": 1, "source": "CENTRAL \u0391-HELIX (RESIDUES 160\u2013173)", "target": "ILE44 PATCH"}, {"weight": 3.0, "description": "The two loop regions of FAAP20-UBZ interact with the zinc ion to stabilize the protein structure.", "source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "order": 1, "source": "TWO LOOPS (RESIDUES 143\u2013159 AND 174\u2013180)", "target": "ZINC ION"}, {"weight": 1.0, "description": "These residues in ubiquitin form a hydrophobic patch that interacts with FAAP20-UBZ via specific molecular interactions to mediate binding affinity.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "order": 1, "source": "FAAP20-UBZ", "target": "LEU8, ILE44, VAL70, THR66, HIS68 (UB)"}, {"weight": 1.0, "description": "Residues in ubiquitin participate in molecular interactions with FAAP20-UBZ that are crucial for maintaining high affinity binding and subsequent cellular functions.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "order": 1, "source": "FAAP20-UBZ", "target": "ARG72, GLN49 (UB)"}, {"weight": 7.0, "description": "FAAP20-UBZ binds Ub via hydrophobic residues on the \u03b1-helix and through specific charged residues crucial for interaction.", "source_id": "chunk-5bfe051a79e5e215dd3fc65296825591", "order": 1, "source": "FAAP20-UBZ", "target": "UB"}, {"weight": 6.0, "description": "The WRNIP1-UBZ domain interacts with Ub through its \u03b2-loop structure, distinct from Pol\u03b7-UBZ due to differences in specific binding residues.", "source_id": "chunk-5bfe051a79e5e215dd3fc65296825591", "order": 1, "source": "WRNIP1-UBZ", "target": "UB"}, {"weight": 5.0, "description": "Pol\u03b7-UBZ binds to Ub in a manner similar to FAAP20-UBZ, indicating conserved residues and structural features that facilitate interaction.", "source_id": "chunk-5bfe051a79e5e215dd3fc65296825591", "order": 1, "source": "POL\u0397-UBZ", "target": "UB"}, {"weight": 3.0, "description": "Both proteins interact differently with Ub compared to WRNIP1, indicating unique binding modes influenced by their distinct sequences.", "source_id": "chunk-5bfe051a79e5e215dd3fc65296825591", "order": 1, "source": "POL\u0397-UBZ", "target": "NEMO-UBZ"}, {"weight": 4.0, "description": "The conservation or replacement of specific FAAP20-UBZ residues in Pol\u03b7-UBZ (e.g., Asp652, Phe655, Ala656) indicates a similar mode of interaction with Ub.", "source_id": "chunk-5bfe051a79e5e215dd3fc65296825591", "order": 1, "source": "POL\u0397-UBZ", "target": "FAAP20-UBZ RESIDUES"}, {"weight": 4.0, "description": "The interaction between NEMO-UBZ and Ub differs significantly compared to other UBZ domains, characterized by the replacement of Pro21-Val22 with charged residues disrupting normal hydrophobic interactions.", "source_id": "chunk-5bfe051a79e5e215dd3fc65296825591", "order": 1, "source": "NEMO-UBZ", "target": "UB"}, {"weight": 5.0, "description": "In NEMO-UBZ, the presence of charged residues like Lys399 disrupts normal hydrophobic interactions with Ile44 of Ub.", "source_id": "chunk-5bfe051a79e5e215dd3fc65296825591", "order": 1, "source": "NEMO-UBZ", "target": "CHARGED RESIDUES"}, {"weight": 4.0, "description": "DQ8/DQX and other HLA-DQ8-related haplotypes are more frequent among CD patients compared to controls, indicating its association with increased risk of celiac disease.", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "order": 1, "source": "HLA-DQ8", "target": "CELIAC DISEASE (CD)"}, {"weight": 5.0, "description": "The minor allele \'G\' in rs2395182 is more prevalent in healthy controls than CD patients, indicating a potential protective role against celiac disease.", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "order": 1, "source": "RS2395182", "target": "CELIAC DISEASE (CD)"}, {"weight": 6.0, "description": "The minor allele \'C\' in rs7775228 is more frequent in controls than CD patients, suggesting its potential protective role against celiac disease.", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "order": 1, "source": "RS7775228", "target": "CELIAC DISEASE (CD)"}, {"weight": 4.0, "description": "The minor allele \'T\' in rs2187668 is significantly more prevalent among CD patients than healthy controls, indicating its role as a risk factor for celiac disease.", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "order": 1, "source": "RS2187668", "target": "CELIAC DISEASE (CD)"}, {"weight": 3.0, "description": "The HLA-DQ2.2 haplotype frequency is higher in control groups compared to patient groups, suggesting a lower susceptibility to celiac disease in individuals with this haplotype.", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "order": 1, "source": "HLA-DQ2.2", "target": "CELIAC DISEASE (CD)"}, {"weight": 4.0, "description": "The homozygous form of the HLA-DQ2.5 haplotype significantly increases the likelihood of developing celiac disease compared to healthy controls.", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "order": 1, "source": "CELIAC DISEASE (CD)", "target": "HOMOZYGOUS DQ2.5 HAPLOTYPE"}, {"weight": 5.0, "description": "Higher frequency of DQ8/DQX haplotype among CD patients than in controls indicates its role as a risk factor for celiac disease.", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "order": 1, "source": "CELIAC DISEASE (CD)", "target": "DQ8/DQX HAPLOTYPE"}, {"weight": 3.0, "description": "Higher frequency of homozygous DQ2.2 haplotype in healthy controls compared to CD patients suggests a protective role against celiac disease.", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "order": 1, "source": "CELIAC DISEASE (CD)", "target": "HOMOZYGOUS DQ2.2 HAPLOTYPE"}, {"weight": 3.0, "description": "Similar frequency of heterozygous DQ2.2 haplotype in both patient and control groups indicates no significant risk or protective role against celiac disease.", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "order": 1, "source": "CELIAC DISEASE (CD)", "target": "HETEROZYGOUS DQ2.2 HAPLOTYPE"}, {"weight": 2.0, "description": "Individuals lacking all high-risk HLA alleles are considered to be at extremely low risk for developing celiac disease, with similar incidence in both patient and control groups.", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "order": 1, "source": "CELIAC DISEASE (CD)", "target": "EXTREMELY LOW RISK GROUP (DQX)"}, {"weight": 4.0, "description": "The ERCC2 variant rs1799793 is significantly correlated with PFI, suggesting its role in the effectiveness of platinum-based chemotherapy and patient prognosis.)", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3", "order": 1, "source": "ERCC2 G>A (RS1799793)", "target": "PLATINUM-FREE INTERVAL (PFI)"}, {"weight": 5.0, "description": "The ERCC2 gene harbors the variant rs1799793, which affects nucleotide excision repair and transcription regulation.)", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3", "order": 1, "source": "ERCC2 G>A (RS1799793)", "target": "ERCC2 GENE"}, {"weight": 3.0, "description": "The ABCC2 variant rs12762549 is significantly associated with PFI in a fully-adjusted model, indicating its involvement in drug resistance or metabolism of platinum-based chemotherapy agents.)", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3", "order": 1, "source": "ABCC2 A>G (RS12762549)", "target": "PLATINUM-FREE INTERVAL (PFI)"}, {"weight": 5.0, "description": "The ABCC2 gene harbors the variant rs12762549, which affects drug resistance and transport activity of MRP2.)", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3", "order": 1, "source": "ABCC2 A>G (RS12762549)", "target": "ABCC2 GENE (MRP2)"}, {"weight": 3.0, "description": "The SERPINB2 variant rs6104 is significantly associated with PFI in a fully-adjusted model, suggesting its impact on patient survival and tumor progression after chemotherapy.)", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3", "order": 1, "source": "SERPINB2 C>G (RS6104)", "target": "PLATINUM-FREE INTERVAL (PFI)"}, {"weight": 5.0, "description": "The SERPINB2 gene harbors the variant rs6104, influencing inflammation and tissue remodeling pathways.)", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3", "order": 1, "source": "SERPINB2 C>G (RS6104)", "target": "SERPINB2 GENE"}, {"weight": 3.0, "description": "Variants in ABCC2 affect drug transport and resistance mechanisms, influencing PFI in patients undergoing chemotherapy.)", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3", "order": 1, "source": "PLATINUM-FREE INTERVAL (PFI)", "target": "ABCC2 GENE (MRP2)"}, {"weight": 3.0, "description": "The influence of SERPINB2 variants on inflammation pathways may impact tumor progression and patient survival post-chemotherapy.)", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3", "order": 1, "source": "PLATINUM-FREE INTERVAL (PFI)", "target": "SERPINB2 GENE"}, {"weight": 3.0, "description": "Higher tumor grade is associated with worse prognosis and can significantly affect PFI outcomes.)", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3", "order": 1, "source": "PLATINUM-FREE INTERVAL (PFI)", "target": "TUMOR GRADE"}, {"weight": 4.0, "description": "Earlier FIGO stages are generally associated with better outcomes and longer PFI in patients undergoing chemotherapy.)", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3", "order": 1, "source": "PLATINUM-FREE INTERVAL (PFI)", "target": "FIGO STAGE"}, {"weight": 5.0, "description": "The variant c.302delA leads to a premature stop codon predicted by protein truncation or nonsense-mediated mRNA decay.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "order": 1, "source": "C.302DELA (P.LYS101ARGFS*9)", "target": "UMPS PROTEIN TRUNCATION AND NMD"}, {"weight": 4.0, "description": "The variant c.385G>T leads to a premature stop codon predicted by protein truncation or nonsense-mediated mRNA decay.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "order": 1, "source": "C.385G>T (P.GLY129*) ", "target": "UMPS PROTEIN TRUNCATION AND NMD"}, {"weight": 4.0, "description": "The variant c.889G>T leads to a premature stop codon predicted by protein truncation or nonsense-mediated mRNA decay.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "order": 1, "source": "C.889G>T (P.GLU297*) ", "target": "UMPS PROTEIN TRUNCATION AND NMD"}, {"weight": 3.0, "description": "Software programs predict the pathogenicity of missense alterations in UMPS gene including c.224C>A.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "order": 1, "source": "C.224C>A (P.PRO75HIS)", "target": "POLYPHEN-2, SIFT, MUTATIONTASTER PREDICTIONS"}, {"weight": 3.0, "description": "Missense alterations in UMPS gene affecting amino acids well-conserved from humans to fruit flies and roundworms.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "order": 1, "source": "C.286A>G (P.ARG96GLY) AND C.1285G>C (P.GLY429ARG)", "target": "H. SAPIENS, D. MELANOGASTER, C. ELEGANS CONSERVATION"}, {"weight": 2.0, "description": "Software programs predict the pathogenicity of missense alterations in UMPS gene including c.310G>A.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "order": 1, "source": "C.310G>A (P.GLY104ARG)", "target": "POLYPHEN-2, SIFT, MUTATIONTASTER PREDICTIONS"}, {"weight": 1.0, "description": "Software programs predict the pathogenicity of missense alterations in UMPS gene including c.689G>A and c.688C>T.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "order": 1, "source": "C.689G>A (P.ARG230HIS) AND C.688C>T (P.ARG230CYS)", "target": "POLYPHEN-2, SIFT, MUTATIONTASTER PREDICTIONS"}, {"weight": 1.0, "description": "Missense alteration in UMPS gene affecting amino acids well-conserved from humans to fruit flies and roundworms.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "order": 1, "source": "C.360A>G (P.LEU120LEU)", "target": "H. SAPIENS, D. MELANOGASTER, C. ELEGANS CONSERVATION"}, {"weight": 1.0, "description": "Software programs predict the pathogenicity of missense alterations in UMPS gene including c.857T>A.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "order": 1, "source": "POLYPHEN-2, SIFT, MUTATIONTASTER PREDICTIONS", "target": "C.857T>A (P.ILE286ASN)"}, {"weight": 1.0, "description": "Software programs predict the pathogenicity of missense alterations in UMPS gene including c.451G>A.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "order": 1, "source": "POLYPHEN-2, SIFT, MUTATIONTASTER PREDICTIONS", "target": "C.451G>A (P.VAL151MET)"}, {"weight": 2.0, "description": "Conservation studies showing well-preserved amino acids across species linked to low frequency of variants in the Exac browser database.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "order": 1, "source": "H. SAPIENS, D. MELANOGASTER, C. ELEGANS CONSERVATION", "target": "EXAC BROWSER VARIANTS FREQUENCY"}, {"weight": 1.0, "description": "The IL-8 gene polymorphism at rs4073 was investigated for its association with CRC risk but no significant difference was observed between patients and controls.", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "order": 1, "source": "IL-8 GENE (RS4073)", "target": "CRC"}, {"weight": 2.0, "description": "The IL-10 gene polymorphism at rs1800896 showed a significantly lower frequency of the heterozygous genotype AG in CRC patients compared to controls, indicating an association with decreased risk.", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "order": 1, "source": "IL-10 GENE (RS1800896)", "target": "CRC"}, {"weight": 3.0, "description": "The IL-22 gene polymorphism at rs1179251 showed a significant decrease in the G allele frequency among CRC patients, indicating an association with decreased risk.", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "order": 1, "source": "IL-22 GENE (RS1179251)", "target": "CRC"}, {"weight": 1.0, "description": "The IL-22 gene polymorphism at rs2227485 did not show a significant association with CRC risk in the investigated population, though trends were observed.", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "order": 1, "source": "IL-22 GENE (RS2227485)", "target": "CRC"}, {"weight": 3.0, "description": "The IL-27 gene polymorphism at rs17855750 showed a slight association with CRC risk, particularly in the homozygous GG genotype.", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "order": 1, "source": "IL-27 GENE (RS17855750)", "target": "CRC"}, {"weight": 1.0, "description": "The TGF-\u03b21 gene polymorphism at rs1800469 showed a significant decrease in the CT and TT genotypes among CRC patients, indicating an association with decreased risk.", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "order": 1, "source": "TGFSS1 GENE (RS1800469)", "target": "CRC"}, {"weight": 5.0, "description": "Variants in the TSLP gene contribute to susceptibility for asthma development and progression.", "source_id": "chunk-6f7ce1c71bd46f223756da44b0d0bb2c", "order": 1, "source": "TSLP GENE", "target": "ASTHMA"}, {"weight": 3.0, "description": "The risk of asthma associated with rs1898671 is higher among individuals who have previously smoked, indicating an interaction between smoking history and genetic susceptibility.", "source_id": "chunk-6f7ce1c71bd46f223756da44b0d0bb2c", "order": 1, "source": "RS1898671", "target": "EX-SMOKERS"}, {"weight": 4.0, "description": "The TSLP protein encoded by the TSLP gene plays a critical role in asthma pathogenesis through its involvement in immune responses.", "source_id": "chunk-6f7ce1c71bd46f223756da44b0d0bb2c", "order": 1, "source": "TSLP PROTEIN", "target": "ASTHMA"}, {"weight": 4.0, "description": "Increased levels of IgE are indicative of atopic conditions such as asthma.", "source_id": "chunk-6f7ce1c71bd46f223756da44b0d0bb2c", "order": 1, "source": "ASTHMA", "target": "IGE (IMMUNOGLOBULIN E)"}, {"weight": 4.0, "description": "Reduced FEV1/FVC ratio is a hallmark sign of obstructive airway disease, such as asthma.", "source_id": "chunk-6f7ce1c71bd46f223756da44b0d0bb2c", "order": 1, "source": "ASTHMA", "target": "FEV1/FVC RATIO"}, {"weight": 6.0, "description": "Sub-analyses excluding individuals with asthma showed persistent genetic associations, indicating disease independence.", "source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "order": 1, "source": "ASTHMA", "target": "FVC AND FEV1/FVC RATIO"}, {"weight": 5.0, "description": "PCA is used to identify and quantify population stratification in genetic association studies.", "source_id": "chunk-6f7ce1c71bd46f223756da44b0d0bb2c", "order": 1, "source": "PRINCIPAL COMPONENT ANALYSIS (PCA)", "target": "POPULATION STRATIFICATION"}, {"weight": 4.0, "description": "The STRUCTURE method complements PCA by estimating individual ancestry proportions, aiding in the adjustment for population stratification effects.", "source_id": "chunk-6f7ce1c71bd46f223756da44b0d0bb2c", "order": 1, "source": "STRUCTURE METHOD", "target": "POPULATION STRATIFICATION"}, {"weight": 9.0, "description": "Genomic variants at this locus significantly impact the FEV1/FVC ratio in Hutterites.", "source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "order": 1, "source": "FEV1/FVC RATIO", "target": "THSD4-UACA-TLE3 LOCUS ON CHROMOSOME 15Q23"}, {"weight": 8.0, "description": "Negligible population stratification ensures accurate interpretation of GWAS results for genetic variants like rs35923643-G and rs735665-A.", "source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a", "order": 1, "source": "POPULATION STRATIFICATION", "target": "GWAS RESULTS INTERPRETATION"}, {"weight": 1.0, "description": "The PTPN22 gene includes the SNP rs2476601, significant in other inflammatory autoimmune diseases but not directly related to Crohn\'s Disease.", "source_id": "chunk-84ec948f22126cef7d93b1d7465b79db", "order": 1, "source": "PTPN22 GENE", "target": "RS2476601"}, {"weight": 1.0, "description": "Presence of rs478582 influences the expression levels of PTPN2 transcript in CD subjects compared to healthy controls.", "source_id": "chunk-84ec948f22126cef7d93b1d7465b79db", "order": 1, "source": "RS478582", "target": "PTPN2 TRANSCRIPT"}, {"weight": 1.0, "description": "The heterozygous or minor/major haplotype is more frequent among CD patients compared to healthy controls.", "source_id": "chunk-84ec948f22126cef7d93b1d7465b79db", "order": 1, "source": "RS478582", "target": "PTPN2:RS478582 HAPLOTYPE C-G"}, {"weight": 0.5, "description": "This haplotype combination shows a lower frequency in Crohn\'s Disease subjects relative to healthy controls.", "source_id": "chunk-84ec948f22126cef7d93b1d7465b79db", "order": 1, "source": "RS478582", "target": "PTPN2:RS478582 HAPLOTYPE T-A"}, {"weight": 1.0, "description": "This haplotype combination is more frequent among CD patients, suggesting a potential role in disease susceptibility.", "source_id": "chunk-84ec948f22126cef7d93b1d7465b79db", "order": 1, "source": "RS478582", "target": "PTPN2:RS478582 HAPLOTYPE C-A"}, {"weight": 1.0, "description": "The SNP rs2476601 does not significantly impact PTPN22 expression levels but is examined for its potential influence on other diseases.", "source_id": "chunk-84ec948f22126cef7d93b1d7465b79db", "order": 1, "source": "RS2476601", "target": "PTPN22 TRANSCRIPT"}, {"weight": 2.0, "description": "Expression of the PTPN2 transcript is lower in Crohn\'s Disease subjects compared to healthy controls, indicating a role for this gene in disease pathology.", "source_id": "chunk-84ec948f22126cef7d93b1d7465b79db", "order": 1, "source": "PTPN2 TRANSCRIPT", "target": "CROHN\'S DISEASE (CD)"}, {"weight": 2.0, "description": "Similarly, expression levels of the PTPN22 transcript are also lower in CD patients relative to healthy controls, suggesting an involvement in disease mechanisms.", "source_id": "chunk-84ec948f22126cef7d93b1d7465b79db", "order": 1, "source": "PTPN22 TRANSCRIPT", "target": "CROHN\'S DISEASE (CD)"}, {"weight": 1.0, "description": "The transcript levels of PTPN22 vary significantly among different lymphocyte subsets such as na\u00efve, memory, and regulatory CD4+ T cells.", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "order": 1, "source": "PTPN22 TRANSCRIPT", "target": "LYMPHOCYTE SUBSET"}, {"weight": 3.0, "description": "Memory CD4+ T cells have higher baseline expression of PTPN22 transcripts compared to na\u00efve T cells at rest and respond differently upon activation.", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "order": 1, "source": "PTPN22 TRANSCRIPT", "target": "MEMORY TCONV CELLS"}, {"weight": 3.0, "description": "The presence of PTPN2:rs478582 genetic variant and MAPbacteremia increases the IFN-\u03b3 gene expression level in Crohn\u2019s disease patients.", "source_id": "chunk-6a657cd0a000b6df4db8f1305b795021", "order": 1, "source": "IFN-\u0393 GENE EXPRESSION", "target": "PTPN2:RS478582"}, {"weight": 2.0, "description": "Gene expression levels for PTPN2/PTPN22 are significantly lower in CD subjects compared to healthy controls, indicating the involvement of these genes in the disease pathology.", "source_id": "chunk-84ec948f22126cef7d93b1d7465b79db", "order": 1, "source": "CROHN\'S DISEASE (CD)", "target": "GENE EXPRESSION LEVEL"}, {"weight": 4.0, "description": "The genomic variant rs478582 is associated with increased susceptibility to Crohn\'s Disease (CD), particularly impacting MAP infection rates.", "source_id": "chunk-6cb127717713bd0ab5be9436fc0c7568", "order": 1, "source": "CROHN\'S DISEASE (CD)", "target": "PTPN2:RS478582"}, {"weight": 6.0, "description": "Genetic variations at rs2476601 are linked with altered gene expression patterns in CD subjects, influencing disease progression and outcomes.<SEP>The genomic variant rs2476601 on the PTPN22 gene increases susceptibility to Crohn\u2019s disease, particularly when combined with MAPbacteremia.", "source_id": "chunk-6cb127717713bd0ab5be9436fc0c7568<SEP>chunk-6a657cd0a000b6df4db8f1305b795021", "order": 1, "source": "CROHN\'S DISEASE (CD)", "target": "PTPN22:RS2476601"}, {"weight": 3.0, "description": "Increased IFN-\u03b3 relative gene expression is observed in CD patients carrying the rs478582 variant at PTPN2, suggesting a role in disease pathogenesis.", "source_id": "chunk-6cb127717713bd0ab5be9436fc0c7568", "order": 1, "source": "CROHN\'S DISEASE (CD)", "target": "IFN-\u0393 RELATIVE GENE EXPRESSION"}, {"weight": 3.0, "description": "The expression of PTPN2/22 genes is significantly lower in Crohn\u2019s disease subjects compared to healthy controls, indicating a role for these variants in disease susceptibility.", "source_id": "chunk-6a657cd0a000b6df4db8f1305b795021", "order": 1, "source": "CROHN\'S DISEASE (CD)", "target": "PTPN2/22 GENE EXPRESSION"}, {"weight": 3.0, "description": "Decreased PTPN22 gene expression in CD subjects with MAPbacteremia and specific genotypes indicates a genetic contribution to disease susceptibility.", "source_id": "chunk-6a657cd0a000b6df4db8f1305b795021", "order": 1, "source": "CROHN\'S DISEASE (CD)", "target": "PTPN22 GENE EXPRESSION"}, {"weight": 3.0, "description": "The genomic variant rs478582 at the PTPN2 gene locus influences IFN-\u03b3 relative gene expression, which is higher in CD subjects compared to those with normal alleles.", "source_id": "chunk-6cb127717713bd0ab5be9436fc0c7568", "order": 1, "source": "PTPN2:RS478582", "target": "IFN-\u0393 RELATIVE GENE EXPRESSION"}, {"weight": 4.0, "description": "The genomic variant rs478582 at the PTPN2 gene locus increases susceptibility to MAP infection in CD subjects compared to healthy controls.", "source_id": "chunk-6cb127717713bd0ab5be9436fc0c7568", "order": 1, "source": "PTPN2:RS478582", "target": "MAP INFECTION SUSCEPTIBILITY"}, {"weight": 3.0, "description": "The haplotype combination of rs478582 and rs2476601 (C-G) increases the risk of MAPbacteremia in Crohn\u2019s disease patients.", "source_id": "chunk-6a657cd0a000b6df4db8f1305b795021", "order": 1, "source": "PTPN2:RS478582", "target": "HAPLOTYPE C-G"}, {"weight": 3.0, "description": "The presence of MAP bacteria and the rs478582 variant increases the risk of Crohn\u2019s disease and alters gene expression patterns.", "source_id": "chunk-6a657cd0a000b6df4db8f1305b795021", "order": 1, "source": "PTPN2:RS478582", "target": "MAPBACTEREMIA PRESENCE"}, {"weight": 3.0, "description": "The genomic variant rs2476601 of the PTPN22 gene also affects its relative gene expression, which is lower in CD subjects compared to healthy controls.", "source_id": "chunk-6cb127717713bd0ab5be9436fc0c7568", "order": 1, "source": "PTPN22:RS2476601", "target": "PTPN22 GENE EXPRESSION"}, {"weight": 6.0, "description": "Genetic variations in the form of PTPN22:rs2476601 significantly impact T-cell proliferation response when MAPbacteremia is present.", "source_id": "chunk-883c371ea1f500a1ba8af8366328e8b0", "order": 1, "source": "PTPN22:RS2476601", "target": "T-CELL PROLIFERATION RESPONSE"}, {"weight": 3.0, "description": "The expression level of PTPN2 protein is correlated with the relative gene expression of PTPN2, which is lower in CD subjects compared to healthy controls.", "source_id": "chunk-6cb127717713bd0ab5be9436fc0c7568", "order": 1, "source": "PTPN2 GENE EXPRESSION", "target": "PTPN2 PROTEIN"}, {"weight": 3.0, "description": "Genetic variations at rs2476601 influence the expression level of PTPN22 protein and its gene, affecting disease outcomes in CD subjects.", "source_id": "chunk-6cb127717713bd0ab5be9436fc0c7568", "order": 1, "source": "PTPN22 GENE EXPRESSION", "target": "PTPN22 PROTEIN"}, {"weight": 4.0, "description": "Higher IFN-\u03b3 gene expression levels are associated with increased MAP infection susceptibility in CD subjects carrying specific genetic variants.", "source_id": "chunk-6cb127717713bd0ab5be9436fc0c7568", "order": 1, "source": "IFN-\u0393 RELATIVE GENE EXPRESSION", "target": "MAP INFECTION SUSCEPTIBILITY"}, {"weight": 3.0, "description": "Increased IFN-\u03b3 levels are associated with the presence of MAP bacteria combined with certain genetic variants in CD patients, indicating an inflammatory response.", "source_id": "chunk-6a657cd0a000b6df4db8f1305b795021", "order": 1, "source": "MAPBACTEREMIA PRESENCE", "target": "IFN-\u0393 EXPRESSION LEVELS"}, {"weight": 3.0, "description": "Treatment with PHA significantly increases T-cell proliferation response in both CD subjects and healthy controls, though differences are observed between groups.", "source_id": "chunk-883c371ea1f500a1ba8af8366328e8b0", "order": 1, "source": "T-CELL PROLIFERATION RESPONSE", "target": "PHA TREATMENT"}, {"weight": 8.0, "description": "The presence or absence of MAPbacteremia affects the overall functionality and proliferation rate of T-cells in CD subjects.", "source_id": "chunk-883c371ea1f500a1ba8af8366328e8b0", "order": 1, "source": "MAPBACTEREMIA", "target": "T-CELLS FUNCTIONALITY"}, {"weight": 4.0, "description": "Treatment with PHA shows a moderate increase in T-cell proliferation in healthy controls compared to the response seen in CD subjects.", "source_id": "chunk-883c371ea1f500a1ba8af8366328e8b0", "order": 1, "source": "PHA TREATMENT", "target": "HEALTHY CONTROL SUBJECTS"}, {"weight": 4.0, "description": "Treatment simulating MAP bacteria exposure affects the functionality of T-cells differently between CD subjects with or without MAPbacteremia.", "source_id": "chunk-883c371ea1f500a1ba8af8366328e8b0", "order": 1, "source": "MAP PPD-LIKE TREATMENT", "target": "T-CELLS FUNCTIONALITY"}, {"weight": 6.0, "description": "The effect of MAP PPD-like treatment on T-cell proliferation is less pronounced in CD subjects who lack evidence of MAPbacteremia, suggesting a role for this environmental factor.", "source_id": "chunk-883c371ea1f500a1ba8af8366328e8b0", "order": 1, "source": "MAP PPD-LIKE TREATMENT", "target": "CD SUBJECTS WITHOUT MAPBACTEREMIA"}, {"weight": 1.0, "description": "The expression levels of PTPN22 differ among various lymphocyte subsets at both rest and in response to activation.", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "order": 1, "source": "PTPN22", "target": "LYMPHOCYTE SUBSET"}, {"weight": 3.0, "description": "The presence of the non-risk allele LYP-620R in lymphocytes influences their functional characteristics and response to activation.", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "order": 1, "source": "LYMPHOCYTE SUBSET", "target": "T1D NON-RISK ALLELE (LYP-620R)"}, {"weight": 2.0, "description": "Different activation states of T cells lead to varying degrees of TCR signaling activity due to differential expression of proteins like PTPN22.", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "order": 1, "source": "ACTIVATION STATE", "target": "TCR SIGNALING"}, {"weight": 2.0, "description": "Naive CD4+ T cells show changes in PTPN22 expression levels when transitioning from resting to activated states.", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "order": 1, "source": "ACTIVATION STATE", "target": "TCONV (NA\u00cfVE CD4+ T CELLS)"}, {"weight": 5.0, "description": "The MAPK/ERK pathway is a downstream signaling pathway initiated by TCR ligation and modulated differently depending on the variant (risk or non-risk) of PTPN22.", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "order": 1, "source": "TCR SIGNALING", "target": "MAPK/ERK PATHWAY"}, {"weight": 4.0, "description": "The risk variant LYP-620W is less effective in regulating downstream signaling pathways initiated by TCR ligation compared to the non-risk variant.", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "order": 1, "source": "TCR SIGNALING", "target": "RISK VARIANT LYP-620W"}, {"weight": 8.0, "description": "Overexpression of LYP-620W variant affects TCR signaling differently than the 620R variant, influencing downstream processes like cell proliferation and cytokine production.)", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "order": 1, "source": "TCR SIGNALING", "target": "LYP-620W"}, {"weight": 4.0, "description": "Following calcium flux, T cells exhibit surface expression dynamics of various activation markers indicating changes in cellular activation state.", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "order": 1, "source": "CALCIUM FLUX", "target": "ACTIVATION MARKERS"}, {"weight": 5.0, "description": "Following activation of the LAT signalosome, calcium flux increases significantly which can be modulated by PTPN22 variants.", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "order": 1, "source": "CALCIUM FLUX", "target": "LAT SIGNALOSOME"}, {"weight": 2.0, "description": "ICOS expression is observed on regulatory T cells, indicating their activation state.)", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "order": 1, "source": "ICOS", "target": "TREGS"}, {"weight": 3.0, "description": "Overexpression of LYP-620R alters the expression kinetics of T cell activation markers, blunting their dynamic changes.)", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "order": 1, "source": "LYP-620R", "target": "T CELL ACTIVATION MARKERS"}, {"weight": 1.0, "description": "The overexpression of LYP-620R significantly represses the proliferation of effector T cells (Tresp).", "source_id": "chunk-dee0a8a550579bff19f48d41446e842d", "order": 1, "source": "LYP-620R", "target": "TRESP PROLIFERATION"}, {"weight": 1.0, "description": "Overexpression of LYP-620R in regulatory T cells does not significantly change their suppressive capacity compared to controls.", "source_id": "chunk-dee0a8a550579bff19f48d41446e842d", "order": 1, "source": "LYP-620R", "target": "TREG SUPPRESSIVE CAPACITY"}, {"weight": 4.0, "description": "The PTPN22 risk variant permits proliferation in conventional T cells but not regulatory T cells when activated by APCs.)", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "order": 1, "source": "PTPN22 RISK VARIANT", "target": "APC-MEDIATED PROLIFERATION"}, {"weight": 9.0, "description": "The rs2476601 risk variant is synonymous with the PTPN22 risk variant, both associated with autoimmune disorders.)", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "order": 1, "source": "PTPN22 RISK VARIANT", "target": "RS2476601 RISK VARIANT"}, {"weight": 10.0, "description": "Used to measure T cell proliferation in response to APC stimulation by assessing dye dilution over time.)", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "order": 1, "source": "APC-MEDIATED PROLIFERATION", "target": "CELL TRACKING DYE DILUTION"}, {"weight": 5.0, "description": "Both microbead and PMA/ionomycin-induced activations do not alter the proliferation of transduced cells, suggesting differences in activation mechanisms.)", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "order": 1, "source": "PMA/IONOMYCIN-INDUCED PROLIFERATION", "target": "MICROBEAD ACTIVATION"}, {"weight": 6.0, "description": "Net accumulation of IL-2 is influenced by LYP variant expression, affecting T cell cytokine production dynamics.)", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "order": 1, "source": "IL-2 ACCUMULATION", "target": "T CELL CYTOKINE PRODUCTION"}, {"weight": 4.0, "description": "Neither LYP-620R nor LYP-620W variants significantly altered the secretion of IFN\u03b3 according to experimental data.", "source_id": "chunk-dee0a8a550579bff19f48d41446e842d", "order": 1, "source": "IFN\u0393 SECRETION", "target": "LYP VARIANTS"}, {"weight": 4.0, "description": "Studies on Ptpn22 knockout mice indicate that overexpression of LYP variants does not affect IFN\u03b3 secretion.", "source_id": "chunk-dee0a8a550579bff19f48d41446e842d", "order": 1, "source": "IFN\u0393 SECRETION", "target": "PTPN22 KNOCKOUT MICE"}, {"weight": 2.0, "description": "Overexpressing LYP-620W in regulatory T cells slightly enhances their suppressive capacity over basal levels.", "source_id": "chunk-dee0a8a550579bff19f48d41446e842d", "order": 1, "source": "LYP-620W", "target": "TREG SUPPRESSIVE CAPACITY"}, {"weight": 2.0, "description": "Overexpressing LYP-620W leads to reduced control over activation, proliferation, and effector mechanisms in conventional T cells (Tconv).", "source_id": "chunk-dee0a8a550579bff19f48d41446e842d", "order": 1, "source": "LYP-620W", "target": "TRESP ACTIVATION"}, {"weight": 5.0, "description": "The expression level of PTPN22 in regulatory T cells (Treg) is higher than that in conventional T cells (Tconv), influencing the suppressive capacity of Tregs.", "source_id": "chunk-dee0a8a550579bff19f48d41446e842d", "order": 1, "source": "TREG-MEDIATED SUPPRESSION", "target": "PTPN22 GENE EXPRESSION LEVELS"}, {"weight": 3.0, "description": "The risk variant of PTPN22 is associated with an increased risk for autoimmune disorders due to its influence on Treg-mediated suppression.", "source_id": "chunk-dee0a8a550579bff19f48d41446e842d", "order": 1, "source": "AUTOIMMUNE DISORDERS", "target": "PTPN22 RISK VARIANT (RS2476601)"}, {"weight": 3.0, "description": "The rs2476601 variant is associated with a Th1 signature, indicating its role in autoimmune disorders.", "source_id": "chunk-dee0a8a550579bff19f48d41446e842d", "order": 1, "source": "TH1 SIGNATURE", "target": "PTPN22 RISK VARIANT (RS2476601)"}, {"weight": 5.0, "description": "APCs are used in the Treg suppression assay to assess the suppressive capacity of regulatory T cells when co-cultured with effector T cells.", "source_id": "chunk-dee0a8a550579bff19f48d41446e842d", "order": 1, "source": "AUTOLOGOUS APCS", "target": "TREG SUPPRESSION ASSAY"}, {"weight": 8.0, "description": "The CC49 scFv specifically targets the TAG72 antigen expressed on cancer cells, facilitating recognition by CAR T cells.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "order": 1, "source": "TAG72", "target": "CC49 SCFV"}, {"weight": 9.0, "description": "The 4-1BB domain is included in the CAR design to enhance activation and persistence of TAG72-BB\u03b6 CAR T cells.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "order": 1, "source": "4-1BB INTRACELLULAR CO-STIMULATORY DOMAIN", "target": "TAG72-BB\u0396 CAR T CELLS"}, {"weight": 7.0, "description": "The CD3\u03b6 domain contributes to the cytotoxic function of TAG72-BB\u03b6 CAR T cells against tumor targets expressing TAG72 antigen.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "order": 1, "source": "CD3\u0396 CYTOLYTIC DOMAIN", "target": "TAG72-BB\u0396 CAR T CELLS"}, {"weight": 5.0, "description": "These cancer cell lines express TAG72 and are used to evaluate the efficacy of TAG72-BB\u03b6 CAR T cells against tumors.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "order": 1, "source": "TAG72-BB\u0396 CAR T CELLS", "target": "SKOV3, OVCAR8, COV362.4, OVCAR3, OV90, LS174T"}, {"weight": 3.0, "description": "The truncated CD19 protein serves as a marker for tracking and identifying TAG72-specific CAR T cells during their development.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "order": 1, "source": "TAG72-BB\u0396 CAR T CELLS", "target": "TRUNCATED CD19 (CD19T)"}, {"weight": 5.0, "description": "Co-culture assays evaluate the ability of TAG72-specific CAR T cells to recognize and kill tumor targets expressing TAG72 antigen.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "order": 1, "source": "TAG72-BB\u0396 CAR T CELLS", "target": "CO-CULTURE ASSAYS"}, {"weight": 6.0, "description": "Regional intraperitoneal delivery of TAG72-BB\u03b6 CAR T cells exhibits potent anti-tumor activity, extending survival in ovarian ascites-bearing mice compared to systemic i.v. delivery.", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "order": 1, "source": "TAG72-BB\u0396 CAR T CELLS", "target": "I.P. DELIVERY"}, {"weight": 5.0, "description": "Upon interaction with TAG72-positive tumor cells, TAG72-BB\u03b6 CAR T cells produce cytokines like IFN\u03b3 and IL-2 as part of their anti-tumor activity.", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "order": 1, "source": "TAG72-BB\u0396 CAR T CELLS", "target": "IFN\u0393, IL-2"}, {"weight": 8.0, "description": "The therapy results in a decrease of TAG72 antigen on tumor cells over time, indicating a mechanism for tumor escape from targeted treatment.", "source_id": "chunk-7fe5e7a40fe11afeb152e614de7ef1cf", "order": 1, "source": "TAG72-BB\u0396 CAR T CELLS", "target": "TAG72 EXPRESSION REDUCTION"}, {"weight": 6.0, "description": "Ovarian cancer cells express varying levels of TAG72, making them suitable targets for the TAG72-specific CAR T cell therapy.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "order": 1, "source": "TAG72 EXPRESSION", "target": "OVARIAN CANCER CELLS"}, {"weight": 4.0, "description": "Cells isolated from ascites fluid represent a subset of ovarian cancer cells, often with elevated TAG72 expression, targeted by CAR T cell therapy.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "order": 1, "source": "OVARIAN CANCER CELLS", "target": "ASCITES CELLS"}, {"weight": 2.0, "description": "Depletion of specific cell populations from dPBMCs is performed to enrich for the desired T cell population used in CAR generation.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "order": 1, "source": "HEALTHY DONOR-DERIVED PERIPHERAL BLOOD MONONUCLEAR CELLS (DPBMC)", "target": "CD14+ AND CD25+"}, {"weight": 4.0, "description": "Peripheral blood mononuclear cells are transduced with the TAG72-BB\u03b6 CAR construct to generate functional CAR T cells.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "order": 1, "source": "HEALTHY DONOR-DERIVED PERIPHERAL BLOOD MONONUCLEAR CELLS (DPBMC)", "target": "CAR TRANSDUCTION"}, {"weight": 4.0, "description": "The E:T ratio is a key parameter in co-culture assays, determining the proportion of effector CAR T cells to target tumor cells for assessing cytotoxic activity.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "order": 1, "source": "CO-CULTURE ASSAYS", "target": "E:T RATIO"}, {"weight": 5.0, "description": "Ascites samples from patients (OAS3, OAS4, OAS7) contain human ovarian cancer cells and are used in vitro to assess the efficacy of CAR T cell therapy.", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "order": 1, "source": "OAS3, OAS4, OAS7", "target": "HUMAN OVARIAN CANCER ASCITES"}, {"weight": 5.0, "description": "Transduction of OVCAR3 cells with eGFP and ffluc allows non-invasive tracking of tumor growth in mice.", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "order": 1, "source": "OVCAR3 CELLS", "target": "EGFP/FFLUC"}, {"weight": 4.0, "description": "Intraperitoneal injection of tumor cells into NSG mice is used to establish models for evaluating the therapeutic potential of TAG72-BB\u03b6 CAR T cells.", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "order": 1, "source": "NSG MICE", "target": "I.P. INJECTION"}, {"weight": 6.0, "description": "The method of delivering CAR T cells directly into the peritoneal cavity enhances their anti-tumor effects compared with systemic administration.", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "order": 1, "source": "REGIONAL I.P. DELIVERY", "target": "CAR T CELL THERAPY"}, {"weight": 5.0, "description": "Multiple doses of CAR T cells over a month demonstrated more durable anti-tumor responses compared with a single dose in aggressive OV90 ovarian cancer models.", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "order": 1, "source": "REPEAT DOSING OF TAG72-BB\u0396 CAR T CELLS", "target": "OV90 MODEL"}, {"weight": 4.0, "description": "In the OV90 model, CAR T cells demonstrate reduced efficacy over time due to suppressive mechanisms within the tumor microenvironment.", "source_id": "chunk-7fe5e7a40fe11afeb152e614de7ef1cf", "order": 1, "source": "OV90 MODEL", "target": "CAR T CELLS EFFICACY"}, {"weight": 6.0, "description": "The reduction in TAG72 expression observed post CAR T cell therapy correlates with the intrinsic tumor antigen heterogeneity characteristic of solid tumors.", "source_id": "chunk-7fe5e7a40fe11afeb152e614de7ef1cf", "order": 1, "source": "TUMOR ANTIGEN HETEROGENEITY", "target": "TAG72 EXPRESSION REDUCTION"}, {"weight": 6.0, "description": "Residual or recurrent cancer can persist and express varying antigen levels due to tumor heterogeneity in solid tumors and ascites sites.", "source_id": "chunk-7fe5e7a40fe11afeb152e614de7ef1cf", "order": 1, "source": "TUMOR ANTIGEN HETEROGENEITY", "target": "SOLID TUMORS AND ASCITES"}, {"weight": 9.0, "description": "The most significant SNP at this locus is rs12441227, explaining a portion of the residual variance in FEV1/FVC.", "source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "order": 1, "source": "THSD4-UACA-TLE3 LOCUS ON CHROMOSOME 15Q23", "target": "RS12441227"}, {"weight": 8.0, "description": "Downstream SNPs of C10orf11 are associated with FEV1, indicating a functional connection.", "source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "order": 1, "source": "C10ORF11 GENE ON CHROMOSOME 10Q22.3", "target": "FEV1"}, {"weight": 7.0, "description": "This genomic variant is associated with both FVC and FEV1/FVC, indicating a role in lung function genetics.", "source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "order": 1, "source": "CCL23-CCL18 ON CHROMOSOME 17Q12", "target": "FVC AND FEV1/FVC"}, {"weight": 7.0, "description": "The PITPNC1 locus shows evidence of association with FEV1/FVC in Hutterites, indicating genetic influence.", "source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "order": 1, "source": "PITPNC1 LOCUS ON CHROMOSOME 17Q24.2", "target": "FEV1/FVC"}, {"weight": 6.0, "description": "Genomic variants near CHAF1B are associated with reduced FEV1/FVC, suggesting a role in lung function genetics.", "source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "order": 1, "source": "CHAF1B ON CHROMOSOME 21Q22.13", "target": "FEV1/FVC"}, {"weight": 5.0, "description": "A SNP downstream of the IL37 gene is significantly associated with reduced FEV1 in Hutterites.", "source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "order": 1, "source": "IL37 GENE ON CHROMOSOME 2Q13", "target": "FEV1"}, {"weight": 4.0, "description": "The ASXL3 locus shows evidence for association with FVC, indicating genetic influence on lung function.", "source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "order": 1, "source": "ASXL3 ON CHROMOSOME 18Q12.1", "target": "FVC"}, {"weight": 8.0, "description": "Both FEV1 and FVC are measures of lung function, with the FEV1/FVC ratio indicating respiratory health.", "source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "order": 1, "source": "FEV1", "target": "FVC"}, {"weight": 7.0, "description": "Genetic variation explains a significant portion of the variance in these physiological measures.", "source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "order": 1, "source": "GENETIC VARIATION", "target": "FEV1, FVC, FEV1/FVC RATIO"}, {"weight": 3.0, "description": "The THSD4-UACA-TLE3 locus is associated with low FEV1/FVC alleles, suggesting a genetic predisposition towards reduced lung function.", "source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "order": 1, "source": "LOW FEV1/FVC ALLELES", "target": "THSD4-UACA-TLE3 LOCUS"}, {"weight": 5.0, "description": "\u03b2-defensins genes were found to be significantly connected with chemokine genes CCL18 and CXCL12 through the GRAIL analysis, suggesting a functional connection in lung immune responses.", "source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "order": 1, "source": "\u0392-DEFENSIN GENES", "target": "CHEMOKINE GENES (CCL18 AND CXCL12)"}, {"weight": 6.0, "description": "SNPs at the CCL23-CCL18 locus are significantly connected to \u03b2-defensin genes, indicating their involvement in lung immune responses and potentially influencing FEV1/FVC.", "source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "order": 1, "source": "\u0392-DEFENSIN GENES", "target": "CCL23-CCL18 LOCUS"}, {"weight": 5.0, "description": "The TNFRSF13B gene was also found to be significantly connected with chemokine genes CCL18 and CXCL12, indicating its role in immune regulation related to lung function.", "source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "order": 1, "source": "CHEMOKINE GENES (CCL18 AND CXCL12)", "target": "TNFRSF13B GENE"}, {"weight": 6.0, "description": "The CCL23-CCL18 locus is also significantly connected to the TNFRSF13B gene, suggesting its role in immune regulation affecting lung function.", "source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "order": 1, "source": "TNFRSF13B GENE", "target": "CCL23-CCL18 LOCUS"}, {"weight": 5.0, "description": "The residual variance in FEV1/FVC for Hutterites was studied and analyzed in the context of genetic factors.", "source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "order": 1, "source": "HUTTERITES", "target": "RESIDUAL FEV1/FVC VARIANCE"}, {"weight": 7.0, "description": "The GRAIL algorithm was used to analyze the Gene Ontology database for functional connections between genes near predictive SNPs identified through GWAS.", "source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "order": 1, "source": "GRAIL ALGORITHM", "target": "GENE ONTOLOGY DATABASE"}, {"weight": 16.0, "description": "Another significant polymorphism (rs231725) in the CTLA4 gene is associated with increased risk for primary biliary cholangitis.", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "order": 1, "source": "CTLA4 GENE", "target": "RS231725"}, {"weight": 18.0, "description": "The CTLA4 gene, and its various SNPs, influence an individual\'s susceptibility to primary biliary cholangitis.", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "order": 1, "source": "CTLA4 GENE", "target": "PBC SUSCEPTIBILITY"}, {"weight": 12.0, "description": "There is no significant linkage disequilibrium observed between these four SNPs in the CTLA4 gene.", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "order": 1, "source": "LINKAGE DISEQUILIBRIUM", "target": "RS231775, RS231725, RS3087243, AND RS5742909"}, {"weight": 8.0, "description": "Results from sensitivity analyses suggest that associations of rs231775 and rs231725 with PBC susceptibility are robust to the exclusion of individual studies.", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "order": 1, "source": "SENSITIVITY ANALYSIS", "target": "RS231775, RS231725"}, {"weight": 6.0, "description": "No significant evidence of publication bias was found for these SNPs in the CTLA4 gene.", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "order": 1, "source": "PUBLICATION BIAS ", "target": "RS231775, RS231725, RS3087243, AND RS5742909"}, {"weight": 8.0, "description": "The findings from sensitivity analysis indicate that results are stable and reliable for these two SNPs when excluding individual studies.", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "order": 1, "source": "SENSITIVITY ANALYSIS RESULTS", "target": "STABILITY OF FINDINGS FOR RS231775 AND RS231725"}, {"weight": 7.0, "description": "A statistical test used to detect publication bias in meta-analysis, showing no significant evidence of bias for most SNP analyses.", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "order": 1, "source": "EGGER\'S TEST", "target": "PUBLICATION BIAS ASSESSMENT"}, {"weight": 7.0, "description": "A visual representation used to assess publication bias in meta-analysis, indicating the lack of significant bias for the majority of SNPs.", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "order": 1, "source": "BEGG\'S FUNNEL PLOT", "target": "VISUAL REPRESENTATION OF PUBLICATION BIAS"}, {"weight": 5.0, "description": "These two SNPs are in strong linkage disequilibrium, both influencing CTLA4 expression levels.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "order": 1, "source": "RS3087243 (CT60A/G)", "target": "RS231806 (MH30C/G)"}, {"weight": 5.0, "description": "The protein product of the CTLA4 gene plays a crucial role in immune regulation and is influenced by the physiological process of gene expression.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "order": 1, "source": "CTLA4 PROTEIN ", "target": "INHIBITORY IMMUNE CHECKPOINT GENE EXPRESSION LEVELS "}, {"weight": 5.0, "description": "Variations within the 3\' UTR of CTLA4 can influence mRNA stability, leading to differential protein levels.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "order": 1, "source": "CTLA4 PROTEIN ", "target": "3\u2019UTR OF CTLA4 "}, {"weight": 5.0, "description": "Variations in the 3\' UTR region affect mRNA expression levels, which are linked to disease susceptibility in autoimmune conditions like T1D.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "order": 1, "source": "T1D ", "target": "3\u2019UTR OF CTLA4 "}, {"weight": 4.0, "description": "Expression patterns and DNA methylation differences between CD4+ and CD8+ T cells indicate cell type-specific regulation of genes like CTLA4.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "order": 1, "source": "CD4+ T CELLS ", "target": "CD8+ T CELLS "}, {"weight": 5.0, "description": "Methylation at this CpG site inversely correlates with CTLA4 mRNA expression levels in CD4+ and CD8+ T cells, affecting immune function.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "order": 1, "source": "CPG SITE (CG26091609)", "target": "CTLA4 GENE "}, {"weight": 4.0, "description": "RP11\u2212534L20.5 is located downstream of the IKBKE gene and could potentially regulate its expression or function.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "order": 1, "source": "LONG CODING RNA RP11\u2212534L20.5 ", "target": "IKBKE GENE "}, {"weight": 5.0, "description": "STAT6 plays a critical role in T cell differentiation, with genetic variants influencing this process through eQTL effects.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "order": 1, "source": "STAT6 ", "target": "T CELL DIFFERENTIATION "}, {"weight": 2.0, "description": "Transcriptional regulation influenced by distant genetic variants can impact the risk for Type 1 Diabetes (T1D).", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "order": 1, "source": "TRANS-EQTL EFFECTS", "target": "T1D"}, {"weight": 3.0, "description": "The trans-eQTL SNP rs1131017 is associated with broad-range effects on genes including RPS26 in CD4+ and CD8+ T cells, influencing disease susceptibility.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "order": 1, "source": "RS1131017", "target": "RPS26 GENE"}, {"weight": 6.0, "description": "The RPS26 gene is affected by a trans-eQTL SNP (rs1131017), influencing expression patterns that contribute to disease susceptibility including Type 1 Diabetes (T1D).", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "order": 1, "source": "RPS26 GENE", "target": "T1D"}, {"weight": 10.0, "description": "The missense SNP in IL-27 leads to decreased expression levels of IRF1, suggesting it plays a causal role in regulating gene expression.", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "order": 1, "source": "IRF1", "target": "SNP RS181206[G]"}, {"weight": 6.0, "description": "IRF1 itself is an interferon-stimulated gene whose expression can be induced by signaling through the STAT1/STAT3 pathway.", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "order": 1, "source": "IRF1", "target": "INTERFERON-INDUCED GENES"}, {"weight": 4.0, "description": "The IL-27 gene region harbors genetic variants that influence the expression of IRF1 and STAT1, contributing to reduced risk for Type 1 Diabetes (T1D).", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "order": 1, "source": "T1D", "target": "IL-27 GENE"}, {"weight": 5.0, "description": "This genetic variant influences the expression of IRF1 and STAT1, contributing to reduced risk for Type 1 Diabetes (T1D) in CD4+ T cells.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "order": 1, "source": "T1D", "target": "IL27 MISSENSE VARIANT RS181206[G]"}, {"weight": 7.0, "description": "The CDK2 gene within the regulatory locus at chr12q13.2 influences transcriptional regulation, affecting multiple genes\' expression levels in T cells.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "order": 1, "source": "CDK2 GENE", "target": "TRANSCRIPTIONAL REGULATION IN T CELLS"}, {"weight": 4.0, "description": "The activation of this pathway leads to the expression and regulation of interferon-stimulated genes, such as IRF1.", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "order": 1, "source": "INTERFERON-INDUCED GENES", "target": "STAT1/STAT3 PATHWAY"}, {"weight": 10.0, "description": "The IL-27 missense SNP influences the activation of STAT1 and STAT3 pathways, affecting downstream gene expression.", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "order": 1, "source": "STAT1/STAT3 PATHWAY", "target": "IL-27 SNP RS181206[G]"}, {"weight": 5.0, "description": "The missense variant of IL-27 induces lower levels of STAT1 and IRF1 transcripts in PBMCs from healthy individuals compared to the wild-type variant.", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "order": 1, "source": "IL-27 (PRO119)", "target": "PBMCS"}, {"weight": 5.0, "description": "The gene STX2 encodes syntaxin 2, which is essential for the proper functioning of vesicle transport within cells, impacting various cellular processes including immune responses.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "order": 1, "source": "INTRACELLULAR VESICLE TRANSPORT ", "target": "STX2 (SYNTAXIN 7)"}, {"weight": 5.0, "description": "The rs4073 polymorphism within the IL-8 gene influences asthma risk by altering genotype frequencies and associated allele effects.", "source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68", "order": 1, "source": "IL-8 GENE", "target": "RS4073 GENOMIC VARIANT"}, {"weight": 6.0, "description": "The rs4073 polymorphism influences IL-8 mRNA expression levels, although no significant differences were observed between different genotypes within asthmatic individuals.", "source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68", "order": 1, "source": "RS4073 GENOMIC VARIANT", "target": "IL-8 MRNA EXPRESSION"}, {"weight": 5.0, "description": "Certain genotypes of the rs2227306 polymorphism are associated with a higher risk for developing asthma, indicating genetic susceptibility to the disease.", "source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68", "order": 1, "source": "RS2227306 GENOMIC VARIANT", "target": "ASTHMA DISEASE"}, {"weight": 7.0, "description": "Increased levels of IL-8 protein in serum are significantly higher among patients with asthma compared to controls, indicating a role for the protein in disease pathogenesis.", "source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68", "order": 1, "source": "IL-8 PROTEIN", "target": "ASTHMA DISEASE"}, {"weight": 5.0, "description": "Specific genotypes of rs4073 and rs2227306 polymorphisms in the IL-8 gene are associated with increased risk for asthma development, particularly atopic asthma.", "source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68", "order": 1, "source": "ASTHMA DISEASE", "target": "IL-8 GENOTYPE DISTRIBUTION"}, {"weight": 4.0, "description": "Rare haplotypes of IL-8 gene polymorphisms were found to be significantly associated with reduced risk of childhood asthma in the population studied.", "source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68", "order": 1, "source": "ASTHMA DISEASE", "target": "HAPLOTYPE FREQUENCIES"}, {"weight": 2.0, "description": "No significant difference was observed between PBMC composition and IL-8 mRNA levels among cases and controls, suggesting that PBMC composition does not significantly affect IL-8 expression.", "source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68", "order": 1, "source": "IL-8 MRNA LEVELS", "target": "PBMC COMPOSITION"}, {"weight": 4.0, "description": "The ASAH1 gene is used in simulations to evaluate the power of kernel machine SNP-set tests against single SNP-based min tests.", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "order": 1, "source": "ASAH1 GENE", "target": "SNP-SET TEST (KERNEL MACHINE)"}, {"weight": 5.0, "description": "The ASAH1 gene region is composed of 86 HapMap SNPs, which are used in SNP-set tests.", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "order": 1, "source": "ASAH1 GENE", "target": "HAPMAP SNPS"}, {"weight": 4.0, "description": "The FGFR2 gene is used in simulations to show that in regions of high linkage disequilibrium, the kernel machine method outperforms min tests.", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "order": 1, "source": "SNP-SET TEST (KERNEL MACHINE)", "target": "FGFR2 GENE"}, {"weight": 4.0, "description": "The performance of SNP-set tests can be influenced by linkage disequilibrium among SNPs within a gene region.", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "order": 1, "source": "SNP-SET TEST (KERNEL MACHINE)", "target": "LD (LINKAGE DISEQUILIBRIUM)"}, {"weight": 3.0, "description": "The type 1 error rate of kernel machine SNP-set tests was evaluated to ensure proper statistical significance.", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "order": 1, "source": "SNP-SET TEST (KERNEL MACHINE)", "target": "TYPE 1 ERROR RATE (\u0391 = 0.05)"}, {"weight": 3.0, "description": "For NAT2, certain SNPs show higher power with the min test compared to the kernel machine method when in high LD with typed SNPs and weak LD with others.", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "order": 1, "source": "MIN TEST (SINGLE SNP-BASED)", "target": "NAT2 GENE"}, {"weight": 4.0, "description": "Both kernel machine and min test methods were assessed using empirical power simulations.", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "order": 1, "source": "MIN TEST (SINGLE SNP-BASED)", "target": "EMPIRICAL POWER"}, {"weight": 5.0, "description": "The HLA-B gene demonstrates how MAF affects SNP test power, with rarer alleles gaining more weight in the weighted IBS kernel.", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "order": 1, "source": "HLA-B GENE (HUMAN LEUKOCYTE ANTIGEN B)", "target": "MAF (MINOR ALLELE FREQUENCY)"}, {"weight": 4.0, "description": "This array includes typed SNPs from the ASAH1 and NAT2 genes used in SNP-set tests.", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "order": 1, "source": "ILLUMINA HUMANHAP550 ARRAY", "target": "TYPED SNPS"}, {"weight": 5.0, "description": "The linear kernel is compared with the IBS and weighted IBS kernels in terms of their effectiveness in SNP-set tests.", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "order": 1, "source": "LINEAR KERNEL", "target": "IBS KERNEL AND WEIGHTED IBS KERNEL"}, {"weight": 16.0, "description": "Testing for the effect of the ASAH1 gene using IBS kernel has higher power compared to other kernels.", "source_id": "chunk-076f6aeeb369546413bc63c9f305553a", "order": 1, "source": "ASAH1 GENE EFFECT", "target": "IBS KERNEL POWER"}, {"weight": 14.0, "description": "Incorporating rare variants importance into the weighted IBS kernel increases its effectiveness.", "source_id": "chunk-076f6aeeb369546413bc63c9f305553a", "order": 1, "source": "RARE VARIANTS IMPORTANCE", "target": "WEIGHTED IBS KERNEL"}, {"weight": 6.0, "description": "The presence of the rs1893217 SNP significantly associates non-responsiveness to anti-CTLA-4 therapy in metastatic melanoma patients.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "order": 1, "source": "RS1893217", "target": "ANTI-CTLA-4 TREATMENT"}, {"weight": 3.0, "description": "Combination therapy involves anti-PD-1 treatment alongside or after anti-CTLA-4 treatment for metastatic melanoma patients, showing a higher response rate compared to single-agent therapies.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "order": 1, "source": "ANTI-CTLA-4 TREATMENT", "target": "COMBINATION THERAPY"}, {"weight": 7.0, "description": "The presence of the rs17388568 SNP is associated with an increased response to anti-PD-1 therapy in metastatic melanoma patients.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "order": 1, "source": "RS17388568", "target": "ANTI-PD-1 TREATMENT"}, {"weight": 4.0, "description": "The rs17388568 SNP is located within the IL2, ADAD1 and IL21 genomic region that has been associated with several autoimmune conditions.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "order": 1, "source": "RS17388568", "target": "IL2/ADAD1/IL21 LOCUS"}, {"weight": 6.0, "description": "These patients are also treated with anti-PD-1 drugs which block the PD-1 receptor to enhance T cell activity against tumors.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "order": 1, "source": "METASTATIC MELANOMA PATIENTS", "target": "ANTI-PD-1 TREATMENTS (NIVOLUMAB, PEMBROLIZUMAB)"}, {"weight": 7.0, "description": "Patients receive treatments at these institutions, indicating a geographic distribution of treatment sites for metastatic melanoma patients.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "order": 1, "source": "METASTATIC MELANOMA PATIENTS", "target": "NYULH, UCLA, MGH"}, {"weight": 4.0, "description": "The efficacy testing of ICI treatments in metastatic melanoma patients considers the impact of different ages, including a median patient age of 62.85 years.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "order": 1, "source": "AGE DISTRIBUTION (62.85 YEARS MEDIAN AGE)", "target": "ICI EFFICACY TESTING"}, {"weight": 3.0, "description": "Evaluations for treatment efficacy consider sex distribution in the study population with males accounting for 67 percent of patients.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "order": 1, "source": "SEX DISTRIBUTION (67% MALE)", "target": "ICI EFFICACY TESTING"}, {"weight": 4.0, "description": "This grouping of patients was created to analyze the association between different treatments and patient responses across multiple therapies.", "source_id": "chunk-0d49552280a277a8a26456d06f8f26a8", "order": 1, "source": "ANTI-CTLA-4, ANTI-PD-1 AND COMBINATION-THERAPY TREATED PATIENTS GROUPING", "target": "TREATMENT RESPONSE ASSOCIATION ANALYSIS"}, {"weight": 2.0, "description": "Adjustments were made to control environmental factors (age, sex, treatment drugs) in the pooled association analysis for more accurate results.", "source_id": "chunk-0d49552280a277a8a26456d06f8f26a8", "order": 1, "source": "TREATMENT RESPONSE ASSOCIATION ANALYSIS", "target": "AGE, SEX AND TREATMENT DRUGS ADJUSTMENT"}, {"weight": 5.0, "description": "EBNA2 preferentially binds to the risk allele for TRAF3 and decreases its expression relative to B cells, suggesting a role in immune evasion through altered gene regulation.", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "order": 1, "source": "EBNA2", "target": "TRAF3"}, {"weight": 6.0, "description": "EBNA2 alters CD40\'s allelic expression directionally compared to uninfected B cells, indicating a potential mechanism for immune evasion by modulating MS risk genes.", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "order": 1, "source": "EBNA2", "target": "CD40"}, {"weight": 7.0, "description": "EBNA2 increases the expression of TNFAIP8, altering its role in host immune response and possibly contributing to enhanced viral survival strategies.", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "order": 1, "source": "EBNA2", "target": "TNFAIP8"}, {"weight": 8.0, "description": "EBNA2 binds to the protective allele for TNFRSF1A and decreases its expression compared to B cells, suggesting a mechanism through which EBV might evade host immune defenses.", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "order": 1, "source": "EBNA2", "target": "TNFRSF1A"}, {"weight": 4.0, "description": "The TRAF3/RCOR1 risk allele binding preference by EBNA2 influences the response to EBNA2-TAT treatment, altering MS-associated gene expression.)", "source_id": "chunk-bb351b97d99fce93d17df522db92dda7", "order": 1, "source": "TRAF3/RCOR1 SNP (RS1258869)", "target": "EBNA2-TAT"}, {"weight": 8.0, "description": "The TNFAIP8 locus genotype influences EBV DNA copy number stability, which is affected upon inhibition of EBNA2 function by EBNA2-TAT treatment.)<SEP>The genotype at TNFAIP8 locus affects EBV DNA copy number stability in untreated LCLs, which is altered upon treatment with EBNA2-TAT.)", "source_id": "chunk-bb351b97d99fce93d17df522db92dda7", "order": 1, "source": "TNFAIP8 LOCUS SNP (RS32658)", "target": "EBV DNA COPY NUMBER STABILITY"}, {"weight": 6.0, "description": "Inhibition of EBNA2 by EBNA2-TAT significantly reduces LMP1 expression, disrupting the EBV latency III growth program.)", "source_id": "chunk-bb351b97d99fce93d17df522db92dda7", "order": 1, "source": "EBNA2-TAT", "target": "LMP1 GENE EXPRESSION REGULATION"}, {"weight": 5.0, "description": "Inhibition of EBNA2 transcriptional function by EBNA2-TAT alters the expression levels of MS risk genes in LCLs.)", "source_id": "chunk-bb351b97d99fce93d17df522db92dda7", "order": 1, "source": "EBNA2-TAT", "target": "TRAF3, CD40, CLECL1, TNFAIP8, AND TNFRSF1A GENE EXPRESSION REGULATION"}, {"weight": 6.0, "description": "Inhibition of the EBNA2 interaction with RBP-J\u03ba is mediated by EBNA2-TAT, leading to altered transcriptional regulation.)", "source_id": "chunk-bb351b97d99fce93d17df522db92dda7", "order": 1, "source": "EBNA2-TAT", "target": "RBP-J\u039a SITE BINDING"}, {"weight": 5.0, "description": "Altered TRAF3 expression due to EBNA2 binding may contribute to immune evasion by affecting signaling pathways involved in host defense.", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "order": 1, "source": "TRAF3", "target": "IMMUNE EVASION"}, {"weight": 7.0, "description": "Increased TNFAIP8 expression due to EBNA2 interaction may serve as a viral survival strategy by altering host inflammatory responses.", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "order": 1, "source": "TNFAIP8", "target": "VIRAL SURVIVAL STRATEGY"}, {"weight": 8.0, "description": "Decreased TNFRSF1A expression from preferential EBNA2 binding may suppress immune defense mechanisms, aiding in the virus\'s evasion of detection.", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "order": 1, "source": "TNFRSF1A", "target": "IMMUNE DEFENSE SUPPRESSION"}, {"weight": 10.0, "description": "EBNA2/risk gene interactions within the EBV latency III program are proposed to increase or decrease gene expression, influencing the virus\'s ability to evade host immunity.", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "order": 1, "source": "EBV LATENCY III PROGRAM", "target": "MS RISK GENES"}, {"weight": 9.0, "description": "The interaction between LMP1 and MS risk genes within the EBV latency III program is crucial for viral survival strategies.", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "order": 1, "source": "EBV LATENCY III PROGRAM", "target": "LMP1"}, {"weight": 9.0, "description": "The effect of EBNA2-TAT treatment on MS risk loci suggests that EBNA2\'s interaction with these genomic variants is crucial for regulating gene expression involved in immune evasion.", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "order": 1, "source": "MS RISK LOCI", "target": "EBNATBXTAT TREATMENT"}, {"weight": 4.0, "description": "Treatment with EBNA2-TAT modulates gene expression in a way that suggests it affects the interaction between EBNA2 and MS risk alleles.", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "order": 1, "source": "EBNA2-TAT TREATMENT", "target": "GENE EXPRESSION"}, {"weight": 10.0, "description": "Proximal interactions of LMP2 with MS risk genes, regulated by EBNA2, suggest roles in immune evasion mechanisms.", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "order": 1, "source": "LMP2", "target": "IMMUNE EVASION MECHANISM"}, {"weight": 5.0, "description": "The COX-1 gene contains the genomic variant rs3842787, which was found to have no significant association with aspirin insensitivity.", "source_id": "chunk-54c4fede216a6c4183b95ee1a2edcb17", "order": 1, "source": "RS3842787", "target": "COX-1 GENE"}, {"weight": 8.0, "description": "The rs20417 genomic variant is significantly associated with increased risk of aspirin insensitivity.", "source_id": "chunk-54c4fede216a6c4183b95ee1a2edcb17", "order": 1, "source": "RS20417", "target": "ASPIRIN INSENSITIVITY"}, {"weight": 6.0, "description": "A polymorphism in the COX-2 gene (rs20417) is associated with increased risk of aspirin insensitivity.", "source_id": "chunk-54c4fede216a6c4183b95ee1a2edcb17", "order": 1, "source": "RS20417", "target": "COX-2 GENE"}, {"weight": 8.0, "description": "The genomic variant rs20417 is significantly related to differences in Coronary Artery Disease between patients and controls.", "source_id": "chunk-734cac289b42d37dad32bd51ea24a1ea", "order": 1, "source": "RS20417", "target": "CAD"}, {"weight": 18.0, "description": "The averaged platelet number contributes significantly to the heterogeneity explained by the genomic variant rs1126643.", "source_id": "chunk-734cac289b42d37dad32bd51ea24a1ea", "order": 1, "source": "RS1126643", "target": "AVERAGED PLATELET NUMBER"}, {"weight": 9.0, "description": "The T allele of the rs1126643 variant is strongly associated with a higher risk of aspirin insensitivity, especially under dominant genetic models.", "source_id": "chunk-54c4fede216a6c4183b95ee1a2edcb17", "order": 1, "source": "ASPIRIN INSENSITIVITY", "target": "RS1126643-T ALLELE"}, {"weight": 7.0, "description": "Differences in frequencies of certain polymorphisms between Caucasian and Chinese populations influence the prediction strength for aspirin insensitivity.", "source_id": "chunk-54c4fede216a6c4183b95ee1a2edcb17", "order": 1, "source": "CAUCASIAN PATIENTS AND CONTROLS", "target": "CHINESE PATIENTS AND CONTROLS"}, {"weight": 7.0, "description": "The ITGA2 gene contains a polymorphism, rs1126643, where the T allele is strongly associated with increased risk of aspirin insensitivity.", "source_id": "chunk-54c4fede216a6c4183b95ee1a2edcb17", "order": 1, "source": "ITGA2 GENE", "target": "RS1126643-T ALLELE"}, {"weight": 7.0, "description": "The meta-regression model incorporates study-level continuous covariates to account for variability and enhance the analysis of genetic variants.", "source_id": "chunk-734cac289b42d37dad32bd51ea24a1ea", "order": 1, "source": "META-REGRESSION MODEL", "target": "STUDY-LEVEL CONTINUOUS COVARIATES"}, {"weight": 8.0, "description": "The risk estimates associated with the T allele of rs1126643 were notably high for aspirin insensitivity, especially under a dominant genetic model.", "source_id": "chunk-54c4fede216a6c4183b95ee1a2edcb17", "order": 1, "source": "RS1126643-T ALLELE", "target": "RISK ESTIMATES"}, {"weight": 5.0, "description": "Deviations from Hardy-Weinberg equilibrium were observed for the genomic variants rs20118426 and rs1126643 in some comparisons.", "source_id": "chunk-54c4fede216a6c4183b95ee1a2edcb17", "order": 1, "source": "HARDY-WEINBERG EQUILIBRIUM DEVIATIONS", "target": "RS20118426 AND RS1126643"}, {"weight": 3.0, "description": "GH signaling involves STAT5B activation, which is impaired in individuals with mutations affecting this gene.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "order": 1, "source": "STAT5B GENE", "target": "GROWTH HORMONE (GH)"}, {"weight": 4.0, "description": "STAT5B is essential for IL-2 signaling, which regulates T cell homeostasis and the induction of FOXP3 expression in regulatory T cells; deficiencies lead to impaired Treg function.)", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "order": 1, "source": "STAT5B GENE", "target": "IL-2 SIGNALING PATHWAY"}, {"weight": 3.0, "description": "rhIGF-1 is used to treat GHI, improving growth and immune function in patients with STAT5B mutations.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "order": 1, "source": "RECOMBINANT HUMAN INSULIN-LIKE GROWTH FACTOR 1 (RHIGF-1)", "target": "GROWTH HORMONE INSENSITIVITY SYNDROME (GHI)"}, {"weight": 2.0, "description": "Despite clinical presentation indicative of GHI, serum GH levels are normal, suggesting a defect downstream from GH signaling.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "order": 1, "source": "GROWTH HORMONE INSENSITIVITY SYNDROME (GHI)", "target": "SERUM GH LEVELS"}, {"weight": 3.0, "description": "Abnormally low IGF-1 levels in patients with STAT5B mutations suggest impaired growth hormone signaling.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "order": 1, "source": "GROWTH HORMONE INSENSITIVITY SYNDROME (GHI)", "target": "IGF-1 LEVELS"}, {"weight": 3.0, "description": "Abnormally low IGFBP3 levels contribute to the diagnosis of GHI, as it affects IGF bioavailability.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "order": 1, "source": "GROWTH HORMONE INSENSITIVITY SYNDROME (GHI)", "target": "IGF BINDING PROTEIN-3 (IGFBP3)"}, {"weight": 3.0, "description": "Low ALS levels are indicative of impaired GH signaling pathways in individuals with GHI.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "order": 1, "source": "GROWTH HORMONE INSENSITIVITY SYNDROME (GHI)", "target": "ACID LABILE SUBUNIT (ALS)"}, {"weight": 2.0, "description": "Both conditions often coexist and are part of a broader immune dysregulation observed in siblings with STAT5B mutations.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "order": 1, "source": "AUTOIMMUNE THYROIDITIS", "target": "REACTIVE AIRWAY DISEASE"}, {"weight": 4.0, "description": "Levothyroxine is prescribed to treat autoimmune thyroiditis by providing the necessary thyroxine hormone.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "order": 1, "source": "AUTOIMMUNE THYROIDITIS", "target": "LEVOTHYROXINE"}, {"weight": 2.0, "description": "The presence of anti-thyroglobulin antibodies is a hallmark of autoimmune thyroiditis, which can develop in individuals with STAT5B deficiency.)", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "order": 1, "source": "AUTOIMMUNE THYROIDITIS", "target": "ANTI-THYROGLOBULIN ANTIBODIES"}, {"weight": 1.0, "description": "Elevated IgE levels, often seen in patients with a LOF STAT5B variant, are associated with chronic eczema and reactive airway disease indicative of an atopic phenotype.)", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "order": 1, "source": "CHRONIC ECZEMA", "target": "ATOPY"}, {"weight": 3.0, "description": "Recurrent infections contribute to growth failure and the overall clinical presentation of GHI in affected individuals.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "order": 1, "source": "SEVERE SHORT STATURE", "target": "INFECTIONS (SKIN, URINARY TRACT, PULMONARY)"}, {"weight": 2.0, "description": "This disease affects physical comfort, impacting quality of life in patients with STAT5B mutations.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "order": 1, "source": "GASTROESOPHAGEAL REFLUX DISEASE", "target": "PHYSICAL COMFORT"}, {"weight": 3.0, "description": "Patients with pneumonia and sepsis may require supplemental oxygen to manage respiratory distress.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "order": 1, "source": "PNEUMONIA WITH SEPSIS", "target": "SUPPLEMENTAL OXYGEN"}, {"weight": 3.0, "description": "Fibroblast cultures from affected individuals confirmed the homozygous mutation in STAT5B through sequencing.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "order": 1, "source": "DERMAL FIBROBLASTS", "target": "MUTATION CONFIRMATION"}, {"weight": 4.0, "description": "The SH2 domain is crucial for STAT5B activation and function; mutations affecting it impair protein activity.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "order": 1, "source": "SRC HOMOLOGY 2 (SH2) DOMAIN", "target": "STAT5B FUNCTIONALITY"}, {"weight": 3.0, "description": "TADs regulate gene expression by binding to DNA and promoting transcription, which is affected in the p.W631* variant.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "order": 1, "source": "TRANSACTIVATION DOMAIN (TAD)", "target": "GENE EXPRESSION REGULATION"}, {"weight": 2.0, "description": "The p.W631* variant of the STAT5B gene is associated with reduced expression and subsequent impairment of T cell levels, leading to T cell lymphopenia in affected individuals.)", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "order": 1, "source": "P.W631* VARIANT STAT5B", "target": "T CELL LYMPHOPENIA"}, {"weight": 3.0, "description": "GH affects the expression and phosphorylation state of p.W631* variant STAT5B, impacting its function in immune cells.)", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "order": 1, "source": "P.W631* VARIANT STAT5B", "target": "GH (GROWTH HORMONE)"}, {"weight": 2.0, "description": "STAT5B deficiency results in a pronounced dysregulation of memory CD8+ T cells, with persistent reductions in na\u00efve and increases in effector memory T cells leading to overall reduced T cell levels.)", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "order": 1, "source": "T CELL LYMPHOPENIA", "target": "MEMORY CD8+ T CELLS DYSREGULATION"}, {"weight": 3.0, "description": "Proportion of CD4+ TEM cells remains within normal ranges despite the genomic variant, indicating no significant impact on this subset.", "source_id": "chunk-4389e37ac64d551cdf89e7f4230a3589", "order": 1, "source": "CD4+ TEM CELLS", "target": "NORMAL RANGE"}, {"weight": 2.0, "description": "Proportion of CD4+ TEM cells does not alter with age, indicating that the STAT5B variant has no significant impact on these T cell subsets.", "source_id": "chunk-4389e37ac64d551cdf89e7f4230a3589", "order": 1, "source": "CD4+ TEM CELLS", "target": "NO ALTERATION"}, {"weight": 4.0, "description": "Increase in CD8+ TEM cell proportions with age is clinically significant and linked to dysregulation due to STAT5B deficiency.", "source_id": "chunk-4389e37ac64d551cdf89e7f4230a3589", "order": 1, "source": "CD8+ TEM CELLS", "target": "DYSREGULATION"}, {"weight": 3.0, "description": "Elevations during infancy normalize around age 4, suggesting a developmental impact of the LOF variant on CD8+ TEMRA cell regulation.", "source_id": "chunk-4389e37ac64d551cdf89e7f4230a3589", "order": 1, "source": "CD8+ TEMRA CELLS", "target": "NORMALIZATION"}, {"weight": 5.0, "description": "The dysregulation observed affects CD8+ memory T cells but does not significantly impact CD4+ memory T cell subsets.", "source_id": "chunk-4389e37ac64d551cdf89e7f4230a3589", "order": 1, "source": "DYSREGULATION OF CD8+ T CELLS", "target": "CD8+ MEMORY T CELLS"}, {"weight": 4.0, "description": "The SNPs are being investigated as potential predictors for the HLA-DRB1*07:01-DQA1*02:01-DQB1*02:02 haplotype carrier status.", "source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "order": 1, "source": "HLA-DRB1*07:01", "target": "RS28383172, RS2395182, RS4713586, RS7775228"}, {"weight": 3.0, "description": "The SNPs exhibit linkage disequilibrium in the studied populations.", "source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "order": 1, "source": "RS28383172, RS2395182, RS4713586, RS7775228", "target": "LINKAGE DISEQUILIBRIUM (LD)"}, {"weight": 4.0, "description": "These genotyping techniques are used to determine the carrier status of this specific HLA haplotype.", "source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "order": 1, "source": "HLA-DRB1*07:01-DQA1*02:01-DQB1*02:02 HAPLOTYPE CARRIER STATUS", "target": "CUSTOM TAQMAN SNP GENOTYPING ASSAY, KASPAR-ON-DEMAND PREVALIDATED ASSAYS"}, {"weight": 5.0, "description": "The genetic variants in these exons are crucial for determining the carrier status of the specific haplotype associated with certain diseases.", "source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "order": 1, "source": "HLA-DRB1*07:01-DQA1*02:01-DQB1*02:02 HAPLOTYPE CARRIER STATUS", "target": "EXON 2 OF HLA-DRB1 GENE, EXONS 2 AND 3 OF HLA-DQB1 GENE"}, {"weight": 5.0, "description": "The presence of these genotypes is associated with a high likelihood of being a carrier for the specific HLA haplotype.", "source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "order": 1, "source": "HLA-DRB1*07:01-DQA1*02:01-DQB1*02:02 HAPLOTYPE CARRIER STATUS", "target": "RS28383172 AG OR GG GENOTYPES"}, {"weight": 5.0, "description": "These specific combinations of genotypes are strongly associated with the HLA haplotype carrier status.", "source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "order": 1, "source": "HLA-DRB1*07:01-DQA1*02:01-DQB1*02:02 HAPLOTYPE CARRIER STATUS", "target": "RS2395182 TT OR TG AND RS4713586 TT AND RS7775228 TC OR CC GENOTYPES"}, {"weight": 5.0, "description": "These genotyping techniques are used to accurately determine the presence of specific SNPs and alleles within the HLA complex.", "source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "order": 1, "source": "CUSTOM TAQMAN SNP GENOTYPING ASSAY, KASPAR-ON-DEMAND PREVALIDATED ASSAYS", "target": "HLA-DQA1*02:01, HLA-DQB1*02:02 ALLELES, RS28383172, RS2395182, RS4713586, RS7775228"}, {"weight": 4.0, "description": "These alleles within the specific exons are being investigated for their role in determining disease susceptibility.", "source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "order": 1, "source": "HLA-DQA1*02:01, HLA-DQB1*02:02 ALLELES", "target": "EXON 2 OF HLA-DRB1 GENE, EXONS 2 AND 3 OF HLA-DQB1 GENE"}, {"weight": 6.0, "description": "The haplotype is a potential marker for screening E. coli ASP hypersensitivity, indicating its genetic contribution to the disease.", "source_id": "chunk-1f50436a36721971a0a256131d7fca62", "order": 1, "source": "HLA-DRB1*07:01-DQA1*02:01-DQB1*02:02 HAPLOTYPE", "target": "E. COLI ASP HYPERSENSITIVITY"}, {"weight": 4.0, "description": "The SNP-genotyped subpopulation was used to evaluate the performance of the HLA haplotype and its surrogate markers.", "source_id": "chunk-1f50436a36721971a0a256131d7fca62", "order": 1, "source": "HLA-DRB1*07:01-DQA1*02:01-DQB1*02:02 HAPLOTYPE", "target": "SNP-GENOTYPED SUBPOPULATION"}, {"weight": 3.0, "description": "Algorithm V was used to identify surrogate markers for the haplotype, showing similar performance metrics but not perfect prediction.", "source_id": "chunk-1f50436a36721971a0a256131d7fca62", "order": 1, "source": "HLA-DRB1*07:01-DQA1*02:01-DQB1*02:02 HAPLOTYPE", "target": "2-SNP TAGGING ALGORITHM V"}, {"weight": 4.0, "description": "The sensitivity and specificity of screening tests were evaluated in a subpopulation genotyped for SNPs related to E. coli ASP hypersensitivity.", "source_id": "chunk-1f50436a36721971a0a256131d7fca62", "order": 1, "source": "E. COLI ASP HYPERSENSITIVITY", "target": "SNP-GENOTYPED SUBPOPULATION"}, {"weight": 3.0, "description": "Algorithm V showed better performance measures compared to Algorithm II, particularly in terms of specificity and positive predictive value.", "source_id": "chunk-1f50436a36721971a0a256131d7fca62", "order": 1, "source": "2-SNP TAGGING ALGORITHM V", "target": "ALGORITHM II"}, {"weight": 4.0, "description": "The values of parameters for Algorithm V were generally higher than those of Algorithm III in various comparisons.", "source_id": "chunk-1f50436a36721971a0a256131d7fca62", "order": 1, "source": "2-SNP TAGGING ALGORITHM V", "target": "ALGORITHM III"}, {"weight": 3.0, "description": "Algorithm V outperformed Algorithm IV across different performance metrics, indicating superior tagging efficiency.", "source_id": "chunk-1f50436a36721971a0a256131d7fca62", "order": 1, "source": "2-SNP TAGGING ALGORITHM V", "target": "ALGORITHM IV"}, {"weight": 5.0, "description": "The G allele of rs28383172 is in perfect concordance with the HLA-DRB1*07:01 allele carrier status.", "source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "order": 1, "source": "RS28383172 AG OR GG GENOTYPES", "target": "HLA-DRB1*07:01 ALLELE CARRIER STATUS"}, {"weight": 3.0, "description": "The prevalence of specific genotypes within the TLR7 gene is associated with different stages of HIV disease progression.)", "source_id": "chunk-05d583f893b703816ad8de9561aa5292", "order": 1, "source": "TLR7 GENE ", "target": "HIV DISEASE STAGE "}, {"weight": 2.0, "description": "The AA genotype of TLR7 rs179008 is distributed similarly among tobacco-consuming and non-consuming HIV-infected individuals.)", "source_id": "chunk-05d583f893b703816ad8de9561aa5292", "order": 1, "source": "TLR7 GENE ", "target": "GENOMIC VARIANT (RS179008 AA)"}, {"weight": 2.0, "description": "The CC genotype of TLR7 rs179008 did not show significant differences in distribution among tobacco-using and non-consuming HIV-infected individuals.)", "source_id": "chunk-05d583f893b703816ad8de9561aa5292", "order": 1, "source": "TLR7 GENE ", "target": "GENOMIC VARIANT (RS179008 CC)"}, {"weight": 2.0, "description": "The CT genotype of TLR7 rs179008 was present with similar frequency in both tobacco-using and non-consumers among HIV-infected individuals.)", "source_id": "chunk-05d583f893b703816ad8de9561aa5292", "order": 1, "source": "TLR7 GENE ", "target": "GENOMIC VARIANT (RS179008 CT)"}, {"weight": 2.0, "description": "The distribution of the AA genotype for TLR7 rs179009 was similar between alcohol-consuming and non-consuming HIV-infected individuals, indicating no significant environmental impact.)", "source_id": "chunk-05d583f893b703816ad8de9561aa5292", "order": 1, "source": "TLR7 GENE ", "target": "GENOMIC VARIANT (RS179009 AA)"}, {"weight": 1.0, "description": "Higher frequency of the AG genotype in tobacco consumers compared to non-users among HIV-infected individuals, although not statistically significant.)", "source_id": "chunk-05d583f893b703816ad8de9561aa5292", "order": 1, "source": "TLR7 GENE ", "target": "GENOMIC VARIANT (RS179009 AG)"}, {"weight": 3.0, "description": "The GG genotype for TLR7 rs179009 showed reduced frequency in advanced stages of HIV disease compared to healthy controls, suggesting potential association with progression.)", "source_id": "chunk-05d583f893b703816ad8de9561aa5292", "order": 1, "source": "HIV DISEASE STAGE ", "target": "GENOMIC VARIANT (RS179009 GG)"}, {"weight": 1.0, "description": "The distribution of TLR7 rs179008 polymorphism did not differ significantly between HIV-infected individuals with and without tobacco or alcohol use.)", "source_id": "chunk-05d583f893b703816ad8de9561aa5292", "order": 1, "source": "ENVIRONMENTAL FACTORS (TOBACCO & ALCOHOL)", "target": "GENOMIC VARIANT (RS179008)"}, {"weight": 1.0, "description": "The distribution of TLR7 rs179009 polymorphism did not differ significantly between HIV-infected individuals with and without tobacco or alcohol use.)", "source_id": "chunk-05d583f893b703816ad8de9561aa5292", "order": 1, "source": "ENVIRONMENTAL FACTORS (TOBACCO & ALCOHOL)", "target": "GENOMIC VARIANT (RS179009)"}, {"weight": 5.0, "description": "Similarly, another genetic variant within the TLR7 gene is rs179009, also investigated concerning HIV disease progression.", "source_id": "chunk-2c91cdebb36ef064eb01a7021a961302", "order": 1, "source": "TLR7", "target": "RS179009"}, {"weight": 2.0, "description": "Tobacco usage may affect the rate and severity of HIV disease progression, acting as a modifiable environmental risk factor.", "source_id": "chunk-2c91cdebb36ef064eb01a7021a961302", "order": 1, "source": "TOBACCO USAGE", "target": "HIV DISEASE PROGRESSION"}, {"weight": 2.0, "description": "Like tobacco, alcohol consumption is considered for its potential impact on accelerating or mitigating HIV disease progression.", "source_id": "chunk-2c91cdebb36ef064eb01a7021a961302", "order": 1, "source": "ALCOHOL USAGE", "target": "HIV DISEASE PROGRESSION"}, {"weight": 6.0, "description": "CD4 counts at the time of initial diagnosis are a key indicator used to predict and monitor HIV disease progression.", "source_id": "chunk-2c91cdebb36ef064eb01a7021a961302", "order": 1, "source": "BASELINE CD4 COUNTS", "target": "HIV DISEASE PROGRESSION"}, {"weight": 5.0, "description": "CD4 counts are a key variable analyzed using multivariate logistic regression in studies of HIV disease progression.", "source_id": "chunk-2c91cdebb36ef064eb01a7021a961302", "order": 1, "source": "BASELINE CD4 COUNTS", "target": "MULTIVARIATE LOGISTIC REGRESSION ANALYSIS"}, {"weight": 3.0, "description": "The table not shown contains results of risk factor assessment concerning factors like TLR7 polymorphisms and CD4 counts.", "source_id": "chunk-2c91cdebb36ef064eb01a7021a961302", "order": 1, "source": "TABLE NOT SHOWN", "target": "RISK FACTOR ASSESSMENT RESULTS FOR HIV DISEASE PROGRESSION"}, {"weight": 2.0, "description": "The distribution of rs179008 polymorphism in healthy controls follows Hardy-Weinberg equilibrium and shows a significant difference compared to HIV-infected individuals.)", "source_id": "chunk-05d583f893b703816ad8de9561aa5292", "order": 1, "source": "GENOMIC VARIANT (RS179008)", "target": "HEALTHY CONTROL "}, {"weight": 2.0, "description": "The distribution of rs179009 polymorphism in healthy controls follows Hardy-Weinberg equilibrium and shows a significant difference compared to HIV-infected individuals.)", "source_id": "chunk-05d583f893b703816ad8de9561aa5292", "order": 1, "source": "HEALTHY CONTROL ", "target": "GENOMIC VARIANT (RS179009)"}, {"weight": 2.0, "description": "Polymorphisms within the TLR7 gene were examined but not found to be significant independent risk factors for HIV disease progression.", "source_id": "chunk-2c91cdebb36ef064eb01a7021a961302", "order": 1, "source": "RISK FACTOR FOR HIV DISEASE PROGRESSION", "target": "TLR7 POLYMORPHISMS (RS179008, RS179009)"}, {"weight": 5.0, "description": "The ProTECT software is used to predict and validate neoepitopes arising from the ALK R1275Q mutation.", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "order": 1, "source": "ALK R1275Q", "target": "PROTECT SOFTWARE"}, {"weight": 9.0, "description": "The MAQDIYRASY neoepitope is derived from the ALK R1275Q mutation and may be a target for immune responses.", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "order": 1, "source": "ALK R1275Q", "target": "MAQDIYRASY (NEOEPITOPE)"}, {"weight": 3.0, "description": "Activating mutations like NRAS Q61K are also observed in neuroblastoma, suggesting roles in tumorigenesis.", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "order": 1, "source": "NRAS Q61K", "target": "NBL (NEUROBLASTOMA)"}, {"weight": 8.0, "description": "The ILDTAGKEEY neoepitope arises from the NRAS Q61K mutation and binds HLA-A*01:01.", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "order": 1, "source": "NRAS Q61K", "target": "ILDTAGKEEY (NEOEPITOPE)"}, {"weight": 2.0, "description": "The ZNF717 Q716 mutation is observed in neuroblastoma samples, indicating its potential role in tumorigenesis.", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "order": 1, "source": "NBL (NEUROBLASTOMA)", "target": "ZNF717 Q716 MUTATION"}, {"weight": 6.0, "description": "The AQDIYRASYY neoepitope binds strongly to HLA-B*15:01, indicating potential immunological relevance.", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "order": 1, "source": "HLA-B*15:01", "target": "AQDIYRASYY (NEOEPITOPE)"}, {"weight": 4.0, "description": "The nonamer peptide adopts a canonical extended conformation when bound to HLA-B*15:01, with N-terminal and C-terminal anchors deeply embedded within the binding groove.", "source_id": "chunk-830d8819004960d1d149ac70149c72a0", "order": 1, "source": "HLA-B*15:01", "target": "NONAMER PEPTIDE AQDIYRASY"}, {"weight": 4.0, "description": "The decamer peptide adopts a short 310 helical backbone conformation when bound to HLA-B*15:01, with Tyr10 replacing Tyr9 as the C-terminal anchor residue.", "source_id": "chunk-830d8819004960d1d149ac70149c72a0", "order": 1, "source": "HLA-B*15:01", "target": "DECAMER PEPTIDE AQDIYRASYY"}, {"weight": 4.0, "description": "The ALK R1275Q neoepitope forms a stable complex with HLA-B*15:01, indicating strong binding affinity and immunogenic potential.)", "source_id": "chunk-de413ae6100407d8dadd5bdee87c1074", "order": 1, "source": "HLA-B*15:01", "target": "ALK R1275Q NEOEPITOPE"}, {"weight": 3.0, "description": "The self-peptide ARDIYRASY shows poor binding to HLA-B*15:01 due to steric hindrance, reflecting immune tolerance mechanisms.)", "source_id": "chunk-de413ae6100407d8dadd5bdee87c1074", "order": 1, "source": "HLA-B*15:01", "target": "SELF-PEPTIDE ARDIYRASY"}, {"weight": 4.0, "description": "Used as a positive control in experiments to validate T cell recognition of known epitopes.", "source_id": "chunk-d3a9c93928447522ce3df4209f8ac803", "order": 1, "source": "HLA-B*15:01", "target": "SARS CORONAVIRUS-DERIVED EPITOPE VQQESSFVM "}, {"weight": 7.0, "description": "SEC was used to purify and confirm the formation of stable complexes between AQDIYRASYY neoepitopes and HLA-B*15:01.", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "order": 1, "source": "AQDIYRASYY (NEOEPITOPE)", "target": "SEC (SIZE EXCLUSION CHROMATOGRAPHY)"}, {"weight": 7.0, "description": "The GMAQDIYRA neoepitope has a predicted binding affinity for HLA-A*02:01, suggesting potential immune responses.", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "order": 1, "source": "GMAQDIYRA (NEOEPITOPE)", "target": "HLA-A*02:01"}, {"weight": 9.0, "description": "The ILDTAGKEEY neoepitope binds effectively to HLA-A*01:01, suggesting it may elicit specific T cell responses.", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "order": 1, "source": "ILDTAGKEEY (NEOEPITOPE)", "target": "HLA-A*01:01"}, {"weight": 6.0, "description": "Formed stable p/MHC complexes with the decamer peptide for structural and functional characterization.", "source_id": "chunk-d3a9c93928447522ce3df4209f8ac803", "order": 1, "source": "HLA-A*01:01", "target": "DECAMER PEPTIDE AQDIYRASYY "}, {"weight": 6.0, "description": "LC-MS confirmed the presence of AQDIYRASYY in HLA-B*15:01 complexes, validating its binding affinity.", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "order": 1, "source": "LC\u2013MS (LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY)", "target": "AQDIYRASY (NEOEPITOPE)"}, {"weight": 4.0, "description": "The decamer peptide forms a more compact 310 helical structure compared to the extended backbone of the nonamer peptide, suggesting distinct binding modes.", "source_id": "chunk-830d8819004960d1d149ac70149c72a0", "order": 1, "source": "NONAMER PEPTIDE AQDIYRASY", "target": "DECAMER PEPTIDE AQDIYRASYY"}, {"weight": 3.0, "description": "The nonamer peptide fits established HLA-B*15:01-binding motifs with preferred anchor residues at positions 2 and 9.", "source_id": "chunk-830d8819004960d1d149ac70149c72a0", "order": 1, "source": "NONAMER PEPTIDE AQDIYRASY", "target": "HLA-B*15:01 BINDING MOTIF"}, {"weight": 2.0, "description": "Both epitopes from Epstein\u2013Barr virus and the nonamer peptide display similar binding conformations within HLA-B*15:01.", "source_id": "chunk-830d8819004960d1d149ac70149c72a0", "order": 1, "source": "NONAMER PEPTIDE AQDIYRASY", "target": "EPSTEIN\u2013BARR VIRUS EPITOPE LEKARGSTY"}, {"weight": 2.0, "description": "Both epitopes from human ubiquitin-conjugating enzyme-E2 and the nonamer peptide display similar binding conformations within HLA-B*15:01.", "source_id": "chunk-830d8819004960d1d149ac70149c72a0", "order": 1, "source": "NONAMER PEPTIDE AQDIYRASY", "target": "HUMAN UBIQUITIN-CONJUGATING ENZYME-E2 EPITOPE ILGPPGSVY"}, {"weight": 2.0, "description": "Both epitopes from SARS coronavirus and the nonamer peptide display similar binding conformations within HLA-B*15:01.", "source_id": "chunk-830d8819004960d1d149ac70149c72a0", "order": 1, "source": "NONAMER PEPTIDE AQDIYRASY", "target": "SARS CORONAVIRUS EPITOPE VQQESSFVM"}, {"weight": 2.0, "description": "Both epitopes exhibit similar extended conformation when bound to HLA-B*15:01, indicating a conserved binding mode.", "source_id": "chunk-830d8819004960d1d149ac70149c72a0", "order": 1, "source": "NONAMER PEPTIDE AQDIYRASY", "target": "EPSTEIN\u2013BARR VIRUS EPITOPE LEKARGSTY BINDING MODE"}, {"weight": 2.0, "description": "Both epitopes exhibit similar extended conformation when bound to HLA-B*15:01, indicating a conserved binding mode.", "source_id": "chunk-830d8819004960d1d149ac70149c72a0", "order": 1, "source": "NONAMER PEPTIDE AQDIYRASY", "target": "HUMAN UBIQUITIN-CONJUGATING ENZYME-E2 EPITOPE ILGPPGSVY BINDING MODE"}, {"weight": 2.0, "description": "Both epitopes exhibit similar extended conformation when bound to HLA-B*15:01, indicating a conserved binding mode.", "source_id": "chunk-830d8819004960d1d149ac70149c72a0", "order": 1, "source": "NONAMER PEPTIDE AQDIYRASY", "target": "SARS CORONAVIRUS EPITOPE VQQESSFVM BINDING MODE"}, {"weight": 3.0, "description": "The decamer peptide fits established HLA-B*15:01-binding motifs but forms a more compact helix, burying residues further into the groove.", "source_id": "chunk-830d8819004960d1d149ac70149c72a0", "order": 1, "source": "DECAMER PEPTIDE AQDIYRASYY", "target": "HLA-B*15:01 BINDING MOTIF"}, {"weight": 4.0, "description": "The decamer peptide forms a more compact helical structure compared to the extended backbone of the nonamer peptide, indicating distinct binding modes within HLA-B*15:01.", "source_id": "chunk-830d8819004960d1d149ac70149c72a0", "order": 1, "source": "DECAMER PEPTIDE AQDIYRASYY", "target": "NONAMER PEPTIDE AQDIYRASY BINDING MODE"}, {"weight": 3.0, "description": "Neoepitopes can be recognized by TCRs when bound to HLA molecules in a manner that depends on their conformation and surface features.", "source_id": "chunk-830d8819004960d1d149ac70149c72a0", "order": 1, "source": "NEOEPITOPES", "target": "T-CELL RECEPTORS (TCRS)"}, {"weight": 2.0, "description": "TCRs recognize nonamer peptides bound to HLA-B*15:01 in an extended conformation, leading to immune responses.", "source_id": "chunk-830d8819004960d1d149ac70149c72a0", "order": 1, "source": "T-CELL RECOGNITION", "target": "NONAMER PEPTIDE AQDIYRASY BINDING MODE"}, {"weight": 2.0, "description": "TCRs may recognize decamer peptides bound to HLA-B*15:01 differently due to the distinct surface features of their binding modes.", "source_id": "chunk-830d8819004960d1d149ac70149c72a0", "order": 1, "source": "T-CELL RECOGNITION", "target": "DECAMER PEPTIDE AQDIYRASYY BINDING MODE"}, {"weight": 4.0, "description": "The ALK R1275Q neoepitope binds to HLA-B*15:01 through a compacted tertiary structure, enhancing stability and interaction strength.)", "source_id": "chunk-de413ae6100407d8dadd5bdee87c1074", "order": 1, "source": "ALK R1275Q NEOEPITOPE", "target": "TERTIARY STRUCTURE COMPACTION"}, {"weight": 2.0, "description": "The self-peptide ARDIYRASY does not undergo similar compaction or stabilization mechanisms as the neoepitope when interacting with HLA-B*15:01.)", "source_id": "chunk-de413ae6100407d8dadd5bdee87c1074", "order": 1, "source": "SELF-PEPTIDE ARDIYRASY", "target": "TERTIARY STRUCTURE COMPACTION"}, {"weight": 3.0, "description": "The docking approach predicts how peptides will interact with HLA molecules, which is essential for understanding TCR recognition of neoepitopes.", "source_id": "chunk-614333487e4b92705503909d34155179", "order": 1, "source": "TCRS", "target": "PEPTIDE DOCKING APPROACH"}, {"weight": 4.0, "description": "The structure of HLA-B*15:01 serves as a template for modeling peptide conformations in other HLA alleles.", "source_id": "chunk-614333487e4b92705503909d34155179", "order": 1, "source": "HLA-B*15:01 STRUCTURE", "target": "NONAMER/HLA-B*15:01 STRUCTURES"}, {"weight": 5.0, "description": "The pocket residues of HLA-A*01:01 play a critical role in stabilizing the extended and helical conformations of ALK-derived peptides.", "source_id": "chunk-614333487e4b92705503909d34155179", "order": 1, "source": "EXTENDED AND 310 HELICAL CONFORMATIONS", "target": "HLA-A*01:01 BINDING POCKET RESIDUES"}, {"weight": 4.0, "description": "Specific polar contacts within the binding pockets of HLA-B*15 alleles are crucial for peptide binding, influencing immune response specificity.", "source_id": "chunk-614333487e4b92705503909d34155179", "order": 1, "source": "HLA-B*15 ALLELES", "target": "POLAR CONTACTS"}, {"weight": 3.0, "description": "Several HLA-A alleles exhibit lower binding energies than the initial HLA-B*15:01 template for the nonamer peptide.", "source_id": "chunk-614333487e4b92705503909d34155179", "order": 1, "source": "HLA-A ALLELES", "target": "NONAMER PEPTIDE "}, {"weight": 4.0, "description": "Some specific HLA-B alleles show low binding energies for the decamer peptide, indicating a broad potential repertoire of HLAs displaying this epitope.", "source_id": "chunk-614333487e4b92705503909d34155179", "order": 1, "source": "HLA-B ALLELES", "target": "DECAMER PEPTIDE "}, {"weight": 4.0, "description": "HLA-C alleles also exhibit lower binding energies than initial templates for both nonamer and decamer peptides, contributing to the broader HLA display of ALK-derived neoepitopes.", "source_id": "chunk-614333487e4b92705503909d34155179", "order": 1, "source": "HLA-C ALLELES", "target": "NONAMER/DECAMER PEPTIDES "}, {"weight": 3.0, "description": "A mock polyAlanine model demonstrates high binding energy compared to actual good binders, indicating its utility as a negative control in peptide-HLA binding studies.", "source_id": "chunk-614333487e4b92705503909d34155179", "order": 1, "source": "MOCK POLYALA HLA ", "target": "NONAMER/DECAMER PEPTIDES "}, {"weight": 3.0, "description": "The sequence logo reveals key residues that allow peptides to be accommodated in the MHC groove, including those specific for high-affinity binders like HLA-B*15:84 and B*15:107.", "source_id": "chunk-614333487e4b92705503909d34155179", "order": 1, "source": "KULLBACK\u2013LEIBLER SEQUENCE LOGO ", "target": "HLA-B*15:84 AND HLA-B*15:107 "}, {"weight": 8.0, "description": "The formation of p/MHC complexes is essential for the presentation and recognition by CD8+ T cells.", "source_id": "chunk-d3a9c93928447522ce3df4209f8ac803", "order": 1, "source": "MHC COMPLEX FORMATION ", "target": "CD8+ T CELL RECOGNITION "}, {"weight": 3.0, "description": "Binds to HLA proteins as part of the MHC class I complex for peptide presentation.", "source_id": "chunk-d3a9c93928447522ce3df4209f8ac803", "order": 1, "source": "\u03922-MICROGLOBULIN (\u03922M)", "target": "HLA-A*01:01, HLA-B*15:01 "}, {"weight": 4.0, "description": "Used to identify CD8+ T cells reactive to specific p/MHC complexes.", "source_id": "chunk-d3a9c93928447522ce3df4209f8ac803", "order": 1, "source": "TETRAMER STAINING ASSAY ", "target": "CD8+ T CELL RECOGNITION "}, {"weight": 3.0, "description": "The binding groove accommodates the extended conformation of nonamer peptides, with specific anchor residues deeply embedded in pockets.", "source_id": "chunk-830d8819004960d1d149ac70149c72a0", "order": 1, "source": "NONAMER PEPTIDE AQDIYRASY BINDING MODE", "target": "HLA-B*15:01 BINDING GROOVE"}, {"weight": 3.0, "description": "The binding groove adapts to accommodate the compact 310 helical conformation of decamer peptides, with a more buried and amphipathic structure.", "source_id": "chunk-830d8819004960d1d149ac70149c72a0", "order": 1, "source": "HLA-B*15:01 BINDING GROOVE", "target": "DECAMER PEPTIDE AQDIYRASYY BINDING MODE"}, {"weight": 7.0, "description": "The rs35923643-G SNP has been identified as a risk allele for CLL based on meta-analysis results.", "source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a", "order": 1, "source": "RS35923643-G", "target": "CLL"}, {"weight": 9.0, "description": "Variants in the GRAMD1B gene are associated with IgM anti-PC levels through linkage disequilibrium.", "source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a", "order": 1, "source": "GRAMD1B GENE", "target": "IGM ANTI-PC LEVELS"}, {"weight": 8.0, "description": "The rs735665-A SNP is a key genetic variant specific for general IgM, as identified in GWAS analyses.", "source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a", "order": 1, "source": "RS735665-A", "target": "GENERAL IGM LEVELS"}, {"weight": 9.0, "description": "A PRS based on alleles increasing IgM anti-PC levels was found to be associated with higher risk of CLL.", "source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a", "order": 1, "source": "IGM ANTI-PC LEVELS", "target": "POLYGENIC RISK SCORE (PRS)"}, {"weight": 8.0, "description": "The discovery phase identified significant SNPs influencing IgM anti-PC levels, providing insights into genetic susceptibility to these levels.", "source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a", "order": 1, "source": "IGM ANTI-PC LEVELS", "target": "IGM ANTI-PC DISCOVERY GWAS"}, {"weight": 9.0, "description": "The significant SNPs in the 11q24.1 region are strongly associated with IgM anti-PC levels, highlighting their importance in the physiological process.", "source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a", "order": 1, "source": "IGM ANTI-PC LEVELS", "target": "11Q24.1 SNPS"}, {"weight": 7.0, "description": "SNPs in the 1p31.3 region were not replicated, indicating a lack of consistent association across different cohorts.", "source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a", "order": 1, "source": "1P31.3 SNPS", "target": "VALIDATION COHORT"}, {"weight": 9.0, "description": "The meta-analysis of CLL GWASs identified the risk allele rs735665-A, contributing to understanding genetic predisposition to CLL.", "source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a", "order": 1, "source": "CLL GWAS META-ANALYSIS", "target": "RS735665-A RISK ALLELE"}, {"weight": 8.0, "description": "The GWAS results indicate that rs735665-A is specific for general IgM levels, distinguishing it from other immunoglobulin types.", "source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a", "order": 1, "source": "GENERAL IGM LEVELS GWAS", "target": "RS735665-A SPECIFICITY FOR GENERAL IGM"}, {"weight": 9.0, "description": "PRS analysis based on IgM anti-PC increasing alleles predicts higher risk of CLL, linking physiological processes to disease susceptibility.", "source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a", "order": 1, "source": "PRS ANALYSIS OF IGM ANTI-PC", "target": "CLL RISK PREDICTION"}, {"weight": 9.0, "description": "The Nagelkerke r^2 statistic measures how well PRSs explain variance in CLL risk, indicating the cumulative impact of genetic variants.", "source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a", "order": 1, "source": "NAGELKERKE R^2 ", "target": "VARIANCE EXPLAINED BY PRSS"}, {"weight": 9.0, "description": "These marks predict potential regulatory functions of genetic variants within the 11q24.1 locus, aiding in understanding their roles in physiological processes.", "source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a", "order": 1, "source": "HISTONE MARK H3K4ME1 AND DNASEI HYPERSENSITIVITY", "target": "REGULATORY FUNCTION PREDICTION"}, {"weight": 1.0, "description": "The genomic variant rs35923643 is located at a peak of monomethylated histone H3 lysine 4, suggesting potential regulatory function.", "source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b", "order": 1, "source": "RS35923643", "target": "H3K4ME1"}, {"weight": 1.0, "description": "Peaks of DNaseI hypersensitivity were found at the genomic position of rs35923643 in GM12878 and other cell lines, indicating regulatory activity.", "source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b", "order": 1, "source": "RS35923643", "target": "DNASEI HYPERSENSITIVITY"}, {"weight": 1.0, "description": "The association between IgM anti-PC levels and CLL cases may be influenced by the genomic variant rs35923643, as it is located in a regulatory region.", "source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b", "order": 1, "source": "RS35923643", "target": "IGM ANTI-PC AND CLL ASSOCIATION"}, {"weight": 2.0, "description": "The RegulomeDB database supports evidence that SNP rs35923643 affects binding of transcription factors, implicating it in regulatory function.", "source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b", "order": 1, "source": "RS35923643", "target": "REGULOMEDB DATABASE"}, {"weight": 1.0, "description": "Binding sites for 10 different transcription factors within the ~700bp region around rs35923643, including RUNX3 binding motifs that include SNP rs35923643.", "source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b", "order": 1, "source": "TRANSCRIPTION FACTORS (TFS)", "target": "RUNX3 BINDING MOTIF"}, {"weight": 1.0, "description": "The ChIP-seq technique was used to identify binding sites for 22 different transcription factors within the genomic region around rs35923643.", "source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b", "order": 1, "source": "TRANSCRIPTION FACTORS (TFS)", "target": "CHROMATIN IMMUNOPRECIPITATION-SEQUENCING (CHIP-SEQ)"}, {"weight": 1.0, "description": "ENCODE data provided evidence for TF binding in the ~700bp region around rs35923643, involving various transcription factors including RUNX3 and SPI1.", "source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b", "order": 1, "source": "TRANSCRIPTION FACTORS (TFS)", "target": "ENCYCLOPEDIA OF DNA ELEMENTS (ENCODE)"}, {"weight": 1.0, "description": "The FIMO tool was used to identify the strongest binding motifs for transcription factors like RUNX3 and SPI1 within the region around rs35923643.", "source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b", "order": 1, "source": "TRANSCRIPTION FACTORS (TFS)", "target": "FIND INDIVIDUAL MOTIF OCCURRENCES (FIMO)"}, {"weight": 1.0, "description": "Both RUNX3 and SPI1 transcription factors show strong binding signals in the region around rs35923643, suggesting potential regulatory roles.", "source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b", "order": 1, "source": "RUNX3 BINDING MOTIF", "target": "SPI1 (PU.1)"}]}